Citrus Sinensis ID: 013074
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 450 | 2.2.26 [Sep-21-2011] | |||||||
| Q3ECH2 | 892 | Probable receptor-like pr | no | no | 0.644 | 0.325 | 0.495 | 1e-85 | |
| Q9FID6 | 813 | Probable receptor-like pr | no | no | 0.657 | 0.364 | 0.476 | 3e-85 | |
| Q9FID5 | 806 | Probable receptor-like pr | no | no | 0.651 | 0.363 | 0.503 | 3e-85 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.682 | 0.370 | 0.373 | 4e-55 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.595 | 0.307 | 0.367 | 3e-54 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.62 | 0.339 | 0.386 | 4e-54 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.597 | 0.260 | 0.389 | 7e-51 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.597 | 0.260 | 0.389 | 1e-50 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.613 | 0.333 | 0.368 | 3e-48 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.593 | 0.335 | 0.369 | 2e-47 |
| >sp|Q3ECH2|Y1670_ARATH Probable receptor-like protein kinase At1g67000 OS=Arabidopsis thaliana GN=At1g67000 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 317 bits (813), Expect = 1e-85, Method: Compositional matrix adjust.
Identities = 164/331 (49%), Positives = 224/331 (67%), Gaps = 41/331 (12%)
Query: 144 LPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------------- 181
+PLK Y +++VKK+T SF + +G+GGFG VY G L D
Sbjct: 541 IPLKHYTYAEVKKMTKSFTEVVGRGGFGIVYSGTLSDSSMVAVKVLKDSKGTDGEDFINE 600
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
+AS+S+TSHVN+V+LLGFC EG+ RA+IYEF+ NGSL+KF+ + K L + +Y
Sbjct: 601 VASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFI----SDKSSVNLDLKTLYG 656
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
I +G+A+GLEYLH GC TRI+HFDIKP N+LLD + CPK+SDFGLAKLC K+ I+ SLL
Sbjct: 657 IALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESIL-SLL 715
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN----NLDSGVDNSSEVYF 357
RGTIGYIA E+ SR +G VSHKSDVYS+GM+++E++G + + +S D SS +YF
Sbjct: 716 DTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSS-IYF 774
Query: 358 PHWIYRHVE----QDREFKLLG-----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNE 408
P WIY+ +E +D E G ++ +E EIA+KM +VGLWCIQ+ P DRPPMN+
Sbjct: 775 PEWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMNK 834
Query: 409 VIEMLQGSTEALQIPPTPFLSSPPRASIDSS 439
V+EM++GS +AL++PP P L +S+ S
Sbjct: 835 VVEMMEGSLDALEVPPRPVLQQISASSVSDS 865
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (809), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 154/323 (47%), Positives = 222/323 (68%), Gaps = 27/323 (8%)
Query: 144 LPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------------L 182
L LK+Y ++++KKIT SF +G+GGFG VY+G L +G +
Sbjct: 481 LLLKQYIYAELKKITKSFSHTVGKGGFGTVYRGNLSNGRTVAVKVLKDLKGNGDDFINEV 540
Query: 183 ASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEI 242
S+S+TSHVN+V+LLGFC EG+ RA+I EF+ +GSL++F+ + P +Y I
Sbjct: 541 TSMSQTSHVNIVSLLGFCYEGSKRAIISEFLEHGSLDQFISRNKSLTP----NVTTLYGI 596
Query: 243 VIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLG 302
+GIA+GLEYLH GC TRI+HFDIKP NILLD +FCPK++DFGLAKLC ++ I+ SL+
Sbjct: 597 ALGIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESIL-SLID 655
Query: 303 ARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY 362
RGTIGYIA EV SR +G +SHKSDVYS+GM++++++G +N +++ N S YFP WIY
Sbjct: 656 TRGTIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPDWIY 715
Query: 363 RHVEQDREFKLLG-VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421
+ +E + ++G + +++N+I KKMI+V LWCI+ P DRPPMN+V+EM++GS +AL+
Sbjct: 716 KDLENGDQTWIIGDEINEEDNKIVKKMILVSLWCIRPCPSDRPPMNKVVEMIEGSLDALE 775
Query: 422 IPPTPFLSSPPRASIDSSTLRYG 444
+PP P ++SS+L G
Sbjct: 776 LPPKPSRHISTELVLESSSLSDG 798
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FID5|Y5393_ARATH Probable receptor-like protein kinase At5g39030 OS=Arabidopsis thaliana GN=At5g39030 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (808), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 163/324 (50%), Positives = 221/324 (68%), Gaps = 31/324 (9%)
Query: 146 LKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------------LAS 184
L Y ++++KKIT SF +G+GGFG VY G L +G +AS
Sbjct: 485 LNMYTYAELKKITKSFSYIIGKGGFGTVYGGNLSNGRKVAVKVLKDLKGSAEDFINEVAS 544
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIV 243
+S+TSHVN+V+LLGFC EG+ RA++YEF+ NGSL++F+ N ++ L Y I
Sbjct: 545 MSQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLTQDVTTL-----YGIA 599
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA 303
+GIA+GLEYLH GC TRI+HFDIKP NILLD + CPK+SDFGLAKLC ++ ++ SL+
Sbjct: 600 LGIARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVL-SLMDT 658
Query: 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNN-LDSGVDN-SSEVYFPHWI 361
RGTIGYIA EVFSR +G VSHKSDVYSFGM++++++G ++ + VD+ +S YFP WI
Sbjct: 659 RGTIGYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPDWI 718
Query: 362 YRHVEQDREFKLLG-VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420
Y+ +E + + G +TK+E EIAKKMI+VGLWCIQ P DRP MN V+EM++GS +AL
Sbjct: 719 YKDLEDGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLDAL 778
Query: 421 QIPPTPFLSSPPRASIDSSTLRYG 444
+IPP P + +SS+L G
Sbjct: 779 EIPPKPSMHISTEVITESSSLSDG 802
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 216 bits (549), Expect = 4e-55, Method: Compositional matrix adjust.
Identities = 127/340 (37%), Positives = 189/340 (55%), Gaps = 33/340 (9%)
Query: 136 FSLQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKG----------KLLDGL--- 182
++L Y ++ + ++++ T SFK+KLG GGFG VY+G K L+G+
Sbjct: 461 YTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRTVVAVKQLEGIEQG 520
Query: 183 --------ASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL 234
A+IS T H+N+V L+GFC +G +R L+YEFM NGSL+ F++ D++K +L
Sbjct: 521 EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAK---FL 577
Query: 235 RWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294
WE + I +G AKG+ YLH C I+H DIKP NIL+D +F K+SDFGLAKL K
Sbjct: 578 TWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKD 637
Query: 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE 354
++ RGT GY+A E + ++ KSDVYS+GM+++ELV K N D + ++
Sbjct: 638 NRY-NMSSVRGTRGYLAPEWLANL--PITSKSDVYSYGMVLLELVSGKRNFDVS-EKTNH 693
Query: 355 VYFPHWIYRHVEQDREFKLLGVVTKKEN----EIAKKMIIVGLWCIQARPYDRPPMNEVI 410
F W Y E+ +L ++ E +M+ WCIQ +P RP M +V+
Sbjct: 694 KKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVV 753
Query: 411 EMLQGSTEALQIPPTPFLSSPPRASIDSSTLRYGIMIDAS 450
+ML+G TE ++ P P S S +S + + M AS
Sbjct: 754 QMLEGITE-IKNPLCPKTISEVSFSGNSMSTSHASMFVAS 792
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 3e-54, Method: Compositional matrix adjust.
Identities = 112/305 (36%), Positives = 173/305 (56%), Gaps = 37/305 (12%)
Query: 149 YNFSDVKKITNSFKDKLGQGGFGGVYKG----------------------KLLDGLASIS 186
+ + D++ TN+F LG GGFG VYKG + + + +I
Sbjct: 520 FTYRDLQNCTNNFSQLLGSGGFGTVYKGTVAGETLVAVKRLDRALSHGEREFITEVNTIG 579
Query: 187 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 246
H+N+V L G+C E ++R L+YE+M NGSL+K++++ + + L W +EI +
Sbjct: 580 SMHHMNLVRLCGYCSEDSHRLLVYEYMINGSLDKWIFSSE--QTANLLDWRTRFEIAVAT 637
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT 306
A+G+ Y H C RI+H DIKP NILLD +FCPK+SDFGLAK+ + V +++ RGT
Sbjct: 638 AQGIAYFHEQCRNRIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMI--RGT 695
Query: 307 IGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE 366
GY+A E S ++ K+DVYS+GM+++E+VG + NLD D + + ++P W Y+ +
Sbjct: 696 RGYLAPEWVSNR--PITVKADVYSYGMLLLEIVGGRRNLDMSYD-AEDFFYPGWAYKELT 752
Query: 367 QDREFK-----LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421
K L GV E E K + V WCIQ RP M EV+++L+G+++ +
Sbjct: 753 NGTSLKAVDKRLQGVA---EEEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEIN 809
Query: 422 IPPTP 426
+PP P
Sbjct: 810 LPPMP 814
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (541), Expect = 4e-54, Method: Compositional matrix adjust.
Identities = 125/323 (38%), Positives = 187/323 (57%), Gaps = 44/323 (13%)
Query: 138 LQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------- 181
L+N +P+ R+ + D++ TN+F KLGQGGFG VY+G L DG
Sbjct: 473 LENLSGMPI-RFAYKDLQSATNNFSVKLGQGGFGSVYEGTLPDGSRLAVKKLEGIGQGKK 531
Query: 182 -----LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY---NGDTSKPCQY 233
++ I H+++V L GFC EG +R L YEF+ GSLE++++ +GD
Sbjct: 532 EFRAEVSIIGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDV-----L 586
Query: 234 LRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293
L W+ + I +G AKGL YLH C RI+H DIKP NILLD +F K+SDFGLAKL T +
Sbjct: 587 LDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTRE 646
Query: 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSS 353
+ V + + RGT GY+A E + N+ +S KSDVYS+GM+++EL+G + N D + S
Sbjct: 647 QSHVFTTM--RGTRGYLAPEWIT-NYA-ISEKSDVYSYGMVLLELIGGRKNYDPS-ETSE 701
Query: 354 EVYFPHWIYRHVEQDREFKLLGVVTKK------ENEIAKKMIIVGLWCIQARPYDRPPMN 407
+ +FP + ++ +E E KL+ +V K +E ++ + LWCIQ RP M+
Sbjct: 702 KCHFPSFAFKKME---EGKLMDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMS 758
Query: 408 EVIEMLQGSTEALQIPPTPFLSS 430
+V++ML+G +Q P + + S
Sbjct: 759 KVVQMLEGVFPVVQPPSSSTMGS 781
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 201 bits (512), Expect = 7e-51, Method: Compositional matrix adjust.
Identities = 118/303 (38%), Positives = 168/303 (55%), Gaps = 34/303 (11%)
Query: 149 YNFSDVKKITNSF--KDKLGQGGFGGVYKGKLLDG----------------------LAS 184
+ +S++K T F +KLG+GGFG VYKGKL DG + +
Sbjct: 681 FTYSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVA 740
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 244
IS H N+V L G C EG +R L+YE++PNGSL++ ++ T +L W YEI +
Sbjct: 741 ISAVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKT----LHLDWSTRYEICL 796
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR 304
G+A+GL YLH RI+H D+K NILLD PK+SDFGLAKL KK +S+ +
Sbjct: 797 GVARGLVYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVA-- 854
Query: 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364
GTIGY+A E R G ++ K+DVY+FG++ +ELV + N D +++ Y W +
Sbjct: 855 GTIGYLAPEYAMR--GHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKR-YLLEWAWNL 911
Query: 365 VEQDREFKLLG-VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIP 423
E+ RE +L+ +T+ E K+MI + L C Q RPPM+ V+ ML G E +
Sbjct: 912 HEKGREVELIDHQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVT 971
Query: 424 PTP 426
P
Sbjct: 972 SKP 974
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 201 bits (510), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 118/303 (38%), Positives = 168/303 (55%), Gaps = 34/303 (11%)
Query: 149 YNFSDVKKITNSF--KDKLGQGGFGGVYKGKLLDG----------------------LAS 184
+ +S++K T F +KLG+GGFG VYKG L DG + +
Sbjct: 682 FTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEIVA 741
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 244
IS H N+V L G C EG +R L+YE++PNGSL++ ++ T +L W YEI +
Sbjct: 742 ISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKT----LHLDWSTRYEICL 797
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR 304
G+A+GL YLH S RI+H D+K NILLD P+ISDFGLAKL KK +S+ +
Sbjct: 798 GVARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVA-- 855
Query: 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364
GTIGY+A E R G ++ K+DVY+FG++ +ELV + N D ++ + Y W +
Sbjct: 856 GTIGYLAPEYAMR--GHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKK-YLLEWAWNL 912
Query: 365 VEQDREFKLL-GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIP 423
E+ R+ +L+ +T E AK+MI + L C Q RPPM+ V+ ML G E +
Sbjct: 913 HEKSRDIELIDDKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVT 972
Query: 424 PTP 426
P
Sbjct: 973 SKP 975
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 193 bits (490), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 115/312 (36%), Positives = 170/312 (54%), Gaps = 36/312 (11%)
Query: 142 GPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKL----------LDGLA-------- 183
G L +++ +++ T +F DKLG GGFG V+KG L L+G++
Sbjct: 476 GDGTLSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSDIAVKRLEGISQGEKQFRT 535
Query: 184 ---SISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 240
+I HVN+V L GFC EG+ + L+Y++MPNGSL+ ++ + L W+ +
Sbjct: 536 EVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKI-VLGWKLRF 594
Query: 241 EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSL 300
+I +G A+GL YLH C I+H DIKP NILLD FCPK++DFGLAKL + L
Sbjct: 595 QIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKL--VGRDFSRVL 652
Query: 301 LGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHW 360
RGT GY+A E S ++ K+DVYS+GMM+ ELV + N + +N +FP W
Sbjct: 653 TTMRGTRGYLAPEWISGV--AITAKADVYSYGMMLFELVSGRRNTEQS-ENEKVRFFPSW 709
Query: 361 IYRHVEQDREFKLLGVVTKKEN-----EIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415
+ +D + + L V + E E + V WCIQ RP M++V+++L+G
Sbjct: 710 AATILTKDGDIRSL-VDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILEG 768
Query: 416 STEALQIPPTPF 427
L++ P PF
Sbjct: 769 ---VLEVNPPPF 777
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 190 bits (482), Expect = 2e-47, Method: Compositional matrix adjust.
Identities = 113/306 (36%), Positives = 157/306 (51%), Gaps = 39/306 (12%)
Query: 141 YGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG------------------- 181
+ L LK ++F +++ TN F DK+G GGFG V+KG L
Sbjct: 443 FAVLNLKVFSFKELQSATNGFSDKVGHGGFGAVFKGTLPGSSTFVAVKRLERPGSGESEF 502
Query: 182 ---LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK 238
+ +I HVN+V L GFC E +R L+Y++MP GSL ++ + + L WE
Sbjct: 503 RAEVCTIGNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYL----SRTSPKLLSWET 558
Query: 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298
+ I +G AKG+ YLH GC I+H DIKP NILLD D+ K+SDFGLAKL +
Sbjct: 559 RFRIALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLL--GRDFSR 616
Query: 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE---- 354
L RGT GY+A E S ++ K+DVYSFGM ++EL+G + N+ D E
Sbjct: 617 VLATMRGTWGYVAPEWISGL--PITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETE 674
Query: 355 ---VYFPHWIYRHVEQDREFKLLGVVTKKE--NEIAKKMIIVGLWCIQARPYDRPPMNEV 409
+FP W R + Q ++ E E +M V +WCIQ RP M V
Sbjct: 675 PEKWFFPPWAAREIIQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTV 734
Query: 410 IEMLQG 415
++ML+G
Sbjct: 735 VKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 450 | ||||||
| 147769927 | 1001 | hypothetical protein VITISV_010117 [Viti | 0.671 | 0.301 | 0.611 | 1e-114 | |
| 147795963 | 624 | hypothetical protein VITISV_039936 [Viti | 0.668 | 0.482 | 0.613 | 1e-113 | |
| 359472674 | 637 | PREDICTED: probable receptor-like protei | 0.668 | 0.472 | 0.613 | 1e-113 | |
| 224133128 | 333 | predicted protein [Populus trichocarpa] | 0.671 | 0.906 | 0.626 | 1e-111 | |
| 224108429 | 365 | predicted protein [Populus trichocarpa] | 0.671 | 0.827 | 0.598 | 1e-110 | |
| 145839451 | 627 | receptor-like protein kinase [Capsicum a | 0.693 | 0.497 | 0.566 | 1e-110 | |
| 224133116 | 415 | predicted protein [Populus trichocarpa] | 0.813 | 0.881 | 0.542 | 1e-110 | |
| 359472676 | 459 | PREDICTED: probable receptor-like protei | 0.704 | 0.690 | 0.595 | 1e-110 | |
| 297737783 | 621 | unnamed protein product [Vitis vinifera] | 0.704 | 0.510 | 0.595 | 1e-109 | |
| 356522799 | 542 | PREDICTED: probable receptor-like protei | 0.668 | 0.555 | 0.589 | 1e-107 |
| >gi|147769927|emb|CAN76446.1| hypothetical protein VITISV_010117 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 417 bits (1073), Expect = e-114, Method: Compositional matrix adjust.
Identities = 198/324 (61%), Positives = 250/324 (77%), Gaps = 22/324 (6%)
Query: 138 LQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------- 181
L+N+ L KRY +S+V+K+T+SFKD++G+GG+G VYKGKLL+G
Sbjct: 675 LRNHESLAPKRYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLSETKGNGE 734
Query: 182 -----LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRW 236
+ASISRTSHVN+V+LLGFC +G+ RALIYEFMPNGSLEKF+Y+ ++S L W
Sbjct: 735 EFINEIASISRTSHVNIVSLLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSMTYHKLGW 794
Query: 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296
E +Y I IGIA+GLEYLHRGC+TRILH DIKPHNILL+QDFCPKISDFGL+KLCT K+ I
Sbjct: 795 ETLYNIAIGIARGLEYLHRGCNTRILHLDIKPHNILLNQDFCPKISDFGLSKLCTRKESI 854
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356
+S + GARGT GYIA EVF RNFG+VS KSDVYS+GMM++E+VG + N D G++++SE+Y
Sbjct: 855 IS-MSGARGTAGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMVGGRKNTDDGINHTSEIY 913
Query: 357 FPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416
FPHWIY+ +E D E L G + ++E A+KMIIV LWCIQ P +RPPMN V++ML+GS
Sbjct: 914 FPHWIYKRLELDEELGLQGFMNEEERTSARKMIIVSLWCIQTNPSNRPPMNGVVDMLEGS 973
Query: 417 TEALQIPPTPFLSSPPRASIDSST 440
E+LQIPP PFL SPPR+ D ST
Sbjct: 974 LESLQIPPKPFLYSPPRSMRDLST 997
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147795963|emb|CAN69599.1| hypothetical protein VITISV_039936 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1065), Expect = e-113, Method: Compositional matrix adjust.
Identities = 198/323 (61%), Positives = 250/323 (77%), Gaps = 22/323 (6%)
Query: 138 LQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------- 181
L+N+ L KRY +S+V+K+T+SFKD++G+GG+G VYKGKLL+G
Sbjct: 298 LRNHESLAPKRYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLSETKGNGE 357
Query: 182 -----LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRW 236
+ASISRTSHVN+V+LLGFC +G+ RALIYEFMPNGSLEKF+Y+ ++S L W
Sbjct: 358 EFINEIASISRTSHVNIVSLLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSMTYDKLGW 417
Query: 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296
E +Y I IGIA+GLEYLHRGC+TRILH DIKPHNILL+QDFCPKISDFGL+KLCT K+ I
Sbjct: 418 ETLYNIAIGIARGLEYLHRGCNTRILHLDIKPHNILLNQDFCPKISDFGLSKLCTRKESI 477
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356
VS + GARGT GYIA EVF RNFG+VS KSDVYS+GMM++E+VG + N+D G++++SE+Y
Sbjct: 478 VS-MSGARGTAGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMVGGRKNIDDGINHTSEIY 536
Query: 357 FPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416
FPHWIY+ +E D E L G + ++E A+KMIIV LWCIQ P +RPPMN V++ML+GS
Sbjct: 537 FPHWIYKRLELDEELGLQGFMNEEERTSARKMIIVSLWCIQTNPSNRPPMNGVVDMLEGS 596
Query: 417 TEALQIPPTPFLSSPPRASIDSS 439
E+LQIPP PFL SPPR+ D S
Sbjct: 597 LESLQIPPKPFLYSPPRSMRDLS 619
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472674|ref|XP_002279652.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 414 bits (1064), Expect = e-113, Method: Compositional matrix adjust.
Identities = 198/323 (61%), Positives = 250/323 (77%), Gaps = 22/323 (6%)
Query: 138 LQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------- 181
L+N+ L KRY +S+V+K+T+SFKD++G+GG+G VYKGKLL+G
Sbjct: 311 LRNHESLAPKRYRYSEVQKMTSSFKDRVGEGGYGAVYKGKLLNGDLVAVKVLSETKGNGE 370
Query: 182 -----LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRW 236
+ASISRTSHVN+V+LLGFC +G+ RALIYEFMPNGSLEKF+Y+ ++S L W
Sbjct: 371 EFINEIASISRTSHVNIVSLLGFCFQGSKRALIYEFMPNGSLEKFIYDKNSSMTYDKLGW 430
Query: 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296
E +Y I IGIA+GLEYLHRGC+TRILH DIKPHNILL+QDFCPKISDFGL+KLCT K+ I
Sbjct: 431 ETLYNIAIGIARGLEYLHRGCNTRILHLDIKPHNILLNQDFCPKISDFGLSKLCTRKESI 490
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356
VS + GARGT GYIA EVF RNFG+VS KSDVYS+GMM++E+VG + N+D G++++SE+Y
Sbjct: 491 VS-MSGARGTAGYIAPEVFCRNFGDVSPKSDVYSYGMMVLEMVGGRKNIDDGINHTSEIY 549
Query: 357 FPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416
FPHWIY+ +E D E L G + ++E A+KMIIV LWCIQ P +RPPMN V++ML+GS
Sbjct: 550 FPHWIYKRLELDEELGLQGFMNEEERTSARKMIIVSLWCIQTNPSNRPPMNGVVDMLEGS 609
Query: 417 TEALQIPPTPFLSSPPRASIDSS 439
E+LQIPP PFL SPPR+ D S
Sbjct: 610 LESLQIPPKPFLYSPPRSMRDLS 632
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133128|ref|XP_002321489.1| predicted protein [Populus trichocarpa] gi|222868485|gb|EEF05616.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 408 bits (1049), Expect = e-111, Method: Compositional matrix adjust.
Identities = 203/324 (62%), Positives = 246/324 (75%), Gaps = 22/324 (6%)
Query: 138 LQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------- 181
++N+GPL LKRYN SDVKK+TN FKDKLGQGG+G VYKGKL DG
Sbjct: 7 IRNHGPLALKRYNLSDVKKMTNFFKDKLGQGGYGIVYKGKLQDGHLVAVKVTQASKGDGE 66
Query: 182 -----LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRW 236
+ASISRTSHVN+VTLLGFCLEG+ R LIY+FM NGSLEKF+ + + S+ Q L W
Sbjct: 67 EFINEVASISRTSHVNIVTLLGFCLEGDKRVLIYDFMVNGSLEKFINHKNASQANQQLGW 126
Query: 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296
K+Y+I++G+A+GLEYLHRGC+TRI+HFDIKPHNILLD DF PKISDFGLAK CT K+
Sbjct: 127 NKLYQILVGVARGLEYLHRGCNTRIVHFDIKPHNILLDADFSPKISDFGLAKPCTRKESN 186
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356
V SLL ARGTIGYIA EVFSRNFG+VSHKSDVYS+GMM +E+VG + N ++ + +SSE Y
Sbjct: 187 V-SLLEARGTIGYIAPEVFSRNFGQVSHKSDVYSYGMMALEIVGGRKNHEAEMSSSSEKY 245
Query: 357 FPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416
FP WIYRH+E D EF+L GV ++++I +++ IVGLWCI P DRP M +VIEML+G
Sbjct: 246 FPDWIYRHLELDDEFELNGVTNAEQSDIMRQIAIVGLWCILTNPSDRPSMRKVIEMLEGP 305
Query: 417 TEALQIPPTPFLSSPPRASIDSST 440
AL+IPP P L SPPR SST
Sbjct: 306 LGALKIPPKPRLYSPPRLLSYSST 329
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224108429|ref|XP_002314844.1| predicted protein [Populus trichocarpa] gi|222863884|gb|EEF01015.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 405 bits (1040), Expect = e-110, Method: Compositional matrix adjust.
Identities = 194/324 (59%), Positives = 245/324 (75%), Gaps = 22/324 (6%)
Query: 138 LQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------- 181
L+NYG L +RY++S++KK+T +FK+KLGQGGFG V+KG LLDG
Sbjct: 41 LRNYGTLAPERYSYSELKKMTKNFKEKLGQGGFGSVFKGNLLDGRLVAVKVLKKSKSNGE 100
Query: 182 -----LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRW 236
++SI RTSHVN+VTLLGFC EG RALIYEFM NGSL+K +Y + SK L W
Sbjct: 101 EFVNEVSSIGRTSHVNIVTLLGFCFEGPKRALIYEFMSNGSLDKHIYEENLSKAHPKLGW 160
Query: 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296
E +Y+I +GIA+GLEYLHRGC+TRILHFDIKPHNILLD++FCPKISDFGLAK+C +K+ I
Sbjct: 161 ETLYQIAVGIARGLEYLHRGCNTRILHFDIKPHNILLDENFCPKISDFGLAKICPSKESI 220
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356
VS +LGARGT GYIA EVF RNFG VSHKSDVYS+GM+++E++G + N GVDN+SE+Y
Sbjct: 221 VS-MLGARGTAGYIAPEVFCRNFGGVSHKSDVYSYGMLVLEMIGGRKNFRVGVDNTSEIY 279
Query: 357 FPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416
FPHWIYR +E E +L G + E + A+KMI+ LWCIQ P +RPPM+ V++MLQGS
Sbjct: 280 FPHWIYRRLEIGEELQLRGAGNEVEEQNARKMILASLWCIQTDPSNRPPMSRVVDMLQGS 339
Query: 417 TEALQIPPTPFLSSPPRASIDSST 440
E+L IPP P+LSSPPR+ S++
Sbjct: 340 LESLPIPPKPYLSSPPRSPHGSNS 363
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145839451|gb|ABP96804.1| receptor-like protein kinase [Capsicum annuum] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1039), Expect = e-110, Method: Compositional matrix adjust.
Identities = 191/337 (56%), Positives = 249/337 (73%), Gaps = 25/337 (7%)
Query: 126 WPQAIINHTLFS--LQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG-- 181
W + +H L+NYG KRYN++D+K+IT+ FK+KL QGGFG VY+G L +G
Sbjct: 281 WGSKVEDHRNIEEFLKNYGSYAPKRYNYTDIKRITSRFKNKLVQGGFGTVYRGSLGNGSQ 340
Query: 182 -------------------LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV 222
+ASISRTSHVNVV+L+GFC EG RAL+YEFMPNGSLEKF+
Sbjct: 341 VAVKVLNELKGSGENFINEVASISRTSHVNVVSLVGFCFEGRKRALVYEFMPNGSLEKFI 400
Query: 223 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKIS 282
Y + S + L W +Y+I +GIA+GLEYLHRGC+TRILHFDIKPHNILLD+DFCPKIS
Sbjct: 401 YE-ERSDTVRQLGWPTLYKIALGIARGLEYLHRGCTTRILHFDIKPHNILLDEDFCPKIS 459
Query: 283 DFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
DFGLAKLC + IVS +LGARGTIGYIA E+ RN G VSHKSD YS+GMM++E++G +
Sbjct: 460 DFGLAKLCMKNESIVS-MLGARGTIGYIAPEIVCRNLGGVSHKSDAYSYGMMVLEMIGGR 518
Query: 343 NNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYD 402
N+D+G D +SE+YFPHW+Y+ +E D + +L+G++ ++ENE A+KM+I LWCIQ P +
Sbjct: 519 KNVDAGADRTSEIYFPHWLYQRIELDEDLQLVGIMNEEENECARKMVIASLWCIQTDPSN 578
Query: 403 RPPMNEVIEMLQGSTEALQIPPTPFLSSPPRASIDSS 439
RP M++V+EML+G ++LQIPP P+L SP R +DSS
Sbjct: 579 RPSMSKVVEMLEGKLDSLQIPPKPYLYSPSRIEVDSS 615
|
Source: Capsicum annuum Species: Capsicum annuum Genus: Capsicum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133116|ref|XP_002321486.1| predicted protein [Populus trichocarpa] gi|222868482|gb|EEF05613.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1039), Expect = e-110, Method: Compositional matrix adjust.
Identities = 217/400 (54%), Positives = 269/400 (67%), Gaps = 34/400 (8%)
Query: 65 CG--RQEFYLDCQNNP-NQNPTQSPTIFMGSEAFRVLDIDDGHQTMIITPARLDLLSSYC 121
CG EF C++ P P Q + GS + +I +R S+
Sbjct: 22 CGFENNEFICFCRDRPLTHQPPQLAGVVSGSAGILFI--------CVILYSRRKASSTTT 73
Query: 122 PSVQWPQAIINHTLFSLQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG 181
P + + H ++N+GPL LKRYN SDVKK+TN FKDKLGQGG+G VYKGKL DG
Sbjct: 74 P-IFLKKKHNQHLEVFIRNHGPLALKRYNLSDVKKMTNFFKDKLGQGGYGIVYKGKLQDG 132
Query: 182 ---------------------LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEK 220
+ASISRTSHVN+VTLLGFCLEG+ R LIY+FM NGSLEK
Sbjct: 133 HLVAVKVMQASKGDGEEFINEVASISRTSHVNIVTLLGFCLEGDKRVLIYDFMVNGSLEK 192
Query: 221 FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPK 280
F+ + + + Q L W K+Y+I++G+A+GLEYLHRGC+TRI+HFDIKPHNILLD DF PK
Sbjct: 193 FINHENALQANQQLGWNKLYQILVGVARGLEYLHRGCNTRIVHFDIKPHNILLDADFSPK 252
Query: 281 ISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG 340
ISDFGLAK CT K+ V SLL ARGTIGYIA EVFSRNFG+VSHKSDVYS+GMM +E+VG
Sbjct: 253 ISDFGLAKPCTRKESNV-SLLEARGTIGYIAPEVFSRNFGQVSHKSDVYSYGMMALEIVG 311
Query: 341 CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARP 400
+ N ++ + +SSE YFP WIYRH+E D EF+L GV ++++I +++ IVGLWCI P
Sbjct: 312 GRKNHEAEMSSSSEKYFPDWIYRHLELDDEFELNGVTNAEQSDIMRQIAIVGLWCILTNP 371
Query: 401 YDRPPMNEVIEMLQGSTEALQIPPTPFLSSPPRASIDSST 440
DRP M +VIEML+G AL+IPP P L SPPR SST
Sbjct: 372 SDRPSMRKVIEMLEGPLGALKIPPKPRLYSPPRLLSYSST 411
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472676|ref|XP_002279634.2| PREDICTED: probable receptor-like protein kinase At1g67000-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 404 bits (1037), Expect = e-110, Method: Compositional matrix adjust.
Identities = 203/341 (59%), Positives = 252/341 (73%), Gaps = 24/341 (7%)
Query: 121 CPSVQWPQAIINHTLFSLQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLD 180
C S++ + N F L+N+G L LKRY SDVKK+TNSFKDK+G+GG+G VYKGKLLD
Sbjct: 118 CKSIKRTKNQPNIEAF-LRNHGSLALKRYRHSDVKKMTNSFKDKIGEGGYGDVYKGKLLD 176
Query: 181 G---------------------LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219
G +ASI+RTSH+N+V+L GFC EG RALIYEFMPNGSLE
Sbjct: 177 GQMVAVKVLNETKGNGEEFINEVASITRTSHINIVSLRGFCFEGPKRALIYEFMPNGSLE 236
Query: 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP 279
K++ NG SK L WE +Y+I +GIA+GLEYLHRGC+TRILHFDIKPHNILL +DFCP
Sbjct: 237 KYICNGHHSKTNCQLGWETLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLSEDFCP 296
Query: 280 KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
KISDFGLAKLCT K I+ S+LG RGT GYIA EVFSR FG VSHKSDVYS+GMM++++V
Sbjct: 297 KISDFGLAKLCTRKDSII-SMLGTRGTPGYIAPEVFSRAFGGVSHKSDVYSYGMMVLDMV 355
Query: 340 GCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQAR 399
G + ++D G ++SE+YFP IY+ +E+D + L ++ E E +KMIIV LWCIQ R
Sbjct: 356 GGRKDVDGGSSHTSEIYFPDSIYKCIEEDEDLGLPEIMN-GERECTRKMIIVSLWCIQTR 414
Query: 400 PYDRPPMNEVIEMLQGSTEALQIPPTPFLSSPPRASIDSST 440
P DRPPM +V++ML GS ++LQIPP P+L SPPR+ DSST
Sbjct: 415 PSDRPPMCQVLDMLGGSLQSLQIPPKPYLFSPPRSLQDSST 455
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297737783|emb|CBI26984.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 402 bits (1034), Expect = e-109, Method: Compositional matrix adjust.
Identities = 203/341 (59%), Positives = 252/341 (73%), Gaps = 24/341 (7%)
Query: 121 CPSVQWPQAIINHTLFSLQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLD 180
C S++ + N F L+N+G L LKRY SDVKK+TNSFKDK+G+GG+G VYKGKLLD
Sbjct: 280 CKSIKRTKNQPNIEAF-LRNHGSLALKRYRHSDVKKMTNSFKDKIGEGGYGDVYKGKLLD 338
Query: 181 G---------------------LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219
G +ASI+RTSH+N+V+L GFC EG RALIYEFMPNGSLE
Sbjct: 339 GQMVAVKVLNETKGNGEEFINEVASITRTSHINIVSLRGFCFEGPKRALIYEFMPNGSLE 398
Query: 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP 279
K++ NG SK L WE +Y+I +GIA+GLEYLHRGC+TRILHFDIKPHNILL +DFCP
Sbjct: 399 KYICNGHHSKTNCQLGWETLYKIAVGIARGLEYLHRGCNTRILHFDIKPHNILLSEDFCP 458
Query: 280 KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
KISDFGLAKLCT K I+ S+LG RGT GYIA EVFSR FG VSHKSDVYS+GMM++++V
Sbjct: 459 KISDFGLAKLCTRKDSII-SMLGTRGTPGYIAPEVFSRAFGGVSHKSDVYSYGMMVLDMV 517
Query: 340 GCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQAR 399
G + ++D G ++SE+YFP IY+ +E+D + L ++ E E +KMIIV LWCIQ R
Sbjct: 518 GGRKDVDGGSSHTSEIYFPDSIYKCIEEDEDLGLPEIMN-GERECTRKMIIVSLWCIQTR 576
Query: 400 PYDRPPMNEVIEMLQGSTEALQIPPTPFLSSPPRASIDSST 440
P DRPPM +V++ML GS ++LQIPP P+L SPPR+ DSST
Sbjct: 577 PSDRPPMCQVLDMLGGSLQSLQIPPKPYLFSPPRSLQDSST 617
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356522799|ref|XP_003530032.1| PREDICTED: probable receptor-like protein kinase At1g67000-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 395 bits (1014), Expect = e-107, Method: Compositional matrix adjust.
Identities = 191/324 (58%), Positives = 244/324 (75%), Gaps = 23/324 (7%)
Query: 138 LQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------- 181
L+N G + KRY FS+VKK+TNSFK KLGQGGFG VYKG+L G
Sbjct: 221 LKNKGAVAQKRYKFSEVKKMTNSFKVKLGQGGFGAVYKGQLPTGCPVAVKLLNSSKGNGE 280
Query: 182 -----LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRW 236
+ASISRTSHVN+VTLLGFCL+G +ALIYEFM NGSL+KF+YN + LRW
Sbjct: 281 EFTNEVASISRTSHVNIVTLLGFCLKGRKKALIYEFMANGSLDKFIYN-RGPETIASLRW 339
Query: 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296
+ +Y+I IGIA+GLEYLHRGC+TRILHFDIKPHNILLD++FCPKISDFGLAKLC K+ I
Sbjct: 340 QNLYQISIGIARGLEYLHRGCNTRILHFDIKPHNILLDENFCPKISDFGLAKLCPRKESI 399
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356
+S + RGT+GY+A E+++R+FG VSHKSDVYS+GMM++E+VG + N+D+ +SE+Y
Sbjct: 400 IS-MSNTRGTLGYVAPEMWNRHFGGVSHKSDVYSYGMMLLEMVGGRKNIDAEASRTSEIY 458
Query: 357 FPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416
FPH Y+ +E D + + V+T +ENEIAK+M IVGLWCIQ P DRP M+ VIEML+GS
Sbjct: 459 FPHLAYKRLELDNDLRPDEVMTTEENEIAKRMTIVGLWCIQTFPNDRPIMSRVIEMLEGS 518
Query: 417 TEALQIPPTPFLSSPPRASIDSST 440
+L++PP P LSSP R++ +SS+
Sbjct: 519 MNSLEMPPKPMLSSPTRSATESSS 542
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 450 | ||||||
| TAIR|locus:2204480 | 666 | AT1G66910 [Arabidopsis thalian | 0.564 | 0.381 | 0.551 | 2.9e-88 | |
| TAIR|locus:2019713 | 892 | AT1G67000 [Arabidopsis thalian | 0.562 | 0.283 | 0.529 | 1.1e-86 | |
| TAIR|locus:2019688 | 674 | AT1G66930 [Arabidopsis thalian | 0.535 | 0.357 | 0.545 | 1.6e-85 | |
| TAIR|locus:2176717 | 638 | AT5G38260 [Arabidopsis thalian | 0.56 | 0.394 | 0.530 | 9.3e-84 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.56 | 0.378 | 0.553 | 3.1e-83 | |
| TAIR|locus:2020583 | 799 | AT1G70250 [Arabidopsis thalian | 0.542 | 0.305 | 0.576 | 4e-81 | |
| TAIR|locus:2141862 | 853 | AT4G18250 [Arabidopsis thalian | 0.54 | 0.284 | 0.543 | 2.2e-80 | |
| TAIR|locus:2176707 | 579 | AT5G38250 [Arabidopsis thalian | 0.553 | 0.430 | 0.541 | 2.5e-79 | |
| TAIR|locus:2177152 | 806 | AT5G39030 [Arabidopsis thalian | 0.573 | 0.320 | 0.541 | 8.5e-77 | |
| TAIR|locus:2176697 | 588 | AT5G38240 [Arabidopsis thalian | 0.531 | 0.406 | 0.529 | 1.4e-76 |
| TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 776 (278.2 bits), Expect = 2.9e-88, Sum P(3) = 2.9e-88
Identities = 145/263 (55%), Positives = 198/263 (75%)
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
+AS+S+TSHVN+VTLLGFC EG RA+IYEFM NGSL+KF+ +SK + W ++Y
Sbjct: 392 VASMSQTSHVNIVTLLGFCSEGYKRAIIYEFMENGSLDKFI----SSKKSSTMDWRELYG 447
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
I +G+A+GLEYLH GC TRI+HFDIKP N+LLD + PK+SDFGLAKLC K+ I+S L+
Sbjct: 448 IALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCERKESILS-LM 506
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN--NLDSGVDNSSEVYFPH 359
RGTIGYIA EVFSR +G VSHKSDVYS+GM++++++G +N + + ++S +YFP
Sbjct: 507 DTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDTTSSTSSMYFPE 566
Query: 360 WIYRHVEQDREFKLLGV-VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418
WIYR +E+ K + ++ +E+EIAKKM +VGLWCIQ P DRP MN V+EM++G+ +
Sbjct: 567 WIYRDLEKAHNGKSIETAISNEEDEIAKKMTLVGLWCIQPWPLDRPAMNRVVEMMEGNLD 626
Query: 419 ALQIPPTPFLSSPPRASI-DSST 440
AL++PP P L P A++ +SST
Sbjct: 627 ALEVPPRPVLQQIPTATLQESST 649
|
|
| TAIR|locus:2019713 AT1G67000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 731 (262.4 bits), Expect = 1.1e-86, Sum P(3) = 1.1e-86
Identities = 143/270 (52%), Positives = 193/270 (71%)
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
+AS+S+TSHVN+V+LLGFC EG+ RA+IYEF+ NGSL+KF+ + K L + +Y
Sbjct: 601 VASMSQTSHVNIVSLLGFCCEGSRRAIIYEFLGNGSLDKFI----SDKSSVNLDLKTLYG 656
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
I +G+A+GLEYLH GC TRI+HFDIKP N+LLD + CPK+SDFGLAKLC K+ I+S LL
Sbjct: 657 IALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLCPKVSDFGLAKLCEKKESILS-LL 715
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGC--KNNLDSGV-DNSSEVYFP 358
RGTIGYIA E+ SR +G VSHKSDVYS+GM+++E++G K D + S +YFP
Sbjct: 716 DTRGTIGYIAPEMISRLYGSVSHKSDVYSYGMLVLEMIGARKKERFDQNSRSDGSSIYFP 775
Query: 359 HWIYRHVEQ----DREFKLLGV-----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEV 409
WIY+ +E+ D E G ++ +E EIA+KM +VGLWCIQ+ P DRPPMN+V
Sbjct: 776 EWIYKDLEKANIKDIEKTENGGLIENGISSEEEEIARKMTLVGLWCIQSSPSDRPPMNKV 835
Query: 410 IEMLQGSTEALQIPPTPFLSSPPRASIDSS 439
+EM++GS +AL++PP P L +S+ S
Sbjct: 836 VEMMEGSLDALEVPPRPVLQQISASSVSDS 865
|
|
| TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 728 (261.3 bits), Expect = 1.6e-85, Sum P(3) = 1.6e-85
Identities = 138/253 (54%), Positives = 188/253 (74%)
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
++S+S+TSHVN+V+LLGFC EG+ RA+IYEF+ NGSL+KF+ + K L +Y
Sbjct: 391 VSSMSQTSHVNIVSLLGFCSEGSRRAIIYEFLENGSLDKFI----SEKTSVILDLTALYG 446
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
I +G+A+GLEYLH GC TRI+HFDIKP N+LLD + PK+SDFGLAKLC K+ ++S L+
Sbjct: 447 IALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMS-LM 505
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD--NSSEVYFPH 359
RGTIGYIA E+ SR +G VSHKSDVYS+GM++ E++G + G + N S +YFP
Sbjct: 506 DTRGTIGYIAPEMISRVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPE 565
Query: 360 WIYRHVEQ----DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415
WIY+ +E+ D E +G+ + +E EIAKKM +VGLWCIQ+ P DRPPMN+V+EM++G
Sbjct: 566 WIYKDLEKADNGDLEHIEIGI-SSEEEEIAKKMTLVGLWCIQSSPSDRPPMNKVVEMMEG 624
Query: 416 STEALQIPPTPFL 428
S +AL++PP P L
Sbjct: 625 SLDALEVPPRPVL 637
|
|
| TAIR|locus:2176717 AT5G38260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 754 (270.5 bits), Expect = 9.3e-84, Sum P(2) = 9.3e-84
Identities = 139/262 (53%), Positives = 194/262 (74%)
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
+AS+S+TSHVN+V+LLGFC EG+ RA++YEF+ NGSL++F+ + K L +Y
Sbjct: 365 VASMSQTSHVNIVSLLGFCYEGSKRAIVYEFLENGSLDQFL----SEKKSLNLDVSTLYR 420
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
I +G+A+GL+YLH GC TRI+HFDIKP NILLD FCPK+SDFGLAKLC ++ I+S LL
Sbjct: 421 IALGVARGLDYLHHGCKTRIVHFDIKPQNILLDDTFCPKVSDFGLAKLCEKRESILS-LL 479
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNL--DSGVDNSSEVYFPH 359
ARGTIGYIA EVFS +G VSHKSDVYS+GM+++E++G KN ++ NSS YFP
Sbjct: 480 DARGTIGYIAPEVFSGMYGRVSHKSDVYSYGMLVLEMIGAKNKEIEETAASNSSSAYFPD 539
Query: 360 WIYRHVEQDRE-FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418
WIY+++E + +K +++++ E+AKKM +VGLWCIQ P +RPPMN ++EM++GS +
Sbjct: 540 WIYKNLENGEDTWKFGDEISREDKEVAKKMTLVGLWCIQPSPLNRPPMNRIVEMMEGSLD 599
Query: 419 ALQIPPTPFL--SSPPRASIDS 438
L++PP P + S+ P + S
Sbjct: 600 VLEVPPKPSIHYSAEPLPQLSS 621
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 793 (284.2 bits), Expect = 3.1e-83, Sum P(2) = 3.1e-83
Identities = 144/260 (55%), Positives = 197/260 (75%)
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
+AS+SRTSHVN+V+LLGFC E N RA+IYEFMPNGSL+K++ ++K + WE++Y+
Sbjct: 376 VASMSRTSHVNIVSLLGFCYEKNKRAIIYEFMPNGSLDKYISANMSTK----MEWERLYD 431
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
+ +GI++GLEYLH C TRI+HFDIKP NIL+D++ CPKISDFGLAKLC K+ I+S +L
Sbjct: 432 VAVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESIIS-ML 490
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN--NLDSGVDNSSEVYFPH 359
RGT GYIA E+FS+NFG VSHKSDVYS+GM+++E++G KN ++ N+ +YFP
Sbjct: 491 HMRGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAKNIEKVEYSGSNNGSMYFPE 550
Query: 360 WIYRHVEQDREFKLLG-VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418
W+Y+ E+ ++ G +T +E +IAKK+++V LWCIQ P DRPPM +VIEML+G+ E
Sbjct: 551 WVYKDFEKGEITRIFGDSITDEEEKIAKKLVLVALWCIQMNPSDRPPMIKVIEMLEGNLE 610
Query: 419 ALQIPPTPFLSSPPRASIDS 438
ALQ+PP P L SP D+
Sbjct: 611 ALQVPPNPLLFSPEETVPDT 630
|
|
| TAIR|locus:2020583 AT1G70250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 782 (280.3 bits), Expect = 4.0e-81, Sum P(2) = 4.0e-81
Identities = 147/255 (57%), Positives = 194/255 (76%)
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
+AS+SRTSH N+V+LLGFC EG +A+IYE MPNGSL+KF+ ++K + W+ +Y
Sbjct: 504 IASMSRTSHANIVSLLGFCYEGRKKAIIYELMPNGSLDKFISKNMSAK----MEWKTLYN 559
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
I +G++ GLEYLH C +RI+HFDIKP NIL+D D CPKISDFGLAKLC + I+S +L
Sbjct: 560 IAVGVSHGLEYLHSHCVSRIVHFDIKPQNILIDGDLCPKISDFGLAKLCKNNESIIS-ML 618
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN---NLDSGVDNSSEVYFP 358
ARGTIGYIA EVFS+NFG VSHKSDVYS+GM+++E++G +N ++G N+S +YFP
Sbjct: 619 HARGTIGYIAPEVFSQNFGGVSHKSDVYSYGMVVLEMIGARNIGRAQNAGSSNTS-MYFP 677
Query: 359 HWIYRHVEQDREFKLLG-VVTKKENE-IAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416
WIY+ +E+ L +T++E+E I KKM++VGLWCIQ PYDRPPM++V+EML+GS
Sbjct: 678 DWIYKDLEKGEIMSFLADQITEEEDEKIVKKMVLVGLWCIQTNPYDRPPMSKVVEMLEGS 737
Query: 417 TEALQIPPTPFLSSP 431
EALQIPP P L P
Sbjct: 738 LEALQIPPKPLLCLP 752
|
|
| TAIR|locus:2141862 AT4G18250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 763 (273.6 bits), Expect = 2.2e-80, Sum P(2) = 2.2e-80
Identities = 138/254 (54%), Positives = 192/254 (75%)
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
L S+SR SHVN+V+L GFC EG+ RA+IYEFMPNGSL+KF+ ++K + W+ +Y
Sbjct: 565 LVSMSRASHVNIVSLFGFCYEGSQRAIIYEFMPNGSLDKFISENMSTK----IEWKTLYN 620
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
I +G+A+GLEYLH C ++I+HFDIKP NIL+D+D CPKISDFGLAKLC K+ I+S +L
Sbjct: 621 IAVGVARGLEYLHNSCVSKIVHFDIKPQNILIDEDLCPKISDFGLAKLCKKKESIIS-ML 679
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGC--KNNLDSGVDNSSEVYFPH 359
ARGT+GYIA E+FS+N+G VSHKSDVYS+GM+++E++G + +++ + S +YFP
Sbjct: 680 DARGTVGYIAPEMFSKNYGGVSHKSDVYSYGMVVLEMIGATKREEVETSATDKSSMYFPD 739
Query: 360 WIYRHVEQDREFKLLG--VVTKKENE-IAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416
W+Y +E+ +LL ++ ++E E I K+M +VGLWCIQ P DRPPM +V+EML+GS
Sbjct: 740 WVYEDLERKETMRLLEDHIIEEEEEEKIVKRMTLVGLWCIQTNPSDRPPMRKVVEMLEGS 799
Query: 417 T-EALQIPPTPFLS 429
EALQ+PP P L+
Sbjct: 800 RLEALQVPPKPLLN 813
|
|
| TAIR|locus:2176707 AT5G38250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 724 (259.9 bits), Expect = 2.5e-79, Sum P(2) = 2.5e-79
Identities = 143/264 (54%), Positives = 195/264 (73%)
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
+AS+S+TSHVN+VTLLGFC EG+ RA+IYEF+ NGSL++ + N D S +Y
Sbjct: 317 VASMSQTSHVNIVTLLGFCYEGSKRAIIYEFLENGSLDQSL-NLDVST---------LYG 366
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
I +G+A+GLEYLH GC TRI+HFDIKP N+LLD++ PK++DFGLAKLC ++ I+S LL
Sbjct: 367 IALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDENLRPKVADFGLAKLCEKQESILS-LL 425
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNN--LDSGVDNSSEVYFPH 359
RGTIGYIA E+FSR +G VSHKSDVYS+GM+++E++G +N + + N+S YFP
Sbjct: 426 DTRGTIGYIAPELFSRMYGSVSHKSDVYSYGMLVLEMIGARNKERVQNADPNNSSAYFPD 485
Query: 360 WIYRHVEQDREFKLLGV-VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418
WIY+ +E +LLG +T++E + AKKMI+VGLWCIQ RP DRP MN+V+EM++GS +
Sbjct: 486 WIYKDLENFDNTRLLGDGLTREEEKNAKKMILVGLWCIQFRPSDRPSMNKVVEMMEGSLD 545
Query: 419 ALQIPPTPFLSSPPRAS-IDSSTL 441
+L PP P L P + + +SS L
Sbjct: 546 SLDPPPKPLLHMPMQNNNAESSQL 569
|
|
| TAIR|locus:2177152 AT5G39030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 8.5e-77, Sum P(2) = 8.5e-77
Identities = 144/266 (54%), Positives = 196/266 (73%)
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
+AS+S+TSHVN+V+LLGFC EG+ RA++YEF+ NGSL++F+ + Q + +Y
Sbjct: 542 VASMSQTSHVNIVSLLGFCFEGSKRAIVYEFLENGSLDQFMSRNKSLT--QDVT--TLYG 597
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
I +GIA+GLEYLH GC TRI+HFDIKP NILLD + CPK+SDFGLAKLC ++ ++S L+
Sbjct: 598 IALGIARGLEYLHYGCKTRIVHFDIKPQNILLDGNLCPKVSDFGLAKLCEKRESVLS-LM 656
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNN-LDSGVDNS-SEVYFPH 359
RGTIGYIA EVFSR +G VSHKSDVYSFGM++++++G ++ + VD++ S YFP
Sbjct: 657 DTRGTIGYIAPEVFSRMYGRVSHKSDVYSFGMLVIDMIGARSKEIVETVDSAASSTYFPD 716
Query: 360 WIYRHVEQDREFKLLG-VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418
WIY+ +E + + G +TK+E EIAKKMI+VGLWCIQ P DRP MN V+EM++GS +
Sbjct: 717 WIYKDLEDGEQTWIFGDEITKEEKEIAKKMIVVGLWCIQPCPSDRPSMNRVVEMMEGSLD 776
Query: 419 ALQIPPTPFLSSPPRASIDSSTLRYG 444
AL+IPP P + +SS+L G
Sbjct: 777 ALEIPPKPSMHISTEVITESSSLSDG 802
|
|
| TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 691 (248.3 bits), Expect = 1.4e-76, Sum P(2) = 1.4e-76
Identities = 134/253 (52%), Positives = 184/253 (72%)
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
+ASIS+TSHVN+V+LLGFC E + RA++YEF+ NGSL++ N D S +Y
Sbjct: 325 VASISQTSHVNIVSLLGFCFEKSKRAIVYEFLENGSLDQSS-NLDVST---------LYG 374
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
I +G+A+G+EYLH GC RI+HFDIKP N+LLD++ PK++DFGLAKLC ++ I+S LL
Sbjct: 375 IALGVARGIEYLHFGCKKRIVHFDIKPQNVLLDENLKPKVADFGLAKLCEKQESILS-LL 433
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNN--LDSGVDNSSEVYFPH 359
RGTIGYIA E+FSR +G VSHKSDVYS+GM+++E+ G +N + + N+S YFP
Sbjct: 434 DTRGTIGYIAPELFSRVYGNVSHKSDVYSYGMLVLEMTGARNKERVQNADSNNSSAYFPD 493
Query: 360 WIYRHVEQDREFKLLGV-VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418
WI++ +E KLL +T++E +IAKKMI+VGLWCIQ RP DRP MN+V+ M++G+ +
Sbjct: 494 WIFKDLENGDYVKLLADGLTREEEDIAKKMILVGLWCIQFRPSDRPSMNKVVGMMEGNLD 553
Query: 419 ALQIPPTPFLSSP 431
+L PP P L P
Sbjct: 554 SLDPPPKPLLHMP 566
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 450 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-38 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-37 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-31 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-28 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-21 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-21 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-21 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-20 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-18 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-17 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-17 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-15 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-14 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-14 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 6e-14 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-13 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-13 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 5e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-13 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-12 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-12 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-12 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-11 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-11 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-11 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-11 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-10 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-09 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-09 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-09 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-09 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 7e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-09 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 8e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 9e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-08 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-08 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-08 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-08 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-08 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-08 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-08 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-07 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-07 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-07 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-07 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-07 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-06 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-06 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 8e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 9e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-05 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-05 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-05 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-05 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-05 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-05 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 4e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-05 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 8e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-04 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-04 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-04 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-04 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.001 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.001 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 0.002 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.002 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.002 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 0.003 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.003 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 0.003 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.003 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.004 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.004 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 37/204 (18%)
Query: 165 LGQGGFGGVYKGK------------------------LLDGLASISRTSHVNVVTLLGFC 200
LG+GGFG VY + LL + + + +H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 201 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR 260
+ N+ L+ E+ GSL+ + + L +++ I++ I +GLEYLH S
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK-----ENEGKLSEDEILRILLQILEGLEYLH---SNG 112
Query: 261 ILHFDIKPHNILLDQD-FCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF 319
I+H D+KP NILLD D K++DFGL+KL T+ K ++ ++ GT Y+A EV
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI---VGTPAYMAPEVLLGK- 168
Query: 320 GEVSHKSDVYSFGMMIMELVGCKN 343
G S KSD++S G+++ EL K+
Sbjct: 169 GYYSEKSDIWSLGVILYELPELKD 192
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 71/289 (24%), Positives = 112/289 (38%), Gaps = 68/289 (23%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRT----------------------------SHV 191
+ KLG+G FG VYKGKL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGL 250
NVV LLG C E ++ E+M G L ++ N L + + IA+G+
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK------LSLSDLLSFALQIARGM 115
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310
EYL S +H D+ N L+ ++ KISDFGL++ G + I ++
Sbjct: 116 EYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR--GGKLPIRWM 170
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELV--GCKNNLDSGVDNSSEVYFPHW----IYRH 364
A E G+ + KSDV+SFG+++ E+ G E +P + +
Sbjct: 171 APESL--KEGKFTSKSDVWSFGVLLWEIFTLG-------------EQPYPGMSNEEVLEY 215
Query: 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413
++ G + ++ + L C P DRP +E++E+L
Sbjct: 216 LKN-------GYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 70/288 (24%), Positives = 113/288 (39%), Gaps = 65/288 (22%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRT----------------------------SHV 191
+ KLG+G FG VYKG L H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251
N+V LLG C E ++ E+MP G L ++ + L + + IA+G+E
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYL----RKNRPKELSLSDLLSFALQIARGME 117
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
YL S +H D+ N L+ ++ KISDFGL++ G + I ++A
Sbjct: 118 YLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVK--GGKLPIRWMA 172
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMELV--GCKNNLDSGVDNSSEVYFPHW----IYRHV 365
E G+ + KSDV+SFG+++ E+ G E +P + ++
Sbjct: 173 PESL--KEGKFTSKSDVWSFGVLLWEIFTLG-------------EEPYPGMSNAEVLEYL 217
Query: 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413
++ G K ++ + L C P DRP +E++E+L
Sbjct: 218 KK-------GYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-34
Identities = 63/205 (30%), Positives = 92/205 (44%), Gaps = 40/205 (19%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG-------------------------LASISRTSHVNVVT 195
KLG G FG VYK K + + R SH N+V
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 196 LLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 254
L+ + ++ L+ E+ G L + G L ++ +I + I +GLEYLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-------PLSEDEAKKIALQILRGLEYLH 115
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEV 314
S I+H D+KP NILLD++ KI+DFGLAK +++ GT Y+A EV
Sbjct: 116 ---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTF---VGTPWYMAPEV 169
Query: 315 FSRNFGEVSHKSDVYSFGMMIMELV 339
G K DV+S G+++ EL+
Sbjct: 170 LLGGNG-YGPKVDVWSLGVILYELL 193
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 78/285 (27%), Positives = 121/285 (42%), Gaps = 61/285 (21%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGL---------------------------ASI-SRTSHVN 192
KLG+G FG VYKG L ASI + SH N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
+V LLG C +G ++ E+MP G L F+ L + + ++ + IAKG+EY
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEK-----LTLKDLLQMALQIAKGMEY 117
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
L S +H D+ N L+ ++ KISDFGL++ + G + I ++A
Sbjct: 118 LE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRD-IYEDDYYRKRGGGKLPIKWMAP 173
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMELV-GCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371
E G+ + KSDV+SFG+++ E+ + G+ N + +E
Sbjct: 174 ESL--KDGKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNEE-------VLELLEDGY-- 221
Query: 372 KLLGVVTKKEN---EIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413
+ + EN E+ + M L C P DRP +E++E L
Sbjct: 222 ----RLPRPENCPDELYELM----LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 79/295 (26%), Positives = 117/295 (39%), Gaps = 76/295 (25%)
Query: 163 DKLGQGGFGGVYKGKLLDG---------------------------LASISRTSHVNVVT 195
KLG+G FG VYKGKL + + H NVV
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 196 LLGFCLEGNNRALIYEFMPNGSLEKFV-----YNGDTSKPCQYLRWEKMYEIVIGIAKGL 250
LLG C E L+ E+M G L ++ K L + + I IAKG+
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKST--LSLKDLLSFAIQIAKGM 118
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310
EYL S + +H D+ N L+ +D KISDFGL++ G + I ++
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK-TGGKLPIRWM 174
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDNSSEVYFPHWIY 362
A E G + KSDV+SFG+++ E+ G N +
Sbjct: 175 APESL--KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---------------EEVL 217
Query: 363 RHVEQDREFKLLGVVTKKEN---EIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
++ + ++L K E E+ + M L C Q P DRP +E++E L+
Sbjct: 218 EYLRKG--YRLP----KPEYCPDELYELM----LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 3e-28
Identities = 54/203 (26%), Positives = 82/203 (40%), Gaps = 39/203 (19%)
Query: 161 FKDKLGQGGFGGVYKG-----------------KLLDGLASI-------SRTSHVNVVTL 196
+KLG+G FG VY K+ I + H N+V L
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
+ + L+ E+ G L + + + + +I+ LEYLH
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFY--LRQIL----SALEYLH-- 114
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
S I+H D+KP NILLD+D K++DFGLA+ L GT Y+A EV
Sbjct: 115 -SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPG----EKLTTFVGTPEYMAPEVLL 169
Query: 317 RNFGEVSHKSDVYSFGMMIMELV 339
D++S G+++ EL+
Sbjct: 170 GK--GYGKAVDIWSLGVILYELL 190
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 59/209 (28%), Positives = 83/209 (39%), Gaps = 53/209 (25%)
Query: 164 KLGQGGFGGVYKG---------------------KLLDGLAS----ISRTSHVNVVTLLG 198
LG+G FG VY + L+ L +S H N+V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 199 FCL--EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 251
E N + E++ GSL + K+ E VI I +GL
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFG-----------KLPEPVIRKYTRQILEGLA 115
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL--CTTKKGIVSSLLGARGTIGY 309
YLH S I+H DIK NIL+D D K++DFG AK S+ RGT +
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSV---RGTPYW 169
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+A EV E +D++S G ++E+
Sbjct: 170 MAPEVIRG--EEYGRAADIWSLGCTVIEM 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 65/203 (32%), Positives = 91/203 (44%), Gaps = 42/203 (20%)
Query: 165 LGQGGFGGVYKG----------------------------KLLDGLASISRTSHVNVVTL 196
LG G FG VYKG ++LD ++ H +VV L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNG-DTSKPCQYLRWEKMYEIVIGIAKGLEYLHR 255
LG CL + LI + MP G L +V N D L W + IAKG+ YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLE- 126
Query: 256 GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF 315
R++H D+ N+L+ KI+DFGLAKL + + G + I ++ALE
Sbjct: 127 --EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAE-GGKVPIKWMALE-- 181
Query: 316 SRNFGEVSHKSDVYSFGMMIMEL 338
S +HKSDV+S+G+ + EL
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 1e-21
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 35/198 (17%)
Query: 161 FKDKLGQGGFGGVYKG--------------------KLLDGLASISRTSHVNVVTLLGFC 200
+G+G FG V G L + ++ H N+V LLG
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 201 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR 260
L+GN ++ E+M GSL ++ S+ + + + + +G+EYL
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL----RSRGRAVITLAQQLGFALDVCEGMEYLE---EKN 122
Query: 261 ILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFG 320
+H D+ N+L+ +D K+SDFGLAK + + + + A E R
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS------QGQDSGKLPVKWTAPEAL-RE-K 174
Query: 321 EVSHKSDVYSFGMMIMEL 338
+ S KSDV+SFG+++ E+
Sbjct: 175 KFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 1e-21
Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 51/207 (24%)
Query: 163 DKLGQGGFGGVYKG------------------------KLLDGLASISRTSHVNVVTLLG 198
LGQG G VYK +LL L ++ VV G
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 199 -FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEY 252
F EG +++ E+M GSL + + K+ E V+ I KGL+Y
Sbjct: 67 AFYKEGE-ISIVLEYMDGGSLADLLK-----------KVGKIPEPVLAYIARQILKGLDY 114
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
LH I+H DIKP N+L++ KI+DFG++K+ ++ + GT+ Y++
Sbjct: 115 LHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV---GTVTYMSP 169
Query: 313 EVFSRNFGEV-SHKSDVYSFGMMIMEL 338
E GE S+ +D++S G+ ++E
Sbjct: 170 ERIQ---GESYSYAADIWSLGLTLLEC 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 94.0 bits (232), Expect = 4e-21
Identities = 66/206 (32%), Positives = 92/206 (44%), Gaps = 39/206 (18%)
Query: 164 KLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLL 197
KLG+G FG VY + + LAS++ N+V L
Sbjct: 7 KLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLN--HPPNIVKLY 64
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
F + + L+ E++ GSLE + P L + I+ I LEYLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGP---LSESEALFILAQILSALEYLH--- 118
Query: 258 STRILHFDIKPHNILLDQD-FCPKISDFGLAKL---CTTKKGIVSSLLGARGTIGYIALE 313
S I+H DIKP NILLD+D K+ DFGLAKL + I + + GT GY+A E
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178
Query: 314 VFSR-NFGEVSHKSDVYSFGMMIMEL 338
V + S SD++S G+ + EL
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYEL 204
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 6e-21
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 47/208 (22%)
Query: 160 SFKDKLGQGGFGGVYKG-----------------------KLLDGLASISRTSHVNVVTL 196
+K+G+GGFG VYK K+++ + + + H N+V
Sbjct: 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKY 62
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE-----IVIGIAKGLE 251
G L+ + ++ EF GSL+ D K + + E + + KGLE
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLK------DLLK----STNQTLTESQIAYVCKELLKGLE 112
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
YLH S I+H DIK NILL D K+ DFGL+ + K + + GT ++A
Sbjct: 113 YLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV----GTPYWMA 165
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMELV 339
EV + +K+D++S G+ +EL
Sbjct: 166 PEVING--KPYDYKADIWSLGITAIELA 191
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 8e-21
Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 32/197 (16%)
Query: 164 KLGQGGFGGVYKGK---------------------LLDGLASISRTSHVNVVTLLGFCLE 202
KLG G FG V+ G L + + H +V L C E
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 203 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRIL 262
++ E+M GSL F+ +G+ K LR ++ ++ IA+G+ YL +
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKK----LRLPQLVDMAAQIAEGMAYLES---RNYI 125
Query: 263 HFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEV 322
H D+ NIL+ ++ KI+DFGLA+L + ++ GA+ I + A E + N+G
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARL--IEDDEYTAREGAKFPIKWTAPE--AANYGRF 181
Query: 323 SHKSDVYSFGMMIMELV 339
+ KSDV+SFG+++ E+V
Sbjct: 182 TIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 6e-20
Identities = 79/286 (27%), Positives = 135/286 (47%), Gaps = 46/286 (16%)
Query: 154 VKKITNSFKDK--LGQGGFGGVYKGKLLDG-------------------LASISRTSHVN 192
+ I +S K++ + +G G YKGK + +A + + H N
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPN 744
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
+V L+G C LI+E++ +L + + N L WE+ +I IGIAK L +
Sbjct: 745 IVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---------LSWERRRKIAIGIAKALRF 795
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
LH CS ++ ++ P I++D P + LCT K +SS Y+A
Sbjct: 796 LHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS--------AYVAP 847
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD--SGVDNSSEVYFPHWIYR--HVEQD 368
E +R +++ KSD+Y FG++++EL+ K+ D GV + S V + + Y H++
Sbjct: 848 E--TRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMW 904
Query: 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ + G V+ +NEI + M + L C P RP N+V++ L+
Sbjct: 905 IDPSIRGDVSVNQNEIVEVMNL-ALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 58/207 (28%), Positives = 90/207 (43%), Gaps = 45/207 (21%)
Query: 160 SFKDKLGQGGFGGVYKG---------------------KLLDGLASISRTS-HVNVVTLL 197
+K+G+G G VYK +L+ I + H N+V
Sbjct: 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYY 81
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEY 252
L G+ ++ E+M GSL + +M E I + +GLEY
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFV----------RMNEPQIAYVCREVLQGLEY 131
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
LH S ++H DIK NILL +D K++DFG A T +K +S++ GT ++A
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV---GTPYWMAP 185
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMELV 339
EV R + K D++S G+M +E+
Sbjct: 186 EVIKRK--DYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 67/288 (23%), Positives = 124/288 (43%), Gaps = 62/288 (21%)
Query: 165 LGQGGFGGVYKGKLL--DG-----------LASISRT---------------SHVNVVTL 196
LG+G FG V +G+L DG L + + H NV+ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 197 LGFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 250
+G C E ++ +I FM +G L F+ + L + + + ++ IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT----KKGIVSSLLGARGT 306
EYL + +H D+ N +L +D ++DFGL+K + ++G ++ +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM-----P 178
Query: 307 IGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE 366
+ +IA+E + + KSDV++FG+ + E+ GV+N E+Y
Sbjct: 179 VKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIY---------- 225
Query: 367 QDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
++ G K+ + ++ + C +A P DRP ++ E+L+
Sbjct: 226 ---DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLE 270
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 38/200 (19%)
Query: 165 LGQGGFGGVYKGKL------------------------LDGL--ASI-SRTSHVNVVTLL 197
+G G FG V +G+L LD L ASI + H N++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
G + +I E+M NGSL+KF+ D ++ ++ GIA G++YL
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLREND-----GKFTVGQLVGMLRGIASGMKYLSEMN 126
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
+H D+ NIL++ + K+SDFGL++ + ++ G + I + A E +
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT-KGGKIPIRWTAPEAIA- 181
Query: 318 NFGEVSHKSDVYSFGMMIME 337
+ + + SDV+SFG+++ E
Sbjct: 182 -YRKFTSASDVWSFGIVMWE 200
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 2e-17
Identities = 59/208 (28%), Positives = 87/208 (41%), Gaps = 52/208 (25%)
Query: 165 LGQGGFGGVYKGKLLDG----------------------------LASISRTSHVNVVTL 196
LG G FG VY+G LD +A +S+ H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 251
LG E +N + E +P GSL K ++ E VI I GLE
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAK-----------LLKKYGSFPEPVIRLYTRQILLGLE 116
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
YLH +H DIK NIL+D + K++DFG+AK S +G+ ++A
Sbjct: 117 YLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS----FKGSPYWMA 169
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMELV 339
EV ++ G +D++S G ++E+
Sbjct: 170 PEVIAQQ-GGYGLAADIWSLGCTVLEMA 196
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 47/211 (22%)
Query: 161 FKDKLGQGGFGGVYKG------------------KLLDGLASI-------SRTSHVNVVT 195
D +G+G FG VYKG + L SI H N+V
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 196 LLGFCLEGNNRALIYEFMPNGSLEKFVYN-GDTSKP--CQYLRWEKMYEIVIGIAKGLEY 252
+G ++ +I E+ NGSL + + G + Y +Y+++ +GL Y
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVY-----VYQVL----QGLAY 114
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA-KLCTTKKGIVSSLLGARGTIGYIA 311
LH ++H DIK NIL +D K++DFG+A KL K S + GT ++A
Sbjct: 115 LHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV----GTPYWMA 167
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
EV S SD++S G ++EL+
Sbjct: 168 PEVI--EMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 4e-17
Identities = 61/225 (27%), Positives = 103/225 (45%), Gaps = 49/225 (21%)
Query: 154 VKKITNSFKDKLGQGGFGGVYKG----------------KLLDGLAS------------- 184
V++ T K +LG+G FG V+ G K L AS
Sbjct: 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSK-------PCQYLRW 236
++ H N+V G C EG+ +++E+M +G L KF+ +G + P L
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK-LCTTKKG 295
++ +I + IA G+ YL S +H D+ N L+ D KI DFG+++ + TT
Sbjct: 122 SQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178
Query: 296 IV--SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
V ++L R ++ E S + + + +SDV+SFG+++ E+
Sbjct: 179 RVGGHTMLPIR----WMPPE--SIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 72/289 (24%), Positives = 116/289 (40%), Gaps = 76/289 (26%)
Query: 163 DKLGQGGFGGVYKGKLLDGLASISRT-----------------------SHVNVVTLLGF 199
+K+G+G FG VYKG L +T H N+V L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH-RGCS 258
C++ ++ E +P GSL F+ K L +K+ ++ + A G+EYL + C
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFL-----RKKKNRLTVKKLLQMSLDAAAGMEYLESKNC- 114
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
+H D+ N L+ ++ KISDFG+++ VS L + I + A E N
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK-QIPIKWTAPEAL--N 168
Query: 319 FGEVSHKSDVYSFGMMIMELV--------GCKNN-----LDSGVDNSSEVYFPHWIYRHV 365
+G + +SDV+S+G+++ E G N ++SG + P IYR +
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLM 228
Query: 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
Q C P +RP +E+ LQ
Sbjct: 229 LQ---------------------------CWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (199), Expect = 5e-17
Identities = 50/202 (24%), Positives = 90/202 (44%), Gaps = 35/202 (17%)
Query: 162 KDKLGQGGFGGVYK------GKL-------LDGLASISRTS------------HVNVVTL 196
++G+G FG VY GKL L ++ R H N++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
E ++ E+ G L + + K + E++ + + + L+YLH
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKK--QKKEGKPFPEEQILDWFVQLCLALKYLH-- 120
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
S +ILH DIKP NI L + K+ DFG++K+ ++ + +++ GT Y++ E+
Sbjct: 121 -SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV---GTPYYLSPELCQ 176
Query: 317 RNFGEVSHKSDVYSFGMMIMEL 338
++KSD++S G ++ EL
Sbjct: 177 NK--PYNYKSDIWSLGCVLYEL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 5e-17
Identities = 70/283 (24%), Positives = 126/283 (44%), Gaps = 55/283 (19%)
Query: 153 DVKKITNSFKDKLGQGGFGGVYKGK-------------------LLDGLASISRTSHVNV 193
+++K+T + +G+G FG V +G+ L+ A +++ H N+
Sbjct: 4 NLQKLT--LGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNL 61
Query: 194 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYN-GDTSKPC-QYLRWEKMYEIVIGIAKGLE 251
V LLG L N ++ E M G+L F+ G Q L++ + +A+G+E
Sbjct: 62 VRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS------LDVAEGME 114
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
YL S +++H D+ NIL+ +D K+SDFGLA++ G+ +S L + T A
Sbjct: 115 YLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARV--GSMGVDNSKLPVKWT----A 165
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371
E + S KSDV+S+G+++ E V + +P + V++ E
Sbjct: 166 PEALKHK--KFSSKSDVWSYGVLLWE-----------VFSYGRAPYPKMSLKEVKECVE- 211
Query: 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
G + + ++ C + P RP +++ E L+
Sbjct: 212 --KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 69/278 (24%), Positives = 123/278 (44%), Gaps = 53/278 (19%)
Query: 160 SFKDKLGQGGFGGVYKGKLL-----------DGLAS----------ISRTSHVNVVTLLG 198
+ ++G G FG V+ G L +G S + + SH +V L G
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 199 FCLEGNNRALIYEFMPNGSLEKFV--YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
C E + L++EFM +G L ++ G S+ E + + + + +G+ YL
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQ-------ETLLGMCLDVCEGMAYLESS 119
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
++H D+ N L+ ++ K+SDFG+ + + +S G + + + + EVFS
Sbjct: 120 N---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWSSPEVFS 174
Query: 317 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ-DREFKLLG 375
F + S KSDV+SFG+++ E V + ++SEV VE + F+L
Sbjct: 175 --FSKYSSKSDVWSFGVLMWE-VFSEGKTPYENRSNSEV---------VETINAGFRLY- 221
Query: 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413
K ++ + + C + RP DRP + ++ L
Sbjct: 222 ----KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-16
Identities = 54/203 (26%), Positives = 91/203 (44%), Gaps = 33/203 (16%)
Query: 160 SFKDKLGQGGFGGVYKGK-----------LLDGLAS----------ISRTSHVNVVTLLG 198
+F +LG G FG V+ GK + +G S + + SH N+V L G
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
C + ++ E+M NG L ++ L E + ++ + + +EYL
Sbjct: 67 VCTKQRPIFIVTEYMANGCLLNYLRERK-----GKLGTEWLLDMCSDVCEAMEYLESNG- 120
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
+H D+ N L+ +D K+SDFGLA+ + S G + + + EVF +
Sbjct: 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ--GTKFPVKWAPPEVF--D 174
Query: 319 FGEVSHKSDVYSFGMMIMELVGC 341
+ S KSDV+SFG+++ E+
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 93/334 (27%), Positives = 140/334 (41%), Gaps = 68/334 (20%)
Query: 156 KITNSFKDK-LGQGGFGGVYKG----------------------------KLLDGLASIS 186
K T K K LG G FG VYKG ++LD ++
Sbjct: 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA 64
Query: 187 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIG 245
+ +V LLG CL + LI + MP G L +V + QYL W +
Sbjct: 65 SVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 117
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
IAKG+ YL R++H D+ N+L+ KI+DFGLAKL + + G +
Sbjct: 118 IAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA-EGGKV 173
Query: 306 TIGYIALE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364
I ++ALE + R + +H+SDV+S+G+ + EL+ + G+ S I
Sbjct: 174 PIKWMALESILHRIY---THQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSI 223
Query: 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQA--RPYDRPPMNEVIEMLQGSTEALQI 422
+E+ + T I MI+V W I A RP R + E +M + L I
Sbjct: 224 LEKGERLPQPPICT-----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVI 278
Query: 423 P-------PTPFLSSPPRASIDSSTLRYGIMIDA 449
P+P S+ RA +D + ++DA
Sbjct: 279 QGDERMHLPSPTDSNFYRALMDEEDM--DDVVDA 310
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-15
Identities = 56/181 (30%), Positives = 90/181 (49%), Gaps = 23/181 (12%)
Query: 162 KDKLGQGGFGGVYKGKLLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF 221
+D+ G+ F + D + ++ H +V LLG C G + L+ + P GSL
Sbjct: 45 QDRSGRQTFQEI-----TDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDH 98
Query: 222 V-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPK 280
V + D+ P + L W + IAKG+ YL ++H ++ NILL D +
Sbjct: 99 VRQHRDSLDPQRLLNW------CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQ 149
Query: 281 ISDFGLAKLC--TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
I+DFG+A L KK S + I ++ALE S FG +H+SDV+S+G+ + E+
Sbjct: 150 IADFGVADLLYPDDKKYFYSE---HKTPIKWMALE--SILFGRYTHQSDVWSYGVTVWEM 204
Query: 339 V 339
+
Sbjct: 205 M 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 32/200 (16%)
Query: 161 FKDKLGQGGFGGVYKG----------KLL--------DGLAS---ISRTSHVNVVTLLGF 199
KLG G FG V++G K L D LA + + H ++ L
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259
C ++ E M GSL +++ G L+ ++ ++ +A G+ YL +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRA----LKLPQLIDMAAQVASGMAYLE---AQ 122
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF 319
+H D+ N+L+ ++ K++DFGLA++ K+ I + GA+ I + A E + +
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARV--IKEDIYEAREGAKFPIKWTAPE--AALY 178
Query: 320 GEVSHKSDVYSFGMMIMELV 339
S KSDV+SFG+++ E+V
Sbjct: 179 NRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 58/276 (21%)
Query: 163 DKLGQGGFGGVYKGK-LLDG---------------------------LASISRTSHVNVV 194
KLG+G +G VYK K L D LAS+ +H N++
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV---NHPNII 62
Query: 195 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 254
+ L+GN ++ E+ P G L K + + + + ++++ I I + +GL+ LH
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR--KLIPEQEIWRIFIQLLRGLQALH 120
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEV 314
+ILH D+K NILL + KI D G++K+ KK + + + GT Y+A EV
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKTQI---GTPHYMAPEV 172
Query: 315 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374
+ S+KSD++S G ++ E+ P + R ++ R
Sbjct: 173 WKGR--PYSYKSDIWSLGCLLYEMATFA---------------PPFEARSMQDLRYKVQR 215
Query: 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410
G ++ + +Q +P RP ++++
Sbjct: 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 4e-15
Identities = 61/220 (27%), Positives = 96/220 (43%), Gaps = 51/220 (23%)
Query: 161 FKDKLGQGGFGGVYKGKL----------------LDGLAS-------------ISRTSHV 191
F ++LG+G FG VYKG+L L A +S H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKF-VYNGDTSKP---------CQYLRWEKMYE 241
N+V LLG C + +++E++ +G L +F V N S L
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK---KGIVS 298
I I IA G+EYL S +H D+ N L+ + KISDFGL++ + +
Sbjct: 129 IAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
SLL R ++ E +G+ + +SD++SFG+++ E+
Sbjct: 186 SLLPVR----WMPPEAIL--YGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 5e-15
Identities = 45/132 (34%), Positives = 73/132 (55%), Gaps = 11/132 (8%)
Query: 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIK 267
+I E+M NGSL F+ + K L K+ ++ IA+G+ ++ R +H D++
Sbjct: 77 IITEYMENGSLVDFLKTPEGIK----LTINKLIDMAAQIAEGMAFIER---KNYIHRDLR 129
Query: 268 PHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSD 327
NIL+ + C KI+DFGLA+L + GA+ I + A E N+G + KSD
Sbjct: 130 AANILVSETLCCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAI--NYGTFTIKSD 185
Query: 328 VYSFGMMIMELV 339
V+SFG+++ E+V
Sbjct: 186 VWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-15
Identities = 54/212 (25%), Positives = 86/212 (40%), Gaps = 52/212 (24%)
Query: 163 DKLGQGGFGGVYKG---------------------KLLDGLAS----ISRTSHVNVVTLL 197
+K+G G FG VY K + +A + H N+V
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 198 GFCLEGNNRALIY-EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 251
G + + I+ E+ G+LE+ + +G + E VI + +GL
Sbjct: 66 GVEVH-REKVYIFMEYCSGGTLEELLEHGRI-----------LDEHVIRVYTLQLLEGLA 113
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK-LCTTKKGIVSSLLGARGTIGYI 310
YLH S I+H DIKP NI LD + K+ DFG A L + + GT Y+
Sbjct: 114 YLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170
Query: 311 ALEVFSRNFGEVSHK---SDVYSFGMMIMELV 339
A EV + + +D++S G +++E+
Sbjct: 171 APEVITGG--KGKGHGRAADIWSLGCVVLEMA 200
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 9e-15
Identities = 58/206 (28%), Positives = 86/206 (41%), Gaps = 42/206 (20%)
Query: 164 KLGQGGFGGVYKG---------------KLLD---GLASIS----------RTSHVNVVT 195
+LG+G FG V K L+ S H N+V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 196 LLGFCLE--GNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
G C + G + LI E++P+GSL ++ + D + L + I KG++Y
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ------ICKGMDY 124
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
L S R +H D+ NIL++ + KISDFGLAK+ K I + A
Sbjct: 125 LG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMEL 338
E + + S SDV+SFG+ + EL
Sbjct: 182 ECLRTS--KFSSASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 65/208 (31%), Positives = 104/208 (50%), Gaps = 47/208 (22%)
Query: 165 LGQGGFGGVYKGKLLD--------GLASISRT-------------------SHVNVVTLL 197
+G+G FG VY G L+D + S++R SH NV++LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 198 GFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG----IAKGLEY 252
G CL L+ +M +G L F+ + +T P + +IG +AKG+EY
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRS-ETHNP--------TVKDLIGFGLQVAKGMEY 113
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI-VSSLLGARGTIGYIA 311
L S + +H D+ N +LD+ F K++DFGLA+ K+ V + GA+ + ++A
Sbjct: 114 L---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA 170
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMELV 339
LE S + + KSDV+SFG+++ EL+
Sbjct: 171 LE--SLQTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 1e-14
Identities = 68/287 (23%), Positives = 115/287 (40%), Gaps = 61/287 (21%)
Query: 165 LGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLL 197
LG+G FG V +G+L L + H NV+ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 198 GFCLEGNNR------ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251
G CL+ +I FM +G L F+ QYL + + + + IA G+E
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT----KKGIVSSLLGARGTI 307
YL S +H D+ N +L+++ ++DFGL+K ++G ++ + +
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM-----PV 178
Query: 308 GYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367
+IA+E + + KSDV+SFG+ + E+ GV+NS IY ++ Q
Sbjct: 179 KWIAIESLADRV--YTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQ 229
Query: 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
G K+ + + + C P DRP + L+
Sbjct: 230 -------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 18/155 (11%)
Query: 187 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 246
+ + +V G + ++ E+M GSL+K + P + L +I + +
Sbjct: 55 KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAV 109
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR-G 305
KGL YLH +I+H D+KP NIL++ K+ DFG++ +V+SL G
Sbjct: 110 LKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ------LVNSLAKTFVG 161
Query: 306 TIGYIALEVFSRNFGEV-SHKSDVYSFGMMIMELV 339
T Y+A E R G S KSD++S G+ ++EL
Sbjct: 162 TSSYMAPE---RIQGNDYSVKSDIWSLGLSLIELA 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 68/278 (24%), Positives = 115/278 (41%), Gaps = 49/278 (17%)
Query: 160 SFKDKLGQGGFGGVYKG----------------------KLLDGLASISRTSHVNVVTLL 197
+ K KLG G +G VY+G + L A + H N+V LL
Sbjct: 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVY-NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
G C +I EFM G+L ++ L + + I+ +EYL +
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLEK- 122
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
+H D+ N L+ ++ K++DFGL++L T ++ GA+ I + A E S
Sbjct: 123 --KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD--TYTAHAGAKFPIKWTAPE--S 176
Query: 317 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376
+ + S KSDV++FG+++ E+ + G+D S +Y +E+ +
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYELLEKGYRMERPEG 229
Query: 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
K E+ + C Q P DRP E+ + +
Sbjct: 230 CPPKVYELMRA-------CWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 54/197 (27%), Positives = 91/197 (46%), Gaps = 33/197 (16%)
Query: 164 KLGQGGFGGVYKG---------------------KLLDGLASISRTSHVNVVTLLGFCLE 202
KLG G FG V+ G L+ + + H +V L E
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 203 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRIL 262
++ E+M GSL F+ +G+ + L+ + ++ +A G+ Y+ R +
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIER---MNYI 124
Query: 263 HFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEV 322
H D++ NIL+ KI+DFGLA+L + ++ GA+ I + A E + +G
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 180
Query: 323 SHKSDVYSFGMMIMELV 339
+ KSDV+SFG+++ ELV
Sbjct: 181 TIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (179), Expect = 3e-14
Identities = 43/155 (27%), Positives = 68/155 (43%), Gaps = 34/155 (21%)
Query: 162 KDKLGQGGFGGVYKG--------------KLLDGLASISRTS-----------HVNVVTL 196
+KLG+G +G VYK +L + I T+ H N+V L
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
L L++E+ L+K++ ++ I+ + +GL Y H
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIK-----SIMYQLLRGLAYCH-- 115
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291
S RILH D+KP NIL+++D K++DFGLA+
Sbjct: 116 -SHRILHRDLKPQNILINRDGVLKLADFGLARAFG 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 4e-14
Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 38/200 (19%)
Query: 164 KLGQGGFGGVYKGKLLDGL----------------------ASISRTSHVNVVTLLGFCL 201
KLG G FG V++G + + ++ R H ++++L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 202 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRI 261
G +I E M GSL F+ + + Q L + ++ +A+G+ YL
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLE---EQNS 125
Query: 262 LHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY--IALEVFSRNF 319
+H D+ NIL+ +D K++DFGLA+L K+ + S + I Y A E S
Sbjct: 126 IHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLS---SDKKIPYKWTAPEAASH-- 178
Query: 320 GEVSHKSDVYSFGMMIMELV 339
G S KSDV+SFG+++ E+
Sbjct: 179 GTFSTKSDVWSFGILLYEMF 198
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 4e-14
Identities = 78/302 (25%), Positives = 135/302 (44%), Gaps = 70/302 (23%)
Query: 160 SFKDKLGQGGFGGVYKG-------------KLLDGLAS--------------ISRTSHVN 192
F+D +G+G FG V + K+L AS H N
Sbjct: 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64
Query: 193 VVTLLGFCLEGNNRALIY---EFMPNGSLEKF-----VYNGDTSKPCQY-----LRWEKM 239
++ LLG C NR +Y E+ P G+L F V D + ++ L +++
Sbjct: 65 IINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
+ +A G++YL + +H D+ N+L+ ++ KI+DFGL++ ++ V
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKK 175
Query: 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY--F 357
+G R + ++A+E S N+ + KSDV+SFG+++ E+V G+ +E+Y
Sbjct: 176 TMG-RLPVRWMAIE--SLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM-TCAELYEKL 231
Query: 358 PHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417
P YR +E+ R ++E+ + M C + RPY+RPP ++ L
Sbjct: 232 PQG-YR-MEKPRNC---------DDEVYELM----RQCWRDRPYERPPFAQISVQLSRML 276
Query: 418 EA 419
EA
Sbjct: 277 EA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 56/209 (26%), Positives = 86/209 (41%), Gaps = 47/209 (22%)
Query: 161 FKDKLGQGGFGGVYK-----------------GKLLDGLASISRT-----------SHVN 192
KLG+G + VYK G+ + I+ T H N
Sbjct: 4 KGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPN 63
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYEIVIGIAKGLE 251
++ LL +N L++EFM LEK + + P + M +GLE
Sbjct: 64 IIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLM------TLRGLE 116
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
YLH ILH D+KP+N+L+ D K++DFGLA+ + ++ + T Y A
Sbjct: 117 YLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV---VTRWYRA 170
Query: 312 LEVFSRNFGEVSHKS--DVYSFGMMIMEL 338
E+ FG + D++S G + EL
Sbjct: 171 PELL---FGARHYGVGVDMWSVGCIFAEL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 5e-14
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 37/202 (18%)
Query: 160 SFKDKLGQGGFGGVYKGK-----------LLDGLAS----------ISRTSHVNVVTLLG 198
+F +LG G FG V+ GK + +G S + + SH +V L G
Sbjct: 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYN--GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
C + ++ EFM NG L ++ G SK + + + + +G+EYL R
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSK-------DMLLSMCQDVCEGMEYLER- 118
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
+H D+ N L+ K+SDFG+ + + SS GA+ + + EVF
Sbjct: 119 --NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS--GAKFPVKWSPPEVF- 173
Query: 317 RNFGEVSHKSDVYSFGMMIMEL 338
NF + S KSDV+SFG+++ E+
Sbjct: 174 -NFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 71/298 (23%), Positives = 132/298 (44%), Gaps = 65/298 (21%)
Query: 150 NFSDVKKITNSFKDKLGQGGFGGVYKGKLL-DGL---ASISRTS---------------- 189
++D+K F+D +G+G FG V K ++ DGL A+I R
Sbjct: 5 EWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 59
Query: 190 -------HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF-----VYNGDTS-----KPCQ 232
H N++ LLG C L E+ P+G+L F V D +
Sbjct: 60 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 119
Query: 233 YLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292
L +++ +A+G++YL + + +H D+ NIL+ +++ KI+DFGL++
Sbjct: 120 TLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---G 173
Query: 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS 352
++ V +G R + ++A+E S N+ + SDV+S+G+++ E+V G+
Sbjct: 174 QEVYVKKTMG-RLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TC 229
Query: 353 SEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410
+E+Y E G +K ++ + C + +PY+RP +++
Sbjct: 230 AELY-------------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 59/197 (29%), Positives = 93/197 (47%), Gaps = 33/197 (16%)
Query: 164 KLGQGGFGGVYKGK---------------------LLDGLASISRTSHVNVVTLLGFCLE 202
KLGQG FG V+ G L + + H +V L E
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 203 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRIL 262
++ EFM GSL F+ GD +YL+ ++ ++ IA G+ Y+ R +
Sbjct: 73 -EPIYIVTEFMGKGSLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIER---MNYI 124
Query: 263 HFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEV 322
H D++ NIL+ + KI+DFGLA+L + ++ GA+ I + A E + +G
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 180
Query: 323 SHKSDVYSFGMMIMELV 339
+ KSDV+SFG+++ ELV
Sbjct: 181 TIKSDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 7e-14
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 33/196 (16%)
Query: 164 KLGQGGFGGVYKGK---------------------LLDGLASISRTSHVNVVTLLGFCLE 202
KLGQG FG V+ G L + + H +V L E
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 203 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRIL 262
++ E+M GSL F+ G+ K YLR ++ ++ IA G+ Y+ R +
Sbjct: 73 -EPIYIVTEYMSKGSLLDFL-KGEMGK---YLRLPQLVDMAAQIASGMAYVER---MNYV 124
Query: 263 HFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEV 322
H D++ NIL+ ++ K++DFGLA+L + ++ GA+ I + A E + +G
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPE--AALYGRF 180
Query: 323 SHKSDVYSFGMMIMEL 338
+ KSDV+SFG+++ EL
Sbjct: 181 TIKSDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 8e-14
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 42/204 (20%)
Query: 165 LGQGGFGGVYKG----------------------------KLLDGLASISRTSHVNVVTL 196
LG G FG VYKG + +D ++ H ++V L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHR 255
LG CL + L+ + MP+G L +V+ + Q L W + IAKG+ YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 256 GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF 315
R++H D+ N+L+ KI+DFGLA+L + ++ G + I ++ALE
Sbjct: 128 ---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA-DGGKMPIKWMALECI 183
Query: 316 SRNFGEVSHKSDVYSFGMMIMELV 339
++ + +H+SDV+S+G+ I EL+
Sbjct: 184 --HYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 58/213 (27%)
Query: 165 LGQGGFGGVYKG----------------------------KLLDGLASISRTSHVNVVTL 196
LG+G +G VY G KL + + + HVN+V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYN-GDTSKP--CQYLRWEKMYEIVIGIAKGLEYL 253
LG CL+ N ++ EF+P GS+ + G +P C+Y + I G+ YL
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK---------QILDGVAYL 118
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK------LCTTKKGIVSSLLGARGTI 307
H C ++H DIK +N++L + K+ DFG A+ L T ++ S+ GT
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM---HGTP 172
Query: 308 GYIALEVFSRNFGEVSH--KSDVYSFGMMIMEL 338
++A EV + E + KSD++S G + E+
Sbjct: 173 YWMAPEVIN----ESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 14/151 (9%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK--MYEIVIGIA 247
H+N+V LGF ++ E++P GS+ + Y R+E+ + +
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRT--------YGRFEEQLVRFFTEQVL 118
Query: 248 KGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTI 307
+GL YLH S ILH D+K N+L+D D KISDFG++K + + +G++
Sbjct: 119 EGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQN-MSMQGSV 174
Query: 308 GYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
++A EV S K D++S G +++E+
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 3e-13
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 56/214 (26%)
Query: 165 LGQGGFGGVY----------------------------KGKLLDGLAS----ISRTSHVN 192
+G G FG VY K +LD LA + H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK--MYEIVIGIAKGL 250
+V LG L+ ++ + E++P GS+ + N Y +E+ + V I KGL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNN--------YGAFEETLVRNFVRQILKGL 119
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK------LCTTKKGIVSSLLGAR 304
YLH + I+H DIK NIL+D KISDFG++K L T G SL +
Sbjct: 120 NYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL---Q 173
Query: 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
G++ ++A EV + + K+D++S G +++E+
Sbjct: 174 GSVFWMAPEVVKQTS--YTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 51/202 (25%), Positives = 79/202 (39%), Gaps = 39/202 (19%)
Query: 165 LGQGGFGGVYKGKLL----------------DGLAS-----------ISRTSHVNVVTLL 197
LG G FG V KG L + +A+ +++ H +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
G C G L+ E P G L K++ +A G+ YL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE--- 112
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
S +H D+ N+LL KISDFG+++ + R + + A E
Sbjct: 113 SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI-- 170
Query: 318 NFGEVSHKSDVYSFGMMIMELV 339
N+G+ S KSDV+S+G+ + E
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 5e-13
Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 44/204 (21%)
Query: 161 FKDKLGQGGFGGVYK------GKLL--------DGLASISR-------TSHVNVVTLLGF 199
+KLG+G +G VYK G+++ + L I + +V G
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-YLRWEKMYEIVIGIAKGLEYLHRGCS 258
+ + ++ E+ GS+ D K L E++ I+ KGLEYLH S
Sbjct: 67 YFKNTDLWIVMEYCGAGSVS------DIMKITNKTLTEEEIAAILYQTLKGLEYLH---S 117
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT-IG---YIALEV 314
+ +H DIK NILL+++ K++DFG++ G ++ + R T IG ++A EV
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVS-------GQLTDTMAKRNTVIGTPFWMAPEV 170
Query: 315 FSRNFGEVSHKSDVYSFGMMIMEL 338
++K+D++S G+ +E+
Sbjct: 171 IQEI--GYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 66/289 (22%), Positives = 111/289 (38%), Gaps = 61/289 (21%)
Query: 163 DKLGQGGFGGVYKG----------------KLLDGLASISR--------------TSHVN 192
+LGQG FG VY+G K ++ AS+ H +
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-H 70
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY----NGDTSKPCQYLRWEKMYEIVIGIAK 248
VV LLG G ++ E M G L+ ++ + + +K ++ IA
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK---KGIVSSLLGARG 305
G+ YL + + +H D+ N ++ +D KI DFG+ + + LL R
Sbjct: 131 GMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR- 186
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365
++A E S G + KSDV+SFG+++ E+ G+ N
Sbjct: 187 ---WMAPE--SLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------------- 227
Query: 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
E+ +F + G K++ + C Q P RP E++ L+
Sbjct: 228 EEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 7e-13
Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 24/232 (10%)
Query: 190 HVNVVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 247
H N+V G C E + LI E++P GSL ++ P L ++ I
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-------PKHKLNLAQLLLFAQQIC 117
Query: 248 KGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTI 307
+G+ YLH S +H D+ N+LLD D KI DFGLAK +
Sbjct: 118 EGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 174
Query: 308 GYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367
+ A+E N + S+ SDV+SFG+ + EL+ + DS S F I Q
Sbjct: 175 FWYAVECLKEN--KFSYASDVWSFGVTLYELL---THCDS--KQSPPKKFEEMIGPKQGQ 227
Query: 368 DREFKLLGVVTKKE-----NEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+L+ ++ + +++ I+ C + RP +I +L+
Sbjct: 228 MTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 37/93 (39%), Positives = 45/93 (48%), Gaps = 9/93 (9%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I LEYLH S I+H DIKP NILLD+ I+DF +A T S+ G
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST----SG 161
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
T GY+A EV R S D +S G+ E
Sbjct: 162 TPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYEC 192
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 7e-13
Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 35/196 (17%)
Query: 165 LGQGGFGGVYKGKLLDGLASISRT-----------------------SHVNVVTLLGFCL 201
LG+G FG V+KG L D +T H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 202 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRI 261
+ ++ E +P G F+ K L+ +++ + + A G+ YL S
Sbjct: 63 QRQPIYIVMELVPGGDFLSFL-----RKKKDELKTKQLVKFALDAAAGMAYLE---SKNC 114
Query: 262 LHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGE 321
+H D+ N L+ ++ KISDFG+++ GI SS + I + A E N+G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSGLKQIPIKWTAPEAL--NYGR 170
Query: 322 VSHKSDVYSFGMMIME 337
S +SDV+S+G+++ E
Sbjct: 171 YSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 8e-13
Identities = 53/228 (23%), Positives = 86/228 (37%), Gaps = 59/228 (25%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGL-------------------ASISR--------TSHVNV 193
F +G+G F V K + + H +
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGI 64
Query: 194 VTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPC-QYLRWEKMYEIVIGIAKGLE 251
+ L + N + E+ PNG L +++ G + C ++ EI++ LE
Sbjct: 65 IKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY----AAEILLA----LE 116
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL------------CTTKKGIVSS 299
YLH S I+H D+KP NILLD+D KI+DFG AK+ T
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 300 LLGAR-----GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
R GT Y++ E+ + SD+++ G +I +++ K
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 9e-13
Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 153 DVKKITNSFKDKLGQGGFGGVYKGK---------------------LLDGLASISRTSHV 191
D K +T F +LG G FG V GK ++ + + SH
Sbjct: 2 DPKDLT--FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHE 59
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251
+V L G C + ++ E+M NG L ++ + + ++ E+ + +G+
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-----KRFQPSQLLEMCKDVCEGMA 114
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
YL S + +H D+ N L+D C K+SDFGL++ + +S +G++ + +
Sbjct: 115 YLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSP 169
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMEL 338
EV + + S KSDV++FG+++ E+
Sbjct: 170 PEVL--LYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 59/235 (25%), Positives = 113/235 (48%), Gaps = 43/235 (18%)
Query: 190 HVNVVTLLGFCLEGNNRALIY---EFMPNGSLEKF-----VYNGDTSKPCQY-----LRW 236
H N++ LLG C +R +Y E+ P+G+L F V D + L
Sbjct: 55 HPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 111
Query: 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296
+++ +A+G++YL + + +H D+ NIL+ +++ KI+DFGL++ ++
Sbjct: 112 QQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY 165
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356
V +G R + ++A+E S N+ + SDV+S+G+++ E+V G+ +E+Y
Sbjct: 166 VKKTMG-RLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCAELY 221
Query: 357 --FPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEV 409
P YR +E+ ++E+ M C + +PY+RP ++
Sbjct: 222 EKLPQG-YR-LEKPLNC---------DDEVYDLM----RQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 44/205 (21%)
Query: 165 LGQGGFGGVYKG----------------------------KLLDGLASISRTSHVNVVTL 196
LG G FG VYKG ++LD ++ V L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL-RWEKMYEIVIGIAKGLEYLHR 255
LG CL + L+ + MP G L +V Q L W + IAKG+ YL
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE- 126
Query: 256 GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALE-V 314
R++H D+ N+L+ KI+DFGLA+L + + G + I ++ALE +
Sbjct: 127 --EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHA-DGGKVPIKWMALESI 183
Query: 315 FSRNFGEVSHKSDVYSFGMMIMELV 339
R F +H+SDV+S+G+ + EL+
Sbjct: 184 LHRRF---THQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 62/235 (26%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YNGDTSK-PCQYLRWEKM 239
H N++ LLG C + ++ E+ G+L +++ Y+ DT K P + L ++ +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
+A+G+EYL S + +H D+ N+L+ +D KI+DFGLA+ +
Sbjct: 137 VSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 300 LLGARGTIGYIALE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP 358
G R + ++A E +F R + +H+SDV+SFG+++ E+ + G+
Sbjct: 194 TNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEIFTLGGSPYPGIP-------- 241
Query: 359 HWIYRHVEQDREFKLL--GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
VE+ FKLL G K ++ ++ C A P RP +++E
Sbjct: 242 ------VEE--LFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 37/200 (18%)
Query: 163 DKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLG 198
+++G+G FG V+ G+L L + + SH N+V L+G
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
C + ++ E + G F+ L+ +++ ++V A G+EYL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGP-----RLKVKELIQMVENAAAGMEYLESKHC 115
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT-IGYIALEVFSR 317
+H D+ N L+ + KISDFG+++ + G+ +S G + + + A E
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEAL-- 168
Query: 318 NFGEVSHKSDVYSFGMMIME 337
N+G S +SDV+SFG+++ E
Sbjct: 169 NYGRYSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIK 267
+I EFM GSL F+ + + SK K+ + IA+G+ ++ + +H D++
Sbjct: 77 IITEFMAKGSLLDFLKSDEGSK----QPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLR 129
Query: 268 PHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSD 327
NIL+ KI+DFGLA++ + GA+ I + A E NFG + KSD
Sbjct: 130 AANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAI--NFGSFTIKSD 185
Query: 328 VYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKK 387
V+SFG+++ME+V G+ N + R +E+ G + ++
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALER-------GYRMPRPENCPEE 231
Query: 388 MIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ + + C + RP +RP + +L
Sbjct: 232 LYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 63/242 (26%), Positives = 110/242 (45%), Gaps = 46/242 (19%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-----------YNGDTSKPCQYLRWEK 238
H N++ LLG C + +I E+ G+L +++ YN P + L ++
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV-PEEQLSFKD 141
Query: 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK----LCTTKK 294
+ +A+G+EYL S + +H D+ N+L+ +D KI+DFGLA+ + KK
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198
Query: 295 GIVSSLLGARGTIGYIALE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSS 353
R + ++A E +F R + +H+SDV+SFG+++ E+ +
Sbjct: 199 TT-----NGRLPVKWMAPEALFDRIY---THQSDVWSFGVLLWEIFTLGGS--------- 241
Query: 354 EVYFPHWIYRHVEQDREFKLL--GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
P Y V + FKLL G K + ++ ++ C A P RP +++E
Sbjct: 242 ----P---YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294
Query: 412 ML 413
L
Sbjct: 295 DL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 51/177 (28%), Positives = 79/177 (44%), Gaps = 30/177 (16%)
Query: 174 YKGKLLDGLASISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVY------NG 225
+ ++L L +V G L+ ++ + E+ GSL+ +Y G
Sbjct: 42 LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGG 100
Query: 226 DTSKPCQYLRWEKMY-EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDF 284
EK+ +I + KGL YLH S +I+H DIKP NILL + K+ DF
Sbjct: 101 RIG--------EKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDF 149
Query: 285 GLAKLCTTKKGIVSSLLGA-RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG 340
G++ +V+SL G GT Y+A E S SDV+S G+ ++E+
Sbjct: 150 GVS------GELVNSLAGTFTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQ 198
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 57/213 (26%), Positives = 89/213 (41%), Gaps = 47/213 (22%)
Query: 163 DKLGQGGFGGVYK-------GKLL-----------DGLASISRTS--------------- 189
+ LG G FG VYK LL G R
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 190 --HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 247
H N+V LE + ++ + + L + + K Q E+++ I + +
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKK--QRFTEERIWNIFVQMV 123
Query: 248 KGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTI 307
L YLH+ RI+H D+ P+NI+L +D I+DFGLAK +K S L GTI
Sbjct: 124 LALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK----QKQPESKLTSVVGTI 177
Query: 308 GYIALEVF-SRNFGEVSHKSDVYSFGMMIMELV 339
Y E+ + +GE K+DV++FG ++ ++
Sbjct: 178 LYSCPEIVKNEPYGE---KADVWAFGCILYQMC 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 32/197 (16%)
Query: 164 KLGQGGFGGVYKG-----------KLLDGLASIS----------RTSHVNVVTLLGFCLE 202
KLG G FG V+ G L G S+ H +V L +
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 203 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRIL 262
+I E+M GSL F+ + + K + K+ + IA+G+ Y+ R +
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGK----VLLPKLIDFSAQIAEGMAYIER---KNYI 125
Query: 263 HFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEV 322
H D++ N+L+ + KI+DFGLA++ + ++ GA+ I + A E NFG
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAI--NFGSF 181
Query: 323 SHKSDVYSFGMMIMELV 339
+ KSDV+SFG+++ E+V
Sbjct: 182 TIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 52/216 (24%)
Query: 165 LGQGGFGGVYKGKLLDGLAS------------------------------ISRTSHVNVV 194
LG G FG VY+G D L +S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 195 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEIVIGIAKGLEYL 253
LLG CL + +I E M G L ++ + L +++ +I + +AKG YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 254 HRGCSTRILHFDIKPHNILL-----DQDFCPKISDFGLAKLCTT-----KKGIVSSLLGA 303
+ +H D+ N L+ D D KI DFGLA+ K+G LL
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG--EGLLPV 177
Query: 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
R ++A E G+ + +SDV+SFG+++ E++
Sbjct: 178 R----WMAPESLLD--GKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 45/151 (29%), Positives = 76/151 (50%), Gaps = 32/151 (21%)
Query: 163 DKLGQGGFGGVYKGKLL-----------------DGLAS-----IS---RTSHVNVVTLL 197
+K+G+G +G VYKG+ +G+ S IS H N+V L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
++ + LI+EF+ + L+K++ D+ QY+ E + + I +G+ + H
Sbjct: 66 DVLMQESRLYLIFEFL-SMDLKKYL---DSLPKGQYMDAELVKSYLYQILQGILFCH--- 118
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK 288
S R+LH D+KP N+L+D K++DFGLA+
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 50/163 (30%), Positives = 74/163 (45%), Gaps = 26/163 (15%)
Query: 186 SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE---KFVYNG---DTSKPCQYLRWEKM 239
S+ +H NVV + G+ L+ ++ GSL K Y D + L+
Sbjct: 54 SQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK---- 109
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
+ KGLEYLH +H DIK NILL +D KI+DFG++ G +
Sbjct: 110 -----EVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSA-SLADGGDRTR 160
Query: 300 LLGAR----GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
R GT ++A EV + G K+D++SFG+ +EL
Sbjct: 161 --KVRKTFVGTPCWMAPEVMEQVHG-YDFKADIWSFGITAIEL 200
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 4e-12
Identities = 48/155 (30%), Positives = 70/155 (45%), Gaps = 20/155 (12%)
Query: 190 HVNVVTLLGFCLEG--NNRALIYEFMPNGSLEKFVYNG----DTSKPCQYLRWEKMYEIV 243
H N+V G C N L+ E++P GSL ++ D K Y +
Sbjct: 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY-ASQ------ 116
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA 303
I KG+EYL S R +H D+ NIL++ + KI DFGL K+ K
Sbjct: 117 --ICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPG 171
Query: 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
I + A E + + + S SDV+SFG+++ EL
Sbjct: 172 ESPIFWYAPESLTES--KFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 4e-12
Identities = 35/94 (37%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK-LCTTKKGIVSSLLGAR 304
I LEYLH S I++ D+KP NILLD D K++DFGLAK L + +
Sbjct: 102 IVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC---- 154
Query: 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
GT Y+A EV D +S G+++ E+
Sbjct: 155 GTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEM 186
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 44/160 (27%), Positives = 86/160 (53%), Gaps = 18/160 (11%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YNGDTSK-PCQYLRWEKM 239
H N++ LLG C + +I E+ G+L +++ Y+ D ++ P + + ++ +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
+A+G+EYL S + +H D+ N+L+ ++ KI+DFGLA+ +
Sbjct: 140 VSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 300 LLGARGTIGYIALE-VFSRNFGEVSHKSDVYSFGMMIMEL 338
G R + ++A E +F R + +H+SDV+SFG+++ E+
Sbjct: 197 TNG-RLPVKWMAPEALFDRVY---THQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 8e-12
Identities = 48/202 (23%), Positives = 88/202 (43%), Gaps = 37/202 (18%)
Query: 162 KDKLGQGGFGGVYK-------------------------GKLLDGLASISRTSHVNVVTL 196
+K+G+G FG V+K + +D +++ ++
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
L+ ++ E+ NG L K + + + L ++++ I I GL +LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLK----MQRGRPLPEDQVWRFFIQILLGLAHLH-- 118
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
S +ILH DIK N+ LD KI D G+AKL + ++++ GT Y++ E+
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV---GTPYYLSPELCE 174
Query: 317 RNFGEVSHKSDVYSFGMMIMEL 338
+ KSDV++ G+++ E
Sbjct: 175 DK--PYNEKSDVWALGVVLYEC 194
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 39/152 (25%), Positives = 67/152 (44%), Gaps = 34/152 (22%)
Query: 163 DKLGQGGFGGVYKGK-LLDG------------------------LASISRTSHVNVVTLL 197
K+G+G +G VYK + L G + + +H N++ LL
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
+ L++EFM + L K + D + L + + + +GL + H
Sbjct: 65 DVFRHKGDLYLVFEFM-DTDLYKLI--KDRQRG---LPESLIKSYLYQLLQGLAFCH--- 115
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKL 289
S ILH D+KP N+L++ + K++DFGLA+
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLARS 147
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 50/164 (30%), Positives = 86/164 (52%), Gaps = 26/164 (15%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YNGDTSK-PCQYLRWEKM 239
H N++ LLG C + +I E+ G+L +F+ Y D +K P + L ++ +
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK----LCTTKKG 295
+A+G+EYL S R +H D+ N+L+ +D KI+DFGLA+ + KK
Sbjct: 137 VSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKK- 192
Query: 296 IVSSLLGARGTIGYIALE-VFSRNFGEVSHKSDVYSFGMMIMEL 338
R + ++A E +F R + +H+SDV+SFG+++ E+
Sbjct: 193 ----TSNGRLPVKWMAPEALFDRVY---THQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 72/292 (24%), Positives = 110/292 (37%), Gaps = 71/292 (24%)
Query: 165 LGQGGFGGVYKGKL--LDGLAS---------------------------ISRTSHVNVVT 195
LG G FG VY+G DG A +S+ +H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 196 LLGFCLEGNNRALIYEFMPNGSLEKFVYNG--DTSKPCQYLRWEKMYEIVIGIAKGLEYL 253
L+G E R ++ E M G L+ F+ +P L + + +AKG +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS-LTMKDLLFCARDVAKGCKYL 132
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCP------KISDFGLAKLCTTKKGIVSSLLGARG-- 305
+H DI N LL C KI+DFG+A+ I + +G
Sbjct: 133 E---ENHFIHRDIAARNCLLT---CKGPGRVAKIADFGMAR------DIYRASYYRKGGR 180
Query: 306 ---TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY 362
I ++ E F G + K+DV+SFG+++ E+ S Y P +
Sbjct: 181 AMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIF-------------SLGYMP-YPG 224
Query: 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
R ++ EF G + + C Q P DRP ++E +Q
Sbjct: 225 RTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 54/205 (26%), Positives = 81/205 (39%), Gaps = 47/205 (22%)
Query: 165 LGQGGFGGVYKGKLLDGLASI-----------------------SRTSHVNVVTLLGFCL 201
LG+G +G VY + L I S H N+V LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 202 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY--EIVIG-----IAKGLEYLH 254
E + E +P GSL + + +W + E I I +GL+YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRS----------KWGPLKDNEQTIIFYTKQILEGLKYLH 125
Query: 255 RGCSTRILHFDIKPHNILLDQ-DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALE 313
+I+H DIK N+L++ KISDFG +K + GT+ Y+A E
Sbjct: 126 ---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TGTLQYMAPE 179
Query: 314 VFSRNFGEVSHKSDVYSFGMMIMEL 338
V + +D++S G I+E+
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 47/156 (30%), Positives = 81/156 (51%), Gaps = 27/156 (17%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
H N+V + L G+ ++ EF+ G+L V + ++ E++ + + + K
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQIATVCLAVLKA 127
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG----LAKLCTTKKGIVSSLLGARG 305
L +LH + ++H DIK +ILL D K+SDFG ++K +K +V G
Sbjct: 128 LSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-------G 177
Query: 306 TIGYIALEVFSRN-FG-EVSHKSDVYSFGMMIMELV 339
T ++A EV SR +G EV D++S G+M++E+V
Sbjct: 178 TPYWMAPEVISRLPYGTEV----DIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 50/205 (24%), Positives = 85/205 (41%), Gaps = 36/205 (17%)
Query: 163 DKLGQGGFGGVYK------GKLL-------DGLASISRTSHVNVVTLL---------GFC 200
+ +G+G FG V K GK+L + + V+ V +L +
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 201 LEGNNRA-----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHR 255
+R+ ++ E+ G L + + K +Y+ E ++ I+ + L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQK--CKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 256 GC--STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALE 313
+LH D+KP NI LD + K+ DFGLAK+ + + GT Y++ E
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV---GTPYYMSPE 180
Query: 314 VFSRNFGEVSHKSDVYSFGMMIMEL 338
+ KSD++S G +I EL
Sbjct: 181 QLNHM--SYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 44/170 (25%), Positives = 82/170 (48%), Gaps = 36/170 (21%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV---------YNGDTSK-PCQYLRWEKM 239
H N++ LLG C + ++ E+ +G+L F+ + D + P + L + +
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA---------KLC 290
+A+G+E+L S + +H D+ N+L+ +D KI+DFGLA +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 291 TTKKGIVSSLLGARGTIGYIALE-VFSRNFGEVSHKSDVYSFGMMIMELV 339
T R + ++A E +F R + +H+SDV+SFG+++ E+
Sbjct: 192 TN----------GRLPVKWMAPEALFDRVY---THQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 4e-11
Identities = 71/290 (24%), Positives = 124/290 (42%), Gaps = 65/290 (22%)
Query: 164 KLGQGGFGGVYKG----------------KLLDGLASI-SRTSHVN------------VV 194
+LGQG FG VY+G K ++ AS+ R +N VV
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 195 TLLGFCLEGNNRALIYEFMPNGSLEKFVYN------GDTSKPCQYLRWEKMYEIVIGIAK 248
LLG +G ++ E M +G L+ ++ + + +P L+ +M ++ IA
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIAD 130
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK-LCTT---KKGIVSSLLGAR 304
G+ YL+ + + +H D+ N ++ DF KI DFG+ + + T +KG LL R
Sbjct: 131 GMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG-GKGLLPVR 186
Query: 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364
+A E S G + SD++SFG+++ E+ G+ N
Sbjct: 187 W----MAPE--SLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN------------- 227
Query: 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
EQ +F + G + + +++ + C Q P RP E++ +L+
Sbjct: 228 -EQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 41/204 (20%)
Query: 165 LGQGGFGGVYKGKL--------------------------LDGLASI-SRTSHVNVVTLL 197
+G G FG V++G L ASI + SH N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
G + +I E+M NG+L+K++ + D Q + ++ GIA G++YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQ------LVGMLRGIAAGMKYL--- 123
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
+H D+ NIL++ + K+SDFGL+++ + G + I + A E +
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183
Query: 317 -RNFGEVSHKSDVYSFGMMIMELV 339
R F + SDV+SFG+++ E++
Sbjct: 184 YRKF---TSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 74/296 (25%), Positives = 121/296 (40%), Gaps = 61/296 (20%)
Query: 155 KKITNSFKDKLGQGGFGGVYKG----------------KLLDGLASI-SRTSHVN----- 192
+KIT S +LGQG FG VY+G K ++ AS+ R +N
Sbjct: 6 EKITMS--RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 193 -------VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN---GDTSKPCQYL-RWEKMYE 241
VV LLG +G +I E M G L+ ++ + + P Q +KM +
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
+ IA G+ YL+ + + +H D+ N ++ +DF KI DFG+ + I +
Sbjct: 124 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDY 174
Query: 302 GARGTIGYIALEVFSRNF---GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP 358
+G G + + S G + SDV+SFG+++ E+ G+ N
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN------- 227
Query: 359 HWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
EQ F + G + K + + + C Q P RP E+I ++
Sbjct: 228 -------EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 49/177 (27%), Positives = 85/177 (48%), Gaps = 21/177 (11%)
Query: 190 HVNVVTLLGFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV 243
H NV+ L+G L + +I FM +G L F+ + L + + +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT----KKGIVSS 299
I IA G+EYL S +H D+ N +L+++ ++DFGL+K + ++G S
Sbjct: 120 IDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASK 176
Query: 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356
L + ++ALE + N SDV++FG+ + E++ +GV+N SE+Y
Sbjct: 177 L-----PVKWLALESLADNVYTT--HSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIY 225
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 6e-11
Identities = 49/234 (20%), Positives = 102/234 (43%), Gaps = 37/234 (15%)
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYEIV 243
+S H N++ ++ N + E+ G+L +K V + + W +++IV
Sbjct: 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-YLFQIV 111
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA 303
++ Y+H ILH DIK NI L + K+ DFG++K+ ++ + +++
Sbjct: 112 SAVS----YIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-- 162
Query: 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363
GT Y++ E+ + + KSD+++ G ++ EL+ K D+ N +
Sbjct: 163 -GTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDA--TNPLNL-------- 209
Query: 364 HVEQDREFKLLGVVTKKENEI----AKKMIIVGLWCIQARPYDRPPMNEVIEML 413
++ +V + + ++I + +Q P RP +EV++
Sbjct: 210 ---------VVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 41/155 (26%)
Query: 163 DKLGQGGFGGVYKGKLL-----------------DGLAS-----IS---RTSHVNVVTLL 197
+K+G+G +G VYK + +G+ S IS +H N+V LL
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK----MYEIVIGIAKGLEYL 253
N L++EF+ + L+K++ S P L +Y+++ GIA Y
Sbjct: 65 DVVHSENKLYLVFEFL-DLDLKKYM----DSSPLTGLDPPLIKSYLYQLLQGIA----YC 115
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
H S R+LH D+KP N+L+D++ K++DFGLA+
Sbjct: 116 H---SHRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 1e-10
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 48/205 (23%)
Query: 163 DKLGQGGFGGVY-----------------------KGKLLDGLASISRTSHVNVVTLLGF 199
+K+GQG G VY K +++ + + H N+V L
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEYLH 254
L G+ ++ E++ GSL V ++ C M E I + LE+LH
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVV-----TETC-------MDEGQIAAVCRECLQALEFLH 132
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEV 314
S +++H DIK NILL D K++DFG T ++ S+++ GT ++A EV
Sbjct: 133 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEV 186
Query: 315 FSRNFGEVSHKSDVYSFGMMIMELV 339
+R K D++S G+M +E+V
Sbjct: 187 VTRK--AYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 2e-10
Identities = 57/203 (28%), Positives = 84/203 (41%), Gaps = 64/203 (31%)
Query: 186 SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR--------WE 237
H +V L G + +N L+ E++P G L F +LR
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL--F----------SHLRKSGRFPEPVA 103
Query: 238 KMY--EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK------- 288
+ Y ++V+ LEYLH S I++ D+KP N+LLD D KI+DFG AK
Sbjct: 104 RFYAAQVVLA----LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY 156
Query: 289 -LCTTKKGIVSSLLGARGTIGYIALEVF-SRNFGEVSHKS-DVYSFGMMIME-LVGCKNN 344
LC GT Y+A E+ S+ +G K+ D ++ G++I E L G
Sbjct: 157 TLC--------------GTPEYLAPEIILSKGYG----KAVDWWALGILIYEMLAGYPPF 198
Query: 345 LDSGVDN------SSEVYFPHWI 361
D +V FP +
Sbjct: 199 FDDNPIQIYEKILEGKVRFPSFF 221
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 52/218 (23%), Positives = 91/218 (41%), Gaps = 49/218 (22%)
Query: 161 FKDKLGQGGFGGVY----------KGKLLDGLASISRTS------------------HVN 192
K +LG+G FG V+ + K+L + ++ S H +
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKF---------VYNGDTSKPCQYLRWEKMYEIV 243
+V G C EG +++E+M +G L +F + G L +M I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS---L 300
IA G+ YL S +H D+ N L+ Q KI DFG++ + I S+
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS------RDIYSTDYYR 179
Query: 301 LGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+G R + + S + + + +SD++SFG+++ E+
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 54/204 (26%), Positives = 78/204 (38%), Gaps = 39/204 (19%)
Query: 163 DKLGQGGFGGVYKG--------------------KLLDGL-------ASISRTSHVNVVT 195
KLG G FG V +G KL D + A + H N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 196 LLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 254
L G L + ++ E P GSL ++ + L + + IA G+ YL
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTL-----CDYAVQIANGMRYLE 114
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEV 314
S R +H D+ NILL D KI DFGL + + + + A E
Sbjct: 115 ---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE- 170
Query: 315 FSRNFGEVSHKSDVYSFGMMIMEL 338
S SH SDV+ FG+ + E+
Sbjct: 171 -SLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 39/201 (19%)
Query: 164 KLGQGGFGGVYKG---------------------------KLLDGLASISRTSHVNVVTL 196
+LG G FG V KG +LL + + + +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
+G C E + L+ E G L KF+ +++ + + E+V ++ G++YL
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKN------KHVTEKNITELVHQVSMGMKYLEE- 113
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
T +H D+ N+LL KISDFGL+K + + + + + A E
Sbjct: 114 --TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM- 170
Query: 317 RNFGEVSHKSDVYSFGMMIME 337
N+ + S KSDV+SFG+++ E
Sbjct: 171 -NYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 49/209 (23%)
Query: 164 KLGQGGFGGVYK-----------------GKLLDG--------LASISRTSHVNVVTLLG 198
++G+G G V+K +L G + ++ H VV LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ----YLRWEKMYEIVIGIAKGLEYLH 254
G+ L+ E+MP L + + + + P Y+R M + KG+ Y+H
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMR---M------LLKGVAYMH 116
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEV 314
+ I+H D+KP N+L+ D KI+DFGLA+L + ++ + S T Y A E+
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS--HQVATRWYRAPEL 171
Query: 315 F--SRNFGEVSHKSDVYSFGMMIMELVGC 341
+R + D+++ G + EL+
Sbjct: 172 LYGARKYDP---GVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPC-QYLRWEKMYEIV 243
+ SH N++ LE ++ E+ P G+L +++ K C L + +
Sbjct: 53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI-----QKRCNSLLDEDTILHFF 107
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-DFCPKISDFGLAKLCTTKKGIVSSLLG 302
+ I L ++H + ILH D+K NILLD+ KI DFG++K+ ++K S
Sbjct: 108 VQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK----SKAYT 160
Query: 303 ARGTIGYIALEVF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS 347
GT YI+ E+ + + + KSD+++ G ++ EL K ++
Sbjct: 161 VVGTPCYISPELCEGKPYNQ---KSDIWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 39/204 (19%)
Query: 165 LGQGGFGGVYKGKL--------------------------LDGLASI-SRTSHVNVVTLL 197
+G G FG V +G+L ASI + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
G + +I EFM NG+L+ F+ D L ++ GIA G++YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL-----VGMLRGIAAGMKYL---S 123
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLC--TTKKGIVSSLLGARGTIGYIALEVF 315
+H D+ NIL++ + K+SDFGL++ T +S LG + I + A E
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 316 SRNFGEVSHKSDVYSFGMMIMELV 339
+ + + + SDV+S+G+++ E++
Sbjct: 184 A--YRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 2e-10
Identities = 50/147 (34%), Positives = 72/147 (48%), Gaps = 23/147 (15%)
Query: 204 NNRALIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMY--EIVIGIAKGLEYLHRGCSTR 260
N L+ E++P G L + N G + ++Y EIV+ LEYLH S
Sbjct: 66 KNLYLVMEYLPGGDLASLLENVGSLDE-----DVARIYIAEIVLA----LEYLH---SNG 113
Query: 261 ILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR-----GTIGYIALEVF 315
I+H D+KP NIL+D + K++DFGL+K+ ++ I + GT YIA EV
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 316 SRNFGEVSHKSDVYSFGMMIME-LVGC 341
G S D +S G ++ E LVG
Sbjct: 174 -LGQGH-SKTVDWWSLGCILYEFLVGI 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 57/249 (22%), Positives = 96/249 (38%), Gaps = 52/249 (20%)
Query: 178 LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE 237
L + ++R +H +++ +LG E ++ L E+M GS+ + K + +
Sbjct: 50 LRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINY- 108
Query: 238 KMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD---QDFCPKISDFGLAKLCTTKK 294
+ +GL YLH +I+H D+K N+L+D Q +I+DFG A K
Sbjct: 109 -----TEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKG 158
Query: 295 GIVSSLLGAR-GTIGYIALEVF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS 352
G GTI ++A EV +G DV+S G +I+E+ +
Sbjct: 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGR---SCDVWSVGCVIIEM--ATAKPPWNAEKH 213
Query: 353 SEVYF----------PHWIYRHVEQD-REFKLLGVVTKKENEIAKKMIIVGLWCIQARPY 401
S I H+ R+ L C++ +P
Sbjct: 214 SNHLALIFKIASATTAPSIPEHLSPGLRDVTLR--------------------CLELQPE 253
Query: 402 DRPPMNEVI 410
DRPP E++
Sbjct: 254 DRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 34/94 (36%), Positives = 48/94 (51%), Gaps = 9/94 (9%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I GLE+LH+ RI++ D+KP N+LLD +ISD GLA K G + G G
Sbjct: 104 IICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLA--VELKGG--KKIKGRAG 156
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
T GY+A EV D ++ G + E++
Sbjct: 157 TPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMI 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 44/163 (26%), Positives = 80/163 (49%), Gaps = 18/163 (11%)
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV--------YNGDTSKPCQYLRW 236
+SR + N++ LLG C+ + +I E+M NG L +F+ + + P +
Sbjct: 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS--VSI 128
Query: 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296
+ + + IA G++YL S +H D+ N L+ + KI+DFG+++ G
Sbjct: 129 ANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR--NLYSGD 183
Query: 297 VSSLLG-ARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+ G A I ++A E S G+ + SDV++FG+ + E+
Sbjct: 184 YYRIQGRAVLPIRWMAWE--SILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 35/194 (18%)
Query: 165 LGQGGFGGV----YKGKLL-------DGLAS--------ISRTSHVNVVTLLGFCLEGNN 205
+G+G FG V Y+G + D A +++ H N+V LLG +E
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73
Query: 206 RALIY-EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHF 264
I E+M GSL ++ S+ L + + + + + + +EYL + +H
Sbjct: 74 GLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHR 126
Query: 265 DIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSH 324
D+ N+L+ +D K+SDFGL K ++ + + + + A E + S
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT------GKLPVKWTAPEALREK--KFST 178
Query: 325 KSDVYSFGMMIMEL 338
KSDV+SFG+++ E+
Sbjct: 179 KSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-10
Identities = 43/152 (28%), Positives = 75/152 (49%), Gaps = 12/152 (7%)
Query: 190 HVNVVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 247
H N+V G C E LI EF+P+GSL++++ + + ++ + + I
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-----PRNKNKINLKQQLKYAVQIC 119
Query: 248 KGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTI 307
KG++YL S + +H D+ N+L++ + KI DFGL K T K + +
Sbjct: 120 KGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 308 GYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ A E ++ + SDV+SFG+ + EL+
Sbjct: 177 FWYAPECLIQS--KFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 4e-10
Identities = 42/158 (26%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 183 ASI-SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
ASI + H N++ L G + ++ E+M NGSL+ F+ D ++
Sbjct: 56 ASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ-----FTVIQLVG 110
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
++ GIA G++YL +H D+ NIL++ + K+SDFGL+++ +
Sbjct: 111 MLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
G + I + A E + + + + SDV+S+G+++ E++
Sbjct: 168 GGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 4e-10
Identities = 51/201 (25%), Positives = 87/201 (43%), Gaps = 36/201 (17%)
Query: 164 KLGQGGFGGVYKGK-LLDGLAS-------------------------ISRTSHVNVVTLL 197
K+G+G F VYK LLDG + + H NV+ L
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
+E N ++ E G L + + + K + + +++ + + LE++H
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKH--FKKQKRLIPERTIWKYFVQLCSALEHMH--- 123
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
S RI+H DIKP N+ + K+ D GL + ++K SL+ GT Y++ E
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIHE 180
Query: 318 NFGEVSHKSDVYSFGMMIMEL 338
N + KSD++S G ++ E+
Sbjct: 181 N--GYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 6e-10
Identities = 66/214 (30%), Positives = 91/214 (42%), Gaps = 55/214 (25%)
Query: 165 LGQGGFGGVY------KGKLLD------GLASISRTSHVN----------------VVTL 196
LGQG FG VY G+ L S VN +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 197 LGFCLEGNNRALIY-EFMPNGSLEKFV--YNGDT-SKPCQYLRWEKMYEIVIGIAKGLEY 252
G CL + I+ E+MP GS++ + Y T + +Y R I +G+EY
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR---------QILEGVEY 119
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG---Y 309
LH S I+H DIK NIL D K+ DFG +K T I SS G + G +
Sbjct: 120 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT---ICSSGTGMKSVTGTPYW 173
Query: 310 IALEVFSRNFGE-VSHKSDVYSFGMMIMELVGCK 342
++ EV S GE K+DV+S G ++E++ K
Sbjct: 174 MSPEVIS---GEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 2e-09
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 41/211 (19%)
Query: 153 DVKKITNSFKDKLGQGGFGGVY-----------------------KGKLLDGLASISRTS 189
D KK F +K+GQG G VY K +++ + +
Sbjct: 17 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
+ N+V L L G+ ++ E++ GSL V ++ C + ++ + +
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETC--MDEGQIAAVCRECLQA 128
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
LE+LH S +++H DIK NILL D K++DFG T ++ S+++ GT +
Sbjct: 129 LEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYW 182
Query: 310 IALEVFSRN-FGEVSHKSDVYSFGMMIMELV 339
+A EV +R +G K D++S G+M +E++
Sbjct: 183 MAPEVVTRKAYGP---KVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 39/157 (24%), Positives = 76/157 (48%), Gaps = 12/157 (7%)
Query: 183 ASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEI 242
++ + H N+V L G GN ++ E+M NG+L+ F+ + L ++ +
Sbjct: 58 LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ-----LVAGQLMGM 112
Query: 243 VIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLG 302
+ G+A G++YL +H + H +L++ D KIS F +L K + + +
Sbjct: 113 LPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMS 167
Query: 303 ARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ + + A E + S SDV+SFG+++ E++
Sbjct: 168 GKSPVLWAAPEAI--QYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 2e-09
Identities = 40/160 (25%), Positives = 65/160 (40%), Gaps = 50/160 (31%)
Query: 163 DKLGQGGFGGVYKG-------------------------------KLLDGLASISRTSHV 191
++G+G +G VYK KLL L H
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL------RHP 58
Query: 192 NVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR-WEKMYEIVIGIAK 248
N+V L + +++E+M + L + + + ++ + K + +
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQ------LLE 111
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
GL+YLH S ILH DIK NIL++ D K++DFGLA+
Sbjct: 112 GLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 39/151 (25%), Positives = 62/151 (41%), Gaps = 35/151 (23%)
Query: 164 KLGQGGFGGVYKGKLLD--GLASISR-----------------------TSHVNVVTLLG 198
+LG G FG VY + + L +I + H N+V L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHR-GC 257
E + ++E+M G+L + KP + I+ I +GL ++H+ G
Sbjct: 66 VFRENDELYFVFEYM-EGNLYQL-MKDRKGKPFSE---SVIRSIIYQILQGLAHIHKHG- 119
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK 288
H D+KP N+L+ KI+DFGLA+
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 2e-09
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 39/210 (18%)
Query: 153 DVKKITNSFKDKLGQGGFGGVY-----------------------KGKLLDGLASISRTS 189
D KK F +K+GQG G VY K +++ + +
Sbjct: 16 DPKKKYTRF-EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK 74
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
+ N+V L L G+ ++ E++ GSL V ++ C + ++ + +
Sbjct: 75 NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----TETC--MDEGQIAAVCRECLQA 127
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
L++LH S +++H DIK NILL D K++DFG T ++ S+++ GT +
Sbjct: 128 LDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYW 181
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+A EV +R K D++S G+M +E+V
Sbjct: 182 MAPEVVTRK--AYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 47/147 (31%), Positives = 76/147 (51%), Gaps = 17/147 (11%)
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
+V+ G L NN + EFM GSL++ K + E + +I + + +GL Y
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRI------YKKGGPIPVEILGKIAVAVVEGLTY 118
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA-RGTIGYIA 311
L+ RI+H DIKP NIL++ K+ DFG++ +++S+ GT Y++
Sbjct: 119 LYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVS------GELINSIADTFVGTSTYMS 170
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMEL 338
E G+ + KSDV+S G+ I+EL
Sbjct: 171 PERIQG--GKYTVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 45/155 (29%), Positives = 80/155 (51%), Gaps = 25/155 (16%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
H NVV + L G+ ++ EF+ G+L V + ++ E++ + + + +
Sbjct: 78 HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQIATVCLSVLRA 130
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG----LAKLCTTKKGIVSSLLGARG 305
L YLH + ++H DIK +ILL D K+SDFG ++K +K +V G
Sbjct: 131 LSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-------G 180
Query: 306 TIGYIALEVFSR-NFGEVSHKSDVYSFGMMIMELV 339
T ++A EV SR +G + D++S G+M++E++
Sbjct: 181 TPYWMAPEVISRLPYGT---EVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 56/240 (23%), Positives = 103/240 (42%), Gaps = 54/240 (22%)
Query: 185 ISRTSHVNVVT--------------LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 230
+S+ H N+V ++GFC G+ +Y+ +
Sbjct: 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGD-----------------LYHKLKEQK 95
Query: 231 CQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290
+ L ++ E + IA L+YLH ILH D+K N+ L + K+ D G+A++
Sbjct: 96 GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVL 152
Query: 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD 350
+ + S+L+ GT Y++ E+FS ++KSDV++ G + E+ K+ ++
Sbjct: 153 ENQCDMASTLI---GTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDM 207
Query: 351 NSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410
NS +YR +E KL + E+ + +I + RP RP + ++
Sbjct: 208 NS-------LVYRIIEG----KLPPMPKDYSPELGE--LIATMLS--KRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 54/219 (24%), Positives = 92/219 (42%), Gaps = 57/219 (26%)
Query: 162 KDKLGQGGFGGVYKGKLLDGLASISR----------------------------TSHVNV 193
D L +G FG ++ G L+D SH N+
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 194 VTLLGFCLEGNNRALI-YEFMPNGSLEKFVYN---GDTSKPCQYLRWEKMYEIVIGIAKG 249
+ +L C+E + Y +M G+L+ F+ G+ + P Q L +++ + I IA G
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNP-QALSTQQLVHMAIQIACG 129
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK-------LCTTKKGIVSSLLG 302
+ YLH+ ++H DI N ++D++ KI+D L++ C LG
Sbjct: 130 MSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC----------LG 176
Query: 303 ARGT--IGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ ++ALE S SDV+SFG+++ EL+
Sbjct: 177 DNENRPVKWMALESLVNKE--YSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 22/158 (13%)
Query: 185 ISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV 243
I R +H NVV ++ EFM GSLE + Q+L ++
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADE-----QFLA-----DVA 174
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK-LCTTKKGIVSSLLG 302
I G+ YLHR I+H DIKP N+L++ KI+DFG+++ L T SS+
Sbjct: 175 RQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-- 229
Query: 303 ARGTIGYIALEVFSRNFGEVSHK---SDVYSFGMMIME 337
GTI Y++ E + + ++ D++S G+ I+E
Sbjct: 230 --GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 12/154 (7%)
Query: 189 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV----YNGDTSKPCQYLRWEKMYEIVI 244
SH NVV LLG C E +I E+ G L++F+ + KP L ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKP-PPLSTKQKVALCT 124
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR 304
IA G+++L R +H D+ N L+ K+S L+K L A
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNAL 179
Query: 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+ ++A E + + S KSDV+SFG+++ E+
Sbjct: 180 IPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 39/116 (33%), Positives = 62/116 (53%), Gaps = 15/116 (12%)
Query: 227 TSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGL 286
+ CQY +Y+++ +GL+Y+H S +LH D+KP N+LL+ + KI DFGL
Sbjct: 106 SDDHCQYF----LYQLL----RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGL 154
Query: 287 AKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
A+ + K ++ + R Y A E+ N E + DV+S G + EL+G K
Sbjct: 155 ARTTSEKGDFMTEYVVTR---WYRAPELL-LNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 44/142 (30%), Positives = 63/142 (44%), Gaps = 28/142 (19%)
Query: 203 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYL--RWEKMY--EIVIGIAKGLEYLH-RGC 257
+ L+ E++ G + K L W K Y E+V+G+ E LH RG
Sbjct: 69 KDYLYLVMEYLNGGDCASLI------KTLGGLPEDWAKQYIAEVVLGV----EDLHQRG- 117
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
I+H DIKP N+L+DQ K++DFGL++ K V GT Y+A E
Sbjct: 118 ---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV-------GTPDYLAPETILG 167
Query: 318 NFGEVSHKSDVYSFGMMIMELV 339
SD +S G +I E +
Sbjct: 168 VGD--DKMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 17/151 (11%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
H NVV + L G+ ++ EF+ G+L V + ++ E++ + + + K
Sbjct: 76 HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNE-------EQIAAVCLAVLKA 128
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
L LH + ++H DIK +ILL D K+SDFG + + SL+ GT +
Sbjct: 129 LSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV---GTPYW 182
Query: 310 IALEVFSR-NFGEVSHKSDVYSFGMMIMELV 339
+A E+ SR +G + D++S G+M++E+V
Sbjct: 183 MAPELISRLPYGP---EVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 6e-09
Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 54/273 (19%)
Query: 163 DKLGQGGFGGVYKG-----------KLLD-------------GLASISRTSHVNVVTLLG 198
+++G+G FG V+KG K++D + +S+ V G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
L+G +I E++ GS + G P + M + ++ KGL+YLH S
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQIATMLKEIL---KGLDYLH---S 119
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
+ +H DIK N+LL + K++DFG+A T + ++ + GT ++A EV ++
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVIQQS 176
Query: 319 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378
K+D++S G+ +EL G +S+++ P + + ++ L G +
Sbjct: 177 --AYDSKADIWSLGITAIELA-------KGEPPNSDMH-PMRVLFLIPKNNPPTLTGEFS 226
Query: 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
K E C+ P RP E+++
Sbjct: 227 KPFKEFIDA-------CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 7e-09
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 53/222 (23%)
Query: 165 LGQGGFGGVYKGKL--LDGLASIS---------------------------RTSHVNVVT 195
LG+G FG V K L G A + + +H +V+
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 196 LLGFCLEGNNRALIYEFMPNGSLEKFV----------YNGDTSKPCQYLRWEKMYEIVIG 245
L G C + LI E+ GSL F+ D ++ YL + +G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 246 --------IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297
I++G++YL +++H D+ N+L+ + KISDFGL++ + V
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
G R + ++A+E + + +SDV+SFG+++ E+V
Sbjct: 185 KRSKG-RIPVKWMAIESLFDHI--YTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 39/200 (19%)
Query: 163 DKLGQGGFGGVYKG-----------KLLD-------------GLASISRTSHVNVVTLLG 198
+++G+G FG VYKG K++D + +S+ + G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
L+G +I E++ GS + G L + I+ I KGL+YLH S
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGP-------LEETYIATILREILKGLDYLH---S 119
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
R +H DIK N+LL + K++DFG+A T + ++ + GT ++A EV ++
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVIKQS 176
Query: 319 FGEVSHKSDVYSFGMMIMEL 338
K+D++S G+ +EL
Sbjct: 177 --AYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 44/150 (29%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 189 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 248
+H N+V LLG C G +I E+ G L F+ K +L E + +AK
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR----RKRESFLTLEDLLSFSYQVAK 152
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG 308
G+ +L S +H D+ N+LL KI DFGLA+ V AR +
Sbjct: 153 GMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVK-GNARLPVK 208
Query: 309 YIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
++A E +SDV+S+G+++ E+
Sbjct: 209 WMAPESIFNCVYTF--ESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 8e-09
Identities = 43/142 (30%), Positives = 63/142 (44%), Gaps = 24/142 (16%)
Query: 208 LIYEFMPNGSLEKFVYNGDTSKP-------CQYLRWEKMYEIVIGIAKGLEYLHRGCSTR 260
L+ M G L +YN D P C Y I GLE+LH+ R
Sbjct: 70 LVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY---------TAQIISGLEHLHQ---RR 117
Query: 261 ILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFG 320
I++ D+KP N+LLD D +ISD GLA + S G GT G++A E+
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAGTPGFMAPELLQGE-- 172
Query: 321 EVSHKSDVYSFGMMIMELVGCK 342
E D ++ G+ + E++ +
Sbjct: 173 EYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-09
Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 36/210 (17%)
Query: 160 SFKDKLGQGGFGGVYKGK-LLDG-------------------------LASISRTSHVNV 193
+ K+G+G F VY+ LLDG + + + +H NV
Sbjct: 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 64
Query: 194 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 253
+ +E N ++ E G L + + + K + + + +++ + + LE++
Sbjct: 65 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK--RLIPEKTVWKYFVQLCSALEHM 122
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALE 313
H S R++H DIKP N+ + K+ D GL + ++K SL+ GT Y++ E
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPE 176
Query: 314 VFSRNFGEVSHKSDVYSFGMMIMELVGCKN 343
N + KSD++S G ++ E+ ++
Sbjct: 177 RIHEN--GYNFKSDIWSLGCLLYEMAALQS 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 9e-09
Identities = 55/208 (26%), Positives = 87/208 (41%), Gaps = 57/208 (27%)
Query: 164 KLGQGGFGGVYKG-----------KLLDGLAS-------------ISRTSHVNVVTLLGF 199
+G+G FG VYK K++D + +S+ + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEYLH 254
L+G+ +I E+ GS D KP K+ E I + GLEYLH
Sbjct: 68 FLKGSKLWIIMEYCGGGSCL------DLLKPG------KLDETYIAFILREVLLGLEYLH 115
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR----GTIGYI 310
+H DIK NILL ++ K++DFG++ G ++S + R GT ++
Sbjct: 116 EE---GKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWM 165
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
A EV + K+D++S G+ +EL
Sbjct: 166 APEVIKQ--SGYDEKADIWSLGITAIEL 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 23/154 (14%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
H NVV + L G ++ EF+ G+L V L E++ + + +
Sbjct: 77 HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-------TRLNEEQIATVCESVLQA 129
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG----LAKLCTTKKGIVSSLLGARG 305
L YLH S ++H DIK +ILL D K+SDFG ++K +K +V G
Sbjct: 130 LCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-------G 179
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
T ++A EV SR + D++S G+M++E+V
Sbjct: 180 TPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 50/220 (22%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 154 VKKITNSFKDKLGQGGFGGVY----------KGKLLDGLASISRTS-------------- 189
+K+ K +LG+G FG V+ + K+L + ++ S
Sbjct: 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 190 ----HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV--YNGDT-----SKPCQYLRWEK 238
H ++V G C+EG+ +++E+M +G L KF+ + D L +
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298
M I IA G+ YL S +H D+ N L+ ++ KI DFG+++ +
Sbjct: 122 MLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD---Y 175
Query: 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+G + + S + + + +SDV+S G+++ E+
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 34/94 (36%), Positives = 57/94 (60%), Gaps = 8/94 (8%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
+A L++LH S I++ D+KP NILLD++ K++DFGL+K + S G
Sbjct: 107 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---G 160
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
T+ Y+A EV +R G + +D +SFG+++ E++
Sbjct: 161 TVEYMAPEVVNRR-GH-TQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 5/98 (5%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL-GAR 304
I GL+Y+H S +LH D+KP N+L++ D KI DFGLA+ + G + +
Sbjct: 114 ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
T Y A E+ +F + DV+S G ++ EL+G K
Sbjct: 171 ATRWYRAPEIM-LSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 51/223 (22%)
Query: 158 TNSFKDKLGQGGFGGVYKG----------------KLLDGLASI-------------SRT 188
T F ++LG+ FG VYKG K L A SR
Sbjct: 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL 65
Query: 189 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF---------VYNGDTSKPCQ-YLRWEK 238
H N+V LLG + ++I+ + + L +F V + D K + L
Sbjct: 66 QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK---KG 295
IV IA G+E+L S ++H D+ N+L+ KISD GL + K
Sbjct: 126 FVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+ +SLL R +++ E +G+ S SD++S+G+++ E+
Sbjct: 183 MGNSLLPIR----WMSPEAIM--YGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 41/202 (20%)
Query: 165 LGQGGFGGVYKGK--------------------LLDGLASI---SRTSHVNVVTLLGFCL 201
LG G FG VYK + L D + I S H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 202 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRI 261
N ++ EF G+L+ + + + L ++ + + + L +LH S ++
Sbjct: 73 YENKLWILIEFCDGGALDSIML--ELERG---LTEPQIRYVCRQMLEALNFLH---SHKV 124
Query: 262 LHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEV-----FS 316
+H D+K NILL D K++DFG++ + + + GT ++A EV F
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPYWMAPEVVACETFK 181
Query: 317 RNFGEVSHKSDVYSFGMMIMEL 338
N +K+D++S G+ ++EL
Sbjct: 182 DN--PYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 43/165 (26%)
Query: 150 NFSDVKKITNSFKDKLGQGGFGGVYK------GKLL-----------DGLAS-------- 184
NF V+KI G+G +G VYK G+++ +G+ S
Sbjct: 1 NFQKVEKI--------GEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 52
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY-LRWEKMYEIV 243
+ +H N+V LL N L++EF+ + L+KF+ D S L K Y +
Sbjct: 53 LKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM---DASPLSGIPLPLIKSY--L 106
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
+ +GL + H S R+LH D+KP N+L++ + K++DFGLA+
Sbjct: 107 FQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 43/161 (26%), Positives = 67/161 (41%), Gaps = 47/161 (29%)
Query: 165 LGQGGFGGVYKGK-LLDG---------------------------LASISRTSHVNVVTL 196
+G+G +G VYK + L G L + H N+V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 197 LGFCL-----EGNNRALIYEFMP---NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 248
L C L++E + L K G + + L M +++ +
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL----MRQLL----R 118
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289
G+++LH S RI+H D+KP NIL+ D KI+DFGLA++
Sbjct: 119 GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 38/145 (26%), Positives = 64/145 (44%), Gaps = 11/145 (7%)
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
+V ++G C E L+ E G L KF+ + E++ ++ G++Y
Sbjct: 57 IVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITV-----SNVVELMHQVSMGMKY 110
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
L +H D+ N+LL KISDFGL+K + + + + A
Sbjct: 111 LE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAP 167
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIME 337
E NF + S +SDV+S+G+ + E
Sbjct: 168 ECI--NFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 50/160 (31%), Positives = 74/160 (46%), Gaps = 32/160 (20%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY------NGDTSK--PCQYLRWEKM 239
H NV+ LL F P SLE F VY D + CQ L + +
Sbjct: 73 HENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHI 120
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
+V I +GL+Y+H S I+H D+KP NI +++D KI DFGLA+ +
Sbjct: 121 QFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE------ 171
Query: 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ G T Y A E+ N+ + D++S G ++ EL+
Sbjct: 172 MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 59/233 (25%), Positives = 104/233 (44%), Gaps = 61/233 (26%)
Query: 161 FKDKLGQGGFGGVY--------------------KG-------KLLDGLAS--------- 184
FK+KLG+G FG V+ KG K+L A+
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 185 ----ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY---------NGDTSKPC 231
+SR N++ LLG C++ + +I E+M NG L +F+ NG+ + P
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 232 QY----LRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287
+ + + + + + IA G++YL S +H D+ N L+ ++ KI+DFG++
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 288 KLCTTKKGIVSSLLG-ARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ G + G A I ++A E G+ + SDV++FG+ + E++
Sbjct: 186 R--NLYAGDYYRIQGRAVLPIRWMAWECIL--MGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 49/206 (23%)
Query: 164 KLGQGGFGGVYKGKLL----------------DGLASISRT-------SHVNVVTLLGFC 200
++G G +G VYK + + D I + H N+V G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 201 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA-------KGLEYL 253
L + ++ E+ GSL+ +Y T P L+ IA KGL YL
Sbjct: 70 LRRDKLWIVMEYCGGGSLQD-IYQ-VTRGPLSELQ----------IAYVCRETLKGLAYL 117
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALE 313
H T +H DIK NILL +D K++DFG++ T S + GT ++A E
Sbjct: 118 H---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI---GTPYWMAPE 171
Query: 314 VFSRNF-GEVSHKSDVYSFGMMIMEL 338
V + G K D+++ G+ +EL
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 3e-08
Identities = 42/148 (28%), Positives = 76/148 (51%), Gaps = 15/148 (10%)
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251
N+V L L G+ ++ E++ GSL V ++ C + ++ + + LE
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETC--MDEAQIAAVCRECLQALE 129
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
+LH + +++H DIK N+LL D K++DFG T ++ S+++ GT ++A
Sbjct: 130 FLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMA 183
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMELV 339
EV +R K D++S G+M +E+V
Sbjct: 184 PEVVTRK--AYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 50/219 (22%), Positives = 93/219 (42%), Gaps = 50/219 (22%)
Query: 161 FKDKLGQGGFGGVY----------KGKLLDGLAS------------------ISRTSHVN 192
K +LG+G FG V+ K K+L + + ++ H +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWEKMYEI 242
+V G C +G+ +++E+M +G L KF + +G + L +M I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 243 VIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS--- 299
IA G+ YL S +H D+ N L+ + KI DFG++ + + S+
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDVYSTDYY 179
Query: 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+G + + S + + + +SDV+SFG+++ E+
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 46/201 (22%), Positives = 88/201 (43%), Gaps = 36/201 (17%)
Query: 164 KLGQGGFGGVYKG-----------------KLLDGLAS---------ISRTSHVNVVTLL 197
K+G+G F VY+ +++D A + + +H NV+ L
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
+E N ++ E G L + + K + + +++ + + +E++H
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQK--RLIPERTVWKYFVQLCSAVEHMH--- 123
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
S R++H DIKP N+ + K+ D GL + ++K SL+ GT Y++ E
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIHE 180
Query: 318 NFGEVSHKSDVYSFGMMIMEL 338
N + KSD++S G ++ E+
Sbjct: 181 N--GYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 41/204 (20%)
Query: 163 DKLGQGGFGGVYKGK-------------LLD---GLAS-----IS---RTSHVNVVTLLG 198
+KLG+G + VYKG+ LD G S IS H N+V L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
N L++E+M + L+K++ DT L + + KG+ + H
Sbjct: 66 VIHTENKLMLVFEYM-DKDLKKYM---DTHGVRGALDPNTVKSFTYQLLKGIAFCHE--- 118
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI-VSSLLGARGTIGYIALEVF-- 315
R+LH D+KP N+L+++ K++DFGLA+ GI V++ T+ Y A +V
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLAR----AFGIPVNTFSNEVVTLWYRAPDVLLG 174
Query: 316 SRNFGEVSHKSDVYSFGMMIMELV 339
SR + S D++S G ++ E++
Sbjct: 175 SRTY---STSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 54/230 (23%), Positives = 98/230 (42%), Gaps = 54/230 (23%)
Query: 160 SFKDKLGQGGFGGVY----------------------------------------KGKLL 179
+FK+KLG+G FG V+ + L
Sbjct: 8 TFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 180 DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-----YL 234
+ +SR N++ LL C+ + +I E+M NG L +F+ + + + +
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 235 RWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294
+ + + IA G++YL S +H D+ N L+ +++ KI+DFG+++
Sbjct: 128 SYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR--NLYS 182
Query: 295 GIVSSLLG-ARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIME-LVGCK 342
G + G A I +++ E S G+ + SDV++FG+ + E L CK
Sbjct: 183 GDYYRIQGRAVLPIRWMSWE--SILLGKFTTASDVWAFGVTLWEILTLCK 230
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 164 KLGQGGFGGVYKGK--------------------LLDGLASI---SRTSHVNVVTLLGFC 200
+LG G FG VYK K L D + I + +H +V LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 201 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR 260
++ EF P G+++ + D L ++ I + + L+YLH S +
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVICRQMLEALQYLH---SMK 130
Query: 261 ILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF---SR 317
I+H D+K N+LL D K++DFG++ S + GT ++A EV +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTPYWMAPEVVMCETM 187
Query: 318 NFGEVSHKSDVYSFGMMIMEL 338
+K+D++S G+ ++E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 4e-08
Identities = 48/202 (23%), Positives = 83/202 (41%), Gaps = 41/202 (20%)
Query: 165 LGQGGFGGVYKGKL-------------LDG--------------LASISRTSHVNVVTLL 197
+G+G +G VY+GK LD L+ + ++ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
G L+G +I E+ GS+ + G ++ + I+ + L+Y+H
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-------IIREVLVALKYIH--- 118
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
++H DIK NIL+ K+ DFG+A L S+ + GT ++A EV
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV---GTPYWMAPEVI-T 174
Query: 318 NFGEVSHKSDVYSFGMMIMELV 339
K+D++S G+ I E+
Sbjct: 175 EGKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 5e-08
Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 40/220 (18%)
Query: 160 SFKDKLGQGGFGGVYKGKLLD--------------------------GLASISRT-SHVN 192
+ +G+G FG VY+G + A I R H +
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH 68
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
+V L+G E N ++ E P G L ++ S L + ++ L Y
Sbjct: 69 IVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYS-----LDLASLILYSYQLSTALAY 122
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
L S R +H DI N+L+ C K+ DFGL++ + +S + I ++A
Sbjct: 123 LE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK--GKLPIKWMAP 177
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS 352
E S NF + SDV+ FG+ + E++ GV N+
Sbjct: 178 E--SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN 215
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 48/210 (22%)
Query: 165 LGQGGFGGVYKGKLLDG--LASISRT---------------------SHVNVVTLLGFCL 201
+G+G +G VYK + L +I +H N+ T G +
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFI 73
Query: 202 EGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHR 255
+ N L+ E GS+ V K + L+ E + I+ +GL YLH
Sbjct: 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKG--LRKKGKRLKEEWIAYILRETLRGLAYLHE 131
Query: 256 GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT-IG---YIA 311
+++H DIK NILL ++ K+ DFG++ + S LG R T IG ++A
Sbjct: 132 ---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ-------LDSTLGRRNTFIGTPYWMA 181
Query: 312 LEVFSRNFG-EVS--HKSDVYSFGMMIMEL 338
EV + + + S +SDV+S G+ +EL
Sbjct: 182 PEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 23/44 (52%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289
I +GL+YLH S ILH DIKP N+L++ + KI DFGLA++
Sbjct: 112 ILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 8e-08
Identities = 55/220 (25%), Positives = 93/220 (42%), Gaps = 51/220 (23%)
Query: 161 FKDKLGQGGFGGVYKGKL-LDGL---------------------------ASISRTSHVN 192
F ++LG+ FG +YKG L L G+ + ++ H N
Sbjct: 9 FMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPN 68
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-----------NGDTSKPCQYLRWEKMYE 241
+V LLG + +++E++ G L +F+ + + L
Sbjct: 69 IVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK---KGIVS 298
I I IA G+EYL S +H D+ NIL+ + KISD GL++ + +
Sbjct: 129 IAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPK 185
Query: 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
SLL R ++ E +G+ S SD++SFG+++ E+
Sbjct: 186 SLLPIR----WMPPEAIM--YGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 36/94 (38%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I GLE LHR RI++ D+KP NILLD +ISD GLA +G ++ G G
Sbjct: 111 ITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEG--ETIRGRVG 163
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
T+GY+A EV + D + G +I E++
Sbjct: 164 TVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 1e-07
Identities = 72/290 (24%), Positives = 118/290 (40%), Gaps = 65/290 (22%)
Query: 151 FSDVKKITNSFKDKLGQGGFGGVY------------------KGK--------LLDGLAS 184
F+D+++I G G FG VY GK ++ +
Sbjct: 27 FTDLREI--------GHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKF 78
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 244
+ R H N + G L + L+ E+ + + + KP Q + ++ I
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVH---KKPLQEV---EIAAITH 132
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR 304
G +GL YLH S ++H DIK NILL + K++DFG A + + V
Sbjct: 133 GALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------- 182
Query: 305 GTIGYIALEV-FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363
GT ++A EV + + G+ K DV+S G+ +EL K L ++ S +Y
Sbjct: 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALY------- 234
Query: 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413
H+ Q+ T + NE + C+Q P DRP E+++ +
Sbjct: 235 HIAQNES------PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 34/94 (36%), Positives = 49/94 (52%), Gaps = 9/94 (9%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I GLE LH+ RI++ D+KP NILLD +ISD GLA + I G G
Sbjct: 111 ICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK----GRVG 163
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
T+GY+A EV + D ++ G ++ E++
Sbjct: 164 TVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 49/209 (23%)
Query: 165 LGQGGFGGV-----------YKGKLLDGLASISRT------------SHVN---VVTLLG 198
+G+G FG V Y KLL I R+ +H N +V L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL-- 108
Query: 199 FCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY--EIVIGIAKGLEYLH 254
+++ L + E+MP G L + N D + +W + Y E+V+ L+ +H
Sbjct: 109 HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-----KWARFYTAEVVLA----LDAIH 159
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEV 314
S +H D+KP N+LLD+ K++DFG + G+V A GT YI+ EV
Sbjct: 160 ---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMVRC-DTAVGTPDYISPEV 214
Query: 315 F--SRNFGEVSHKSDVYSFGMMIME-LVG 340
G + D +S G+ + E LVG
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 41/150 (27%), Positives = 72/150 (48%), Gaps = 33/150 (22%)
Query: 163 DKLGQGGFGGVYKG--KLLDGLASISRT----------------------SHVNVVTLLG 198
DKLG+G + VYKG KL D L ++ H N+VTL
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
+ L++E++ + L++++ D + K++ + + +GL Y HR
Sbjct: 72 IIHTEKSLTLVFEYL-DKDLKQYL---DDCGNSINMHNVKLF--LFQLLRGLNYCHR--- 122
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAK 288
++LH D+KP N+L+++ K++DFGLA+
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 36/98 (36%), Positives = 50/98 (51%), Gaps = 11/98 (11%)
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
I G +GL YLH S +H DIK NILL + K++DFG A L + V
Sbjct: 120 ICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV---- 172
Query: 302 GARGTIGYIALEV-FSRNFGEVSHKSDVYSFGMMIMEL 338
GT ++A EV + + G+ K DV+S G+ +EL
Sbjct: 173 ---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 43/133 (32%), Positives = 61/133 (45%), Gaps = 15/133 (11%)
Query: 208 LIYEFMPNGSLEKFVYN-GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDI 266
L+ M G L+ +YN G+ E+ I GLE LHR ++ D+
Sbjct: 77 LVLTIMNGGDLKFHIYNMGNPG-----FEEERALFYAAEILCGLEDLHR---ENTVYRDL 128
Query: 267 KPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKS 326
KP NILLD +ISD GLA K S+ G GT+GY+A EV + +
Sbjct: 129 KPENILLDDYGHIRISDLGLA----VKIPEGESIRGRVGTVGYMAPEVLNNQ--RYTLSP 182
Query: 327 DVYSFGMMIMELV 339
D + G +I E++
Sbjct: 183 DYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 52/204 (25%), Positives = 78/204 (38%), Gaps = 44/204 (21%)
Query: 164 KLGQGGFGGVYKGKLLDG-------------LASISRTSHVN-------------VVTLL 197
++GQGG+G V+ K D L ++ HV +V LL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
+ L E++P G + N + R+ M E+ + LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSE-DHARF-YMAEMFEAVDA----LHE-- 119
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
+H D+KP N L+D K++DFGL+ KGIV+ G+ Y+A EV
Sbjct: 120 -LGYIHRDLKPENFLIDASGHIKLTDFGLS------KGIVTYANSVVGSPDYMAPEVL-- 170
Query: 318 NFGEVSHKSDVYSFGMMIME-LVG 340
D +S G M+ E L G
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
H N+V L+ L++EF+ + L+ D K L ++ + + I +G
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLD------DLEKYPNGLDESRVRKYLFQILRG 112
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
+E+ H S I+H DIKP NIL+ Q K+ DFG A+
Sbjct: 113 IEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 29/104 (27%), Positives = 56/104 (53%), Gaps = 11/104 (10%)
Query: 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298
+Y+++ +GL+Y+H S ++H D+KP N+L+++D +I DFG+A+ ++
Sbjct: 113 LYQLL----RGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHK 165
Query: 299 SLLGAR-GTIGYIALEV-FSRNFGEVSHKSDVYSFGMMIMELVG 340
+ T Y A E+ S E + D++S G + E++G
Sbjct: 166 YFMTEYVATRWYRAPELLLS--LPEYTTAIDMWSVGCIFAEMLG 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 49/222 (22%), Positives = 87/222 (39%), Gaps = 57/222 (25%)
Query: 165 LGQGGFGGVYKG----------------KLLDGLAS-------------ISRTSHVNVVT 195
+GQG FG V++ K+L AS ++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 196 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK----------------M 239
LLG C G L++E+M G L +F+ + C
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK---LCTTKKGI 296
I +A G+ YL + +H D+ N L+ ++ KI+DFGL++ K
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+ + R ++ E S + + +SDV+++G+++ E+
Sbjct: 190 ENDAIPIR----WMPPE--SIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (126), Expect = 2e-07
Identities = 29/83 (34%), Positives = 45/83 (54%), Gaps = 14/83 (16%)
Query: 208 LIYEFMPNGSLEKFVYNGD--TSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFD 265
++ E M L K + + T QY +Y+I+ +GL+YLH S ++H D
Sbjct: 81 IVTELMET-DLHKVIKSPQPLTDDHIQYF----LYQIL----RGLKYLH---SANVIHRD 128
Query: 266 IKPHNILLDQDFCPKISDFGLAK 288
+KP NIL++ + KI DFGLA+
Sbjct: 129 LKPSNILVNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 52/168 (30%), Positives = 67/168 (39%), Gaps = 50/168 (29%)
Query: 164 KLGQGGFGGVYKG------------KLL-----DG-----LASIS---RTSHVNVVTLLG 198
KLG+G FG VYK K+L DG L I + H NVV L+
Sbjct: 15 KLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLID 74
Query: 199 FCLE-----GNNRALIYEFMP------NGSLEKFVYNGD-TSKPCQYLRWEKMYEIVIGI 246
+E R +Y P +G LE N Q K Y ++ +
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE----NPSVKLTESQI----KCY--MLQL 124
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294
+G+ YLH ILH DIK NIL+D KI+DFGLA+
Sbjct: 125 LEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 53/189 (28%), Positives = 75/189 (39%), Gaps = 53/189 (28%)
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 244
+ SH ++ L + ++ E++P G L YLR +
Sbjct: 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGEL------------FSYLRNSGRFSNST 102
Query: 245 G------IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK--------LC 290
G I LEYLH S I++ D+KP NILLD++ K++DFG AK LC
Sbjct: 103 GLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC 159
Query: 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKS--DVYSFGMMIME-LVGCKNNLDS 347
GT Y+A EV H D ++ G++I E LVG D
Sbjct: 160 --------------GTPEYLAPEVIQSK----GHNKAVDWWALGILIYEMLVGYPPFFD- 200
Query: 348 GVDNSSEVY 356
DN +Y
Sbjct: 201 --DNPFGIY 207
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 3e-07
Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 29/109 (26%)
Query: 190 HVNVVTLLGFCLEGNNRA--LIYEFMPN--------GSLEKFVYNGDTSKPCQYLRWEKM 239
H N+V LL N++ L++E+M LE D K +Y+ M
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILE------DVHK--RYI----M 113
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
Y+++ K L+Y+H S ++H D+KP NILL+ D K++DFGLA+
Sbjct: 114 YQLL----KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 33/150 (22%)
Query: 163 DKLGQGGFGGVYKG--KLLDGLASISRT----------------------SHVNVVTLLG 198
+KLG+G + V+KG KL + L ++ H N+VTL
Sbjct: 12 EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
+ L++E++ + L++++ D + K++ + I +GL Y HR
Sbjct: 72 IVHTDKSLTLVFEYL-DKDLKQYM---DDCGNIMSMHNVKIF--LYQILRGLAYCHR--- 122
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAK 288
++LH D+KP N+L+++ K++DFGLA+
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 44/205 (21%)
Query: 165 LGQGGFG-----------GVYKGKLLDGLASISRTSHVN---------------VVTLLG 198
+G+G FG VY KLL I R+ VV L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-- 108
Query: 199 FCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
FC +++ L + E+MP G L + N D + +W K Y + +A L+ +H
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-----KWAKFYTAEVVLA--LDAIH-- 159
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
S ++H D+KP N+LLD+ K++DFG + + G+V A GT YI+ EV
Sbjct: 160 -SMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVRCDT-AVGTPDYISPEVLK 216
Query: 317 RNFGE--VSHKSDVYSFGMMIMELV 339
G+ + D +S G+ + E++
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 27/110 (24%), Positives = 44/110 (40%), Gaps = 15/110 (13%)
Query: 189 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK---PCQYLRWEKMYEIVIG 245
H N+V L L++E++ LE + S P +R +
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYVERTLLELL----EASPGGLPPDAVR-----SYIWQ 108
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295
+ + + Y H I+H DIKP NIL+ + K+ DFG A+ +
Sbjct: 109 LLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 40/134 (29%), Positives = 68/134 (50%), Gaps = 14/134 (10%)
Query: 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIK 267
++ E+MP G L + N D + +W + Y + +A L+ +H S +H D+K
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPE-----KWARFYTAEVVLA--LDAIH---SMGFIHRDVK 169
Query: 268 PHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGE--VSHK 325
P N+LLD+ K++DFG + K+G+V A GT YI+ EV G+ +
Sbjct: 170 PDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGYYGRE 227
Query: 326 SDVYSFGMMIMELV 339
D +S G+ + E++
Sbjct: 228 CDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 66/273 (24%), Positives = 116/273 (42%), Gaps = 54/273 (19%)
Query: 163 DKLGQGGFGGVYKG-----------KLLD-------------GLASISRTSHVNVVTLLG 198
+K+G+G FG V+KG K++D + +S+ V G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
L+ +I E++ GS + G L ++ I+ I KGL+YLH S
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGP-------LDETQIATILREILKGLDYLH---S 119
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
+ +H DIK N+LL + K++DFG+A T + ++ + GT ++A EV ++
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV---GTPFWMAPEVIKQS 176
Query: 319 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378
K+D++S G+ +EL G SE++ P + + ++ L G +
Sbjct: 177 --AYDSKADIWSLGITAIELA-------KGEPPHSELH-PMKVLFLIPKNNPPTLEGNYS 226
Query: 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
K E + C+ P RP E+++
Sbjct: 227 KPLKEFVEA-------CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 46/136 (33%), Positives = 66/136 (48%), Gaps = 22/136 (16%)
Query: 204 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILH 263
N ++ EFM GSL+ VY P L I + + KGL YL S +ILH
Sbjct: 72 NRISICTEFMDGGSLD--VYR---KIPEHVLG-----RIAVAVVKGLTYL---WSLKILH 118
Query: 264 FDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR-GTIGYIALEVFSRNFGEV 322
D+KP N+L++ K+ DFG++ +V+S+ GT Y+A E S +
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVS------TQLVNSIAKTYVGTNAYMAPERISGE--QY 170
Query: 323 SHKSDVYSFGMMIMEL 338
SDV+S G+ MEL
Sbjct: 171 GIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 11/97 (11%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I GL++LH I++ D+K N+LLD+D KI+DFG+ K +G S+ G
Sbjct: 105 IICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC---G 158
Query: 306 TIGYIALEVFSRNFGE-VSHKSDVYSFGMMIME-LVG 340
T YIA E+ G+ + D +SFG+++ E L+G
Sbjct: 159 TPDYIAPEILK---GQKYNESVDWWSFGVLLYEMLIG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 66/281 (23%), Positives = 114/281 (40%), Gaps = 67/281 (23%)
Query: 164 KLGQGGFGGVY--KGK-----------------LLDGLAS------ISRTSHVNVVTLLG 198
K+G+G FG +Y K K + + AS +++ H N+VT
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 199 FCLEGNNRALIYEFMPNGSLEKFV--YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
E ++ E+ G L K + G Q L W + I+ GL+++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGLKHIH-- 118
Query: 257 CSTRILHFDIKPHNILLDQD-FCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF 315
+ILH DIK NI L ++ K+ DFG+A+ + + + GT Y++ E+
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV---GTPYYLSPEIC 174
Query: 316 SRNFGEVSHKSDVYSFGMMIMELVGCK-----NNLDSGVDNSSEVYFPHWIYRHVEQDRE 370
++K+D++S G ++ EL K NNL V + YF I + +D
Sbjct: 175 QNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF-APISPNFSRDL- 230
Query: 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
+ +I L+ + P DRP + +++
Sbjct: 231 ----------------RSLISQLF--KVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 38/116 (32%), Positives = 55/116 (47%), Gaps = 14/116 (12%)
Query: 241 EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSL 300
EIV+ L++LH+ I++ DIK NILLD + ++DFGL+K ++
Sbjct: 113 EIVLA----LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE--ERA 163
Query: 301 LGARGTIGYIALEVFSRNFGEVSHKS--DVYSFGMMIMELV-GCKNNLDSGVDNSS 353
GTI Y+A EV G H D +S G++ EL+ G G NS
Sbjct: 164 YSFCGTIEYMAPEVIRG--GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 7e-07
Identities = 52/209 (24%), Positives = 82/209 (39%), Gaps = 47/209 (22%)
Query: 162 KDKLGQGGFGGVY--------KGKLLDGLASI--------------------SRTSHVNV 193
+ +LG+G FG VY + L L I S+ H +
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 194 VTLLGFCLEGNNRALIYEFMPNGSL----EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
V LE + +I E+ L E+ + G T Q W I + G
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW------FIQLLLG 118
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
+ Y+H+ RILH D+K NI L + KI DFG+++L + ++ GT Y
Sbjct: 119 VHYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATTF---TGTPYY 171
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
++ E KSD++S G ++ E+
Sbjct: 172 MSPEALKHQ--GYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 7e-07
Identities = 55/188 (29%), Positives = 83/188 (44%), Gaps = 52/188 (27%)
Query: 165 LGQGGFGGVYKGKLLDGL-------------ASISR----TSHVN-------------VV 194
LG+GG+G V++ + + G A+I R T+H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 195 TLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
L+ G LI E++ G L + ++ DT+ C YL EI +
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA--CFYLS-----EISLA---- 112
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
LE+LH I++ D+KP NILLD K++DFGL K + +G V+ GTI Y
Sbjct: 113 LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFC--GTIEY 166
Query: 310 IALEVFSR 317
+A E+ R
Sbjct: 167 MAPEILMR 174
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 29/103 (28%), Positives = 53/103 (51%), Gaps = 12/103 (11%)
Query: 188 TSHVNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG 245
+ H N++ L+ + AL++E M + +L + + P + ++ MY+++
Sbjct: 55 SPHPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKS-YMYQLL-- 110
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
K L+++HR I H DIKP NIL+ D K++DFG +
Sbjct: 111 --KSLDHMHR---NGIFHRDIKPENILIKDD-ILKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 8e-07
Identities = 49/157 (31%), Positives = 72/157 (45%), Gaps = 23/157 (14%)
Query: 190 HVNVVTLLGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 247
H +V G + + L E+MP GS++ D K L + I
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK------DQLKAYGALTESVTRKYTRQIL 116
Query: 248 KGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK----LCTTKKGIVSSLLGA 303
+G+ YLH S I+H DIK NIL D K+ DFG +K +C + GI S
Sbjct: 117 EGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS----V 169
Query: 304 RGTIGYIALEVFSRNFGE-VSHKSDVYSFGMMIMELV 339
GT +++ EV S GE K+DV+S G ++E++
Sbjct: 170 TGTPYWMSPEVIS---GEGYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 47/193 (24%), Positives = 92/193 (47%), Gaps = 22/193 (11%)
Query: 164 KLGQGGFGGVYKGKLLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY 223
K+GQ G L++ + + +H +V+ + + G ++ +P+ S + + Y
Sbjct: 97 KIGQKG------TTLIEAML-LQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY 146
Query: 224 NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283
S+P L ++ I I +GL YLH + RI+H D+K NI ++ I D
Sbjct: 147 LTKRSRP---LPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGD 200
Query: 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 343
G A+ + + LG GT+ A EV +R+ + + K+D++S G+++ E++ +
Sbjct: 201 LGAAQFPV----VAPAFLGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPS 254
Query: 344 NLDSGVDNSSEVY 356
+ ++ E Y
Sbjct: 255 TIFEDPPSTPEEY 267
|
Length = 357 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 40/130 (30%), Positives = 66/130 (50%), Gaps = 22/130 (16%)
Query: 217 SLEKF---VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL 273
SL+KF VY + E + +I + K L YL +I+H D+KP NILL
Sbjct: 88 SLDKFYKYVYE----VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILL 141
Query: 274 DQDFCPKISDFGLAKLCTTKKGIVSSLLGAR--GTIGYIA---LEVFSRNFGEVSHKSDV 328
D++ K+ DFG++ +V S+ R G Y+A ++ +R+ +V +SDV
Sbjct: 142 DRNGNIKLCDFGISGQ------LVDSIAKTRDAGCRPYMAPERIDPSARDGYDV--RSDV 193
Query: 329 YSFGMMIMEL 338
+S G+ + E+
Sbjct: 194 WSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 51/213 (23%)
Query: 139 QNYGPLPLKRYNFSDV---KKITNSFKDKLGQGGFGGVYKGKLLDGLASISRTSHVNVVT 195
+++ P+ +KR+ S + K++ + F ++ K+L+ + +H V
Sbjct: 54 EDFPPVAIKRFEKSKIIKQKQVDHVFSER------------KILNYI------NHPFCVN 95
Query: 196 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG------IAKG 249
L G + + L+ EF+ G F LR K + +G I
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTF------------LRRNKRFPNDVGCFYAAQIVLI 143
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
EYL S I++ D+KP N+LLD+D K++DFG AK+ T+ + GT Y
Sbjct: 144 FEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC------GTPEY 194
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMIME-LVGC 341
IA E+ N G +D ++ G+ I E LVGC
Sbjct: 195 IAPEIL-LNVGH-GKAADWWTLGIFIYEILVGC 225
|
Length = 340 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 52/183 (28%), Positives = 81/183 (44%), Gaps = 28/183 (15%)
Query: 229 KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
KP Q + ++ I G +GL YLH ++H DIK NILL + K++DFG A
Sbjct: 116 KPLQEV---EIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSAS 169
Query: 289 LCTTKKGIVSSLLGARGTIGYIALEV-FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS 347
+ V GT ++A EV + + G+ K DV+S G+ +EL K L
Sbjct: 170 KSSPANSFV-------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-F 221
Query: 348 GVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMN 407
++ S +Y H+ Q+ T + NE +C+Q P +RP
Sbjct: 222 NMNAMSALY-------HIAQNDS------PTLQSNEWTDSFRGFVDYCLQKIPQERPASA 268
Query: 408 EVI 410
E++
Sbjct: 269 ELL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 34/91 (37%), Positives = 50/91 (54%), Gaps = 9/91 (9%)
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG 308
GLE L R RI++ D+KP NILLD +ISD GLA +G ++ G GT+G
Sbjct: 114 GLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEG--ETVRGRVGTVG 166
Query: 309 YIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
Y+A EV + + + D + G +I E++
Sbjct: 167 YMAPEVINNE--KYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 42/153 (27%), Positives = 72/153 (47%), Gaps = 39/153 (25%)
Query: 163 DKLGQGGFGGVYKG--KLLDGLASISRT----------------------SHVNVVTLLG 198
DKLG+G + V+KG KL + L ++ H N+VTL
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI---GIAKGLEYLHR 255
L++E++ + L++++ N C L M+ + I + +GL Y H+
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDN------CGNLM--SMHNVKIFMFQLLRGLSYCHK 121
Query: 256 GCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
+ILH D+KP N+L+++ K++DFGLA+
Sbjct: 122 ---RKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 27/172 (15%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
+A+G+E+L S + +H D+ NILL ++ KI DFGLA+ V AR
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK-GDARL 237
Query: 306 TIGYIALE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364
+ ++A E +F + + + +SDV+SFG+++ E+ + P Y
Sbjct: 238 PLKWMAPESIFDKVY---TTQSDVWSFGVLLWEIFSLGAS-------------P---YPG 278
Query: 365 VEQDREF--KLL-GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413
V+ D EF +L G + ++ + L C P DRP +E++E+L
Sbjct: 279 VQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 34/91 (37%), Positives = 51/91 (56%), Gaps = 9/91 (9%)
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG 308
GLE++H + +++ D+KP NILLD+ +ISD GLA + KK S GT G
Sbjct: 109 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----GTHG 160
Query: 309 YIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
Y+A EV + S +D +S G M+ +L+
Sbjct: 161 YMAPEVLQKGVAYDS-SADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 51/210 (24%), Positives = 89/210 (42%), Gaps = 42/210 (20%)
Query: 163 DKLGQGGFGGVYKGKLLDGLASISRT---------------------------SHVNVVT 195
D++G G FG V G+ G+ S +R +H NV+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGM-SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 196 LLGFCLEGNNRALIYEFMPNGSLEKFVYN--GDTSKPCQYLRWEKMYEIVIGIAKGLEYL 253
LG C+E L+ EF P G L+ ++ + G ++ Q ++M +A GL +L
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM---ACEVASGLLWL 116
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALE 313
H+ +H D+ N L D KI D+GLA L + + + ++A E
Sbjct: 117 HQ---ADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPE 172
Query: 314 V---FSRNF--GEVSHKSDVYSFGMMIMEL 338
+ ++ + + KS+++S G+ + EL
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 32/160 (20%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY------NGDTSK--PCQYLRWEKM 239
H NV+ LL F P SLE+F VY D + CQ L + +
Sbjct: 75 HENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 122
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
++ I +GL+Y+H S I+H D+KP N+ +++D KI DFGLA+ +
Sbjct: 123 QFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE------ 173
Query: 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ G T Y A E+ N+ + D++S G ++ EL+
Sbjct: 174 MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 212
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 22/172 (12%)
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN--GDTSKPCQYLRWEKM 239
+A +S H N+V E N ++ ++ G L K + G Q L W
Sbjct: 50 VAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW--- 106
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
+ I L+++H +ILH DIK NI L +D K+ DFG+A++ + S+
Sbjct: 107 ---FVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV------LNST 154
Query: 300 LLGARGTIG---YIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 348
+ AR IG Y++ E+ ++KSD+++ G ++ E+ K+ ++G
Sbjct: 155 VELARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 2e-06
Identities = 48/157 (30%), Positives = 71/157 (45%), Gaps = 23/157 (14%)
Query: 190 HVNVVTLLGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 247
H +V G + R L E MP GS++ D K L + I
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK------DQLKSYGALTENVTRKYTRQIL 116
Query: 248 KGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK----LCTTKKGIVSSLLGA 303
+G+ YLH S I+H DIK NIL D K+ DFG +K +C + G+ S
Sbjct: 117 EGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS----V 169
Query: 304 RGTIGYIALEVFSRNFGE-VSHKSDVYSFGMMIMELV 339
GT +++ EV S GE K+D++S G ++E++
Sbjct: 170 TGTPYWMSPEVIS---GEGYGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 49/184 (26%)
Query: 149 YNFSDVKKITNSFKD--KLGQGGFGGVYKGK-------------------------LLDG 181
Y F + ++ K+GQG FG V+K + L
Sbjct: 3 YEFP-FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE 61
Query: 182 LASISRTSHVNVVTLLGFC-----LEGNNRA---LIYEFMPNGSLEKFVYNGDTSKPCQY 233
+ + H NVV L+ C + L++EF + L + N +
Sbjct: 62 IKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSN-------KN 113
Query: 234 LRW--EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291
+++ ++ +++ + GL Y+HR +ILH D+K NIL+ +D K++DFGLA+ +
Sbjct: 114 VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFS 170
Query: 292 TKKG 295
K
Sbjct: 171 LSKN 174
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 39/136 (28%), Positives = 65/136 (47%), Gaps = 14/136 (10%)
Query: 208 LIYEFMPNGSLEKFVYNGDTSKP-CQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDI 266
++ E M L K + S QY +Y+I+ +GL+Y+H S +LH D+
Sbjct: 85 IVQELMET-DLYKLIKTQHLSNDHIQYF----LYQIL----RGLKYIH---SANVLHRDL 132
Query: 267 KPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKS 326
KP N+LL+ + KI DFGLA++ + L T Y A E+ N +
Sbjct: 133 KPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIM-LNSKGYTKAI 191
Query: 327 DVYSFGMMIMELVGCK 342
D++S G ++ E++ +
Sbjct: 192 DIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 51/194 (26%), Positives = 84/194 (43%), Gaps = 30/194 (15%)
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR--GTIGYI 310
+H S ++H DIK NILL + K+ DFG +K+ VS +G GT Y+
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT---VSDDVGRTFCGTPYYV 212
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370
A E++ R S K+D++S G+++ EL+ K D G + +E+
Sbjct: 213 APEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFD-GEN--------------MEEVMH 255
Query: 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM------LQGSTEALQIPP 424
L G I+ +M + + + P RP ++++ M + G E +Q P
Sbjct: 256 KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQTQP 315
Query: 425 TPFLSSPPRASIDS 438
S P R +I
Sbjct: 316 G--FSGPLRDTISR 327
|
Length = 496 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 32/163 (19%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--VY------NGDTSK--PCQYLRWEKM 239
H NV+ LL F P S+E F VY D + CQ L E +
Sbjct: 73 HENVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHV 120
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
++ + +GL+Y+H S I+H D+KP N+ +++D +I DFGLA+ +
Sbjct: 121 QFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE------ 171
Query: 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
+ G T Y A E+ N+ + D++S G ++ EL+ K
Sbjct: 172 MTGYVATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 47/157 (29%)
Query: 163 DKLGQGGFGGVYKG--KLLDGL---------------------ASISRT-SHVNVVTLLG 198
DKLG+G + VYKG KL L AS+ + H N+VTL
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHD 70
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE----KMYEIVI---GIAKGLE 251
L++E++ + QY+ M+ + + + +GL
Sbjct: 71 IIHTKKTLTLVFEYL-------------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
Y H+ R+LH D+KP N+L+ + K++DFGLA+
Sbjct: 118 YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 55/216 (25%)
Query: 163 DKLGQGGFGGVYK------GKLL-----------DG-----------LASISRTSHVNVV 194
+K+G+G +G VYK GKL+ +G L +S + ++ V
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI--V 64
Query: 195 TLLGF--CLEGNNRALIY---EFMPNGSLEKFV--YNGDTSKPCQYLRWEK-MYEIVIGI 246
LL E N + +Y E++ + L+KF+ +P + MY+++ G+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQD-FCPKISDFGLAKLCTTKKGIVSSLLGARG 305
A + H ++H D+KP N+L+D+ KI+D GL + + V S
Sbjct: 124 A----HCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP---VKSYTHEIV 173
Query: 306 TIGYIALEVF--SRNFGEVSHKSDVYSFGMMIMELV 339
T+ Y A EV S ++ S D++S G + E+
Sbjct: 174 TLWYRAPEVLLGSTHY---STPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 62/270 (22%), Positives = 111/270 (41%), Gaps = 66/270 (24%)
Query: 164 KLGQGGFGGVYKGKLLDG-----------------LASISRT-----------SHVNVVT 195
+G+G +G VYK K +G IS++ H NVV+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 196 LLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK--MYEIVIGIAKGLE 251
L+ LE +++ L++++ + + ++ + K +++I+ G+
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH---- 122
Query: 252 YLHRGCSTRILHFDIKPHNILL----DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTI 307
YLH S +LH D+KP NIL+ + KI D GLA+L ++ L TI
Sbjct: 123 YLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179
Query: 308 GYIALEVF--SRNFGEVSHKSDVYSFGMMIMELVG------CKNNLDSGVDNSSEVYFPH 359
Y A E+ +R++ + D+++ G + EL+ + F
Sbjct: 180 WYRAPELLLGARHY---TKAIDIWAIGCIFAELLTLEPIFKGREA-----KIKKSNPF-- 229
Query: 360 WIYRHVEQ-DREFKLLGVVTKKENEIAKKM 388
+Q +R F++LG T+K+ KKM
Sbjct: 230 ----QRDQLERIFEVLGTPTEKDWPDIKKM 255
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 50/158 (31%), Positives = 72/158 (45%), Gaps = 25/158 (15%)
Query: 190 HVNVVTLLGFCL---EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 246
H +V G CL E ++ E+MP GS++ D K L I
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIK------DQLKAYGALTENVTRRYTRQI 115
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK----LCTTKKGIVSSLLG 302
+G+ YLH S I+H DIK NIL D K+ DFG +K +C + GI S
Sbjct: 116 LQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS---- 168
Query: 303 ARGTIGYIALEVFSRNFGE-VSHKSDVYSFGMMIMELV 339
GT +++ EV S GE K+DV+S ++E++
Sbjct: 169 VTGTPYWMSPEVIS---GEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 31/89 (34%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
LE+LH+ I++ D+KP NILLD + DFGL+K T ++ GT Y
Sbjct: 109 LEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEY 162
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+A EV G H D +S G+++ E+
Sbjct: 163 LAPEVLLDEKGYTKH-VDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 43/160 (26%), Positives = 75/160 (46%), Gaps = 15/160 (9%)
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY-----NGDTSKPCQYLRWEKM 239
+SR S N+ LLG C +I E+M NG L +F+ + + L + +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
+ IA G+ YL S +H D+ N L+ +++ KI+DFG+++ +
Sbjct: 133 LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS---DYY 186
Query: 300 LLGARGT--IGYIALEVFSRNFGEVSHKSDVYSFGMMIME 337
+ R I ++A E G+ + KSDV++FG+ + E
Sbjct: 187 RVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWE 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 47/171 (27%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
+AKG+E+L S + +H D+ NILL ++ KI DFGLA+ V AR
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK-GDARL 243
Query: 306 TIGYIALE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364
+ ++A E +F R + + +SDV+SFG+++ E+ + GV
Sbjct: 244 PLKWMAPETIFDRVY---TIQSDVWSFGVLLWEIFSLGASPYPGV--------------K 286
Query: 365 VEQD--REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413
++++ R K G + + +M L C P RP +E++E L
Sbjct: 287 IDEEFCRRLK-EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 8/100 (8%)
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
+ + I K L YL ++H D+KP NILLD K+ DFG++ K S
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS-- 174
Query: 302 GARGTIGYIALEVFSRN--FGEVSHKSDVYSFGMMIMELV 339
G Y+A E + ++DV+S G+ ++EL
Sbjct: 175 --AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELA 212
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 40/154 (25%)
Query: 163 DKLGQGGFGGVYKGK-------------LLD----GLAS--------ISRTSHVNVVTLL 197
+K+G+G +G V+K K LD G+ S + H N+V L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFV--YNGDTSKP-CQYLRWEKMYEIVIGIAKGLEYLH 254
L++E+ + L+K+ NGD + M++++ KGL + H
Sbjct: 66 DVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSF----MFQLL----KGLAFCH 116
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
S +LH D+KP N+L++++ K++DFGLA+
Sbjct: 117 ---SHNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 44/164 (26%), Positives = 65/164 (39%), Gaps = 46/164 (28%)
Query: 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY--EIVIGIAKGLEYLHR-GCSTRILHF 264
L+ E+MP G L + D + Y E+V+ + + +H+ G +H
Sbjct: 78 LVMEYMPGGDLMNLLIRKDVFPE----ETARFYIAELVLAL----DSVHKLGF----IHR 125
Query: 265 DIKPHNILLDQDFCPKISDFGLAK------------------LCTTKKGIVSSLLGAR-- 304
DIKP NIL+D D K++DFGL K L + R
Sbjct: 126 DIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRV 185
Query: 305 ------GTIGYIALEVF-SRNFGEVSHKSDVYSFGMMIME-LVG 340
GT YIA EV +G + D +S G+++ E L G
Sbjct: 186 RANSTVGTPDYIAPEVLRGTPYG---LECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 57/208 (27%), Positives = 90/208 (43%), Gaps = 46/208 (22%)
Query: 163 DKLGQGGFGGVYKGK------------------------LLDGLASISRTSH-VNVVTLL 197
++LG+G +G V K + LL L R+ VT
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 198 GFCLEGNNRALIYEFMPNGSLEKF---VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 254
G + + E M + SL+KF VY+ + P L +I + I K LEYLH
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG-----KIAVSIVKALEYLH 120
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR--GTIGYIAL 312
S ++H D+KP N+L++++ K+ DFG++ +V S+ G Y+A
Sbjct: 121 SKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGY------LVDSVAKTIDAGCKPYMAP 172
Query: 313 EVFS--RNFGEVSHKSDVYSFGMMIMEL 338
E + N KSDV+S G+ ++EL
Sbjct: 173 ERINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 9/94 (9%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I GLE++H + +++ D+KP NILLD+ +ISD GLA + KK S G
Sbjct: 106 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-----G 157
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
T GY+A EV + S +D +S G M+ +L+
Sbjct: 158 THGYMAPEVLQKGTAYDS-SADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 5e-06
Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 46/208 (22%)
Query: 165 LGQGGFGGVYKGKLLDG--LASIS---------------------RTSHVNVVTLLGFCL 201
+G G +G VYKG+ + LA+I + H N+ T G +
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 202 EGNNRA------LIYEFMPNGSLEKFVYN--GDTSKPCQYLRWEKMYEIVIGIAKGLEYL 253
+ N L+ EF GS+ + N G+T L+ E + I I +GL +L
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT------LKEEWIAYICREILRGLSHL 127
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALE 313
H+ +++H DIK N+LL ++ K+ DFG++ G ++ + GT ++A E
Sbjct: 128 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWMAPE 181
Query: 314 VFSRNF---GEVSHKSDVYSFGMMIMEL 338
V + + KSD++S G+ +E+
Sbjct: 182 VIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 164 KLGQGGFGGVYKGKLLDG-----------------------LASISRTSHVNVVTLLGFC 200
K+G+G +G VYK K DG +A + H NV++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 201 LEGNNRA--LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
L +R L++++ + + KF +K L + ++ I G+ YLH
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-- 125
Query: 257 CSTRILHFDIKPHNILL----DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
+ +LH D+KP NIL+ + KI+D G A+L + ++ L T Y A
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 313 EVF--SRNFGEVSHKSDVYSFGMMIMELVG------CKNNLDSGVDNSSEVYFPHWIYRH 364
E+ +R++ + D+++ G + EL+ C+ D N Y H
Sbjct: 185 ELLLGARHY---TKAIDIWAIGCIFAELLTSEPIFHCRQE-DIKTSNP---------YHH 231
Query: 365 VEQDREFKLLGVVTKKENEIAKKM 388
+ DR F ++G K+ E KKM
Sbjct: 232 DQLDRIFNVMGFPADKDWEDIKKM 255
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 44/209 (21%)
Query: 163 DKLGQGGFGGVYKGKLL-----------------DGLAS--------ISRTSHVNVVTLL 197
+K+G+G +G VYK + +G+ S + H N+V L
Sbjct: 8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQ 67
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
L++E++ + L+K + + L +Y+I+ GIA Y H
Sbjct: 68 DVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA----YCH--- 119
Query: 258 STRILHFDIKPHNILLDQDFCP-KISDFGLAKLCTTKKGI-VSSLLGARGTIGYIALEVF 315
S R+LH D+KP N+L+D+ K++DFGLA+ GI V + T+ Y A E+
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR----AFGIPVRTFTHEVVTLWYRAPEIL 175
Query: 316 --SRNFGEVSHKSDVYSFGMMIMELVGCK 342
SR++ S D++S G + E+V K
Sbjct: 176 LGSRHY---STPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 8e-06
Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 8/94 (8%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I L+YLH G +I++ D+K N++LD+D KI+DFGL K T + + G
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC---G 157
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
T Y+A EV N + D + G+++ E++
Sbjct: 158 TPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 37/177 (20%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC-----TTKKGIVSSL 300
+A+G+E+L S + +H D+ NILL ++ KI DFGLA+ +KG
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG----- 234
Query: 301 LGARGTIGYIALE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPH 359
AR + ++A E +F + + + +SDV+SFG+++ E+ + P
Sbjct: 235 -SARLPLKWMAPESIFDKVY---TTQSDVWSFGVLLWEIFSLGAS-------------P- 276
Query: 360 WIYRHVEQDREF--KLLGVVTKKENEIAKKMII-VGLWCIQARPYDRPPMNEVIEML 413
Y V+ + EF +L + E A I + L C Q P +RP + ++E+L
Sbjct: 277 --YPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 9e-06
Identities = 32/95 (33%), Positives = 48/95 (50%), Gaps = 19/95 (20%)
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR----- 304
EYLH + I++ D+KP N+LLD + K+ DFG AK + S G +
Sbjct: 106 FEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAK-------KLKS--GQKTWTFC 153
Query: 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
GT Y+A E+ N G D +S G+++ EL+
Sbjct: 154 GTPEYVAPEIIL-NKGY-DFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 30/103 (29%), Positives = 53/103 (51%), Gaps = 11/103 (10%)
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
+++ + +GL+YLH I+H D+K N+LL C KI+DFGLA+ +
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL---PAKPMT 166
Query: 302 GARGTIGYIALEVFSRNFGEVSHKS--DVYSFGMMIMELVGCK 342
T+ Y A E+ G ++ + D+++ G ++ EL+ K
Sbjct: 167 PKVVTLWYRAPELL---LGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I LEYLH S +++ DIK N++LD+D KI+DFGL K + + + G
Sbjct: 104 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---G 157
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
T Y+A EV N + D + G+++ E++
Sbjct: 158 TPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 47/163 (28%), Positives = 75/163 (46%), Gaps = 38/163 (23%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--------VYNGDTSKPCQYLRWEKMYE 241
H NV+ LL F P+ SL++F D K ++ EK+ E
Sbjct: 73 HENVIGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGK---LMKHEKLSE 117
Query: 242 -----IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296
+V + KGL+Y+H + I+H D+KP N+ +++D KI DFGLA+
Sbjct: 118 DRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----- 169
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
S + G T Y A EV N+ + D++S G ++ E++
Sbjct: 170 -SEMTGYVVTRWYRAPEVI-LNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 19/101 (18%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR- 304
I GL++LH I++ D+K N+LLD + KI+DFG +C K+GI L G
Sbjct: 105 IVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFG---MC--KEGI---LGGVTT 153
Query: 305 ----GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIME-LVG 340
GT YIA E+ S D ++ G+++ E L G
Sbjct: 154 STFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 42/236 (17%)
Query: 135 LFSLQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKG-----------KLLDGLA 183
L+ L Y L + D T + +G+G +G VYK K+LD ++
Sbjct: 1 LYGLFPYNSSMLGLESLGDPTD-TWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS 59
Query: 184 SI------------SRTSHVNVVTLLGFC-----LEGNNRALIYEFMPNGSLEKFVYNGD 226
+ S +H NVV G L G L+ E GS+ + V
Sbjct: 60 DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG-- 117
Query: 227 TSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGL 286
Q L + I+ G GL++LH + RI+H D+K +NILL + K+ DFG+
Sbjct: 118 LLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGV 174
Query: 287 -AKLCTTKKGIVSSLLGARGTIGYIALEVFS---RNFGEVSHKSDVYSFGMMIMEL 338
A+L +T+ +S+ GT ++A EV + + + DV+S G+ +EL
Sbjct: 175 SAQLTSTRLRRNTSV----GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 21/51 (41%), Positives = 36/51 (70%), Gaps = 7/51 (13%)
Query: 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289
+Y+I+ +GL+Y+H S ++H D+KP NIL++++ KI DFGLA++
Sbjct: 114 LYQIL----RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 12/95 (12%)
Query: 207 ALIYEFMPNGSLEKF-----VYNGDTSKPCQY----LRWEKMYEIVIGIAKGLEYLHRGC 257
+L+ F P SLE+F V + CQ L E+M ++ + G+++LH
Sbjct: 84 SLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH--- 140
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292
S I+H D+KP NI++ D KI DFGLA+ T
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 30/102 (29%), Positives = 59/102 (57%), Gaps = 9/102 (8%)
Query: 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296
E + +++ + +GL++LH S R++H D+KP NIL+ K++DFGLA++ + + +
Sbjct: 110 ETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 166
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
S ++ T+ Y A EV ++ + D++S G + E+
Sbjct: 167 TSVVV----TLWYRAPEVLLQS--SYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 36/101 (35%), Positives = 55/101 (54%), Gaps = 22/101 (21%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLG-AR 304
I GL++LH S I++ D+K NILLD D KI+DFG+ K ++LG A+
Sbjct: 105 IICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCK---------ENMLGDAK 152
Query: 305 -----GTIGYIALEVFSRNFGE-VSHKSDVYSFGMMIMELV 339
GT YIA E+ G+ + D +SFG+++ E++
Sbjct: 153 TCTFCGTPDYIAPEIL---LGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 36/111 (32%), Positives = 55/111 (49%), Gaps = 14/111 (12%)
Query: 229 KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
KP Q + ++ + G +GL YLH S ++H D+K NILL + K+ DFG A
Sbjct: 110 KPLQEV---EIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS 163
Query: 289 LCTTKKGIVSSLLGARGTIGYIALEV-FSRNFGEVSHKSDVYSFGMMIMEL 338
+ V GT ++A EV + + G+ K DV+S G+ +EL
Sbjct: 164 IMAPANXFV-------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 51/201 (25%), Positives = 88/201 (43%), Gaps = 37/201 (18%)
Query: 164 KLGQGGFGGVYKG-----------KLLDGLAS------------ISRTSHVNVVTLLGFC 200
+LG G FG VYK K++D + ++ H N+V LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 201 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR 260
NN ++ EF G+++ + + +P L ++ + + L YLH +
Sbjct: 72 YYENNLWILIEFCAGGAVDAVML--ELERP---LTEPQIRVVCKQTLEALNYLH---ENK 123
Query: 261 ILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF---SR 317
I+H D+K NIL D K++DFG++ T S + GT ++A EV +
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI---GTPYWMAPEVVMCETS 180
Query: 318 NFGEVSHKSDVYSFGMMIMEL 338
+K+DV+S G+ ++E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 40/132 (30%), Positives = 59/132 (44%), Gaps = 13/132 (9%)
Query: 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIK 267
L+ M G L+ +YN L E++ I G+ +LH S I++ D+K
Sbjct: 70 LVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLH---SMDIVYRDMK 122
Query: 268 PHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSD 327
P N+LLD ++SD GLA K I GT GY+A E+ S+ D
Sbjct: 123 PENVLLDDQGNCRLSDLGLAVELKDGKTITQR----AGTNGYMAPEILKEE--PYSYPVD 176
Query: 328 VYSFGMMIMELV 339
++ G I E+V
Sbjct: 177 WFAMGCSIYEMV 188
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 31/100 (31%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG 308
G++++H R+LH DIK NI L Q+ K+ DFG A+L T+ + + GT
Sbjct: 112 GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV---GTPY 165
Query: 309 YIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 348
Y+ E++ ++KSD++S G ++ EL K+ +
Sbjct: 166 YVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQAN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 30/90 (33%), Positives = 47/90 (52%), Gaps = 13/90 (14%)
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310
EYLH S I++ D+KP N+LLD K++DFG AK + + GT Y+
Sbjct: 132 EYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC------GTPEYL 182
Query: 311 ALEVF-SRNFGEVSHKSDVYSFGMMIMELV 339
A EV S+ G+ D ++ G+++ E +
Sbjct: 183 APEVIQSKGHGKA---VDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 63/264 (23%), Positives = 109/264 (41%), Gaps = 55/264 (20%)
Query: 164 KLGQGGFGGVYKGKLLDG-----------------------LASISRTSHVNVVTLLGFC 200
K+G+G +G VYK K DG +A + H NV+ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 201 LEGNNRA--LIYEFMPNG--SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
L ++R L++++ + + KF +K L + ++ I G+ YLH
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH-- 125
Query: 257 CSTRILHFDIKPHNILL----DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
+ +LH D+KP NIL+ + KI+D G A+L + ++ L T Y A
Sbjct: 126 -ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 313 EVF--SRNFGEVSHKSDVYSFGMMIMELVG------CKNNLDSGVDNSSEVYFPHWIYRH 364
E+ +R++ + D+++ G + EL+ C+ D N + H
Sbjct: 185 ELLLGARHY---TKAIDIWAIGCIFAELLTSEPIFHCRQE-DIKTSNP---------FHH 231
Query: 365 VEQDREFKLLGVVTKKENEIAKKM 388
+ DR F ++G K+ E +KM
Sbjct: 232 DQLDRIFSVMGFPADKDWEDIRKM 255
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 10/106 (9%)
Query: 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296
+K+ +V + GL+Y+H S I+H D+KP N+ +++D KI DFGLA+
Sbjct: 117 DKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD----- 168
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
+ + G T Y A EV N+ + D++S G ++ E++ K
Sbjct: 169 -AEMTGYVVTRWYRAPEVI-LNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 57/219 (26%)
Query: 161 FKDKLGQGGFGGVYK------------------------GKLLDGLASISRTSHVNVVTL 196
D+LG+G +G VYK +++ L + + +V
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 197 LG-FCLEGNNRALIY--EFMPNGSLEKFVYNGDTS---KPCQYLRWEKMYEIVIGIAKGL 250
G F +EG A+ E+M GSL+K +Y G + P LR I + KGL
Sbjct: 65 YGAFFIEG---AVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLR-----RITYAVVKGL 115
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG-- 308
++L I+H D+KP N+L++ + K+ DFG++ +V+SL A+ IG
Sbjct: 116 KFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASL--AKTNIGCQ 165
Query: 309 -YIALEVFS----RNFGEVSHKSDVYSFGMMIMEL-VGC 341
Y+A E + +SDV+S G+ I+E+ +G
Sbjct: 166 SYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 27/92 (29%), Positives = 44/92 (47%), Gaps = 3/92 (3%)
Query: 248 KGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTI 307
+ L+Y+H + + H D+KP NIL + D KI DFGLA++ T
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 308 GYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
Y A E+ F + + D++S G + E++
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 36/132 (27%), Positives = 67/132 (50%), Gaps = 15/132 (11%)
Query: 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDI 266
++ E M GSL++ + K + + E + ++ I + +GL YL +I+H D+
Sbjct: 79 SICMEHMDGGSLDQVL------KEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDV 130
Query: 267 KPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKS 326
KP NIL++ K+ DFG++ + +S +G R Y++ E S +S
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR---SYMSPERLQGT--HYSVQS 183
Query: 327 DVYSFGMMIMEL 338
D++S G+ ++EL
Sbjct: 184 DIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 25/73 (34%), Positives = 37/73 (50%), Gaps = 6/73 (8%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I L YLH +++ D+K N++LD+D KI+DFGL K + + + G
Sbjct: 104 IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---G 157
Query: 306 TIGYIALEVFSRN 318
T Y+A EV N
Sbjct: 158 TPEYLAPEVLEDN 170
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 46/208 (22%), Positives = 86/208 (41%), Gaps = 47/208 (22%)
Query: 164 KLGQGGFGGVYKGKLLDG----------------------------LASISRTSHVNVVT 195
++G G +G VYK + L + H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 196 LLGFCLEGNNR-----ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 250
L+ C L++E + + L ++ P L E + +++ +GL
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL----DKVPPPGLPAETIKDLMRQFLRGL 121
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310
++LH C I+H D+KP NIL+ K++DFGLA++ + + + ++ T+ Y
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV----TLWYR 174
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
A EV ++ + D++S G + E+
Sbjct: 175 APEVLLQS--TYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 31/82 (37%), Positives = 41/82 (50%), Gaps = 13/82 (15%)
Query: 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA--KGLEYLHRGCSTRILHFD 265
LI EF+P G L + DT R+ M E V+ I L ++HR D
Sbjct: 78 LIMEFLPGGDLMTMLIKYDTFSE-DVTRF-YMAECVLAIEAVHKLGFIHR---------D 126
Query: 266 IKPHNILLDQDFCPKISDFGLA 287
IKP NIL+D+ K+SDFGL+
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 4e-05
Identities = 26/80 (32%), Positives = 36/80 (45%), Gaps = 18/80 (22%)
Query: 44 CGTLSLDIGYPFW-GDGLRPQYCGRQE-FYLDCQNNPNQNPTQSPTIFMGSEAFRVLDID 101
CG ++ I YPF G G C R F L C N T P + +G+ + VL I
Sbjct: 8 CG--NVSIPYPFGIGPG-----CARDPGFELTCNNT-----TSPPRLLLGNGNYEVLSIS 55
Query: 102 DGHQTMIITPARLDLLSSYC 121
+ T+ + LD +SS C
Sbjct: 56 LANGTVRV----LDPISSNC 71
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 28/69 (40%), Positives = 35/69 (50%), Gaps = 6/69 (8%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
IA L YLH S I++ D+KP NILLD ++DFGL K S+ G
Sbjct: 105 IASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC---G 158
Query: 306 TIGYIALEV 314
T Y+A EV
Sbjct: 159 TPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 32/95 (33%), Positives = 49/95 (51%), Gaps = 12/95 (12%)
Query: 207 ALIYEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KMYEIVIGIAKGLEYLHRGC 257
L+ F P SLE+F V + CQ ++ E +M ++ + G+++LH
Sbjct: 87 GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH--- 143
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292
S I+H D+KP NI++ D KI DFGLA+ T
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 16/157 (10%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK--PCQYLRWEKM-YEIVIGI 246
H N++ LG C E L+ EF P G L+ ++ + ++ ++M EI
Sbjct: 54 HSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI---- 109
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT 306
A GL +LH+ +H D+ N LL D KI D+GL+ K+ +
Sbjct: 110 ALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVP 165
Query: 307 IGYIALEVFSRNFGEV-----SHKSDVYSFGMMIMEL 338
+ +IA E+ G + + +S+V+S G+ I EL
Sbjct: 166 LRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 25/172 (14%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
+AKG+ +L S +H D+ NILL KI DFGLA+ V AR
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK-GNARL 278
Query: 306 TIGYIALE-VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364
+ ++A E +F+ + + +SDV+S+G+++ E+ ++ G+ S+ Y
Sbjct: 279 PVKWMAPESIFNCVY---TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY-------- 327
Query: 365 VEQDREFKLL--GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
K++ G +M + C A P RP +++++++
Sbjct: 328 -------KMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 5e-05
Identities = 52/201 (25%), Positives = 81/201 (40%), Gaps = 40/201 (19%)
Query: 164 KLGQGGFGGVYKGKLLDG--LASIS---------------------RTSHVNVVTLLGFC 200
++G G +G VYK + L LA++ H N+V G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 201 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ--YLRWEKMYEIVIGIAKGLEYLHRGCS 258
L + E+ GSL+ + Q Y+ E + +GL YLH S
Sbjct: 76 LSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL--------QGLAYLH---S 124
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS-R 317
+H DIK NILL + K++DFG+A T S + GT ++A EV +
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI---GTPYWMAPEVAAVE 181
Query: 318 NFGEVSHKSDVYSFGMMIMEL 338
G + D+++ G+ +EL
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 21/52 (40%), Positives = 34/52 (65%), Gaps = 8/52 (15%)
Query: 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-DFCPKISDFGLAKL 289
MY+++ +GL+Y+H S +LH D+KP N+ ++ D KI DFGLA++
Sbjct: 120 MYQLL----RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 26/148 (17%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I GL++LH S I++ D+K N++LD+D KI+DFG+ K S+ G
Sbjct: 105 IVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC---G 158
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY--------- 356
T YIA E+ + + D +SFG+++ E++ ++ D+ E++
Sbjct: 159 TPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHG--DDEDELFESIRVDTPH 214
Query: 357 FPHWIYRHVEQ------DRE-FKLLGVV 377
+P WI + + +R+ + LGVV
Sbjct: 215 YPRWITKESKDILEKLFERDPTRRLGVV 242
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 7e-05
Identities = 35/113 (30%), Positives = 55/113 (48%), Gaps = 24/113 (21%)
Query: 189 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF-----VYNGDTSKPCQYLRWE----KM 239
+H N+++LL F P SLE+F V + CQ ++ E +M
Sbjct: 74 NHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERM 121
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292
++ + G+++LH S I+H D+KP NI++ D KI DFGLA+ T
Sbjct: 122 SYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 36/129 (27%), Positives = 64/129 (49%), Gaps = 17/129 (13%)
Query: 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHN 270
E M GSL++ + K + + +I I + +GL YL I+H D+KP N
Sbjct: 79 EHMDGGSLDQVL------KKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSN 130
Query: 271 ILLDQDFCPKISDFGLA-KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVY 329
IL++ K+ DFG++ +L + + +S +G R Y++ E V SD++
Sbjct: 131 ILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTR---SYMSPERLQGTHYTVQ--SDIW 182
Query: 330 SFGMMIMEL 338
S G+ ++E+
Sbjct: 183 SLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ--DFCPKISDFGLAKLCTTKKGI 296
+ I + + ++YLH RI+H DIK NI ++ D C + DFG A C
Sbjct: 184 ILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVC--LGDFGAA--CFPVDIN 236
Query: 297 VSSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNL 345
+ G GTI A E+ +R+ +G D++S G+++ E+ C ++L
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPA---VDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 47/188 (25%), Positives = 76/188 (40%), Gaps = 49/188 (26%)
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE--KMY-- 240
++ H + TL L+ ++ P G L + + +P + L E + Y
Sbjct: 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLL----QRQPGKCLSEEVARFYAA 110
Query: 241 EIVIGIAKGLEYLH-RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
E+++ LEYLH G I++ D+KP NILL + +SDF L+K + VS
Sbjct: 111 EVLLA----LEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK 162
Query: 300 LLGAR--------------------------GTIGYIALEVFSRNFGEVSHKSDV--YSF 331
L GT YIA EV S + H S V ++
Sbjct: 163 ALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD----GHGSAVDWWTL 218
Query: 332 GMMIMELV 339
G+++ E++
Sbjct: 219 GILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 32/114 (28%), Positives = 50/114 (43%), Gaps = 22/114 (19%)
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT---------- 291
I I +EY+H S +LH D+KP NILL I D+G A
Sbjct: 118 IFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174
Query: 292 -TKKGIVSSLLGAR----GTIGYIALEVFSRNFG-EVSHKSDVYSFGMMIMELV 339
++ I S + GT Y+A E R G S +D+Y+ G+++ +++
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPE---RLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 31/86 (36%), Positives = 45/86 (52%), Gaps = 12/86 (13%)
Query: 212 FMPNGSLEKF-----VYNGDTSKPCQY----LRWEKMYEIVIGIAKGLEYLHRGCSTRIL 262
F P SLE+F V + CQ L E+M ++ + G+++LH S I+
Sbjct: 84 FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLH---SAGII 140
Query: 263 HFDIKPHNILLDQDFCPKISDFGLAK 288
H D+KP NI++ D KI DFGLA+
Sbjct: 141 HRDLKPSNIVVKSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 41/145 (28%), Positives = 67/145 (46%), Gaps = 23/145 (15%)
Query: 163 DKLGQGGFGGVYKGKL-----LDGLASI-------SRTSHVNVVTLLGFCLEGNNRALIY 210
+KLG+G + VYKGK L L I + + + +LL L+ N L++
Sbjct: 11 EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLK-GLKHANIVLLH 69
Query: 211 EFMPNGSLEKFVYNGDTSKPCQY-------LRWEKMYEIVIGIAKGLEYLHRGCSTRILH 263
+ + V+ + CQY L E + + + +GL Y+H+ ILH
Sbjct: 70 DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYILH 126
Query: 264 FDIKPHNILLDQDFCPKISDFGLAK 288
D+KP N+L+ K++DFGLA+
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 31/119 (26%), Positives = 53/119 (44%), Gaps = 15/119 (12%)
Query: 170 FGGVYKGKLLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK 229
F + + LL GL H N+V L ++E+M + + +
Sbjct: 48 FTAIREASLLKGL------KHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH 101
Query: 230 PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
P + M++++ +GL Y+H ILH D+KP N+L+ K++DFGLA+
Sbjct: 102 PYNVRLF--MFQLL----RGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 16/106 (15%)
Query: 186 SRTSHVNVVTLLGFCLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY--EI 242
+ H +V L C + + + E+ G L ++ S+P Y +
Sbjct: 57 NSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACV 110
Query: 243 VIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
V+G L+YLH +I++ D+K N+LLD + KI+DFGL K
Sbjct: 111 VLG----LQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK 149
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 52/224 (23%)
Query: 152 SDVKKITN-SFK--DKLGQGGFGGVYKGKLLDG-------------------LASISRTS 189
+D+ + N S+K + +G G FG VY+ +D L + +
Sbjct: 58 NDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN 117
Query: 190 HVNVVTLLGF----CLEGNNRAL----IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
H+N++ L + C + N + + + EF+P ++ K++ + + L K+Y
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYS 176
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD-QDFCPKISDFGLAKLCTTKKGIVSSL 300
+ + L Y+H S I H D+KP N+L+D K+ DFG AK +L
Sbjct: 177 Y--QLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK----------NL 221
Query: 301 LGARGTIGYIALEVFSRN---FGEVSHKS--DVYSFGMMIMELV 339
L + ++ YI + G ++ + D++S G +I E++
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 35/106 (33%), Positives = 55/106 (51%), Gaps = 10/106 (9%)
Query: 237 EKMYEIVIG-IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295
E+ +I G I LE+LH+ I++ DIK NILLD + ++DFGL+K +
Sbjct: 104 EQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159
Query: 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKS--DVYSFGMMIMELV 339
V GTI Y+A ++ G+ H D +S G+++ EL+
Sbjct: 160 -VERAYSFCGTIEYMAPDIVRG--GDGGHDKAVDWWSMGVLMYELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 42/134 (31%), Positives = 63/134 (47%), Gaps = 16/134 (11%)
Query: 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-IAKGLEYLHRGCSTRILHFDI 266
LI +++ G + +Y D E G I LE+LH+ I++ DI
Sbjct: 82 LILDYVSGGEMFTHLYQRDNFS-------EDEVRFYSGEIILALEHLHK---LGIVYRDI 131
Query: 267 KPHNILLDQDFCPKISDFGLAK-LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHK 325
K NILLD + ++DFGL+K + +K S GTI Y+A E+ R G
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFC---GTIEYMAPEII-RGKGGHGKA 187
Query: 326 SDVYSFGMMIMELV 339
D +S G++I EL+
Sbjct: 188 VDWWSLGILIFELL 201
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 17/154 (11%)
Query: 200 CLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH-RGC 257
C + +R L+ E++ G L F P ++ R+ Y I IA L +LH RG
Sbjct: 64 CFQTTSRLFLVIEYVNGGDL-MFHMQRQRKLPEEHARF---YAAEICIA--LNFLHERG- 116
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
I++ D+K N+LLD D K++D+G+ K S+ GT YIA E+
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC---GTPNYIAPEILRG 170
Query: 318 NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN 351
E D ++ G+++ E++ ++ D DN
Sbjct: 171 E--EYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 29/72 (40%), Positives = 37/72 (51%), Gaps = 6/72 (8%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
IA L YLH S I++ D+KP NILLD ++DFGL K G S+ G
Sbjct: 105 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC---G 158
Query: 306 TIGYIALEVFSR 317
T Y+A EV +
Sbjct: 159 TPEYLAPEVLHK 170
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 42/206 (20%)
Query: 165 LGQGGFGGVYKGKLLDG--LASIS---------------------RTSHVNVVTLLGFCL 201
+G G +G VYKG+ + LA+I + H N+ T G +
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 202 E----GNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHR 255
+ G++ L + EF GS+ V N T L+ + + I I +GL +LH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKN--TKGNA--LKEDWIAYICREILRGLAHLH- 138
Query: 256 GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF 315
+ +++H DIK N+LL ++ K+ DFG++ G ++ + GT ++A EV
Sbjct: 139 --AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWMAPEVI 193
Query: 316 SRNFGEVS---HKSDVYSFGMMIMEL 338
+ + + ++SD++S G+ +E+
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 20/92 (21%)
Query: 204 NNRALIYEFMPNGSLEKFVYNGDT--SKPCQYLRWEKMYEIVIGI--AKGLEYLHRGCST 259
N LI E++P G + + DT + ++ + E ++ I L Y+HR
Sbjct: 74 NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY----IAETILAIDSIHKLGYIHR---- 125
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291
DIKP N+LLD K+SDFG LCT
Sbjct: 126 -----DIKPDNLLLDAKGHIKLSDFG---LCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 23/166 (13%)
Query: 182 LASISRTSHVNVVTLL--GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 239
A +R H N+V LL G G A ++E++P +L + + + R
Sbjct: 29 TALCARLYHPNIVALLDSGEAPPGLLFA-VFEYVPGRTLREVLAADGALPAGETGR---- 83
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGI 296
+++ + L H I+H D+KP NI++ K+ DFG+ L +
Sbjct: 84 --LMLQVLDALACAHN---QGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138
Query: 297 VSSLLGAR----GTIGYIALEVFSRNFGE-VSHKSDVYSFGMMIME 337
+ L GT Y A E GE V+ SD+Y++G++ +E
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLR---GEPVTPNSDLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 3e-04
Identities = 45/203 (22%), Positives = 82/203 (40%), Gaps = 44/203 (21%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEIVIGIAK 248
H N++ LG C+E L++E+ G L+ ++ + Q L ++M IA
Sbjct: 54 HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRM---ACEIAA 110
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA-------------KLCTTKKG 295
G+ ++H+ LH D+ N L D K+ D+G+ C +
Sbjct: 111 GVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRW 167
Query: 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEV 355
+ L+G G I E + S+V++ G+ + EL +N+++
Sbjct: 168 LAPELVGEFHG-GLITA--------EQTKPSNVWALGVTLWEL----------FENAAQP 208
Query: 356 YFPHW----IYRHVEQDREFKLL 374
Y H + HV +D++ KL
Sbjct: 209 Y-SHLSDREVLNHVIKDQQVKLF 230
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 37/111 (33%), Positives = 55/111 (49%), Gaps = 30/111 (27%)
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLG------- 302
LEYLH + I+H D+KP N+L+ K++DFGL+K+ G++S
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI-----GLMSLTTNLYEGHIE 165
Query: 303 --AR--------GTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIME-LVGC 341
R GT YIA EV R +G+ D ++ G+++ E LVGC
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGK---PVDWWAMGIILYEFLVGC 213
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 26/146 (17%)
Query: 204 NNRALIYEFMPNGSLEKFV--YNG--DTSKPCQYLRWEKMYEIVIGI--AKGLEYLHRGC 257
+N L+ E+ P G L + Y D YL E+V+ I + Y+HR
Sbjct: 74 DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLA-----ELVLAIHSVHQMGYVHR-- 126
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS- 316
DIKP N+L+D+ K++DFG A T K + S L GT YIA EV +
Sbjct: 127 -------DIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKL--PVGTPDYIAPEVLTT 177
Query: 317 -RNFGEVSH--KSDVYSFGMMIMELV 339
G+ ++ + D +S G++ E++
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 34/149 (22%), Positives = 60/149 (40%), Gaps = 22/149 (14%)
Query: 146 LKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDGLASISRTSHVNVVTLLGFCLEGNN 205
+K+ ++ + +G G L L ++ H N++ L+ +EG+
Sbjct: 39 IKKVKIIEISNDVTKDRQLVGMCGIHFT----TLRELKIMNEIKHENIMGLVDVYVEGDF 94
Query: 206 RALIYEFMPNGSLEKFVYN----GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRI 261
L+ + M L+K V ++ C I++ I GL LH
Sbjct: 95 INLVMDIM-ASDLKKVVDRKIRLTESQVKC----------ILLQILNGLNVLH---KWYF 140
Query: 262 LHFDIKPHNILLDQDFCPKISDFGLAKLC 290
+H D+ P NI ++ KI+DFGLA+
Sbjct: 141 MHRDLSPANIFINSKGICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 26/72 (36%), Positives = 37/72 (51%), Gaps = 6/72 (8%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
+A + YLH S I++ D+KP NILLD ++DFGL K + S+ G
Sbjct: 105 VASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC---G 158
Query: 306 TIGYIALEVFSR 317
T Y+A EV +
Sbjct: 159 TPEYLAPEVLRK 170
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 55/224 (24%)
Query: 152 SDVKKITNSFKDKLGQGGFGGVYKG-----------KLLDGLASISR------------T 188
SD +I + +G+G +G V+K K+LD + I +
Sbjct: 17 SDTWEIIET----IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS 72
Query: 189 SHVNVVTLLGFCLE-----GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV 243
H NVV G + G+ L+ E GS+ V R E+M E +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG-------FLKRGERMEEPI 125
Query: 244 IGIA-----KGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGL-AKLCTTKKGIV 297
I GL++LH + +H D+K +NILL + K+ DFG+ A+L +T+
Sbjct: 126 IAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 298 SSLLGARGTIGYIALEVFS---RNFGEVSHKSDVYSFGMMIMEL 338
+S+ GT ++A EV + + + DV+S G+ +EL
Sbjct: 183 TSV----GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 32/102 (31%), Positives = 55/102 (53%), Gaps = 14/102 (13%)
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
Y+IV+ L+ +H S +++H D+K NI L K+ DFG +K + VS
Sbjct: 176 YQIVLA----LDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS---VSL 225
Query: 300 LLGAR--GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ + GT Y+A E++ R S K+D++S G+++ EL+
Sbjct: 226 DVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 35/132 (26%), Positives = 66/132 (50%), Gaps = 15/132 (11%)
Query: 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDI 266
++ E M GSL++ + K + + + ++ I + KGL YL +I+H D+
Sbjct: 79 SICMEHMDGGSLDQVL------KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDV 130
Query: 267 KPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKS 326
KP NIL++ K+ DFG++ + +S +G R Y++ E S +S
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTR---SYMSPERLQGT--HYSVQS 183
Query: 327 DVYSFGMMIMEL 338
D++S G+ ++E+
Sbjct: 184 DIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 33/161 (20%), Positives = 63/161 (39%), Gaps = 27/161 (16%)
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI----- 244
H N++ + + + ++ M GS E + E + E+ I
Sbjct: 58 HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP---------EGLPELAIAFILK 108
Query: 245 GIAKGLEYLHR-GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT------TKKGIV 297
+ L+Y+H G +H +K +ILL D +S GL + ++ +
Sbjct: 109 DVLNALDYIHSKGF----IHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVH 162
Query: 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+ + +++ EV +N + KSD+YS G+ EL
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 17/143 (11%)
Query: 202 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI--AKGLEYLHRGCST 259
+ NN L+ ++ G L + + P R+ + E+VI I L Y+HR
Sbjct: 72 DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YLAEMVIAIDSVHQLHYVHR---- 126
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA---LEVFS 316
DIKP NIL+D + +++DFG + L + G V S + A GT YI+ L+
Sbjct: 127 -----DIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSV-AVGTPDYISPEILQAME 179
Query: 317 RNFGEVSHKSDVYSFGMMIMELV 339
G+ + D +S G+ + E++
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 7/94 (7%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I L+YLH +++ D+K N++LD+D KI+DFGL K + + G
Sbjct: 104 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---G 158
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
T Y+A EV N + D + G+++ E++
Sbjct: 159 TPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 8e-04
Identities = 19/42 (45%), Positives = 27/42 (64%), Gaps = 6/42 (14%)
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291
+E +H+ +H DIKP NIL+D+D K++DFG LCT
Sbjct: 114 IESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFG---LCT 149
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 31/99 (31%), Positives = 51/99 (51%), Gaps = 18/99 (18%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL-----CTTKKGIVSSL 300
IA GL +LH S I++ D+K N++LD + KI+DFG+ K TT+
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---- 162
Query: 301 LGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
GT YIA E+ + + D ++FG+++ E++
Sbjct: 163 ----GTPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 19/44 (43%), Positives = 30/44 (68%), Gaps = 3/44 (6%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289
+A L+YLHR I+H D+KP N+L+ + K++DFGL+K+
Sbjct: 113 VALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 32/92 (34%), Positives = 43/92 (46%), Gaps = 16/92 (17%)
Query: 205 NRALIYEFMPNGSLEKFVYNGDT--SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRIL 262
N LI EF+P G + + DT + Q+ E + + I L ++HR
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETV--LAIDAIHQLGFIHR------- 125
Query: 263 HFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294
DIKP N+LLD K+SDFG LCT K
Sbjct: 126 --DIKPDNLLLDAKGHVKLSDFG---LCTGLK 152
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 20/41 (48%), Positives = 25/41 (60%), Gaps = 3/41 (7%)
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289
GL Y H+ LH DIK NILL+ K++DFGLA+L
Sbjct: 128 GLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 32/92 (34%), Positives = 43/92 (46%), Gaps = 16/92 (17%)
Query: 205 NRALIYEFMPNGSLEKFVYNGDT--SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRIL 262
N LI EF+P G + + DT + Q+ E + + I L ++HR
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETV--LAIDSIHQLGFIHR------- 125
Query: 263 HFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294
DIKP N+LLD K+SDFG LCT K
Sbjct: 126 --DIKPDNLLLDSKGHVKLSDFG---LCTGLK 152
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 27/83 (32%), Positives = 45/83 (54%), Gaps = 5/83 (6%)
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA---LEVFS 316
+H DIKP N+LLD + +++DFG + L + G V S + A GT YI+ L+
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSV-AVGTPDYISPEILQAME 179
Query: 317 RNFGEVSHKSDVYSFGMMIMELV 339
G+ + D +S G+ + E++
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 37/144 (25%), Positives = 65/144 (45%), Gaps = 23/144 (15%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR- 304
I L +LH I++ D+K N+LLD + K++DFG+ K+GI + +
Sbjct: 105 ITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC-----KEGIFNGKTTSTF 156
Query: 305 -GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN-------SSEVY 356
GT YIA E+ S D ++ G+++ E++ ++ ++ + EV
Sbjct: 157 CGTPDYIAPEILQEMLYGPS--VDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV 214
Query: 357 FPHWIYRHVEQDREFKLLGVVTKK 380
+P W+ QD L +TK
Sbjct: 215 YPTWL----SQDAVDILKAFMTKN 234
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 27/72 (37%), Positives = 37/72 (51%), Gaps = 6/72 (8%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
IA L YLH S I++ D+KP NILLD ++DFGL K + ++ G
Sbjct: 105 IASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFC---G 158
Query: 306 TIGYIALEVFSR 317
T Y+A EV +
Sbjct: 159 TPEYLAPEVIRK 170
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 33/115 (28%), Positives = 54/115 (46%), Gaps = 14/115 (12%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
+A+G+E+L S +H D+ N+LL Q KI DFGLA+ VS +G
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS-----KG 297
Query: 306 T----IGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356
+ + ++A E N + SDV+S+G+++ E+ G+ S Y
Sbjct: 298 STFLPVKWMAPESIFDNL--YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 33/125 (26%), Positives = 61/125 (48%), Gaps = 23/125 (18%)
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR--GTI 307
L +LHR +++ D+K NILLD + K++DFG+ K+GI++ + GT
Sbjct: 109 LMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMC-----KEGILNGVTTTTFCGTP 160
Query: 308 GYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE---------VYFP 358
YIA E+ E D ++ G+++ E++ + ++ DN + V +P
Sbjct: 161 DYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEA--DNEDDLFESILHDDVLYP 216
Query: 359 HWIYR 363
W+ +
Sbjct: 217 VWLSK 221
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.003
Identities = 18/42 (42%), Positives = 24/42 (57%), Gaps = 3/42 (7%)
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290
G+ +LH ILH D+K N+LL+ KI DFGLA+
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY 156
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 39/147 (26%), Positives = 74/147 (50%), Gaps = 23/147 (15%)
Query: 246 IAKGLEYLH-RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR 304
I+ L YLH RG I++ D+K N+LLD + K++D+G+ K + G +S
Sbjct: 105 ISLALNYLHERG----IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFC-- 157
Query: 305 GTIGYIALEVF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363
GT YIA E+ ++G D ++ G+++ E++ ++ D + SS+
Sbjct: 158 GTPNYIAPEILRGEDYG---FSVDWWALGVLMFEMMAGRSPFD--IVGSSD--------- 203
Query: 364 HVEQDREFKLLGVVTKKENEIAKKMII 390
+ +Q+ E L V+ +K+ I + + +
Sbjct: 204 NPDQNTEDYLFQVILEKQIRIPRSLSV 230
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 16/52 (30%), Positives = 28/52 (53%), Gaps = 5/52 (9%)
Query: 242 IVIGIAKGLEYLHR-GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292
I+ + + + H+ C +H D+KP NIL+ + K+ DFG A++ T
Sbjct: 105 IIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTG 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 40/201 (19%)
Query: 164 KLGQGGFGGVYKGKLLDG--LASIS---------------------RTSHVNVVTLLGFC 200
++G G +G VYK + ++ LA+I H N+V G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 201 LEGNNRALIYEFMPNGSLEKFVY-NGDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
L + + EF GSL+ + G S+ Y+ E + +GL YLH S
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL--------QGLYYLH---S 124
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS-R 317
+H DIK NILL + K++DFG++ T S + GT ++A EV +
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI---GTPYWMAPEVAAVE 181
Query: 318 NFGEVSHKSDVYSFGMMIMEL 338
G + D+++ G+ +EL
Sbjct: 182 RKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 8/95 (8%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
IA GL +LH S I++ D+K N++LD + KI+DFG+ K G+ + G
Sbjct: 110 IAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFC--G 163
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG 340
T YIA E+ + + D ++FG+++ E++
Sbjct: 164 TPDYIAPEIIA--YQPYGKSVDWWAFGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 53/196 (27%), Positives = 74/196 (37%), Gaps = 39/196 (19%)
Query: 175 KGKLLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQ-- 232
K +L+ + + H N+V + L N+ L Y M +F GD S+ Q
Sbjct: 56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL-YILM------EFCDAGDLSRNIQKC 108
Query: 233 YLRWEKMYE-----IVIGIAKGLEYLHR----GCSTRILHFDIKPHNILLDQDF------ 277
Y + K+ E I + L Y H R+LH D+KP NI L
Sbjct: 109 YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168
Query: 278 -----------CPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKS 326
KI DFGL+K GI S GT Y + E+ KS
Sbjct: 169 TAQANNLNGRPIAKIGDFGLSK----NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKS 224
Query: 327 DVYSFGMMIMELVGCK 342
D+++ G +I EL K
Sbjct: 225 DMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.6 bits (90), Expect = 0.004
Identities = 26/74 (35%), Positives = 42/74 (56%), Gaps = 9/74 (12%)
Query: 241 EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSL 300
E+V+ I + +H+ +H DIKP N+LLD++ +++DFG + L G V S
Sbjct: 110 EMVLAI----DSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSN 161
Query: 301 LGARGTIGYIALEV 314
+ A GT YI+ E+
Sbjct: 162 V-AVGTPDYISPEI 174
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 450 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.81 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.75 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.7 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.65 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.65 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.57 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.57 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.55 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.5 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.46 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.38 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.36 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.34 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.32 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.27 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.11 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.95 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.88 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.8 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.77 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.71 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.7 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.7 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.69 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.61 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.55 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.44 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.33 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.22 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.07 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.02 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.79 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.73 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.71 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.6 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.59 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 96.83 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 96.81 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 96.79 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.63 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 96.52 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 96.38 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 95.96 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 95.39 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 95.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 95.28 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 94.98 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 94.92 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.79 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.35 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.86 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 92.97 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 91.88 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 91.88 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 91.45 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 90.34 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 90.25 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 89.92 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 89.41 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 88.29 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 88.2 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 87.83 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 87.36 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 87.26 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 85.95 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 85.85 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 85.43 | |
| PLN02236 | 344 | choline kinase | 84.75 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 84.47 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 82.8 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 82.21 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 82.17 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 81.68 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-49 Score=388.71 Aligned_cols=263 Identities=40% Similarity=0.758 Sum_probs=220.4
Q ss_pred CCcccchhHHHHHhhHhh--hccccccceEEEEEEEc----------------------chhhhhhhcCCCceeeeeeEE
Q 013074 145 PLKRYNFSDVKKITNSFK--DKLGQGGFGGVYKGKLL----------------------DGLASISRTSHVNVVTLLGFC 200 (450)
Q Consensus 145 ~~~~~~~~ei~~~~~~~~--~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l~HpnIv~l~~~~ 200 (450)
..+.|++.|++++|.+|. ..||+|+||.||+|.+. .|++++++++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 567899999999999998 48999999999999532 357889999999999999999
Q ss_pred EeCC-ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCe
Q 013074 201 LEGN-NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP 279 (450)
Q Consensus 201 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 279 (450)
.+++ ..+||||||++|+|.++++..... .++|.++++|+.++|+||+|||+.+...|+|||||++|||||+++++
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~----~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a 216 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE----PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA 216 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC----CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence 9998 599999999999999999876542 48999999999999999999999877789999999999999999999
Q ss_pred EEeeccccccccC-CCCccccccCC-CCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 013074 280 KISDFGLAKLCTT-KKGIVSSLLGA-RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF 357 (450)
Q Consensus 280 kl~DFGla~~~~~-~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~ 357 (450)
||+|||+++.... .... ... .||.+|+|||++.. +..+.|+|||||||+++||++|+.+.+... ...+..+
T Consensus 217 KlsDFGLa~~~~~~~~~~----~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~-~~~~~~l 289 (361)
T KOG1187|consen 217 KLSDFGLAKLGPEGDTSV----STTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSR-PRGELSL 289 (361)
T ss_pred EccCccCcccCCccccce----eeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCC-CcccccH
Confidence 9999999976654 2211 111 69999999999976 589999999999999999999999888654 2333447
Q ss_pred hhhhhhhhhhhhhhhhcccc---cchhH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 358 PHWIYRHVEQDREFKLLGVV---TKKEN-EIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 358 ~~~i~~~~~~~~~~~~~~~~---~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
..|....+......++.+.. ..... +...++..++.+|++.+|++||+|.||+++|+.+..
T Consensus 290 ~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 290 VEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 88877777665444443322 22222 577889999999999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=352.23 Aligned_cols=237 Identities=30% Similarity=0.473 Sum_probs=193.5
Q ss_pred hhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCC-ceEEEEEecCC
Q 013074 161 FKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGN-NRALIYEFMPN 215 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~~ 215 (450)
+.+.||+|+||+||+|.+ .+|+.+|++++|||||+++|+|.+.. ..++||||+++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 456699999999999853 34678899999999999999999987 79999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc-eEeeeeccccEEEcCCC-CeEEeeccccccccCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR-ILHFDIKPHNILLDQDF-CPKISDFGLAKLCTTK 293 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~ 293 (450)
|+|.++++.... ..+++..++.++.+||+||.|||. .+ |||||||++|||++.++ ++||+|||+++.....
T Consensus 125 GsL~~~l~~~~~----~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 125 GSLSVLLHKKRK----RKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999987411 339999999999999999999995 77 99999999999999997 9999999999876543
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
. .......||..|||||++.+....++.|+||||||+++|||+||+.||...... ..+...+ .
T Consensus 198 ~---~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-------~~~~~v~-------~ 260 (362)
T KOG0192|consen 198 K---TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-------QVASAVV-------V 260 (362)
T ss_pred c---ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHH-------h
Confidence 2 113346699999999999842137999999999999999999999999765321 0011111 1
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
.+.+...+..+...+..++.+||+.||..||++.|++..|+.+.....
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 222333344477889999999999999999999999999998766443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-44 Score=337.59 Aligned_cols=234 Identities=24% Similarity=0.367 Sum_probs=192.5
Q ss_pred cchhHHHHHhhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCC
Q 013074 149 YNFSDVKKITNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGN 204 (450)
Q Consensus 149 ~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~ 204 (450)
++.+|+.. .+.||+|..|+||++++ .+|++++.+.+|||||++||.|..+.
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 45556654 46799999999999963 35688999999999999999999998
Q ss_pred c-eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 205 N-RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 205 ~-~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
. +.++||||++|||++.+...+. +++..+-+++.++++||.|||+ ..+||||||||+|||++..|.+||+|
T Consensus 151 ~~isI~mEYMDgGSLd~~~k~~g~------i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicD 222 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILKRVGR------IPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICD 222 (364)
T ss_pred ceEEeehhhcCCCCHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEecc
Confidence 5 9999999999999999976543 8999999999999999999996 58999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
||.++...+. ...+..||..|||||.+.+. .|+.++||||||++++|+.+|+.|+....... .. +.+
T Consensus 223 FGVS~~lvnS-----~a~tfvGT~~YMsPERi~g~--~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~--~~----~~~ 289 (364)
T KOG0581|consen 223 FGVSGILVNS-----IANTFVGTSAYMSPERISGE--SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY--LD----IFE 289 (364)
T ss_pred ccccHHhhhh-----hcccccccccccChhhhcCC--cCCcccceecccHHHHHHhhCCCCCCCcCCCC--CC----HHH
Confidence 9999877554 24567799999999999985 89999999999999999999999997651111 11 111
Q ss_pred hhhhhhhhhhcccccchhH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 364 HVEQDREFKLLGVVTKKEN-EIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+.. ...+..+..+. .++.++.+++..||+.||.+||++.|+++.
T Consensus 290 Ll~~----Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 290 LLCA----IVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred HHHH----HhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1111 11122223333 488999999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=339.10 Aligned_cols=234 Identities=25% Similarity=0.360 Sum_probs=191.4
Q ss_pred HHHhhHhhhccccccceEEEEEE------------------------------EcchhhhhhhcCCCceeeeeeEEEeCC
Q 013074 155 KKITNSFKDKLGQGGFGGVYKGK------------------------------LLDGLASISRTSHVNVVTLLGFCLEGN 204 (450)
Q Consensus 155 ~~~~~~~~~~LG~G~fg~Vy~~~------------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~ 204 (450)
....|.+.+.||.|+||.|-+|. ..+|+++|++++|||||++++++....
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 33445567899999999998873 246899999999999999999999999
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC---CCeEE
Q 013074 205 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD---FCPKI 281 (450)
Q Consensus 205 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl 281 (450)
..|+||||++||+|.+++-.++. +.+..-..++.|++.|+.|||+ +||+||||||+|||+..+ ..+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~------l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKI 320 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY------LREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKI 320 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc------cccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEe
Confidence 99999999999999999976653 7777778899999999999995 999999999999999765 78999
Q ss_pred eeccccccccCCCCccccccCCCCccccccccccccccCC-CCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhh
Q 013074 282 SDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGE-VSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 360 (450)
+|||+|+..... +.+.+.|||+.|.|||++...... +..+.|+||+||+||-+++|.+||........
T Consensus 321 tDFGlAK~~g~~----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s------- 389 (475)
T KOG0615|consen 321 TDFGLAKVSGEG----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS------- 389 (475)
T ss_pred cccchhhccccc----eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-------
Confidence 999999988643 236778999999999999864223 34588999999999999999999986643321
Q ss_pred hhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 361 IYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 361 i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+.+++..+.- ...+....+++++..+++.+||..||++|||++|+++.
T Consensus 390 l~eQI~~G~y----~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 LKEQILKGRY----AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHHHhcCcc----cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2222222211 11223456788999999999999999999999999854
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=322.49 Aligned_cols=236 Identities=21% Similarity=0.374 Sum_probs=189.7
Q ss_pred hhHhhhccccccceEEEEEE-------------------------EcchhhhhhhcCCCceeeeee-EEEeCCc-eEEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGK-------------------------LLDGLASISRTSHVNVVTLLG-FCLEGNN-RALIY 210 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~-------------------------~~~e~~~l~~l~HpnIv~l~~-~~~~~~~-~~lV~ 210 (450)
.+.+.++||+|.||+||+++ +.+|+.+|++|+|||||++++ -+.++.. +++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45577899999999999995 235688999999999999999 4555544 89999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC-ceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST-RILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|+|.+|+|...+...... .+.+++..+|+++.|+++||.++|....+ -|+||||||.||+|+.+|.|||+|||+++.
T Consensus 100 E~c~~GDLsqmIk~~K~q--kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQ--KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HhhcccCHHHHHHHHHhc--cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 999999999999764432 25599999999999999999999942222 399999999999999999999999999999
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
+.++.+.. ...+||+.||+||.+..+ .++.||||||+||++|||..-++||.... +.. +.+++.+.
T Consensus 178 l~s~~tfA---~S~VGTPyYMSPE~i~~~--~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------~~~-L~~KI~qg- 243 (375)
T KOG0591|consen 178 LSSKTTFA---HSLVGTPYYMSPERIHES--GYNFKSDIWSLGCLLYEMCALQSPFYGDN-------LLS-LCKKIEQG- 243 (375)
T ss_pred hcchhHHH---HhhcCCCcccCHHHHhcC--CCCcchhHHHHHHHHHHHHhcCCCccccc-------HHH-HHHHHHcC-
Confidence 98776553 355699999999999986 89999999999999999999999997541 111 22222222
Q ss_pred hhhhcccccchh-HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 370 EFKLLGVVTKKE-NEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 370 ~~~~~~~~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
..+..+ .-++.++..++..|+..||+.||+...++..+..
T Consensus 244 ------d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 ------DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ------CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 122222 5678899999999999999999986666655554
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=344.28 Aligned_cols=238 Identities=28% Similarity=0.467 Sum_probs=194.3
Q ss_pred HHHhhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 155 KKITNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 155 ~~~~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
......+.++||+|.||.||.|++ .+|+.++++|+|+|||+++|+|..+..++||||||
T Consensus 204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEec
Confidence 333445678999999999999963 35799999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
+.|+|.++|...++ ..+...+.+.++.|||+|++||+ ++++|||||.+.|||++++..+||+|||||+...+.
T Consensus 284 ~~GsLl~yLr~~~~----~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~ 356 (468)
T KOG0197|consen 284 PKGSLLDYLRTREG----GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD 356 (468)
T ss_pred ccCcHHHHhhhcCC----CccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCC
Confidence 99999999987433 23888999999999999999999 599999999999999999999999999999954433
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCC-CCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK-NNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
. +.. .....-...|.|||.+.. +.++.|||||||||+||||+|-. .|+..... ..+.+.+++
T Consensus 357 ~-Y~~-~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn--------~ev~~~le~----- 419 (468)
T KOG0197|consen 357 E-YTA-SEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN--------EEVLELLER----- 419 (468)
T ss_pred c-eee-cCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCCH--------HHHHHHHhc-----
Confidence 2 222 234445678999999987 48999999999999999999754 44433221 112333333
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
+.+...+..++.++.+++..||+.+|++|||++.+...|+....
T Consensus 420 --GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 420 --GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred --cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 33445566788999999999999999999999999999987654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=328.94 Aligned_cols=225 Identities=24% Similarity=0.403 Sum_probs=180.4
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.++||+|+||+||+|++ ..|+++|+.++|||||.+++++..++.++||||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 34567899999999999963 34688999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC------CCeEEeecccc
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD------FCPKISDFGLA 287 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~------~~~kl~DFGla 287 (450)
.+|+|.+++++.+. +++.+...++.|+|.||++||+ ++||||||||.||||+.. -.+||+|||+|
T Consensus 92 ~gGDLs~yi~~~~~------l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 92 NGGDLSDYIRRRGR------LPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred CCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999988764 8999999999999999999995 999999999999999864 56899999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
+.+..... ..+.||++-|||||++... +|+.|+|+||+|+++|++++|+.||+.....+ +.....+
T Consensus 163 R~L~~~~~----a~tlcGSplYMAPEV~~~~--~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e--------L~~~~~k 228 (429)
T KOG0595|consen 163 RFLQPGSM----AETLCGSPLYMAPEVIMSQ--QYDAKADLWSIGTILYQCLTGKPPFDAETPKE--------LLLYIKK 228 (429)
T ss_pred hhCCchhH----HHHhhCCccccCHHHHHhc--cccchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHhc
Confidence 99875432 3567899999999999764 89999999999999999999999997543211 1111111
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+. ..+...+......+.++....++.+|.+|-+..+...
T Consensus 229 ~~-----~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 229 GN-----EIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred cc-----cccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 11 1122233344455556667777777777776665543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=343.39 Aligned_cols=225 Identities=25% Similarity=0.388 Sum_probs=189.6
Q ss_pred hhHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+|...+.||+|||..||+++. .+|+++.++++|||||+++++|++.+++|+|.|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 445567899999999999853 357999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
+|++++|..++..+. .+++.++..++.||+.||.||| +.+|+|||||..|++|+++.+|||+|||||..+.
T Consensus 99 LC~~~sL~el~Krrk------~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRK------PLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred ecCCccHHHHHHhcC------CCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeec
Confidence 999999999987443 3999999999999999999999 5999999999999999999999999999999887
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
..... ..+.|||+-|+|||++... ..+..+||||+|||+|-||.|++||....- +-.+..+.... .
T Consensus 170 ~~~Er---k~TlCGTPNYIAPEVl~k~--gHsfEvDiWSlGcvmYtLL~G~PPFetk~v--------kety~~Ik~~~-Y 235 (592)
T KOG0575|consen 170 YDGER---KKTLCGTPNYIAPEVLNKS--GHSFEVDIWSLGCVMYTLLVGRPPFETKTV--------KETYNKIKLNE-Y 235 (592)
T ss_pred Ccccc---cceecCCCcccChhHhccC--CCCCchhhhhhhhHHHhhhhCCCCcccchH--------HHHHHHHHhcC-c
Confidence 54322 4567899999999999875 889999999999999999999999975421 11222222211 1
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..+..++.+..+++..+|+.||.+|||+++|+..
T Consensus 236 -------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 -------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred -------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1223556778899999999999999999999954
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=326.70 Aligned_cols=238 Identities=26% Similarity=0.459 Sum_probs=198.8
Q ss_pred CCcccchhHHHHHhhHhhhccccccceEEEEEEEcch--------------hhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 145 PLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG--------------LASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 145 ~~~~~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~~~~e--------------~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
..+.+.|++|... +-||.|+.|.||+|++.+| ++-|.+|+||||+.+.|+|.....+|+||
T Consensus 117 e~WeiPFe~IsEL-----eWlGSGaQGAVF~Grl~netVAVKKV~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiM 191 (904)
T KOG4721|consen 117 ELWEIPFEEISEL-----EWLGSGAQGAVFLGRLHNETVAVKKVRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIM 191 (904)
T ss_pred hhccCCHHHhhhh-----hhhccCcccceeeeeccCceehhHHHhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEee
Confidence 3466788887754 4699999999999998776 56678889999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
|||..|-|.+.|..... ++......|..+||.|+.||| .+.|||||||.-||||..+..|||+|||-++..
T Consensus 192 EfCa~GqL~~VLka~~~------itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 192 EFCAQGQLYEVLKAGRP------ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eccccccHHHHHhccCc------cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999999976654 888999999999999999999 499999999999999999999999999999877
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.... ....++||..|||||++.+. ..++|+|||||||||||||||..|+.+-.... |..-+..+.
T Consensus 263 ~~~S----TkMSFaGTVaWMAPEvIrne--PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA--------IIwGVGsNs- 327 (904)
T KOG4721|consen 263 SDKS----TKMSFAGTVAWMAPEVIRNE--PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA--------IIWGVGSNS- 327 (904)
T ss_pred hhhh----hhhhhhhhHhhhCHHHhhcC--CcccccceehhHHHHHHHHhcCCCccccchhe--------eEEeccCCc-
Confidence 6552 24567899999999999885 89999999999999999999999997543221 111111110
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.-..-+..+++.+.-++..||+..|..||++++++..|+=.
T Consensus 328 -----L~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 328 -----LHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred -----ccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 11123456778899999999999999999999999998743
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=322.07 Aligned_cols=241 Identities=23% Similarity=0.364 Sum_probs=191.5
Q ss_pred HhhHhhhccccccceEEEEEEE------------------------cchhhhhhhcC-CCceeeeeeEEEeCC-ceEEEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTS-HVNVVTLLGFCLEGN-NRALIY 210 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~-HpnIv~l~~~~~~~~-~~~lV~ 210 (450)
.+|...++||.|+||.||+|+- .+|+..|++++ ||||+++.+++.+.+ .+++||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 4566788999999999999962 45788999999 999999999999887 999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||| ..+|...+..++ ..|++..+..|+.||++||+|+|+ +|+.|||+||+|||+..+..+||+|||+|+..
T Consensus 90 E~M-d~NLYqLmK~R~-----r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 90 EFM-DCNLYQLMKDRN-----RLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred Hhh-hhhHHHHHhhcC-----CcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccc
Confidence 999 569999998764 349999999999999999999995 99999999999999998889999999999998
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch----------hhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF----------PHW 360 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~----------~~~ 360 (450)
..+..+ +..+.|..|+|||++.+. +.|+.+.|+||+||+++|+.+-++.|.+..+.+. .+- ..|
T Consensus 161 ~SkpPY----TeYVSTRWYRAPEvLLrs-~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dq-i~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 161 RSKPPY----TEYVSTRWYRAPEVLLRS-GYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQ-IYKICEVLGTPDKDSW 234 (538)
T ss_pred ccCCCc----chhhhcccccchHHhhhc-cccCCchHHHHHHHHHHHHHHhcccCCCCcHHHH-HHHHHHHhCCCccccc
Confidence 877654 344589999999999886 7899999999999999999999998876543221 000 000
Q ss_pred hh-hhhhhhhhhhh----cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 361 IY-RHVEQDREFKL----LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 361 i~-~~~~~~~~~~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.. ..+........ ...+.......+.+..+++.+|+++||.+|||++|.+++
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 00 00000000000 111112223467889999999999999999999999976
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=311.22 Aligned_cols=217 Identities=21% Similarity=0.285 Sum_probs=180.5
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+++.+.||+|+||+||.++- .+|..+|++++||.||+++-.|++.+.+|+|+||
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~ 106 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY 106 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence 34678999999999999863 2457788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+.||.|..+|.+.+. +++..+.-++..|+.||.|||+ .+||||||||+|||||.+|+++|+|||+++....
T Consensus 107 ~~GGeLf~hL~~eg~------F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 107 LNGGELFYHLQREGR------FSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred cCCccHHHHHHhcCC------cchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 999999999976654 8999999999999999999995 9999999999999999999999999999996544
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... ..+.+||+.|||||++.+. .++.++|.||||+++|||++|.+||...... + +++.+....
T Consensus 178 ~~~~---t~tfcGT~eYmAPEil~~~--gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------~-~~~~I~~~k--- 241 (357)
T KOG0598|consen 178 DGDA---TRTFCGTPEYMAPEILLGK--GYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------K-MYDKILKGK--- 241 (357)
T ss_pred CCCc---cccccCCccccChHHHhcC--CCCcccchHhHHHHHHHHhhCCCCCcCccHH-------H-HHHHHhcCc---
Confidence 3322 3457899999999999985 8999999999999999999999999765321 1 222222211
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCC
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRP 404 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 404 (450)
....+.-.+.+.++++.+.|+.||++|-
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1222233567889999999999999995
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=344.26 Aligned_cols=244 Identities=26% Similarity=0.436 Sum_probs=200.3
Q ss_pred HHHhhHhhhccccccceEEEEEE-----------------------------EcchhhhhhhcCCCceeeeeeEEEeCCc
Q 013074 155 KKITNSFKDKLGQGGFGGVYKGK-----------------------------LLDGLASISRTSHVNVVTLLGFCLEGNN 205 (450)
Q Consensus 155 ~~~~~~~~~~LG~G~fg~Vy~~~-----------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 205 (450)
..-...+.++||+|+||+||+|+ |++|++++..++|||||+++|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 33334478899999999999994 4567999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCCC----C----CccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSK----P----CQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF 277 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~----~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 277 (450)
.++|+|||..|+|.+||....+.. . ..+|+..+.+.||.|||.|++||- ++.+|||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccce
Confidence 999999999999999996543221 1 223899999999999999999999 59999999999999999999
Q ss_pred CeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccc
Q 013074 278 CPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVY 356 (450)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 356 (450)
.|||+|||+++..-..+.+... ....-..+|||||.+.. +++|.+||||||||||||+++ |+.|+....+.+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~-~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---- 713 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVR-GNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---- 713 (774)
T ss_pred EEEecccccchhhhhhhhhccc-CCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence 9999999999977665544331 12234689999999976 499999999999999999995 667776543321
Q ss_pred hhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 357 FPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 357 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
+.+.+.+ +...+.+..++.++.+++..||+.+|++||+++||-.+|+...++
T Consensus 714 ----VIe~i~~-------g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 714 ----VIECIRA-------GQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ----HHHHHHc-------CCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 2333322 233456678889999999999999999999999999999987654
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=318.03 Aligned_cols=227 Identities=22% Similarity=0.327 Sum_probs=186.9
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.|.+.||+|+|++|++|+-. .|-.+|.+| .||.|++|+-.|.++..+|+|+|
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe 154 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLE 154 (604)
T ss_pred cchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEE
Confidence 348899999999999999632 234566677 89999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.++|...+. |++.....++.+|+.||+||| ++|||||||||+|||||+|+++||.|||.|+.+.
T Consensus 155 ~A~nGdll~~i~K~Gs------fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~ 225 (604)
T KOG0592|consen 155 YAPNGDLLDLIKKYGS------FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKILS 225 (604)
T ss_pred ecCCCcHHHHHHHhCc------chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccCC
Confidence 9999999999987754 899999999999999999999 5999999999999999999999999999999775
Q ss_pred CCCCc----------cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhh
Q 013074 292 TKKGI----------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI 361 (450)
Q Consensus 292 ~~~~~----------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i 361 (450)
..... ......++||..|.+||++... ..+..+|+|+|||++|.|+.|.+||....+- .+
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~--~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--------li 295 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDS--PAGPSSDLWALGCILYQMLAGQPPFRAANEY--------LI 295 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcCC--CCCcccchHHHHHHHHHHhcCCCCCccccHH--------HH
Confidence 42221 1112457899999999999885 8899999999999999999999999765321 12
Q ss_pred hhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 362 YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+.+.. ..-..+...++.+.+++.+.|..||.+|+|.++|-+.
T Consensus 296 FqkI~~--------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 296 FQKIQA--------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHH--------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 222211 1112233445778889999999999999999998865
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=312.50 Aligned_cols=232 Identities=29% Similarity=0.387 Sum_probs=185.0
Q ss_pred hhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCC--ceEEEEEecCC
Q 013074 161 FKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGN--NRALIYEFMPN 215 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~E~~~~ 215 (450)
..+.||+|+||.||++.. .+|+.+|++++|||||+++|...... .++++|||+++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~ 100 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG 100 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence 457899999999999853 34688899999999999999755444 58999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-CCCeEEeeccccccccCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-DFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~ 294 (450)
|+|.+++.+.+. . +++..+..+..|+++||+||| +++|+|+||||+|||++. ++.+||+|||+++......
T Consensus 101 GsL~~~~~~~g~-~----l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 101 GSLSDLIKRYGG-K----LPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred CcHHHHHHHcCC-C----CCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 999999987664 2 999999999999999999999 599999999999999999 7999999999998776422
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
..........||+.|||||++... .....++|||||||++.||+||++||.... ....++.......
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g-~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~------~~~~~~~~ig~~~------ 239 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNG-EVARRESDIWSLGCTVVEMLTGKPPWSEFF------EEAEALLLIGRED------ 239 (313)
T ss_pred ccccccccccCCccccCchhhcCC-CcCCccchhhhcCCEEEeccCCCCcchhhc------chHHHHHHHhccC------
Confidence 222223456799999999999851 233469999999999999999999997530 0111122221111
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
..+..+..++.+..+++.+|++.||+.|||++|+++..-
T Consensus 240 -~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 -SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred -CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 122344557788999999999999999999999998743
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=323.60 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=195.3
Q ss_pred CcccchhHHHHHhhHhhhccccccceEEEEEE----------------------EcchhhhhhhcCCCceeeeeeEEEeC
Q 013074 146 LKRYNFSDVKKITNSFKDKLGQGGFGGVYKGK----------------------LLDGLASISRTSHVNVVTLLGFCLEG 203 (450)
Q Consensus 146 ~~~~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~----------------------~~~e~~~l~~l~HpnIv~l~~~~~~~ 203 (450)
.+.+.++|++ +.+.||+|.||+||||+ +++|+.++++.+|.||+-++|+|...
T Consensus 386 ~WeIp~~ev~-----l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 386 EWEIPPEEVL-----LGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred ccccCHHHhh-----ccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 3445555554 46789999999999996 35679999999999999999999988
Q ss_pred CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 204 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
.. ++|..+|+|.+|+.+++-.+.+ |...+..+|+.|++.|+.||| +++|||||||..||+|.+++.|||+|
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etk-----fdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETK-----FDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhh-----hhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEec
Confidence 77 9999999999999999876532 899999999999999999999 69999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccc-cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~ 362 (450)
||++.....-. .........|...|||||++... ...|+..+||||||+|+|||++|..|+.... ... +.
T Consensus 532 FGLatvk~~w~-g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~--~dq------Ii 602 (678)
T KOG0193|consen 532 FGLATVKTRWS-GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQN--RDQ------II 602 (678)
T ss_pred ccceeeeeeec-cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCC--hhh------eE
Confidence 99986442211 11112334477899999998642 2479999999999999999999999998332 111 11
Q ss_pred hhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
-++..+. +..........++++|.+++..||..++++||.+.+|+.+|+.+...
T Consensus 603 fmVGrG~---l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 603 FMVGRGY---LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred EEecccc---cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 1111110 11112223345678999999999999999999999999999886654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=317.82 Aligned_cols=241 Identities=25% Similarity=0.382 Sum_probs=183.0
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeC-Cce
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEG-NNR 206 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~-~~~ 206 (450)
.+.+.++||+|+||.||+|+. .+|+.+++++ +||||++++++|... ...
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 455678999999999999842 1246667777 899999999988764 468
Q ss_pred EEEEEecCCCChhhhhhcCCCCC--------------------------------------------------------C
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSK--------------------------------------------------------P 230 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~--------------------------------------------------------~ 230 (450)
++||||+++|+|.+++....... .
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 89999999999999986532100 0
Q ss_pred CccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccc
Q 013074 231 CQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310 (450)
Q Consensus 231 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~ 310 (450)
...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......... .....++..|+
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~-~~~~~~~~~y~ 243 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGSARLPLKWM 243 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhc-ccCCCCCcccc
Confidence 1347888999999999999999995 8999999999999999999999999999986543322111 12334668899
Q ss_pred cccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHH
Q 013074 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMI 389 (450)
Q Consensus 311 aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 389 (450)
|||++.+. .++.++||||||+++|||++ |..||....... .+...+.... ....+...+..+.
T Consensus 244 aPE~~~~~--~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~-------~~~~~~~~~~~l~ 307 (338)
T cd05102 244 APESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFCQRLKDGT-------RMRAPENATPEIY 307 (338)
T ss_pred CcHHhhcC--CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHhcCC-------CCCCCCCCCHHHH
Confidence 99999764 78999999999999999996 888886432110 0111111111 1111223456789
Q ss_pred HHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 390 IVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 390 ~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
+++.+||+.||++|||+.|+++.|+....
T Consensus 308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 308 RIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=298.14 Aligned_cols=238 Identities=20% Similarity=0.307 Sum_probs=181.3
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|+...++|+|+||.||+++. ++|+++|++++|+|+|.++.+|.....++||+|||
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 34456899999999999863 34689999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC-
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT- 292 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~- 292 (450)
+. ++.+-+.... ..++.+.+.+++.|++.|+.|+| ++++|||||||+||||+.+|.+||||||.|+....
T Consensus 84 dh-TvL~eLe~~p-----~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 84 DH-TVLHELERYP-----NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ch-HHHHHHHhcc-----CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 76 4444444332 22889999999999999999999 59999999999999999999999999999998763
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhh-hhhhhhhh---
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHW-IYRHVEQD--- 368 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~-i~~~~~~~--- 368 (450)
.+.+ +....|..|+|||.+.+. .+|....||||+||++.||++|.+.|....+.+. .+.... +...+...
T Consensus 155 gd~Y----TDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-Ly~I~ktLG~L~prhq~i 228 (396)
T KOG0593|consen 155 GDNY----TDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-LYLIRKTLGNLIPRHQSI 228 (396)
T ss_pred cchh----hhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-HHHHHHHHcccCHHHHHH
Confidence 3322 344579999999999885 4899999999999999999999998876543222 111111 11111110
Q ss_pred ----hhh---hh-----cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 369 ----REF---KL-----LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 369 ----~~~---~~-----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..+ .+ ...........+.-+.+++..||+.||.+|++.++++.
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 000 00 01111222345567899999999999999999999873
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=309.93 Aligned_cols=240 Identities=23% Similarity=0.311 Sum_probs=186.6
Q ss_pred HhhHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC--CceEEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG--NNRALI 209 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 209 (450)
..|+-.++||+|+||.||+|+. .+|+.+|++++||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 3344457899999999999962 2469999999999999999999886 689999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+|||++ +|..++...+ ..|++.++..++.|++.||+||| +++|+|||||.+|||||.+|.+||+|||||++
T Consensus 197 FeYMdh-DL~GLl~~p~-----vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG-----VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred Eecccc-hhhhhhcCCC-----cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceee
Confidence 999965 8988886544 23999999999999999999999 59999999999999999999999999999998
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
+....... .+..+-|..|+|||++.+. ..|+.+.|+||.||||.||+.|++.+....+.. ..+.|++....-.
T Consensus 268 y~~~~~~~--~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve----Ql~kIfklcGSP~ 340 (560)
T KOG0600|consen 268 YTPSGSAP--YTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVE----QLHKIFKLCGSPT 340 (560)
T ss_pred ccCCCCcc--cccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHH----HHHHHHHHhCCCC
Confidence 86554321 3455679999999999987 589999999999999999999999887653321 1122222111000
Q ss_pred h-------------hhh----cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 370 E-------------FKL----LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 370 ~-------------~~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+ ... ...+.+.....+...++++..+|..||.+|.|+.++++.
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0 000 000111123345678889999999999999999998853
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=316.78 Aligned_cols=222 Identities=27% Similarity=0.389 Sum_probs=188.7
Q ss_pred hccccccceEEEEEE-----------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGK-----------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~-----------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 219 (450)
++||+|+-|.||.++ +.+|+.+++..+|+|||.+++.+..++.+++|||||++|+|.
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLT 358 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLT 358 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchh
Confidence 589999999999984 457899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcccc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 299 (450)
+.+.... +++.++..|.++++.||+||| .++|+|||||.+|||++.+|.+||+|||++..+......
T Consensus 359 DvVt~~~-------~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--- 425 (550)
T KOG0578|consen 359 DVVTKTR-------MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--- 425 (550)
T ss_pred hhhhccc-------ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccCc---
Confidence 9986443 899999999999999999999 599999999999999999999999999999877655432
Q ss_pred ccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccc
Q 013074 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379 (450)
Q Consensus 300 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 379 (450)
.....||++|||||+...+ .|.++.||||||++++||+-|++||..+..... ...+.. .......
T Consensus 426 R~TmVGTPYWMAPEVvtrk--~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA--------lyLIa~-----ng~P~lk 490 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRK--PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIAT-----NGTPKLK 490 (550)
T ss_pred cccccCCCCccchhhhhhc--ccCccccchhhhhHHHHHhcCCCCccCCChHHH--------HHHHhh-----cCCCCcC
Confidence 3455699999999999886 899999999999999999999999976433211 111111 1122334
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 380 KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 380 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
....++..+.+++.+||+.|+++|+++.|+|+.
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 456678899999999999999999999999975
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=314.50 Aligned_cols=244 Identities=26% Similarity=0.386 Sum_probs=202.0
Q ss_pred hHhhhccccccceEEEEEE-------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGK-------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~-------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.+.||+|.||+||||+ +.+|++++.+++|||||.++++|++..++++|.||+
T Consensus 4 yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 4 YHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 3456789999999999995 345799999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
.+ +|..++...+. ++++.+..++.+++.||.||| +++|+|||+||.|||+++.+.+|++|||+|+....+
T Consensus 84 ~g-~L~~il~~d~~------lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 84 VG-DLFTILEQDGK------LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hh-hHHHHHHhccC------CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 66 99999976654 999999999999999999999 599999999999999999999999999999988664
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
... .+...||+.|||||++.+. .++..+|.||+||++||+..|++||.... +.+.+... .
T Consensus 154 t~v---ltsikGtPlYmAPElv~e~--pyd~~sDlWslGcilYE~~~G~PPF~a~s-----------i~~Lv~~I----~ 213 (808)
T KOG0597|consen 154 TSV---LTSIKGTPLYMAPELVEEQ--PYDHTSDLWSLGCILYELYVGQPPFYARS-----------ITQLVKSI----L 213 (808)
T ss_pred cee---eeeccCcccccCHHHHcCC--CccchhhHHHHHHHHHHHhcCCCCchHHH-----------HHHHHHHH----h
Confidence 332 4556799999999999974 89999999999999999999999996432 22211111 0
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccccccCCCCCCCCCCCCC
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGSTEALQIPPTPFLSSPPR 433 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~~l~~p~~p~~~~~~~ 433 (450)
......+...+..+.+++...|+.||..|.+-.+++.. .++.....+.|..|...+|-+
T Consensus 214 -~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spft 274 (808)
T KOG0597|consen 214 -KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFT 274 (808)
T ss_pred -cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccc
Confidence 11112234677889999999999999999999999854 677666777777666655544
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=303.41 Aligned_cols=240 Identities=23% Similarity=0.321 Sum_probs=189.7
Q ss_pred hHhhhccccccceEEEEEE------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGK------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|++.++||.|.-++||+|+ +.+|+..++.++||||++++..|..++.+++||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 4466789999999999995 2456778888899999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+||+.+.+...-.. .+++..+..|++++++||.|||+ +|.||||||+.||||+.+|.|||+|||.+..+....
T Consensus 108 ~GS~ldIik~~~~~----Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 108 GGSLLDIIKTYYPD----GLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred CCcHHHHHHHHccc----cccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999765432 29999999999999999999995 999999999999999999999999999876553322
Q ss_pred -CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh-h
Q 013074 295 -GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF-K 372 (450)
Q Consensus 295 -~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~-~ 372 (450)
..........||+.|||||++..+...|+.|+||||||+...||.+|..||....... .+...+...... .
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-------vLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-------VLLLTLQNDPPTLL 253 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-------HHHHHhcCCCCCcc
Confidence 2222225668999999999976655789999999999999999999999997543211 111111111100 0
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.............+.+.+++..||+.||++|||++++++.
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 1111223334566789999999999999999999999853
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=288.42 Aligned_cols=217 Identities=25% Similarity=0.340 Sum_probs=183.9
Q ss_pred cchhHHHHHhhHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEe
Q 013074 149 YNFSDVKKITNSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLE 202 (450)
Q Consensus 149 ~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~ 202 (450)
++++|+. +.+.||.|+||+|.+++. .+|..+|+.+.||.++++++.+.+
T Consensus 41 ~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 5555543 567899999999998862 356788899999999999999999
Q ss_pred CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEe
Q 013074 203 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKIS 282 (450)
Q Consensus 203 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 282 (450)
.+.+++||||.+||.|..++++.++ +++..++-++.||+.||+||| +.+|++||+||+|||||.+|.+||.
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk~~r------F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKit 186 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRKSGR------FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKIT 186 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHhcCC------CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEE
Confidence 9999999999999999999977654 899999999999999999999 5999999999999999999999999
Q ss_pred eccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh
Q 013074 283 DFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~ 362 (450)
|||.|+..... ..+.|||+.|+|||.+... .++.++|.|||||++|||+.|.+||..... -.++
T Consensus 187 DFGFAK~v~~r------T~TlCGTPeYLAPEii~sk--~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY 250 (355)
T KOG0616|consen 187 DFGFAKRVSGR------TWTLCGTPEYLAPEIIQSK--GYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIY 250 (355)
T ss_pred eccceEEecCc------EEEecCCccccChHHhhcC--CCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHH
Confidence 99999987654 4567899999999999886 899999999999999999999999986543 1244
Q ss_pred hhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCC
Q 013074 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDR 403 (450)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 403 (450)
+++.++.. ..+......+.+++...|+.|-.+|
T Consensus 251 ~KI~~~~v--------~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 251 EKILEGKV--------KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred HHHHhCcc--------cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 44433321 2334556778888888899998888
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=308.59 Aligned_cols=245 Identities=22% Similarity=0.357 Sum_probs=182.3
Q ss_pred HhhHhhhccccccceEEEEEEE----------------------------------------cchhhhhhhcCCCceeee
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL----------------------------------------LDGLASISRTSHVNVVTL 196 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~----------------------------------------~~e~~~l~~l~HpnIv~l 196 (450)
..+.+.++||+|+||.||++.. .+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 3455678999999999998742 235778889999999999
Q ss_pred eeEEEeCCceEEEEEecCCCChhhhhhcCCCC-------------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEe
Q 013074 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTS-------------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILH 263 (450)
Q Consensus 197 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH 263 (450)
++++.+.+..++||||+++++|.+++...... .....+++..++.++.|++.||.|||+ .+|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence 99999999999999999999999988653210 111347889999999999999999995 89999
Q ss_pred eeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcC--
Q 013074 264 FDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGC-- 341 (450)
Q Consensus 264 ~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg-- 341 (450)
|||||+|||+++++.+||+|||+++......... ......++..|+|||++... .++.++||||||+++|||+++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR-IQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeE-ecCcCCCCccccCHHHHhcC--CCCchhhhHHHHHHHHHHHHccC
Confidence 9999999999999999999999998664433211 12233467889999998764 789999999999999999864
Q ss_pred CCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 342 KNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 342 ~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
..|+...... .....+........ ..........++..+.+++.+||+.||++|||+.||++.|++
T Consensus 239 ~~p~~~~~~~----~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 239 EQPYGELTDE----QVIENAGEFFRDQG----RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCCCcCCHH----HHHHHHHHHhhhcc----ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 4555432211 01111111000000 000011122345778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=337.64 Aligned_cols=244 Identities=27% Similarity=0.425 Sum_probs=194.9
Q ss_pred HHhhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCce
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNR 206 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 206 (450)
...-.+.+.||+|+||.||+|.+ .+|..++++++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 33334567899999999999963 3457788999999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCCCCC-CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
++++|||++|+|..||.+..... ....++...++.++.|||+|+.||++ +++|||||..+|+||+....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998753211 13458999999999999999999995 999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCC-CCCCCCCCCCCccchhhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK-NNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~-~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
+|+.....+.+.. .....-...|||||.+.. +.++.|+|||||||++||+++.. .|+....+.+ +..
T Consensus 848 lArDiy~~~yyr~-~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~--------v~~- 915 (1025)
T KOG1095|consen 848 LARDIYDKDYYRK-HGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE--------VLL- 915 (1025)
T ss_pred hhHhhhhchheec-cCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchHH--------HHH-
Confidence 9995554443322 111234578999999987 59999999999999999999755 4554332111 111
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
....+.+...+..++..+.+++..||+.+|++||++..+++.+..+...+
T Consensus 916 ------~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 916 ------DVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred ------HHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11122255667788899999999999999999999999999998766553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=309.56 Aligned_cols=226 Identities=25% Similarity=0.373 Sum_probs=184.3
Q ss_pred hhHhhhccccccceEEEEEEEc----------------------------chhhhhhhcC-CCceeeeeeEEEeCCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL----------------------------DGLASISRTS-HVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l~-HpnIv~l~~~~~~~~~~~l 208 (450)
.|.+.+.||+|+||+|+.|+.. +|+.++++++ ||||++++.++.....+++
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~i 97 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYI 97 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEE
Confidence 4556789999999999999421 3677888888 9999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC-CCeEEeecccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD-FCPKISDFGLA 287 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla 287 (450)
||||+.+|+|.+++.+.+. +.+.....++.|++.|++||| +.+|+||||||+|||++.+ +++||+|||++
T Consensus 98 vmEy~~gGdL~~~i~~~g~------l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 98 VMEYCSGGDLFDYIVNKGR------LKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEecCCccHHHHHHHcCC------CChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999987433 888999999999999999999 5999999999999999999 99999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
....... ......+||+.|+|||++.+....-..++||||+||+||.|++|..||+.... +. +...+..
T Consensus 169 ~~~~~~~---~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-------~~-l~~ki~~ 237 (370)
T KOG0583|consen 169 AISPGED---GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-------PN-LYRKIRK 237 (370)
T ss_pred cccCCCC---CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-------HH-HHHHHhc
Confidence 9884111 12466789999999999998621335899999999999999999999986321 11 1111111
Q ss_pred hhhhhhcccccchhHHH-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 368 DREFKLLGVVTKKENEI-AKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~-~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+ ....+..+ +.++..++.+|++.||..|+++.|+++
T Consensus 238 ~--------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 238 G--------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred C--------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 11112222 688999999999999999999999993
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=299.21 Aligned_cols=227 Identities=19% Similarity=0.311 Sum_probs=181.4
Q ss_pred hccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEe----CCceEEEEEecC
Q 013074 163 DKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLE----GNNRALIYEFMP 214 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~ 214 (450)
..||+|++|.||+|++ .+|+.++++++||||++++|++.+ ....++||||++
T Consensus 26 ~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~ 105 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCT 105 (283)
T ss_pred eEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCC
Confidence 3699999999999963 156788999999999999999877 346889999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+|+|.+++.... .+++.....++.+++.||.|||+ ..+++||||||+||++++++.+||+|||+++......
T Consensus 106 ~g~L~~~l~~~~------~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 106 RGYLREVLDKEK------DLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCcHHHHHhhCC------CCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 999999997543 28899999999999999999995 3588899999999999999999999999988654322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
....|+..|+|||++.+....++.++|||||||++|||++|+.||...... . +...+....
T Consensus 178 ------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-------~-~~~~i~~~~----- 238 (283)
T PHA02988 178 ------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-------E-IYDLIINKN----- 238 (283)
T ss_pred ------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHhcC-----
Confidence 223478999999999764347899999999999999999999999743211 1 111111100
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
.....+...+..+.+++.+||+.||++|||++|+++.|+...
T Consensus 239 -~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 239 -NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 011112235678999999999999999999999999998653
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=312.07 Aligned_cols=237 Identities=26% Similarity=0.416 Sum_probs=182.1
Q ss_pred hHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeCCceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 208 (450)
+.+.+.||+|+||.||+|+. .+|+.+++.+ +||||++++++|.++...++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 45678999999999998741 1357777788 89999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCC------------------------------------------------------------
Q 013074 209 IYEFMPNGSLEKFVYNGDTS------------------------------------------------------------ 228 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~------------------------------------------------------------ 228 (450)
||||+++|+|.+++......
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 99999999999998653210
Q ss_pred ---------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcccc
Q 013074 229 ---------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299 (450)
Q Consensus 229 ---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 299 (450)
.....+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..........
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~- 272 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV- 272 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc-
Confidence 001247889999999999999999994 8999999999999999999999999999986644322111
Q ss_pred ccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 300 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....++..|+|||++.+. .++.++||||||+++|||++ |..||....... . ..+.+..... .
T Consensus 273 ~~~~~~~~~y~aPE~~~~~--~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~----~~~~~~~~~~-------~ 336 (375)
T cd05104 273 KGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---K----FYKMIKEGYR-------M 336 (375)
T ss_pred cCCCCCCcceeChhHhcCC--CCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---H----HHHHHHhCcc-------C
Confidence 1223356789999999764 78999999999999999997 777775432111 1 1111111100 0
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
..+...+.++.+++.+||+.||++||+++||+++|+.
T Consensus 337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1112234678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=296.39 Aligned_cols=233 Identities=23% Similarity=0.379 Sum_probs=182.8
Q ss_pred HhhHhhhccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
..+.+.+.||+|+||.||+|++ .+|+..+++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 3455678999999999999853 1346778888999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+|++|||.+..
T Consensus 85 ~e~~~~~~L~~~l~~~~-----~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~ 156 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-----GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE 156 (266)
T ss_pred EEeCCCCcHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence 99999999999987543 238999999999999999999995 8999999999999999999999999998765
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
........ .....++..|+|||.+.+. .++.++|||||||++||+++ |..||...... . +.+.+...
T Consensus 157 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-------~-~~~~~~~~ 224 (266)
T cd05064 157 DKSEAIYT--TMSGKSPVLWAAPEAIQYH--HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-------D-VIKAVEDG 224 (266)
T ss_pred ccccchhc--ccCCCCceeecCHHHHhhC--CccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------H-HHHHHHCC
Confidence 43221111 1122356789999998764 78999999999999999775 88888643211 0 11111111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.....+..++..+.+++.+||+.+|.+||+++++++.|++.
T Consensus 225 -------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 -------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 01112234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=277.74 Aligned_cols=237 Identities=25% Similarity=0.385 Sum_probs=196.4
Q ss_pred CCCCCCcccchhHHHHHhhHhhhccccccceEEEEEE--------------------------EcchhhhhhhcCCCcee
Q 013074 141 YGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGK--------------------------LLDGLASISRTSHVNVV 194 (450)
Q Consensus 141 ~~~~~~~~~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~--------------------------~~~e~~~l~~l~HpnIv 194 (450)
++....+.++++++ ++.+.||+|.||.||.|+ +++|+++-++|+||||+
T Consensus 11 ~~~~~~~~~~l~df-----eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnil 85 (281)
T KOG0580|consen 11 FGSRATKTWTLDDF-----EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNIL 85 (281)
T ss_pred cccccccccchhhc-----cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHH
Confidence 33444556666655 467899999999999995 45678888999999999
Q ss_pred eeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc
Q 013074 195 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD 274 (450)
Q Consensus 195 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~ 274 (450)
++|++|.+....||++||..+|+|...|..+... .+++.....+..|+|.||.|+|. .+|+||||||+|+|++
T Consensus 86 rlY~~fhd~~riyLilEya~~gel~k~L~~~~~~----~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg 158 (281)
T KOG0580|consen 86 RLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMK----RFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLG 158 (281)
T ss_pred hhhhheeccceeEEEEEecCCchHHHHHHhcccc----cccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccC
Confidence 9999999999999999999999999999865543 38888899999999999999994 9999999999999999
Q ss_pred CCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 013074 275 QDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE 354 (450)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~ 354 (450)
.++.+||+|||-+...+... ..+.|||..|.+||...+. ..+...|+|++|++.||++.|.+||......
T Consensus 159 ~~~~lkiAdfGwsV~~p~~k-----R~tlcgt~dyl~pEmv~~~--~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~--- 228 (281)
T KOG0580|consen 159 SAGELKIADFGWSVHAPSNK-----RKTLCGTLDYLPPEMVEGR--GHDKFVDLWSLGVLCYEFLVGLPPFESQSHS--- 228 (281)
T ss_pred CCCCeeccCCCceeecCCCC-----ceeeecccccCCHhhcCCC--CccchhhHHHHHHHHHHHHhcCCchhhhhhH---
Confidence 99999999999988665322 4567899999999999886 8899999999999999999999999765411
Q ss_pred cchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 355 VYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 355 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
-.++.+... ....+..++....+++.+|+..+|.+|.+..|+++.
T Consensus 229 -----etYkrI~k~--------~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 229 -----ETYKRIRKV--------DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----HHHHHHHHc--------cccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 122322221 112235567889999999999999999999999864
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=310.99 Aligned_cols=240 Identities=25% Similarity=0.409 Sum_probs=183.5
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeCCceE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~ 207 (450)
.+.+.+.||+|+||.||+++. .+|+++++++ +|+||++++++|.++...+
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~ 118 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVL 118 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeE
Confidence 345678999999999998641 2357778888 8999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCC------------------------------------------------------------
Q 013074 208 LIYEFMPNGSLEKFVYNGDT------------------------------------------------------------ 227 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~------------------------------------------------------------ 227 (450)
+||||+++|+|.+++.....
T Consensus 119 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (374)
T cd05106 119 VITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSK 198 (374)
T ss_pred EeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccccc
Confidence 99999999999998854211
Q ss_pred ----CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCC
Q 013074 228 ----SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA 303 (450)
Q Consensus 228 ----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 303 (450)
......+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......... .....
T Consensus 199 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~-~~~~~ 274 (374)
T cd05106 199 DEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV-VKGNA 274 (374)
T ss_pred chhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee-eccCC
Confidence 0011347889999999999999999994 899999999999999999999999999998654332211 11223
Q ss_pred CCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhH
Q 013074 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKEN 382 (450)
Q Consensus 304 ~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 382 (450)
.++..|+|||++.+. .++.++|||||||++|||++ |+.||....... ...+...... ....+.
T Consensus 275 ~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-------~~~~~~~~~~-------~~~~~~ 338 (374)
T cd05106 275 RLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-------KFYKMVKRGY-------QMSRPD 338 (374)
T ss_pred CCccceeCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccccccH-------HHHHHHHccc-------CccCCC
Confidence 356789999998764 78999999999999999997 998886532211 0111111110 001111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 383 EIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 383 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
..+.++.+++.+||+.||++|||+.+|+++|+++.
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 23577899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=298.28 Aligned_cols=228 Identities=24% Similarity=0.334 Sum_probs=180.2
Q ss_pred HhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 160 SFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
...+.||+|+||.||+++. .+|+.++++++|+||+++++++.+++..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 3457899999999999852 13577888899999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++|+|..++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++......
T Consensus 83 ~~g~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 83 NGGDLKFHIYNMGN----PGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred CCCcHHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999988864332 238899999999999999999994 89999999999999999999999999999875433
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
.. .....||..|+|||++.+. .++.++|||||||++|||++|+.||........ ...+...+.
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~----~~~~~~~~~------- 218 (285)
T cd05631 156 ET----VRGRVGTVGYMAPEVINNE--KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK----REEVDRRVK------- 218 (285)
T ss_pred Ce----ecCCCCCCCccCHhhhcCC--CCCcccCchhHHHHHHHHHhCCCCCCCCCcchh----HHHHHHHhh-------
Confidence 21 1234589999999999874 789999999999999999999999975432111 001111110
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIEM 412 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 412 (450)
..........+..+.+++.+||+.||++||+ ++|+++.
T Consensus 219 -~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 219 -EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 0111122345678899999999999999997 7888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=294.69 Aligned_cols=239 Identities=22% Similarity=0.343 Sum_probs=198.8
Q ss_pred CCCcccchhHHHHHhhHhhhccccccceEEEEEE--------------------------EcchhhhhhhcCCCceeeee
Q 013074 144 LPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGK--------------------------LLDGLASISRTSHVNVVTLL 197 (450)
Q Consensus 144 ~~~~~~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~--------------------------~~~e~~~l~~l~HpnIv~l~ 197 (450)
...++.+-.--.+-+|+|.+.||+|.||+|-++. .++|+++++.|+||||+.++
T Consensus 40 ~gvkrhhhkhnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~Iy 119 (668)
T KOG0611|consen 40 SGVKRHHHKHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIY 119 (668)
T ss_pred ccccccCcccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehh
Confidence 3445555555566788999999999999998873 34679999999999999999
Q ss_pred eEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC
Q 013074 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF 277 (450)
Q Consensus 198 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 277 (450)
.+|++.+.+.+||||..+|.|.+++...+. |++.....+++||.+|+.|+|+ ++++|||||.+|||+|+|+
T Consensus 120 EVFENkdKIvivMEYaS~GeLYDYiSer~~------LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~ 190 (668)
T KOG0611|consen 120 EVFENKDKIVIVMEYASGGELYDYISERGS------LSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNN 190 (668)
T ss_pred hhhcCCceEEEEEEecCCccHHHHHHHhcc------ccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCC
Confidence 999999999999999999999999987664 9999999999999999999995 9999999999999999999
Q ss_pred CeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 013074 278 CPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF 357 (450)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~ 357 (450)
++||+|||++..+..+.. ..++||++-|.+||.+.+. ..-.+..|-|||||+||-|+.|..||+.....
T Consensus 191 NiKIADFGLSNly~~~kf----LqTFCGSPLYASPEIvNG~-PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk------ 259 (668)
T KOG0611|consen 191 NIKIADFGLSNLYADKKF----LQTFCGSPLYASPEIVNGT-PYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK------ 259 (668)
T ss_pred CeeeeccchhhhhccccH----HHHhcCCcccCCccccCCC-CCCCCccchhhHHHHHHHHhhcccccCCchHH------
Confidence 999999999998876543 5678899999999999886 34578999999999999999999999865321
Q ss_pred hhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 013074 358 PHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413 (450)
Q Consensus 358 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 413 (450)
. +.+++..+. ..+.+-+....-+++|||-.||++|.|+.+|....
T Consensus 260 -~-lvrQIs~Ga---------YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 260 -R-LVRQISRGA---------YREPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -H-HHHHhhccc---------ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1 122222111 11122335567789999999999999999998763
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=305.83 Aligned_cols=236 Identities=20% Similarity=0.279 Sum_probs=180.7
Q ss_pred hhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.+++.+.||+|+||.||+++. .+|++++++++||||+++++++..++..++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 445567899999999999852 23577889999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++.... .+++..+..++.|++.||.|||+ ..+|+|+||||+||+++.++.+||+|||++......
T Consensus 86 ~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 86 DGGSLDQVLKEAK------RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999986543 28899999999999999999995 346999999999999999999999999998765432
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh-------
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE------- 366 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~------- 366 (450)
. .....|+..|+|||++.+. .++.++|||||||++|||++|+.||....... +...+.....
T Consensus 158 ~-----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~ 226 (331)
T cd06649 158 M-----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE----LEAIFGRPVVDGEEGEP 226 (331)
T ss_pred c-----cccCCCCcCcCCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHhcccccccccCCc
Confidence 1 2234589999999999874 78999999999999999999999996432110 0000000000
Q ss_pred ----------------------------hhhhhhhcc-cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 367 ----------------------------QDREFKLLG-VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 367 ----------------------------~~~~~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
......... ...........++.+++.+||+.||++|||++|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 227 HSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 0000011345679999999999999999999999876
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=293.95 Aligned_cols=236 Identities=23% Similarity=0.418 Sum_probs=185.6
Q ss_pred hHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
+.+.+.||+|+||.||+|.. .+|+..+++++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 34678999999999999842 2346778889999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCC----------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCe
Q 013074 210 YEFMPNGSLEKFVYNGDTSK----------PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP 279 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 279 (450)
|||+++++|.+++....... ....+++..++.++.|++.||.|||+ .+++|+||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCCcE
Confidence 99999999999986542211 11348899999999999999999995 899999999999999999999
Q ss_pred EEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchh
Q 013074 280 KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFP 358 (450)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 358 (450)
||+|||+++.......... .....++..|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus 164 ~L~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~sDv~slG~il~el~~~g~~p~~~~~~~------- 233 (283)
T cd05048 164 KISDFGLSRDIYSADYYRV-QSKSLLPVRWMPPEAILYG--KFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ------- 233 (283)
T ss_pred EECCCcceeeccccccccc-cCCCcccccccCHHHhccC--cCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-------
Confidence 9999999876543322111 2233467889999998764 78999999999999999997 88888643211
Q ss_pred hhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 359 HWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 359 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
.+...+.. ......+..++.++.+++.+||+.||.+||+++||++.|++
T Consensus 234 -~~~~~i~~-------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 234 -EVIEMIRS-------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHc-------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111111 11112234567889999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=312.62 Aligned_cols=234 Identities=28% Similarity=0.419 Sum_probs=187.2
Q ss_pred hhhccccccceEEEEEEE------------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 161 FKDKLGQGGFGGVYKGKL------------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~------------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
+.++||+|+||.||+|++ .+|.+++.+++|||||+++|++.....+++||
T Consensus 161 l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivm 240 (474)
T KOG0194|consen 161 LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVM 240 (474)
T ss_pred ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEE
Confidence 458999999999999963 23577888999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
|+|.||+|.++|...+. .++..++..++.+.|+||+||| +.+++||||..+|+|++.++.+||+|||+++..
T Consensus 241 El~~gGsL~~~L~k~~~-----~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 241 ELCNGGSLDDYLKKNKK-----SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRAG 312 (474)
T ss_pred EecCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence 99999999999986653 3899999999999999999999 599999999999999999999999999998865
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
.. +........-...|+|||.+.. +.++.++|||||||++||+++ |..|+...... .+...+.
T Consensus 313 ~~---~~~~~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--------~v~~kI~--- 376 (474)
T KOG0194|consen 313 SQ---YVMKKFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--------EVKAKIV--- 376 (474)
T ss_pred cc---eeeccccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCCHH--------HHHHHHH---
Confidence 41 1111111124679999999987 489999999999999999997 66666543211 1111110
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
..+.....+...+.++..++..||..+|++||+|.++.+.|+.+.....
T Consensus 377 ---~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 377 ---KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ---hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1111222333556778888889999999999999999999998776644
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=278.70 Aligned_cols=237 Identities=24% Similarity=0.325 Sum_probs=184.3
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.-.++||+|.||.||+|+. .+|++.|+.++|+||+.++++|...+.+.+|+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 44457899999999999952 35789999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
+ .+|+..+.+.. ..++...+..++.++++||+|||. +.|+||||||.|+|++.+|.+||+|||+++.+...
T Consensus 84 ~-tdLe~vIkd~~-----i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 84 P-TDLEVVIKDKN-----IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred c-ccHHHHhcccc-----cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 5 59999997654 348999999999999999999994 99999999999999999999999999999998765
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh--------
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV-------- 365 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~-------- 365 (450)
..... ...-|..|+|||.+-+. ..|....|+||.||++.||+-|.+.|....+.+. ...+...+
T Consensus 155 ~~~~~---~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ----L~~If~~LGTP~~~~W 226 (318)
T KOG0659|consen 155 NRIQT---HQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ----LSKIFRALGTPTPDQW 226 (318)
T ss_pred Ccccc---cceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH----HHHHHHHcCCCCcccC
Confidence 43221 22578999999999886 5899999999999999999988776654432111 11111111
Q ss_pred ---hhhhhhhh----cc-cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 366 ---EQDREFKL----LG-VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 366 ---~~~~~~~~----~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..-.+... .. ........++....+++..|+..||.+|++++|++++
T Consensus 227 P~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 227 PEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 00000000 00 0011223345677999999999999999999999976
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=302.83 Aligned_cols=220 Identities=20% Similarity=0.261 Sum_probs=176.0
Q ss_pred hccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 163 DKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.||+|+||.||+++.. +|+.++++++||||+++++++.+++..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999998521 2466788899999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~- 150 (323)
T cd05571 81 ELFFHLSRER------VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-
Confidence 9999986543 28899999999999999999994 8999999999999999999999999999875432211
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . +...+...
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~-~~~~~~~~-------- 210 (323)
T cd05571 151 --TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELILME-------- 210 (323)
T ss_pred --cccceecCccccChhhhcCC--CCCccccCcccchhhhhhhcCCCCCCCCCHH-------H-HHHHHHcC--------
Confidence 12345689999999999774 7899999999999999999999999643210 0 11111100
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
....+...+.++.+++.+||+.||++|| ++.++++.
T Consensus 211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 0111233567788999999999999999 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=304.75 Aligned_cols=227 Identities=22% Similarity=0.355 Sum_probs=193.2
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCc-eEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNN-RALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~-~~lV~E~ 212 (450)
|...+++|+|+||.++..+. ..|+.+++++.|||||.+.+.|.+++. .++||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 45678999999999987642 346889999999999999999999988 9999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
++||+|.+.+...++ ..++++++.+|+.|++.|+.|||+ .+|+|||||+.||++++++.+||.|||+|+....
T Consensus 86 ~eGg~l~~~i~~~k~----~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQKG----VLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred cCCCCHHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999987653 349999999999999999999995 9999999999999999999999999999999877
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... .....||+.||+||.+.+. .|+.|+|||||||++|||++-+++|..... ...+.+..
T Consensus 159 ~~~~---a~tvvGTp~YmcPEil~d~--pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------~~Li~ki~------- 219 (426)
T KOG0589|consen 159 EDSL---ASTVVGTPYYMCPEILSDI--PYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------SELILKIN------- 219 (426)
T ss_pred chhh---hheecCCCcccCHHHhCCC--CCCccCcchhhcchHHHHHhcccccCccch-------HHHHHHHh-------
Confidence 6533 3455699999999999986 899999999999999999999999975421 11122211
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.......+...+.++..++..|++.+|+.||++.+++.+
T Consensus 220 -~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 220 -RGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred -hccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 122345566778899999999999999999999999976
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=303.54 Aligned_cols=221 Identities=23% Similarity=0.293 Sum_probs=178.5
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+++..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 34678899999999999853 2357788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 100 VVGGELFTHLRKAGR------FPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred CCCChHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999875432 7888999999999999999995 9999999999999999999999999999986643
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.. ....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ....+.+....
T Consensus 171 ~~------~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~--- 231 (329)
T PTZ00263 171 RT------FTLCGTPEYLAPEVIQSK--GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAGR--- 231 (329)
T ss_pred Cc------ceecCChhhcCHHHHcCC--CCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCC---
Confidence 32 234589999999999875 678999999999999999999999964321 01111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 412 (450)
...+.....++.+++.+||+.||.+||+ ++++++.
T Consensus 232 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 -----LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred -----cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0111224467889999999999999996 6777744
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=299.60 Aligned_cols=221 Identities=22% Similarity=0.250 Sum_probs=178.8
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 34567899999999999852 1356788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++...+. +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~~~L~~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 83 VPGGELFSYLRNSGR------FSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred CCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 999999999975432 8889999999999999999994 9999999999999999999999999999886643
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.. ....|++.|+|||++.+. .++.++|||||||++|+|++|+.||..... ..+.+.+....
T Consensus 154 ~~------~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~--- 214 (291)
T cd05612 154 RT------WTLCGTPEYLAPEVIQSK--GHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGK--- 214 (291)
T ss_pred Cc------ccccCChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC---
Confidence 21 234589999999999774 688999999999999999999999964321 01111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 412 (450)
...+......+.+++.+||+.||.+||+ ++|+++.
T Consensus 215 -----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 -----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0111223567889999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=307.97 Aligned_cols=241 Identities=18% Similarity=0.224 Sum_probs=180.5
Q ss_pred hhHhhhccccccceEEEEEEE-----------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhh
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEK 220 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 220 (450)
.|.+.+.||+|+||.||+++. .+|++++++++||||+++++++..+...++|+|++ .++|..
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~ 171 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYC 171 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHH
Confidence 455678999999999999852 35789999999999999999999999999999999 578888
Q ss_pred hhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccc
Q 013074 221 FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSL 300 (450)
Q Consensus 221 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~ 300 (450)
++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 172 ~l~~~~------~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~--~~~ 240 (391)
T PHA03212 172 YLAAKR------NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA--NKY 240 (391)
T ss_pred HHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc--ccc
Confidence 886543 28899999999999999999995 8999999999999999999999999999875432211 112
Q ss_pred cCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccc---hhhhhhhhhh-----------
Q 013074 301 LGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY---FPHWIYRHVE----------- 366 (450)
Q Consensus 301 ~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~---~~~~i~~~~~----------- 366 (450)
....||+.|+|||++.+. .++.++|||||||++|||++|+.|+........... ....+.....
T Consensus 241 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 241 YGWAGTIATNAPELLARD--PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccCccCCCChhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 345699999999999774 789999999999999999999988754322111100 0000000000
Q ss_pred ----hhh---hh---hhcccc--cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 367 ----QDR---EF---KLLGVV--TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 367 ----~~~---~~---~~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... .. ...... .......+.++.+++.+||+.||++|||++|+++.
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000 00 000000 01122456788999999999999999999999953
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=295.15 Aligned_cols=240 Identities=23% Similarity=0.379 Sum_probs=187.0
Q ss_pred hhHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
.+.+.+.||+|+||.||+++. .+|++.+++++|+||+++++++.++...++|
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMV 85 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEE
Confidence 344567899999999999852 2346778899999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCe
Q 013074 210 YEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP 279 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 279 (450)
|||+++++|.+++...... .....+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 86 FEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 9999999999999754320 112348999999999999999999994 999999999999999999999
Q ss_pred EEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchh
Q 013074 280 KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFP 358 (450)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 358 (450)
+|+|||++.......... ......++..|+|||++.+. .++.++||||||+++|||++ |..||......
T Consensus 163 ~l~dfg~a~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~------- 232 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYR-VGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYGKQPWFQLSNT------- 232 (291)
T ss_pred EECCCCcccccCCCceee-cCCCCCcceeecChHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------
Confidence 999999987654332111 12233467889999998774 78999999999999999998 88887543211
Q ss_pred hhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 359 HWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 359 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
+ ..+..... .........+..+.+++.+||+.+|++||++++|+++|+.+..
T Consensus 233 ~-~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 233 E-VIECITQG-------RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred H-HHHHHhCC-------CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 0 11111111 1111122345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=293.14 Aligned_cols=246 Identities=26% Similarity=0.343 Sum_probs=180.8
Q ss_pred HhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeC--CceEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEG--NNRALI 209 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 209 (450)
.+.+.||+|+||+||+++. .+|++++++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 4567899999999977421 2357789999999999999988764 457899
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++++|.+++... .+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.
T Consensus 87 ~e~~~~~~l~~~~~~~-------~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-------KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred ecCCCCCCHHHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccc
Confidence 9999999999998643 28999999999999999999995 8999999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
...............++..|+|||.+.+. .++.++||||||++++||++|..|+........+...............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKEN--KFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhccc--CCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 65433221111223356779999998764 7899999999999999999999887543221110000000000000000
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
...........+...+.++.+++.+||+.+|++|||+++++++|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 000000111112334578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=291.78 Aligned_cols=239 Identities=25% Similarity=0.425 Sum_probs=186.4
Q ss_pred HHhhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCce
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNR 206 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 206 (450)
..++.+.+.||+|+||.||+|+. .+|++++++++|+||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 34566788999999999999853 1256788899999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCCC--------CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC
Q 013074 207 ALIYEFMPNGSLEKFVYNGDT--------SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC 278 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~--------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 278 (450)
++||||+++++|.+++...+. ......+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 999999999999999976532 1122348899999999999999999994 89999999999999999999
Q ss_pred eEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccch
Q 013074 279 PKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYF 357 (450)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 357 (450)
+||+|||+++.......... .....++..|+|||++.+. .++.++||||||+++|||++ |..||......
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~------ 231 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRV-GGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE------ 231 (280)
T ss_pred EEECCcccceecccCcceec-CCCCcccceecChhhhccC--CcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH------
Confidence 99999999876533221111 1223357789999999764 78999999999999999998 98888643211
Q ss_pred hhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 358 PHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 358 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
. ....... +.........+..+.+++.+||+.||++||++.||++.|++
T Consensus 232 -~-~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 232 -E-VIECITQ-------GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred -H-HHHHHHc-------CCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 0 1111111 11111122355788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=301.28 Aligned_cols=180 Identities=24% Similarity=0.356 Sum_probs=154.1
Q ss_pred HHHHhhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 154 VKKITNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 154 i~~~~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
+....|++.++||+|+||.||+++. .+|++++++++||||+++++++.+++..++|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 3445567788999999999999852 2357788999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++++|.+++...+ .+++..+..++.|++.||.|||+ ..+++|+||||+|||++.++.+||+|||++..
T Consensus 82 ~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 82 MEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 99999999999997543 27888999999999999999995 34799999999999999999999999999876
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCC
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 348 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~ 348 (450)
..... .....|+..|+|||++.+. .++.++|||||||++|+|++|+.||...
T Consensus 154 ~~~~~-----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 154 LIDSM-----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhhhc-----cccCCCCccccCHHHhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 54321 1234589999999999774 7889999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=298.94 Aligned_cols=217 Identities=20% Similarity=0.256 Sum_probs=173.2
Q ss_pred cccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 165 LGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 165 LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
||+|+||.||+++.. .|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999998531 246778889999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~-- 149 (312)
T cd05585 81 FHHLQREG------RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK-- 149 (312)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc--
Confidence 99986543 28899999999999999999994 99999999999999999999999999998864332211
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .. ..+..... ..
T Consensus 150 -~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~-~~~~~~~~--------~~ 210 (312)
T cd05585 150 -TNTFCGTPEYLAPELLLGH--GYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NE-MYRKILQE--------PL 210 (312)
T ss_pred -cccccCCcccCCHHHHcCC--CCCCccceechhHHHHHHHhCCCCcCCCCH-------HH-HHHHHHcC--------CC
Confidence 2345689999999999874 789999999999999999999999964321 11 11111110 11
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPP---MNEVIE 411 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~ 411 (450)
..+...+.++.+++.+||+.||++||+ +.|++.
T Consensus 211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 112345577889999999999999986 455553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=307.78 Aligned_cols=239 Identities=23% Similarity=0.373 Sum_probs=184.6
Q ss_pred hHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcC-CCceeeeeeEEEeCCceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTS-HVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~l 208 (450)
+.+.+.||+|+||.||+|+. .+|+.+++++. ||||++++++|.+....++
T Consensus 39 ~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~l 118 (400)
T cd05105 39 LVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYI 118 (400)
T ss_pred eehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEE
Confidence 34678999999999998752 13577788886 9999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCC------------------------------------------------------------
Q 013074 209 IYEFMPNGSLEKFVYNGDTS------------------------------------------------------------ 228 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~------------------------------------------------------------ 228 (450)
||||+++|+|.+++......
T Consensus 119 v~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (400)
T cd05105 119 ITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEAS 198 (400)
T ss_pred EEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhh
Confidence 99999999999988643210
Q ss_pred ------------------------------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC
Q 013074 229 ------------------------------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC 278 (450)
Q Consensus 229 ------------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 278 (450)
.....+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 199 KYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCE
Confidence 011247888999999999999999994 89999999999999999999
Q ss_pred eEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccch
Q 013074 279 PKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYF 357 (450)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 357 (450)
+||+|||+++.......... .....++..|+|||.+.+. .++.++||||||+++|||++ |..||.......
T Consensus 276 ~kL~DfGla~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~----- 347 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVS-KGSTFLPVKWMAPESIFDN--LYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS----- 347 (400)
T ss_pred EEEEeCCcceeccccccccc-cCCcCCCcceEChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-----
Confidence 99999999986643322111 2233467889999998764 78999999999999999996 888886432110
Q ss_pred hhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 358 PHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 358 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
.....+... .........+.++.+++.+||+.||++||++.+|+++|+...
T Consensus 348 --~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 --TFYNKIKSG-------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHHhcC-------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 011111111 111122345678999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=305.68 Aligned_cols=227 Identities=26% Similarity=0.359 Sum_probs=190.8
Q ss_pred hhhccccccceEEEEEE--------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 161 FKDKLGQGGFGGVYKGK--------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~--------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+.+.||.|+-|.|-+|+ ...|+.+++-+.||||+.+++++++..++|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 46789999999998875 2457889999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+|.|.+++-..+. +++.+..+++.||+.|+.|+| ..+|+|||+||+|+|||..+++||+|||+|..-..+.
T Consensus 96 gGELFdylv~kG~------l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 96 GGELFDYLVRKGP------LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred CchhHHHHHhhCC------CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 9999999987664 899999999999999999999 4999999999999999999999999999998765543
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
. ..+.||.+.|.|||++.+. .....++||||.||+||.||+|+.||++.. + +-+..++..+
T Consensus 167 l----LeTSCGSPHYA~PEIV~G~-pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------i-r~LLlKV~~G------ 227 (786)
T KOG0588|consen 167 L----LETSCGSPHYAAPEIVSGR-PYDGRPSDVWSCGVILFALLTGKLPFDDDN-------I-RVLLLKVQRG------ 227 (786)
T ss_pred c----ccccCCCcccCCchhhcCC-CCCCCccccchhHHHHHHHHhCCCCCCCcc-------H-HHHHHHHHcC------
Confidence 2 4567899999999999986 355789999999999999999999998442 1 1122222221
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccc
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGST 417 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 417 (450)
....+..++.+..+++.+|+..||+.|.|++||++. |.+-.
T Consensus 228 --~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 228 --VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred --cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 122335667888999999999999999999999987 55543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=302.71 Aligned_cols=229 Identities=21% Similarity=0.259 Sum_probs=180.9
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 345678999999999999632 246678888999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++..... +++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~~~------l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 83 VPGGDFRTLLNNLGV------LSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred CCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 999999999965432 8899999999999999999995 8999999999999999999999999999886543
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
. .....||+.|+|||++.+. .++.++|||||||++|||++|..||....... ....+.......
T Consensus 154 ~------~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~~~ 217 (333)
T cd05600 154 Y------ANSVVGSPDYMAPEVLRGK--GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE--------TWENLKYWKETL 217 (333)
T ss_pred c------cCCcccCccccChhHhcCC--CCCCccceecchHHHhhhhhCCCCCCCCCHHH--------HHHHHHhccccc
Confidence 1 2345689999999999875 78999999999999999999999996432110 111111100000
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
...........++.++.+++.+||+.+|.+||+++|+++.
T Consensus 218 ~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 218 QRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000001112346788999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=302.98 Aligned_cols=243 Identities=21% Similarity=0.277 Sum_probs=176.5
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCC-----ceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGN-----NRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~l 208 (450)
|.+.++||+|+||.||+|+. .+|+.++++++||||+++++++.... ..++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 34567899999999999852 23677889999999999999886432 4799
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
||||+ +++|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 82 v~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 82 VFELM-ESDLHQVIKAND------DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEecC-CCCHHHHHHhcc------cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 99999 568988886543 28999999999999999999995 899999999999999999999999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccc--------hhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY--------FPHW 360 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~--------~~~~ 360 (450)
................||..|+|||++.+....++.++|||||||++|||++|+.||........... ....
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 65432222121234568999999999875334789999999999999999999999865321100000 0000
Q ss_pred hhhhhhhhhhh----hh----cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 361 IYRHVEQDREF----KL----LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 361 i~~~~~~~~~~----~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
...+...... .. ..............+.+++.+||+.||++|||++|+++.
T Consensus 232 -~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 232 -ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred -HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000 00 000000011234567899999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=293.28 Aligned_cols=243 Identities=24% Similarity=0.384 Sum_probs=187.5
Q ss_pred HHhhHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
+..+.+.+.||+|+||+||+++. .+|++++++++||||+++++++..+...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 33445678899999999999852 23467788999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCC-------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeE
Q 013074 208 LIYEFMPNGSLEKFVYNGDTS-------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPK 280 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~-------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 280 (450)
+||||+++++|.+++...... .....+++..++.++.|++.||+|||+ .+++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence 999999999999998654310 112348999999999999999999994 8999999999999999999999
Q ss_pred EeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh
Q 013074 281 ISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPH 359 (450)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 359 (450)
|+|||+++.......... .....++..|+|||++.+. .++.++||||||+++++|++ |..||...... .
T Consensus 161 l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-------~ 230 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRV-GGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-------E 230 (288)
T ss_pred eccCCccccccCCceeec-CCCCCccccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-------H
Confidence 999999886543322111 1223357789999998764 78999999999999999998 88887543211 0
Q ss_pred hhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 360 WIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 360 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
....+..... .......+..+.+++.+||+.||.+|||+.|+++.|+.+...
T Consensus 231 -~~~~i~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 -VIECITQGRV-------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HHHHHHcCCc-------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111110 111123446799999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=287.52 Aligned_cols=229 Identities=25% Similarity=0.430 Sum_probs=180.2
Q ss_pred hHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
+.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.++...++||||+++|+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~ 85 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGC 85 (256)
T ss_pred cEEeeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCc
Confidence 34567899999999999853 235778999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||.++.........
T Consensus 86 L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 86 LLNYLRQRQG-----KLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred HHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999865432 28899999999999999999995 899999999999999999999999999987654322111
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.....++..|+|||.+.+. .++.++||||||+++|||++ |+.||...... + ....+.....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~--~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-------~-~~~~i~~~~~------ 219 (256)
T cd05114 158 --SSGAKFPVKWSPPEVFNFS--KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-------E-VVEMISRGFR------ 219 (256)
T ss_pred --cCCCCCchhhCChhhcccC--ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHHCCCC------
Confidence 1222356789999998764 78899999999999999999 88888543210 1 1111111110
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
...+...+..+.+++.+||+.+|++||+++|+++.|.
T Consensus 220 -~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 220 -LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111223467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=301.02 Aligned_cols=224 Identities=23% Similarity=0.358 Sum_probs=173.4
Q ss_pred hhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 161 FKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.++||+|+||.||+|+. .+|++++++++|+||+++++++.+++..++||||++++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 457899999999999853 23578889999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+.. ...+..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++........
T Consensus 158 ~L~~~~----------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 158 SLEGTH----------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred cccccc----------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 986432 15677888999999999999995 89999999999999999999999999999866432211
Q ss_pred cccccCCCCcccccccccccccc---CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 297 VSSLLGARGTIGYIALEVFSRNF---GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
.....||..|+|||++.... ...+.++|||||||++|||++|+.||....... ....... . .
T Consensus 225 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~~-~-------~ 289 (353)
T PLN00034 225 ---CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD----WASLMCA-I-------C 289 (353)
T ss_pred ---ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc----HHHHHHH-H-------h
Confidence 22345899999999985321 134568999999999999999999997332111 0000000 0 0
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........+..++.+++.+||+.||++||++.|+++.
T Consensus 290 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 290 MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111223456789999999999999999999999976
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=292.15 Aligned_cols=228 Identities=30% Similarity=0.530 Sum_probs=174.1
Q ss_pred hhhccccccceEEEEEEEc----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 161 FKDKLGQGGFGGVYKGKLL----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.||.|.||.||+|.+. +|++.+++++||||++++|++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999998755 236778889999999999999988889999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++..... ..+++..++.++.|++.||.|||+ .+++|++|+++||++++++.+||+|||++.....
T Consensus 83 ~~~g~L~~~L~~~~~----~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK----EPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp -TTEBHHHHHHHTCT----TTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccc----cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 999999999987622 238999999999999999999995 8999999999999999999999999999987733
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.... ...........|+|||.+... .++.++||||||+++||+++ |+.|+..... .. +...+.+..
T Consensus 156 ~~~~-~~~~~~~~~~~~~aPE~~~~~--~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-------~~-~~~~~~~~~-- 222 (259)
T PF07714_consen 156 KSKY-KNDSSQQLPLRYLAPEVLKDG--EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-------EE-IIEKLKQGQ-- 222 (259)
T ss_dssp SSSE-EESTTSESGGGGS-HHHHHHS--EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-------HH-HHHHHHTTE--
T ss_pred cccc-ccccccccccccccccccccc--ccccccccccccccccccccccccccccccc-------cc-ccccccccc--
Confidence 2222 112334467899999999875 68999999999999999999 5677643311 11 112221111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 413 (450)
.......++..+.+++.+||+.+|++||++.++++.|
T Consensus 223 -----~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 -----RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -----ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -----cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1122233567789999999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=288.49 Aligned_cols=232 Identities=25% Similarity=0.435 Sum_probs=183.3
Q ss_pred hHhhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||.||+|++. +|+..+++++||||+++++++.+++..++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 456788999999999998531 24677889999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++..... .+++..++.++.|++.||.|||+ .+|+|+||||+||++++++.++|+|||+++...
T Consensus 86 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 86 YMENGSLDKFLRENDG-----KFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred cCCCCCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999865432 38999999999999999999995 999999999999999999999999999998775
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
....... .....++..|+|||.+.+. .++.++||||||+++++|++ |..||...... + +...+....
T Consensus 158 ~~~~~~~-~~~~~~~~~y~~Pe~~~~~--~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~-~~~~~~~~~- 225 (266)
T cd05033 158 DSEATYT-TKGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------D-VIKAVEDGY- 225 (266)
T ss_pred cccccee-ccCCCCCccccChhhhccC--CCccccchHHHHHHHHHHHccCCCCCCCCCHH-------H-HHHHHHcCC-
Confidence 3222111 1122356789999998764 78999999999999999997 88887533210 0 111111110
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
........+..+.+++.+||+.+|++||+++||++.|+++
T Consensus 226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=287.86 Aligned_cols=232 Identities=28% Similarity=0.431 Sum_probs=183.4
Q ss_pred hHhhhccccccceEEEEEEE----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.+.++||+|+||.||+|.. .+|++.+++++|+||+++++++..+...++||||++++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYG 87 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCC
Confidence 44677899999999999853 23577888999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++..... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 88 ~L~~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 88 NLLDYLRECNR----QEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred cHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99999865432 238999999999999999999995 89999999999999999999999999999876543221
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....++..|+|||.+.+. .++.++||||||+++|||++ |..|+..... .+ ....+....
T Consensus 161 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~-~~~~~~~~~------ 222 (263)
T cd05052 161 A--HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQ-VYELLEKGY------ 222 (263)
T ss_pred c--cCCCCCccccCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HH-HHHHHHCCC------
Confidence 1 1222346689999998764 78899999999999999998 8888753311 01 111111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
....+...+..+.+++.+||+.||++||++.+++++|+.+
T Consensus 223 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 -RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1112233457799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.49 Aligned_cols=230 Identities=19% Similarity=0.251 Sum_probs=182.1
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|.+.+.||+|+||.||+|.. ..|+.++++++||||+++++++.+++..++||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 45678899999999999841 236788999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+|+|.+++..... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 149 gg~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 149 GGDLNKQIKQRLK--EHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCHHHHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999998864321 11348899999999999999999994 899999999999999999999999999998764432
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+ .... .
T Consensus 224 ~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~-~~~~-------~ 285 (478)
T PTZ00267 224 SL-DVASSFCGTPYYLAPELWERK--RYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIM-QQVL-------Y 285 (478)
T ss_pred cc-ccccccCCCccccCHhHhCCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHH-HHHH-------h
Confidence 21 112345699999999999774 789999999999999999999999864321 0111 1110 0
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+.....+..++.++.+++.+||+.||++||++++++.
T Consensus 286 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 286 GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1111122335577999999999999999999999874
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=290.87 Aligned_cols=241 Identities=24% Similarity=0.386 Sum_probs=182.8
Q ss_pred hhHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeC--CceE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEG--NNRA 207 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~ 207 (450)
++.+.+.||+|+||.||++++ .+|++++++++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 445667899999999998752 1247788999999999999998875 5688
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 85 lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-----NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccc
Confidence 9999999999999986442 128999999999999999999995 99999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCC--------Cccchhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS--------SEVYFPH 359 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~--------~~~~~~~ 359 (450)
+................++..|+|||++.+. .++.++||||||++++||++++.+........ .+.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQS--KFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR 234 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccC--CCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH
Confidence 8765433322222334567789999998764 78899999999999999999876543221100 0000010
Q ss_pred hhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 360 WIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 360 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.+ ..... +........++..+.+++.+||+.+|++||+++++++.|+++
T Consensus 235 ~~-~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 235 LV-RVLEE-------GKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HH-HHHHc-------CccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 00000 111111233567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=302.48 Aligned_cols=222 Identities=23% Similarity=0.265 Sum_probs=179.9
Q ss_pred hhHhhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
.+.+.+.||+|+||.||+|+.. .|+.++++++||||+++++++.+++..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 4556789999999999998521 2567788899999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++|+|.+++..... +++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 111 Ey~~~g~L~~~i~~~~~------~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNKR------FPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred eCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999975432 8899999999999999999994 99999999999999999999999999999865
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+.+.+....
T Consensus 182 ~~~------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~~- 244 (340)
T PTZ00426 182 DTR------TYTLCGTPEYIAPEILLNV--GHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEGI- 244 (340)
T ss_pred CCC------cceecCChhhcCHHHHhCC--CCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcCC-
Confidence 432 1234589999999999774 688999999999999999999999974321 11122221111
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
...+...+..+.+++.+|++.||++|+ +++|+++.
T Consensus 245 -------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 -------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011122446678999999999999995 88888765
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=287.74 Aligned_cols=232 Identities=23% Similarity=0.382 Sum_probs=183.2
Q ss_pred hhHhhhccccccceEEEEEEEc---------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL---------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~---------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
.+.+.++||+|+||.||+|... +|+.++++++|+||+++++.+.+++..+++|||++++
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 86 (261)
T cd05072 7 SIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKG 86 (261)
T ss_pred HeEEeeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCC
Confidence 3456789999999999998531 3577888999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++..... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++.........
T Consensus 87 ~L~~~l~~~~~----~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 87 SLLDFLKSDEG----GKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred cHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 99999865432 238889999999999999999995 89999999999999999999999999999876443211
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....++..|+|||++... .++.++||||||+++|+|++ |..||...... .....+....
T Consensus 160 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~~------ 221 (261)
T cd05072 160 A--REGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--------DVMSALQRGY------ 221 (261)
T ss_pred c--cCCCccceecCCHHHhccC--CCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--------HHHHHHHcCC------
Confidence 1 1223356789999998764 78899999999999999998 88888543210 0111111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
.......++.++.+++.+|++.+|++||+++++++.|+.
T Consensus 222 -~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 222 -RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 011112345678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=298.17 Aligned_cols=220 Identities=22% Similarity=0.277 Sum_probs=175.2
Q ss_pred hccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 163 DKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.||+|+||.||+++. .+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3699999999999852 13467888899999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|..++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~- 150 (323)
T cd05595 81 ELFFHLSRER------VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 150 (323)
T ss_pred cHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-
Confidence 9998886543 28899999999999999999994 8999999999999999999999999999875422211
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
......||..|+|||++.+. .++.++|||||||++|||++|+.||....... ..+.+...
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--------~~~~~~~~-------- 210 (323)
T cd05595 151 --TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILME-------- 210 (323)
T ss_pred --ccccccCCcCcCCcccccCC--CCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcC--------
Confidence 12345689999999999764 78999999999999999999999996432110 11111000
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
....+..++.++.+++.+||+.||++|| ++.++++.
T Consensus 211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 211 EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 0011223457788999999999999998 78888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=285.44 Aligned_cols=225 Identities=25% Similarity=0.381 Sum_probs=176.4
Q ss_pred ccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 164 KLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 164 ~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+||+|+||.||+|.+ .+|+.++++++||||+++++++. +...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 699999999999842 12367788899999999999875 45678999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 81 PLNKFLQKNK------HVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 9999986543 28899999999999999999995 89999999999999999999999999999876544332
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
........++..|+|||.+.. ..++.++|+||||+++|||++ |..||...... . +.+.+....
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~----~~~~i~~~~------ 215 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN----E----VTQMIESGE------ 215 (257)
T ss_pred eeecCCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----H----HHHHHHCCC------
Confidence 221222334678999999865 378899999999999999997 88888643211 1 111111111
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
....+...+.++.+++.+||+.||++||++++|++.|+.
T Consensus 216 -~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 216 -RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 111122355778999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=286.16 Aligned_cols=234 Identities=25% Similarity=0.399 Sum_probs=184.5
Q ss_pred HHhhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
...+.+.+.||+|+||.||+|.. .+|++++++++|+||+++++++..++..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMK 84 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeeccc
Confidence 34456778999999999999852 235778899999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++......
T Consensus 85 ~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 85 YGSLLEYLQGGAG----RALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred CCcHHHHHhccCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999865432 238999999999999999999995 899999999999999999999999999998765322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
.. .......+..|+|||++.+. .++.++||||||++++||++ |+.||..... ..+...+....
T Consensus 158 ~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~---- 221 (261)
T cd05068 158 YE--AREGAKFPIKWTAPEAALYN--RFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVDQGY---- 221 (261)
T ss_pred cc--ccCCCcCceeccCccccccC--CCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC----
Confidence 11 11222234689999998764 78999999999999999998 8888754321 00111111110
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
........+..+.+++.+|++.+|++||+++++++.|+.
T Consensus 222 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 ---RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 011122345779999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=299.13 Aligned_cols=221 Identities=26% Similarity=0.367 Sum_probs=184.3
Q ss_pred hhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 162 KDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
.+.||+|.||.||+|.. .+|+.+|+.++++||.++||.+..+..++++||||.+|+
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred chhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 46899999999999952 236888999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
+.+.+..... +.+..+.-++++++.||.||| ..+.+|||||+.|||+..+|.+||+|||.+..........
T Consensus 98 v~~lL~~~~~------~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 98 VLDLLKSGNI------LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hhhhhccCCC------CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999865442 477778888999999999999 5999999999999999999999999999998876554332
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVV 377 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 377 (450)
....||+.|||||++.+. .|+.|+||||||++.+||++|.+|+...........+++. ..
T Consensus 169 ---~tfvGTPfwMAPEVI~~~--~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~---------------~P 228 (467)
T KOG0201|consen 169 ---KTFVGTPFWMAPEVIKQS--GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS---------------AP 228 (467)
T ss_pred ---ccccccccccchhhhccc--cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC---------------CC
Confidence 466799999999999964 8999999999999999999999999766543221111111 11
Q ss_pred cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 378 TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 378 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+.....+++.+.+++..||+.||+.||++.++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 1222356788999999999999999999999885
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=287.43 Aligned_cols=235 Identities=26% Similarity=0.418 Sum_probs=178.5
Q ss_pred hhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeC------CceE
Q 013074 161 FKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEG------NNRA 207 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~------~~~~ 207 (450)
+.++||+|+||.||+|+.. .|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 4678999999999998531 235678889999999999988542 2468
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+++||+++|+|.+++...........+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcc
Confidence 999999999999887533222222448999999999999999999995 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVE 366 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~ 366 (450)
+.......... .....++..|+|||++.+. .++.++||||||+++|||++ |+.||..... ..+.+.+.
T Consensus 160 ~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~ 228 (272)
T cd05075 160 KKIYNGDYYRQ-GRIAKMPVKWIAIESLADR--VYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDYLR 228 (272)
T ss_pred cccCcccceec-CCcccCCcccCCHHHccCC--CcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHH
Confidence 87654322111 1222356789999999774 78999999999999999998 7777753211 11112221
Q ss_pred hhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 367 QDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.... .......+..+.+++.+||+.||++|||++|+++.|+.+
T Consensus 229 ~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNR-------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCC-------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 111223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=297.84 Aligned_cols=220 Identities=21% Similarity=0.276 Sum_probs=175.7
Q ss_pred hccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 163 DKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.||+|+||.||+++. .+|++++++++||||+++++++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999852 12467788999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~- 150 (328)
T cd05593 81 ELFFHLSRER------VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA- 150 (328)
T ss_pred CHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-
Confidence 9998886543 28999999999999999999994 8999999999999999999999999999875432211
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... . +.+.+...
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~Pf~~~~~~-------~-~~~~~~~~-------- 210 (328)
T cd05593 151 --TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELILME-------- 210 (328)
T ss_pred --ccccccCCcCccChhhhcCC--CCCccCCccccchHHHHHhhCCCCCCCCCHH-------H-HHHHhccC--------
Confidence 12345689999999999764 7899999999999999999999999643210 0 11111000
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
....+...+.++.+++.+||+.||++|| ++.|+++.
T Consensus 211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 211 DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0011223456788999999999999997 88988864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=286.58 Aligned_cols=235 Identities=26% Similarity=0.446 Sum_probs=181.0
Q ss_pred hhhccccccceEEEEEEEc----------------------------chhhhhhhcCCCceeeeeeEEEeCCc------e
Q 013074 161 FKDKLGQGGFGGVYKGKLL----------------------------DGLASISRTSHVNVVTLLGFCLEGNN------R 206 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~------~ 206 (450)
+.+.||+|+||.||+|+.. .|++.+++++||||+++++++.+... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 4678999999999998632 24667788899999999999876554 7
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccc
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGL 286 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 286 (450)
++++||+++++|..++...........+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999998654322223458999999999999999999995 8999999999999999999999999999
Q ss_pred cccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhh
Q 013074 287 AKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 287 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
++.......... .....++..|+|||.+.+. .++.++||||||+++|||++ |..||...... + +.+..
T Consensus 160 ~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-------~-~~~~~ 228 (273)
T cd05035 160 SKKIYSGDYYRQ-GRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-------E-IYDYL 228 (273)
T ss_pred eeeccccccccc-cccccCCccccCHhhcccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHH
Confidence 987654332211 1122356789999998764 78999999999999999998 77777543211 0 11111
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
... .....+..++.++.+++.+||+.||++||++.|+++.|+.+
T Consensus 229 ~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 229 RHG-------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HcC-------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 11112234567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=293.21 Aligned_cols=240 Identities=18% Similarity=0.239 Sum_probs=177.1
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.+.||+|+||.||+++. .+|++++++++||||+++++++.+++..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 45677899999999999852 23577889999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
+++.+..+.... ..+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~l~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 83 EKNMLELLEEMP------NGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 887666544322 228899999999999999999995 89999999999999999999999999999876432
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhh-------hhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI-------YRHVE 366 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i-------~~~~~ 366 (450)
... ......|+..|+|||++.+. .++.++|||||||++|||++|+.||................ .+...
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 154 SNA--NYTEYVATRWYRSPELLLGA--PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred ccc--cccccccccccCCcHHHcCC--CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 211 12234589999999999774 68999999999999999999999997542211000000000 00000
Q ss_pred hhhhh---hhcc--cc----cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 367 QDREF---KLLG--VV----TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 367 ~~~~~---~~~~--~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..... .... .. .......+..+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 0000 00 0001124567999999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=290.23 Aligned_cols=236 Identities=24% Similarity=0.391 Sum_probs=182.8
Q ss_pred hHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
+++.++||+|+||.||+|+. .+|++++++++||||+++++++..+...++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 45678999999999999852 13577889999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCC-----------CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCe
Q 013074 211 EFMPNGSLEKFVYNGDT-----------SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP 279 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~ 279 (450)
||+++++|.+++..... ......+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCCcE
Confidence 99999999999853321 0112347899999999999999999995 899999999999999999999
Q ss_pred EEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchh
Q 013074 280 KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFP 358 (450)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~ 358 (450)
||+|||+++.......... .....++..|+|||++.+. .++.++||||||++++||++ |..||.....
T Consensus 164 kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------- 232 (283)
T cd05090 164 KISDLGLSREIYSADYYRV-QPKSLLPIRWMPPEAIMYG--KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------- 232 (283)
T ss_pred EeccccccccccCCcceec-ccCCCccceecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------
Confidence 9999999986643322111 2233456789999998764 78999999999999999998 8778754211
Q ss_pred hhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 359 HWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 359 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
..+.+.+.... .......++.++.+++.+||+.||++||++.+++++|.+
T Consensus 233 ~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 QEVIEMVRKRQ-------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcCC-------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 01111111111 111222345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=290.76 Aligned_cols=237 Identities=24% Similarity=0.422 Sum_probs=184.5
Q ss_pred HhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
.+.+.||+|+||.||+|+. .+|+..+++++||||+++++.+..++..++++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 3567899999999999852 12567788999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCC------------------CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEE
Q 013074 211 EFMPNGSLEKFVYNGDT------------------SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNIL 272 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~------------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIl 272 (450)
||+.+++|.+++..... .+....+++..++.++.|++.||+|||+ .+++||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhheEE
Confidence 99999999999864321 1122358899999999999999999995 89999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCC
Q 013074 273 LDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDN 351 (450)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~ 351 (450)
+++++.+||+|||+++.......... .....++..|+|||.+.+. .++.++||||||++++||++ |..||....
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~-- 234 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVK-RSKGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-- 234 (290)
T ss_pred EcCCCcEEeccccccccccCccchhc-ccCCCCCccccCHHHHccC--CcchHhHHHHHHHHHHHHHhcCCCCCCCCC--
Confidence 99999999999999986543332211 1233456789999998764 78999999999999999998 888875321
Q ss_pred CCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 352 SSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 352 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
+..+.+...... ........+..+.+++.+||+.+|++||+++|+++.|+++.
T Consensus 235 ------~~~~~~~~~~~~-------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 235 ------PERLFNLLKTGY-------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ------HHHHHHHHhCCC-------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111112111110 01112234567899999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=289.53 Aligned_cols=238 Identities=24% Similarity=0.374 Sum_probs=181.6
Q ss_pred HhhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
..+.+.+.||+|+||.||+|.. .+|+.++++++||||+++++++.++...+
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~ 85 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 85 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeE
Confidence 3455678999999999998642 12466788899999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCC----CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSK----PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
+||||+++++|.+++....... ....+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 86 VIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEECC
Confidence 9999999999999986533210 11236888999999999999999995 8999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~ 362 (450)
||+++.......... .....++..|+|||++.+. .++.++||||||+++|||++ |..||..... .. ..
T Consensus 163 fg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~-~~ 231 (277)
T cd05062 163 FGMTRDIYETDYYRK-GGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQ-VL 231 (277)
T ss_pred CCCccccCCcceeec-CCCCccCHhhcChhHhhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HH-HH
Confidence 999876543322211 1123457889999999764 78999999999999999998 6777753211 00 11
Q ss_pred hhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
+...... ........+..+.+++.+||+.||++|||+.|+++.|++
T Consensus 232 ~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 232 RFVMEGG-------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHHHcCC-------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 1111110 111122345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=285.16 Aligned_cols=233 Identities=27% Similarity=0.445 Sum_probs=185.8
Q ss_pred HHhhHhhhccccccceEEEEEEEc----------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
+..+.+.++||.|+||.||+|+.. +|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 345667889999999999998632 3467888999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||||+||++++++.+||+|||.+......
T Consensus 85 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 85 EKGSLLAFLRSPEG----QVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred ccCCHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 99999999976432 238999999999999999999995 89999999999999999999999999999866432
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... .....++..|+|||.+... .++.++||||||+++++|++ |+.||...... ........
T Consensus 158 ~~~---~~~~~~~~~~~~PE~~~~~--~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--------~~~~~~~~----- 219 (261)
T cd05148 158 VYL---SSDKKIPYKWTAPEAASHG--TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--------EVYDQITA----- 219 (261)
T ss_pred ccc---ccCCCCceEecCHHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--------HHHHHHHh-----
Confidence 211 1233467789999998764 78899999999999999998 78888543210 01111111
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
......+..++..+.+++.+||+.||++|||++++++.|+.
T Consensus 220 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 220 --GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred --CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11112223445778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=277.75 Aligned_cols=234 Identities=21% Similarity=0.268 Sum_probs=181.3
Q ss_pred hhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC--CceEEEEEecC
Q 013074 162 KDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG--NNRALIYEFMP 214 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E~~~ 214 (450)
...|++|+||.||+|+. .+|+.+|.+.+|||||.+-.+.... +.+|+|||||+
T Consensus 81 lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 81 LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 45799999999999962 3568899999999999999987754 57999999996
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+ +|...+.+-. +++...++..+..|+++|++|||. +.|+|||||++|+|++..|.+||+|||+|+.+....
T Consensus 161 h-DLksl~d~m~-----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 161 H-DLKSLMETMK-----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred h-hHHHHHHhcc-----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 5 8999887654 348889999999999999999994 899999999999999999999999999999987653
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .+..+-|..|+|||.+.+. ..|+...|+||+||++.||+++++.|....+.+ ..+.|...+..-.+....
T Consensus 232 k~---~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d----Ql~~If~llGtPte~iwp 303 (419)
T KOG0663|consen 232 KP---YTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID----QLDKIFKLLGTPSEAIWP 303 (419)
T ss_pred cc---CcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchHH----HHHHHHHHhCCCccccCC
Confidence 22 3445578999999999986 589999999999999999999999887553321 112222221111100000
Q ss_pred c------------------cccch--hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 G------------------VVTKK--ENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~------------------~~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+ ..... ....++.-.+++..++..||.+|.|++|.++.
T Consensus 304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 0 00000 00134667888999999999999999999865
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=293.72 Aligned_cols=236 Identities=21% Similarity=0.369 Sum_probs=176.9
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|.+.++||+|+||.||+|+. .+|+.++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 44567899999999999842 246788999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++|.+++...+. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 87 -~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 87 -SDLKQYLDNCGN-----LMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred -cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 599988865432 27889999999999999999994 999999999999999999999999999987654322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh---------
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV--------- 365 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~--------- 365 (450)
.. .....++..|+|||++.+. ..++.++||||+||++|+|++|+.||........ + ..+....
T Consensus 158 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~---~-~~~~~~~~~~~~~~~~ 229 (288)
T cd07871 158 KT---YSNEVVTLWYRPPDVLLGS-TEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE---L-HLIFRLLGTPTEETWP 229 (288)
T ss_pred cc---ccCceecccccChHHhcCC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---H-HHHHHHhCCCChHHhh
Confidence 11 2234578999999998653 3688999999999999999999999965421110 0 0000000
Q ss_pred --hhhhhhh---hccc----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 366 --EQDREFK---LLGV----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 366 --~~~~~~~---~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
....... .... ..........+..+++.+||+.||.+|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 230 GITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000 0000 00001123467889999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=298.90 Aligned_cols=230 Identities=22% Similarity=0.264 Sum_probs=177.7
Q ss_pred hHhhhccccccceEEEEEEEc------------------------------chhhhhhhc-CCCceeeeeeEEEeCCceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL------------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~------------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~ 207 (450)
+.+.+.||+|+||.||+++.. .|+.++.++ +|+||+++++++.+++..+
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (332)
T cd05614 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLH 81 (332)
T ss_pred ceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEE
Confidence 345788999999999987421 245667777 5999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+++|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 82 lv~e~~~~g~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 82 LILDYVSGGEMFTHLYQRDN------FSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 99999999999999865432 8899999999999999999995 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
+......... .....||..|+|||++.+. ..++.++|||||||++|||++|+.||......... ..+...+..
T Consensus 153 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~ 225 (332)
T cd05614 153 KEFLSEEKER--TYSFCGTIEYMAPEIIRGK-GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ----SEVSRRILK 225 (332)
T ss_pred ccccccCCCc--cccccCCccccCHHHhcCC-CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH----HHHHHHHhc
Confidence 8654332211 2234689999999998764 35788999999999999999999999644322111 111111110
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
.........+..+.+++.+||+.||++|| +++++++.
T Consensus 226 --------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 --------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 01111223456788999999999999999 67777753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=294.99 Aligned_cols=238 Identities=22% Similarity=0.328 Sum_probs=175.8
Q ss_pred hhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.|.+.++||+|+||.||+|+. .+|+.++++++||||+++++++.++...++||||+
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred cceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 345678999999999999852 23577889999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
.++|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 -~~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 86 -HTDLCQYMDKHP-----GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred -CcCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 468888776543 227889999999999999999994 99999999999999999999999999998754322
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh---
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE--- 370 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~--- 370 (450)
.. ......++..|+|||++.+. ..++.++|||||||++|||++|..||........ .+ ..+.........
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~-~~~~~~~~~~~~~~~ 229 (303)
T cd07869 157 SH---TYSNEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QL-ERIFLVLGTPNEDTW 229 (303)
T ss_pred Cc---cCCCCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HH-HHHHHHhCCCChhhc
Confidence 11 12334588999999998653 3678899999999999999999999975322100 00 000000000000
Q ss_pred --------hh--hccc-ccchh------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 371 --------FK--LLGV-VTKKE------NEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 371 --------~~--~~~~-~~~~~------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.. .... ..... ......+.+++.+||+.||++|||+.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 230 PGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 0000 00000 012356788999999999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=295.21 Aligned_cols=235 Identities=27% Similarity=0.419 Sum_probs=181.3
Q ss_pred HhhHhhhccccccceEEEEEEEc----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLL----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
..+...+.||+|+||.||+|++. +|+.+++.++||||++++|+|..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 34455678999999999998531 235678889999999999999765 5789
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
|+||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++
T Consensus 86 v~e~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeecCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 9999999999999875432 28889999999999999999994 899999999999999999999999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
.......... .....++..|+|||++.+. .++.++||||||+++|||++ |+.||...... . +......
T Consensus 158 ~~~~~~~~~~-~~~~~~~~~y~apE~~~~~--~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-------~-~~~~~~~ 226 (316)
T cd05108 158 LLGADEKEYH-AEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------E-ISSILEK 226 (316)
T ss_pred cccCCCccee-ccCCccceeecChHHhccC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHHHhC
Confidence 7654332211 1222346789999999764 78999999999999999997 88888543110 0 1111111
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.. .......+...+.+++.+||+.+|.+||++.+++..|.....
T Consensus 227 ~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 227 GE-------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CC-------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 10 011112234578899999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=296.03 Aligned_cols=219 Identities=22% Similarity=0.292 Sum_probs=174.7
Q ss_pred hccccccceEEEEEEE------------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 163 DKLGQGGFGGVYKGKL------------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~------------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.||+|+||.||+++. ..|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999998752 1246778899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++...+. +.+..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 82 LSGGELFMHLEREGI------FMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred CCCchHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 999999999865432 7888889999999999999994 9999999999999999999999999999875433
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... .....||..|+|||++.+. .++.++||||||+++|||++|+.||...... . ....+...
T Consensus 153 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~pf~~~~~~-------~-~~~~~~~~---- 215 (323)
T cd05584 153 EGTV---THTFCGTIEYMAPEILMRS--GHGKAVDWWSLGALMYDMLTGAPPFTAENRK-------K-TIDKILKG---- 215 (323)
T ss_pred CCCc---ccccCCCccccChhhccCC--CCCCcceecccHHHHHHHhcCCCCCCCCCHH-------H-HHHHHHcC----
Confidence 2211 2234689999999999774 6789999999999999999999999643210 0 11111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIE 411 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 411 (450)
....+...+..+.+++.+||+.+|++|| +++++++
T Consensus 216 ----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 216 ----KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred ----CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0111223456788999999999999999 7888766
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=288.02 Aligned_cols=236 Identities=22% Similarity=0.348 Sum_probs=182.2
Q ss_pred hHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
+.+.++||+|+||.||+++. .+|++++++++|+||+++++++.++...++++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 34578999999999998841 23467888999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCC---------CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEE
Q 013074 211 EFMPNGSLEKFVYNGDT---------SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKI 281 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 281 (450)
||+++++|.+++..... ......+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCEEE
Confidence 99999999999875432 0112348899999999999999999994 99999999999999999999999
Q ss_pred eeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhh
Q 013074 282 SDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 360 (450)
+|||++........... .....++..|+|||++.+. .++.++|||||||++|||++ |..||...... .
T Consensus 164 ~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~- 232 (280)
T cd05092 164 GDFGMSRDIYSTDYYRV-GGRTMLPIRWMPPESILYR--KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------E- 232 (280)
T ss_pred CCCCceeEcCCCceeec-CCCccccccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------H-
Confidence 99999876543322111 1222356789999998774 78999999999999999998 88887543211 0
Q ss_pred hhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 361 IYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 361 i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
........ ........++..+.+++.+||+.||.+||+++||++.|++
T Consensus 233 ~~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 AIECITQG-------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHcC-------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 01111111 0111122345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=285.87 Aligned_cols=233 Identities=23% Similarity=0.400 Sum_probs=181.7
Q ss_pred hHhhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+...+.||+|+||.||+|+.. .|++++++++|+||+++.+++.+.+..++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 345678999999999988532 24677888999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 87 YMENGALDKYLRDHDG-----EFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred cCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999865432 28999999999999999999995 899999999999999999999999999988664
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
..............+..|+|||++... .++.++||||||+++|||++ |+.||..... .+ +...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~-~~~~i~~~-- 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYR--KFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HE-VMKAINDG-- 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcC--CcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HH-HHHHHhcC--
Confidence 332211111112234579999998764 78999999999999999997 8988854321 11 11111111
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.........+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 -----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111223457789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=282.70 Aligned_cols=226 Identities=25% Similarity=0.390 Sum_probs=175.8
Q ss_pred hccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 163 DKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
+.||+|+||.||+|+. .+|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 4699999999999853 2357788999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
.+++.... ..+++..++.++.|++.||.||| +.+++|+||||+||+++.++.+||+|||++......... .
T Consensus 81 ~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~ 151 (252)
T cd05084 81 LTFLRTEG-----PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA-S 151 (252)
T ss_pred HHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccc-c
Confidence 99986533 22889999999999999999999 489999999999999999999999999998754432111 1
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVV 377 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 377 (450)
.......+..|+|||.+.+. .++.++||||||+++|||++ |..|+...... ......... ..
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~~-------~~ 214 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYG--RYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQG-------VR 214 (252)
T ss_pred cCCCCCCceeecCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHcC-------CC
Confidence 01111234679999998764 78999999999999999997 77777532110 011111110 01
Q ss_pred cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 378 TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 378 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
.......+..+.+++.+||+.+|++|||++|++++|+
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1122234578899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=284.82 Aligned_cols=229 Identities=24% Similarity=0.440 Sum_probs=180.5
Q ss_pred hHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
+.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+....++||||+.+++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGC 85 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCc
Confidence 44677899999999999853 235778889999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++..... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||.++........
T Consensus 86 l~~~i~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 86 LLNYLREHGK-----RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred HHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence 9999865432 38999999999999999999995 89999999999999999999999999998765433211
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
......++..|+|||++.+. .++.++||||||+++|+|++ |..||...... . +........
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~-~~~~~~~~~------- 218 (256)
T cd05113 157 -SSVGSKFPVRWSPPEVLLYS--KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-------E-TVEKVSQGL------- 218 (256)
T ss_pred -ecCCCccChhhCCHHHHhcC--cccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-------H-HHHHHhcCC-------
Confidence 11223356789999999764 78899999999999999998 88887543211 0 111111110
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
........+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11111223578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=290.79 Aligned_cols=231 Identities=23% Similarity=0.314 Sum_probs=179.3
Q ss_pred hHhhhccccccceEEEEEE-------------------------------------EcchhhhhhhcCCCceeeeeeEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGK-------------------------------------LLDGLASISRTSHVNVVTLLGFCL 201 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~-------------------------------------~~~e~~~l~~l~HpnIv~l~~~~~ 201 (450)
|.+.+.||+|.||+|-+|+ ..+|+.+++++.|||||+|+.+..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 4467789999999998884 235799999999999999999887
Q ss_pred eC--CceEEEEEecCCCChhhhhhcCCCCCCCcc-CCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC
Q 013074 202 EG--NNRALIYEFMPNGSLEKFVYNGDTSKPCQY-LRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC 278 (450)
Q Consensus 202 ~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~-l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 278 (450)
+. +.+|||+|||..|.+...- ..++ +++.++++++.++..||+||| .++||||||||+|+||+++|+
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p-------~d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCP-------PDKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred CcccCceEEEEEeccCCccccCC-------CCcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCc
Confidence 64 6899999999988775321 1233 899999999999999999999 699999999999999999999
Q ss_pred eEEeeccccccccCCC--CccccccCCCCcccccccccccccc--CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 013074 279 PKISDFGLAKLCTTKK--GIVSSLLGARGTIGYIALEVFSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE 354 (450)
Q Consensus 279 ~kl~DFGla~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~ 354 (450)
+||+|||.+..+.... ..........||+.|+|||...+.. ...+.+.||||+||+||.|+.|+.||......
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~--- 325 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL--- 325 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH---
Confidence 9999999998763321 1111233467999999999987621 23467889999999999999999999754211
Q ss_pred cchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 013074 355 VYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413 (450)
Q Consensus 355 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 413 (450)
.++.++... ........++.+.+.+++.++|+.||+.|.++.+|....
T Consensus 326 -----~l~~KIvn~------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 326 -----ELFDKIVND------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred -----HHHHHHhcC------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 011111111 111222335678899999999999999999999998764
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.23 Aligned_cols=242 Identities=19% Similarity=0.232 Sum_probs=181.4
Q ss_pred hHhhhccccccceEEEEEEEc-----------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhhh
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-----------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF 221 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-----------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 221 (450)
+.+.+.||+|+||.||+++.. +|++++++++|+|||++++++..+...++|||++ .++|.++
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~ 249 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTY 249 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEecccccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHH
Confidence 445678999999999999642 5789999999999999999999999999999999 5789888
Q ss_pred hhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcccccc
Q 013074 222 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301 (450)
Q Consensus 222 l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~ 301 (450)
+.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......... ...
T Consensus 250 l~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~-~~~ 320 (461)
T PHA03211 250 LGARL-----RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP-FHY 320 (461)
T ss_pred HHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc-ccc
Confidence 86532 238999999999999999999994 899999999999999999999999999998664332111 122
Q ss_pred CCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh--hhc-----
Q 013074 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF--KLL----- 374 (450)
Q Consensus 302 ~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~----- 374 (450)
...||..|+|||++.+. .++.++|||||||++|||++|..++...........+...+.+.+...... ...
T Consensus 321 ~~~GT~~Y~APE~~~~~--~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~ 398 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGD--PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS 398 (461)
T ss_pred ccCCCcCCcCHHHHcCC--CCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence 45699999999999774 789999999999999999998876654332222112222222211111000 000
Q ss_pred ------------ccc-------cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 ------------GVV-------TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ------------~~~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 00001233468889999999999999999999975
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=282.38 Aligned_cols=228 Identities=25% Similarity=0.430 Sum_probs=178.6
Q ss_pred hccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
++||+|+||.||+|+. .+|+.++++++|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 4699999999999842 12467888899999999999876 5568999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++.... .+++..+..++.|++.||+|||. .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 80 GPLLKYLKKRR------EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CcHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999997654 28899999999999999999995 8999999999999999999999999999987654432
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.........++..|+|||.+.+. .++.++||||||+++|+|++ |..||..... .. +...+....
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~----~~~~~~~~~----- 215 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYG--KFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AE----VIAMLESGE----- 215 (257)
T ss_pred ccccccCccccccccCHHHhcCC--CCCccchHHHHHHHHHHHHcCCCCCcccCCH----HH----HHHHHHcCC-----
Confidence 22212222345689999998764 78999999999999999997 8888854321 01 111111111
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
.......++..+.+++.+||+.+|++||++.++++.|++..
T Consensus 216 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 --RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred --cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11122334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=289.68 Aligned_cols=245 Identities=22% Similarity=0.358 Sum_probs=181.2
Q ss_pred HHhhHhhhccccccceEEEEEEE--------------------------------------cchhhhhhhcCCCceeeee
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL--------------------------------------LDGLASISRTSHVNVVTLL 197 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~--------------------------------------~~e~~~l~~l~HpnIv~l~ 197 (450)
+-.+.+.+.||+|+||.||+++. .+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 44566778999999999997531 1367889999999999999
Q ss_pred eEEEeCCceEEEEEecCCCChhhhhhcCCCC------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccE
Q 013074 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTS------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNI 271 (450)
Q Consensus 198 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NI 271 (450)
+++..+...++||||+++++|.+++...... .....+++..++.++.|++.||+|||+ .+++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 9999999999999999999999998653211 111237889999999999999999994 8999999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc--CCCCCCCCC
Q 013074 272 LLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG--CKNNLDSGV 349 (450)
Q Consensus 272 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt--g~~p~~~~~ 349 (450)
++++++.+||+|||++......... .......++..|+|||++... .++.++||||||+++++|++ +..||....
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYY-RIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EEcCCCcEEecccccccccccCcce-eccCcCcCceeecChhhhccC--CcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 9999999999999998765433211 112223456789999998764 78999999999999999987 445554321
Q ss_pred CCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 350 DNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 350 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
.. .....+.+........ .........+..+.+++.+||+.||++||++++|++.|+
T Consensus 238 ~~----~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 238 DE----QVIENTGEFFRNQGRQ----IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred hH----HHHHHHHHhhhhcccc----ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 10 0000000000000000 001111224568999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=287.84 Aligned_cols=237 Identities=23% Similarity=0.356 Sum_probs=182.0
Q ss_pred hhHhhhccccccceEEEEEEEc-----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL-----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~-----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
++.+.++||+|+||.||+|+.. .|+.++++++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4557789999999999998531 23556778899999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCC----------CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC
Q 013074 209 IYEFMPNGSLEKFVYNGDT----------SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC 278 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 278 (450)
++||+.+++|.+++..... ......+++..++.++.|++.||+|||+ .+++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence 9999999999999853211 0112347888999999999999999994 89999999999999999999
Q ss_pred eEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccch
Q 013074 279 PKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYF 357 (450)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 357 (450)
+||+|||+++........ .......+++.|+|||++... .++.++||||||+++|||++ |..||.....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~------- 232 (283)
T cd05091 163 VKISDLGLFREVYAADYY-KLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------- 232 (283)
T ss_pred eEecccccccccccchhe-eeccCccCCccccCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence 999999998865433221 112233467899999998763 78999999999999999998 6667653211
Q ss_pred hhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 358 PHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 358 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
..+.+.+.... .......++..+.+++..||+.+|++||++++|+..|+.
T Consensus 233 -~~~~~~i~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 -QDVIEMIRNRQ-------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHHHHcCC-------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 01111111111 111223456778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=289.34 Aligned_cols=243 Identities=25% Similarity=0.367 Sum_probs=182.3
Q ss_pred hhHhhhccccccceEEEEEEE----------------------------------------cchhhhhhhcCCCceeeee
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL----------------------------------------LDGLASISRTSHVNVVTLL 197 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~----------------------------------------~~e~~~l~~l~HpnIv~l~ 197 (450)
.+.+.++||+|+||.||+++. .+|++++++++||||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 345678999999999998642 1257788999999999999
Q ss_pred eEEEeCCceEEEEEecCCCChhhhhhcCCCC-----CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEE
Q 013074 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTS-----KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNIL 272 (450)
Q Consensus 198 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIl 272 (450)
+++..+...++++|++++++|.+++...... .....+++..++.++.|++.||+|||+ .+++|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhcee
Confidence 9999999999999999999999998764421 111248999999999999999999995 89999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc--CCCCCCCCCC
Q 013074 273 LDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG--CKNNLDSGVD 350 (450)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt--g~~p~~~~~~ 350 (450)
++.++.++|+|||+++.......... .....++..|+|||++.+. .++.++||||||+++|||++ +..|+.....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRV-QGRAPLPIRWMAWESVLLG--KFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ecCCCceEEccccceeecccCcceee-cCcCCCCceecCHHHhhcC--CCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999876543322111 2234467889999998764 78999999999999999997 5556643211
Q ss_pred CCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 351 NSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 351 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
..+......................++.++.+++.+||+.||++|||++||++.|+
T Consensus 240 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --------QQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --------HHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111000000000001112234578999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=289.58 Aligned_cols=238 Identities=22% Similarity=0.404 Sum_probs=183.5
Q ss_pred hHhhhccccccceEEEEEEEc-----------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-----------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-----------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 208 (450)
+.+.+.||+|+||.||+++.. +|+++++++ +|+||+++++++.++...++
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 93 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYV 93 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEE
Confidence 345678999999999998531 245667777 89999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCC----------CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC
Q 013074 209 IYEFMPNGSLEKFVYNGDT----------SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC 278 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 278 (450)
+|||+++++|.+++..... ......+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.
T Consensus 94 i~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 94 VVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred EEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEcCCCe
Confidence 9999999999999865321 0123458999999999999999999995 89999999999999999999
Q ss_pred eEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccch
Q 013074 279 PKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYF 357 (450)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~ 357 (450)
+||+|||+++.......... .....++..|+|||++.+. .++.++|||||||++|||++ |..|+......
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------ 241 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRK-TTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE------ 241 (293)
T ss_pred EEeCccccccccccccceec-cCCCCCCccccCHHHhccC--CcCcccceeehhhHHHHHhcCCCCCCCCCCHH------
Confidence 99999999987654322111 2223356789999998764 78999999999999999997 87777532110
Q ss_pred hhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 358 PHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 358 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
...+..... ............+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 242 --~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 --ELFKLLKEG-------YRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --HHHHHHHcC-------CcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 011111111 111122234567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=274.25 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=187.3
Q ss_pred hHhhhccccccceEEEEEE-----------------------EcchhhhhhhcCCCceeeeeeEEEeCC-----ceEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGK-----------------------LLDGLASISRTSHVNVVTLLGFCLEGN-----NRALIY 210 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~-----------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~ 210 (450)
|.+.+.||+|||+.||.++ .++|++.-++++||||+++++++..+. ..|+++
T Consensus 23 yri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~ 102 (302)
T KOG2345|consen 23 YRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLL 102 (302)
T ss_pred EEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEe
Confidence 4467899999999999986 134677888999999999999886544 489999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
+|...|+|.+.+..... .+..+++.+.+.|+.++++||++||+.. ..+.||||||.|||+.+.+.+++.|||.+...
T Consensus 103 Pyy~~Gsl~d~i~~~k~--kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a 179 (302)
T KOG2345|consen 103 PYYKRGSLLDEIERLKI--KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQA 179 (302)
T ss_pred ehhccccHHHHHHHHhh--cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcccc
Confidence 99999999999976543 2346999999999999999999999621 24999999999999999999999999998765
Q ss_pred cCCC------CccccccCCCCccccccccccccccC-CCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh
Q 013074 291 TTKK------GIVSSLLGARGTIGYIALEVFSRNFG-EVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 291 ~~~~------~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
.-.. ...........|..|+|||.+....+ ..++++|||||||+||+|+.|..||+......+...+.
T Consensus 180 ~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA----- 254 (302)
T KOG2345|consen 180 PIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA----- 254 (302)
T ss_pred ceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe-----
Confidence 3211 11122334457899999999975422 57899999999999999999999997544322211110
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
+ .. .....+.....++.+.+++.+|+|.||.+||++.+++..++.+.
T Consensus 255 -v-~n-----~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 255 -V-QN-----AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -e-ec-----cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0 00 00011112237788999999999999999999999999988653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=296.41 Aligned_cols=227 Identities=23% Similarity=0.291 Sum_probs=176.6
Q ss_pred hhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 161 FKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
..+.||+|+||.||+++-+ .|-.+|....+|.||+++-.|++.+.+||||||++
T Consensus 145 ~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 145 LLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred hheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 4578999999999999632 23445666689999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC-
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK- 293 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~- 293 (450)
||++..+|.+.+. |++..+..++.+++.|++-+|+ .|+|||||||+|+|||..|++||+||||+.-....
T Consensus 225 GGD~mTLL~~~~~------L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 225 GGDMMTLLMRKDT------LTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred CccHHHHHHhcCc------CchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 9999999987654 9999999999999999999995 99999999999999999999999999998532110
Q ss_pred --------------------CCcc-----------------------ccccCCCCccccccccccccccCCCCccCchHh
Q 013074 294 --------------------KGIV-----------------------SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYS 330 (450)
Q Consensus 294 --------------------~~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwS 330 (450)
.... .......||+.|||||++.+. .++..+|.||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~k--gY~~~cDwWS 373 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGK--GYGKECDWWS 373 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcC--CCCccccHHH
Confidence 0000 001134599999999999996 7999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCC---HH
Q 013074 331 FGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP---MN 407 (450)
Q Consensus 331 lGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~ 407 (450)
||||+||||.|-+||....... .++.+..-+.. ...+.....+.+..+++.+|+. ||++|.- ++
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~~--------T~rkI~nwr~~----l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~ 440 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQE--------TYRKIVNWRET----LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAE 440 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHHH--------HHHHHHHHhhh----ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence 9999999999999998664332 22222111110 1112223344778889999999 9999975 56
Q ss_pred HHHH
Q 013074 408 EVIE 411 (450)
Q Consensus 408 evl~ 411 (450)
||-+
T Consensus 441 EIK~ 444 (550)
T KOG0605|consen 441 EIKK 444 (550)
T ss_pred HHhc
Confidence 6653
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=295.57 Aligned_cols=241 Identities=25% Similarity=0.396 Sum_probs=182.7
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeC-Cce
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEG-NNR 206 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~-~~~ 206 (450)
.+.+.+.||+|+||.||+|.. .+|+.++.++ +|+||++++++|... ...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 456778999999999998731 1246677788 899999999988654 578
Q ss_pred EEEEEecCCCChhhhhhcCCCC-------------------------------------------------------CCC
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTS-------------------------------------------------------KPC 231 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~-------------------------------------------------------~~~ 231 (450)
++++||+++++|.+++...... ...
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 8999999999999988643210 001
Q ss_pred ccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCcccccc
Q 013074 232 QYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311 (450)
Q Consensus 232 ~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~a 311 (450)
..+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......... .....++..|+|
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~-~~~~~~~~~y~a 243 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMA 243 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhh-ccCCCCCccccC
Confidence 258999999999999999999994 8999999999999999999999999999987643322111 223346778999
Q ss_pred ccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHH
Q 013074 312 LEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMII 390 (450)
Q Consensus 312 PE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 390 (450)
||++.+. .++.++|||||||+++||++ |..||....... . ....+... .....+.....++.+
T Consensus 244 PE~~~~~--~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~----~~~~~~~~-------~~~~~~~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDK--VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---E----FCRRLKEG-------TRMRAPEYATPEIYS 307 (337)
T ss_pred cHHhcCC--CCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---H----HHHHHhcc-------CCCCCCccCCHHHHH
Confidence 9998774 78999999999999999997 888885432110 1 11111111 011112234567899
Q ss_pred HHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 391 VGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 391 l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
++.+||+.+|++||++.|++++|+.+.+
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=284.39 Aligned_cols=236 Identities=25% Similarity=0.393 Sum_probs=173.6
Q ss_pred hccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 163 DKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
++||+|+||.||+|+. .+|++.++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 3699999999999842 13466778889999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++....... ....++.....++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 81 DLKNYLRSNRGMV-AQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred cHHHHHHhccccc-cccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 9999997654321 1235778889999999999999995 89999999999999999999999999998754332211
Q ss_pred cccccCCCCccccccccccccc-----cCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 297 VSSLLGARGTIGYIALEVFSRN-----FGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~-----~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.. .....++..|+|||++... ...++.++||||||+++|||++ |..||...... .......... .
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~~~~~~~~~-~ 227 (269)
T cd05042 157 IT-KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-------QVLKQVVREQ-D 227 (269)
T ss_pred ec-cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-------HHHHHHhhcc-C
Confidence 11 1233456789999997532 1256889999999999999998 66676533210 0011111111 0
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
.... ........+..+.+++..|+ .||++|||++||++.|.
T Consensus 228 ~~~~--~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 228 IKLP--KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ccCC--CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0111 11112234566777888888 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=297.32 Aligned_cols=221 Identities=20% Similarity=0.265 Sum_probs=174.5
Q ss_pred hccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 163 DKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.||+|+||.||+++. ..|++++++++||||+++++++.++...++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999998852 12356778889999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|..++.... .+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~------~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 152 (325)
T cd05594 81 ELFFHLSRER------VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT 152 (325)
T ss_pred cHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence 9998886543 28999999999999999999993 269999999999999999999999999998754322111
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.....||..|+|||++.+. .++.++|||||||++|||++|+.||...... . ..+.+...
T Consensus 153 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-------~-~~~~i~~~-------- 211 (325)
T cd05594 153 ---MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K-LFELILME-------- 211 (325)
T ss_pred ---cccccCCcccCCHHHHccC--CCCCccccccccceeeeeccCCCCCCCCCHH-------H-HHHHHhcC--------
Confidence 2234589999999999764 7899999999999999999999999643210 0 11111000
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
....+...+.++.+++.+||+.||++|+ ++.++++.
T Consensus 212 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 212 EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0011123456788999999999999996 89998854
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=289.05 Aligned_cols=235 Identities=23% Similarity=0.368 Sum_probs=172.0
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhh---cCCCceeeeeeEEEe-----CC
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISR---TSHVNVVTLLGFCLE-----GN 204 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~---l~HpnIv~l~~~~~~-----~~ 204 (450)
|.+.+.||+|+||.||+|+.. +|+.++++ ++||||++++++|.. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 456778999999999998531 12333443 479999999999863 35
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeec
Q 013074 205 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDF 284 (450)
Q Consensus 205 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 284 (450)
..++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccc
Confidence 6899999995 699998865432 238999999999999999999995 89999999999999999999999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
|+++...... ......||..|+|||.+.+. .++.++|||||||++|||++|+.||........ + ..+...
T Consensus 155 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~-~~i~~~ 224 (290)
T cd07862 155 GLARIYSFQM----ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---L-GKILDV 224 (290)
T ss_pred cceEeccCCc----ccccccccccccChHHHhCC--CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---H-HHHHHH
Confidence 9998654331 12344589999999999764 788999999999999999999999975432110 0 001000
Q ss_pred hhhhhh-----------hhhcc----cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 365 VEQDRE-----------FKLLG----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 365 ~~~~~~-----------~~~~~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
...... ..... ............+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 225 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000 00000 000001124466789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=283.40 Aligned_cols=236 Identities=21% Similarity=0.369 Sum_probs=185.7
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.+.+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 34677899999999999852 2357788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++...... ...+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 84 ADAGDLSQMIKYFKKQ--KRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCcHHHHHHHhhhc--cCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999888643221 1347889999999999999999995 8999999999999999999999999999887654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... .....++..|+|||.+.+. ..+.++|+||||+++|||++|+.||....... .. +...+...
T Consensus 159 ~~~~---~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~-~~~~~~~~---- 223 (267)
T cd08228 159 KTTA---AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----FS-LCQKIEQC---- 223 (267)
T ss_pred hhHH---HhcCCCCccccChhhhccC--CCCchhhHHHHHHHHHHHhcCCCCCccccccH-----HH-HHHHHhcC----
Confidence 3221 1234578899999998764 68899999999999999999999986432211 11 11111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
..........+..+.+++.+||+.+|++||++.||++.|+.+
T Consensus 224 --~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 224 --DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 011111234567899999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=289.50 Aligned_cols=244 Identities=23% Similarity=0.377 Sum_probs=181.5
Q ss_pred hhHhhhccccccceEEEEEE----------------------------------------EcchhhhhhhcCCCceeeee
Q 013074 158 TNSFKDKLGQGGFGGVYKGK----------------------------------------LLDGLASISRTSHVNVVTLL 197 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~----------------------------------------~~~e~~~l~~l~HpnIv~l~ 197 (450)
.+.+.++||+|+||.||+++ +.+|++++++++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 34567899999999999862 12357788899999999999
Q ss_pred eEEEeCCceEEEEEecCCCChhhhhhcCCCCC-----CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEE
Q 013074 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK-----PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNIL 272 (450)
Q Consensus 198 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIl 272 (450)
+++..++..++||||+++++|.+++....... ....+++..+..++.|++.||+|||+ .+++|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheEE
Confidence 99999999999999999999999987643211 12347889999999999999999995 89999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc--CCCCCCCCCC
Q 013074 273 LDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG--CKNNLDSGVD 350 (450)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt--g~~p~~~~~~ 350 (450)
+++++.++|+|||+++......... ......++..|++||...+ +.++.++|||||||++|||++ |..||.....
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYR-IQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD 239 (296)
T ss_pred EcCCCCEEeccCcccccccCCccee-ccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence 9999999999999988654332111 1122234678999998766 378999999999999999997 6667653321
Q ss_pred CCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 351 NSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 351 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
.. ......+...... ..........++..+.+++.+||+.||.+||++.||++.|+.
T Consensus 240 ~~----~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 EQ----VIENTGEFFRDQG----RQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH----HHHHHHHHHhhcc----ccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 0000000000000 000011122345778999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=286.74 Aligned_cols=229 Identities=26% Similarity=0.320 Sum_probs=180.5
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|+..+.||+|+||.||+++. .+|+.++++++||||+++++.+.+++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 44567899999999999852 1256788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 82 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 82 MNGGDLKFHIYNMGN----PGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred cCCCcHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999988865432 238999999999999999999995 8999999999999999999999999999886543
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... .....|+..|+|||++.+. .++.++||||+|+++|||++|+.||........ .+.+...+
T Consensus 155 ~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~----~~~~~~~~------- 217 (285)
T cd05605 155 GET----IRGRVGTVGYMAPEVVKNE--RYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK----REEVERRV------- 217 (285)
T ss_pred CCc----cccccCCCCccCcHHhcCC--CCCccccchhHHHHHHHHHHCCCCCCCCchhhH----HHHHHHHh-------
Confidence 322 1234589999999999764 788999999999999999999999975322110 00011111
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
..........++..+.+++.+||+.||.+|| +++++++.
T Consensus 218 -~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 218 -KEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -hhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 0111122234567789999999999999999 88888654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=282.79 Aligned_cols=229 Identities=26% Similarity=0.437 Sum_probs=180.5
Q ss_pred hHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
+.+.+.||+|+||.||+++. .+|++++++++||||+++++++.+.+..++||||+++++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 85 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85 (256)
T ss_pred cchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCC
Confidence 45678899999999999852 135778889999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++..... .+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.........
T Consensus 86 L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 86 LLNYLRERKG-----KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred HHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999875432 38999999999999999999995 899999999999999999999999999988664332111
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.....++..|+|||.+.+. .++.++||||||+++|+|++ |+.||....... .........
T Consensus 158 --~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~------- 218 (256)
T cd05059 158 --SQGTKFPVKWAPPEVFDYS--RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--------VVESVSAGY------- 218 (256)
T ss_pred --cCCCCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--------HHHHHHcCC-------
Confidence 1122244679999999764 78899999999999999998 777875432110 111111110
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
........+.++.+++.+||+.+|++|||+.|+++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 219 RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 11112235678999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=285.32 Aligned_cols=232 Identities=25% Similarity=0.383 Sum_probs=177.6
Q ss_pred HhhhccccccceEEEEEEEcc----------------------------hhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKLLD----------------------------GLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~----------------------------e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
.+.+.||+|+||.||+|+... ++..+++++||||+++++++. +...++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEE
Confidence 345789999999999986421 133567789999999999875 456789999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++...
T Consensus 89 ~~~~gsL~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 89 LSPLGSLLDHVRQHRD-----SLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred eCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999975432 38999999999999999999995 899999999999999999999999999998654
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
....... .....++..|+|||++.+. .++.++||||||+++||+++ |..||...... . +.+.+.....
T Consensus 161 ~~~~~~~-~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~----~----~~~~~~~~~~ 229 (279)
T cd05111 161 PDDKKYF-YSEHKTPIKWMALESILFG--RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH----E----VPDLLEKGER 229 (279)
T ss_pred CCCcccc-cCCCCCcccccCHHHhccC--CcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH----H----HHHHHHCCCc
Confidence 3321111 2234467889999999764 78999999999999999998 88888543210 0 1111111111
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
. .........+..++.+||+.||.+|||+.|+++.|+.+..
T Consensus 230 ~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 L-------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred C-------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0 1111234567888999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=286.39 Aligned_cols=238 Identities=22% Similarity=0.351 Sum_probs=183.8
Q ss_pred HhhHhhhccccccceEEEEEEEc-----------------------------chhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLL-----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~-----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
..+.+.+.||+|+||.||+|... +|+.++++++||||+++++++..+...+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 34456788999999999987532 2467788899999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCC----CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSK----PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
+||||+++++|.+++....... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence 9999999999999986543211 12347889999999999999999994 8999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~ 362 (450)
||+++.......... .....++..|+|||.+... .++.++||||||+++||+++ |..||...... ...
T Consensus 163 fg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~~ 231 (277)
T cd05032 163 FGMTRDIYETDYYRK-GGKGLLPVRWMAPESLKDG--VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--------EVL 231 (277)
T ss_pred cccchhhccCccccc-CCCCCccccccCHHHHhcC--CCCcccchHHHHHHHHHhhccCCCCCccCCHH--------HHH
Confidence 999886544322111 2233467899999998764 78999999999999999998 88777532110 011
Q ss_pred hhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
+...... ....+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 232 ~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 232 KFVIDGG-------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHhcCC-------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1111111 111122346789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=285.01 Aligned_cols=226 Identities=24% Similarity=0.319 Sum_probs=176.7
Q ss_pred cccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 165 LGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 165 LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
||+|+||.||+++.. .|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999998521 256788999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--- 150 (277)
T cd05607 81 KYHIYNVGE----RGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--- 150 (277)
T ss_pred HHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---
Confidence 988865432 238899999999999999999995 9999999999999999999999999999886654321
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....|+..|+|||++.+. .++.++|||||||++|||++|+.||......... .. +.... ......
T Consensus 151 -~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~---~~-~~~~~-------~~~~~~ 216 (277)
T cd05607 151 -ITQRAGTNGYMAPEILKEE--PYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK---EE-LKRRT-------LEDEVK 216 (277)
T ss_pred -eeccCCCCCccCHHHHccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH---HH-HHHHh-------hccccc
Confidence 1234589999999999775 6899999999999999999999998643221110 00 11100 001111
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
.....++.++.+++.+||+.||++||++.|+++.+.
T Consensus 217 ~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 111235677899999999999999999977664433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=312.46 Aligned_cols=246 Identities=24% Similarity=0.434 Sum_probs=201.3
Q ss_pred ccchhHHHHHhhHhh-----------hccccccceEEEEEEE---------------------------cchhhhhhhcC
Q 013074 148 RYNFSDVKKITNSFK-----------DKLGQGGFGGVYKGKL---------------------------LDGLASISRTS 189 (450)
Q Consensus 148 ~~~~~ei~~~~~~~~-----------~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~ 189 (450)
.++|+|--++..+|. +.||.|.||.|++|++ +.|..++-+++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 466666666665553 5799999999999963 45688899999
Q ss_pred CCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccc
Q 013074 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPH 269 (450)
Q Consensus 190 HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~ 269 (450)
||||++|.|+.......++|.|||++|+|+.||..+.+. |++.++..++++||.|++||.+ .++|||||..+
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq-----ftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAAR 760 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ-----FTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAAR 760 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc-----eEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhh
Confidence 999999999999999999999999999999999887653 8999999999999999999995 99999999999
Q ss_pred cEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHH-cCCCCCCCC
Q 013074 270 NILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV-GCKNNLDSG 348 (450)
Q Consensus 270 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ell-tg~~p~~~~ 348 (450)
|||++.+...|++|||+++...+.........+-.-...|.|||.+.-. +++.+|||||||+|+||.+ .|..|+...
T Consensus 761 NILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~R--KFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 761 NILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred heeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhc--ccCchhhccccceEEEEecccCCCccccc
Confidence 9999999999999999999876544221112222234789999999875 8999999999999999977 688888765
Q ss_pred CCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 349 VDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 349 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.+.+ +.+.+++ +-+.+.+.+++..+.++++.|||.|-.+||.+++|+..|.++..
T Consensus 839 SNQd--------VIkaIe~-------gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 839 SNQD--------VIKAIEQ-------GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred chHH--------HHHHHHh-------ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 4321 2222222 23345566788999999999999999999999999999988654
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=291.95 Aligned_cols=238 Identities=24% Similarity=0.455 Sum_probs=182.4
Q ss_pred hhHhhhccccccceEEEEEEEc--------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
.+.+.+.||+|+||.||+|+.. +|++++.++ +|+||+++++++.+++..++||
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 3456788999999999999521 256778888 8999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeE
Q 013074 211 EFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPK 280 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 280 (450)
||+++++|.+++...... .....+++..++.++.|++.||+|||+ .+++||||||+|||+++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEE
Confidence 999999999999754311 111248899999999999999999994 9999999999999999999999
Q ss_pred EeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh
Q 013074 281 ISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPH 359 (450)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 359 (450)
|+|||+++....... .....++..|+|||++.+. .++.++||||||++++||++ |..||...... .
T Consensus 165 l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~ 231 (303)
T cd05088 165 IADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------E 231 (303)
T ss_pred eCccccCcccchhhh----cccCCCcccccCHHHHhcc--CCcccccchhhhhHHHHHHhcCCCCcccCChH-------H
Confidence 999999864321110 1112245679999998764 68899999999999999998 88888533211 0
Q ss_pred hhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 360 WIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 360 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
..+..... .........+..+.+++.+||+.+|++||+++++++.|+.+.+.
T Consensus 232 -~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 232 -LYEKLPQG-------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred -HHHHHhcC-------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111110 00111123456789999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=281.14 Aligned_cols=227 Identities=23% Similarity=0.371 Sum_probs=176.3
Q ss_pred ccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 164 KLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 164 ~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
.||+|+||.||+|.+ .+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 489999999998743 13467888999999999999885 457899999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 81 LNKFLSGKK-----DEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred HHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 999986433 238999999999999999999995 899999999999999999999999999998654433221
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.......++..|+|||.+... .++.++||||||+++||+++ |..||...... -+...+....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~~~------- 215 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP--------EVMSFIEQGK------- 215 (257)
T ss_pred eccCCCCCCcccCCHHHHccC--CCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH--------HHHHHHHCCC-------
Confidence 112222345789999998764 78999999999999999996 88888643211 0111111111
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
....+...+.++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 216 ~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 216 RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1112233457888999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=290.04 Aligned_cols=241 Identities=24% Similarity=0.439 Sum_probs=184.3
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||.||+|+.. .|+.+++++ +||||+++++++.+....++|+|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 346678999999999998531 246677788 79999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEE
Q 013074 212 FMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKI 281 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 281 (450)
|+++++|.+++...... .....+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeEEE
Confidence 99999999999653311 111348899999999999999999995 89999999999999999999999
Q ss_pred eeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhh
Q 013074 282 SDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 360 (450)
+|||++........ ......+..|+|||++... .++.++|||||||++|||++ |..||...... .
T Consensus 161 ~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-------~- 226 (297)
T cd05089 161 ADFGLSRGEEVYVK----KTMGRLPVRWMAIESLNYS--VYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-------E- 226 (297)
T ss_pred CCcCCCccccceec----cCCCCcCccccCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------H-
Confidence 99999864322110 1112235679999998764 78999999999999999997 88888543211 1
Q ss_pred hhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCC
Q 013074 361 IYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIP 423 (450)
Q Consensus 361 i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p 423 (450)
+....... ........++..+.+++.+||+.+|.+||+++++++.|+.+.+.....
T Consensus 227 ~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 227 LYEKLPQG-------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred HHHHHhcC-------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhccc
Confidence 11111111 011112234577899999999999999999999999999887765443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=296.71 Aligned_cols=216 Identities=23% Similarity=0.270 Sum_probs=172.8
Q ss_pred hccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 163 DKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+.||+|+||.||+++. ..|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999998642 125678899999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 82 GGDLFTRLSKEV------MFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 999999986543 28999999999999999999994 999999999999999999999999999987654332
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .....||..|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+...
T Consensus 153 ~~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~tg~~p~~~~~~~--------~~~~~i~~~------ 213 (318)
T cd05582 153 KK---AYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--------ETMTMILKA------ 213 (318)
T ss_pred Cc---eecccCChhhcCHHHHcCC--CCCCccceeccceEeeeeccCCCCCCCCCHH--------HHHHHHHcC------
Confidence 11 2345689999999999774 6789999999999999999999999643210 011111110
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNE 408 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 408 (450)
....+...+..+.+++.+||+.||++||++.+
T Consensus 214 --~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 --KLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 01112234567889999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.64 Aligned_cols=222 Identities=20% Similarity=0.312 Sum_probs=172.7
Q ss_pred HhhhccccccceEEEEEEEcc--------------------------h---hhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKLLD--------------------------G---LASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~--------------------------e---~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
.+.+.||+|+||.||+++... | +..+++++||||+++++++.+++..++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 356789999999999986321 1 12235678999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++++|...+... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 82 E~~~~~~L~~~~~~~-------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 82 EYAAGGDLMMHIHTD-------VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred cCCCCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999998887532 28999999999999999999995 99999999999999999999999999998754
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
..... ......|+..|+|||.+.+. .++.++|||||||++|||++|+.||...... . +...+...
T Consensus 152 ~~~~~---~~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~G~~pf~~~~~~-------~-~~~~i~~~-- 216 (324)
T cd05589 152 MGFGD---RTSTFCGTPEFLAPEVLTET--SYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-------E-VFDSIVND-- 216 (324)
T ss_pred CCCCC---cccccccCccccCHhHhcCC--CCCcccchhhHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhC--
Confidence 32211 12345689999999999874 7899999999999999999999999643211 0 11111110
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
....+..++..+.+++.+||+.||.+|| ++.++++.
T Consensus 217 ------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 217 ------EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0011223457788999999999999999 46666653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=291.57 Aligned_cols=215 Identities=21% Similarity=0.235 Sum_probs=169.6
Q ss_pred hccccccceEEEEEEEcc--------------------------h-hhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLLD--------------------------G-LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~--------------------------e-~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||+||+|+... | ..+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 369999999999996321 1 1235678999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|..++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (323)
T cd05575 81 GELFFHLQRER------SFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK 151 (323)
T ss_pred CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC
Confidence 99999886543 28899999999999999999995 8999999999999999999999999999875432221
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .. +.+.+....
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~-~~~~i~~~~------ 212 (323)
T cd05575 152 ---TTSTFCGTPEYLAPEVLRKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AE-MYDNILNKP------ 212 (323)
T ss_pred ---ccccccCChhhcChhhhcCC--CCCccccccccchhhhhhhcCCCCCCCCCH-------HH-HHHHHHcCC------
Confidence 12344689999999999774 789999999999999999999999964321 01 111111100
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMN 407 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 407 (450)
.......+..+.+++.+||+.||.+||++.
T Consensus 213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 --LRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 011123457789999999999999999884
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=293.65 Aligned_cols=228 Identities=18% Similarity=0.265 Sum_probs=173.4
Q ss_pred hccccccceEEEEEEEc--------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLL--------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||.||+++.. .|..++.++ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999998532 123344444 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~------~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~ 151 (329)
T cd05618 81 GDLMFHMQRQR------KLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 151 (329)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC
Confidence 99998886543 28999999999999999999995 8999999999999999999999999999875432211
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCC-ccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSS-EVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~i~~~~~~~~~~~~~ 374 (450)
. .....||..|+|||++.+. .++.++|||||||++|||++|+.||........ ......++.+.+....
T Consensus 152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 221 (329)
T cd05618 152 T---TSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 221 (329)
T ss_pred c---cccccCCccccCHHHHcCC--CCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-----
Confidence 1 2334689999999999874 788999999999999999999999964321111 1111122222221111
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPP------MNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~~ 412 (450)
...+...+.++.+++.+||+.||++||+ +.++++.
T Consensus 222 ---~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 222 ---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 1112234567889999999999999998 4666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=283.29 Aligned_cols=233 Identities=23% Similarity=0.413 Sum_probs=182.4
Q ss_pred hHhhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++.+++..++|||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 345678999999999988531 24667888999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++..... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||+++...
T Consensus 86 ~~~~~~L~~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 86 YMENGSLDAFLRKHDG-----QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred cCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999975432 28899999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.............++..|+|||++.+. .++.++|+||||++++|+++ |..||....... ....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~- 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--------VIKAIEEGY- 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccC--ccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--------HHHHHhCCC-
Confidence 433222111222235689999999764 78999999999999999886 888886432110 111111110
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
........+..+.+++.+|++.+|.+||++.++++.|++.
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111223456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=281.91 Aligned_cols=236 Identities=25% Similarity=0.360 Sum_probs=173.9
Q ss_pred hccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 163 DKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.||+|+||.||+|+. .+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 3699999999999852 12467788899999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++...... ....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 81 DLKGYLRSCRKA-ELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred cHHHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999754321 11236778888999999999999995 89999999999999999999999999998754332221
Q ss_pred cccccCCCCcccccccccccccc-----CCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 297 VSSLLGARGTIGYIALEVFSRNF-----GEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~-----~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.. .....++..|+|||++.+.. ..++.++||||||+++|||++ |+.||....... . ........ .
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~----~---~~~~~~~~-~ 227 (269)
T cd05087 157 VT-PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ----V---LTYTVREQ-Q 227 (269)
T ss_pred ec-CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH----H---HHHHhhcc-c
Confidence 11 12345678899999986431 135789999999999999996 988886432211 0 00000000 0
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
.... ...........+.+++..|+ .+|++|||++||++.|+
T Consensus 228 ~~~~--~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 228 LKLP--KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCC--CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 0000 01111123456788889998 58999999999999885
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=289.99 Aligned_cols=219 Identities=21% Similarity=0.289 Sum_probs=170.8
Q ss_pred hccccccceEEEEEEEcc--------------------------hhhhhh-hcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLLD--------------------------GLASIS-RTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~--------------------------e~~~l~-~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||.||+|+..+ |..++. ..+||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999996321 122333 34899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~------~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~ 151 (316)
T cd05592 81 GDLMFHIQSSG------RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG 151 (316)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC
Confidence 99999886543 28889999999999999999995 8999999999999999999999999999986533221
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....||..|+|||++.+. .++.++|||||||++|||++|+.||...... .+...+..
T Consensus 152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--------~~~~~i~~-------- 210 (316)
T cd05592 152 K---ASTFCGTPDYIAPEILKGQ--KYNESVDWWSFGVLLYEMLIGQSPFHGEDED--------ELFDSILN-------- 210 (316)
T ss_pred c---cccccCCccccCHHHHcCC--CCCCcccchhHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHc--------
Confidence 1 2345689999999999874 7899999999999999999999999643210 01111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMN-EVIE 411 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 411 (450)
.....+...+.++.+++.+||+.||++||++. ++++
T Consensus 211 ~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 211 DRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11111223456788999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=284.69 Aligned_cols=226 Identities=23% Similarity=0.319 Sum_probs=176.5
Q ss_pred cccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 165 LGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 165 LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
||+|+||+||+++. ..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999842 1256788999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
..++...... ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 153 (280)
T cd05608 81 RYHIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-- 153 (280)
T ss_pred HHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--
Confidence 9887543221 1348999999999999999999995 89999999999999999999999999998766443221
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....||..|+|||++.+. .++.++||||||+++|||++|+.||......... ..+.... .....
T Consensus 154 -~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~----~~~~~~~--------~~~~~ 218 (280)
T cd05608 154 -TKGYAGTPGFMAPELLQGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRI--------LNDSV 218 (280)
T ss_pred -ccccCCCcCccCHHHhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH----HHHHHhh--------cccCC
Confidence 2234689999999999874 7889999999999999999999999654221110 0000000 00011
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
..+..++..+.+++.+||+.||++|| +++++++.
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 12234567789999999999999999 67777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=289.47 Aligned_cols=242 Identities=22% Similarity=0.386 Sum_probs=185.1
Q ss_pred HhhHhhhccccccceEEEEEEE-------------------------------cchhhhhhhc-CCCceeeeeeEEEeCC
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL-------------------------------LDGLASISRT-SHVNVVTLLGFCLEGN 204 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~-------------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~ 204 (450)
..+.+.+.||+|+||.||+++. ..|+++++++ +||||+++++++..+.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 4556788999999999998742 1246667777 7999999999999999
Q ss_pred ceEEEEEecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc
Q 013074 205 NRALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD 274 (450)
Q Consensus 205 ~~~lV~E~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~ 274 (450)
..++||||+++++|.+++...... .....+++..+..++.|++.||+|||+ .+++|+||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence 999999999999999999764321 112348999999999999999999995 8999999999999999
Q ss_pred CCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCC
Q 013074 275 QDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSS 353 (450)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~ 353 (450)
+++.+||+|||+++.......... .....++..|+|||.+.+. .++.++||||||+++|||++ |..||.....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--- 248 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKK-TTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--- 248 (307)
T ss_pred CCCcEEECCCcccccccccchhhc-cccCCCccceeChHHhccC--CCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---
Confidence 999999999999876543221111 1122245689999998764 78999999999999999998 7777743210
Q ss_pred ccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 354 EVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 354 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
..+.+.+... .........+.++.+++.+||+.+|++||++.||++.|+.+.+.
T Consensus 249 -----~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 -----EELFKLLKEG-------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -----HHHHHHHHcC-------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 0111111111 11122234457888999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=287.95 Aligned_cols=244 Identities=21% Similarity=0.398 Sum_probs=186.5
Q ss_pred HHHHhhHhhhccccccceEEEEEEE-------------------------------cchhhhhhhc-CCCceeeeeeEEE
Q 013074 154 VKKITNSFKDKLGQGGFGGVYKGKL-------------------------------LDGLASISRT-SHVNVVTLLGFCL 201 (450)
Q Consensus 154 i~~~~~~~~~~LG~G~fg~Vy~~~~-------------------------------~~e~~~l~~l-~HpnIv~l~~~~~ 201 (450)
+....+.+.+.||+|+||.||+++. .+|+..++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3344556778999999999998842 1246677777 8999999999999
Q ss_pred eCCceEEEEEecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccE
Q 013074 202 EGNNRALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNI 271 (450)
Q Consensus 202 ~~~~~~lV~E~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NI 271 (450)
.....++||||+++++|.+++...... .+...+++..+..++.|++.||.|||+ .+++|+||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence 999999999999999999999764321 012347889999999999999999995 8999999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCC
Q 013074 272 LLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVD 350 (450)
Q Consensus 272 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~ 350 (450)
++++++.+||+|||+++.......... .....++..|+|||++.+. .++.++||||||+++|+|++ |..|+....
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~- 244 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKK-TTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP- 244 (304)
T ss_pred EEcCCCcEEECCCccceeccccccccc-ccCCCCCceeeCchhhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCC-
Confidence 999999999999999987644322111 1223456789999998764 78999999999999999998 666664321
Q ss_pred CCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 351 NSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 351 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
..+ +.+.+.... .......++..+.+++.+||+.+|.+||++.|+++.|+++..
T Consensus 245 ------~~~-~~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 245 ------VEE-LFKLLKEGH-------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ------HHH-HHHHHHcCC-------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 011 111111111 111123455778999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=292.19 Aligned_cols=214 Identities=20% Similarity=0.259 Sum_probs=168.8
Q ss_pred hccccccceEEEEEEEcc--------------------------hhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLLD--------------------------GLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~--------------------------e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||.||+++... |.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999986321 23344444 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~~------l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~ 151 (320)
T cd05590 81 GDLMFHIQKSRR------FDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK 151 (320)
T ss_pred chHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC
Confidence 999998865432 8899999999999999999995 9999999999999999999999999999875432211
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .+.+.+....
T Consensus 152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--------~~~~~i~~~~------ 212 (320)
T cd05590 152 T---TSTFCGTPDYIAPEILQEM--LYGPSVDWWAMGVLLYEMLCGHAPFEAENED--------DLFEAILNDE------ 212 (320)
T ss_pred c---ccccccCccccCHHHHcCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCHH--------HHHHHHhcCC------
Confidence 1 2334689999999999764 7899999999999999999999999643211 1111111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPM 406 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 406 (450)
...+...+.++.+++.+||+.||++||++
T Consensus 213 --~~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 --VVYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 01112345678899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.82 Aligned_cols=230 Identities=19% Similarity=0.255 Sum_probs=173.5
Q ss_pred HhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 160 SFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.+.+.||+|+||+||+|+. ..|++++++++||||+++++++.+++..++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 4 VKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 4567899999999999852 23567888999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++|+|.+++..... +++..+..++.|++.||+|||. .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~gg~L~~~l~~~~~------~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 84 PGGDMMSLLIRMEV------FPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred CCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99999999875432 8888999999999999999994 99999999999999999999999999997643210
Q ss_pred CCc--------------------------------------------cccccCCCCccccccccccccccCCCCccCchH
Q 013074 294 KGI--------------------------------------------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVY 329 (450)
Q Consensus 294 ~~~--------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiw 329 (450)
... ........||..|+|||++.+. .++.++|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~Diw 232 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRK--GYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCC--CCCCcccee
Confidence 000 0001234699999999999774 789999999
Q ss_pred hHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHH--ccccCCCCCCCHH
Q 013074 330 SFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLW--CIQARPYDRPPMN 407 (450)
Q Consensus 330 SlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~ 407 (450)
||||++|||++|+.||........ ............ ......++.++.+++.+ |+..++..||+++
T Consensus 233 SlG~il~elltG~~Pf~~~~~~~~-------~~~i~~~~~~~~-----~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPTET-------QLKVINWENTLH-----IPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHHHH-------HHHHHccccccC-----CCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 999999999999999975432110 000000000000 01111234566777766 5566777799999
Q ss_pred HHHHH
Q 013074 408 EVIEM 412 (450)
Q Consensus 408 evl~~ 412 (450)
|+++.
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=284.89 Aligned_cols=243 Identities=25% Similarity=0.364 Sum_probs=178.2
Q ss_pred HhhhccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEe--CCceEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLE--GNNRALIY 210 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~ 210 (450)
.+.+.||+|+||.||+++. .+|++++++++||||+++++++.. ....++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 4567899999999999752 235788899999999999998754 34688999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++++|.+++..... .+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++..
T Consensus 87 e~~~~~~L~~~l~~~~~-----~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 87 EYLPYGSLRDYLQKHRE-----RLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EecCCCCHHHHHHhcCc-----CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999865432 28999999999999999999995 89999999999999999999999999999876
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCC-----ccchhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSS-----EVYFPHWIYRHV 365 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~-----~~~~~~~i~~~~ 365 (450)
..............++..|+|||++.+. .++.++||||||++++||++|..++........ .......... +
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 235 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH-L 235 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccC--CcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH-H
Confidence 5433221111122244569999998764 788999999999999999998766532211000 0000000000 0
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.+ ..............+.++.+++.+||+.+|++|||+.||++.|+.+
T Consensus 236 ~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IE---LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HH---HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00 0000011111223456799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=299.59 Aligned_cols=216 Identities=20% Similarity=0.298 Sum_probs=175.1
Q ss_pred HhhhccccccceEEEEEEEcc--------------------------hhhhhhhc-CCCceeeeeeEEEeCCceEEEEEe
Q 013074 160 SFKDKLGQGGFGGVYKGKLLD--------------------------GLASISRT-SHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~--------------------------e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
.|.++||+|+||+|+++++.. |.+++... +||.++.++..|++.+++++||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 467899999999999996432 12222222 699999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+.||++..+++.. .+++..+.-++..|+.||.|||+ ++||+||||.+|||||.+|.+||+|||+++....
T Consensus 451 ~~Ggdm~~~~~~~-------~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 451 VAGGDLMHHIHTD-------VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred cCCCcEEEEEecc-------cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccCC
Confidence 9999955444322 29999999999999999999995 9999999999999999999999999999986543
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.. ....+.|||+.|||||++.+. .|+.++|.|||||+|||||.|..||....+. ..| ..+
T Consensus 521 ~g---~~TsTfCGTpey~aPEil~e~--~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---e~F-----dsI------- 580 (694)
T KOG0694|consen 521 QG---DRTSTFCGTPEFLAPEVLTEQ--SYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---EVF-----DSI------- 580 (694)
T ss_pred CC---CccccccCChhhcChhhhccC--cccchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHH-----HHH-------
Confidence 22 235788999999999999985 8999999999999999999999999755321 111 111
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM 406 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 406 (450)
.......+..++.+.+.++.+++..||++|.-+
T Consensus 581 -~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 -VNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -hcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111223455677899999999999999999866
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=291.84 Aligned_cols=220 Identities=19% Similarity=0.269 Sum_probs=172.5
Q ss_pred hccccccceEEEEEEEcc--------------------------hhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLLD--------------------------GLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~--------------------------e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||.||+|+... |.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999995321 23444444 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|..++..... +++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 151 (321)
T cd05591 81 GDLMFQIQRSRK------FDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV 151 (321)
T ss_pred CcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc
Confidence 999988865432 8899999999999999999995 8999999999999999999999999999875432221
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....||..|+|||++.+. .++.++|||||||++|||++|+.||...... . ..+.+....
T Consensus 152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-------~-~~~~i~~~~------ 212 (321)
T cd05591 152 T---TTTFCGTPDYIAPEILQEL--EYGPSVDWWALGVLMYEMMAGQPPFEADNED-------D-LFESILHDD------ 212 (321)
T ss_pred c---ccccccCccccCHHHHcCC--CCCCccceechhHHHHHHhcCCCCCCCCCHH-------H-HHHHHHcCC------
Confidence 1 2344689999999999764 7899999999999999999999999643211 0 111111100
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRP-------PMNEVIEM 412 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~~ 412 (450)
...+...+.++.+++.+||+.||++|| +++++++.
T Consensus 213 --~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 213 --VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 011122456788999999999999999 77778754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=277.92 Aligned_cols=229 Identities=26% Similarity=0.397 Sum_probs=180.7
Q ss_pred hccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|++|.||+|++. .|+..+++++||||+++++++.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 46899999999998642 25677889999999999999988 889999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 80 GSLLDRLRKDAL----GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CcHHHHHHhccc----ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999976542 238999999999999999999995 8999999999999999999999999999987755332
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.........++..|+|||.+... .++.++||||||++++||++ |+.||...... + +.+.... .
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~-~~~~~~~------~ 216 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTR--TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------Q-ILKKIDK------E 216 (257)
T ss_pred ceecccCCCCCceecCHHHhccc--CcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHh------c
Confidence 22222234577899999998764 78999999999999999998 99888533211 0 1111110 0
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
..........+..+.+++.+||+.+|++||++.|+++.|.+
T Consensus 217 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 217 GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred CCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 00111122345789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=292.60 Aligned_cols=227 Identities=19% Similarity=0.262 Sum_probs=174.3
Q ss_pred hccccccceEEEEEEEc--------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLL--------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||.||+++.. .|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999998532 224455566 799999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++...+ .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~ 151 (329)
T cd05588 81 GDLMFHMQRQR------KLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD 151 (329)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence 99998886543 28999999999999999999995 8999999999999999999999999999875322111
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCC-Cccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS-SEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~-~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
......||..|+|||++.+. .++.++|||||||++|+|++|+.||....... ......+++.+.+....
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----- 221 (329)
T cd05588 152 ---TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----- 221 (329)
T ss_pred ---ccccccCCccccCHHHHcCC--CCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC-----
Confidence 12345689999999999874 78899999999999999999999996432111 11111222222221111
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCC------HHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPP------MNEVIE 411 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~ 411 (450)
...+..++.++.+++.+||+.||.+|++ ++++++
T Consensus 222 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 222 ---IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ---CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 0112234567889999999999999997 567764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=280.11 Aligned_cols=237 Identities=21% Similarity=0.380 Sum_probs=185.8
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||.||+++. .+|+.++++++|+||+++++++.+++..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 45678899999999999852 1246778889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++...... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 84 ADAGDLSRMIKHFKKQ--KRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred cCCCCHHHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999988643221 1348999999999999999999995 9999999999999999999999999999876644
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||....... .. ..+.+...
T Consensus 159 ~~~~---~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~---- 223 (267)
T cd08229 159 KTTA---AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YS-LCKKIEQC---- 223 (267)
T ss_pred CCcc---cccccCCcCccCHHHhcCC--CccchhhHHHHHHHHHHHHhCCCCcccccchH-----HH-HhhhhhcC----
Confidence 3221 1234588999999999764 78899999999999999999999986432110 00 01111100
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
..........+..+.+++.+||+.||++|||+.+|++.+++..
T Consensus 224 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 224 --DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred --CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0011112345678999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=281.46 Aligned_cols=220 Identities=22% Similarity=0.324 Sum_probs=170.4
Q ss_pred hccccccceEEEEEEEc------------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 163 DKLGQGGFGGVYKGKLL------------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~------------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.||+|+||.||+|... +|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999998531 235567788999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC--------eEEeec
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC--------PKISDF 284 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--------~kl~DF 284 (450)
+++|+|..++...+. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++. ++++||
T Consensus 81 ~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 81 VKFGSLDTYLKKNKN-----LINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CCCCcHHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999975442 28899999999999999999995 99999999999999987765 599999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
|++...... ....++..|+|||++.+. ..++.++||||||+++|||++|..++........ . ..
T Consensus 153 g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~--~~ 216 (258)
T cd05078 153 GISITVLPK-------EILLERIPWVPPECIENP-QNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------K--LQ 216 (258)
T ss_pred ccccccCCc-------hhccccCCccCchhccCC-CCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------H--HH
Confidence 987655332 223478899999999763 3578999999999999999998644332211100 0 00
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
.... ....+.....++.+++.+||+.||++|||++++++.|+
T Consensus 217 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 217 FYED--------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHc--------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00111123356899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=287.38 Aligned_cols=236 Identities=25% Similarity=0.420 Sum_probs=183.9
Q ss_pred HhhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeCCce
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEGNNR 206 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~ 206 (450)
..+.+.+.||+|+||.||+++. .+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 3455678999999999998742 1357788888 799999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccc
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGL 286 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 286 (450)
++||||+.+++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++++|||+
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRE----SFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999865332 228999999999999999999995 8999999999999999999999999999
Q ss_pred cccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhh
Q 013074 287 AKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 287 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
++.......... .....++..|+|||.+.+. .++.++||||||+++|||++ |..||....... . ..+..
T Consensus 188 ~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---~----~~~~~ 257 (302)
T cd05055 188 ARDIMNDSNYVV-KGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---K----FYKLI 257 (302)
T ss_pred cccccCCCceee-cCCCCcccccCCHhhhccC--CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---H----HHHHH
Confidence 986644322111 1223467789999998764 78999999999999999998 888875432110 0 11111
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
... .........+.++.+++.+||+.+|++||++.|+++.|+..
T Consensus 258 ~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEG-------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcC-------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111 00111122356799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=281.03 Aligned_cols=219 Identities=22% Similarity=0.348 Sum_probs=169.2
Q ss_pred hccccccceEEEEEEEc-----------------------------------chhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 163 DKLGQGGFGGVYKGKLL-----------------------------------DGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~-----------------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
+.||+|+||.||+|+.. +++.+++.++||||+++++++.++...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 36899999999999531 1245677889999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC-------eE
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC-------PK 280 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-------~k 280 (450)
+||||+++++|..++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. ++
T Consensus 81 lv~e~~~~~~l~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-----DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EEEecccCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeE
Confidence 9999999999998886543 238899999999999999999994 99999999999999987664 89
Q ss_pred EeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHH-cCCCCCCCCCCCCCccchhh
Q 013074 281 ISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV-GCKNNLDSGVDNSSEVYFPH 359 (450)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ell-tg~~p~~~~~~~~~~~~~~~ 359 (450)
++|||++...... ....++..|+|||.+... ..++.++|||||||++|||+ +|..|+.......
T Consensus 153 l~d~g~~~~~~~~-------~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------- 217 (262)
T cd05077 153 LSDPGIPITVLSR-------QECVERIPWIAPECVEDS-KNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------- 217 (262)
T ss_pred eCCCCCCccccCc-------ccccccccccChhhhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------
Confidence 9999998755332 223478899999988643 46889999999999999998 5776664321100
Q ss_pred hhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 360 WIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 360 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
... .... .. ........++.+++.+||+.||.+||++.++++.++
T Consensus 218 -~~~-~~~~-~~-------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 218 -KER-FYEG-QC-------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred -HHH-HHhc-Cc-------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 0000 00 001112356889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=281.10 Aligned_cols=231 Identities=24% Similarity=0.457 Sum_probs=177.5
Q ss_pred hccccccceEEEEEEEc--------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLL--------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||.||+|+.. +|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 35899999999998531 246677888 799999999999999999999999999
Q ss_pred CChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 216 GSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 216 gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
++|.+++...... .....+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence 9999998654311 112348899999999999999999995 899999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
++....... . ......+..|+|||++... .++.++||||||++++||++ |..||..... .. ..+.
T Consensus 158 l~~~~~~~~---~-~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~-~~~~ 223 (270)
T cd05047 158 LSRGQEVYV---K-KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AE-LYEK 223 (270)
T ss_pred Cccccchhh---h-ccCCCCccccCChHHHccC--CCCchhhHHHHHHHHHHHHcCCCCCccccCH-------HH-HHHH
Confidence 986332111 0 1122245679999998764 78999999999999999996 8888854211 11 1111
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
..... ...........+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 224 ~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 224 LPQGY-------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HhCCC-------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11110 01111234567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=293.12 Aligned_cols=178 Identities=22% Similarity=0.357 Sum_probs=150.0
Q ss_pred HHHhhHhhhccccccceEEEEEEEc-----------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 155 KKITNSFKDKLGQGGFGGVYKGKLL-----------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 155 ~~~~~~~~~~LG~G~fg~Vy~~~~~-----------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
....|.+.+.||+|+||.||+|+.. .|+.++++++||||+++++++.++...++|+|++ .++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~ 142 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSD 142 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCc
Confidence 3345667789999999999999642 3678899999999999999999999999999999 568
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 143 l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 212 (357)
T PHA03209 143 LYTYLTKRS-----RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPA-- 212 (357)
T ss_pred HHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCcc--
Confidence 888886533 238999999999999999999995 8999999999999999999999999999875432211
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCC
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS 347 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~ 347 (450)
.....||..|+|||++.+. .++.++|||||||++|||+++..++..
T Consensus 213 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 213 --FLGLAGTVETNAPEVLARD--KYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred --cccccccccccCCeecCCC--CCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 2234589999999999774 789999999999999999986665543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=297.41 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=196.9
Q ss_pred cchhHHHHHhhHhhhccccccceEEEEEE-----------------------EcchhhhhhhcCCCceeeeeeEEEeCCc
Q 013074 149 YNFSDVKKITNSFKDKLGQGGFGGVYKGK-----------------------LLDGLASISRTSHVNVVTLLGFCLEGNN 205 (450)
Q Consensus 149 ~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~-----------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~ 205 (450)
-...|+.+....|+++||+|.||.|.+.. +.+|+++|.+++||||+.++|+|..++.
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 34555556666688999999999998874 4567999999999999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
+++|+|||++|+|..|+..+.... +.-+....|+.||++||+||. +.++||||+.+.|+|++.++++||+|||
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt----~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfg 682 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPT----AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFG 682 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcc----cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcc
Confidence 999999999999999998775322 344566779999999999999 6999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHH--cCCCCCCCCCCCCCccchhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV--GCKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ell--tg~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
+++-.-.++.+.. .....-...|||+|.+.. ++++.+||||+||+.+||++ ....|+....+.. +.+
T Consensus 683 msR~lysg~yy~v-qgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--------vve 751 (807)
T KOG1094|consen 683 MSRNLYSGDYYRV-QGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--------VVE 751 (807)
T ss_pred cccccccCCceee-ecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--------HHH
Confidence 9997665554433 233445789999999877 49999999999999999976 5666775443211 111
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
....--...-.......+.-++.++.+++.+||..|-++||+++++...|+...
T Consensus 752 n~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 752 NAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred hhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 111100000111233345567788999999999999999999999999998643
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=279.07 Aligned_cols=226 Identities=24% Similarity=0.351 Sum_probs=182.0
Q ss_pred HhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.||+|+||.||+++.. +|++++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 45678999999999999532 24777889999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++......
T Consensus 83 ~~~L~~~l~~~~~----~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 83 NGDLHKLLKMQRG----RPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999976422 238999999999999999999995 899999999999999999999999999988665433
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .....|+..|+|||++.+. .++.++|+||||+++++|++|+.||..... ........ .
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-------~ 215 (256)
T cd08529 156 NF---ANTIVGTPYYLSPELCEDK--PYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKII-------R 215 (256)
T ss_pred ch---hhccccCccccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-------c
Confidence 22 1234578899999999774 688999999999999999999999864321 00111111 1
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.........+...+.+++.+||+.+|++||++.++++.
T Consensus 216 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 216 GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11112222456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=290.29 Aligned_cols=244 Identities=22% Similarity=0.405 Sum_probs=186.4
Q ss_pred HHHHhhHhhhccccccceEEEEEEE-------------------------------cchhhhhhhc-CCCceeeeeeEEE
Q 013074 154 VKKITNSFKDKLGQGGFGGVYKGKL-------------------------------LDGLASISRT-SHVNVVTLLGFCL 201 (450)
Q Consensus 154 i~~~~~~~~~~LG~G~fg~Vy~~~~-------------------------------~~e~~~l~~l-~HpnIv~l~~~~~ 201 (450)
+...++.+.+.||+|+||.||+++. .+|+++++++ +||||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 3344566788999999999998741 1246777788 7999999999999
Q ss_pred eCCceEEEEEecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccE
Q 013074 202 EGNNRALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNI 271 (450)
Q Consensus 202 ~~~~~~lV~E~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NI 271 (450)
++...++++||+++|+|.+++...... .+...+++..+..++.|++.||+|||+ .+++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceE
Confidence 999999999999999999998753210 122348899999999999999999995 8999999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCC
Q 013074 272 LLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVD 350 (450)
Q Consensus 272 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~ 350 (450)
++++++.+||+|||+++.......... .....++..|+|||++.+. .++.++||||||+++|||++ |..||.....
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKK-TTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred EEcCCCcEEECCcccceeccccccccc-ccCCCcCceEcCHHHhccC--CcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999886644322111 1222345689999999764 78899999999999999998 7777743211
Q ss_pred CCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 351 NSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 351 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.+ ....+... .........+.++.+++.+||+.+|++||++.|+++.|+....
T Consensus 243 -------~~-~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 -------EE-LFKLLKEG-------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred -------HH-HHHHHHcC-------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11 11111111 1111122345678899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=299.65 Aligned_cols=243 Identities=18% Similarity=0.236 Sum_probs=182.4
Q ss_pred HHhhHhhhccccccceEEEEEEE--------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL--------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~--------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
...|.+.+.||+|+||.||++.. .+|++++++++||||+++++++......++|||++ .
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~ 169 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-K 169 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-C
Confidence 34566788999999999998742 24788999999999999999999999999999999 4
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 170 ~~l~~~l~~~~------~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 170 CDLFTYVDRSG------PLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 68888884332 28999999999999999999995 8999999999999999999999999999976544322
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh------
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR------ 369 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~------ 369 (450)
.. ......||..|+|||++.+. .++.++|||||||++|||++|+.||...........+.. +.+.+....
T Consensus 241 ~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~-i~~~~~~~~~~~~~~ 316 (392)
T PHA03207 241 TP-QCYGWSGTLETNSPELLALD--PYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRS-IIRCMQVHPLEFPQN 316 (392)
T ss_pred cc-cccccccccCccCHhHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHH-HHHHhccCccccCCc
Confidence 11 12345689999999999774 789999999999999999999999976543221111111 111000000
Q ss_pred ----------hhhh---cc-cccc--hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 370 ----------EFKL---LG-VVTK--KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 370 ----------~~~~---~~-~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... .. .... .......++.+++.+||+.||++|||+.|++..
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000 00 0000 001224567889999999999999999999976
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=281.84 Aligned_cols=235 Identities=25% Similarity=0.362 Sum_probs=180.2
Q ss_pred hHhhhccccccceEEEEEEEcc-----------------------------hhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLD-----------------------------GLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~-----------------------------e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
+.+.+.||+|+||.||+|...+ |+.++++++|+||+++++++.+....++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 3456789999999999986533 25567889999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCC-CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC---CeEEeecc
Q 013074 210 YEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF---CPKISDFG 285 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DFG 285 (450)
|||+++++|.+++...... .....+++..+..++.|++.||+|||+ .+++|+||||+||+++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCc
Confidence 9999999999999765321 112348999999999999999999995 8999999999999998654 69999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
+++.......... ......+..|+|||++.+. .++.++|||||||++|||++ |..||...... + +...
T Consensus 165 ~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~-~~~~ 233 (277)
T cd05036 165 MARDIYRASYYRK-GGRAMLPIKWMPPEAFLDG--IFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------E-VMEF 233 (277)
T ss_pred cccccCCccceec-CCCCCccHhhCCHHHHhcC--CcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------H-HHHH
Confidence 9987643221111 1122235689999999764 78999999999999999996 88888643211 1 1111
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
+... .....+..++..+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~~~~-------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 234 VTGG-------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHcC-------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111 011112334577899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=282.99 Aligned_cols=200 Identities=21% Similarity=0.354 Sum_probs=155.3
Q ss_pred hhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 013074 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRI 261 (450)
Q Consensus 182 ~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 261 (450)
+.++++++||||+++++++.++...++||||+++++|..++..... .+++..+..++.|+++||+|||+ .+|
T Consensus 67 ~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~i 138 (274)
T cd05076 67 ASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG-----RVPVAWKITVAQQLASALSYLED---KNL 138 (274)
T ss_pred HHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHc---CCc
Confidence 5567788999999999999999999999999999999998865332 27889999999999999999995 899
Q ss_pred EeeeeccccEEEcCCC-------CeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHH
Q 013074 262 LHFDIKPHNILLDQDF-------CPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMM 334 (450)
Q Consensus 262 vH~Dikp~NIll~~~~-------~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvv 334 (450)
+||||||+||++++++ .+|++|||++....... ...++..|+|||.+.+. ..++.++||||||++
T Consensus 139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~-------~~~~~~~~~aPe~~~~~-~~~~~~~Dv~slG~~ 210 (274)
T cd05076 139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE-------ERVERIPWIAPECVPGG-NSLSTAADKWSFGTT 210 (274)
T ss_pred cCCCCCcccEEEeccCcccCccceeeecCCcccccccccc-------ccccCCcccCchhhcCC-CCCCcHHHHHHHHHH
Confidence 9999999999998644 47999999876543221 22367889999998753 468999999999999
Q ss_pred HHHHH-cCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 013074 335 IMELV-GCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413 (450)
Q Consensus 335 l~ell-tg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 413 (450)
+|||+ +|..|+........ ... .... . ..+.....++.+++.+||+.+|++|||+.++++.|
T Consensus 211 l~el~~~g~~p~~~~~~~~~----~~~----~~~~--~-------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 211 LLEICFDGEVPLKERTPSEK----ERF----YEKK--H-------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHhCCCCCccccChHHH----HHH----HHhc--c-------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 99985 78888764321110 000 0000 0 00011235688999999999999999999999987
Q ss_pred h
Q 013074 414 Q 414 (450)
Q Consensus 414 ~ 414 (450)
+
T Consensus 274 ~ 274 (274)
T cd05076 274 T 274 (274)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=291.63 Aligned_cols=218 Identities=21% Similarity=0.244 Sum_probs=170.9
Q ss_pred hccccccceEEEEEEEcch---------------------------hhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLLDG---------------------------LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~e---------------------------~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||+||+++.... ..+++.++||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999963211 1235678999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++..... +.+..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~~------~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~ 151 (325)
T cd05602 81 GELFYHLQRERC------FLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG 151 (325)
T ss_pred CcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence 999999865432 7788888999999999999994 9999999999999999999999999999875432221
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . ..+.+...
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~-~~~~i~~~------- 211 (325)
T cd05602 152 ---TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA-------E-MYDNILNK------- 211 (325)
T ss_pred ---CcccccCCccccCHHHHcCC--CCCCccccccccHHHHHHhcCCCCCCCCCHH-------H-HHHHHHhC-------
Confidence 12345689999999999874 7899999999999999999999999643211 0 11111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 410 (450)
........+..+.+++.+|++.||.+||++.+.+
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 212 -PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred -CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 0011123457788999999999999999887433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=276.87 Aligned_cols=244 Identities=24% Similarity=0.326 Sum_probs=184.4
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCc-eeeeeeEEEeCC------ce
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVN-VVTLLGFCLEGN------NR 206 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~Hpn-Iv~l~~~~~~~~------~~ 206 (450)
+...++||+|+||+||+|+. .+|+.++++++|+| |+.+++++.+.+ ..
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 34456799999999999952 34688899999999 999999999887 78
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccc
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGL 286 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 286 (450)
++|+||+ .-+|..++....... ..++...+..++.|+++||+||| +++|+||||||.||||+++|.+||+|||+
T Consensus 93 ~lvfe~~-d~DL~~ymd~~~~~~--~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 93 YLVFEFL-DRDLKKYMDSLPKKP--QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred EEEEEee-cccHHHHHHhccccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccch
Confidence 9999999 569999997765321 33777899999999999999999 59999999999999999999999999999
Q ss_pred cccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh
Q 013074 287 AKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE 366 (450)
Q Consensus 287 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~ 366 (450)
|+...-... .....++|..|+|||++.+. ..|+...||||+||++.||+++++.|....+. .....+.+.+.
T Consensus 167 Ara~~ip~~---~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~----~ql~~If~~lG 238 (323)
T KOG0594|consen 167 ARAFSIPMR---TYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI----DQLFRIFRLLG 238 (323)
T ss_pred HHHhcCCcc---cccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH----HHHHHHHHHcC
Confidence 996652221 13445688999999999886 46999999999999999999998888765431 11111222211
Q ss_pred hhh-----------hhhh----cccccchh---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcc
Q 013074 367 QDR-----------EFKL----LGVVTKKE---NEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGS 416 (450)
Q Consensus 367 ~~~-----------~~~~----~~~~~~~~---~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 416 (450)
... +... ........ ........+++.+||+.+|.+|.|++..+++ +...
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 110 0000 00000001 1112478889999999999999999999986 5544
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=285.68 Aligned_cols=183 Identities=26% Similarity=0.358 Sum_probs=146.5
Q ss_pred hhccccccceEEEEEEEc-----------------------chhhhhhhcCCCceeeeeeEEEe--CCceEEEEEecCCC
Q 013074 162 KDKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNG 216 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~g 216 (450)
.++||+|+||.||+|+.. +|+.++++++||||+++++++.. +...++|+||+. +
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 358999999999998632 35788999999999999998864 456889999984 5
Q ss_pred ChhhhhhcCCCC---CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE----cCCCCeEEeecccccc
Q 013074 217 SLEKFVYNGDTS---KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL----DQDFCPKISDFGLAKL 289 (450)
Q Consensus 217 sL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla~~ 289 (450)
+|..++...... .....+++..+..++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence 888777532211 112348899999999999999999994 899999999999999 4567899999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCC
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV 349 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~ 349 (450)
...............||+.|+|||++.+. ..++.++||||+||+++||++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 162 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cCCCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 65433222223445689999999998764 357899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=278.74 Aligned_cols=231 Identities=26% Similarity=0.436 Sum_probs=180.2
Q ss_pred hhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
.+.+.++||+|+||.||+|+. .+|+.++++++|+|++++++++. ....+++|||++++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKG 85 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCC
Confidence 456778999999999999852 24577899999999999999875 45689999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 86 ~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 86 SLLDFLKDGEG----RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999875432 238999999999999999999995 89999999999999999999999999999865433211
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....++..|+|||++.+. .++.++||||||+++|+|++ |..||...... + ....+...
T Consensus 159 ~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-------~-~~~~~~~~------- 219 (260)
T cd05070 159 A--RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------E-VLEQVERG------- 219 (260)
T ss_pred c--ccCCCCCccccChHHHhcC--CCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH-------H-HHHHHHcC-------
Confidence 1 1122356689999998763 78899999999999999998 77787542110 1 11111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
.....+...+..+.+++.+|++.+|++|||++++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 220 YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111123445679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=279.49 Aligned_cols=231 Identities=28% Similarity=0.458 Sum_probs=173.4
Q ss_pred hccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEe-CCceEEEEEecC
Q 013074 163 DKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLE-GNNRALIYEFMP 214 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~ 214 (450)
+.||+|+||.||+|+.. .|+.+++.++||||+++++++.. ++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999988532 13556778899999999998764 556889999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++..... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++......
T Consensus 81 ~~~L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 81 HGDLRNFIRSETH-----NPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 9999999975432 26778888999999999999995 899999999999999999999999999987654322
Q ss_pred Ccc-ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 295 GIV-SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 295 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
... .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... .+ +...+...
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~~-~~~~~~~~----- 218 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVDS------FD-ITVYLLQG----- 218 (262)
T ss_pred ceeecccccCcCCccccChhHhccC--ccchHHHHHHHHHHHHHHHcCCCCCCCCCCH------HH-HHHHHhcC-----
Confidence 111 111233467789999998764 7899999999999999999965543322110 00 11111111
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
.........+..+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus 219 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 219 --RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011111233567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=278.56 Aligned_cols=229 Identities=24% Similarity=0.386 Sum_probs=179.5
Q ss_pred hhHhhhccccccceEEEEEEE-------------------cchhhhhhhcCCCceeeeeeEEE-eCCceEEEEEecCCCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-------------------LDGLASISRTSHVNVVTLLGFCL-EGNNRALIYEFMPNGS 217 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-------------------~~e~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~E~~~~gs 217 (450)
.+.+.+.||+|+||.||+++. .+|+.++++++|+|++++++++. +++..++|+||+++++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 86 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCc
Confidence 344678899999999999852 24678889999999999999765 4567899999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++..... ..+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++......
T Consensus 87 L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 87 LVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred HHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999875443 238899999999999999999994 899999999999999999999999999987554322
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
....++..|+|||++... .++.++||||||+++|||++ |+.|+..... .. +...+....
T Consensus 157 ---~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~~-~~~~~~~~~------- 216 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KD-VVPRVEKGY------- 216 (256)
T ss_pred ---CCCccceeecCHHHHccC--CCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHhcCC-------
Confidence 122356789999998764 78999999999999999997 8888753211 11 111111110
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.......++..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0111223457789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=297.26 Aligned_cols=232 Identities=20% Similarity=0.249 Sum_probs=180.2
Q ss_pred HhhHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
..+.+.+.||+|+||.||+++.. +|+.++++++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 34556788999999999998521 3467788899999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++|+|.+++.... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++...
T Consensus 123 Ey~~gg~L~~~l~~~~-------l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 123 EYMPGGDLVNLMSNYD-------IPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred cCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999986432 7888889999999999999995 89999999999999999999999999998865
Q ss_pred cCCCCccccccCCCCcccccccccccccc--CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
...... ......||+.|+|||++.+.. ..++.++|||||||++|||++|+.||...... . ....+...
T Consensus 193 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~-~~~~i~~~ 262 (370)
T cd05596 193 DANGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------G-TYSKIMDH 262 (370)
T ss_pred cCCCcc--cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-------H-HHHHHHcC
Confidence 432211 123456999999999986531 24789999999999999999999999754211 0 11111111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYD--RPPMNEVIEM 412 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 412 (450)
... .........+.++.+++.+||+.+|.+ |++++|+++.
T Consensus 263 ~~~----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 263 KNS----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCc----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 000 001111234678889999999999987 9999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=282.80 Aligned_cols=245 Identities=26% Similarity=0.377 Sum_probs=183.9
Q ss_pred hHhhhccccccceEEEEEEEc----------------------------chhhhhhhcCCCceeeeeeEEEe--CCceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL----------------------------DGLASISRTSHVNVVTLLGFCLE--GNNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l~HpnIv~l~~~~~~--~~~~~l 208 (450)
+.+.+.||+|+||.||+++.. +|++.+++++|+||+++++++.. +...++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 445688999999999998631 34677889999999999999887 567899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
||||+++++|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++.
T Consensus 86 v~e~~~~~~l~~~l~~~~~-----~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRD-----QINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEecCCCCCHHHHHHhCcc-----ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999975442 28999999999999999999995 899999999999999999999999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchh---hhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP---HWIYRHV 365 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~---~~i~~~~ 365 (450)
................++..|+|||.+... .++.++||||||++++||++|+.|+............. ......+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTS--KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccC--CCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 775332221111223355679999998764 78899999999999999999998876432211100000 0000000
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
... ............++.++.+++.+||+.+|++|||+.||+++|+.+
T Consensus 236 ~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LEL---LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHH---HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000 000111111233457799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=289.89 Aligned_cols=220 Identities=20% Similarity=0.279 Sum_probs=173.2
Q ss_pred hccccccceEEEEEEEcc--------------------------hhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLLD--------------------------GLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~--------------------------e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||+||+++... |.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999985321 23445555 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|..++.... .+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 151 (318)
T cd05570 81 GDLMFHIQRSG------RFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151 (318)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence 99998886543 28999999999999999999994 9999999999999999999999999999875322221
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. ....+|+..|+|||++.+. .++.++|||||||++|+|++|+.||...... .+...+...
T Consensus 152 ~---~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--------~~~~~i~~~------- 211 (318)
T cd05570 152 T---TSTFCGTPDYIAPEILSYQ--PYGPAVDWWALGVLLYEMLAGQSPFEGDDED--------ELFQSILED------- 211 (318)
T ss_pred c---ccceecCccccCHHHhcCC--CCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--------HHHHHHHcC-------
Confidence 1 2234589999999999774 7899999999999999999999999643210 011111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPM-----NEVIEM 412 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~~ 412 (450)
....+...+..+.+++.+||+.||.+||++ .++++.
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 212 -EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred -CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 001122345778999999999999999999 888753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=289.63 Aligned_cols=218 Identities=21% Similarity=0.269 Sum_probs=170.2
Q ss_pred hccccccceEEEEEEEcc--------------------------hhhhhhh-cCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLLD--------------------------GLASISR-TSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~--------------------------e~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||.||+|+... |..++.. .+||||+++++++.+++..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999986321 1233433 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05620 81 GDLMFHIQDKG------RFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN 151 (316)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC
Confidence 99999886543 28889999999999999999995 8999999999999999999999999999875322211
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
......||..|+|||++.+. .++.++|||||||++|||++|+.||...... .+.+.+...
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--------~~~~~~~~~------- 211 (316)
T cd05620 152 ---RASTFCGTPDYIAPEILQGL--KYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--------ELFESIRVD------- 211 (316)
T ss_pred ---ceeccCCCcCccCHHHHcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC-------
Confidence 12345689999999999874 7899999999999999999999999643210 011111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMN-EVI 410 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 410 (450)
....+.....++.+++.+||+.||++||++. +++
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 -TPHYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0111122456788999999999999999984 565
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=281.78 Aligned_cols=242 Identities=24% Similarity=0.372 Sum_probs=185.9
Q ss_pred HHhhHhhhccccccceEEEEEEEcc----------------------------hhhhhhhcCCCceeeeeeEEEe-CCce
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKLLD----------------------------GLASISRTSHVNVVTLLGFCLE-GNNR 206 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~~~----------------------------e~~~l~~l~HpnIv~l~~~~~~-~~~~ 206 (450)
...+.+.+.||+|+||.||+|...+ |+.++++++|+||+++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 3445567889999999999997533 4667888899999999998876 4678
Q ss_pred EEEEEecCCCChhhhhhcCCCC--CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeec
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTS--KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDF 284 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 284 (450)
++++||+++++|.+++...... .....+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998654221 112348999999999999999999995 89999999999999999999999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
|+++.......... .....++..|+|||++.+. .++.++||||||+++||+++ |+.||...... . +..
T Consensus 162 g~~~~~~~~~~~~~-~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~----~~~ 230 (280)
T cd05043 162 ALSRDLFPMDYHCL-GDNENRPVKWMALESLVNK--EYSSASDVWSFGVLLWELMTLGQTPYVEIDPF----E----MAA 230 (280)
T ss_pred CCcccccCCceEEe-CCCCCcchhccCHHHHhcC--CCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH----H----HHH
Confidence 99986644332211 1223467789999999764 78999999999999999998 88888643210 1 111
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.+.... .......++..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 231 ~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 231 YLKDGY-------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHcCC-------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111110 001112245678999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=278.53 Aligned_cols=228 Identities=24% Similarity=0.272 Sum_probs=179.3
Q ss_pred HhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
...+.||+|++|.||++.. .+|++++++++||||+++++++.++...++|+|
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 84 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFME 84 (263)
T ss_pred cccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEE
Confidence 4467899999999999842 125677889999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++...
T Consensus 85 ~~~~~~l~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 85 YMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred ECCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999987543 27889999999999999999995 899999999999999999999999999987654
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.............++..|+|||++.+. .++.++||||||+++|||++|+.||...... ........
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~----- 221 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGE--GYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIAT----- 221 (263)
T ss_pred ccccccccccCCCcCccccCcceeccC--CCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhc-----
Confidence 322111111234578899999999875 6899999999999999999999998643210 00001000
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.......+......+.+++.+||+.+|.+|||+.|+++.
T Consensus 222 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 --QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred --cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001111223456778999999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=281.21 Aligned_cols=233 Identities=22% Similarity=0.289 Sum_probs=180.7
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++..+...++|+||++
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 456678999999999999852 135778889999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||||+||++++++.+||+|||++.......
T Consensus 90 ~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 90 GGSLQDIYHVTG------PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999886543 28899999999999999999995 899999999999999999999999999998664322
Q ss_pred CccccccCCCCccccccccccccc-cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
.. .....++..|+|||.+... ...++.++|+||||++++||++|+.|+........... .... ..
T Consensus 161 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--------~~~~-~~-- 226 (267)
T cd06646 161 AK---RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--------MSKS-NF-- 226 (267)
T ss_pred cc---cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--------eecC-CC--
Confidence 11 1234588899999998532 13578899999999999999999999864322111000 0000 00
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 413 (450)
...........+..+.+++.+||+.+|++||+++++++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 227 QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0000111123457889999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=296.86 Aligned_cols=229 Identities=23% Similarity=0.299 Sum_probs=180.6
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++.. .|+.++..++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 445678999999999998532 246778889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 83 MPGGDLMNLLIRKD------VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred CCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999997653 28899999999999999999995 9999999999999999999999999999886543
Q ss_pred CCC--------------------------ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCC
Q 013074 293 KKG--------------------------IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD 346 (450)
Q Consensus 293 ~~~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~ 346 (450)
... .........||..|+|||++.+. .++.++|||||||++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~Pf~ 231 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT--PYGLECDWWSLGVILYEMLYGFPPFY 231 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC--CCCCceeeEecchhhhhhccCCCCCC
Confidence 320 00112344689999999999875 78999999999999999999999997
Q ss_pred CCCCCCCccchhhhhhhhhhhh-hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 013074 347 SGVDNSSEVYFPHWIYRHVEQD-REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-MNEVIEM 412 (450)
Q Consensus 347 ~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~ 412 (450)
...... ....+... ..... .....++.++.+++.+|++ ||.+||+ ++|+++.
T Consensus 232 ~~~~~~--------~~~~i~~~~~~~~~-----p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 232 SDTLQE--------TYNKIINWKESLRF-----PPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CCCHHH--------HHHHHhccCCcccC-----CCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 543110 11111110 00000 1111146778899999998 9999999 9999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=287.06 Aligned_cols=241 Identities=24% Similarity=0.416 Sum_probs=184.2
Q ss_pred hhHhhhccccccceEEEEEEE-------------------------------cchhhhhhhc-CCCceeeeeeEEEeCCc
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-------------------------------LDGLASISRT-SHVNVVTLLGFCLEGNN 205 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-------------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~ 205 (450)
.+.+.++||+|+||.||+++. .+|+++++++ +||||+++++++.++..
T Consensus 13 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 13 RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred HeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 445678999999999998742 1246667777 69999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~ 275 (450)
.++||||+++|+|.+++...... .....+++..+..++.|++.||.|||+ .+++|+||||+||++++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~~ 169 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTE 169 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEcC
Confidence 99999999999999999764310 112348999999999999999999995 89999999999999999
Q ss_pred CCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 013074 276 DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSE 354 (450)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~ 354 (450)
++.+||+|||+++.......... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||.....
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---- 242 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKK-TSNGRLPVKWMAPEALFDR--VYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---- 242 (314)
T ss_pred CCcEEEccccccccccccccccc-cccCCCCccccCHHHHccC--CcCccchhhHHHHHHHHHHhCCCCCCCCCCH----
Confidence 99999999999986643322111 1122245679999998764 78999999999999999998 7777743211
Q ss_pred cchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 355 VYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 355 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
..+.+..... ........++.++.+++.+||+.+|++||++.|+++.|++....
T Consensus 243 ----~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 243 ----EELFKLLREG-------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred ----HHHHHHHHcC-------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 0111111111 01111223456788999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=296.41 Aligned_cols=239 Identities=22% Similarity=0.348 Sum_probs=183.0
Q ss_pred hHhhhccccccceEEEEEEEc-----------------------------chhhhhhhcC-CCceeeeeeEEEeCCceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-----------------------------DGLASISRTS-HVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-----------------------------~e~~~l~~l~-HpnIv~l~~~~~~~~~~~l 208 (450)
+.+.++||+|+||.||+|+.. +|++++.++. ||||++++++|.+....++
T Consensus 39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~i 118 (401)
T cd05107 39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYI 118 (401)
T ss_pred eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEE
Confidence 345678999999999998531 2567788887 9999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCC------------------------------------------------------------
Q 013074 209 IYEFMPNGSLEKFVYNGDTS------------------------------------------------------------ 228 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~------------------------------------------------------------ 228 (450)
|+||+++|+|.++++.....
T Consensus 119 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (401)
T cd05107 119 ITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGT 198 (401)
T ss_pred EEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhh
Confidence 99999999999998653210
Q ss_pred --------------------------------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC
Q 013074 229 --------------------------------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD 276 (450)
Q Consensus 229 --------------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~ 276 (450)
.....+++..++.++.|++.||+|||+ .+++||||||+|||++++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 199 VKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCC
Confidence 011247788899999999999999994 899999999999999999
Q ss_pred CCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 013074 277 FCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEV 355 (450)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~ 355 (450)
+.+||+|||+++.......... .....++..|+|||.+.+. .++.++||||||++++||++ |+.||......
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~---- 348 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYIS-KGSTFLPLKWMAPESIFNN--LYTTLSDVWSFGILLWEIFTLGGTPYPELPMN---- 348 (401)
T ss_pred CEEEEEecCcceeccccccccc-CCCcCCCCceeChHHhcCC--CCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch----
Confidence 9999999999986543222111 1233467889999999764 68999999999999999997 78887543210
Q ss_pred chhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 356 YFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 356 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
+.....+... .....+..++.++.+++.+||+.+|.+||+++||++.|+.+.
T Consensus 349 ---~~~~~~~~~~-------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 ---EQFYNAIKRG-------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---HHHHHHHHcC-------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111111 011112234578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=279.57 Aligned_cols=232 Identities=27% Similarity=0.422 Sum_probs=181.1
Q ss_pred hhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
.+.+.++||+|+||.||+|+. .+|++++++++||||+++++++. ....++||||++++
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~ 85 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKG 85 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCC
Confidence 456788999999999999853 23567888899999999999874 45689999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||.++........
T Consensus 86 ~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 86 SLLDFLKGEMG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred cHHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999975322 237899999999999999999995 89999999999999999999999999999866443221
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....++..|+|||+..+. .++.++||||||+++|||++ |..||..... ..+.......
T Consensus 159 ~--~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~------- 219 (262)
T cd05071 159 A--RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERG------- 219 (262)
T ss_pred c--ccCCcccceecCHhHhccC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHhcC-------
Confidence 1 1223466789999998764 78999999999999999999 7777753321 0111111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.........+..+.+++.+|++.+|++||++.++++.|+..
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01112234567889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=282.19 Aligned_cols=241 Identities=26% Similarity=0.308 Sum_probs=184.6
Q ss_pred HHHhhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 155 KKITNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 155 ~~~~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
+...+++.++||+|+||+||+++. .+|+++++.++||||+++++++......++||
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 344566778999999999999852 23577888999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++++|.+++...+ .+++..+..++.+++.||.|||+ ..+++|+||||+||++++++.++|+|||++...
T Consensus 83 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 83 EFMDCGSLDRIYKKGG------PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred ecCCCCCHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 9999999999886543 28899999999999999999995 358999999999999999999999999998654
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.... .....|+..|+|||++.+. .++.++|||||||++++|++|+.||............+..+.........
T Consensus 155 ~~~~-----~~~~~~~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd06620 155 INSI-----ADTFVGTSTYMSPERIQGG--KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ 227 (284)
T ss_pred hhhc-----cCccccCcccCCHHHHccC--CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh
Confidence 3221 1234589999999998764 78899999999999999999999997543221110011111111110000
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 413 (450)
...........+.++.+++.+||+.||++|||++|++++.
T Consensus 228 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 228 ---EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred ---ccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 0000111123567789999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=278.32 Aligned_cols=235 Identities=26% Similarity=0.449 Sum_probs=183.4
Q ss_pred HHHHhhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 154 VKKITNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 154 i~~~~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+...++.+.++||+|+||.||+|.. .+|+.++++++|+||+++++++. .+..+++|||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 3445667788999999999999853 23578889999999999999864 5678999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.....
T Consensus 82 ~~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 82 MENGSLVDFLKTPEG----IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred CCCCCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 999999999865432 238999999999999999999994 8999999999999999999999999999876653
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
..... .....++..|+|||++... .++.++||||||++++|+++ |+.||...... . ....+....
T Consensus 155 ~~~~~--~~~~~~~~~y~~pe~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~-~~~~~~~~~-- 220 (260)
T cd05067 155 NEYTA--REGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------E-VIQNLERGY-- 220 (260)
T ss_pred CCccc--ccCCcccccccCHHHhccC--CcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------H-HHHHHHcCC--
Confidence 22111 1223356789999998764 78899999999999999998 88888643211 0 111111110
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
........+.++.+++.+||+.+|++||+++++++.|+.
T Consensus 221 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 -----RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 011112345679999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=294.57 Aligned_cols=230 Identities=24% Similarity=0.278 Sum_probs=172.0
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+++.+.||+|+||+||+++. ..|..++.+++|+||+++++.+.++...++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 34567899999999999852 1246678889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++...+. +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 83 LPGGDMMTLLMKKDT------LTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred CCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999975432 8999999999999999999994 9999999999999999999999999999875432
Q ss_pred CCCc--------------------------------cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc
Q 013074 293 KKGI--------------------------------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG 340 (450)
Q Consensus 293 ~~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt 340 (450)
.... .......+||+.|+|||++.+. .++.++|||||||++|||++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DvwSlGvil~ell~ 231 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLI 231 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC--CCCCchhhhhhHHHHHHHHh
Confidence 1100 0001234699999999999774 78999999999999999999
Q ss_pred CCCCCCCCCCCCCccchhhhhhhhhhhhh-hhhhcccccchhHHHHHHHHHHHHHcc--ccCCCCCCCHHHHHHH
Q 013074 341 CKNNLDSGVDNSSEVYFPHWIYRHVEQDR-EFKLLGVVTKKENEIAKKMIIVGLWCI--QARPYDRPPMNEVIEM 412 (450)
Q Consensus 341 g~~p~~~~~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~l~~~Cl--~~dP~~RPs~~evl~~ 412 (450)
|+.||...... .....+.... ..... .....+.++.+++.+++ ..++..||+++|+++.
T Consensus 232 G~~Pf~~~~~~--------~~~~~i~~~~~~~~~p-----~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 232 GYPPFCSETPQ--------ETYKKVMNWKETLIFP-----PEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCCCHH--------HHHHHHHcCcCcccCC-----CcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99999653211 1111111100 00000 01113345556655533 3344567999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=296.86 Aligned_cols=230 Identities=23% Similarity=0.269 Sum_probs=176.5
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||+||+++. .+|+.++..++||||+++++++.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 34567899999999999852 1357788889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++...+. +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~g~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 83 LPGGDMMTLLMKKDT------FTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCcHHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999875432 8999999999999999999995 8999999999999999999999999999875432
Q ss_pred CCCcc-----------------------------------ccccCCCCccccccccccccccCCCCccCchHhHHHHHHH
Q 013074 293 KKGIV-----------------------------------SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIME 337 (450)
Q Consensus 293 ~~~~~-----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~e 337 (450)
..... .......||+.|+|||++.+. .++.++|||||||++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~e 231 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT--GYNKECDWWSLGVIMYE 231 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCC--CCCCeeeeecchhHHHH
Confidence 11000 001124589999999999764 78999999999999999
Q ss_pred HHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 013074 338 LVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP---MNEVIEM 412 (450)
Q Consensus 338 lltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 412 (450)
|++|..||....... ....+..... .. ........+..+.+++.+|+. +|.+|++ ++|+++.
T Consensus 232 l~~G~~Pf~~~~~~~--------~~~~i~~~~~-~~---~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 232 MLVGYPPFCSDNPQE--------TYRKIINWKE-TL---QFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred hhcCCCCCCCCCHHH--------HHHHHHcCCC-cc---CCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999996542110 1111100000 00 001111345677888888986 9999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=287.14 Aligned_cols=219 Identities=22% Similarity=0.287 Sum_probs=171.2
Q ss_pred hccccccceEEEEEEEcc--------------------------hhhhhhh-cCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLLD--------------------------GLASISR-TSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~--------------------------e~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||+||+|+..+ |..+++. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999996321 2334443 4899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 151 (316)
T cd05619 81 GDLMFHIQSCH------KFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA 151 (316)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC
Confidence 99999986543 28889999999999999999995 8999999999999999999999999999875432221
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....||..|+|||++.+. .++.++|||||||++|||++|+.||..... ..+.+.+... .
T Consensus 152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~------~ 212 (316)
T cd05619 152 K---TCTFCGTPDYIAPEILLGQ--KYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSIRMD------N 212 (316)
T ss_pred c---eeeecCCccccCHHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC------C
Confidence 1 2234589999999999774 789999999999999999999999964321 0111111110 0
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMN-EVIE 411 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 411 (450)
...+.....++.+++.+||+.||++||++. ++.+
T Consensus 213 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 213 --PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred --CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 011123456788999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=305.69 Aligned_cols=232 Identities=21% Similarity=0.282 Sum_probs=179.5
Q ss_pred hhHhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCC--------
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGN-------- 204 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~-------- 204 (450)
.|.+.+.||+|+||+||+++.. +|+..+..++|+||+++...+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 4456788999999999998531 2456678889999999988775432
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeec
Q 013074 205 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDF 284 (450)
Q Consensus 205 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 284 (450)
.+++||||+++|+|.+++..... ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+||
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~--~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAK--TNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEec
Confidence 36799999999999999865432 12348999999999999999999994 89999999999999999999999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
|+++......... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+...
T Consensus 188 Gls~~~~~~~~~~-~~~~~~Gt~~Y~aPE~~~~~--~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-------~~~~~~~ 257 (496)
T PTZ00283 188 GFSKMYAATVSDD-VGRTFCGTPYYVAPEIWRRK--PYSKKADMFSLGVLLYELLTLKRPFDGENM-------EEVMHKT 257 (496)
T ss_pred ccCeecccccccc-ccccccCCcceeCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHH
Confidence 9998764332111 12345699999999999874 789999999999999999999999964311 1111111
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
. .+.....+...+.++.+++.+||+.||.+||++.++++.
T Consensus 258 ~--------~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 258 L--------AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred h--------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 111112233456789999999999999999999999864
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=282.19 Aligned_cols=233 Identities=26% Similarity=0.427 Sum_probs=179.3
Q ss_pred hhHhhhccccccceEEEEEEEc----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
.+.+.++||+|+||+||+|+.. +|...+++++|+||+++++++... ..+++
T Consensus 8 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~ 86 (279)
T cd05109 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLV 86 (279)
T ss_pred heeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEE
Confidence 3445678999999999998521 235567778999999999998754 57899
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+++||||||+||++++++.+||+|||+++.
T Consensus 87 ~~~~~~g~l~~~l~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 87 TQLMPYGCLLDYVRENKD-----RIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEcCCCCCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999875432 38999999999999999999994 8999999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
......... .....++..|+|||.+.+. .++.++||||||+++|||++ |..||..... .....+ +...
T Consensus 159 ~~~~~~~~~-~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~----~~~~ 227 (279)
T cd05109 159 LDIDETEYH-ADGGKVPIKWMALESILHR--RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA----REIPDL----LEKG 227 (279)
T ss_pred cccccceee-cCCCccchhhCCHHHhccC--CCCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHH----HHCC
Confidence 654322111 1222356789999998764 78999999999999999998 8888754321 111111 1111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
.........+..+.+++.+||+.||++||++.|+++.|+...
T Consensus 228 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 228 -------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred -------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 011112234567889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=286.61 Aligned_cols=182 Identities=25% Similarity=0.360 Sum_probs=145.7
Q ss_pred hccccccceEEEEEEEc-----------------------chhhhhhhcCCCceeeeeeEEEe--CCceEEEEEecCCCC
Q 013074 163 DKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNGS 217 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gs 217 (450)
.+||+|+||.||+|+.. +|++++++++||||+++++++.. +...++|+||+. ++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-Cc
Confidence 47999999999999632 35788899999999999998854 457889999985 57
Q ss_pred hhhhhhcCCC---CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE----cCCCCeEEeeccccccc
Q 013074 218 LEKFVYNGDT---SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL----DQDFCPKISDFGLAKLC 290 (450)
Q Consensus 218 L~~~l~~~~~---~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla~~~ 290 (450)
|.+++..... ......+++..++.++.|++.||.|||+ .+|+||||||+||++ ++++.+||+|||+++..
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~ 162 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence 8777643211 1112348899999999999999999994 899999999999999 56679999999999876
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCC
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV 349 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~ 349 (450)
..............+|..|+|||++.+. ..++.++|||||||++|||++|+.||....
T Consensus 163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 163 NSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred CCCcccccccCcceecccccCcHHhcCC-CccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 5433222223345689999999998763 357899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=277.72 Aligned_cols=231 Identities=28% Similarity=0.459 Sum_probs=180.2
Q ss_pred hhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
.+.+.++||+|+||.||+++. .+|+.++++++|+|++++++++. ....++||||+.++
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 85 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKG 85 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCC
Confidence 345677899999999999852 23577899999999999999875 45688999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 86 ~L~~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 86 SLLDFLKEGDG----KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999975432 237899999999999999999995 89999999999999999999999999999766433211
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....++..|+|||+..+. ..+.++||||||+++|||++ |..||...... . ........
T Consensus 159 ~--~~~~~~~~~y~~Pe~~~~~--~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~-~~~~~~~~------- 219 (260)
T cd05069 159 A--RQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------E-VLEQVERG------- 219 (260)
T ss_pred c--cCCCccchhhCCHHHhccC--CcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHcC-------
Confidence 1 1223356789999988764 78999999999999999998 78887543211 0 11111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
.........+..+.+++.+||+.||++||++++|++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 220 YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111123456789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=287.35 Aligned_cols=215 Identities=19% Similarity=0.211 Sum_probs=168.4
Q ss_pred hccccccceEEEEEEEcc--------------------------h-hhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLLD--------------------------G-LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~--------------------------e-~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||.||+++... | ..+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999996321 1 1246778999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|...+.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 151 (321)
T cd05603 81 GELFFHLQRER------CFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE 151 (321)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC
Confidence 99988886533 27888899999999999999994 8999999999999999999999999999875422221
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....||+.|+|||++.+. .++.++|||||||++|||++|..||..... .. +.+.+...
T Consensus 152 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~-~~~~i~~~------- 211 (321)
T cd05603 152 T---TSTFCGTPEYLAPEVLRKE--PYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQ-MYDNILHK------- 211 (321)
T ss_pred c---cccccCCcccCCHHHhcCC--CCCCcCcccccchhhhhhhcCCCCCCCCCH-------HH-HHHHHhcC-------
Confidence 1 2344689999999999764 789999999999999999999999965321 01 11111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMN 407 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ 407 (450)
....+......+.+++.+||+.||.+||++.
T Consensus 212 -~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 212 -PLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 0111123346788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=295.13 Aligned_cols=232 Identities=21% Similarity=0.261 Sum_probs=177.8
Q ss_pred HhhHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
..+.+.+.||+|+||.||+++.. +|+.+++.++||||+++++++.++...++||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 34556778999999999998531 3466778889999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++|+|.+++.... +++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||++...
T Consensus 123 Ey~~gg~L~~~l~~~~-------~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 123 EYMPGGDLVNLMSNYD-------VPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred cCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999986432 7888999999999999999994 99999999999999999999999999999876
Q ss_pred cCCCCccccccCCCCcccccccccccccc--CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
...... ......||+.|+|||++.+.. +.++.++|||||||++|||++|+.||...... . ....+...
T Consensus 193 ~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~-------~-~~~~i~~~ 262 (370)
T cd05621 193 DETGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV-------G-TYSKIMDH 262 (370)
T ss_pred ccCCce--ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhC
Confidence 432211 123456999999999987531 24789999999999999999999999643210 0 11111110
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYD--RPPMNEVIEM 412 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 412 (450)
.. ..........+..+.+++.+|++.++.+ |+++.|+++.
T Consensus 263 ~~----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KN----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred Cc----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 00 0001112234667888888999855543 8899999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=275.04 Aligned_cols=225 Identities=24% Similarity=0.384 Sum_probs=176.7
Q ss_pred hccccccceEEEEEEEc-----------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 219 (450)
+.||+|+||.||+|+.. +|++.+++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36999999999998531 3467888899999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcccc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 299 (450)
+++..... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++..........
T Consensus 81 ~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-- 150 (250)
T cd05085 81 SFLRKKKD-----ELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-- 150 (250)
T ss_pred HHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc--
Confidence 99865432 27899999999999999999994 899999999999999999999999999987543322111
Q ss_pred ccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 300 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....++..|+|||++... .++.++||||||+++|++++ |..||...... ......... ...
T Consensus 151 ~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~-------~~~ 213 (250)
T cd05085 151 SGLKQIPIKWTAPEALNYG--RYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKG-------YRM 213 (250)
T ss_pred CCCCCCcccccCHHHhccC--CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcC-------CCC
Confidence 1122345789999998763 78999999999999999998 88888543211 011111111 011
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
.....++..+.+++.+|++.+|++||++.|+++.|.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 112234578999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=278.43 Aligned_cols=231 Identities=26% Similarity=0.432 Sum_probs=178.9
Q ss_pred ccccccceEEEEEEEc------------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 164 KLGQGGFGGVYKGKLL------------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 164 ~LG~G~fg~Vy~~~~~------------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.||+|+||.||+|+.. +|+.++++++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 5899999999988642 2366778889999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCC-CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-----CeEEeecccc
Q 013074 214 PNGSLEKFVYNGDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-----CPKISDFGLA 287 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-----~~kl~DFGla 287 (450)
++++|.+++....... ....+++..++.++.|++.||+|||+ .+++|+||||+||+++.++ .++++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999997543211 22348899999999999999999994 8999999999999999877 8999999998
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVE 366 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~ 366 (450)
+.......... .....++..|+|||++.+. .++.++||||||+++|||++ |+.||...... + ....+.
T Consensus 159 ~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------~-~~~~~~ 227 (269)
T cd05044 159 RDIYKSDYYRK-EGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------E-VLQHVT 227 (269)
T ss_pred ccccccccccc-CcccCCCccccCHHHHccC--CcccchhHHHHHHHHHHHHHcCCCCCcccCHH-------H-HHHHHh
Confidence 76543322111 1223356789999999764 78999999999999999997 88888533210 0 111111
Q ss_pred hhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 367 QDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
.. .........+..+.+++.+||+.+|.+||++++|++.|+.
T Consensus 228 ~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 228 AG-------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred cC-------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 10 1112223456788999999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=276.03 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=185.3
Q ss_pred hhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe-----CCceEEEEE
Q 013074 162 KDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE-----GNNRALIYE 211 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~-----~~~~~lV~E 211 (450)
.+.||+|+||.|..+.. .+|++.|++++|+||+.+++++.. -+.+|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 35799999999999852 356889999999999999998865 357899999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
+| +.+|...++.+.. |+.....-++.|+++||+|+| +.+|+|||+||+|++++.+..+||+|||+|+...
T Consensus 107 lM-etDL~~iik~~~~------L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQD------LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred HH-hhHHHHHHHcCcc------ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceeecc
Confidence 99 6799999976543 889999999999999999999 6999999999999999999999999999999885
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchh--------hhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP--------HWIYR 363 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~--------~~i~~ 363 (450)
.. .....++....|..|+|||++... ..++.+.||||.||++.||++|++.|.+...... ..+. +....
T Consensus 177 ~~-~~~~~mTeYVaTRWYRAPElll~~-~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Q-l~lI~~~lGtP~~e~l~ 253 (359)
T KOG0660|consen 177 KF-FEDGFMTEYVATRWYRAPELLLNS-SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQ-LQLILELLGTPSEEDLQ 253 (359)
T ss_pred cc-CcccchhcceeeeeecCHHHHhcc-ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHH-HHHHHHhcCCCCHHHHH
Confidence 43 223335666789999999999664 6899999999999999999999998875532111 1000 00001
Q ss_pred hhhhhh--hhhh-ccc-----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccccc
Q 013074 364 HVEQDR--EFKL-LGV-----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGSTEA 419 (450)
Q Consensus 364 ~~~~~~--~~~~-~~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~~ 419 (450)
.+.... .... ... ............++++.+||..||.+|+|++|.++. |+...+.
T Consensus 254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 111000 0000 000 011112345678899999999999999999999976 5554443
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=276.70 Aligned_cols=236 Identities=22% Similarity=0.385 Sum_probs=186.1
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+|... +|++++++++|+||+++++++.+++..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 456788999999999998532 346778899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++..... ....+++..++.++.+++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 84 ADAGDLSRMIKHFKK--QKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred CCCCCHHHHHHHhcc--cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999865322 12348999999999999999999995 8999999999999999999999999999876544
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... .... .+....
T Consensus 159 ~~~~---~~~~~~~~~y~apE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~-~~~~~~----- 222 (267)
T cd08224 159 KTTA---AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYSL-CKKIEK----- 222 (267)
T ss_pred CCcc---cceecCCccccCHHHhccC--CCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHHH-Hhhhhc-----
Confidence 3211 1233578899999998764 7899999999999999999999998643211 1111 111110
Q ss_pred hcccccch-hHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 373 LLGVVTKK-ENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 373 ~~~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
+..... ....+..+.+++.+||+.+|++||++.+|+++|+++.
T Consensus 223 --~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 223 --CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 011111 1245678899999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=283.21 Aligned_cols=240 Identities=21% Similarity=0.363 Sum_probs=182.2
Q ss_pred HhhHhhhccccccceEEEEEEEc-----------------------------chhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLL-----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~-----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
..+.+.+.||+|+||.||+|+.. +|+..+++++||||+++++++.+....+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 34556789999999999987421 2356788889999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCC----CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 208 LIYEFMPNGSLEKFVYNGDTS----KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
+||||+++|+|.+++...... .....+++..+..++.|++.||.|||+ .+|+||||||+||++++++.++|+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEECc
Confidence 999999999999999753321 111235778889999999999999995 8999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~ 362 (450)
||+++.......... .....++..|+|||.+.+. .++.++|||||||+++||++ |..||..... .+ +.
T Consensus 163 fg~~~~~~~~~~~~~-~~~~~~~~~y~~pE~~~~~--~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~-~~ 231 (288)
T cd05061 163 FGMTRDIYETDYYRK-GGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQ-VL 231 (288)
T ss_pred CCccccccccccccc-cCCCcccccccCHHHhccC--CCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HH
Confidence 999886543222111 1222356789999998764 78999999999999999998 6667743211 01 11
Q ss_pred hhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
..+... .........+..+.+++.+||+.+|++|||+.++++.|++..
T Consensus 232 ~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 KFVMDG-------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHcC-------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111000 011111233578999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=285.83 Aligned_cols=235 Identities=20% Similarity=0.292 Sum_probs=179.1
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+.+.+.||+|+||.||+++. .+|++++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 34567899999999999852 235778889999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++.... .+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 83 GGSLDQVLKKAG------RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred CCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999997543 28899999999999999999995 3589999999999999999999999999987553321
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh------
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD------ 368 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~------ 368 (450)
.....++..|+|||.+.+. .++.++|+||||+++++|++|+.||........ ..+........
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~ 223 (308)
T cd06615 155 -----ANSFVGTRSYMSPERLQGT--HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL----EAMFGRPVSEGEAKESH 223 (308)
T ss_pred -----cccCCCCcCccChhHhcCC--CCCccchHHHHHHHHHHHHhCCCCCCCcchhhH----HHhhcCccccccccCCc
Confidence 1234588999999998764 688999999999999999999999864321110 00000000000
Q ss_pred -------------------hhhhhcccccc-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 369 -------------------REFKLLGVVTK-KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 369 -------------------~~~~~~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........... ....+..++.+++.+||+.+|++||++.|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 001245678999999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=288.96 Aligned_cols=218 Identities=20% Similarity=0.265 Sum_probs=170.1
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCC-ceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHV-NVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||.||+|+.. .|.+++..+.|+ +|+.+++++.+.+..++|||
T Consensus 2 y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred ceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 346778999999999999532 134556666665 58889999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~g~L~~~~~~~~~------~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 82 YVNGGDLMYHIQQVGK------FKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred CCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 9999999998865432 7889999999999999999995 899999999999999999999999999987532
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.... ......||..|+|||++.+. .++.++|||||||++|||++|+.||...... -....+...
T Consensus 153 ~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~~--------~~~~~i~~~--- 216 (324)
T cd05587 153 FGGK---TTRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--------ELFQSIMEH--- 216 (324)
T ss_pred CCCC---ceeeecCCccccChhhhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCHH--------HHHHHHHcC---
Confidence 2211 12344689999999999874 7889999999999999999999999643210 011111110
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM 406 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 406 (450)
....+...+.++.+++.+||+.||.+|++.
T Consensus 217 -----~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 -----NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -----CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011122345678899999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=289.09 Aligned_cols=218 Identities=19% Similarity=0.254 Sum_probs=170.5
Q ss_pred hHhhhccccccceEEEEEEEcc--------------------------hhhhhhhc-CCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLD--------------------------GLASISRT-SHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~--------------------------e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||.||+|+... |..++..+ .|++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 3456789999999999985321 12333444 58999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 82 ~~~~g~L~~~~~~~~~------~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 82 YVNGGDLMYQIQQVGR------FKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred CCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 9999999998865432 8899999999999999999994 899999999999999999999999999987543
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .+...+...
T Consensus 153 ~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--------~~~~~i~~~--- 216 (323)
T cd05616 153 WDGVT---TKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--------ELFQSIMEH--- 216 (323)
T ss_pred CCCCc---cccCCCChhhcCHHHhcCC--CCCCccchhchhHHHHHHHhCCCCCCCCCHH--------HHHHHHHhC---
Confidence 22111 2345689999999999874 7899999999999999999999999643211 011111111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM 406 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 406 (450)
....+...+.++.+++.+|++.||.+|++.
T Consensus 217 -----~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 -----NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -----CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 011122355778999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=296.53 Aligned_cols=230 Identities=23% Similarity=0.247 Sum_probs=173.8
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.++||+|+||+||+++. .+|++++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 34567899999999999852 2256778889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++.... .+++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++.+..
T Consensus 83 ~~gg~L~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 83 LPGGDLMTMLIKYD------TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999986543 2888999999999999999999 49999999999999999999999999999864321
Q ss_pred CCCc------------c--------------------------------ccccCCCCccccccccccccccCCCCccCch
Q 013074 293 KKGI------------V--------------------------------SSLLGARGTIGYIALEVFSRNFGEVSHKSDV 328 (450)
Q Consensus 293 ~~~~------------~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDi 328 (450)
.... . .......||+.|+|||++.+. .++.++||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di 231 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ--GYGQECDW 231 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC--CCCCceee
Confidence 1000 0 000124589999999999774 78999999
Q ss_pred HhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCC---CC
Q 013074 329 YSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDR---PP 405 (450)
Q Consensus 329 wSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps 405 (450)
|||||++|||++|..||....... ....+...... .........+.++.+++.+|++ +|.+| ++
T Consensus 232 wSlGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~----~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 232 WSLGAIMFECLIGWPPFCSENSHE--------TYRKIINWRET----LYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred EecchhhhhhhcCCCCCCCCCHHH--------HHHHHHccCCc----cCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 999999999999999996432110 11111100000 0001111245678889999997 66665 59
Q ss_pred HHHHHHH
Q 013074 406 MNEVIEM 412 (450)
Q Consensus 406 ~~evl~~ 412 (450)
+.|+++.
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=288.56 Aligned_cols=218 Identities=20% Similarity=0.205 Sum_probs=169.9
Q ss_pred hccccccceEEEEEEEcc--------------------------h-hhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLLD--------------------------G-LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~--------------------------e-~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||+||+++... | ..+++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 369999999999985321 1 1245678999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 151 (325)
T cd05604 81 GELFFHLQRER------SFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD 151 (325)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC
Confidence 99998886543 28899999999999999999995 8999999999999999999999999999875432211
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
......||..|+|||++.+. .++.++|||||||++|||++|..||...... + +.+.+....
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslG~il~el~~G~~pf~~~~~~-------~-~~~~~~~~~------ 212 (325)
T cd05604 152 ---TTTTFCGTPEYLAPEVIRKQ--PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-------E-MYDNILHKP------ 212 (325)
T ss_pred ---CcccccCChhhCCHHHHcCC--CCCCcCccccccceehhhhcCCCCCCCCCHH-------H-HHHHHHcCC------
Confidence 12345689999999999774 7889999999999999999999999653211 1 111111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 410 (450)
.......+..+.+++.+|++.+|.+||++.+.+
T Consensus 213 --~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 213 --LVLRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred --ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 001112456688899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=296.20 Aligned_cols=229 Identities=20% Similarity=0.249 Sum_probs=171.5
Q ss_pred HhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 160 SFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.+.++||+|+||.||+|+. .+|+.++++++||||+++++.+.++...++||||+
T Consensus 4 ~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 4 VKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 4567899999999999852 13567788899999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~gg~L~~~l~~~~------~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 84 PGGDMMSLLIRMG------IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999986543 27888999999999999999995 89999999999999999999999999997533210
Q ss_pred CC--------------------------------------------ccccccCCCCccccccccccccccCCCCccCchH
Q 013074 294 KG--------------------------------------------IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVY 329 (450)
Q Consensus 294 ~~--------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiw 329 (450)
.. .........||+.|+|||++.+. .++.++|||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~Diw 232 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCC--CCCCeeeEE
Confidence 00 00001234689999999999774 789999999
Q ss_pred hHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCC---H
Q 013074 330 SFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP---M 406 (450)
Q Consensus 330 SlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~ 406 (450)
||||++|||++|+.||........ ........... ........+.+..+++.+|+ .+|.+|++ +
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~~~~-----~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTPLET-------QMKVINWQTSL-----HIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred echHHHHHHHhCCCCCCCCCHHHH-------HHHHHccCCCc-----CCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 999999999999999975421100 00000000000 00111223455667666665 49999997 8
Q ss_pred HHHHHH
Q 013074 407 NEVIEM 412 (450)
Q Consensus 407 ~evl~~ 412 (450)
+|+++.
T Consensus 300 ~ei~~h 305 (382)
T cd05625 300 DEIKAH 305 (382)
T ss_pred HHHhcC
Confidence 887753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=281.90 Aligned_cols=237 Identities=23% Similarity=0.385 Sum_probs=180.5
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
.+.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.++...++
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~l 85 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCL 85 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEE
Confidence 344567899999999999753 124677888999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCC----------------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEE
Q 013074 209 IYEFMPNGSLEKFVYNGDTS----------------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNIL 272 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIl 272 (450)
|+||+++++|.+++...... .....+++..++.++.|++.||+|||+ .+++|+||||+||+
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil 162 (288)
T cd05050 86 LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCL 162 (288)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheE
Confidence 99999999999998643210 111237889999999999999999995 89999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCC
Q 013074 273 LDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDN 351 (450)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~ 351 (450)
+++++.++|+|||+++.......... ......+..|+|||.+.+. .++.++|||||||++|||++ |..||.....
T Consensus 163 ~~~~~~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~~~~~p~~~~~~- 238 (288)
T cd05050 163 VGENMVVKIADFGLSRNIYSADYYKA-SENDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGMQPYYGMAH- 238 (288)
T ss_pred ecCCCceEECccccceecccCccccc-cCCCccChhhcCHHHHhcC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999876533221111 1122346679999998764 78999999999999999997 7677743211
Q ss_pred CCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 352 SSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 352 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
.+ +...+.... ........+.++.+++.+||+.+|.+|||+.|+++.|+.
T Consensus 239 ------~~-~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ------EE-VIYYVRDGN-------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HH-HHHHHhcCC-------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11 111111110 111122345789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=277.09 Aligned_cols=234 Identities=21% Similarity=0.337 Sum_probs=170.0
Q ss_pred ccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 164 KLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 164 ~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
+||+|+||.||+|+.. +|+..++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 6999999999998521 22455777899999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++...... ...+++..++.++.|++.||+|||+ .+++|+||||+|||++.++.+||+|||++....... ..
T Consensus 82 L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 155 (268)
T cd05086 82 LKSYLSQEQWH--RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YI 155 (268)
T ss_pred HHHHHHhhhcc--cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcch-hh
Confidence 99999764321 1236777888999999999999995 899999999999999999999999999976432211 11
Q ss_pred ccccCCCCcccccccccccccc-----CCCCccCchHhHHHHHHHHHcC-CCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 298 SSLLGARGTIGYIALEVFSRNF-----GEVSHKSDVYSFGMMIMELVGC-KNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~-----~~~s~~sDiwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.......++..|+|||++.... ..++.++||||||+++|||+++ ..|+..... .+.+.... .....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-------~~~~~~~~-~~~~~ 227 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-------REVLNHVI-KDQQV 227 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHH-hhccc
Confidence 1123345788999999985321 2457899999999999999965 556543211 11111111 11111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
.... ..........+.+++..|| .+|++||+++||++.|.
T Consensus 228 ~~~~--~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 228 KLFK--PQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred ccCC--CccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1100 1111224466788888999 67999999999999884
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=297.25 Aligned_cols=230 Identities=20% Similarity=0.227 Sum_probs=174.0
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.++||+|+||.||+++. .+|++++++++|+||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 34567899999999999852 1356788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++..+..
T Consensus 83 ~~~g~L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 83 IPGGDMMSLLIRLG------IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999996543 27888899999999999999995 9999999999999999999999999999753311
Q ss_pred CCC----------------------------------------ccccccCCCCccccccccccccccCCCCccCchHhHH
Q 013074 293 KKG----------------------------------------IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFG 332 (450)
Q Consensus 293 ~~~----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlG 332 (450)
... .........||+.|+|||++.+. .++.++||||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG 231 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT--GYTQLCDWWSVG 231 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCC--CCCcceeeeecc
Confidence 000 00001234699999999999874 789999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCC---CHHHH
Q 013074 333 MMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRP---PMNEV 409 (450)
Q Consensus 333 vvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~ev 409 (450)
|++|||++|+.||....... .. ..+.... ... .......++.++.+++.+|+ .+|.+|+ ++.|+
T Consensus 232 vilyell~G~~Pf~~~~~~~-------~~-~~i~~~~-~~~---~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 232 VILYEMLVGQPPFLADTPAE-------TQ-LKVINWE-TTL---HIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred ceeeehhhCCCCCCCCCHHH-------HH-HHHhccC-ccc---cCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999999997543211 00 0000000 000 00111223456677777765 5999999 88998
Q ss_pred HHH
Q 013074 410 IEM 412 (450)
Q Consensus 410 l~~ 412 (450)
++.
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=273.71 Aligned_cols=231 Identities=31% Similarity=0.490 Sum_probs=182.9
Q ss_pred hccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||.||+++.. +|++.+++++|+||+++++++.++...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 46999999999999653 246778888999999999999999999999999999
Q ss_pred CChhhhhhcCCCC---CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 216 GSLEKFVYNGDTS---KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 216 gsL~~~l~~~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
++|.+++...... .....+++..++.++.|++.||+|||+ .+++|+||||+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999765210 001338999999999999999999994 9999999999999999999999999999987765
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
..... ......++..|+|||.+... .++.++||||||+++++|++ |..||..... ..+.+.+..
T Consensus 158 ~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~---- 222 (262)
T cd00192 158 DDYYR-KKTGGKLPIRWMAPESLKDG--IFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRK---- 222 (262)
T ss_pred ccccc-cccCCCcCccccCHHHhccC--CcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc----
Confidence 43211 12344578899999998774 78999999999999999998 5888765411 111111111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
+........++.++.+++.+||+.+|++|||+.|+++.|+
T Consensus 223 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 ---GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111223344678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=293.06 Aligned_cols=231 Identities=20% Similarity=0.251 Sum_probs=178.8
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||+||+++. .+|+.+++.++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 34577899999999999852 2346677788999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++..... .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 83 QPGGDLLSLLNRYED-----QFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999976522 28999999999999999999994 9999999999999999999999999999987654
Q ss_pred CCCccccccCCCCccccccccccccc----cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRN----FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
..... .....||..|+|||++... ...++.++|||||||++|||++|+.||....... ....+...
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~ 224 (330)
T cd05601 155 NKMVN--SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--------TYNNIMNF 224 (330)
T ss_pred CCcee--eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--------HHHHHHcC
Confidence 32221 2234589999999998631 1367899999999999999999999996542210 11111110
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... .........+..+.+++.+|++ +|.+||+++++++.
T Consensus 225 ~~~----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 QRF----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred CCc----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000 0001112345678889999998 99999999999853
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=286.77 Aligned_cols=240 Identities=20% Similarity=0.344 Sum_probs=177.3
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|.+.++||+|+||.||+|+. .+|+.++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 44567899999999999842 246788899999999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++|.+++...+. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 88 -~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 88 -KDLKQYMDDCGN-----IMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred -CCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 488888765432 27889999999999999999995 899999999999999999999999999987653322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------hhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPH-------WIYRHVEQ 367 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~-------~i~~~~~~ 367 (450)
.. .....++..|+|||.+.+. ..++.++||||||+++++|++|+.||.............. ..+.....
T Consensus 159 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 159 KT---YSNEVVTLWYRPPDVLLGS-SEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred cc---cccccccccccCCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence 11 1234578999999998653 4678999999999999999999999965432110000000 00000000
Q ss_pred hhhhh---hccc----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 368 DREFK---LLGV----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 368 ~~~~~---~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..... .... .......++.++.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000 0000 00011234567889999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=280.13 Aligned_cols=229 Identities=29% Similarity=0.445 Sum_probs=178.4
Q ss_pred HhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
++.+.||+|+||+||+++.. .|+..+++++||||+++++++.+....++|||+++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 45678999999999999632 25678889999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++.... .+++..++.++.|++.||++||+ .+++|+||||+||++++++.++|+|||.+.......
T Consensus 82 ~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 82 GGSLQDYLQKNK------PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp TEBHHHHHHHHS------SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred cccccccccccc------ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 999999997322 28999999999999999999995 899999999999999999999999999987641111
Q ss_pred CccccccCCCCccccccccccc-cccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFS-RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
.......++..|+|||++. + ...+.++||||+|+++++|++|..|+....... ....+.+... ...
T Consensus 153 ---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~----~~~~~~~~~~----~~~ 219 (260)
T PF00069_consen 153 ---ENFNPFVGTPEYMAPEVLQQG--KKYTRKSDIWSLGIILYELLTGKLPFEESNSDD----QLEIIEKILK----RPL 219 (260)
T ss_dssp ---SEBSSSSSSGGGSCHHHHTTT--SSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH----HHHHHHHHHH----THH
T ss_pred ---ccccccccccccccccccccc--ccccccccccccccccccccccccccccccchh----hhhhhhhccc----ccc
Confidence 1234456899999999987 4 478999999999999999999999987541000 0000111110 000
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.... .........+.+++.+||+.||++||+++++++
T Consensus 220 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 220 PSSS-QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHT-TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccc-cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 001111278999999999999999999999985
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=293.46 Aligned_cols=235 Identities=25% Similarity=0.427 Sum_probs=194.1
Q ss_pred HHhhHhhhccccccceEEEEEE----------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 156 KITNSFKDKLGQGGFGGVYKGK----------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~----------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
+.....++.||+|.||.||+|. +..|..++++++||||++++|+|.+. ..+
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 3334456899999999999995 34467889999999999999999764 689
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+|||.++.|.|..++...... |+..++..++.|+..||.||| +.+.|||||..+|||+....+|||+|||++
T Consensus 467 ivmEL~~~GELr~yLq~nk~s-----L~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDS-----LPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred EEEecccchhHHHHHHhcccc-----chHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchh
Confidence 999999999999999876543 888999999999999999999 699999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHH-cCCCCCCCCCCCCCccchhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV-GCKNNLDSGVDNSSEVYFPHWIYRHVE 366 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ell-tg~~p~~~~~~~~~~~~~~~~i~~~~~ 366 (450)
+...+...+... ...-...|||||-+.-. .++.+||||-|||.+||++ .|..||..-.+.+ +..+++
T Consensus 539 R~~ed~~yYkaS--~~kLPIKWmaPESINfR--rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--------VI~~iE 606 (974)
T KOG4257|consen 539 RYLEDDAYYKAS--RGKLPIKWMAPESINFR--RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--------VIGHIE 606 (974)
T ss_pred hhccccchhhcc--ccccceeecCccccchh--cccchhhHHHHHHHHHHHHHhcCCccccccccc--------eEEEec
Confidence 998876655442 33356789999998664 8999999999999999987 5778887554332 112222
Q ss_pred hhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 367 QDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
. +.+.+.+..++..+..++.+||..+|.+||++.|+.+.|+.+.+
T Consensus 607 n-------GeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 607 N-------GERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred C-------CCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 2 33456677788999999999999999999999999988876443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=294.86 Aligned_cols=234 Identities=28% Similarity=0.440 Sum_probs=190.6
Q ss_pred hhHhhhccccccceEEEEEEE----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
....+.+||-|.||.||.|.+ +.|..+++.++|||+|+++|+|..+..+|+|.|||.+
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y 347 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY 347 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence 334567999999999999953 4568889999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+||..-.... ++...++.++.||++|++||.. .++|||||...|+|+.++..|||+||||++++....
T Consensus 348 GNLLdYLRecnr~e----v~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT- 419 (1157)
T KOG4278|consen 348 GNLLDYLRECNRSE----VPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT- 419 (1157)
T ss_pred ccHHHHHHHhchhh----cchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCc-
Confidence 99999998765432 7777888999999999999994 999999999999999999999999999999886543
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
+.. ..+..-.+.|.|||-+.-+ .++.|+|||+|||+|||+.|-......+.+. ..++..++.+-
T Consensus 420 YTA-HAGAKFPIKWTAPEsLAyN--tFSiKSDVWAFGVLLWEIATYGMsPYPGidl-------SqVY~LLEkgy------ 483 (1157)
T KOG4278|consen 420 YTA-HAGAKFPIKWTAPESLAYN--TFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYGLLEKGY------ 483 (1157)
T ss_pred eec-ccCccCcccccCccccccc--ccccchhhHHHHHHHHHHHhcCCCCCCCccH-------HHHHHHHhccc------
Confidence 222 3344457889999999775 8999999999999999999754433333221 11344443332
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
+...+..++..+.++++.||+++|.+||++.|+.+.++.+
T Consensus 484 -RM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 484 -RMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred -cccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 2244566788999999999999999999999999888753
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=278.76 Aligned_cols=226 Identities=24% Similarity=0.376 Sum_probs=175.9
Q ss_pred HhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 160 SFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
.+.+.||+|+||.||+|+. .+|++++++++||||+++++++..++..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 4567899999999999952 2367788899999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|..+. .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 84 GSLDVYR----------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CChHHhh----------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 9986542 16788899999999999999995 999999999999999999999999999988654322
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
.....++..|+|||++.+. .++.++|+||||+++|+|++|+.||............... .+..... .
T Consensus 150 ----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~------~ 216 (279)
T cd06619 150 ----AKTYVGTNAYMAPERISGE--QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL-LQCIVDE------D 216 (279)
T ss_pred ----ccCCCCChhhcCceeecCC--CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHH-HHHHhcc------C
Confidence 2334689999999999874 7899999999999999999999998653322111100010 0000000 0
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.........+.++.+++.+||+.+|++||+++|+++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000112244678899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=276.48 Aligned_cols=226 Identities=21% Similarity=0.304 Sum_probs=179.6
Q ss_pred HhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 160 SFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
.+.+.||+|+||.||+++. .+|+.++++++|+||+++++.+.+++..++||||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 4567899999999999852 1246778889999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||||+||++++++.++++|||++........
T Consensus 83 ~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 83 GDLMQKIKLQRG----KLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 999998864332 237899999999999999999994 8999999999999999999999999999876643322
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....++..|+|||++.+. ..+.++|+||||+++++|++|..||..... ... ...+.. +
T Consensus 156 ~---~~~~~~~~~~~aPE~~~~~--~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~-~~~~~~-------~ 215 (255)
T cd08219 156 Y---ACTYVGTPYYVPPEIWENM--PYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNL-ILKVCQ-------G 215 (255)
T ss_pred c---cccccCCccccCHHHHccC--CcCchhhhhhhchhheehhhccCCCCCCCH-------HHH-HHHHhc-------C
Confidence 1 1234588899999998774 789999999999999999999999964321 001 111111 1
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.....+...+..+.+++.+||+.||++||++.|++..
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1111223345678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=288.81 Aligned_cols=243 Identities=26% Similarity=0.382 Sum_probs=181.1
Q ss_pred HHhhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeC-C
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEG-N 204 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~-~ 204 (450)
...+.+.+.||+|+||.||+|+. .+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 34566788999999999999841 1356777888 689999999988654 5
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCC-------------------------------------------------------
Q 013074 205 NRALIYEFMPNGSLEKFVYNGDTSK------------------------------------------------------- 229 (450)
Q Consensus 205 ~~~lV~E~~~~gsL~~~l~~~~~~~------------------------------------------------------- 229 (450)
..++||||+++|+|.+++.......
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986532100
Q ss_pred ------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCC
Q 013074 230 ------PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA 303 (450)
Q Consensus 230 ------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 303 (450)
....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++........... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~ 241 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR-KGDA 241 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh-cCCC
Confidence 01237888899999999999999995 9999999999999999999999999999886543222111 1223
Q ss_pred CCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhH
Q 013074 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKEN 382 (450)
Q Consensus 304 ~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 382 (450)
.++..|+|||.+.+. .++.++||||||+++|+|++ |..|+...... ......+..... ...+.
T Consensus 242 ~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~-------~~~~~ 305 (343)
T cd05103 242 RLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTR-------MRAPD 305 (343)
T ss_pred CCCcceECcHHhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccCC-------CCCCC
Confidence 356789999998764 78999999999999999996 88777543111 001111111110 11111
Q ss_pred HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 383 EIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 383 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
....++.+++.+||+.||++||++.|+++.|+.+.+
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 234578899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=287.06 Aligned_cols=221 Identities=21% Similarity=0.270 Sum_probs=170.6
Q ss_pred hccccccceEEEEEEEc--------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLL--------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||+||+++.. +|..++.++ +||||+.+++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999998532 234455555 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 151 (327)
T cd05617 81 GDLMFHMQRQR------KLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD 151 (327)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence 99998886543 28999999999999999999995 8999999999999999999999999999875322111
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .......+.+.....
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~------- 218 (327)
T cd05617 152 ---TTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIITDNP-DMNTEDYLFQVILEK------- 218 (327)
T ss_pred ---ceecccCCcccCCHHHHCCC--CCCchheeehhHHHHHHHHhCCCCCCccCCCc-ccccHHHHHHHHHhC-------
Confidence 12345689999999999774 78999999999999999999999996432211 111112222222111
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPM 406 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 406 (450)
....+...+..+.+++.+||+.||++|+++
T Consensus 219 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 219 -PIRIPRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred -CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 011122345678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=281.81 Aligned_cols=236 Identities=25% Similarity=0.296 Sum_probs=176.2
Q ss_pred hhccccccceEEEEEEEc-------------------chhhhhhhcCCCceeeeeeEEEeCC-----ceEEEEEecCCCC
Q 013074 162 KDKLGQGGFGGVYKGKLL-------------------DGLASISRTSHVNVVTLLGFCLEGN-----NRALIYEFMPNGS 217 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~~-------------------~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~E~~~~gs 217 (450)
.+.+|.|+||.||+|++. .|+.+|.+++|||||++.-+|.... ...+|||||+ .+
T Consensus 29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~t 107 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ET 107 (364)
T ss_pred eEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HH
Confidence 357999999999999753 3688999999999999998886532 3458999996 49
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC-CCeEEeeccccccccCCCCc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD-FCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~~~~~~~ 296 (450)
|...+......+ ..++...+.-+..|+.+||.||| +.+|+||||||.|+|+|.+ |.+||||||.|+....++..
T Consensus 108 L~~~~r~~~~~~--~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epn 182 (364)
T KOG0658|consen 108 LYRVIRHYTRAN--QRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPN 182 (364)
T ss_pred HHHHHHHHhhcC--CCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCc
Confidence 998887532111 22677777888999999999999 4999999999999999965 99999999999988665443
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh-----
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF----- 371 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~----- 371 (450)
. ....|..|+|||.+.+. ..|+.+.||||.|||+.||+-|++.|.+...... ...+.+.+..-...
T Consensus 183 i----SYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ----L~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 183 I----SYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ----LVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred e----eEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH----HHHHHHHhCCCCHHHHhhc
Confidence 2 23368899999999987 5899999999999999999999999876432211 11111111100000
Q ss_pred ----------hh-cccccc-hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 372 ----------KL-LGVVTK-KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 372 ----------~~-~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.. ...... .......+..+++.++++.+|.+|.++.|++..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 00 000000 223456789999999999999999999998854
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=274.81 Aligned_cols=228 Identities=26% Similarity=0.439 Sum_probs=182.3
Q ss_pred hhHhhhccccccceEEEEEEE--------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL--------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~--------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
.+.+.+.||.|+||.||+|.. .+|+.++++++|+||+++++++.++...++||||+++++
T Consensus 7 ~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 86 (256)
T cd05039 7 ELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGS 86 (256)
T ss_pred hccceeeeecCCCceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCc
Confidence 345678899999999999853 235778889999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||.++.......
T Consensus 87 L~~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 87 LVDYLRSRGR----AVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred HHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999975542 238999999999999999999994 9999999999999999999999999999987643221
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
....+..|+|||++... .++.++||||||++++|+++ |..||..... ..+........
T Consensus 158 ----~~~~~~~~~ape~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~------- 216 (256)
T cd05039 158 ----SGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEKGY------- 216 (256)
T ss_pred ----cCCCcccccCchhhcCC--cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhcCC-------
Confidence 22356789999998763 78899999999999999997 8888753311 01111111110
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
........+..+.+++.+||+.+|++||+++|++++|+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 217 RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111122345788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=277.31 Aligned_cols=233 Identities=24% Similarity=0.425 Sum_probs=180.0
Q ss_pred hHhhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||.||+|+.. .|+..+++++||||+++++++.++...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 446788999999999998532 24677888999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++..... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 86 ~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 86 FMENGALDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred cCCCCcHHHHHhhCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999865432 28899999999999999999995 899999999999999999999999999987654
Q ss_pred CCCCccccc--cCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 292 TKKGIVSSL--LGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 292 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
......... .....+..|+|||.+.+. .++.++||||||+++||+++ |..||...... . +.+.+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~----~----~~~~i~~~ 227 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYR--KFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ----D----VINAIEQD 227 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccC--cccchhhhhhhHHHHHHHhcCCCCCCCCCCHH----H----HHHHHHcC
Confidence 332211101 111124579999999764 78999999999999999886 88888543211 0 11111110
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
. ........+..+.+++.+||+.+|.+||++++++..|+..
T Consensus 228 ~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 Y-------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred C-------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0111223456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=291.38 Aligned_cols=223 Identities=26% Similarity=0.400 Sum_probs=187.4
Q ss_pred hhhccccccceEEEEEE---------------------------EcchhhhhhhcCCCceeeeeeEEEeCCc--eEEEEE
Q 013074 161 FKDKLGQGGFGGVYKGK---------------------------LLDGLASISRTSHVNVVTLLGFCLEGNN--RALIYE 211 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~---------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~--~~lV~E 211 (450)
|..+||+|+|-+||+|- +..|+.+|+.|+||||++++.++.+... +-+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 45689999999999993 4567999999999999999999988765 778999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-CCCeEEeeccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-DFCPKISDFGLAKLC 290 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~ 290 (450)
.|..|+|..|+.+.+. ++.+.+..|++||++||.|||.. ..+|+|||||-+||+|+. .|.|||+|+|||...
T Consensus 124 L~TSGtLr~Y~kk~~~------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRR------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred cccCCcHHHHHHHhcc------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 9999999999987765 77889999999999999999963 357999999999999985 589999999999987
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
..... ....||+.|||||.+.. .|++..||||||+.++||+|+..|+..... +..|++++..+..
T Consensus 197 r~s~a-----ksvIGTPEFMAPEmYEE---~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-------~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 197 RKSHA-----KSVIGTPEFMAPEMYEE---NYNELVDVYAFGMCMLEMVTSEYPYSECTN-------PAQIYKKVTSGIK 261 (632)
T ss_pred hcccc-----ceeccCccccChHHHhh---hcchhhhhhhhhHHHHHHHhccCChhhhCC-------HHHHHHHHHcCCC
Confidence 66542 23469999999999985 799999999999999999999999976643 3447777766654
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
......+. ..++.+++.+||.. ..+|||+.|+|+.
T Consensus 262 P~sl~kV~------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 262 PAALSKVK------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HHHhhccC------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 43333222 25688899999999 8999999999954
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=281.89 Aligned_cols=226 Identities=23% Similarity=0.334 Sum_probs=178.9
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.+.+.||+|+||.||+|+. .+|+.+++.++|+||+++++.+..+...++||||+++
T Consensus 22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 34567899999999999952 2346788889999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++... .+++..+..++.|++.||+||| +.+|+|+||||+||+++.++.+||+|||++........
T Consensus 102 ~~L~~~~~~~-------~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 102 GSLTDVVTET-------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999998542 2788999999999999999999 48999999999999999999999999999876543321
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....++..|+|||.+.+. ..+.++|||||||++|+|++|+.||....... ........ . .
T Consensus 172 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-------~~~~~~~~-~-----~ 233 (296)
T cd06654 172 K---RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-------ALYLIATN-G-----T 233 (296)
T ss_pred c---cCcccCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-------hHHHHhcC-C-----C
Confidence 1 1233588999999998764 67899999999999999999999996432211 01110000 0 0
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
............+.+++.+||+.+|++||++.|+++.
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0011123455778899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=280.79 Aligned_cols=227 Identities=25% Similarity=0.331 Sum_probs=178.1
Q ss_pred HhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 160 SFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
...+.||+|+||.||++.. ..|+.++++++|+||+.+++.+.+++..++||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 3456899999999998742 13567888999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++..... ..+++..+..++.|++.||.|||+ .+|+|+||||+||++++++.++|+|||++......
T Consensus 83 ~g~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 83 NGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred CCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 99999998865432 238899999999999999999994 99999999999999999999999999998765433
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
.. .....|+..|+|||++.+. .++.++||||||+++|+|++|+.||.......... .........
T Consensus 156 ~~----~~~~~g~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~----~~~~~~~~~----- 220 (285)
T cd05630 156 QT----IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE----EVERLVKEV----- 220 (285)
T ss_pred cc----ccCCCCCccccChHHHcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH----HHHhhhhhh-----
Confidence 22 1234589999999999764 78999999999999999999999997543211000 000000000
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIE 411 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 411 (450)
..........++.+++..||+.||++||| ++|+++
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 221 ---QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00111234567889999999999999999 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=266.08 Aligned_cols=226 Identities=22% Similarity=0.329 Sum_probs=182.9
Q ss_pred hhHhhhccccccceEEEEE-------------------------EEcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 158 TNSFKDKLGQGGFGGVYKG-------------------------KLLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~-------------------------~~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
.+++.+.||+|.|+.||+. ++.+|+++...++||||+++.....+....|+|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 3456788999999999875 245678999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---CCCeEEeecccccc
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ---DFCPKISDFGLAKL 289 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~ 289 (450)
|.|++|..-+-.+ ..+++..+-....||+.+|.|+| .++|||||+||+|+++.. ..-+||+|||+|..
T Consensus 92 m~G~dl~~eIV~R------~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 92 VTGGELFEDIVAR------EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ccchHHHHHHHHH------HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999997655433 23788888899999999999999 599999999999999963 34689999999998
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
...+.. ..+..||++|||||++... .++..+|||+.||+||-|+.|..||...... .+++.+.++.
T Consensus 163 l~~g~~----~~G~~GtP~fmaPEvvrkd--py~kpvDiW~cGViLfiLL~G~~PF~~~~~~--------rlye~I~~g~ 228 (355)
T KOG0033|consen 163 VNDGEA----WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYEQIKAGA 228 (355)
T ss_pred eCCccc----cccccCCCcccCHHHhhcC--CCCCcchhhhhhHHHHHHHhCCCCCCCccHH--------HHHHHHhccc
Confidence 874432 3466799999999999885 8999999999999999999999999864322 2444443332
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 410 (450)
-. .....-..+.++..+++++||..||.+|.|+.|.+
T Consensus 229 yd----~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 229 YD----YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cC----CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 11 11122344567788999999999999999998766
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=275.26 Aligned_cols=232 Identities=25% Similarity=0.419 Sum_probs=181.5
Q ss_pred HhhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
.++.+.++||+|+||.||+++. .+|++++++++|+||+++.+++.+ ...+++|||+++
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 3455678999999999999852 235778999999999999999877 778999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 85 ~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 85 GSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CcHHHHHHhCCc----cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999975432 237889999999999999999995 8999999999999999999999999999876643321
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .....++..|+|||++... .++.++|+||||++++++++ |+.||...... . ..+.....
T Consensus 158 ~~--~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~----~~~~~~~~------ 219 (260)
T cd05073 158 TA--REGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP----E----VIRALERG------ 219 (260)
T ss_pred cc--ccCCcccccccCHhHhccC--CcCccccchHHHHHHHHHHhcCCCCCCCCCHH----H----HHHHHhCC------
Confidence 11 1223456789999999764 78999999999999999998 88887543110 0 11111111
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
.........+..+.+++.+|++.+|++||+++++.+.|+.
T Consensus 220 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 220 -YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0111123345678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=276.33 Aligned_cols=230 Identities=21% Similarity=0.280 Sum_probs=178.5
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+++.+.||+|+||.||+|+. .+|++++++++||||+++++++..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 34567899999999999853 2357788889999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|..++.+.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~ 158 (282)
T cd06643 87 GAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 158 (282)
T ss_pred CcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence 99998876532 238999999999999999999995 8999999999999999999999999999876543221
Q ss_pred ccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 296 IVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
. .....++..|+|||++... ...++.++|||||||++|||++|+.||...... ..... .....
T Consensus 159 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~-~~~~~--- 224 (282)
T cd06643 159 R---RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM-------RVLLK-IAKSE--- 224 (282)
T ss_pred c---cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH-------HHHHH-HhhcC---
Confidence 1 2234588999999998531 135778999999999999999999998643210 00001 00000
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
......+..++.++.+++.+||+.||.+||+++++++.
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 225 --PPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011122345778999999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=279.10 Aligned_cols=227 Identities=25% Similarity=0.321 Sum_probs=177.5
Q ss_pred hhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 161 FKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
..+.||+|+||+||+++. .+|++++++++|+||+.+.+.+..++..++||||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 446799999999999842 135778889999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++..... ..+++..+..++.|++.||.||| +.+|+||||||+||++++++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 84 GGDLKFHIYNMGN----PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred CccHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999988865432 23899999999999999999999 4899999999999999999999999999987654322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
. .....|+..|+|||++.+. .++.++|+||||+++|+|++|..||........ ...+...+...
T Consensus 157 ~----~~~~~g~~~~~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~------ 220 (285)
T cd05632 157 S----IRGRVGTVGYMAPEVLNNQ--RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLET------ 220 (285)
T ss_pred c----ccCCCCCcCccChHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhcc------
Confidence 1 1234589999999999764 789999999999999999999999965421100 00111111110
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 412 (450)
........+..+.+++.+|++.||++||+ ++++++.
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 --EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred --ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 01112234567889999999999999999 6677654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=276.86 Aligned_cols=234 Identities=21% Similarity=0.354 Sum_probs=181.9
Q ss_pred HhhHhhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
.++.+.+.||+|+||.||+|... +|+.++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 34556789999999999998531 24677888999999999998875 557899
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++++|.+++..... .+++..++.++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 85 MELAPLGELRSYLQVNKY-----SLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEcCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeee
Confidence 999999999999965432 28999999999999999999994 8999999999999999999999999999886
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
......... ....++..|+|||.+... .++.++||||||++++|+++ |..||....... ....+...
T Consensus 157 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~ 224 (270)
T cd05056 157 LEDESYYKA--SKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND--------VIGRIENG 224 (270)
T ss_pred cccccceec--CCCCccccccChhhhccC--CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHcC
Confidence 654322111 122345689999998764 78899999999999999985 998886442110 00111111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
. .......++..+.+++.+|+..+|.+|||+.++++.|++...
T Consensus 225 ~-------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 225 E-------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred C-------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 111123345679999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=274.90 Aligned_cols=233 Identities=27% Similarity=0.465 Sum_probs=182.5
Q ss_pred HhhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
..+.+.++||+|+||.||+|.. .+|+..+++++|+||+++++++.++...++||||+++
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK 85 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence 3445678899999999999853 2357788999999999999999988999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 86 ~~L~~~i~~~~~----~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 86 GSLLDFLKSGEG----KKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred CCHHHHHhcccc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999976432 238999999999999999999995 8999999999999999999999999999887653211
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .....++..|+|||.+.+. .++.++|+||||++++++++ |+.||...... . ........
T Consensus 159 ~~--~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~-~~~~~~~~------ 220 (261)
T cd05034 159 TA--REGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-------E-VLEQVERG------ 220 (261)
T ss_pred hh--hhccCCCccccCHHHhccC--CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHcC------
Confidence 11 1122345689999999764 78999999999999999998 88887532110 0 11111110
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
.........+.++.+++.+|++.+|++||+++++++.|+.
T Consensus 221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 -YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011112235678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=291.41 Aligned_cols=233 Identities=21% Similarity=0.257 Sum_probs=177.4
Q ss_pred HHhhHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
...+.+.+.||+|+||.||+++.. +|..+++.++||||+++++.+.++...++|
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 345566789999999999998532 345677788999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++|+|.+++.... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 122 ~Ey~~gg~L~~~~~~~~-------~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 122 MEYMPGGDLVNLMSNYD-------VPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EcCCCCCcHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 99999999999986432 7888889999999999999994 9999999999999999999999999999986
Q ss_pred ccCCCCccccccCCCCcccccccccccccc--CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
....... ......||+.|+|||++.... +.++.++|||||||++|||++|+.||...... . ....+..
T Consensus 192 ~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~-~~~~i~~ 261 (371)
T cd05622 192 MNKEGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------G-TYSKIMN 261 (371)
T ss_pred cCcCCcc--cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH-------H-HHHHHHc
Confidence 6432211 123456999999999987531 24789999999999999999999999743210 0 1111111
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYD--RPPMNEVIEM 412 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 412 (450)
.... .........+..+.+++.+|++.++.+ |++++|+++.
T Consensus 262 ~~~~----~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 262 HKNS----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCc----ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1000 000112245677888999999844433 7799998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=272.51 Aligned_cols=245 Identities=22% Similarity=0.243 Sum_probs=194.1
Q ss_pred hhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 161 FKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+.+.||.|.-|+||++++. .|.++|+.++||-+++||+.++.+...|+|||||+
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 4578999999999999643 24678999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
||+|....+.+.. +.+++..+.-++..++.||+||| ..|||.|||||+||||.++|++-|+||.|+..+....
T Consensus 161 GGdL~~LrqkQp~----~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 161 GGDLHSLRQKQPG----KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred CccHHHHHhhCCC----CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999998876544 44999999999999999999999 5999999999999999999999999999875431100
Q ss_pred ---------------------------------C--------------------ccccccCCCCccccccccccccccCC
Q 013074 295 ---------------------------------G--------------------IVSSLLGARGTIGYIALEVFSRNFGE 321 (450)
Q Consensus 295 ---------------------------------~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~~ 321 (450)
. ........+||-+|+|||++.+. .
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~--G 311 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE--G 311 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC--C
Confidence 0 00112245699999999999996 8
Q ss_pred CCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCC
Q 013074 322 VSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPY 401 (450)
Q Consensus 322 ~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~ 401 (450)
.+.++|.|+||+++|||+.|..||....... .+.+.+.+.+ ........+....+++++.|..||+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~---Tl~NIv~~~l-----------~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---TLRNIVGQPL-----------KFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh---hHHHHhcCCC-----------cCCCCCcchhHHHHHHHHHhccChh
Confidence 8999999999999999999999998764432 2222211111 1122235678899999999999999
Q ss_pred CCCC----HHHHHHH--hhccccccCCCCCCCC
Q 013074 402 DRPP----MNEVIEM--LQGSTEALQIPPTPFL 428 (450)
Q Consensus 402 ~RPs----~~evl~~--L~~~~~~l~~p~~p~~ 428 (450)
+|.. +.||-+. .++...+|-.-.+|+.
T Consensus 378 kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~ 410 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE 410 (459)
T ss_pred hhhccccchHHhhcCccccCCChhheeccCCCc
Confidence 9997 8888764 7777777655544443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=293.65 Aligned_cols=236 Identities=22% Similarity=0.300 Sum_probs=175.6
Q ss_pred HhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCC-----ceEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGN-----NRALI 209 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV 209 (450)
++.+.||+|+||.||+++. .+|+++++.++|+||+++++++.... ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 3467899999999999852 23577888999999999999998776 78999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+||+. ++|.+.+.... .+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++.
T Consensus 83 ~e~~~-~~l~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQ------PLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred eeccc-cCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceee
Confidence 99995 68888775433 28999999999999999999994 8999999999999999999999999999986
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh---
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE--- 366 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~--- 366 (450)
....... ......++..|+|||++.+. ..++.++|||||||+++||++|+.||........ ...+.+...
T Consensus 153 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~i~~~~g~~~ 225 (372)
T cd07853 153 EEPDESK--HMTQEVVTQYYRAPEILMGS-RHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ----LDLITDLLGTPS 225 (372)
T ss_pred cccCccc--cCCCCCcCCCcCCHHHHcCC-CCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH----HHHHHHHcCCCC
Confidence 5433211 12334578999999998764 3578999999999999999999999965432110 000000000
Q ss_pred ---------hhhhhhhccc--cc------chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 367 ---------QDREFKLLGV--VT------KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 367 ---------~~~~~~~~~~--~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.......... .. ........++.+++.+||+.||++|||++|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 00 0011235678899999999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=273.99 Aligned_cols=232 Identities=21% Similarity=0.300 Sum_probs=178.9
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.++||+|+||.||+|+. .+|+.+++.++||||+++++.+..++..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 456678999999999999852 125677888999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++...+. +++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 90 ~~~L~~~~~~~~~------~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06645 90 GGSLQDIYHVTGP------LSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI 160 (267)
T ss_pred CCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence 9999999865432 8899999999999999999995 899999999999999999999999999987654322
Q ss_pred CccccccCCCCccccccccccccc-cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
. ......|+..|+|||++... .+.++.++|+|||||++|+|++|+.|+........ +....... .
T Consensus 161 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-------~~~~~~~~----~ 226 (267)
T cd06645 161 A---KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-------LFLMTKSN----F 226 (267)
T ss_pred c---ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-------HHhhhccC----C
Confidence 1 12334589999999997421 13688999999999999999999999864321110 00000000 0
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........++..+.+++.+|++.+|++||+++++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 227 QPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred CCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 000000111234668899999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=275.15 Aligned_cols=229 Identities=24% Similarity=0.347 Sum_probs=175.5
Q ss_pred hHhhhccccccceEEEEEEEc----------------------chhhhhhhc-CCCceeeeeeEEEeC------CceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRT-SHVNVVTLLGFCLEG------NNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l-~HpnIv~l~~~~~~~------~~~~lV 209 (450)
+++.+.||+|+||.||+|+.. .|+.+++++ +|+||+++++++... ...++|
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv 87 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLV 87 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEE
Confidence 455678999999999998532 245667777 699999999998753 357899
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+.+++|.+++..... ..+++..+..++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 88 MEFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEcCCCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999875432 238899999999999999999995 8999999999999999999999999999876
Q ss_pred ccCCCCccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE 366 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~ 366 (450)
...... ......|+..|+|||++... ...++.++|||||||++|||++|+.||....... ......
T Consensus 161 ~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~--------~~~~~~ 229 (272)
T cd06637 161 LDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR--------ALFLIP 229 (272)
T ss_pred cccccc---cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH--------HHHHHh
Confidence 543221 12334588999999998632 1357889999999999999999999986432110 000000
Q ss_pred hhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 367 QDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.. ..........+..+.+++.+||+.+|.+|||++|+++
T Consensus 230 ~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RN------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cC------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 0011111234567899999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=273.52 Aligned_cols=226 Identities=25% Similarity=0.458 Sum_probs=178.0
Q ss_pred hHhhhccccccceEEEEEEE-------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChh
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 219 (450)
+.+.+.||+|+||.||+++. .+|+.++++++||||+++++++..+ ..++||||+++++|.
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~ 86 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLV 86 (254)
T ss_pred ceeeeeeccCCCCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHH
Confidence 45678899999999999852 2457888899999999999988654 579999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcccc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 299 (450)
+++..... ..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......
T Consensus 87 ~~l~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 87 NFLRTRGR----ALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred HHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 99975432 238899999999999999999995 899999999999999999999999999987653321
Q ss_pred ccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 300 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....+..|+|||.+.+. .++.++|+||||++++||++ |+.||..... .. ........ ...
T Consensus 155 -~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~-~~~~~~~~-------~~~ 216 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHK--KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KE-VKECVEKG-------YRM 216 (254)
T ss_pred -CCCCCCceecCHHHhccC--CcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HH-HHHHHhCC-------CCC
Confidence 122245689999998763 78999999999999999997 8888754321 01 11111111 011
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
.....++..+.+++.+||+.+|++||+++++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1122345778899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=285.22 Aligned_cols=233 Identities=18% Similarity=0.212 Sum_probs=175.1
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.++||+|+||.||+++.. +|..++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 345678999999999998632 235566778999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~~g~L~~~l~~~~~-----~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 83 YVGGDLLTLLSKFED-----RLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred cCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999975432 28899999999999999999995 9999999999999999999999999999876533
Q ss_pred CCCccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
..... .....||+.|+|||++... .+.++.++|||||||++|||++|+.||..... .+..........
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~ 225 (332)
T cd05623 155 DGTVQ--SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKE 225 (332)
T ss_pred CCcce--ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCc
Confidence 22111 1234689999999998631 13678999999999999999999999964321 111111111100
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPY--DRPPMNEVIEM 412 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPs~~evl~~ 412 (450)
.. ........++.++.+++.+|+..++. .|++++|+++.
T Consensus 226 ~~----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 226 RF----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cc----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00 11111233467788888888865444 36899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=276.95 Aligned_cols=233 Identities=30% Similarity=0.439 Sum_probs=181.9
Q ss_pred hhHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
.+.+.+.||+|+||.||+|.. .+|+..+++++||||+++++++.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 345668899999999999852 124678889999999999999987 788999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+||+++|+|.+++..... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+++.
T Consensus 87 ~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKD-----NIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred EecCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 999999999999976432 28999999999999999999995 9999999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
......... .....++..|+|||.+... .++.++|+||||++++|+++ |+.||..... ..+...+...
T Consensus 159 ~~~~~~~~~-~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~ 227 (279)
T cd05057 159 LDVDEKEYH-AEGGKVPIKWMALESILHR--IYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEKG 227 (279)
T ss_pred ccCccccee-cCCCcccccccCHHHhhcC--CcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhCC
Confidence 654332211 1122245689999998653 78999999999999999998 8888864321 1111111111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
.. ...+......+.+++.+||..+|.+||++.++++.|+...
T Consensus 228 ~~-------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 228 ER-------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CC-------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 10 1111123356888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=285.21 Aligned_cols=241 Identities=17% Similarity=0.189 Sum_probs=174.9
Q ss_pred hhhccccc--cceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 161 FKDKLGQG--GFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 161 ~~~~LG~G--~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
+.++||+| +|++||+++.. +|+.+++.++||||+++++++.+++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45689999 78899998521 2466778889999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++++||+........
T Consensus 82 ~~~~l~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~ 154 (327)
T cd08227 82 AYGSAKDLICTHFM----DGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH 154 (327)
T ss_pred CCCcHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence 99999999865432 228899999999999999999995 89999999999999999999999999865433211
Q ss_pred CCcc----ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh--
Q 013074 294 KGIV----SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ-- 367 (450)
Q Consensus 294 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~-- 367 (450)
.... .......++..|+|||++.+....++.++|||||||+++||++|+.||........ ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 231 (327)
T cd08227 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPCLL 231 (327)
T ss_pred cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH---HHHHhcCCccccc
Confidence 1000 00112346778999999976434688999999999999999999999964321110 00000000000
Q ss_pred -----------------hhhh--------------hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 368 -----------------DREF--------------KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 368 -----------------~~~~--------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.... ................+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0000 0000001112234567899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=302.24 Aligned_cols=235 Identities=20% Similarity=0.276 Sum_probs=181.3
Q ss_pred hhhccccccceEEEEEEE-----------------------cchhhhhhhcC-CCceeeeeeEE-Ee---C---CceEEE
Q 013074 161 FKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTS-HVNVVTLLGFC-LE---G---NNRALI 209 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~-HpnIv~l~~~~-~~---~---~~~~lV 209 (450)
+.+.|.+|||+.||.++. .+|+.++++|+ |+|||.+++.. .. + -.++|.
T Consensus 41 V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL 120 (738)
T KOG1989|consen 41 VEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL 120 (738)
T ss_pred EEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence 467899999999999963 35688999997 99999999932 21 1 256789
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
||||++|+|-+++..+... .|++.++++|+.++++|+.+||. +...|||||||-+||||+.++..||||||.+..
T Consensus 121 mEyC~gg~Lvd~mn~Rlq~----~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 121 MEYCKGGSLVDFMNTRLQT----RLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred hhhccCCcHHHHHHHHHhc----cCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 9999999999999765432 29999999999999999999994 345699999999999999999999999999864
Q ss_pred ccCCCC------ccccccCCCCcccccccccccccc-CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh
Q 013074 290 CTTKKG------IVSSLLGARGTIGYIALEVFSRNF-GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 290 ~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~ 362 (450)
...... .....-....|+-|+|||.+.-.. -.+++|+|||+|||+||-|+....||+......-
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI--------- 266 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI--------- 266 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE---------
Confidence 422211 011111223689999999975421 2789999999999999999999999976522110
Q ss_pred hhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.+..+ ..+....++..|.+||+.||+.||.+||++-+|++.+..+..
T Consensus 267 ----lng~Y-----~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 267 ----LNGNY-----SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred ----Eeccc-----cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 00001 011225678999999999999999999999999988776554
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=293.07 Aligned_cols=224 Identities=27% Similarity=0.395 Sum_probs=183.8
Q ss_pred ccccccceEEEEEE-----------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhh
Q 013074 164 KLGQGGFGGVYKGK-----------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEK 220 (450)
Q Consensus 164 ~LG~G~fg~Vy~~~-----------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 220 (450)
+||+|.||+||.|+ +.+|+..-++++|.|||+++|.|.+++.+-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 69999999999996 3456888899999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCccC--CHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc-CCCCeEEeeccccccccCCCCcc
Q 013074 221 FVYNGDTSKPCQYL--RWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD-QDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 221 ~l~~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
.+...-+. + .+.++-.+..||+.||.|||+ +.|||||||-+|||++ -.|.+||+|||-++....-..
T Consensus 662 LLrskWGP-----lKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-- 731 (1226)
T KOG4279|consen 662 LLRSKWGP-----LKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-- 731 (1226)
T ss_pred HHHhccCC-----CccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCc--
Confidence 99764322 4 677888889999999999996 9999999999999997 578999999999886643221
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVV 377 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 377 (450)
...++.||..|||||++......|..++|||||||.+.||.||++||....+....+.-. .....-
T Consensus 732 -~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV-------------GmyKvH 797 (1226)
T KOG4279|consen 732 -CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV-------------GMYKVH 797 (1226)
T ss_pred -cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh-------------cceecC
Confidence 134456999999999998766689999999999999999999999996543322111100 011122
Q ss_pred cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 378 TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 378 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+..+.+.+.+..+++++|+.++|.+||++.++++
T Consensus 798 P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 798 PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 3456778889999999999999999999999985
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=275.15 Aligned_cols=228 Identities=24% Similarity=0.318 Sum_probs=175.4
Q ss_pred hccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 219 (450)
..||+|+||.||+|+. .+|+.++++++|+||+++++++..++..++|+||+++++|.
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 93 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHH
Confidence 4799999999999963 23577889999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-CCCeEEeeccccccccCCCCccc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-DFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
+++...... ...++..+..++.|++.||.|||+ .+|+|+||||+||+++. ++.++|+|||++.........
T Consensus 94 ~~l~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~-- 165 (268)
T cd06624 94 ALLRSKWGP---LKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC-- 165 (268)
T ss_pred HHHHHhccc---CCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc--
Confidence 999754221 012778888999999999999994 89999999999999986 679999999998765432211
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....++..|+|||++.+....++.++||||||+++|+|++|+.|+......... .+ .. .......
T Consensus 166 -~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~----~~--~~-------~~~~~~~ 231 (268)
T cd06624 166 -TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA----MF--KV-------GMFKIHP 231 (268)
T ss_pred -cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh----Hh--hh-------hhhccCC
Confidence 1223478999999998764335789999999999999999999998643211100 00 00 0000111
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..+.....++.+++.+||+.+|.+|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 232 EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1223455778999999999999999999999863
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=275.76 Aligned_cols=232 Identities=22% Similarity=0.330 Sum_probs=180.8
Q ss_pred hHhhhccccccceEEEEEEEc------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+++.+.||+|+||.||+++.. +|+.++++++|+||+++++.+..++..++||||++
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 3 IEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 456789999999999998532 25677888999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|..++..... ...+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~l~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 83 AGSLDKLYAGGVA---TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred CCCHHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999988865321 1248999999999999999999995 3589999999999999999999999999987654322
Q ss_pred CccccccCCCCcccccccccccccc----CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNF----GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.....++..|+|||.+.+.. ..++.++|+|||||++|+|++|+.||....... ....+...
T Consensus 158 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~-- 222 (286)
T cd06622 158 -----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--------IFAQLSAI-- 222 (286)
T ss_pred -----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--------HHHHHHHH--
Confidence 12334788999999986531 135889999999999999999999986432110 11111110
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
...........+..++.+++.+||+.+|++||+++++++.
T Consensus 223 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 223 --VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 1111112233467788999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=284.57 Aligned_cols=232 Identities=18% Similarity=0.230 Sum_probs=174.7
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++.. +|..++..++|+||+++++++.+++..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345678999999999998632 235566778999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 83 YVGGDLLTLLSKFED-----RLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred CCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999975332 28889999999999999999994 9999999999999999999999999999976644
Q ss_pred CCCccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh-h
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ-D 368 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~-~ 368 (450)
..... .....||..|+|||++.+. .+.++.++||||||+++|||++|+.||...... . ....+.. .
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~-~~~~i~~~~ 224 (331)
T cd05624 155 DGTVQ--SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV-------E-TYGKIMNHE 224 (331)
T ss_pred CCcee--eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH-------H-HHHHHHcCC
Confidence 32211 1234589999999998642 135788999999999999999999999643210 0 1111110 0
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYD--RPPMNEVIEM 412 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 412 (450)
... ........++.++.+++.+|++.++++ |++++++++.
T Consensus 225 ~~~----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 225 ERF----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred Ccc----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 000 011111234567888888888865544 4688888754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=278.94 Aligned_cols=235 Identities=23% Similarity=0.340 Sum_probs=171.7
Q ss_pred hHhhhccccccceEEEEEEEc-------------------------chhhhhhh---cCCCceeeeeeEEEeC-----Cc
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISR---TSHVNVVTLLGFCLEG-----NN 205 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~---l~HpnIv~l~~~~~~~-----~~ 205 (450)
|.+.+.||+|+||.||+|+.. +|+.++++ ++||||+++++++... ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 345678999999999999532 13444544 4799999999988653 45
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
.++||||+. ++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVPP----PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccC
Confidence 789999996 588888865432 238999999999999999999995 899999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
+++....... .....+|..|+|||++.+. .++.++|||||||++|+|++|+++|....... .+.+ +....
T Consensus 154 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~---~~~~-~~~~~ 223 (288)
T cd07863 154 LARIYSCQMA----LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGK-IFDLI 223 (288)
T ss_pred ccccccCccc----CCCccccccccCchHhhCC--CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH---HHHH-HHHHh
Confidence 9986643321 1234578999999999764 78999999999999999999999986432110 0100 00000
Q ss_pred hhhhhhh-----------hc----ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 366 EQDREFK-----------LL----GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 366 ~~~~~~~-----------~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
....... .. .........+..++.+++.+||+.||++|||+.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 224 GLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 00 0000111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=298.94 Aligned_cols=239 Identities=19% Similarity=0.252 Sum_probs=172.6
Q ss_pred hHhhhccccccceEEEEEEEc-------------------chhhhhhhcCCCceeeeeeEEEeC--------CceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-------------------DGLASISRTSHVNVVTLLGFCLEG--------NNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-------------------~e~~~l~~l~HpnIv~l~~~~~~~--------~~~~lV~E 211 (450)
|.+.+.||+|+||.||+|... +|+.++++++||||+++++++... ..+++|||
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE 147 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME 147 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEe
Confidence 445788999999999998531 368899999999999999887532 24678999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-CeEEeeccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-CPKISDFGLAKLC 290 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~ 290 (450)
|++ ++|.+++..... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++..
T Consensus 148 ~~~-~~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 148 FIP-QTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred cCC-ccHHHHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 996 577777653221 11348999999999999999999994 9999999999999999664 7999999999866
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh-
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR- 369 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~- 369 (450)
..... .....||+.|+|||++.+. ..++.++|||||||++|||++|.+||....... .+... .+......
T Consensus 222 ~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~---~~~~i-~~~~~~p~~ 292 (440)
T PTZ00036 222 LAGQR----SVSYICSRFYRAPELMLGA-TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD---QLVRI-IQVLGTPTE 292 (440)
T ss_pred cCCCC----cccCCCCcCccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHH-HHHhCCCCH
Confidence 44322 1234579999999998653 368999999999999999999999996542211 01100 00000000
Q ss_pred -----------hhhhcccc-----cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 370 -----------EFKLLGVV-----TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 370 -----------~~~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........ ...+...+.++.+++.+||+.||.+|||+.|+++.
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000000 00011234678999999999999999999999854
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=272.96 Aligned_cols=229 Identities=24% Similarity=0.472 Sum_probs=179.2
Q ss_pred hHhhhccccccceEEEEEEEc---------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL---------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~---------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
+.+.+.||+|+||.||++... +|++++++++||||+++++++......++|+||+++++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 85 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCc
Confidence 345688999999999998532 35778999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++..... .++++.++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++..........
T Consensus 86 L~~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 86 LSDYLRAQRG-----KFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred HHHHHHhCcc-----CCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999865432 27899999999999999999995 899999999999999999999999999987654332111
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.....++..|+|||++.+. .++.++||||||+++|||++ |..||...... . +.+........
T Consensus 158 --~~~~~~~~~~~aPe~~~~~--~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~-~~~~~~~~~~~----- 220 (256)
T cd05112 158 --STGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------E-VVETINAGFRL----- 220 (256)
T ss_pred --cCCCccchhhcCHhHhccC--CcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------H-HHHHHhCCCCC-----
Confidence 1222356789999998764 78899999999999999998 88887543210 0 11111111000
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
......+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 221 --~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 221 --YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred --CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 011123467999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=286.68 Aligned_cols=219 Identities=24% Similarity=0.287 Sum_probs=168.1
Q ss_pred cccccceEEEEEEEcc--------------------------hhhhhhhc---CCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 165 LGQGGFGGVYKGKLLD--------------------------GLASISRT---SHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 165 LG~G~fg~Vy~~~~~~--------------------------e~~~l~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
||+|+||+||+|+... |..++.+. .||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999986321 12233333 699999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|..++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~------~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~ 151 (330)
T cd05586 81 GELFWHLQKEG------RFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK 151 (330)
T ss_pred ChHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC
Confidence 99998886543 28899999999999999999994 8999999999999999999999999999875433221
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....||..|+|||++.+. ..++.++|||||||++|+|++|+.||...... ...+.+....
T Consensus 152 ~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslGvil~elltG~~Pf~~~~~~--------~~~~~i~~~~------ 213 (330)
T cd05586 152 T---TNTFCGTTEYLAPEVLLDE-KGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--------QMYRNIAFGK------ 213 (330)
T ss_pred C---ccCccCCccccCHHHHcCC-CCCCCccceeccccEEEEeccCCCCCCCCCHH--------HHHHHHHcCC------
Confidence 1 2345689999999998753 35789999999999999999999999643210 0111111110
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPP----MNEVIE 411 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~ 411 (450)
........+..+.+++.+||+.||.+||+ +.++++
T Consensus 214 -~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 214 -VRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00011124567889999999999999984 556554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=318.15 Aligned_cols=236 Identities=26% Similarity=0.469 Sum_probs=183.3
Q ss_pred hhccccccceEEEEEEEc-------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhhhh
Q 013074 162 KDKLGQGGFGGVYKGKLL-------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV 222 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~~-------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l 222 (450)
.+.||+|+||.||+|+.. +|++.+++++|||||+++++|.++...++||||+++|+|.+++
T Consensus 695 ~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l 774 (968)
T PLN00113 695 ENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774 (968)
T ss_pred ccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHH
Confidence 457999999999999642 2477889999999999999999999999999999999999998
Q ss_pred hcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccC
Q 013074 223 YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLG 302 (450)
Q Consensus 223 ~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 302 (450)
+. ++|..+.+++.|+++||+|||..+..+|+||||||+||+++.++.+++. ||........ ..
T Consensus 775 ~~---------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-------~~ 837 (968)
T PLN00113 775 RN---------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-------TK 837 (968)
T ss_pred hc---------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-------CC
Confidence 41 7899999999999999999997656899999999999999999888875 6655433221 12
Q ss_pred CCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc----ccc
Q 013074 303 ARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG----VVT 378 (450)
Q Consensus 303 ~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~----~~~ 378 (450)
..+|..|+|||++.+. .++.++|||||||++|||++|+.|++..... .....+|..............+ ...
T Consensus 838 ~~~t~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 913 (968)
T PLN00113 838 CFISSAYVAPETRETK--DITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDV 913 (968)
T ss_pred ccccccccCcccccCC--CCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCC
Confidence 2478999999998764 7899999999999999999999998543221 2233344332221111111000 011
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
....+...++.+++.+||+.||++||||+||++.|++...
T Consensus 914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2233456678899999999999999999999999998754
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=271.07 Aligned_cols=227 Identities=22% Similarity=0.331 Sum_probs=181.0
Q ss_pred hHhhhccccccceEEEEEEEc---------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL---------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~---------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
+.+.+.||+|+||.||+|+.. +|++.+++++|+||+++++++.++...++++||+++++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 84 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCc
Confidence 456778999999999999642 34677888999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 85 L~~~l~~~~-----~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~- 155 (256)
T cd06612 85 VSDIMKITN-----KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK- 155 (256)
T ss_pred HHHHHHhCc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCccc-
Confidence 999986533 238999999999999999999994 89999999999999999999999999998876543211
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVV 377 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 377 (450)
.....++..|+|||++.+. .++.++||||||+++++|++|+.|+.......... .... .....
T Consensus 156 --~~~~~~~~~y~~PE~~~~~--~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~--------~~~~-----~~~~~ 218 (256)
T cd06612 156 --RNTVIGTPFWMAPEVIQEI--GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF--------MIPN-----KPPPT 218 (256)
T ss_pred --cccccCCccccCHHHHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh--------hhcc-----CCCCC
Confidence 1223478899999998775 78999999999999999999999986532211000 0000 00001
Q ss_pred cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 378 TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 378 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..........+.+++.+||+.||++|||+.|+++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1122334567899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=280.85 Aligned_cols=232 Identities=28% Similarity=0.431 Sum_probs=178.1
Q ss_pred HhhhccccccceEEEEEEEc----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKLL----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
...+.||+|+||.||+|+.. +|+.++++++||||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 34568999999999998531 235677888999999999998754 5679999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++..... .+++..++.++.|++.||.|||+ .+|+|+||||+||++++++.+||+|||+++...
T Consensus 89 ~~~~g~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 89 LMPHGCLLDYVHEHKD-----NIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred hcCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999865432 38899999999999999999994 899999999999999999999999999998764
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
....... .....++..|+|||.+.+. .++.++||||||+++|||++ |+.||..... .. +.+.+.....
T Consensus 161 ~~~~~~~-~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~~----~~~~~~~~~~ 229 (303)
T cd05110 161 GDEKEYN-ADGGKMPIKWMALECIHYR--KFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----RE----IPDLLEKGER 229 (303)
T ss_pred Ccccccc-cCCCccccccCCHHHhccC--CCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----HH----HHHHHHCCCC
Confidence 3322111 2223456789999998764 78999999999999999997 8888754211 00 1111111110
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.......+..+.+++..||..+|++||+++++++.|+.+.+
T Consensus 230 -------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 230 -------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11112234578899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=278.87 Aligned_cols=241 Identities=23% Similarity=0.339 Sum_probs=176.2
Q ss_pred HhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.++...++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 4567899999999999952 235677888999999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++|.+++..... ...+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 83 -~~l~~~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 83 -MDLKKYLDSLPK---GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred -CCHHHHHhcCCC---CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 689888865332 1338999999999999999999994 899999999999999999999999999987653321
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------hhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPH-------WIYRHVEQ 367 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~-------~i~~~~~~ 367 (450)
. ......++..|+|||.+.+. ..++.++||||||+++++|++|+.||.............. ..+.....
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 R---VYTHEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred c---cccCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 1 11233468899999998654 3578899999999999999999999864321100000000 00000000
Q ss_pred hhhhh--h----cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 368 DREFK--L----LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 368 ~~~~~--~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..... . ..........++.++.+++.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 0 00000111224567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=284.32 Aligned_cols=218 Identities=19% Similarity=0.268 Sum_probs=169.8
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcC-CCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTS-HVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+++.+.||+|+||.||+++.. .|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456788999999999998532 1234444554 5778889999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 82 y~~~g~L~~~i~~~~~------l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 82 YVNGGDLMYHIQQVGK------FKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred CCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 9999999999865432 8999999999999999999995 899999999999999999999999999987543
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
..... .....||..|+|||++.+. .++.++|||||||++|||++|+.||..... ..+.+.+....
T Consensus 153 ~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~-- 217 (323)
T cd05615 153 VDGVT---TRTFCGTPDYIAPEIIAYQ--PYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHN-- 217 (323)
T ss_pred CCCcc---ccCccCCccccCHHHHcCC--CCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC--
Confidence 22211 2334589999999999764 789999999999999999999999965321 01111111100
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM 406 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 406 (450)
...+...+.++.+++.+||+.+|.+|++.
T Consensus 218 ------~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ------VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 01122345678899999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=271.83 Aligned_cols=233 Identities=24% Similarity=0.378 Sum_probs=179.8
Q ss_pred hHhhhccccccceEEEEEEEcc----------------------------------hhhhhh-hcCCCceeeeeeEEEeC
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLD----------------------------------GLASIS-RTSHVNVVTLLGFCLEG 203 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~----------------------------------e~~~l~-~l~HpnIv~l~~~~~~~ 203 (450)
|.+.+.||+|+||.||+|+... |+.++. .++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 3456789999999999986433 233343 47899999999999999
Q ss_pred CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 204 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
+..++||||+++++|.+++...... ...+++..++.++.|++.||.|||. ..+++|+||+|+||+++.++.+||+|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEK--KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 9999999999999999887542111 1338999999999999999999994 36899999999999999999999999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
||.+....... ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...... ... .
T Consensus 158 fg~~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~-------~~~-~ 223 (269)
T cd08528 158 FGLAKQKQPES----KLTSVVGTILYSCPEIVKNE--PYGEKADVWAFGCILYQMCTLQPPFYSTNML-------SLA-T 223 (269)
T ss_pred ccceeeccccc----ccccccCcccCcChhhhcCC--CCchHHHHHHHHHHHHHHHhCCCcccccCHH-------HHH-H
Confidence 99998765433 12344588999999999763 6899999999999999999999998643210 000 0
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
...... .........+..+.+++.+||+.||++||++.|+.++++.
T Consensus 224 ~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 224 KIVEAV------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred HHhhcc------CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 110000 0011112345678999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=275.98 Aligned_cols=231 Identities=22% Similarity=0.295 Sum_probs=178.1
Q ss_pred hhHhhhccccccceEEEEEEEc-----------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.|.+.++||+|+||.||+|+.. +|++++++++|+||+++++.+..+...++||||++
T Consensus 13 ~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 13 VWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 3456788999999999999632 35677889999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|..++..... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 93 ~~~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 93 GGAVDAIMLELDR-----GLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCcHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 9999888754332 28999999999999999999995 899999999999999999999999999887543221
Q ss_pred CccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.. .....++..|+|||++... ...++.++|||||||++|||++|+.||...... . .........
T Consensus 165 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~-~~~~~~~~~-- 231 (292)
T cd06644 165 QR---RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------R-VLLKIAKSE-- 231 (292)
T ss_pred cc---cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------H-HHHHHhcCC--
Confidence 11 1233478899999998531 135688999999999999999999998643210 0 001110000
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.........++.++.+++.+||+.+|++||+++|+++.
T Consensus 232 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 ---PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00111123445678899999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=271.16 Aligned_cols=228 Identities=24% Similarity=0.349 Sum_probs=182.5
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.+.||+|+||.||.++. .+|++++++++|+||+++++++.+....+++|||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 34567899999998887742 23578899999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++..... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 82 NGGTLYDKIVRQKG----QLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred CCCcHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999975432 238999999999999999999995 89999999999999999999999999998876543
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
... .....++..|+|||.+.+. ..+.++||||||++++||++|..||..... ........ .
T Consensus 155 ~~~---~~~~~~~~~y~ape~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~-~------ 215 (256)
T cd08221 155 YSM---AETVVGTPYYMSPELCQGV--KYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKIV-Q------ 215 (256)
T ss_pred ccc---ccccCCCccccCHhhcCCC--CCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHH-c------
Confidence 321 2334588999999998764 678899999999999999999999864321 11111111 1
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 413 (450)
+.........+.++.+++.+||+.+|.+||++.|+++.+
T Consensus 216 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 216 -GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -CCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111112244567899999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=272.34 Aligned_cols=226 Identities=25% Similarity=0.295 Sum_probs=172.2
Q ss_pred HhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeC--CceEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEG--NNRALI 209 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 209 (450)
...+.||+|+||.||+|.. .+|+.++++++||||+++++++.+. ...+++
T Consensus 5 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 5 RRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred cccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 4467899999999999842 1246688899999999999988753 567899
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+||+++++|.+++..... +++...+.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||+++.
T Consensus 85 ~e~~~~~~L~~~l~~~~~------l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGA------LTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EeCCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 999999999999965432 7888999999999999999994 8999999999999999999999999999876
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
...............++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ...+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~~~~~~~---- 222 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGE--GYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MAAIFKIA---- 222 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCC--CCCchhhhHHHHHHHHHHHHCCCCccccch-------HHHHHHHh----
Confidence 54322111112234578899999999764 789999999999999999999999864311 00011110
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
........+......+..++ .||..+|++||+++||++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 ---TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ---cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00011122233445566666 688889999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=270.89 Aligned_cols=231 Identities=23% Similarity=0.326 Sum_probs=180.3
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.+.+.||.|+||.||+++. .+|++++++++||||+++++++.++...+++|||+++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~ 84 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGG 84 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCC
Confidence 44567899999999999953 2347788899999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||++........
T Consensus 85 ~~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 85 GSLQDIYQVTR-----GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CcHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999886542 228899999999999999999995 8999999999999999999999999999876543221
Q ss_pred ccccccCCCCccccccccccccc-cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
......++..|+|||.+... ...++.++|+||||+++++|++|+.|+........ ... ... ....
T Consensus 157 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-------~~~-~~~---~~~~ 222 (262)
T cd06613 157 ---KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-------LFL-ISK---SNFP 222 (262)
T ss_pred ---ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-------HHH-HHh---ccCC
Confidence 12234578899999998652 12678899999999999999999999864321100 000 000 0000
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..........+.++.+++.+||+.+|.+|||+++|+.
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111123345678999999999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=268.50 Aligned_cols=227 Identities=26% Similarity=0.421 Sum_probs=176.9
Q ss_pred hccccccceEEEEEEEc-----------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 219 (450)
++||+|+||.||++... +|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999998632 2467788999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcccc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 299 (450)
+++..... .+++..+..++.+++.||+|||+ .+++|+||||+||+++.++.+||+|||++...........
T Consensus 81 ~~l~~~~~-----~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~- 151 (251)
T cd05041 81 TFLRKKKN-----RLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS- 151 (251)
T ss_pred HHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec-
Confidence 99865332 37889999999999999999995 8999999999999999999999999999886543221111
Q ss_pred ccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 300 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
......+..|+|||.+.+. .++.++|+||||++++||++ |..||....... ....+... ...
T Consensus 152 ~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--------~~~~~~~~-------~~~ 214 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--------TRERIESG-------YRM 214 (251)
T ss_pred cccCcceeccCChHhhccC--CCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--------HHHHHhcC-------CCC
Confidence 1122245679999998764 78999999999999999998 777774432110 11111110 011
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
......+.++.+++.+||+.+|.+|||+.|+++.|++
T Consensus 215 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 215 PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred CCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 1123345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=283.64 Aligned_cols=233 Identities=17% Similarity=0.210 Sum_probs=173.8
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++.. +|..++++++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 446788999999999998632 245667778999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 83 YVGGDLLTLLSKFED-----RLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred CCCCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999965322 28899999999999999999995 9999999999999999999999999999876543
Q ss_pred CCCccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
..... .....||+.|+|||++... .+.++.++|||||||++|||++|+.||..... .+..........
T Consensus 155 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-------~~~~~~i~~~~~ 225 (331)
T cd05597 155 DGTVQ--SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKE 225 (331)
T ss_pred CCCcc--ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCC
Confidence 22211 1223589999999998631 23578899999999999999999999964321 011111110000
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQA--RPYDRPPMNEVIEM 412 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~ 412 (450)
... ........+..+.+++.+|+.. ++..|++++++++.
T Consensus 226 ~~~----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 226 HFQ----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccc----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 000 1111122456677788877754 33447899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=295.31 Aligned_cols=248 Identities=17% Similarity=0.202 Sum_probs=175.7
Q ss_pred HHhhHhhhccccccceEEEEEEE-----------------------------------------cchhhhhhhcCCCcee
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL-----------------------------------------LDGLASISRTSHVNVV 194 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~-----------------------------------------~~e~~~l~~l~HpnIv 194 (450)
...|.+.++||+|+||+||+++. .+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 34566778999999999998642 2467888999999999
Q ss_pred eeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc
Q 013074 195 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD 274 (450)
Q Consensus 195 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~ 274 (450)
++++++.+.+..++|+|++ .++|.+++....... ........+..++.|++.||+|||+ .+|+||||||+|||++
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDW-KDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN 301 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccc-cccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence 9999999999999999998 567877775432111 1123456677899999999999994 8999999999999999
Q ss_pred CCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 013074 275 QDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE 354 (450)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~ 354 (450)
.++.+||+|||+++......... .....||..|+|||++.+. .++.++|||||||++|||++|+.++.........
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~ 377 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAF--DYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG 377 (501)
T ss_pred CCCCEEEEeCCCceecCcccccc--cccccCCcCCCCchhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence 99999999999998765432211 2235689999999999874 7899999999999999999987654332211111
Q ss_pred cchhhhhh-----------------hhhhhhhhhhhcccccc--hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 355 VYFPHWIY-----------------RHVEQDREFKLLGVVTK--KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 355 ~~~~~~i~-----------------~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..+.+.+. ..+.............. ........+.+++.+||+.||++|||+.|+++.
T Consensus 378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11111100 00000000000000000 001123456778999999999999999999864
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=283.86 Aligned_cols=236 Identities=22% Similarity=0.236 Sum_probs=171.2
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCC------ceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGN------NRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~------~~~ 207 (450)
|.+.+.||+|+||.||+++. .+|+.+++.++||||+++++++.... ..+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence 44567899999999999842 13577888999999999999986543 479
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||++ ++|...+.. .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 103 lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 103 LVMELMD-ANLCQVIHM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred EEEeCCC-cCHHHHHhc--------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 9999995 466666532 27888999999999999999995 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc--------cchhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE--------VYFPH 359 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~ 359 (450)
+....... .....||..|+|||++.+. .++.++|||||||++|+|++|+.||........- .....
T Consensus 171 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 244 (359)
T cd07876 171 RTACTNFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244 (359)
T ss_pred cccccCcc----CCCCcccCCCCCchhccCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHH
Confidence 76433221 2334589999999999774 7899999999999999999999999754211000 00000
Q ss_pred hhhhhhhhhhhhhh-----cc-------------cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 360 WIYRHVEQDREFKL-----LG-------------VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 360 ~i~~~~~~~~~~~~-----~~-------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+............. .. ............+.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000000 00 0000011124568899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=281.66 Aligned_cols=240 Identities=19% Similarity=0.318 Sum_probs=176.9
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|.+.++||+|+||.||+|+. .+|+..+++++||||+++++++.++...++||||++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 44567899999999999852 235788899999999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++|..++..... .+++..+..++.|++.||+||| +.+++|+||||+||+++.++.+||+|||++.......
T Consensus 88 -~~l~~~l~~~~~-----~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 88 -KDLKQYLDDCGN-----SINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred -cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 689888865432 2788999999999999999999 4999999999999999999999999999987643322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-------hhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPH-------WIYRHVEQ 367 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~-------~i~~~~~~ 367 (450)
.. .....++..|+|||.+.+. ..++.++||||||+++|||++|+.||...........+.. ..+.....
T Consensus 159 ~~---~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 159 KT---YSNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred Cc---ccccceeecccCcHHHhCC-CCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 11 1233468899999998764 3578899999999999999999999965421100000000 00000000
Q ss_pred hhhhhh---ccc----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 368 DREFKL---LGV----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 368 ~~~~~~---~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
...... ... .......++..+.+++.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 000 00011224567889999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=274.11 Aligned_cols=225 Identities=26% Similarity=0.352 Sum_probs=179.5
Q ss_pred hhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.|...+.||+|+||.||+|.. .+|++.+++++||||+++++++..+...++|+||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 344567899999999999952 23577888999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++... .+++..+..++.|++.|+.|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~L~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 85 GGGSALDLLKPG-------PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred CCCcHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 999999988532 28899999999999999999995 89999999999999999999999999998765433
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
... .....++..|+|||++.+. .++.++||||||++++||++|+.|+....... ........
T Consensus 155 ~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~~~----- 216 (277)
T cd06642 155 QIK---RNTFVGTPFWMAPEVIKQS--AYDFKADIWSLGITAIELAKGEPPNSDLHPMR--------VLFLIPKN----- 216 (277)
T ss_pred chh---hhcccCcccccCHHHhCcC--CCchhhhHHHHHHHHHHHHhCCCCCcccchhh--------HHhhhhcC-----
Confidence 211 1234578899999999774 78899999999999999999999986432111 00001000
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.........+..+.+++.+||+.+|++||++.++++.
T Consensus 217 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 217 --SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred --CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0111122345778999999999999999999999974
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=265.30 Aligned_cols=208 Identities=24% Similarity=0.353 Sum_probs=170.5
Q ss_pred chhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCC
Q 013074 180 DGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258 (450)
Q Consensus 180 ~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~ 258 (450)
.|+.+|.++ .||||+++.++++++...++|+|.|+.|.|.+++...-. ++++....|+.|+..|++||| .
T Consensus 71 ~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt------lSEK~tR~iMrqlfegVeylH---a 141 (411)
T KOG0599|consen 71 QEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT------LSEKETRRIMRQLFEGVEYLH---A 141 (411)
T ss_pred HHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhee------ecHHHHHHHHHHHHHHHHHHH---H
Confidence 346777776 699999999999999999999999999999999976543 899999999999999999999 5
Q ss_pred CceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCcccccccccccccc----CCCCccCchHhHHHH
Q 013074 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF----GEVSHKSDVYSFGMM 334 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~s~~sDiwSlGvv 334 (450)
.+||||||||+|||+|++.++||+|||.+.....+.. ....|||++|+|||.+..+. ..|+...|+||+||+
T Consensus 142 ~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek----LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVI 217 (411)
T KOG0599|consen 142 RNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK----LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVI 217 (411)
T ss_pred hhhhhcccChhheeeccccceEEeccceeeccCCchh----HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHH
Confidence 9999999999999999999999999999998876643 45678999999999986532 368899999999999
Q ss_pred HHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 335 IMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 335 l~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+|-|+.|.+||.... ++. ....+.++.- . -..+.-.+.+....+++.+||+.||.+|.|++|+++.
T Consensus 218 myTLLaGcpPFwHRk----Qml----MLR~ImeGky-q---F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 218 MYTLLAGCPPFWHRK----QML----MLRMIMEGKY-Q---FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred HHHHHcCCCchhHHH----HHH----HHHHHHhccc-c---cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 999999999996431 111 1111111111 0 1123335667889999999999999999999999864
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=271.79 Aligned_cols=226 Identities=26% Similarity=0.412 Sum_probs=178.5
Q ss_pred HhhhccccccceEEEEEEEc--------------------------------chhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 160 SFKDKLGQGGFGGVYKGKLL--------------------------------DGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~--------------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
.+.+.||+|+||.||+|... .|+.++++++||||+++++++.+....+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 35678999999999998421 2467788999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+|+||+++++|.+++..... +++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||.+
T Consensus 83 lv~e~~~~~~L~~~l~~~~~------l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYGA------FEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EEEEecCCCCHHHHHHhccC------ccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999965432 7888999999999999999995 89999999999999999999999999998
Q ss_pred ccccCCCCcc---ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 288 KLCTTKKGIV---SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 288 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
+......... .......|+..|+|||.+.+. .++.++|+||||+++++|++|+.||...... ..+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~- 223 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT--SYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIFK- 223 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccC--CCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHHH-
Confidence 8765321111 011223478899999998764 7889999999999999999999999643210 00000
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
... ......+...+..+.+++.+||+.||.+||++.|+++
T Consensus 224 ~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 IGE-------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred Hhc-------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 1111222345678899999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=272.16 Aligned_cols=227 Identities=26% Similarity=0.392 Sum_probs=177.9
Q ss_pred hhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 161 FKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.||+|+||.||+|+. .+|++.+++++|+||+++++++.++...++|+||
T Consensus 4 ~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEF 83 (265)
T ss_pred ccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEec
Confidence 457899999999999842 1256778889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++..... +++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 84 ~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 84 VPGGSISSILNRFGP------LPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred CCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999965432 7889999999999999999994 8999999999999999999999999999876532
Q ss_pred CCC---ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 293 KKG---IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 293 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
... .........++..|+|||++.+. .++.++||||||+++++|++|..||...... .. ... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~-~~~-~~~-- 222 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINES--GYGRKSDIWSIGCTVFEMATGKPPLASMDRL------AA-MFY-IGA-- 222 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCC--CCcchhhHHHHHHHHHHHHhCCCccccCChH------HH-HHH-hhh--
Confidence 111 11112234588999999999764 6889999999999999999999999643211 00 000 000
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
............+.++.+++.+||+.+|++||++.|+++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 ---HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001111222345677899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=274.40 Aligned_cols=235 Identities=25% Similarity=0.374 Sum_probs=180.1
Q ss_pred HhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
...+.||+|+||.||+|+. .+|++++++++|+||+++++++.+....++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (275)
T cd05046 8 QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL 87 (275)
T ss_pred eeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEE
Confidence 3456899999999999863 22477889999999999999999989999999
Q ss_pred EecCCCChhhhhhcCCCCC---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 211 EFMPNGSLEKFVYNGDTSK---PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
||+++++|.+++....... ....+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++++|||++
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999997544211 01248999999999999999999994 89999999999999999999999999998
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVE 366 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~ 366 (450)
......... ......++..|+|||.+.+. ..+.++||||||+++++|++ |..||...... . +.....
T Consensus 165 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~-------~-~~~~~~ 232 (275)
T cd05046 165 KDVYNSEYY--KLRNALIPLRWLAPEAVQED--DFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-------E-VLNRLQ 232 (275)
T ss_pred cccCccccc--ccCCceeEEeecChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccchH-------H-HHHHHH
Confidence 754332211 12233467789999998764 67899999999999999998 66777432110 0 111111
Q ss_pred hhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 367 QDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
... . .......++..+.+++.+||+.+|++||++.|+++.|++
T Consensus 233 ~~~---~---~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 AGK---L---ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCC---c---CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 000 0 001112345679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=308.06 Aligned_cols=237 Identities=22% Similarity=0.308 Sum_probs=178.9
Q ss_pred HHHHhhHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC--Cce
Q 013074 154 VKKITNSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG--NNR 206 (450)
Q Consensus 154 i~~~~~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~ 206 (450)
.....|.+.++||+|+||+||+++. ..|+.++++++|||||++++++.+. ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3334456778999999999999852 2367889999999999999988653 568
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC----CCceEeeeeccccEEEcC-------
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC----STRILHFDIKPHNILLDQ------- 275 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----~~~ivH~Dikp~NIll~~------- 275 (450)
++||||+++++|.+++...... ...+++..++.|+.||+.||.|||... ..+|+|+||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~--~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKM--FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 9999999999999998653211 123899999999999999999999521 145999999999999964
Q ss_pred ----------CCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCC
Q 013074 276 ----------DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNL 345 (450)
Q Consensus 276 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~ 345 (450)
.+.+||+|||++........ .....||+.|+|||++.+....++.++|||||||++|||++|..||
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~----~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF 243 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESM----AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243 (1021)
T ss_pred ccccccccCCCCceEEccCCcccccccccc----ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence 33589999999986543221 2234589999999998754346889999999999999999999999
Q ss_pred CCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 346 DSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 346 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..... +.. +...+.... .......+.++.+++..||+.+|.+||++.|++.
T Consensus 244 ~~~~~------~~q-li~~lk~~p--------~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 244 HKANN------FSQ-LISELKRGP--------DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcCCc------HHH-HHHHHhcCC--------CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 64321 111 111111110 0011223567899999999999999999999984
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=270.02 Aligned_cols=219 Identities=21% Similarity=0.369 Sum_probs=170.6
Q ss_pred hccccccceEEEEEEEc--------------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 163 DKLGQGGFGGVYKGKLL--------------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~--------------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
+.||+|+||.||+|... +|+.++++++||||+++++++.. ...++||
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 46999999999988642 23567888899999999999988 7789999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-------CeEEee
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-------CPKISD 283 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-------~~kl~D 283 (450)
||+++++|.+++..... .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++ .+||+|
T Consensus 80 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 80 EYVKFGPLDVFLHREKN-----NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EcCCCCcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCC
Confidence 99999999999876442 38899999999999999999994 8999999999999999887 799999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcC-CCCCCCCCCCCCccchhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGC-KNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~i~ 362 (450)
||++...... ....++..|+|||++......++.++||||||++++||++| ..|+....... ...+
T Consensus 152 fg~a~~~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~----~~~~-- 218 (259)
T cd05037 152 PGIPITVLSR-------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE----KERF-- 218 (259)
T ss_pred CCcccccccc-------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh----HHHH--
Confidence 9998865432 12236678999999876434688999999999999999985 55554332110 0000
Q ss_pred hhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
.... ..... .....+.+++.+||+.+|.+|||+.|+++.|+
T Consensus 219 --~~~~------~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 219 --YQDQ------HRLPM---PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --HhcC------CCCCC---CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00000 01167889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=276.16 Aligned_cols=237 Identities=22% Similarity=0.317 Sum_probs=176.9
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.+....++|+||+
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 34567899999999999852 24678889999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
+ ++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++.....
T Consensus 82 ~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 82 D-QDLKKYFDSCN-----GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred C-CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 6 58888776433 228999999999999999999995 89999999999999999999999999998865432
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh--------
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV-------- 365 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~-------- 365 (450)
... .....++..|+|||++.+. ..++.++||||||+++|+|++|+.|+..+.... ..+ +.+....
T Consensus 153 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~-~~~~~~~~~~~~~~~ 225 (284)
T cd07839 153 VRC---YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQL-KRIFRLLGTPTEESW 225 (284)
T ss_pred CCC---cCCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHH-HHHHHHhCCCChHHh
Confidence 211 2233478899999998663 357899999999999999999998875443211 000 0010000
Q ss_pred ---hhhhhhhhcccc------cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 366 ---EQDREFKLLGVV------TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 366 ---~~~~~~~~~~~~------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
............ .......+.++.+++.+||+.||.+|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000000000 0111234578889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=288.60 Aligned_cols=229 Identities=25% Similarity=0.287 Sum_probs=172.4
Q ss_pred HhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 160 SFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
++.+.||+|+||.||+++.. .|..++.+++|+||+++++.+.+++..++||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 45678999999999998521 2466788889999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 84 PGGDMMTLLMKKDT------LSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred CCccHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999875432 8899999999999999999994 99999999999999999999999999998754321
Q ss_pred CCc--------------------------------cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcC
Q 013074 294 KGI--------------------------------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGC 341 (450)
Q Consensus 294 ~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg 341 (450)
... ........||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT--GYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC--CCCCcceeccccceeeecccC
Confidence 100 0001234699999999999874 789999999999999999999
Q ss_pred CCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 013074 342 KNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP---MNEVIEM 412 (450)
Q Consensus 342 ~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 412 (450)
+.||...... .....+...... .........+.++.+++.+++. ||.+|++ ++|+++.
T Consensus 233 ~~Pf~~~~~~--------~~~~~i~~~~~~----~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 233 YPPFCSETPQ--------ETYRKVMNWKET----LVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCCHH--------HHHHHHHcCCCc----eecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 9999654211 011111110000 0000111234567777777664 9999985 5666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-34 Score=268.44 Aligned_cols=227 Identities=22% Similarity=0.344 Sum_probs=178.4
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe-CCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE-GNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E~ 212 (450)
|.+.+.||+|++|.||+++. ..|++++++++|+|++++++.+.. +...++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 45678999999999998852 124677888999999999998764 4467899999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++..... ..+++.+++.++.+++.||++||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~l~~~l~~~~~----~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 82 CEGGDLYHKLKEQKG----KLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred cCCCcHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 999999999875322 238999999999999999999995 8999999999999999999999999999886643
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... .....++..|+|||++.+. .++.++||||||+++++|++|+.||..... ........ .
T Consensus 155 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~-~----- 216 (257)
T cd08223 155 QCDM---ASTLIGTPYYMSPELFSNK--PYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRII-E----- 216 (257)
T ss_pred cCCc---cccccCCcCccChhHhcCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHH-h-----
Confidence 3221 2234578899999998774 788999999999999999999998863211 11111111 0
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+.........+..+.+++.+|++.+|++||++.|+++.
T Consensus 217 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 217 --GKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --cCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11112223456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=269.93 Aligned_cols=224 Identities=25% Similarity=0.332 Sum_probs=179.5
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+...+.||.|+||.||+|+. .+|++++++++|+||+++++++.++...++||||++
T Consensus 6 y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06640 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred hhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCC
Confidence 34457899999999999952 234677888999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++... .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 86 ~~~L~~~i~~~-------~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 86 GGSALDLLRAG-------PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 99999988642 27888999999999999999994 899999999999999999999999999997664432
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .....++..|+|||++.+. .++.++|+||||+++|||++|..|+....... ...... .
T Consensus 156 ~~---~~~~~~~~~y~apE~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--------~~~~~~-------~ 215 (277)
T cd06640 156 IK---RNTFVGTPFWMAPEVIQQS--AYDSKADIWSLGITAIELAKGEPPNSDMHPMR--------VLFLIP-------K 215 (277)
T ss_pred cc---cccccCcccccCHhHhccC--CCccHHHHHHHHHHHHHHHHCCCCCCCcChHh--------Hhhhhh-------c
Confidence 11 1223478899999998764 78999999999999999999999986432110 000000 0
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.........++..+.+++.+||+.+|++||++.+++..
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11122234466788999999999999999999999865
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=269.14 Aligned_cols=227 Identities=23% Similarity=0.358 Sum_probs=180.6
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+.+..++|+||+
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 34567899999999999752 13577889999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 82 EGGDLYKKINAQRG----VLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 99999998865332 237899999999999999999994 89999999999999999999999999998765443
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
... .....|+..|+|||++.+. ..+.++|+||||+++++|++|+.|+..... ...+.+..
T Consensus 155 ~~~---~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~-------- 214 (256)
T cd08218 155 VEL---ARTCIGTPYYLSPEICENR--PYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKII-------- 214 (256)
T ss_pred hhh---hhhccCCccccCHHHhCCC--CCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHh--------
Confidence 211 1223478899999998764 788999999999999999999999864321 11111111
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+.........+.++.+++.+||+.+|.+||+++||++.
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 215 RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111112233456789999999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=276.69 Aligned_cols=227 Identities=22% Similarity=0.323 Sum_probs=179.5
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.|.+.+.||+|+||.||+++. .+|+.+++.++|+||+++++++..+...++||||++
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 344567899999999999952 234678888999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~L~~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 100 GGSLTDVVTET-------CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 99999998542 27889999999999999999995 899999999999999999999999999987654332
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||......... .... .. .
T Consensus 170 ~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-------~~~~-~~-----~ 231 (297)
T cd06656 170 SK---RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIA-TN-----G 231 (297)
T ss_pred cC---cCcccCCccccCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-------eeec-cC-----C
Confidence 21 1233578899999999774 7889999999999999999999999654321110 0000 00 0
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........+..+.+++.+||+.+|++||+++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 232 TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011123345678899999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=269.39 Aligned_cols=227 Identities=23% Similarity=0.244 Sum_probs=174.5
Q ss_pred HhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeC--CceEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEG--NNRALI 209 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 209 (450)
.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+. ...++|
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 3467899999999999842 1256788899999999999988764 467899
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++++|.+++..... +++....+++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 85 ~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 85 MEHMPGGSIKDQLKSYGA------LTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEecCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccc
Confidence 999999999999875432 7888899999999999999994 8999999999999999999999999999886
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
...............++..|+|||++.+. .++.++||||||+++|||++|+.||...... ..+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~---- 222 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGE--GYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIA---- 222 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCC--CCCcchhHHHHHHHHHHHhhCCCCCCccchH-------HHHHHHh----
Confidence 54322111112334588999999998764 7899999999999999999999998632110 0010000
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........+......+.+++.+|+. +|++||+++|+++.
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 223 ---TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred ---cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111122234556778888899985 99999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=281.09 Aligned_cols=228 Identities=23% Similarity=0.299 Sum_probs=187.9
Q ss_pred HhhHhhhccccccceEEEEEE--------------------------EcchhhhhhhcC-CCceeeeeeEEEeCCceEEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGK--------------------------LLDGLASISRTS-HVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~--------------------------~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 209 (450)
..|++.+.||+|.||.||+++ ..+|+.+|++++ |||||.+++++++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 345667899999999999984 234688999998 99999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC----CCCeEEeecc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ----DFCPKISDFG 285 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~----~~~~kl~DFG 285 (450)
||++.||.|.+.+... .+++.....++.|++.+++||| +.+|+||||||+|+|+.. ++.+|++|||
T Consensus 115 mEL~~GGeLfd~i~~~-------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEecCCchHHHHHHHc-------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999765 1899999999999999999999 499999999999999963 3579999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
++....... .....+||++|+|||++... .++..+||||+||++|.|++|.+||........ ...+
T Consensus 185 la~~~~~~~----~~~~~~Gtp~y~APEvl~~~--~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~--------~~~i 250 (382)
T KOG0032|consen 185 LAKFIKPGE----RLHTIVGTPEYVAPEVLGGR--PYGDEVDVWSIGVILYILLSGVPPFWGETEFEI--------FLAI 250 (382)
T ss_pred CceEccCCc----eEeeecCCccccCchhhcCC--CCCcccchhHHHHHHHHHhhCCCCCcCCChhHH--------HHHH
Confidence 999887622 24567799999999999864 899999999999999999999999986643211 1111
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
....- .-....-..++....+++..|+..||.+|+|+.++++.
T Consensus 251 ~~~~~----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 251 LRGDF----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HcCCC----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11110 11112234557889999999999999999999999984
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=274.34 Aligned_cols=240 Identities=20% Similarity=0.290 Sum_probs=177.8
Q ss_pred hHhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|++.+.||+|+||.||+|+.. +|+.++++++|+||+++++++..+...++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 345678999999999998531 3577888999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|..++.... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~l~~~~~~~~------~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 83 DHTVLNELEKNPR------GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred CccHHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9888877764332 28999999999999999999995 99999999999999999999999999999876543
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh---
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE--- 370 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~--- 370 (450)
... .....++..|+|||++.+. ..++.++||||||+++++|++|+.||.........................
T Consensus 154 ~~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 154 GDD---YTDYVATRWYRAPELLVGD-TQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred ccc---ccCcccccccCCHHHHhCC-CCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 211 1233477899999998653 357889999999999999999999996543211100000000000000000
Q ss_pred ---h----hhcc-----cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 371 ---F----KLLG-----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 371 ---~----~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
. .... .........+..+.+++.+||+.+|++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 0000 000011234577899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=305.07 Aligned_cols=242 Identities=19% Similarity=0.256 Sum_probs=181.9
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.++||+|+||.||+|+. .+|++++++++||||+++++++.+++..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 34567899999999999842 2357788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCC-----CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 213 MPNGSLEKFVYNGDTS-----KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+++++|.+++...... .....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999988642110 111235677889999999999999995 89999999999999999999999999999
Q ss_pred ccccCCCCc---------------cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCC
Q 013074 288 KLCTTKKGI---------------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS 352 (450)
Q Consensus 288 ~~~~~~~~~---------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~ 352 (450)
+........ ........||+.|+|||++.+. .++.++|||||||+++||++|+.||.......
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~--~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV--PASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC--CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 866221100 0011234689999999999774 78999999999999999999999996532110
Q ss_pred CccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcccc
Q 013074 353 SEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-PMNEVIEMLQGSTE 418 (450)
Q Consensus 353 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~ 418 (450)
.... ..... . .........+..+.+++.+|++.||++|| +++++++.|+...+
T Consensus 239 --i~~~----~~i~~------P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 --ISYR----DVILS------P-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred --hhhh----hhccC------h-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 00000 0 00011124556788999999999999996 67778887776544
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=286.47 Aligned_cols=236 Identities=22% Similarity=0.250 Sum_probs=171.3
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC------CceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG------NNRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~------~~~~ 207 (450)
|.+.+.||+|+||.||+++. .+|+.+++.++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 34567899999999999841 1356778889999999999988643 3478
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||++ ++|.+.+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 99 lv~e~~~-~~l~~~~~~--------~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 99 LVMELMD-ANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred EEhhhhc-ccHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence 9999995 467666632 27888999999999999999995 99999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc--------cchhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE--------VYFPH 359 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~ 359 (450)
+....... .....||..|+|||++.+. .++.++|||||||++|+|++|+.||........- ...+.
T Consensus 167 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 167 RTAGTSFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred ccCCCccc----cCCccccCCccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 86543221 2334589999999999774 7899999999999999999999999643211000 00000
Q ss_pred hhhh-------hhhhhhhh---hhc----c----cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 360 WIYR-------HVEQDREF---KLL----G----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 360 ~i~~-------~~~~~~~~---~~~----~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+... ........ ... . ............+.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 00000000 000 0 0000111234578899999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=283.67 Aligned_cols=236 Identities=22% Similarity=0.245 Sum_probs=171.2
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC------CceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG------NNRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~------~~~~ 207 (450)
|.+.+.||+|+||.||++.. .+|+.+++.++||||+++++++... ...+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 44567899999999999842 1356778889999999999987543 3579
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||++ ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 106 lv~e~~~-~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 106 IVMELMD-ANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred EEEeCCC-CCHHHHHHh--------cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 9999995 577776632 27888999999999999999994 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc--------cchhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE--------VYFPH 359 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~ 359 (450)
+....... .....+|..|+|||++.+. .++.++|||||||++|+|++|+.||......... ...+.
T Consensus 174 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (364)
T cd07875 174 RTAGTSFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 247 (364)
T ss_pred cccCCCCc----ccCCcccCCcCCHHHHhCC--CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 86543221 2334589999999999774 7899999999999999999999999654211000 00000
Q ss_pred hhhh-------hhhhhhhh------hh-ccc----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 360 WIYR-------HVEQDREF------KL-LGV----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 360 ~i~~-------~~~~~~~~------~~-~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+... ........ .. ... ..........++.+++.+|++.||.+|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 248 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 00000000 00 000 000011123568899999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=272.52 Aligned_cols=231 Identities=22% Similarity=0.295 Sum_probs=180.3
Q ss_pred hhHhhhccccccceEEEEEEEc-----------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.+.||.|+||.||+++.. .|++++++++|+||+++++++.++...++||||++
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 3567788999999999999632 35788899999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++...+. .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 86 GGALDSIMLELER-----GLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred CCcHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999865432 38999999999999999999995 899999999999999999999999999887654322
Q ss_pred CccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.. .....++..|+|||++... ...++.++|+||||+++|+|++|+.||...... ..+ ........
T Consensus 158 ~~---~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~~~-~~~~~~~~- 225 (280)
T cd06611 158 QK---RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------RVL-LKILKSEP- 225 (280)
T ss_pred cc---cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------HHH-HHHhcCCC-
Confidence 11 1233488999999997532 135678999999999999999999998643211 000 11111000
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.....+...+.++.+++.+||+.+|.+||++.++++.
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ----PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ----CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0011122345678899999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=275.31 Aligned_cols=225 Identities=22% Similarity=0.348 Sum_probs=178.4
Q ss_pred HhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 160 SFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
.+.+.||.|+||.||+|.. .+|++.+++++||||+++++++.++...++|+||++++
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 3457899999999999842 23577888999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|..++... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 102 ~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 102 SLTDVVTET-------CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred cHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999988532 28899999999999999999994 89999999999999999999999999998765443221
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.....++..|+|||.+.+. .++.++|||||||++|+|++|+.||....... . ... ..... ..
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~-~~~-~~~~~-----~~ 233 (296)
T cd06655 172 ---RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------A-LYL-IATNG-----TP 233 (296)
T ss_pred ---CCCcCCCccccCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H-HHH-HHhcC-----Cc
Confidence 1234588899999998764 68899999999999999999999996542110 0 000 00000 00
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.......++..+.+++.+||+.||++||++.+++..
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 111223345678899999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=275.09 Aligned_cols=237 Identities=19% Similarity=0.245 Sum_probs=170.2
Q ss_pred HhhHhhhccccccceEEEEEEEcch-------------------------------------hhhhhhcCCCceeeeeeE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLLDG-------------------------------------LASISRTSHVNVVTLLGF 199 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~~e-------------------------------------~~~l~~l~HpnIv~l~~~ 199 (450)
..+.+.+.||+|+||+||+|+..+. ...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 3455678999999999999974322 012334589999999997
Q ss_pred EEeCC----ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC
Q 013074 200 CLEGN----NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 200 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~ 275 (450)
+.... ..++++|++ ..++.+.+.... ..++..+..++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKL-VENTKEIFKRIK------CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDG 161 (294)
T ss_pred eeEecCCceEEEEEEehh-ccCHHHHHHhhc------cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcC
Confidence 66543 346777776 346666654332 15678889999999999999995 89999999999999999
Q ss_pred CCCeEEeeccccccccCCCCc----cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCC
Q 013074 276 DFCPKISDFGLAKLCTTKKGI----VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN 351 (450)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~ 351 (450)
++.++|+|||+++........ ........||+.|+|||++.+. .++.++|||||||+++||++|+.||......
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~--~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA--CVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 999999999999866432111 0112234699999999999874 7899999999999999999999999755322
Q ss_pred CCccchhh-hhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 352 SSEVYFPH-WIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 352 ~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
........ ...+.+.... ......++.+.+++..|++.+|++||+++++++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 240 GNLIHAAKCDFIKRLHEGK---------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHHHHhHHHHHHHhhhhh---------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 11000000 0001111100 011233577999999999999999999999998873
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=270.56 Aligned_cols=235 Identities=24% Similarity=0.397 Sum_probs=176.5
Q ss_pred hhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCC------ce
Q 013074 161 FKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGN------NR 206 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~------~~ 206 (450)
+.+.||+|+||.||+|.. .+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 457899999999998852 13477888999999999999886542 24
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccc
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGL 286 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 286 (450)
++++||+.+|+|.+++...........+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccc
Confidence 6889999999999887543221112347899999999999999999995 8999999999999999999999999999
Q ss_pred cccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhh
Q 013074 287 AKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 287 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
++.......... .....++..|++||.+... .++.++||||||+++|||++ |+.||..... .. +....
T Consensus 160 ~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~--~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~----~~~~~ 228 (273)
T cd05074 160 SKKIYSGDYYRQ-GCASKLPVKWLALESLADN--VYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SE----IYNYL 228 (273)
T ss_pred cccccCCcceec-CCCccCchhhcCHhHHhcC--ccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HH----HHHHH
Confidence 886643322111 1222356789999998764 78899999999999999998 7777653211 00 11111
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
..... .......+..+.+++.+||+.+|++||++.|+++.|+++
T Consensus 229 ~~~~~-------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGNR-------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCCc-------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11100 011123456899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=278.90 Aligned_cols=235 Identities=20% Similarity=0.287 Sum_probs=179.6
Q ss_pred HHHhhHhhhccccccceEEEEEE------------------------EcchhhhhhhcC-CCceeeeeeEEEeCCceEEE
Q 013074 155 KKITNSFKDKLGQGGFGGVYKGK------------------------LLDGLASISRTS-HVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 155 ~~~~~~~~~~LG~G~fg~Vy~~~------------------------~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV 209 (450)
+.-.|++.++||+||.++||++. +.+|+..|.+|+ |.+|+++++|-..++.+|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 33445667899999999999985 356788888884 89999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||- ..+|..+|....... ..| .++.+..|++.++.+.|+ .+|||.||||.|.|+- .|.+||+|||.|..
T Consensus 439 mE~G-d~DL~kiL~k~~~~~----~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~a 508 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSID----PDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANA 508 (677)
T ss_pred eecc-cccHHHHHHhccCCC----chH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence 9997 569999998765421 334 778899999999999996 9999999999999987 46999999999998
Q ss_pred ccCCCCccccccCCCCccccccccccccccC---------CCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFG---------EVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---------~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 360 (450)
.....+... ....+||..||+||.+..... ..+.+||||||||+||+|+.|+.||..-..
T Consensus 509 I~~DTTsI~-kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n---------- 577 (677)
T KOG0596|consen 509 IQPDTTSIV-KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN---------- 577 (677)
T ss_pred cCcccccee-eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------
Confidence 876544333 456789999999999854311 378899999999999999999999964321
Q ss_pred hhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 361 IYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 361 i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+.++....+.. ..+.........++++++..||+.||.+||++.|+|+.
T Consensus 578 ~~aKl~aI~~P~--~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 578 QIAKLHAITDPN--HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred HHHHHHhhcCCC--ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 111111111110 00011111112339999999999999999999999864
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=283.28 Aligned_cols=234 Identities=21% Similarity=0.281 Sum_probs=172.5
Q ss_pred hhHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC------Cce
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG------NNR 206 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~------~~~ 206 (450)
.|.+.+.||+|+||.||+|.. .+|++++++++||||+++++++... ...
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEV 95 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcE
Confidence 344567899999999999842 1368889999999999999987643 356
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccc
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGL 286 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 286 (450)
++++|++ +++|.+++... .+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||+
T Consensus 96 ~~~~~~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 96 YLVTNLM-GADLNNIVKCQ-------KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred EEEeecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCcc
Confidence 8999998 78998877532 28999999999999999999995 9999999999999999999999999999
Q ss_pred cccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhh-----
Q 013074 287 AKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI----- 361 (450)
Q Consensus 287 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i----- 361 (450)
++..... .....||..|+|||++.+. ..++.++|||||||++|+|++|+.||....... .+..+.
T Consensus 165 ~~~~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~ 234 (343)
T cd07878 165 ARQADDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGT 234 (343)
T ss_pred ceecCCC------cCCccccccccCchHhcCC-ccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCC
Confidence 9865432 2334589999999998763 368899999999999999999999986432110 000000
Q ss_pred -----hhhhhhhhhhhhcc---cccch-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 362 -----YRHVEQDREFKLLG---VVTKK-----ENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 362 -----~~~~~~~~~~~~~~---~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
...+.......... ..... .......+.+++.+|++.||.+|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000 00000 01123457899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=269.23 Aligned_cols=225 Identities=25% Similarity=0.355 Sum_probs=179.8
Q ss_pred hHhhhccccccceEEEEEEEc------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|.+.+.||.|+||.||+|+.. +|+.++++++|+||+++++++.++...++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 456678999999999999632 35677888999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++......
T Consensus 83 ~~~L~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 83 GGSCLDLLKPG-------KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred CCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 99999998643 38999999999999999999994 899999999999999999999999999998765432
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
. ......++..|+|||++.+. .++.++||||||+++|+|++|..||....... ....+.....
T Consensus 153 ~---~~~~~~~~~~y~~PE~~~~~--~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--------~~~~~~~~~~---- 215 (274)
T cd06609 153 S---KRNTFVGTPFWMAPEVIKQS--GYDEKADIWSLGITAIELAKGEPPLSDLHPMR--------VLFLIPKNNP---- 215 (274)
T ss_pred c---ccccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccCchHH--------HHHHhhhcCC----
Confidence 1 12334578899999999874 68999999999999999999999986432110 1111111100
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... ....++..+.+++.+||+.+|++|||++++++.
T Consensus 216 ~~~--~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 216 PSL--EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCC--cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 000 011155678899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=273.29 Aligned_cols=232 Identities=21% Similarity=0.275 Sum_probs=174.5
Q ss_pred HhhhccccccceEEEEEEE----------------------cchhhhhhhc-CCCceeeeeeEEE-----eCCceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL----------------------LDGLASISRT-SHVNVVTLLGFCL-----EGNNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l-~HpnIv~l~~~~~-----~~~~~~lV~E 211 (450)
++.+.||+|+||.||+++. ..|+.+++++ +||||+++++++. .+...++|||
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 100 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLE 100 (286)
T ss_pred eeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEe
Confidence 4567899999999999842 1246677888 6999999999884 3456899999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++...... ...+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||+++...
T Consensus 101 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 101 LCNGGSVTDLVKGFLKR--GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred ecCCCCHHHHHHHhhcc--CccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 99999999987643211 1338889999999999999999994 899999999999999999999999999987664
Q ss_pred CCCCccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
..... .....|+..|+|||++... ...++.++|||||||++|||++|+.|+........ +.. ....
T Consensus 176 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-------~~~-~~~~ 244 (286)
T cd06638 176 STRLR---RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LFK-IPRN 244 (286)
T ss_pred cCCCc---cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-------Hhh-cccc
Confidence 32211 1234588999999998532 13578899999999999999999999865421110 000 0000
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... ..........++.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 245 PPP-----TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCC-----cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 000111234578899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=268.30 Aligned_cols=221 Identities=26% Similarity=0.319 Sum_probs=170.9
Q ss_pred ccccccceEEEEEEEcc--------------------------hh---hhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 164 KLGQGGFGGVYKGKLLD--------------------------GL---ASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 164 ~LG~G~fg~Vy~~~~~~--------------------------e~---~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.||+|+||.||+++..+ +. ..+....||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999985321 01 12233479999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++...+ .+++..+..++.|++.||+||| +.+++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~------~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~ 151 (279)
T cd05633 81 GGDLHYHLSQHG------VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (279)
T ss_pred CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC
Confidence 999999886543 2899999999999999999999 4899999999999999999999999999987554322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.....|+..|+|||.+... ..++.++|||||||++++|++|..||........ ..+.... .
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~--------~ 212 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKG-TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMT--------L 212 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-----HHHHHHh--------h
Confidence 1233589999999998642 3578999999999999999999999965422110 0011100 0
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
......+...+.++.+++.+||+.||.+|| +++|+++.
T Consensus 213 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 001112234567889999999999999999 59999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=268.42 Aligned_cols=232 Identities=22% Similarity=0.351 Sum_probs=178.2
Q ss_pred hhhccccccceEEEEEEE---------------------------------cchhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 161 FKDKLGQGGFGGVYKGKL---------------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~---------------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
..+.||.|+||.||+|.. .+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 356899999999999841 12466788889999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+|+||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred EEEecCCCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999986543 28889999999999999999995 89999999999999999999999999998
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
+......... ......++..|+|||.+......++.++|+||||++++++++|..|+...... .. ..+....
T Consensus 156 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~-~~~~~~~ 227 (272)
T cd06629 156 KKSDDIYDND-QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI------AA-MFKLGNK 227 (272)
T ss_pred cccccccccc-ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH------HH-HHHhhcc
Confidence 7654322111 12234578999999998764224789999999999999999999998533211 00 1110000
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... .........++..+.+++.+||+.+|++||++++|++.
T Consensus 228 ~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAP---PIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCC---cCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0000 00111122356789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=271.43 Aligned_cols=230 Identities=24% Similarity=0.341 Sum_probs=175.3
Q ss_pred hhHhhhccccccceEEEEEEEc----------------------chhhhhhhc-CCCceeeeeeEEEe------CCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRT-SHVNVVTLLGFCLE------GNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l-~HpnIv~l~~~~~~------~~~~~l 208 (450)
.+.+.+.||.|+||.||+|+.. .|+.+++++ +|+||+++++++.. ....++
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 3445678999999999998642 235566676 69999999999853 457899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
+|||+++++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||||+||++++++.++|+|||++.
T Consensus 97 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~ 169 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKG----NALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSA 169 (282)
T ss_pred EEEeCCCCcHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchh
Confidence 9999999999999875432 237888899999999999999994 899999999999999999999999999987
Q ss_pred cccCCCCccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
....... ......|+..|+|||.+... ...++.++||||||+++|||++|+.||........ +. ..
T Consensus 170 ~~~~~~~---~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-------~~-~~ 238 (282)
T cd06636 170 QLDRTVG---RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-------LF-LI 238 (282)
T ss_pred hhhcccc---CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-------hh-hH
Confidence 6543221 12234588999999998631 13578899999999999999999999864321110 00 00
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
. ...........++..+.+++.+||+.||.+||++.|+++
T Consensus 239 ~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 239 P------RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h------hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 001111122345678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=276.15 Aligned_cols=232 Identities=20% Similarity=0.322 Sum_probs=191.0
Q ss_pred hHhhhccccccceEEEEEE-------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGK-------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~-------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.+.||+|.|..|-+++ +.+|++.++-.+|||||++|.+......+|||+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 3456789999999997663 456788999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE-cCCCCeEEeeccccccccC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL-DQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll-~~~~~~kl~DFGla~~~~~ 292 (450)
.+|+|.+|+..+.. .+.+....+++.||+.|+.|+|+ ..+|||||||+||.+ .+-|-|||.|||++..+..
T Consensus 100 D~GDl~DyImKHe~-----Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEE-----GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred CCchHHHHHHhhhc-----cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999976653 28999999999999999999995 999999999999886 4678999999999988766
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
+.. ....||...|-|||.+.+. ....++.|||||||+||.|+.|+.||....+..... .
T Consensus 172 G~k----L~TsCGSLAYSAPEILLGD-sYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT----------------m 230 (864)
T KOG4717|consen 172 GKK----LTTSCGSLAYSAPEILLGD-SYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT----------------M 230 (864)
T ss_pred cch----hhcccchhhccCchhhhcC-ccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh----------------h
Confidence 543 5667899999999999885 345688999999999999999999998664432210 0
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccccc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGSTEA 419 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~~ 419 (450)
+.+-....+..++.+..+++..||+.||++|.+.+||+.. |++.-+.
T Consensus 231 ImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 231 IMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 1111123345678899999999999999999999999864 5554433
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=293.41 Aligned_cols=238 Identities=16% Similarity=0.193 Sum_probs=167.9
Q ss_pred hhHhhhccccccceEEEEEEEc----------------------chhhhhhhcC------CCceeeeeeEEEeC-CceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRTS------HVNVVTLLGFCLEG-NNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l~------HpnIv~l~~~~~~~-~~~~l 208 (450)
.|.+.++||+|+||+||+|+.. .|+.++++++ |.+++++++++..+ ...++
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~i 209 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCI 209 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEE
Confidence 4556778999999999999531 1344455554 44588999988765 57889
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-----------
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF----------- 277 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----------- 277 (450)
|||++ +++|.+++...+ .+++..+..++.|++.||+|||. ..+|+||||||+|||++.++
T Consensus 210 v~~~~-g~~l~~~l~~~~------~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 210 VMPKY-GPCLLDWIMKHG------PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred EEecc-CCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCccccccccccc
Confidence 99998 788998886543 28999999999999999999994 25999999999999998765
Q ss_pred -----CeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCC
Q 013074 278 -----CPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS 352 (450)
Q Consensus 278 -----~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~ 352 (450)
.+||+|||.+...... .....||..|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~------~~~~~gt~~Y~APE~~~~~--~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS------RTAIVSTRHYRSPEVVLGL--GWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred CCCCceEEECCCCccccCccc------cccccCCccccCcHHhhcC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 4999999987543221 2345689999999999874 78999999999999999999999997543211
Q ss_pred Cccc-------hh-hhhhhhhh-hhhh-hh----------------hcccccchhHHHHHHHHHHHHHccccCCCCCCCH
Q 013074 353 SEVY-------FP-HWIYRHVE-QDRE-FK----------------LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM 406 (450)
Q Consensus 353 ~~~~-------~~-~~i~~~~~-~~~~-~~----------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 406 (450)
.... ++ .|...... .... .. ...............+.+++.+||+.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 0000 00 01000000 0000 00 0000000001113457899999999999999999
Q ss_pred HHHHHH
Q 013074 407 NEVIEM 412 (450)
Q Consensus 407 ~evl~~ 412 (450)
+|+++.
T Consensus 433 ~e~L~H 438 (467)
T PTZ00284 433 RQMTTH 438 (467)
T ss_pred HHHhcC
Confidence 999973
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=266.26 Aligned_cols=224 Identities=28% Similarity=0.387 Sum_probs=177.9
Q ss_pred HhhhccccccceEEEEEEEc----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKLL----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
.+.+.||+|+||.||+|... .|++++++++|+||+++++++.++...++++|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 34578999999999998532 24677888999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++....
T Consensus 83 ~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 83 LVPGGSLAKLLKKYG------SFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred ecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999986543 27899999999999999999994 899999999999999999999999999987664
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.... .....++..|++||.+... ..++.++|+||||+++++|++|+.||...... ........
T Consensus 154 ~~~~----~~~~~~~~~y~~pe~~~~~-~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~----- 216 (258)
T cd06632 154 EFSF----AKSFKGSPYWMAPEVIAQQ-GGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGR----- 216 (258)
T ss_pred cccc----ccccCCCcceeCHHHhcCC-CCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHh-----
Confidence 4321 2334588999999998764 23889999999999999999999998654210 01111000
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..........+...+.+++.+||+.+|.+||++.++++
T Consensus 217 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 217 --SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --cccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 00111122234577889999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=266.01 Aligned_cols=226 Identities=23% Similarity=0.400 Sum_probs=178.5
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.+.||+|+||.||++.. .+|++++++++||||+++++.+..++..++|+||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 34567899999999998742 23577889999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC-CCeEEeeccccccccC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD-FCPKISDFGLAKLCTT 292 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~~~ 292 (450)
++++|.+++..... ..+++..+..++.+++.||+|||+ .+++|+||||+||+++++ +.+||+|||.+.....
T Consensus 82 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 82 PGGTLAEYIQKRCN----SLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999976432 238899999999999999999994 899999999999999855 4689999999987654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... .....++..|+|||.+.+. ..+.++||||||+++++|++|+.||..... .....+...
T Consensus 155 ~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-------~~~~~~~~~------ 215 (256)
T cd08220 155 KSK----AYTVVGTPCYISPELCEGK--PYNQKSDIWALGCVLYELASLKRAFEAANL-------PALVLKIMS------ 215 (256)
T ss_pred Ccc----ccccccCCcccCchhccCC--CCCcccchHHHHHHHHHHHhCCCCcccCch-------HHHHHHHHh------
Confidence 321 1234578899999999764 688999999999999999999999864321 111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........+..+.+++.+||+.+|++|||++|++..
T Consensus 216 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 216 --GTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --cCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01111122356778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=273.32 Aligned_cols=236 Identities=24% Similarity=0.306 Sum_probs=177.3
Q ss_pred HhhhccccccceEEEEEEEc----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKLL----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
.+.+.||+|+||.||+|... .|++++++++|+||+++++++.+++..++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 45678999999999998521 25678889999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+ +++|.+++.... ..+++..++.++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 83 ~~-~~~L~~~i~~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 83 FM-ETDLEKVIKDKS-----IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred cc-CCCHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 99 899999986543 138999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh----
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ---- 367 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~---- 367 (450)
..... .....++..|+|||.+.+. ..++.++||||||++++||++|.++|....... .+.+ +......
T Consensus 154 ~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~---~~~~-~~~~~~~~~~~ 225 (298)
T cd07841 154 SPNRK---MTHQVVTRWYRAPELLFGA-RHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID---QLGK-IFEALGTPTEE 225 (298)
T ss_pred CCCcc---ccccccceeeeCHHHHhCC-CCCCcHHHHHHHHHHHHHHHcCCccccCCccHH---HHHH-HHHHcCCCchh
Confidence 43211 1223467889999988653 367899999999999999999977665322110 0000 0000000
Q ss_pred -------hhhhhh-----cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 368 -------DREFKL-----LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 368 -------~~~~~~-----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
...... ...........+..+.+++.+||+.+|++|||+.|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 000000112345788999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=264.14 Aligned_cols=227 Identities=28% Similarity=0.513 Sum_probs=179.0
Q ss_pred hhhccccccceEEEEEEEcc----------------------------hhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 161 FKDKLGQGGFGGVYKGKLLD----------------------------GLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~~----------------------------e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.||+|+||.||+++..+ |++.+.+++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 46789999999999986432 36677888999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++...... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~l~~~~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 83 MEGGDLLDYLRKNRPK----ELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred cCCCCHHHHHHhhhhc----cCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999998754321 18999999999999999999995 8999999999999999999999999999987765
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
...... ....++..|+|||.+.. ..++.++||||||+++++|++ |..|+..... .. +.+......
T Consensus 156 ~~~~~~--~~~~~~~~y~~Pe~~~~--~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~-~~~~~~~~~-- 221 (258)
T smart00219 156 DDYYKK--KGGKLPIRWMAPESLKD--GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EE-VLEYLKKGY-- 221 (258)
T ss_pred cccccc--ccCCCcccccChHHhcc--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HH-HHHHHhcCC--
Confidence 432221 12336789999999865 478999999999999999998 6666653211 00 111111111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 413 (450)
........+.++.+++.+|++.+|++|||+.|+++.|
T Consensus 222 -----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 -----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1111223567899999999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=275.56 Aligned_cols=240 Identities=21% Similarity=0.342 Sum_probs=177.1
Q ss_pred hHhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
+++.++||+|+||.||+|... +|++++++++||||+++++++.++...++|+||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 345678999999999998532 3577888899999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|..+..... .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++......
T Consensus 83 ~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 83 DHTVLDDLEKYPN------GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred CccHHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9988887765432 28999999999999999999995 89999999999999999999999999998865443
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh-------hhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY-------RHVE 366 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~-------~~~~ 366 (450)
... .....++..|+|||++.+. ..++.++||||||++++||++|+.+|................. +...
T Consensus 154 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07846 154 GEV---YTDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229 (286)
T ss_pred ccc---cCcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhc
Confidence 211 2234478899999998653 3578899999999999999999988864321100000000000 0000
Q ss_pred hhhhh---hhccc-----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 367 QDREF---KLLGV-----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 367 ~~~~~---~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..... ..... .......++..+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000 00000 00011234677999999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=285.45 Aligned_cols=219 Identities=29% Similarity=0.402 Sum_probs=180.1
Q ss_pred hccccccceEEEEEE--------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 163 DKLGQGGFGGVYKGK--------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~--------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.||.|+||.||.++ ..+|++.|.+++|||++.+-|++..+...+|||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 579999999999985 235688899999999999999999999999999999 56
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+-.+.+.-.. +++.+..+..|..+.+.||+||| +.+.||||||..|||+++.|.|||+|||.|......
T Consensus 111 SAsDlleVhk-----KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 111 SASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred cHHHHHHHHh-----ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 7777775443 33899999999999999999999 699999999999999999999999999999876543
Q ss_pred cccccCCCCcccccccccccc-ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 297 VSSLLGARGTIGYIALEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
..+.||++|||||++.- ..|.|+-++||||||+...||...++|........ ...++.++....+
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--------ALYHIAQNesPtL-- 245 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESPTL-- 245 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--------HHHHHHhcCCCCC--
Confidence 45669999999999853 23689999999999999999999999987543211 1122222222111
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
...+.+..++.++..||+.-|.+|||.+++++
T Consensus 246 ----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 ----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 13466788999999999999999999988874
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=266.54 Aligned_cols=230 Identities=24% Similarity=0.355 Sum_probs=180.3
Q ss_pred hHhhhccccccceEEEEEEEc------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+++.+.||+|+||.||+++.. +|++.+++++||||+++++.+..+...++++||++
T Consensus 3 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred chHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 356778999999999998532 34667888999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++.... ..+++..+..++.|++.||+|||+ ..+++|+||||+||++++++.++|+|||.+.......
T Consensus 83 ~~~L~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 83 GGSLDKILKEVQ-----GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCcHHHHHHHcc-----CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999987643 238899999999999999999993 2899999999999999999999999999987654322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
. ....++..|+|||.+.+. .++.++||||||+++++|++|+.|+......... ....+.....
T Consensus 156 ~-----~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~-------- 218 (265)
T cd06605 156 A-----KTFVGTSSYMAPERIQGN--DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--IFELLQYIVN-------- 218 (265)
T ss_pred h-----hcccCChhccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccccccc--HHHHHHHHhc--------
Confidence 1 114588899999999774 7899999999999999999999998654321110 0011111100
Q ss_pred ccccchhH-HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKEN-EIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........ ..+.++.+++.+||..||++|||+.++++.
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 219 EPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 00111111 256779999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=283.56 Aligned_cols=228 Identities=21% Similarity=0.322 Sum_probs=182.0
Q ss_pred HhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 160 SFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
++...||.|+||+||++.. .-|+++|+.++||+||++++.+.-++.+++..|||.||
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 4566899999999999852 33588999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
-++..+-..+. .|++.++.-+.+|++.||.||| +.+|||||||..|||++-+|.++|+|||.+........
T Consensus 115 AVDaimlEL~r-----~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q- 185 (1187)
T KOG0579|consen 115 AVDAIMLELGR-----VLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ- 185 (1187)
T ss_pred hHhHHHHHhcc-----ccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhHHh-
Confidence 99988866553 3999999999999999999999 59999999999999999999999999998865433221
Q ss_pred cccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 297 VSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
....+.||++|||||+.... ...|+.++||||||+.|.||.-+.+|-..-.... +.-.+...
T Consensus 186 --kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--------VllKiaKS----- 250 (1187)
T KOG0579|consen 186 --KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--------VLLKIAKS----- 250 (1187)
T ss_pred --hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--------HHHHHhhc-----
Confidence 23456799999999998643 2378999999999999999999888764332111 11111111
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
...-...+...+..+.+++.+||..||..||+++++++
T Consensus 251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11111234556788999999999999999999998874
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=272.82 Aligned_cols=229 Identities=22% Similarity=0.245 Sum_probs=177.3
Q ss_pred HhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 160 SFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.+.+.||+|+||.||+++.. .|++++++++|+||+++++.+.++...++||||+
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence 44678999999999998532 2467888999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
.+++|.+++..... ..+++..+..++.|++.||+||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~L~~~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 84 PGGELFRLLQRQPG----KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred CCCCHHHHHHhCCC----CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999865432 33899999999999999999999 489999999999999999999999999998755322
Q ss_pred CCcc--------------------------ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCC
Q 013074 294 KGIV--------------------------SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS 347 (450)
Q Consensus 294 ~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~ 347 (450)
.... .......|+..|+|||++.+. .++.++||||||+++|+|++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD--GHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC--CCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 1100 001123578899999999774 789999999999999999999999864
Q ss_pred CCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 013074 348 GVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP----MNEVIE 411 (450)
Q Consensus 348 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~ 411 (450)
.... ..+ .+..... .........+..+.+++.+||+.||++||+ ++|++.
T Consensus 235 ~~~~---~~~----~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNRD---ETF----SNILKKE-------VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CchH---HHH----HHHhcCC-------ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 4211 001 1111000 001111225688999999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=272.81 Aligned_cols=233 Identities=19% Similarity=0.234 Sum_probs=178.3
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||.||+++. .+|+.++++++||||+++++.+.+++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 34567899999999998852 1346678889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 83 VEGGDCATLLKNIG------ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred CCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999996543 28899999999999999999995 8999999999999999999999999999874211
Q ss_pred CCCc------------cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhh
Q 013074 293 KKGI------------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 293 ~~~~------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 360 (450)
.... ........++..|+|||.+... .++.++|+||||+++|||++|..||..... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~- 223 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EE- 223 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HH-
Confidence 1000 0001123478899999998764 789999999999999999999999864321 01
Q ss_pred hhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 361 IYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 361 i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
+........ . .........+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 224 ~~~~~~~~~---~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 224 LFGQVISDD---I--EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHHhcc---c--CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111110000 0 0111112356778999999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=266.20 Aligned_cols=232 Identities=22% Similarity=0.369 Sum_probs=180.7
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe--CCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE--GNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E 211 (450)
|++.+.||.|+||.||++.. .+|++++++++|+||+++++++.. +...+++||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred ceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 34567899999999999842 125678889999999999998764 456789999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC--CCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC--STRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|+++++|.+++..... ....+++..++.++.|++.||+|||..+ +.+++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~~~~~L~~~l~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 82 YCEGGDLAQLIQKCKK--ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hccCCCHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999865421 1234899999999999999999999322 38899999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
....... .....++..|+|||.+... .++.++|+||||+++++|++|..|+..... .. +.+....
T Consensus 160 ~~~~~~~---~~~~~~~~~~~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~-~~~~~~~-- 224 (265)
T cd08217 160 LGHDSSF---AKTYVGTPYYMSPEQLNHM--SYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQ-LASKIKE-- 224 (265)
T ss_pred ccCCccc---ccccccCCCccChhhhcCC--CCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HH-HHHHHhc--
Confidence 7544321 1234588999999999774 688999999999999999999999865321 01 1111111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........+..+.+++.+|++.+|++||++.+|++.
T Consensus 225 -----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 -----GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -----CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11112233456789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=265.78 Aligned_cols=229 Identities=24% Similarity=0.408 Sum_probs=178.4
Q ss_pred hhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 161 FKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
..+.||+|+||.||+++. ..|++.+++++|+||+++++++.+.+..++|+|
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e 83 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVE 83 (268)
T ss_pred ccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEe
Confidence 456899999999999841 235778888999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-CeEEeeccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-CPKISDFGLAKLC 290 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~ 290 (450)
|+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .+||+|||++...
T Consensus 84 ~~~~~~L~~~l~~~~------~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 84 WMAGGSVSHLLSKYG------AFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred ccCCCcHHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999986543 28899999999999999999995 8999999999999998776 5999999998776
Q ss_pred cCCCCccc-cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 291 TTKKGIVS-SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 291 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
........ ......++..|+|||.+.+. .++.++|+||+|+++++|++|+.||........ ...+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~---- 224 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGE--QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH----LALIFKIA---- 224 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccC--CCCcccchHHHHHHHHHHHhCCCCCCCCCCcch----HHHHHHHh----
Confidence 54321111 11234578899999998764 778999999999999999999999864322110 01111100
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
........+.....++.+++.+|++.+|.+||++.|+++
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 ---SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 001112233456678999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=270.38 Aligned_cols=238 Identities=23% Similarity=0.332 Sum_probs=183.6
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.+.||+|+||.||++.. .+|+.++++++||||+++++++..++..++|+||++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 345567899999999999852 234677888999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~L~~~~~~~-------~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 100 GGSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCcHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 99999998643 27888999999999999999995 899999999999999999999999999887654332
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .....++..|+|||.+... .++.++|+||||+++|++++|+.||......... .. .....
T Consensus 170 ~~---~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-------~~-~~~~~----- 231 (293)
T cd06647 170 SK---RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YL-IATNG----- 231 (293)
T ss_pred cc---cccccCChhhcCchhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-------ee-hhcCC-----
Confidence 21 1233588899999998764 6889999999999999999999999654321110 00 00000
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccccccCCC
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGSTEALQIP 423 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~~l~~p 423 (450)
.............+.+++.+||+.+|++||++++++.+ ++......++|
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~ 282 (293)
T cd06647 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLT 282 (293)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccccccc
Confidence 00011122345678899999999999999999999976 44444333333
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=273.38 Aligned_cols=222 Identities=24% Similarity=0.336 Sum_probs=175.2
Q ss_pred hccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 219 (450)
.+||+|+||.||+++. .+|+..+..++||||+++++++..++..++|+||+++++|.
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 106 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALT 106 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHH
Confidence 4799999999999852 23567788899999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcccc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 299 (450)
.++... .+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.........
T Consensus 107 ~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--- 173 (297)
T cd06659 107 DIVSQT-------RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--- 173 (297)
T ss_pred HHHhhc-------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc---
Confidence 877432 28899999999999999999994 89999999999999999999999999998755432211
Q ss_pred ccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccc
Q 013074 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379 (450)
Q Consensus 300 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 379 (450)
.....++..|+|||++.+. .++.++||||||++++||++|+.||....... ....+.... .....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~~-----~~~~~ 238 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRT--PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--------AMKRLRDSP-----PPKLK 238 (297)
T ss_pred ccceecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhccC-----CCCcc
Confidence 1234588999999999764 78899999999999999999999986432110 001110000 00001
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 380 KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 380 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........+.+++.+||+.+|++||+++|+++.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 112344668899999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=308.03 Aligned_cols=227 Identities=25% Similarity=0.337 Sum_probs=185.4
Q ss_pred hccccccceEEEEEE-------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 163 DKLGQGGFGGVYKGK-------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~-------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
..||.|.||.||-|. +.+|+.++..++|||+|+.+|+-.+.+..++.||||++|+
T Consensus 1241 ~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred cccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 379999999999983 3467889999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC-Cc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK-GI 296 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~-~~ 296 (450)
|.+.+..++. .++.....+..|++.|+.|||+ .+||||||||.||+|+.+|.+|++|||.|+...... +.
T Consensus 1321 La~ll~~gri------~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1321 LASLLEHGRI------EDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred HHHHHHhcch------hhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 9999976543 5666667778899999999995 999999999999999999999999999998876543 22
Q ss_pred cccccCCCCcccccccccccccc-CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNF-GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
........||+-|||||++.+.. .+...+.||||+|||++||+||+.||......-. |--++.. +
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a-------IMy~V~~-------g 1457 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA-------IMYHVAA-------G 1457 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH-------HHhHHhc-------c
Confidence 33345567999999999998753 3567789999999999999999999975533110 1112222 2
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..+..+..++.+-.+++..||+.||++|-++.|+++.
T Consensus 1458 h~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 HKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred CCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2334445578888999999999999999999888775
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=270.93 Aligned_cols=222 Identities=23% Similarity=0.350 Sum_probs=175.0
Q ss_pred hccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 219 (450)
..||+|+||.||++.. .+|+..+++++|+||+++++.+..++..++||||+++++|.
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALT 107 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHH
Confidence 4699999999999852 23567788899999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcccc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 299 (450)
+++... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++.........
T Consensus 108 ~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--- 174 (292)
T cd06658 108 DIVTHT-------RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--- 174 (292)
T ss_pred HHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc---
Confidence 987532 27889999999999999999994 89999999999999999999999999998765432211
Q ss_pred ccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccc
Q 013074 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379 (450)
Q Consensus 300 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 379 (450)
.....++..|+|||.+.+. .++.++||||||++++||++|+.||....... ....+... . .....
T Consensus 175 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~----~-~~~~~ 239 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--------AMRRIRDN----L-PPRVK 239 (292)
T ss_pred CceeecCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhc----C-CCccc
Confidence 1234578999999998764 78899999999999999999999986432110 00110000 0 00111
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 380 KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 380 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........+.+++.+||+.||.+|||++|+++.
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112345678889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=265.74 Aligned_cols=224 Identities=25% Similarity=0.339 Sum_probs=178.3
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+.+.+.||.|+||.||+|.. .+|+..+++++||||+++++++.++...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 44567899999999999842 134677888999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++... .+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~l~~~i~~~-------~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06641 86 GGSALDLLEPG-------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence 99999988532 27899999999999999999995 999999999999999999999999999987654332
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .....++..|+|||.+... ..+.++|+|||||++++|++|..|+...... .....+...
T Consensus 156 ~~---~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~------ 216 (277)
T cd06641 156 IK---RNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLFLIPKN------ 216 (277)
T ss_pred hh---hccccCCccccChhhhccC--CCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHHHHhcC------
Confidence 11 1234578899999998763 7889999999999999999999998542210 011111110
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........++..+.+++.+||+.+|.+||++.++++.
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 217 -NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -CCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111122345778899999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=270.05 Aligned_cols=220 Identities=24% Similarity=0.297 Sum_probs=177.1
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++.. +|++++++++||||+++++++.++...++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 345678999999999998532 246788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~L~~~~~~~~------~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 83 VPGGELFSHLRKSG------RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred CCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999986653 28899999999999999999995 9999999999999999999999999999887654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
. .....++..|+|||.+.+. ..+.++||||||+++++|++|+.||..... ....+.....
T Consensus 154 ~------~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~---- 213 (290)
T cd05580 154 R------TYTLCGTPEYLAPEIILSK--GYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEG---- 213 (290)
T ss_pred C------CCCCCCCccccChhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcC----
Confidence 3 1234588999999998764 678999999999999999999999864321 0111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIE 411 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 411 (450)
....+......+.+++.+||+.||.+|+ +++|+++
T Consensus 214 ----~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 214 ----KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ----CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0011122357788999999999999999 6677663
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=264.36 Aligned_cols=236 Identities=24% Similarity=0.314 Sum_probs=182.2
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+++.+.||.|+||+||+|.. .+|++.++.++|+||+++++.+..++..++|+|+++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 45677899999999999853 124667888999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++..... ...+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 83 ~~~l~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 83 GGSLLDIMKSSYP---RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred CCcHHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 9999999975432 1238999999999999999999994 999999999999999999999999999988765443
Q ss_pred Ccc-ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 295 GIV-SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 295 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
... .......|+..|+|||++... ...+.++|+||||+++++|++|+.||....... .+ .+..... ....
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~----~~~~~~~-~~~~ 227 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VL----MLTLQND-PPSL 227 (267)
T ss_pred cccccccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCccccChhh---hH----HHHhcCC-CCCc
Confidence 221 112334588999999998764 368899999999999999999999986432211 01 1111100 0000
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
. ........+..+.+++.+||+.||++||++.++++
T Consensus 228 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 E--TGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred C--CccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 00011245678899999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=264.48 Aligned_cols=231 Identities=24% Similarity=0.384 Sum_probs=179.5
Q ss_pred HhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
...+.||+|+||.||+|.. .+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence 4567899999999999952 235778899999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++.... .+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~~------~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 83 GGTLEELLEHGR------ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCcHHHHHhhcC------CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999987543 27888999999999999999994 899999999999999999999999999988765443
Q ss_pred Ccccc-ccCCCCcccccccccccccc-CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 295 GIVSS-LLGARGTIGYIALEVFSRNF-GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 295 ~~~~~-~~~~~gt~~y~aPE~~~~~~-~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
..... .....++..|+|||++.+.. ...+.++||||||++++++++|+.||....... ..... .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------~~~~~-~~~~~--- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------QIMFH-VGAGH--- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------HHHHH-HhcCC---
Confidence 32211 22345788999999997642 237899999999999999999999996432110 00000 00000
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.............+.+++.+||+.+|.+||++.|++.
T Consensus 224 --~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 --KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0001111233567889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=269.01 Aligned_cols=234 Identities=24% Similarity=0.292 Sum_probs=172.0
Q ss_pred hhhccccccceEEEEEEEc------------------------chhhhhhhcC-CCceeeeeeEEEeCCceEEEEEecCC
Q 013074 161 FKDKLGQGGFGGVYKGKLL------------------------DGLASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.++||+|+||.||+++.. +|+..+.++. |+||+++++++..+...+++|||+.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~- 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD- 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence 4568999999999998531 2466677775 9999999999999999999999985
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.++...... .....+++..+..++.|++.||+|||+ ..+++||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~l~~l~~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 ISLDKFYKYVYE-VLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred CCHHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 466554321100 001238999999999999999999995 35899999999999999999999999999876543221
Q ss_pred ccccccCCCCcccccccccccccc-CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNF-GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
. ....|+..|+|||++.+.. ..++.++||||||+++++|++|+.||..... ..+.+.+.......
T Consensus 164 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----------~~~~~~~~~~~~~~ 229 (288)
T cd06616 164 K----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----------VFDQLTQVVKGDPP 229 (288)
T ss_pred c----ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----------HHHHHhhhcCCCCC
Confidence 1 2234788999999987531 2578999999999999999999999864321 01111110000000
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.........++.++.+++.+||+.+|++|||+++|++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111113356789999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=270.30 Aligned_cols=237 Identities=23% Similarity=0.355 Sum_probs=174.3
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|.+.+.||+|+||.||+|+. .+|++++++++|+||+++++++.++...++||||+.
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 34567899999999999852 136788999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++|.+++..... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++......
T Consensus 87 -~~L~~~~~~~~~-----~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 87 -TDLKQYMDDCGG-----GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred -CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 599988865432 38899999999999999999994 899999999999999999999999999987543221
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh---
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF--- 371 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~--- 371 (450)
.. .....++..|+|||++.+. ..++.++||||+|+++|+|++|+.||........ ....+.+.+......
T Consensus 158 ~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 158 KT---YSNEVVTLWYRPPDVLLGS-TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED---QLHKIFRVLGTPTEETWP 230 (291)
T ss_pred cc---ccccccccccCCcHHhhcC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH---HHHHHHHhcCCCChhhhh
Confidence 11 1223467889999998653 3578899999999999999999999864431100 000000000000000
Q ss_pred --------hh--c-----ccccchhHHH--HHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 372 --------KL--L-----GVVTKKENEI--AKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 372 --------~~--~-----~~~~~~~~~~--~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.. . .......... ..++.+++.+||+.+|++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0 0000000011 266788999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=267.45 Aligned_cols=238 Identities=21% Similarity=0.299 Sum_probs=178.8
Q ss_pred hHhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++..+...++|+||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 346678999999999998531 3477888999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
+++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 82 -~~~L~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 82 -PSDLSEVLRDEE-----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred -CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 999999986543 238999999999999999999994 89999999999999999999999999998876543
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh-----
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD----- 368 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~----- 368 (450)
.. .......++..|+|||.+.+. ..++.++||||+|++++||++|.++|...... .....+.......
T Consensus 153 ~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07832 153 EP--RLYSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGENDI----EQLAIVFRTLGTPNEETW 225 (286)
T ss_pred CC--CccccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH----HHHHHHHHHcCCCChHHH
Confidence 21 112234588999999998653 35689999999999999999997776533211 0000111100000
Q ss_pred ------hhh---hhccc----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 369 ------REF---KLLGV----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 369 ------~~~---~~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... ..... ......+....+.+++.+||+.+|++||+++++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 226 PGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 00000 000111335788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=272.19 Aligned_cols=248 Identities=22% Similarity=0.268 Sum_probs=177.7
Q ss_pred hHhhhccccccceEEEEEEEcc----------------------------hhhhhhhcCCCceeeeeeEEEeC--CceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLD----------------------------GLASISRTSHVNVVTLLGFCLEG--NNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~----------------------------e~~~l~~l~HpnIv~l~~~~~~~--~~~~l 208 (450)
|.+.++||+|+||.||+|+... |+.++++++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 3456789999999999986422 56788889999999999999988 78999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC----CCCeEEeec
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ----DFCPKISDF 284 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~----~~~~kl~DF 284 (450)
||||++ ++|.+.+....... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++. ++.+||+||
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQAK-RVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEeCCC-cCHHHHHHhhccCC-CcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 999996 47777664332211 1248999999999999999999994 89999999999999999 999999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc-cchhh----
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE-VYFPH---- 359 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~---- 359 (450)
|++.................++..|+|||++.+. ..++.++||||||+++++|++|+.||......... .....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 9998764433211222344578899999988653 35789999999999999999999999754332200 00000
Q ss_pred hhhhhhhhh--------------hh---hhhccccc--chhH------HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 360 WIYRHVEQD--------------RE---FKLLGVVT--KKEN------EIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 360 ~i~~~~~~~--------------~~---~~~~~~~~--~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+...+... .. ........ .... ....++.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000000000 00 00000000 0000 234578999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=266.82 Aligned_cols=236 Identities=24% Similarity=0.303 Sum_probs=177.7
Q ss_pred HhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeC--CceEEEEEec
Q 013074 160 SFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEG--NNRALIYEFM 213 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E~~ 213 (450)
++.+.||.|++|.||++.. .+|++++++++||||+++++++.+. ...++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 3467899999999999853 2457888999999999999988654 4689999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++..... ....+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 84 EGGSLDSIYKKVKK--RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred CCCCHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 99999988754221 11338889999999999999999995 99999999999999999999999999998755432
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCC-Cccchhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS-SEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~-~~~~~~~~i~~~~~~~~~~~ 372 (450)
.. ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... .......++. ......
T Consensus 159 ~~-----~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~ 227 (287)
T cd06621 159 LA-----GTFTGTSFYMAPERIQGK--PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV----NMPNPE 227 (287)
T ss_pred cc-----ccccCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh----cCCchh
Confidence 21 123478899999998764 78899999999999999999999997553211 0011111111 100011
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... .......+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 228 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 228 LKDE-PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hccC-CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 1100 11112345678999999999999999999999973
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=269.98 Aligned_cols=241 Identities=20% Similarity=0.293 Sum_probs=176.8
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
+++.+.||+|+||.||+|+. .+|++++++++|+||+++++++.+++..++|+||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 45677899999999999853 23577888999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
+++.+..+..... .+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++......
T Consensus 83 ~~~~l~~~~~~~~------~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 83 ERTLLELLEASPG------GLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred CCCHHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 8766665553322 28899999999999999999995 89999999999999999999999999998876544
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh-------hhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY-------RHVE 366 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~-------~~~~ 366 (450)
... ......++..|+|||++.+. ..++.++||||||+++|+|++|+.||................. ....
T Consensus 154 ~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 154 PAS--PLTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ccc--cccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 321 12234578899999998764 3678999999999999999999998864321100000000000 0000
Q ss_pred hhhhh---hhccccc------chhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 367 QDREF---KLLGVVT------KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 367 ~~~~~---~~~~~~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..... ....... .....++.++.+++.+||+.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 0000000 011123678999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=268.46 Aligned_cols=241 Identities=21% Similarity=0.306 Sum_probs=175.9
Q ss_pred HhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+..+.||.|+||.||+|+. .+|++++++++||||+++++++.++...++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 3457899999999999852 236788999999999999999999999999999995
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.......
T Consensus 83 -~~l~~~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 83 -QDLKKFMDASPL----SGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred -cCHHHHHHhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 689888865432 238999999999999999999995 899999999999999999999999999987654322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchh-------hhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP-------HWIYRHVEQ 367 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~-------~~i~~~~~~ 367 (450)
.. .....++..|+|||++.+. ..++.++||||||+++|||++|+.||............. ...+.....
T Consensus 155 ~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 155 RT---YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred cc---cccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence 11 1223467899999988764 346889999999999999999999986432111000000 000000000
Q ss_pred hhhh--hhcc----cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 368 DREF--KLLG----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 368 ~~~~--~~~~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... .... ...........++.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000 0000 0000011234667899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=265.79 Aligned_cols=233 Identities=26% Similarity=0.352 Sum_probs=177.6
Q ss_pred hhHhhhccccccceEEEEEEEc----------------------chhhhhhhc-CCCceeeeeeEEEeCC------ceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRT-SHVNVVTLLGFCLEGN------NRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l-~HpnIv~l~~~~~~~~------~~~l 208 (450)
.|.+.+.||+|+||.||+|+.. +|+.+++++ .|+||+++++++.+.. ..++
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~l 86 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWL 86 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEE
Confidence 3456788999999999999642 356778888 7999999999997654 4899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
||||+++++|.+++...... ...+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+|||++.
T Consensus 87 v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 87 VMELCGGGSVTDLVKGLRKK--GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEcCCCCcHHHHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999988653311 133899999999999999999999 4899999999999999999999999999987
Q ss_pred cccCCCCccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
........ .....++..|+|||++... ...++.++||||||+++++|++|..||....... .+.+ .
T Consensus 162 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~-~ 230 (275)
T cd06608 162 QLDSTLGR---RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-------ALFK-I 230 (275)
T ss_pred ecccchhh---hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-------HHHH-h
Confidence 65432211 2334588999999998542 1356789999999999999999999996432110 0011 0
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.... ..........+.++.+++.+||+.||++|||++++++
T Consensus 231 ~~~~-----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNP-----PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccC-----CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000 0011112335678999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=265.55 Aligned_cols=226 Identities=23% Similarity=0.357 Sum_probs=176.4
Q ss_pred hHhhhccccccceEEEEEEEc------------------------chhhhhhhcC---CCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL------------------------DGLASISRTS---HVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E 211 (450)
|.+.+.||+|+||.||+|+.. +|+.++++++ |||++++++++.++...++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 345678999999999998631 2355667775 9999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++... .+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++....
T Consensus 83 ~~~~~~L~~~~~~~-------~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 83 YAEGGSVRTLMKAG-------PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred cCCCCcHHHHHHcc-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 99999999988543 28899999999999999999995 899999999999999999999999999988765
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
..... .....|+..|+|||.+.+. ..++.++|+||||+++|+|++|..||....... ... ......
T Consensus 153 ~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-------~~~-~~~~~~-- 218 (277)
T cd06917 153 QNSSK---RSTFVGTPYWMAPEVITEG-KYYDTKADIWSLGITIYEMATGNPPYSDVDAFR-------AMM-LIPKSK-- 218 (277)
T ss_pred CCccc---cccccCCcceeCHHHhccC-CccccchhHHHHHHHHHHHHhCCCCCCCCChhh-------hhh-ccccCC--
Confidence 43321 2234588899999998653 356889999999999999999999986432111 010 000000
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... . .....+.++.+++.+||+.||++||++.|+++.
T Consensus 219 -~~~-~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 -PPR-L--EDNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred -CCC-C--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 000 0 011245678999999999999999999999863
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=268.20 Aligned_cols=224 Identities=29% Similarity=0.374 Sum_probs=175.1
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.++||+|+||.||+|+. .+|++++++++||||+++.+++.++...++|+||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 45567899999999999852 1346678889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+. |+|.+.+.... ..+++..+..++.|++.||.||| +.+++|+||+|+||++++++.++|+|||++.....
T Consensus 97 ~~-g~l~~~~~~~~-----~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 97 CL-GSASDILEVHK-----KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred hC-CCHHHHHHHcc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 95 67777765432 23899999999999999999999 48999999999999999999999999999876543
Q ss_pred CCCccccccCCCCcccccccccccc-ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
. ....++..|+|||++.+ ..+.++.++||||||+++|||++|..|+....... .... ....
T Consensus 168 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~-------~~~~-~~~~--- 229 (307)
T cd06607 168 A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYH-IAQN--- 229 (307)
T ss_pred C-------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH-------HHHH-HhcC---
Confidence 2 22347889999998753 12468899999999999999999999986432100 0000 0000
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........+..+.+++.+||+.+|++||++.+++..
T Consensus 230 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 230 ---DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00111123356789999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=277.46 Aligned_cols=244 Identities=21% Similarity=0.276 Sum_probs=177.6
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCC-----ceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGN-----NRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV 209 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++|+||+++++++.... ..++|
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 44567899999999999842 12577888999999999999876543 57999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+||+. ++|.+.+... .+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 87 ~e~~~-~~l~~~~~~~-------~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 87 QELME-TDLYKLIKTQ-------HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred ehhcc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceee
Confidence 99995 5887777432 28999999999999999999994 8999999999999999999999999999886
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh-
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD- 368 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~- 368 (450)
...............|+..|+|||.+.+. ..++.++||||||+++++|++|+.||....... ....+...+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~----~~~~~~~~~~~~~ 230 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH----QLNLILGVLGTPS 230 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCC
Confidence 64433222222334688999999987553 367899999999999999999999996432100 000000000000
Q ss_pred -----------hhhhh---c-c-cc--cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcccc
Q 013074 369 -----------REFKL---L-G-VV--TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGSTE 418 (450)
Q Consensus 369 -----------~~~~~---~-~-~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~ 418 (450)
..... . . .. .......+.++.+++.+||+.+|++|||+.|+++. ++....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00000 0 0 00 00012235678999999999999999999999987 665443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=263.95 Aligned_cols=226 Identities=22% Similarity=0.411 Sum_probs=178.2
Q ss_pred HhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.||+|+||.||++.. .+|+.++++++|+||+++++.+.++...++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 4567899999999999853 135677889999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-CeEEeeccccccccCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-CPKISDFGLAKLCTTK 293 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~ 293 (450)
+++|.+++..... ..+++..+..++.|++.||.|||. .+++|+||||+||++++++ .+||+|||.+......
T Consensus 83 ~~~L~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 83 GGDLMKRINRQRG----VLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999865432 237999999999999999999994 8999999999999999875 5699999998766443
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
... .....|+..|+|||++... .++.++|+||||++++||++|..|+.... ..+++.+...
T Consensus 156 ~~~---~~~~~~~~~~~ape~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~------- 216 (257)
T cd08225 156 MEL---AYTCVGTPYYLSPEICQNR--PYNNKTDIWSLGCVLYELCTLKHPFEGNN-------LHQLVLKICQ------- 216 (257)
T ss_pred ccc---ccccCCCccccCHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHhc-------
Confidence 211 1223488899999998764 78899999999999999999999985431 1111111111
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........+..+.+++.+||+.+|++|||+.|+++.
T Consensus 217 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 217 -GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -ccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 01111122345679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=268.21 Aligned_cols=237 Identities=19% Similarity=0.255 Sum_probs=177.0
Q ss_pred hhHhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeC--CceEEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEG--NNRALIY 210 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~ 210 (450)
.+.+.+.||+|+||.||+|+.. +|+.++.+++||||+++++++... ...++|+
T Consensus 6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 3456788999999999998532 357788899999999999999887 8899999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+. ++|.+++..... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++...
T Consensus 86 e~~~-~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 86 EYVE-HDLKSLMETMKQ-----PFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred hhcC-cCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 9996 599888865432 38999999999999999999995 89999999999999999999999999998876
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh-----
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV----- 365 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~----- 365 (450)
...... .....++..|+|||.+.+. ...+.++|+||||+++++|++|+.||........ +.+ +....
T Consensus 157 ~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~---~~~-~~~~~~~~~~ 228 (293)
T cd07843 157 GSPLKP---YTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ---LNK-IFKLLGTPTE 228 (293)
T ss_pred cCCccc---cccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH---HHH-HHHHhCCCch
Confidence 543211 1233478899999998764 3468899999999999999999999864422110 000 00000
Q ss_pred ---------hhhhhhh----hcccccchhHH--HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 366 ---------EQDREFK----LLGVVTKKENE--IAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 366 ---------~~~~~~~----~~~~~~~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
....... ........... ....+.+++.+||+.+|++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000 00000000011 3567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=268.13 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=187.4
Q ss_pred hhhccccccceEEEEEEEcchh--------------------hhhhhcCCCceeeeeeEEEeCC----ceEEEEEecCCC
Q 013074 161 FKDKLGQGGFGGVYKGKLLDGL--------------------ASISRTSHVNVVTLLGFCLEGN----NRALIYEFMPNG 216 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~~e~--------------------~~l~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~~g 216 (450)
+.+.+|+|.||+||+|++.++. -.+-.++|+||++++++-..+. .+.||+||.+.|
T Consensus 214 l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kG 293 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKG 293 (534)
T ss_pred hHHHhhcCccceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCC
Confidence 4678999999999999876542 2233568999999999876655 789999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhc------CCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHR------GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~------~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
+|.++|..+. ++|....+++..+++||+|||+ +....|+|||||.+|||+..|++..|+|||+|..+
T Consensus 294 sL~dyL~~nt-------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 294 SLCDYLKANT-------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred cHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 9999998654 8999999999999999999997 33458999999999999999999999999999887
Q ss_pred cCCCCccccccCCCCccccccccccccccC----CCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFG----EVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE 366 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~ 366 (450)
........ ..+..||.+|||||++.+... ..-.+.||||+|.|||||++.-..++.+....-+..|...+..+-.
T Consensus 367 ~p~~~~~d-~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt 445 (534)
T KOG3653|consen 367 EPGKPQGD-THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT 445 (534)
T ss_pred cCCCCCcc-hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence 65443322 344789999999999987521 1224789999999999999887766543333333334333222211
Q ss_pred hhh----------hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 367 QDR----------EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 367 ~~~----------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
-.. ...+..... ......-+.+.+..||..||+.|.|+.=|-+++..+...
T Consensus 446 ~e~mq~~VV~kK~RP~~p~~W~--~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 446 LEEMQELVVRKKQRPKIPDAWR--KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HHHHHHHHHhhccCCCChhhhh--cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 111 111111111 113456788999999999999999999888888776654
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=266.44 Aligned_cols=232 Identities=23% Similarity=0.287 Sum_probs=173.8
Q ss_pred HhhhccccccceEEEEEEEc----------------------chhhhhhhc-CCCceeeeeeEEEeC-----CceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKLL----------------------DGLASISRT-SHVNVVTLLGFCLEG-----NNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l-~HpnIv~l~~~~~~~-----~~~~lV~E 211 (450)
.+.+.||+|+||.||+++.. +|+.++.++ +|||++++++++... ...++|+|
T Consensus 25 ~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~e 104 (291)
T cd06639 25 EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLE 104 (291)
T ss_pred EEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEE
Confidence 34568999999999998531 246667777 799999999998754 35899999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++..... ....+++..++.++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++....
T Consensus 105 y~~~~sL~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~ 179 (291)
T cd06639 105 LCNGGSVTELVKGLLI--CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 179 (291)
T ss_pred ECCCCcHHHHHHHhhh--cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhcc
Confidence 9999999998864221 11338999999999999999999995 899999999999999999999999999988654
Q ss_pred CCCCccccccCCCCcccccccccccccc---CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNF---GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
..... .....++..|+|||.+.... ..++.++|||||||++|||++|+.||....... .+.+ ....
T Consensus 180 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-------~~~~-~~~~ 248 (291)
T cd06639 180 STRLR---RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-------TLFK-IPRN 248 (291)
T ss_pred ccccc---ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-------HHHH-HhcC
Confidence 32211 12235788999999986431 136899999999999999999999986432110 0000 0000
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.. ............+.+++.+||+.+|++||++.|+++.
T Consensus 249 ~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 249 PP-----PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CC-----CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 0001122344678999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=265.87 Aligned_cols=234 Identities=21% Similarity=0.277 Sum_probs=173.6
Q ss_pred HhhhccccccceEEEEEEEc------------------------chhhhhhhcC-CCceeeeeeEEEeC--CceEEEEEe
Q 013074 160 SFKDKLGQGGFGGVYKGKLL------------------------DGLASISRTS-HVNVVTLLGFCLEG--NNRALIYEF 212 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~E~ 212 (450)
.+.++||+|+||.||+|+.. +|+..+.++. |+||+++++++.++ +..++|+||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 35678999999999999521 2455667775 99999999999987 889999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
++ ++|.+++.... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++. +.+||+|||+++....
T Consensus 82 ~~-~~l~~~l~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 82 MD-MNLYELIKGRK-----RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred CC-ccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 96 58888876533 238999999999999999999995 89999999999999999 9999999999986644
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh---------
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR--------- 363 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~--------- 363 (450)
.... ....++..|+|||++... +.++.++|||||||++|||++|..||....... ....+..
T Consensus 152 ~~~~----~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~ 222 (282)
T cd07831 152 KPPY----TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD----QIAKIHDVLGTPDAEV 222 (282)
T ss_pred CCCc----CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH----HHHHHHHHcCCCCHHH
Confidence 3221 223478899999987543 357889999999999999999999986432110 0001100
Q ss_pred --hhhhhhhh--hhcc----cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 364 --HVEQDREF--KLLG----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 364 --~~~~~~~~--~~~~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........ .... .........+..+.+++.+||+.+|++||+++++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 223 LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000 0000 0001112456889999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=265.05 Aligned_cols=224 Identities=25% Similarity=0.263 Sum_probs=179.7
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||.|+||.||+++. .+|++++++++||||+++++.+.++...++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 34567899999999999953 2246778899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+.+++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 82 ~~~~~L~~~l~~~~------~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 82 LLGGDLRYHLSQKV------KFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999986542 28899999999999999999995 8999999999999999999999999999887654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... .....|+..|+|||.+... ..+.++|+||||+++|+|++|..|+....... ..+.......
T Consensus 153 ~~~----~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~----- 216 (258)
T cd05578 153 DTL----TTSTSGTPGYMAPEVLCRQ--GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI-----RDQIRAKQET----- 216 (258)
T ss_pred Ccc----ccccCCChhhcCHHHHccc--CCCCcccchhhHHHHHHHHhCCCCCCCCCccH-----HHHHHHHhcc-----
Confidence 321 2334588899999999775 68999999999999999999999987553221 1111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM--NEVI 410 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl 410 (450)
.....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 217 ---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ---ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ---ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112223455889999999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=262.90 Aligned_cols=221 Identities=25% Similarity=0.303 Sum_probs=171.1
Q ss_pred ccccccceEEEEEEEcc--------------------------h---hhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 164 KLGQGGFGGVYKGKLLD--------------------------G---LASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 164 ~LG~G~fg~Vy~~~~~~--------------------------e---~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.||+|+||.||+++..+ + .+.++...||||+++++++.+++..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 38999999999885311 0 122334579999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|..++...+ .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~~------~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~ 151 (278)
T cd05606 81 GGDLHYHLSQHG------VFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151 (278)
T ss_pred CCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC
Confidence 999998886433 38999999999999999999995 899999999999999999999999999987554322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.....|+..|+|||.+.+. ..++.++||||+|++++||++|+.||......... ...+...
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~-------- 212 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-----EIDRMTL-------- 212 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCC-CCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH-----HHHHHhh--------
Confidence 1234589999999998753 25789999999999999999999999754221110 0000000
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
......+...+.++.+++.+|++.+|.+|| ++.|+++.
T Consensus 213 ~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 213 TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred ccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 000111122457899999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=264.62 Aligned_cols=231 Identities=24% Similarity=0.332 Sum_probs=173.2
Q ss_pred hHhhhccccccceEEEEEEEcc------------------------hhh-hhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLD------------------------GLA-SISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~------------------------e~~-~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
+.+.+.||+|+||.||+++... |+. .++.++||||+++++++..+...++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 3456789999999999986321 122 245568999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
+ ++|.+++...... ...+++..++.++.|++.||+|||+ ..+++|+||||+||+++.++.+||+|||++......
T Consensus 83 ~-~~l~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~--~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 83 D-TSLDKFYKKVYDK--GLTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred c-ccHHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhh--cCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 5 7888887653221 1348999999999999999999995 238999999999999999999999999998865432
Q ss_pred CCccccccCCCCccccccccccccc--cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRN--FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.. .....++..|+|||.+.+. ...++.++|+||||+++|+|++|+.||...... +.. +..... .
T Consensus 158 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~-~~~~~~-~--- 223 (283)
T cd06617 158 VA----KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----FQQ-LKQVVE-E--- 223 (283)
T ss_pred cc----cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----HHH-HHHHHh-c---
Confidence 21 1223478899999988652 125688999999999999999999998642211 000 001000 0
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.........++.++.+++.+||+.+|++||+++++++
T Consensus 224 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 ---PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000111235678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=267.84 Aligned_cols=229 Identities=28% Similarity=0.361 Sum_probs=177.6
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+...+.||+|+||.||+++.. +|++++++++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 455678999999999998521 246778889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+. |+|.+.+.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 107 CL-GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 96 58877775432 238999999999999999999994 8999999999999999999999999999875433
Q ss_pred CCCccccccCCCCcccccccccccc-ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
. ....++..|+|||++.. ..+.++.++|||||||+++||++|+.||...... ..... ....
T Consensus 178 ~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~-~~~~--- 239 (317)
T cd06635 178 A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYH-IAQN--- 239 (317)
T ss_pred c-------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-------HHHHH-HHhc---
Confidence 2 23357889999999753 1246889999999999999999999998643110 00111 1000
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
..........+..+.+++.+||+.+|.+||++.++++.+--..
T Consensus 240 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 240 ---ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred ---cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0011112234567899999999999999999999998755433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=263.97 Aligned_cols=222 Identities=26% Similarity=0.349 Sum_probs=173.8
Q ss_pred cccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 165 LGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 165 LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
||+|+||+||++.. ..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999842 2357788999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
.+++..... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--- 150 (277)
T cd05577 81 KYHIYNVGE----PGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--- 150 (277)
T ss_pred HHHHHHcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---
Confidence 999876542 238999999999999999999995 8999999999999999999999999999876543211
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....++..|+|||.+.+. .++.++||||||+++++|++|+.||......... ..+.+... ....
T Consensus 151 -~~~~~~~~~y~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~--------~~~~ 215 (277)
T cd05577 151 -IKGRAGTPGYMAPEVLQGE--VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK----EELKRRTL--------EMAV 215 (277)
T ss_pred -cccccCCCCcCCHHHhcCC--CCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH----HHHHhccc--------cccc
Confidence 1233478899999998764 6889999999999999999999998654321110 00111100 0011
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIE 411 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 411 (450)
......+..+.+++.+||+.||.+|| ++.++++
T Consensus 216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 11223467789999999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=266.94 Aligned_cols=220 Identities=26% Similarity=0.356 Sum_probs=181.0
Q ss_pred hhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 162 KDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
-+.||+||||.||-.+. .+|-.+|++.+.+.||.+--.+++.+.+|+|+..|.|
T Consensus 190 ~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNG 269 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNG 269 (591)
T ss_pred eEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecC
Confidence 35899999999998753 3456788889999999998889999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.-+|.+.+.. .+++..+..++.+|+.||++||+ .+||.||+||+|||+|+.|+++|+|+|||..+..+..
T Consensus 270 GDLkfHiyn~g~~----gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~ 342 (591)
T KOG0986|consen 270 GDLKFHIYNHGNP----GFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP 342 (591)
T ss_pred CceeEEeeccCCC----CCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence 9999999887752 29999999999999999999995 9999999999999999999999999999999887654
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. ....||.+|||||++.+. .|+...|.|||||++|||+.|+.||....+... .+.+. .....
T Consensus 343 ~----~~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk--------~eEvd----rr~~~ 404 (591)
T KOG0986|consen 343 I----RGRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK--------REEVD----RRTLE 404 (591)
T ss_pred c----ccccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhhhhhh--------HHHHH----HHHhc
Confidence 3 344699999999999885 799999999999999999999999975533211 01111 11111
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPM 406 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~ 406 (450)
.........+++..++....|+.||.+|...
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1122335677888889999999999999754
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=260.67 Aligned_cols=227 Identities=26% Similarity=0.346 Sum_probs=181.5
Q ss_pred HhhhccccccceEEEEEEEc------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 160 SFKDKLGQGGFGGVYKGKLL------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
++.+.||+|++|.||+++.. +|++.+++++|+||+++++++..+...++|+||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 45678999999999999532 236778889999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCC-CceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS-TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~-~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++|.+++.... .+++..++.++.|++.||+||| . .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~L~~~l~~~~------~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 84 GSLADLLKKVG------KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999997542 2899999999999999999999 6 899999999999999999999999999988765433
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
... ....++..|+|||.+... .++.++|+||||+++|+|++|+.|+...... .+.+.... +..
T Consensus 155 ~~~---~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~-~~~------- 217 (264)
T cd06623 155 DQC---NTFVGTVTYMSPERIQGE--SYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFELMQA-ICD------- 217 (264)
T ss_pred Ccc---cceeecccccCHhhhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHHHHHH-Hhc-------
Confidence 221 233478899999998764 7889999999999999999999998655321 11111111 100
Q ss_pred ccccchhHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENE-IAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
......... .+..+.+++.+||+.+|++||++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 218 GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011111222 56789999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=281.33 Aligned_cols=227 Identities=24% Similarity=0.405 Sum_probs=186.5
Q ss_pred hhhccccccceEEEEEE---------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 161 FKDKLGQGGFGGVYKGK---------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~---------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
+.++||+|.||.|++|. |+.|+.++.+++|||+++|||+..+ ....+|+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 35789999999999984 3567889999999999999999887 7789999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
+.|+|.+.|+.... ..|....+..++.|||.||.||. +++.|||||...|+|+.....|||+||||.+.+...
T Consensus 193 plGSLldrLrka~~----~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKK----AILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred ccchHHHHHhhccc----cceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 99999999987221 33888899999999999999999 699999999999999999999999999999988776
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
+.+........-...|.|||.+... .++.+||||+|||.+|||++ |+.||...... .|.+.++
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~--kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------qIL~~iD------ 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHR--KFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------QILKNID------ 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccc--cccccchhhhhhhhHHhhhccCCCCCCCCCHH--------HHHHhcc------
Confidence 6554322223345789999999874 89999999999999999996 55666543211 1222222
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+.+...+..+++++.+++..||..+|++|||+..+.+.
T Consensus 330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~ 368 (1039)
T KOG0199|consen 330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED 368 (1039)
T ss_pred -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence 233445667789999999999999999999999999744
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=260.27 Aligned_cols=220 Identities=21% Similarity=0.278 Sum_probs=174.6
Q ss_pred cccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 165 LGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 165 LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
||.|+||.||+++.. +|+.++++++||||+++++.+.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999632 246778889999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
.+++..... +++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~------l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~--- 148 (262)
T cd05572 81 WTILRDRGL------FDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--- 148 (262)
T ss_pred HHHHhhcCC------CCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccc---
Confidence 999965432 8889999999999999999994 9999999999999999999999999999987654321
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....++..|++||.+.+. .++.++|+||||+++|+|++|..||....... .... ...... ....
T Consensus 149 -~~~~~~~~~~~~PE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~------~~~~ 213 (262)
T cd05572 149 -TWTFCGTPEYVAPEIILNK--GYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----MEIY-NDILKG------NGKL 213 (262)
T ss_pred -cccccCCcCccChhHhcCC--CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-----HHHH-HHHhcc------CCCC
Confidence 1233578899999998764 78999999999999999999999997553211 1111 111100 0011
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIE 411 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 411 (450)
..+...+.++.+++.+||+.+|++||+ ++|+++
T Consensus 214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 112223678999999999999999999 666665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=259.31 Aligned_cols=222 Identities=21% Similarity=0.255 Sum_probs=171.4
Q ss_pred hccccccceEEEEEEEcc--------------------------hh-hhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKLLD--------------------------GL-ASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~--------------------------e~-~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.||+|+||.||+|+... |. ......+|+||+++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 469999999999985311 01 122344899999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 150 (260)
T cd05611 82 GDCASLIKTLG------GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-- 150 (260)
T ss_pred CCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceecccc--
Confidence 99999986543 27889999999999999999994 89999999999999999999999999998754331
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
....++..|+|||.+.+. .++.++||||||+++++|++|..||...... . ......... ..
T Consensus 151 -----~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~-~~~~~~~~~----~~ 211 (260)
T cd05611 151 -----KKFVGTPDYLAPETILGV--GDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------A-VFDNILSRR----IN 211 (260)
T ss_pred -----ccCCCCcCccChhhhcCC--CCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------H-HHHHHHhcc----cC
Confidence 223478899999999875 5889999999999999999999999643210 0 111111100 00
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
........++..+.+++.+||+.+|++||++.++.+.|+
T Consensus 212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 011111235678999999999999999998876666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=266.95 Aligned_cols=240 Identities=22% Similarity=0.329 Sum_probs=175.9
Q ss_pred HhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
++.+.||.|++|.||+|+. .+|++.+++++|||++++++++.++...+++|||+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~- 80 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL- 80 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc-
Confidence 3467899999999999852 23678889999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++..... ..+++..++.++.|++.||+|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~~~----~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 DLDLKKYMDSSPL----TGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred CcCHHHHHhhCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 5689998865442 238999999999999999999995 899999999999999999999999999987653321
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchh-------hhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP-------HWIYRHVEQ 367 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~-------~~i~~~~~~ 367 (450)
.. .....++..|+|||++.+. ..++.++||||||+++|+|++|+.||............. ...+.....
T Consensus 154 ~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 154 RT---YTHEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred cc---cCccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 11 1223468899999988653 357889999999999999999999986432110000000 000000000
Q ss_pred hhhhh--hc----ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 368 DREFK--LL----GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 368 ~~~~~--~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..... .. ..........+..+.+++.+|++.+|++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 00 0000111223467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=264.91 Aligned_cols=238 Identities=22% Similarity=0.313 Sum_probs=177.4
Q ss_pred HhhhccccccceEEEEEEEc------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 160 SFKDKLGQGGFGGVYKGKLL------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
++.++||.|++|.||+|+.. +|++++++++|+||+++++++.+++..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 81 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD- 81 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-
Confidence 45678999999999998631 35788899999999999999999999999999997
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++...... ..+++..+..++.|++.||+|||+ .+++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~l~~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 82 KDLKKYMDTHGVR---GALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred ccHHHHHHhcCCC---CCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 5888888654421 238999999999999999999994 8999999999999999999999999999876543221
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhh----------hhhh
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI----------YRHV 365 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i----------~~~~ 365 (450)
. .....++..|++||.+.+. ..++.++||||||+++++|++|+.||....... ...... ++.+
T Consensus 156 ~---~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07836 156 T---FSNEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED---QLLKIFRIMGTPTESTWPGI 228 (284)
T ss_pred c---cccccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhHHHH
Confidence 1 1233478899999998653 357889999999999999999999986543211 000000 0000
Q ss_pred hhhhhhhh--cc----cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 366 EQDREFKL--LG----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 366 ~~~~~~~~--~~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
........ .. .........+..+.+++.+|++.||.+||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 229 SQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 00 000011234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=262.76 Aligned_cols=222 Identities=23% Similarity=0.334 Sum_probs=175.8
Q ss_pred hccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 219 (450)
+.||+|++|.||++.. .+|+.++++++||||+++++++..++..++|+||+++++|.
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~ 104 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT 104 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence 5899999999999852 23577788899999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcccc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 299 (450)
+++... .+++..+..++.|++.||+|||+ .+++||||+|+||+++.++.++|+|||.+.........
T Consensus 105 ~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--- 171 (285)
T cd06648 105 DIVTHT-------RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--- 171 (285)
T ss_pred HHHHhC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc---
Confidence 998652 17889999999999999999994 89999999999999999999999999988755432211
Q ss_pred ccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccc
Q 013074 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379 (450)
Q Consensus 300 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 379 (450)
.....|+..|+|||.+.+. .++.++||||||+++++|++|+.||...... . ......... .....
T Consensus 172 ~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~-------~-~~~~~~~~~-----~~~~~ 236 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRL--PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-------Q-AMKRIRDNL-----PPKLK 236 (285)
T ss_pred cccccCCccccCHHHhcCC--CCCCcccHHHHHHHHHHHHhCCCCCcCCCHH-------H-HHHHHHhcC-----CCCCc
Confidence 1234588999999998764 6889999999999999999999998643210 0 011111110 00011
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 380 KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 380 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
....++..+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 112245689999999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=259.17 Aligned_cols=227 Identities=22% Similarity=0.237 Sum_probs=175.6
Q ss_pred hHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeC--CceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEG--NNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~l 208 (450)
+.+.+.||+|+||.||+|+. .+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 34567899999999999852 1246788899999999999998764 45789
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
++||+++++|.+++..... +++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++
T Consensus 84 v~e~~~~~~L~~~~~~~~~------l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYGA------LTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEeCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 9999999999999865432 7888999999999999999994 899999999999999999999999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
................++..|+|||++.+. ..+.++|+||||+++++|++|+.||...... ..+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~--- 222 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGE--GYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIA--- 222 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCC--CCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHHHHH---
Confidence 654321111112234588999999999774 6889999999999999999999998643110 0011100
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
........+....+.+.+++.+|++ +|..||++.+++.
T Consensus 223 ----~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 ----TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ----cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111122344566789999999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=268.68 Aligned_cols=241 Identities=22% Similarity=0.273 Sum_probs=176.5
Q ss_pred HhhHhhhccccccceEEEEEEEc-------------------------chhhhhhhc-CCCceeeeeeEEEeC--CceEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRT-SHVNVVTLLGFCLEG--NNRAL 208 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l-~HpnIv~l~~~~~~~--~~~~l 208 (450)
..+.+.+.||+|+||.||+|... .|+.+++++ +||||+++++++... ...++
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 34567789999999999998521 257788899 999999999998654 36899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
||||+. ++|..++... .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++.
T Consensus 87 v~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 87 VFEYME-TDLHAVIRAN-------ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred Eecccc-cCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 999996 5998888643 27888999999999999999994 899999999999999999999999999998
Q ss_pred cccCCCCc--cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh----
Q 013074 289 LCTTKKGI--VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY---- 362 (450)
Q Consensus 289 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~---- 362 (450)
........ ........|+..|+|||++.+. ...+.++||||||+++|+|++|+.||........ ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~---~~~~~~~~~~ 231 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGS-TRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ---LEKIIEVIGP 231 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeecc-ccccccchHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCC
Confidence 66443221 0112234578899999988653 4678999999999999999999999864321100 000000
Q ss_pred ------hhhhhhhhhhh----c----ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 363 ------RHVEQDREFKL----L----GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 363 ------~~~~~~~~~~~----~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..+........ . ..........+.++.+++.+||+.+|++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000000 0 00001111245778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=264.35 Aligned_cols=236 Identities=20% Similarity=0.277 Sum_probs=171.5
Q ss_pred HhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 160 SFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
.+.+.||+|+||.||+|.. .+|+.++++++|+||+++++++.++...++|+||+.
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~- 86 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH- 86 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-
Confidence 3567899999999999842 235778899999999999999999999999999995
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++..... .+.+..+..++.|++.||.|||. .+++|+||||+||+++.++.+||+|||+++.......
T Consensus 87 ~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 87 TDLAQYMIQHPG-----GLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred CCHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 788777654321 27788888999999999999994 8999999999999999999999999999875433221
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh-----------h
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR-----------H 364 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~-----------~ 364 (450)
. .....++..|+|||.+.+. ..++.++||||||+++++|++|..||....... ..+.+ +.. .
T Consensus 159 ~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~-~~~~~~~~~~~~~~~ 231 (291)
T cd07870 159 T---YSSEVVTLWYRPPDVLLGA-TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEK-IWTVLGVPTEDTWPG 231 (291)
T ss_pred C---CCCccccccccCCceeecC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHH-HHHHcCCCChhhhhh
Confidence 1 1233468899999998753 357889999999999999999999986432210 00000 000 0
Q ss_pred hhhhhh--hhhcccc-cch------hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 365 VEQDRE--FKLLGVV-TKK------ENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 365 ~~~~~~--~~~~~~~-~~~------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+..... ....... ... .......+.+++.+|++.||.+|||++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 0000000 000 0011356788999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=264.78 Aligned_cols=240 Identities=20% Similarity=0.317 Sum_probs=173.9
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcC-CCceeeeeeEEEeCCc-----eE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTS-HVNVVTLLGFCLEGNN-----RA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~-HpnIv~l~~~~~~~~~-----~~ 207 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++ |+||+++++++...+. .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 34567899999999999952 23567788885 6999999999987665 89
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-CCCeEEeeccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-DFCPKISDFGL 286 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGl 286 (450)
+||||+++ +|.+++...... ....+++..++.++.|++.||.|||+ .+++|+||||+||+++. ++.+||+|||+
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRG-PGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEeeccCc-CHHHHHHHhccc-CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeeccc
Confidence 99999975 898888654322 12348999999999999999999995 89999999999999998 88999999999
Q ss_pred cccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh
Q 013074 287 AKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE 366 (450)
Q Consensus 287 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~ 366 (450)
++........ .....+++.|+|||.+.+. ..++.++||||||+++|+|++|..||........ ..+ +...+.
T Consensus 158 ~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~-~~~~~~ 229 (295)
T cd07837 158 GRAFSIPVKS---YTHEIVTLWYRAPEVLLGS-THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LLH-IFKLLG 229 (295)
T ss_pred ceecCCCccc---cCCcccccCCCChHHhhCC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH-HHHHhC
Confidence 8765332111 1222467889999988653 3578999999999999999999998864321110 000 000000
Q ss_pred hhhhh------------hhcc----cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 367 QDREF------------KLLG----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 367 ~~~~~------------~~~~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..... .... .........+.++.+++.+||+.||.+||+++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 0000 000011235677899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-32 Score=265.35 Aligned_cols=242 Identities=16% Similarity=0.180 Sum_probs=176.5
Q ss_pred hhhccccccceEEEEEE-----------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 161 FKDKLGQGGFGGVYKGK-----------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~-----------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
+.+.+|.|+++.||+++ +.+|++.+++++|+||+++++++.+++..+++|||+++++
T Consensus 6 i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 44556777777777663 1245778899999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc-
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI- 296 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~- 296 (450)
|.+++..... ..+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||.+.........
T Consensus 86 l~~~l~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 86 CEDLLKTHFP----EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred HHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999975432 228889999999999999999995 89999999999999999999999999988755322110
Q ss_pred ---cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh----hhhhh
Q 013074 297 ---VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH----VEQDR 369 (450)
Q Consensus 297 ---~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~----~~~~~ 369 (450)
........++..|+|||++......++.++|+||||++++||++|+.||........ .. +.+... +....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~-~~~~~~~~~~~~~~~ 235 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LL-EKVRGTVPCLLDKST 235 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-HHHhccCccccccCc
Confidence 111123346788999999876434688999999999999999999999975422110 00 000000 00000
Q ss_pred -----------------hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 370 -----------------EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 370 -----------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.................++.+++.+||+.||++|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000001111223455678899999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=267.26 Aligned_cols=240 Identities=18% Similarity=0.233 Sum_probs=172.4
Q ss_pred hccccc--cceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQG--GFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G--~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
..||+| +||+||+++. .+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999963 1235566678999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++..... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~ 156 (328)
T cd08226 84 GSANSLLKTYFP----EGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ 156 (328)
T ss_pred CCHHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc
Confidence 999998876432 238899999999999999999994 8999999999999999999999999986543221110
Q ss_pred cc----ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh--------
Q 013074 296 IV----SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR-------- 363 (450)
Q Consensus 296 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~-------- 363 (450)
.. .......++..|+|||++.+....++.++|||||||+++||++|+.||........ ..+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~ 233 (328)
T cd08226 157 KAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM---LLQKLKGPPYSPLDI 233 (328)
T ss_pred cccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH---HHHHhcCCCCCCccc
Confidence 00 00011124567999999976544678999999999999999999999865421110 0000000
Q ss_pred --------hhh-----------hhh-------hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 364 --------HVE-----------QDR-------EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 364 --------~~~-----------~~~-------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... +.. ..............+...+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 000 0000000111233466789999999999999999999999853
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=264.83 Aligned_cols=233 Identities=22% Similarity=0.247 Sum_probs=179.4
Q ss_pred HhhhccccccceEEEEEEEc------------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEE
Q 013074 160 SFKDKLGQGGFGGVYKGKLL------------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~------------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 208 (450)
.+.+.||+|+||.||+++.. +|+.++.++ +||||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 45678999999999987521 245667777 59999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
||||+++++|.+++.... .+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||+++
T Consensus 83 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 83 ILDYVNGGELFTHLYQRE------HFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEecCCCCcHHHHHhhcC------CcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999986532 28889999999999999999994 899999999999999999999999999987
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
......... .....|+..|+|||.+.+.....+.++||||||++++||++|..||........ ...+.+...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~----~~~~~~~~~-- 225 (288)
T cd05583 154 EFLAEEEER--AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS----QSEISRRIL-- 225 (288)
T ss_pred ccccccccc--cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch----HHHHHHHHH--
Confidence 654332211 123457899999999876433478899999999999999999999864321111 011111110
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
.............+.+++.+||+.||++|||+.++.+.|+.
T Consensus 226 ------~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 226 ------KSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ------ccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 01111222345678899999999999999999988887765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=254.73 Aligned_cols=249 Identities=23% Similarity=0.291 Sum_probs=184.4
Q ss_pred hHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEe-CCceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLE-GNNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~-~~~~~l 208 (450)
|+...+||+|+||.||+|.- -+|+..+..++||||+.+..++.+ +..+++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 45567899999999999931 135777888999999999999988 788999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC----CCeEEeec
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD----FCPKISDF 284 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~----~~~kl~DF 284 (450)
++||.++ +|...++-+...+. +.++...+..|+.||+.|+.||| ++=|+||||||.|||+..+ |.|||+||
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~~-~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASKA-KQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred Eehhhhh-hHHHHHHHhccchh-ccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 9999976 88888866554443 56899999999999999999999 4889999999999999877 89999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCcc-chh-h---
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEV-YFP-H--- 359 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~-~~~-~--- 359 (450)
|+++.+.+.-.........+-|..|+|||.+.+. ..|+++.||||.||++.||++-++.|.......... .|. .
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999887654433334455678999999999987 589999999999999999999998887654332211 110 1
Q ss_pred hhhhhhhhhhhhhhcc--cccch----------------hHH-------HHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 013074 360 WIYRHVEQDREFKLLG--VVTKK----------------ENE-------IAKKMIIVGLWCIQARPYDRPPMNEVIEML 413 (450)
Q Consensus 360 ~i~~~~~~~~~~~~~~--~~~~~----------------~~~-------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 413 (450)
.+.+.+..-.+....+ ..+.. ... -...-.+++.++|+.||.+|.|+++.++..
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1111110000000000 00000 000 112367888999999999999999998763
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.3e-33 Score=277.32 Aligned_cols=176 Identities=24% Similarity=0.319 Sum_probs=150.0
Q ss_pred hhHhhhccccccceEEEEEEE----------------------cchhhhhhhcC-C-----CceeeeeeEEEeCCceEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTS-H-----VNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~-H-----pnIv~l~~~~~~~~~~~lV 209 (450)
+|.+.+.||+|+||.|-++.. ..|+.+|.+++ | -|+|+++++|...++.|||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciV 266 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIV 266 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeee
Confidence 566788999999999999842 23577888886 3 3899999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC--CCeEEeecccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD--FCPKISDFGLA 287 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DFGla 287 (450)
+|.+ ..+|.+++..+.- ..++...+..++.||+.||..||+ .+|||+||||+||||.+. ..+||+|||++
T Consensus 267 fELL-~~NLYellK~n~f----~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 267 FELL-STNLYELLKNNKF----RGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred ehhh-hhhHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccc
Confidence 9999 6699999987653 339999999999999999999995 999999999999999743 47999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCC
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV 349 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~ 349 (450)
....... ....-+..|+|||++.+- .|+.+.||||||||+.||++|.+.|....
T Consensus 339 c~~~q~v------ytYiQSRfYRAPEVILGl--pY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 339 CFESQRV------YTYIQSRFYRAPEVILGL--PYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cccCCcc------eeeeeccccccchhhccC--CCCCccceeehhhhHHhHhcCccccCCCC
Confidence 8765442 233467899999999995 99999999999999999999977776543
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=260.71 Aligned_cols=228 Identities=23% Similarity=0.342 Sum_probs=177.7
Q ss_pred hHhhhccccccceEEEEEEEc----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
|.+.++||+|+||.||+++.. .|..++++++||||+++++++.+....++|+
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 456788999999999987421 1356778889999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++++|.+++...... ...+++..++.++.|++.||.|||+ .+++|+||||+||++++ +.++|+|||++...
T Consensus 82 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 82 EYCEGRDLDCKLEELKHT--GKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EeCCCCCHHHHHHHHhhc--ccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999988643211 1348999999999999999999995 89999999999999975 56999999998766
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
...... .....++..|+|||.+.+. .++.++|+||||+++++|++|..||..... ..... ..
T Consensus 156 ~~~~~~---~~~~~~~~~~~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-------~~~~~-~~----- 217 (260)
T cd08222 156 MGSCDL---ATTFTGTPYYMSPEALKHQ--GYDSKSDIWSLGCILYEMCCLAHAFEGQNF-------LSVVL-RI----- 217 (260)
T ss_pred CCCccc---ccCCCCCcCccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHH-HH-----
Confidence 443221 1234578899999998663 678899999999999999999999853211 01111 10
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..+.....+..++.++.+++.+||+.+|++||++.|+++.
T Consensus 218 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 218 --VEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred --HcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0111222234566789999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.4e-32 Score=257.96 Aligned_cols=217 Identities=22% Similarity=0.253 Sum_probs=169.6
Q ss_pred cccccceEEEEEEEcc------------------hhhhhhh-cCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcC
Q 013074 165 LGQGGFGGVYKGKLLD------------------GLASISR-TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNG 225 (450)
Q Consensus 165 LG~G~fg~Vy~~~~~~------------------e~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~ 225 (450)
||+|+||.||+++... |+..... .+||||+++++.+..++..++||||+++++|.+++...
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~ 103 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE 103 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc
Confidence 5999999999985321 1222211 27999999999999999999999999999999999754
Q ss_pred CCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-CeEEeeccccccccCCCCccccccCCC
Q 013074 226 DTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-CPKISDFGLAKLCTTKKGIVSSLLGAR 304 (450)
Q Consensus 226 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~ 304 (450)
. .+++..+..++.|+++||.|||+ .+++|+||||+||+++.++ .++|+|||++....... ...
T Consensus 104 ~------~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-------~~~ 167 (267)
T PHA03390 104 G------KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-------CYD 167 (267)
T ss_pred C------CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-------cCC
Confidence 3 38999999999999999999995 8999999999999999988 99999999987654321 234
Q ss_pred CccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHH
Q 013074 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEI 384 (450)
Q Consensus 305 gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 384 (450)
++..|+|||++.+. .++.++||||||+++++|++|+.||...... ......+.... ..........
T Consensus 168 ~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~----------~~~~~~~~~~ 233 (267)
T PHA03390 168 GTLDYFSPEKIKGH--NYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--ELDLESLLKRQ----------QKKLPFIKNV 233 (267)
T ss_pred CCCcccChhhhcCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCcc--hhhHHHHHHhh----------cccCCccccc
Confidence 78999999999764 7889999999999999999999999743221 11111111111 0111122246
Q ss_pred HHHHHHHHHHccccCCCCCCC-HHHHHH
Q 013074 385 AKKMIIVGLWCIQARPYDRPP-MNEVIE 411 (450)
Q Consensus 385 ~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 411 (450)
+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 678999999999999999995 688874
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.1e-32 Score=260.31 Aligned_cols=228 Identities=25% Similarity=0.356 Sum_probs=179.8
Q ss_pred hHhhhccccccceEEEEEEEc----------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.+.+.||+|+||.||+|+.. +|++.+++++|+||+++++.+..+...++|+||++++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 445678999999999998632 3577888999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++.... ..+++..+..++.|++.||.|||. .+++|+||+|+||+++.++.++|+|||++.........
T Consensus 101 ~L~~~l~~~~-----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 101 SLTDIITQNF-----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred cHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 9999997654 238999999999999999999994 99999999999999999999999999988755433211
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.....++..|++||.+.+. .++.++|+||||+++|+|++|+.|+....... ...... . ... .
T Consensus 173 ---~~~~~~~~~y~~PE~~~~~--~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-------~~~~~~-~---~~~--~ 234 (286)
T cd06614 173 ---RNSVVGTPYWMAPEVIKRK--DYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-------ALFLIT-T---KGI--P 234 (286)
T ss_pred ---hccccCCcccCCHhHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHH-h---cCC--C
Confidence 1233478899999998764 68999999999999999999999986432110 000000 0 000 0
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.......++..+.+++.+||+.+|.+||++.++++.
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 011122256789999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-32 Score=267.30 Aligned_cols=243 Identities=21% Similarity=0.300 Sum_probs=172.1
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCC--------c
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGN--------N 205 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~--------~ 205 (450)
|.+.++||+|+||.||+|+. .+|++++++++||||+++++++.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 44567899999999999852 23678889999999999999987654 3
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
.++||||+. ++|.+.+.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||
T Consensus 94 ~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSNKN-----VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred EEEEEcCCC-cCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCC
Confidence 599999995 58888775432 238999999999999999999995 899999999999999999999999999
Q ss_pred ccccccCCCCc-cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhh-----
Q 013074 286 LAKLCTTKKGI-VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPH----- 359 (450)
Q Consensus 286 la~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~----- 359 (450)
++......... ........++..|+|||.+.+. ..++.++||||||+++|||++|..||...........+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99866433211 1112234577889999988653 3468899999999999999999988864422110000000
Q ss_pred --hhhhhhhhhhh---hhhccccc-ch-----hHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 360 --WIYRHVEQDRE---FKLLGVVT-KK-----ENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 360 --~i~~~~~~~~~---~~~~~~~~-~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.+......... ........ .. .......+.+++.+||+.||.+|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000 00000000 00 0001345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-32 Score=264.46 Aligned_cols=228 Identities=25% Similarity=0.345 Sum_probs=176.5
Q ss_pred HHhhHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
..++...+.||+|+||.||+|+. .+|++++++++|+|++++++++.++...++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 33455567899999999999852 1356778889999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+||+. ++|.+.+.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++..
T Consensus 94 ~e~~~-~~l~~~~~~~~-----~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 164 (308)
T cd06634 94 MEYCL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164 (308)
T ss_pred EEccC-CCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCccccee
Confidence 99995 68887775432 228899999999999999999994 8999999999999999999999999999876
Q ss_pred ccCCCCccccccCCCCcccccccccccc-ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
.... ....++..|+|||.+.+ ..+..+.++|||||||++++|++|..|+...... .... .....
T Consensus 165 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~-~~~~~ 229 (308)
T cd06634 165 MAPA-------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALY-HIAQN 229 (308)
T ss_pred ecCc-------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHH-HHhhc
Confidence 5432 22347889999999753 1136788999999999999999999998543110 0000 00000
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 413 (450)
.............+.+++.+||+.+|++||+++++++..
T Consensus 230 ------~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 230 ------ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ------CCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 001111234567789999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-32 Score=263.10 Aligned_cols=240 Identities=21% Similarity=0.333 Sum_probs=176.7
Q ss_pred HhhhccccccceEEEEEEEc------------------------chhhhhhhcC-CCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKLL------------------------DGLASISRTS-HVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.||+|+||+||+|+.. +|+..+++++ |+||+++++++.+++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 35678999999999999642 1456677888 999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++..... ..+++..+..++.|++.+|.|||+ .+++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~l~~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (283)
T cd07830 81 EGNLYQLMKDRKG----KPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP 153 (283)
T ss_pred CCCHHHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence 8899988876542 238999999999999999999995 899999999999999999999999999988664432
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchh---------hhhhhh-
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP---------HWIYRH- 364 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~---------~~i~~~- 364 (450)
.. ....++..|+|||++... ..++.++|+||||++++||++|+.||............. .|....
T Consensus 154 ~~----~~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 154 PY----TDYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred Cc----CCCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 21 223478899999998654 367899999999999999999998885442211000000 000000
Q ss_pred hhhhhhhhhccc----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 365 VEQDREFKLLGV----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 365 ~~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
............ ..........++.+++.+||+.+|++|||++|++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 000011124678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=262.34 Aligned_cols=236 Identities=21% Similarity=0.301 Sum_probs=175.7
Q ss_pred HhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeC--CceEEEEEe
Q 013074 160 SFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEG--NNRALIYEF 212 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E~ 212 (450)
.+.++||+|+||.||+|+.. +|++++++++|+|++++++++.+. ...++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 35678999999999999532 256788899999999999999988 889999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
++ ++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||+|+||++++++.+||+|||++.....
T Consensus 82 ~~-~~l~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 82 MD-HDLTGLLDSPE-----VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred cc-ccHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 96 58888886542 238999999999999999999995 8999999999999999999999999999986654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh--
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE-- 370 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~-- 370 (450)
.... ......++..|+|||.+.+. ..++.++||||||++++||++|+.||....... .. ..+.+.......
T Consensus 153 ~~~~--~~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~---~~-~~~~~~~~~~~~~~ 225 (287)
T cd07840 153 RNSA--DYTNRVITLWYRPPELLLGA-TRYGPEVDMWSVGCILAELFLGKPIFQGSTELE---QL-EKIFELCGSPTDEN 225 (287)
T ss_pred CCcc--cccccccccccCCceeeEcc-ccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH---HH-HHHHHHhCCCchhh
Confidence 3211 12233467889999987653 357899999999999999999999986443210 00 000000000000
Q ss_pred ---------h-------hhcccccchhHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 371 ---------F-------KLLGVVTKKENE-IAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 371 ---------~-------~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
. ............ ++..+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 000000000111 2677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=267.63 Aligned_cols=241 Identities=22% Similarity=0.297 Sum_probs=175.0
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC--CceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG--NNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E 211 (450)
+++.+.||+|+||.||+|+. .+|+.++++++|+||+++++++.+. +..++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 34567899999999999852 2367888999999999999998765 46899999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+. ++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++....
T Consensus 89 ~~~-~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 89 YCE-QDLASLLDNMP-----TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred cCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 995 58888876532 238999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhh-------hhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHW-------IYRH 364 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~-------i~~~ 364 (450)
..... .....++..|+|||.+.+. ..++.++||||||+++|||++|+.||............... .+..
T Consensus 160 ~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAKP---MTPKVVTLWYRAPELLLGC-TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccCC---CCcccccccccChhhhcCC-CCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 43211 1223357889999998653 35789999999999999999999998643221100000000 0000
Q ss_pred hhhh---hhhhhccc----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 365 VEQD---REFKLLGV----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 365 ~~~~---~~~~~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... ........ ........+..+.+++.+|++.||++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 00000000 000011235678899999999999999999999965
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-32 Score=265.51 Aligned_cols=241 Identities=21% Similarity=0.264 Sum_probs=176.0
Q ss_pred HHhhHhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCC------
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGN------ 204 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~------ 204 (450)
...+.+.+.||+|+||.||+|... +|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 345566789999999999999632 3567888999999999999987655
Q ss_pred ----ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeE
Q 013074 205 ----NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPK 280 (450)
Q Consensus 205 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 280 (450)
..++|+||+++ ++.+.+.... ..+++..++.++.|++.||.|||+ .+|+|+||||+||++++++.+|
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGL-----VHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence 78999999965 7777775432 238999999999999999999995 8999999999999999999999
Q ss_pred EeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhh
Q 013074 281 ISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 360 (450)
|+|||++.......... .....++..|+|||.+.+. ...+.++|||||||+++||++|+.||........ ...
T Consensus 157 l~dfg~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~----~~~ 229 (302)
T cd07864 157 LADFGLARLYNSEESRP--YTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ----LEL 229 (302)
T ss_pred eCcccccccccCCcccc--cccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH----HHH
Confidence 99999998765432211 1222357789999988653 3578899999999999999999998864321100 000
Q ss_pred hhhhhhhhhhhhh------------------cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 361 IYRHVEQDREFKL------------------LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 361 i~~~~~~~~~~~~------------------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+.+.......... ...........+..+.+++.+||+.+|.+||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000000000000 000000111235778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-34 Score=261.85 Aligned_cols=228 Identities=23% Similarity=0.301 Sum_probs=188.4
Q ss_pred hHhhhccccccceEEEEEE---------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGK---------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~---------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
+.+.++||+|+||.||++- ..+|+.++++++.|+||++||.+.....+++|||||-.|+
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGS 114 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGS 114 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCc
Confidence 4567899999999999872 2356888999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
+.+.+..+. +.|++..+..++...++||+|||. ..-+|||||..|||++-+|.+||+|||.+....+.-..
T Consensus 115 iSDI~R~R~-----K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK- 185 (502)
T KOG0574|consen 115 ISDIMRARR-----KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK- 185 (502)
T ss_pred HHHHHHHhc-----CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHh-
Confidence 999997654 339999999999999999999995 88899999999999999999999999999877553322
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVV 377 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 377 (450)
.....||+.|||||++..- .|+.++||||||+...||..|++|+..-...+.-..+ ......-
T Consensus 186 --RNTVIGTPFWMAPEVI~EI--GY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------------PT~PPPT 248 (502)
T KOG0574|consen 186 --RNTVIGTPFWMAPEVIEEI--GYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------------PTKPPPT 248 (502)
T ss_pred --hCccccCcccccHHHHHHh--ccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------------cCCCCCC
Confidence 2455699999999999875 7899999999999999999999999755332211000 0111222
Q ss_pred cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 378 TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 378 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..++...+.++.++++.||-.+|++|-|+.++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 34566778899999999999999999999888753
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=261.09 Aligned_cols=222 Identities=23% Similarity=0.321 Sum_probs=174.5
Q ss_pred hccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 219 (450)
.+||+|+||.||++.. .+|+.++++++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999853 23567888899999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcccc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 299 (450)
+++... .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 106 ~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--- 172 (292)
T cd06657 106 DIVTHT-------RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--- 172 (292)
T ss_pred HHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccccc---
Confidence 887532 27889999999999999999995 89999999999999999999999999988765433211
Q ss_pred ccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccc
Q 013074 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379 (450)
Q Consensus 300 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 379 (450)
.....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...... .. ....... ... ...
T Consensus 173 ~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slGvil~el~tg~~p~~~~~~~----~~----~~~~~~~----~~~-~~~ 237 (292)
T cd06657 173 RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL----KA----MKMIRDN----LPP-KLK 237 (292)
T ss_pred ccccccCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HH----HHHHHhh----CCc-ccC
Confidence 1234578999999998763 6789999999999999999999998643211 00 0000000 000 001
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 380 KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 380 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
....++..+.+++.+||+.+|.+||++.++++.
T Consensus 238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 112345668889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=258.56 Aligned_cols=225 Identities=25% Similarity=0.339 Sum_probs=175.2
Q ss_pred cccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 165 LGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 165 LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
||.|+||.||+++.. +|++.+++++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999998642 235678888999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc--
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI-- 296 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~-- 296 (450)
.+++.... .+++..+..++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.........
T Consensus 81 ~~~l~~~~------~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 151 (265)
T cd05579 81 ASLLENVG------SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL 151 (265)
T ss_pred HHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc
Confidence 99997643 28999999999999999999995 89999999999999999999999999998765432110
Q ss_pred ---cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 297 ---VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 297 ---~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
........++..|++||..... ..+.++||||||+++++|++|..||...... . ......... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-------~-~~~~~~~~~-~-- 218 (265)
T cd05579 152 NDDEKEDKRIVGTPDYIAPEVILGQ--GHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------E-IFQNILNGK-I-- 218 (265)
T ss_pred ccccccccCcccCccccCHHHhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHhcCC-c--
Confidence 0012234578899999998774 6889999999999999999999998644211 0 111111100 0
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
........+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 219 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 ---EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00111113678899999999999999999977766665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=257.61 Aligned_cols=226 Identities=26% Similarity=0.409 Sum_probs=181.1
Q ss_pred HhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.++||+|+||.||+++. .+|++.+++++|+||+++.+++.++...++|+||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 4567899999999999852 134677888999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++...... ...+++..++.++.|++.||.||| +.+++|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~L~~~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 83 FGDLSKAISKRKKK--RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred CCCHHHHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999998663221 134899999999999999999999 4899999999999999999999999999998765541
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.....++..|++||.+.+. .++.++|+||||+++++|++|+.||...... . ...... .
T Consensus 158 -----~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~----~----~~~~~~-------~ 215 (256)
T cd08530 158 -----AKTQIGTPHYMAPEVWKGR--PYSYKSDIWSLGCLLYEMATFAPPFEARSMQ----D----LRYKVQ-------R 215 (256)
T ss_pred -----cccccCCccccCHHHHCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----H----HHHHHh-------c
Confidence 1223478899999999764 7888999999999999999999998643210 0 111111 1
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
............++.+++.+|++.+|++||++.|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11122233566889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=253.20 Aligned_cols=226 Identities=27% Similarity=0.408 Sum_probs=179.3
Q ss_pred HhhhccccccceEEEEEEEc-----------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 160 SFKDKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
...+.||+|++|.||+++.. +|++.+++++|+||+++++++..+...++++||++++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 34578999999999999632 3467888899999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++.... ..+++..+..++.|++.||.+||+ .+++|+||+|+||++++++.++|+|||.+........
T Consensus 83 ~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 83 SLKDLLKSTN-----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred cHHHHHhhcC-----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 9999986543 238999999999999999999995 9999999999999999999999999999887654432
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.....++..|+|||.+... ..+.++|+||||+++++|++|+.|+....... ...... .. ...
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~-~~-----~~~ 215 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGK--PYDYKADIWSLGITAIELAEGKPPYSELPPMK-------ALFKIA-TN-----GPP 215 (253)
T ss_pred ---ccceecCCcccCHHHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCchHH-------HHHHHH-hc-----CCC
Confidence 1234578899999999774 68899999999999999999999986542110 000000 00 000
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........+..+.+++.+||+.||++|||+.|+++.
T Consensus 216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 216 GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001111235779999999999999999999999863
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=269.67 Aligned_cols=247 Identities=22% Similarity=0.292 Sum_probs=178.4
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC-----CceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG-----NNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~-----~~~~l 208 (450)
|.+.+.||+|+||.||+++. .+|+.++++++|+||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 34456899999999999852 1257788889999999999988654 35799
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
|+||+. ++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||+++
T Consensus 87 v~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 87 VYELMD-TDLHQIIRSSQ------TLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEeCCC-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 999994 78988886443 28999999999999999999994 899999999999999999999999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhh-------
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI------- 361 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i------- 361 (450)
........ .....++..|+|||.+... ..++.++||||||+++++|++|+.||...........+....
T Consensus 157 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKGDF---MTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED 232 (337)
T ss_pred ccCCCccc---ccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHH
Confidence 66443211 1233578899999998653 358899999999999999999999986432100000000000
Q ss_pred hhhhhhhhh----hhhc----ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccccc
Q 013074 362 YRHVEQDRE----FKLL----GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGSTEA 419 (450)
Q Consensus 362 ~~~~~~~~~----~~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~~ 419 (450)
......... .... .........++.++.+++.+||+.+|++|||++|+++. ++.....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 000000000 0000 00001112356778999999999999999999999987 7665444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-32 Score=264.56 Aligned_cols=238 Identities=21% Similarity=0.318 Sum_probs=174.0
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
+++.+.||+|++|.||+|+. .+|++++++++||||+++++++.++...++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 34567899999999999852 13578889999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-CCCeEEeeccccccccC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-DFCPKISDFGLAKLCTT 292 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~ 292 (450)
+ ++|.+++..... ..+++..+..++.|++.||+|||+ .+++|+||+|+||+++. ++.+||+|||++.....
T Consensus 84 ~-~~l~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 84 D-LDLKKHMDSSPD----FAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred c-ccHHHHHHhCCC----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 5 588887754432 226788889999999999999995 89999999999999985 56799999999976543
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh----
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD---- 368 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~---- 368 (450)
.... .....++..|+|||++.+. ..++.++||||||+++|+|++|+.||........ ..+ +.......
T Consensus 156 ~~~~---~~~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~-~~~~~~~~~~~~ 227 (294)
T PLN00009 156 PVRT---FTHEVVTLWYRAPEILLGS-RHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFK-IFRILGTPNEET 227 (294)
T ss_pred Cccc---cccCceeecccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHH-HHHHhCCCChhh
Confidence 2111 1223468899999998653 3578999999999999999999999865422100 000 00000000
Q ss_pred -------hhhh--hcc----cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 369 -------REFK--LLG----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 369 -------~~~~--~~~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... ... .........+.++.+++.+|++.+|++||++.++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 228 WPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 000 0000012245678899999999999999999999863
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=260.97 Aligned_cols=230 Identities=21% Similarity=0.245 Sum_probs=175.9
Q ss_pred HhhhccccccceEEEEEEEc------------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEE
Q 013074 160 SFKDKLGQGGFGGVYKGKLL------------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~------------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 208 (450)
.+.+.||+|+||.||+++.. +|+.+++++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 35678999999999987531 246677777 59999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.
T Consensus 83 v~e~~~~~~L~~~l~~~~------~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 83 ILDYINGGELFTHLSQRE------RFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEecCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999986543 27889999999999999999995 999999999999999999999999999988
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
........ ......|+..|+|||.+.......+.++||||||+++|+|++|..|+........ .... .+....
T Consensus 154 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~-~~~~~~- 226 (290)
T cd05613 154 EFHEDEVE--RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS---QAEI-SRRILK- 226 (290)
T ss_pred eccccccc--ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc---HHHH-HHHhhc-
Confidence 65433211 1123458899999999876434578899999999999999999999864321111 1111 111100
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
............+.+++.+||+.||++|| +++++++.
T Consensus 227 -------~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 227 -------SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -------cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 01111223456788999999999999997 66777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=253.35 Aligned_cols=226 Identities=26% Similarity=0.345 Sum_probs=180.4
Q ss_pred hhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeC--CceEEEEEec
Q 013074 161 FKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEG--NNRALIYEFM 213 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E~~ 213 (450)
..+.||+|++|.||+|+.. +|+..+++++|+||+++++.+.+. ...++|+||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 3568999999999999532 246778899999999999999988 8899999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+......
T Consensus 84 ~~~~L~~~~~~~~------~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 84 SGGSLSSLLKKFG------KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred CCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999987653 38999999999999999999995 89999999999999999999999999998877654
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
.... ......++..|+|||.+.+. ..+.++||||||+++++|++|..||...... .........
T Consensus 155 ~~~~-~~~~~~~~~~y~~pE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~------- 218 (260)
T cd06606 155 ETGE-GTGSVRGTPYWMAPEVIRGE--EYGRAADIWSLGCTVIEMATGKPPWSELGNP------MAALYKIGS------- 218 (260)
T ss_pred cccc-cccCCCCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch------HHHHHhccc-------
Confidence 3210 01234588899999998774 5899999999999999999999998754310 000111000
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.......+...+..+.+++.+|++.+|++||++.|++.
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 01111222334678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-32 Score=268.59 Aligned_cols=243 Identities=19% Similarity=0.257 Sum_probs=175.9
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe----CCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE----GNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~----~~~~~lV 209 (450)
+.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.. ....++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 34567899999999999852 235788999999999999998763 3468999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+||+. ++|.+++.... .+++..+..++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++..
T Consensus 87 ~e~~~-~~l~~~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 87 MDLME-SDLHHIIHSDQ------PLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred Eehhh-hhHHHHhccCC------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99995 68988886433 28999999999999999999995 8999999999999999999999999999876
Q ss_pred ccCCCCc-cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch-------hhhh
Q 013074 290 CTTKKGI-VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF-------PHWI 361 (450)
Q Consensus 290 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~-------~~~i 361 (450)
....... ........++..|+|||.+.+. ..++.++||||||+++|||++|+.||...........+ +..+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 5432211 1112234688999999998653 36889999999999999999999999643211000000 0000
Q ss_pred hhhhhhhhhh----hhccc----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 362 YRHVEQDREF----KLLGV----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 362 ~~~~~~~~~~----~~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+........ ..... ........+.++.+++.+||+.+|++||++++++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 00000 001112346789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-32 Score=253.97 Aligned_cols=224 Identities=26% Similarity=0.368 Sum_probs=179.5
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
+.+.+.||+|++|.||+++. .+|++++++++|+|++++++++.+++..++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 34567899999999999852 24567788999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~L~~~~~~~~------~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 82 ENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCcHHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999986542 2899999999999999999999 489999999999999999999999999999876544
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
... .....++..|+|||...+. ..+.++||||+|+++++|++|..|+...... .. ..... .
T Consensus 153 ~~~---~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~------~~-~~~~~-~------ 213 (254)
T cd06627 153 SKD---DASVVGTPYWMAPEVIEMS--GASTASDIWSLGCTVIELLTGNPPYYDLNPM------AA-LFRIV-Q------ 213 (254)
T ss_pred ccc---ccccccchhhcCHhhhcCC--CCCcchhHHHHHHHHHHHHhCCCCCCCccHH------HH-HHHHh-c------
Confidence 321 1234578899999998764 5889999999999999999999998643210 00 00100 0
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..........+..+.+++.+||+.+|++||++.+++.
T Consensus 214 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 214 -DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0111122234578889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=260.54 Aligned_cols=221 Identities=28% Similarity=0.378 Sum_probs=171.8
Q ss_pred hhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 162 KDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
.++||+|+||+||+|+. .+|++++++++|||++++++++.++...++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 45799999999999952 134678889999999999999999999999999995
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||++.....
T Consensus 105 ~~l~~~l~~~~-----~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 105 GSASDLLEVHK-----KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 68877775433 238899999999999999999994 8999999999999999999999999998864322
Q ss_pred ccccccCCCCcccccccccccc-ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.....|+..|+|||++.. ..+.++.++||||||+++++|++|..|+....... ........
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-------~~~~~~~~------- 235 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQN------- 235 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-------HHHHHHhc-------
Confidence 123458889999999853 12468889999999999999999999986542110 01110000
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........+..+.+++.+||+.+|.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 236 DSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00001112234568899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=285.52 Aligned_cols=239 Identities=26% Similarity=0.409 Sum_probs=187.3
Q ss_pred HhhhccccccceEEEEEEEc-------------------------------chhhhhhhc-CCCceeeeeeEEEeCCceE
Q 013074 160 SFKDKLGQGGFGGVYKGKLL-------------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~-------------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~ 207 (450)
.+.+.||+|.||.|++|.+. .|+++++.+ .|+||+.++|+|.+++..+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~ 378 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY 378 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence 45669999999999999532 235555555 5999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCC---CCCC-----C--ccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC
Q 013074 208 LIYEFMPNGSLEKFVYNGD---TSKP-----C--QYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF 277 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~---~~~~-----~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 277 (450)
+|.||+..|+|.+++...+ .... . ..++...++.++.|||.|++||+ +.++|||||..+|||+.++.
T Consensus 379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~ 455 (609)
T KOG0200|consen 379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNK 455 (609)
T ss_pred EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCC
Confidence 9999999999999998765 1111 1 23899999999999999999999 48999999999999999999
Q ss_pred CeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 013074 278 CPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF 357 (450)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~ 357 (450)
.+||+|||+++.......+........-...|||||.+... .++.+|||||||++|||+++...+...+....
T Consensus 456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~--~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~----- 528 (609)
T KOG0200|consen 456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDR--VFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT----- 528 (609)
T ss_pred EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccC--cccccchhhHHHHHHHHHhhCCCCCCCCCCcH-----
Confidence 99999999999776655544222211134569999999874 89999999999999999997554433331101
Q ss_pred hhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 358 PHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 358 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.-+.+.+. .+.+...+..+..++.++++.||+.+|++||++.++++.++..
T Consensus 529 -~~l~~~l~-------~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 -EELLEFLK-------EGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -HHHHHHHh-------cCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11122222 3334456666788999999999999999999999999999884
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=248.05 Aligned_cols=228 Identities=21% Similarity=0.324 Sum_probs=175.5
Q ss_pred hhhccccccceEEEEEEEcch------------------------hhh-hhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 161 FKDKLGQGGFGGVYKGKLLDG------------------------LAS-ISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~~e------------------------~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+...||.|+.|.||+++++.. +.+ ++.-.+|+||+.+|+|..+....+.||.| .
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-S 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-H
Confidence 456799999999999976541 222 22235899999999999999999999999 4
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
..++.++.... +++++..+-++...+.+||.||-+ .++|+|||+||+|||+|+.|++|++|||++..+.+...
T Consensus 175 ~C~ekLlkrik-----~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 175 TCAEKLLKRIK-----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHhc-----CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 45666665433 338888888999999999999998 78999999999999999999999999999987655433
Q ss_pred ccccccCCCCccccccccccccc-cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.+...|-+.|||||.+.-. ...|+.++||||||+.++||.||..|+.....+ |. +...+.... .
T Consensus 248 ----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-----Fe--~ltkvln~e----P 312 (391)
T KOG0983|consen 248 ----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-----FE--VLTKVLNEE----P 312 (391)
T ss_pred ----cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-----HH--HHHHHHhcC----C
Confidence 2334588999999999754 357899999999999999999999999764321 11 111111111 1
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........++..+.+++..||+.|+.+||...++++.
T Consensus 313 -P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 -PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1112223377889999999999999999999998864
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=257.42 Aligned_cols=234 Identities=22% Similarity=0.305 Sum_probs=177.1
Q ss_pred hhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 161 FKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.+.||+|++|.||+++. .+|++++++++|+||+++++++..+...++|+||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD- 81 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-
Confidence 456899999999999852 135778889999999999999999999999999996
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|..++.... ..+++..+..++.|++.||.|||+ .+++|+||||+||++++++.++|+|||.+........
T Consensus 82 ~~l~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 82 TDLYKLIKDRQ-----RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CCHHHHHHhhc-----ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 48888876543 238999999999999999999995 8999999999999999999999999999887654431
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh-------
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD------- 368 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~------- 368 (450)
. .....++..|+|||.+.+. ...+.++|+||||+++++|++|+.+|....... ....+.+.+...
T Consensus 154 ~---~~~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd05118 154 P---YTHYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID----QLFKIFRTLGTPDPEVWPK 225 (283)
T ss_pred c---ccCccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCchHhccc
Confidence 1 1223477899999998763 368899999999999999999998885432110 000000000000
Q ss_pred -------hhhhhc----ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 369 -------REFKLL----GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 369 -------~~~~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
...... ..........+.++.+++.+||+.||.+||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred chhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000 0001112345788999999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=252.68 Aligned_cols=228 Identities=21% Similarity=0.367 Sum_probs=181.2
Q ss_pred HhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.||+|+||.||+++.. +|++.+++++|+|++++.+.+..+...++|+|+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 45678999999999998632 34778888999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++..... ....+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||.+.......
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 83 GGDLSQKIKKQKK--EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred CCcHHHHHHHhhc--cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999876431 11348999999999999999999995 899999999999999999999999999998765443
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .....|+..|+|||.+... .++.++|+||+|+++++|++|+.|+..... .. +.......
T Consensus 158 ~~---~~~~~~~~~y~~pe~~~~~--~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~-~~~~~~~~------ 218 (258)
T cd08215 158 DL---AKTVVGTPYYLSPELCQNK--PYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LE-LALKILKG------ 218 (258)
T ss_pred ce---ecceeeeecccChhHhccC--CCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HH-HHHHHhcC------
Confidence 11 2234588899999998764 688999999999999999999999864321 11 11111110
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.....+......+.+++.+||+.+|++||++.|+++.
T Consensus 219 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 219 -QYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111122455778999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=271.08 Aligned_cols=223 Identities=22% Similarity=0.313 Sum_probs=185.3
Q ss_pred HhhhccccccceEEEEEE-------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGK-------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~-------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.++||+|.|++|.+|+ +.+|+++++.++|||||+++.+......+|+||||+.
T Consensus 59 ~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~ 138 (596)
T KOG0586|consen 59 VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYAS 138 (596)
T ss_pred eeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEecc
Confidence 356789999999999985 2356899999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+|.+.+++.+.+. ..+.....++.|+.+|++||| +..|+|||||++||||+.+.++||+|||++.++....
T Consensus 139 ~ge~~~yl~~~gr------~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~ 209 (596)
T KOG0586|consen 139 GGELFDYLVKHGR------MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGL 209 (596)
T ss_pred CchhHHHHHhccc------chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeecccc
Confidence 9999999988765 555788889999999999999 5999999999999999999999999999999886443
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.....+|++.|.|||++.+. ....+++|+||+|+++|-|+.|..||+...-.. +.+.+ +.
T Consensus 210 ----~lqt~cgsppyAaPEl~~g~-~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~--------Lr~rv-------l~ 269 (596)
T KOG0586|consen 210 ----MLQTFCGSPPYAAPELFNGK-KYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE--------LRPRV-------LR 269 (596)
T ss_pred ----cccccCCCCCccChHhhcCc-ccCCcceehhhhhhhheeeeecccccCCccccc--------ccchh-------ee
Confidence 24677899999999999986 467899999999999999999999998653211 00110 00
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+ .-..+.....+..++++++|-.+|.+|++++++-+.
T Consensus 270 g-k~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 270 G-KYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred e-eecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 0 011223345678889999999999999999998754
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=259.87 Aligned_cols=229 Identities=21% Similarity=0.344 Sum_probs=171.8
Q ss_pred HhhhccccccceEEEEEEEcc------------------------hhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKLLD------------------------GLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~------------------------e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.||+|+||.||+|+..+ ++..+.+. .|+||+++++++.++...++||||+
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 96 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM- 96 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-
Confidence 457899999999999996431 23334444 4999999999999999999999998
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
.++|.+.+..... .+++..+..++.|++.||.|||+ ..+|+|+||+|+||++++++.+||+|||++.......
T Consensus 97 ~~~l~~l~~~~~~-----~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 97 STCLDKLLKRIQG-----PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred CcCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 4577777654322 38999999999999999999995 3589999999999999999999999999987654332
Q ss_pred CccccccCCCCcccccccccccccc--CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNF--GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.. ....++..|+|||.+.+.. +.++.++||||||+++|+|++|+.||...... + +.+....... ..
T Consensus 170 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~-~~~~~~~~~~-~~- 237 (296)
T cd06618 170 AK----TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----F-EVLTKILQEE-PP- 237 (296)
T ss_pred cc----cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----H-HHHHHHhcCC-CC-
Confidence 21 2234778999999987542 34789999999999999999999998643111 0 0011111100 00
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.. .....+..++.+++.+||+.||++||+++++++.
T Consensus 238 ---~~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 238 ---SL-PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---CC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0111345678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=263.40 Aligned_cols=239 Identities=23% Similarity=0.331 Sum_probs=171.8
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCC--------c
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGN--------N 205 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~--------~ 205 (450)
+.+.++||+|+||.||+|+. .+|++++++++||||+++++++.+.. .
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence 34567899999999999852 23678899999999999999875543 4
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
.++|+||+. ++|...+.... ..+++..+..++.|+++||+||| +.+++|+||||+||++++++.+||+|||
T Consensus 90 ~~lv~~~~~-~~l~~~~~~~~-----~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 90 VYMVTPYMD-HDLSGLLENPS-----VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred EEEEEecCC-cCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 689999995 47777765432 23899999999999999999999 4899999999999999999999999999
Q ss_pred ccccccCCCCcc--------ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 013074 286 LAKLCTTKKGIV--------SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF 357 (450)
Q Consensus 286 la~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~ 357 (450)
+++......... .......++..|+|||.+.+. ..++.++||||||++++||++|+.||........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---- 235 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGE-RRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---- 235 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCC-CccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH----
Confidence 998654322111 111233467889999988653 3578999999999999999999999864322110
Q ss_pred hhhhhhhh--------------hhhhh----hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 358 PHWIYRHV--------------EQDRE----FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 358 ~~~i~~~~--------------~~~~~----~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
...+.... ..... .................+.+++.+||+.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 00000000 00000 00000000001123367889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=265.84 Aligned_cols=236 Identities=21% Similarity=0.227 Sum_probs=172.3
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC------CceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG------NNRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~------~~~~ 207 (450)
|...+.||+|+||.||+++. .+|+.++++++|+||+++++++... ...+
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 44567899999999999852 1357888899999999999988643 3579
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+. ++|.+.+... +++..+..++.|++.||+|||. .+++|+||||+||+++.++.+||+|||++
T Consensus 98 lv~e~~~-~~l~~~~~~~--------l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 98 LVMELMD-ANLCQVIQMD--------LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred EEEeccC-CCHHHHHhhc--------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 9999995 5888877421 7888899999999999999994 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc--------cchhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE--------VYFPH 359 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~--------~~~~~ 359 (450)
+....... .....++..|+|||.+.+. .++.++|||||||++++|++|+.||........- ....+
T Consensus 166 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 166 RTAGTSFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred eeCCCCCC----CCCCcccccccCHHHHhCC--CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 86543221 2233578899999999774 7899999999999999999999998644211000 00000
Q ss_pred hhh-------hhhhhhhhh------hh------cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 360 WIY-------RHVEQDREF------KL------LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 360 ~i~-------~~~~~~~~~------~~------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+.. ......... .. ...........+..+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000 000000000 00 000000012345678899999999999999999999965
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=263.61 Aligned_cols=237 Identities=22% Similarity=0.265 Sum_probs=175.0
Q ss_pred hhhccccccceEEEEEEE-------------------------------------cchhhhhhhcCCCceeeeeeEEEeC
Q 013074 161 FKDKLGQGGFGGVYKGKL-------------------------------------LDGLASISRTSHVNVVTLLGFCLEG 203 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~-------------------------------------~~e~~~l~~l~HpnIv~l~~~~~~~ 203 (450)
+.+.||+|+||.||+|+. .+|++++++++|+||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 346799999999999841 1356778899999999999999999
Q ss_pred CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 204 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
+..++||||+. ++|.+++.... .+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKI------RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECC
Confidence 99999999995 68998886432 28899999999999999999995 8999999999999999999999999
Q ss_pred ccccccccCCCC-----------ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCC
Q 013074 284 FGLAKLCTTKKG-----------IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS 352 (450)
Q Consensus 284 FGla~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~ 352 (450)
||++........ .........++..|+|||.+.+. ..++.++||||||++++||++|..||.......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA-EKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 999876541110 00111223467889999998753 357899999999999999999999986543211
Q ss_pred Cccchhhhhhhhhhhhhhh------------hh----cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 353 SEVYFPHWIYRHVEQDREF------------KL----LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 353 ~~~~~~~~i~~~~~~~~~~------------~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
....+.......... .. ...........+.++.+++.+||+.+|++||+++|++..
T Consensus 242 ----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 242 ----QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred ----HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 000011100000000 00 000000011235678899999999999999999999974
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=256.09 Aligned_cols=234 Identities=24% Similarity=0.356 Sum_probs=172.9
Q ss_pred HhhhccccccceEEEEEEEcc-------------------------hhhhhhh---cCCCceeeeeeEEEeCCc-----e
Q 013074 160 SFKDKLGQGGFGGVYKGKLLD-------------------------GLASISR---TSHVNVVTLLGFCLEGNN-----R 206 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~-------------------------e~~~l~~---l~HpnIv~l~~~~~~~~~-----~ 206 (450)
++.+.||+|+||.||+|+... |+.++++ ++|+||+++++++..... .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 346789999999999996421 3344444 469999999999988776 8
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccc
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGL 286 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 286 (450)
+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+ .+++|+||+|+||++++++.+||+|||+
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~~----~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCPK----PGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred EEEehhcc-cCHHHHHHHccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCc
Confidence 99999996 589888865432 238999999999999999999995 8999999999999999999999999999
Q ss_pred cccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh
Q 013074 287 AKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE 366 (450)
Q Consensus 287 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~ 366 (450)
+........ .....++..|+|||++.+. .++.++|+||||+++++|++|..||...... ..+.+.. +...
T Consensus 154 ~~~~~~~~~----~~~~~~~~~~~~PE~~~~~--~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~---~~~~~~~-~~~~ 223 (287)
T cd07838 154 ARIYSFEMA----LTSVVVTLWYRAPEVLLQS--SYATPVDMWSVGCIFAELFRRRPLFRGTSEA---DQLDKIF-DVIG 223 (287)
T ss_pred ceeccCCcc----cccccccccccChHHhccC--CCCCcchhhhHHHHHHHHHhCCCcccCCChH---HHHHHHH-HHcC
Confidence 877644321 1223478899999999774 7889999999999999999998888643211 1111111 0000
Q ss_pred hhh-------------hh--hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 367 QDR-------------EF--KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 367 ~~~-------------~~--~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
... .. ................+.+++.+||+.||.+||+++|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 000 00 0000011112245677889999999999999999999984
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=246.15 Aligned_cols=229 Identities=21% Similarity=0.268 Sum_probs=178.8
Q ss_pred hccccccceEEEEEEEcc------------------hhhhh-hhcCCCceeeeeeEEEe----CCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKLLD------------------GLASI-SRTSHVNVVTLLGFCLE----GNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~------------------e~~~l-~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~ 219 (450)
++||-|-.|+|-....+. |++.- ..-.|||||.+++++.+ ...+.+|||.|+||.|.
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLf 147 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELF 147 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHH
Confidence 579999999998875332 23221 11259999999999865 34677899999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc---CCCCeEEeeccccccccCCCCc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD---QDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~~~~~~~~~ 296 (450)
..+..++. +.++++++-.|..||..|+.||| +.+|.||||||+|+|.. .|..+||+|||+|+......
T Consensus 148 sriq~~g~----~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~-- 218 (400)
T KOG0604|consen 148 SRIQDRGD----QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG-- 218 (400)
T ss_pred HHHHHccc----ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCCCc--
Confidence 99987765 34999999999999999999999 59999999999999996 45679999999999776432
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
...+.+-|+.|.|||++... .++...|+||+||++|-|+.|-+||....... +..-....+..+. + .-
T Consensus 219 --~L~TPc~TPyYvaPevlg~e--KydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~gq-y---~F 286 (400)
T KOG0604|consen 219 --DLMTPCFTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTGQ-Y---EF 286 (400)
T ss_pred --cccCCcccccccCHHHhCch--hcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhccC-c---cC
Confidence 25667899999999999875 79999999999999999999999998654321 1111222221111 1 11
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..++-.++++...++++.+|..+|.+|.|+.|+.+.
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 123345677888999999999999999999999875
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=285.58 Aligned_cols=184 Identities=23% Similarity=0.379 Sum_probs=130.9
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
+|+-||||+...|.+++..+... -.....|+++++|+.||.|+|+ .+||||||||.||+++++..|||+|||
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~-----~~~d~~wrLFreIlEGLaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFG 742 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFN-----SQRDEAWRLFREILEGLAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFG 742 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccc-----hhhHHHHHHHHHHHHHHHHHHh---CceeeccCCcceeEEcCCCCeeecccc
Confidence 46778999887777777654311 0357789999999999999995 899999999999999999999999999
Q ss_pred cccccc--------------CCC-CccccccCCCCccccccccccccccC-CCCccCchHhHHHHHHHHHcCCCCCCCCC
Q 013074 286 LAKLCT--------------TKK-GIVSSLLGARGTIGYIALEVFSRNFG-EVSHKSDVYSFGMMIMELVGCKNNLDSGV 349 (450)
Q Consensus 286 la~~~~--------------~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~~sDiwSlGvvl~elltg~~p~~~~~ 349 (450)
+|.... ... ......++..||.-|+|||++.+... .|+.|+|+||||+|++||+ .||....
T Consensus 743 LAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsM 819 (1351)
T KOG1035|consen 743 LATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML---YPFGTSM 819 (1351)
T ss_pred cchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh---ccCCchH
Confidence 998621 001 11113456779999999999987522 6999999999999999999 3455432
Q ss_pred CCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 350 DNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 350 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+.. .+...+.. ..+... .....+....=..+++|+++.||.+|||+.|++.
T Consensus 820 ERa-------~iL~~LR~---g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 820 ERA-------SILTNLRK---GSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHH-------HHHHhccc---CCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 110 01111111 111111 1112233344567899999999999999999985
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-32 Score=249.43 Aligned_cols=223 Identities=22% Similarity=0.250 Sum_probs=178.3
Q ss_pred cccchhHHHHHhhHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEE
Q 013074 147 KRYNFSDVKKITNSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFC 200 (450)
Q Consensus 147 ~~~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~ 200 (450)
++++++++ +|.+.||+|.||+|-+.+- ..|-++|++.+||.+..+.-.|
T Consensus 163 ~kvTm~dF-----dfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF 237 (516)
T KOG0690|consen 163 NKVTMEDF-----DFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF 237 (516)
T ss_pred ceeccchh-----hHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh
Confidence 34555544 4788999999999988751 1235678889999999998889
Q ss_pred EeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeE
Q 013074 201 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPK 280 (450)
Q Consensus 201 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 280 (450)
+..+.+|+||||..||.|.-++.+... +++.....+-..|..||.||| +.+||.||+|.+|.|+|++|++|
T Consensus 238 Qt~drlCFVMeyanGGeLf~HLsrer~------FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIK 308 (516)
T KOG0690|consen 238 QTQDRLCFVMEYANGGELFFHLSRERV------FSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIK 308 (516)
T ss_pred ccCceEEEEEEEccCceEeeehhhhhc------ccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceE
Confidence 999999999999999999988865432 888888888899999999999 59999999999999999999999
Q ss_pred EeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhh
Q 013074 281 ISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 360 (450)
|+|||+.+.- ..+.......|||+.|+|||++..+ .|..+.|.|.+|||+|||+.|+.||..... +..|
T Consensus 309 itDFGLCKE~---I~~g~t~kTFCGTPEYLAPEVleDn--DYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLF--- 377 (516)
T KOG0690|consen 309 ITDFGLCKEE---IKYGDTTKTFCGTPEYLAPEVLEDN--DYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLF--- 377 (516)
T ss_pred eeecccchhc---ccccceeccccCChhhcCchhhccc--cccceeehhhhhHHHHHHHhccCcccccch---hHHH---
Confidence 9999998743 2223346788999999999999986 899999999999999999999999976532 1111
Q ss_pred hhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCC
Q 013074 361 IYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRP 404 (450)
Q Consensus 361 i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 404 (450)
+.+.. .....+..++.+...++...|..||.+|.
T Consensus 378 --eLIl~--------ed~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 378 --ELILM--------EDLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred --HHHHh--------hhccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 11110 01122344556778888889999999996
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=265.41 Aligned_cols=244 Identities=22% Similarity=0.255 Sum_probs=180.7
Q ss_pred hHhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCC-----ceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGN-----NRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~l 208 (450)
|.+.+.||+|+||.||+|+.. +|++++++++|+||+++++++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 345678999999999999522 2577888899999999999998775 7899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
||||+. ++|.+++.... .+++..++.++.|++.||+|||. .+++|+||||+||+++.++.++|+|||++.
T Consensus 82 v~e~~~-~~l~~~l~~~~------~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 82 VTELME-TDLHKVIKSPQ------PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred Eecchh-hhHHHHHhCCC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 999996 58888886543 38999999999999999999994 899999999999999999999999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh-
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ- 367 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~- 367 (450)
................++..|+|||.+.+. ..++.++|+||||+++++|++|+.||....... ..+.+......
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~ 226 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID----QLNLIVEVLGTP 226 (330)
T ss_pred eecccccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH----HHHHHHHhcCCC
Confidence 765543211112334578899999999774 268899999999999999999999986543110 00000000000
Q ss_pred ------------hhhhhh-cc-----cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccc
Q 013074 368 ------------DREFKL-LG-----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGST 417 (450)
Q Consensus 368 ------------~~~~~~-~~-----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 417 (450)
...... .. .........+..+.+++.+||+.+|.+||++++++.. +++..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 000000 00 0000112245778999999999999999999999975 55433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-32 Score=258.00 Aligned_cols=226 Identities=23% Similarity=0.337 Sum_probs=178.1
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcC-CCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTS-HVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E 211 (450)
|.+.+.||+|+||.||+++.. .|.++++++. |+||+++++++.+++..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 345678999999999998632 2356677888 9999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
++++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++....
T Consensus 83 ~~~~~~L~~~l~~~~------~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 83 YAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred CCCCCcHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999997653 38999999999999999999995 899999999999999999999999999988664
Q ss_pred CCCCc-----------------cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 013074 292 TKKGI-----------------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE 354 (450)
Q Consensus 292 ~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~ 354 (450)
..... ........++..|+|||.+... ..+.++|+||||++++++++|+.||......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--- 228 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK--PAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--- 228 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCC--CCChhhhHHHHHHHHHHHHhCCCCCCCccHH---
Confidence 43211 0112234578899999998764 6889999999999999999999998754310
Q ss_pred cchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 013074 355 VYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM----NEVIE 411 (450)
Q Consensus 355 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~ 411 (450)
. ..+... ......+...+..+.+++.+||+.+|.+||++ +++++
T Consensus 229 ~-----~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 L-----TFQKIL--------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred H-----HHHHHH--------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 011110 01111223346778999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=271.19 Aligned_cols=179 Identities=25% Similarity=0.413 Sum_probs=153.2
Q ss_pred hhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCC------ceEEEEE
Q 013074 162 KDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGN------NRALIYE 211 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~------~~~lV~E 211 (450)
.+.||+|+||.||+|+. ..|++++++++|+|||+++++-.+.. ...+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 45799999999999962 34689999999999999999766544 4569999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc--CCC--CeEEeecccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD--QDF--CPKISDFGLA 287 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~--~~kl~DFGla 287 (450)
||.+|||...+..-... ..|++...+.++.+++.||.|||+ ++|+||||||.||++- .+| ..||+|||.|
T Consensus 98 yC~gGsL~~~L~~PEN~---~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPENA---YGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ecCCCcHHHHhcCcccc---cCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999765543 349999999999999999999996 9999999999999984 333 5799999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCC
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN 351 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~ 351 (450)
+...++. ......||..|.+||++..+ ..++...|.|||||++|+.+||..||......
T Consensus 172 rel~d~s----~~~S~vGT~~YLhPel~E~q-~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 172 RELDDNS----LFTSLVGTEEYLHPELYERQ-KKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ccCCCCC----eeeeecCchhhcChHHHhhc-cCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 9887765 35667799999999999863 48999999999999999999999999766543
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=268.13 Aligned_cols=242 Identities=19% Similarity=0.226 Sum_probs=170.9
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeC------------
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEG------------ 203 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~------------ 203 (450)
|.+.+.||.|+||.||+|.. .+|++++++++||||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccccc
Confidence 44567899999999999852 2357889999999999999876543
Q ss_pred --CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc-CCCCeE
Q 013074 204 --NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD-QDFCPK 280 (450)
Q Consensus 204 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~k 280 (450)
...++|+||++ ++|.+++... .+++..++.++.|++.||.|||+ .+++||||||+||+++ +++.+|
T Consensus 87 ~~~~~~lv~e~~~-~~L~~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 87 ELNSVYIVQEYME-TDLANVLEQG-------PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccceEEEEeeccc-ccHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEE
Confidence 35789999996 5888877532 28899999999999999999995 8999999999999997 456789
Q ss_pred EeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch---
Q 013074 281 ISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF--- 357 (450)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~--- 357 (450)
|+|||++.................++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...........+
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCc-cccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999987654322211112233578899999987543 36788999999999999999999999644221100000
Q ss_pred -----hhhh---hhhhhhhhh---hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 358 -----PHWI---YRHVEQDRE---FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 358 -----~~~i---~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... ......... ................++.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000 000000000 000000000011345678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=265.93 Aligned_cols=219 Identities=20% Similarity=0.276 Sum_probs=176.1
Q ss_pred hHhhhccccccceEEEEEEE-------------------cchhhhh-hhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------LDGLASI-SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------~~e~~~l-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
|++...+|.|+|+.|-++.. .+|+.++ ..-+||||+++.+.+.++.+.++|||.+.++-|
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~el 403 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGEL 403 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHH
Confidence 45667899999999987742 2233233 233799999999999999999999999999988
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE-cCCCCeEEeeccccccccCCCCcc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL-DQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll-~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
.+.+..... +. ..+..|+.+|+.|+.|||+ .++||||+||+|||+ +..++++|+|||.++.....
T Consensus 404 l~ri~~~~~------~~-~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---- 469 (612)
T KOG0603|consen 404 LRRIRSKPE------FC-SEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---- 469 (612)
T ss_pred HHHHHhcch------hH-HHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh----
Confidence 887754331 23 6777899999999999995 999999999999999 58999999999999987654
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVV 377 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 377 (450)
....+-|..|.|||++... .+++++|+||||++||+||+|+.||...... ..+...+..
T Consensus 470 --~~tp~~t~~y~APEvl~~~--~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~---------- 528 (612)
T KOG0603|consen 470 --CDTPALTLQYVAPEVLAIQ--EYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQM---------- 528 (612)
T ss_pred --hcccchhhcccChhhhccC--CCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcC----------
Confidence 3345678999999999864 8999999999999999999999999876443 112222211
Q ss_pred cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 378 TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 378 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
......++...++++.+||+.||.+||+|+++...
T Consensus 529 ~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 11225677889999999999999999999998764
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=260.67 Aligned_cols=243 Identities=23% Similarity=0.255 Sum_probs=171.1
Q ss_pred hHhhhccccccceEEEEEEEc---------------------------chhhhhhhc-CCCceeeeeeEEEeC----Cce
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRT-SHVNVVTLLGFCLEG----NNR 206 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l-~HpnIv~l~~~~~~~----~~~ 206 (450)
+.+.+.||+|+||.||+++.. +|+++++++ +||||+++++.+... ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 345678999999999998632 245667777 599999999876433 457
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccc
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGL 286 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 286 (450)
++++|++. ++|.+++.... .+++..+..++.|++.||+|||+ .+++|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~------~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQ------PLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEeccc-CCHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 88899984 68988886433 28899999999999999999994 8999999999999999999999999999
Q ss_pred cccccCCCCc-cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc--------cch
Q 013074 287 AKLCTTKKGI-VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE--------VYF 357 (450)
Q Consensus 287 a~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~--------~~~ 357 (450)
++........ ........|+..|+|||++.+. ..++.++||||||+++++|++|+.||........- ...
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 230 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSF-QSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPD 230 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCC
Confidence 9865432211 1112334688999999988653 36789999999999999999999988653210000 000
Q ss_pred hhhhhhhhhhhhhh---hhcc----cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 358 PHWIYRHVEQDREF---KLLG----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 358 ~~~i~~~~~~~~~~---~~~~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.............. .... ............+.+++.+|++.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 0000 0000011124678899999999999999999999854
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-31 Score=251.74 Aligned_cols=234 Identities=24% Similarity=0.321 Sum_probs=175.8
Q ss_pred hhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 161 FKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.+.||+|+||.||+|+.. .|+.++++++|+||+++++++.+....++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4567999999999998532 25678889999999999999999999999999996
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++.... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++++++.++|+|||+++.......
T Consensus 82 ~~l~~~i~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 82 MDLKKYLDKRP-----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred cCHHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 59999997643 128999999999999999999995 8999999999999999999999999999887644321
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh----------
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV---------- 365 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~---------- 365 (450)
. .....++..|+|||.+.+. ..++.++||||||++++||++|+.||........ ...+.+..
T Consensus 154 ~---~~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07829 154 T---YTHEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ----LFKIFQILGTPTEESWPG 225 (282)
T ss_pred c---cCccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH----HHHHHHHhCCCcHHHHHh
Confidence 1 1223357789999998653 3788999999999999999999988865321100 00000000
Q ss_pred -hhhh--hhhhc----ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 366 -EQDR--EFKLL----GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 366 -~~~~--~~~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.... ..... .............+.+++.+||+.+|++||++.+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 226 VTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred hcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000 00000 0000111123567999999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=262.25 Aligned_cols=236 Identities=22% Similarity=0.274 Sum_probs=171.2
Q ss_pred hhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCC------ceEEE
Q 013074 161 FKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGN------NRALI 209 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~------~~~lV 209 (450)
+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.... ..++|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 356899999999999852 13577888899999999999987543 46899
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+||+. .+|..+.. ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.
T Consensus 99 ~e~~~-~~l~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 99 MPYMQ-TDLQKIMG--------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred ecccc-cCHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 99995 47766542 128889999999999999999995 8999999999999999999999999999876
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh-------
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY------- 362 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~------- 362 (450)
.... .....++..|+|||.+.+. ..++.++||||||++++||++|+.||....... .+...+.
T Consensus 167 ~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 236 (342)
T cd07879 167 ADAE------MTGYVVTRWYRAPEVILNW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGP 236 (342)
T ss_pred CCCC------CCCceeeecccChhhhcCc-cccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 5332 1233478899999998653 357899999999999999999999996432100 0000000
Q ss_pred ---hhhhhhhhhhh---ccccc-----chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcccc
Q 013074 363 ---RHVEQDREFKL---LGVVT-----KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGSTE 418 (450)
Q Consensus 363 ---~~~~~~~~~~~---~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~ 418 (450)
+.......... ..... .........+.+++.+||+.||++||+++|++.. +++..+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000000 00000 0001234668899999999999999999999955 766554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=259.40 Aligned_cols=235 Identities=20% Similarity=0.276 Sum_probs=171.9
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe-CCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE-GNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++. ..|++++++++||||+++++++.. +...++|+||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 34467899999999999841 135788889999999999998876 5678999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+ +++|.+++... .+++.....++.|++.||+|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 92 ~-~~~L~~~~~~~-------~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 92 L-GTDLHRLLTSR-------PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred h-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 8 67898887532 27788888999999999999995 8999999999999999999999999999875432
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch--------hhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF--------PHWIYRH 364 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~--------~~~i~~~ 364 (450)
. .....++..|+|||.+.+. ..++.++||||||+++++|++|+.||............ .++....
T Consensus 161 ~------~~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 161 Q------MTGYVSTRYYRAPEIMLTW-QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred C------cCCCcccccccCceeeecc-CCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 2 1233478899999987652 36789999999999999999999998643211000000 0000000
Q ss_pred hhhhhhhhh---cc---c--ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 365 VEQDREFKL---LG---V--VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 365 ~~~~~~~~~---~~---~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... ..... .. . ........+..+.+++.+||+.+|++||++++++..
T Consensus 234 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000 00 0 000011235788999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=246.62 Aligned_cols=214 Identities=27% Similarity=0.308 Sum_probs=171.5
Q ss_pred cccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 165 LGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 165 LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
||+|+||.||+++.. +|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999998532 236778899999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
.+++.... .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~------~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--- 148 (250)
T cd05123 81 FSHLSKEG------RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--- 148 (250)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC---
Confidence 99997543 28999999999999999999995 9999999999999999999999999999887644321
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
......++..|++||...+. ..+.++|+||||++++++++|..||..... .. ....+... ..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~--~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~-~~~~~~~~--------~~ 210 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGK--GYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KE-IYEKILKD--------PL 210 (250)
T ss_pred cccCCcCCccccChHHhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHhcC--------CC
Confidence 12334578899999998764 678899999999999999999999864321 00 11111110 01
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHH
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNE 408 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 408 (450)
..+...+..+.+++.+||+.||++||++.+
T Consensus 211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 211 RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 112223577899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=258.20 Aligned_cols=235 Identities=22% Similarity=0.252 Sum_probs=171.8
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCC------ceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGN------NRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~------~~~ 207 (450)
|.+.+.||+|+||.||++.. .+|+.++++++||||+++++++..+. ..+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 33457899999999999841 13577889999999999999987654 358
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+ +++|.+++... .+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++
T Consensus 97 lv~e~~-~~~l~~~~~~~-------~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 97 LVMPFM-GTDLGKLMKHE-------KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 999999 77998887532 28899999999999999999995 89999999999999999999999999998
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch-------hhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF-------PHW 360 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~-------~~~ 360 (450)
....... ....++..|+|||.+.+. ..++.++|+||||+++++|++|+.||............ +..
T Consensus 166 ~~~~~~~------~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 166 RQTDSEM------TGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccCc------cccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 8654321 233478899999998753 35789999999999999999999998644211000000 000
Q ss_pred hhhhhhhhhhhh----hccc----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 361 IYRHVEQDREFK----LLGV----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 361 i~~~~~~~~~~~----~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
....+....... .... .......+...+.+++.+|++.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000000 0000 00011233456889999999999999999999994
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-31 Score=259.58 Aligned_cols=234 Identities=21% Similarity=0.259 Sum_probs=169.4
Q ss_pred hhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC------CceEEE
Q 013074 161 FKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG------NNRALI 209 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~------~~~~lV 209 (450)
+.+.||+|+||.||+|.. .+|+.++++++||||+++++++... ...+++
T Consensus 21 ~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 100 (345)
T cd07877 21 NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100 (345)
T ss_pred EEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEE
Confidence 356899999999999842 1257788899999999999988643 346788
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
++++ +++|.+++... .+++..++.++.|++.||.|||+ .+++|+||||+||++++++.+||+|||++..
T Consensus 101 ~~~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 101 THLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH 169 (345)
T ss_pred ehhc-ccCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccc
Confidence 8887 78998877532 28899999999999999999995 8999999999999999999999999999876
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch-------hhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF-------PHWIY 362 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~-------~~~i~ 362 (450)
.... .....++..|+|||.+.+. ..++.++||||||+++++|++|+.||...........+ +..+.
T Consensus 170 ~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (345)
T cd07877 170 TDDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 242 (345)
T ss_pred cccc------ccccccCCCccCHHHHhCc-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5332 1234578899999998653 36788999999999999999999998543211000000 00000
Q ss_pred hhhhhhhhhhh---cccccc-----hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 363 RHVEQDREFKL---LGVVTK-----KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 363 ~~~~~~~~~~~---~~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..+........ ...... .......++.+++.+|++.||.+||++.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 243 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000000 000000 001134678899999999999999999999866
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=272.81 Aligned_cols=230 Identities=30% Similarity=0.461 Sum_probs=185.4
Q ss_pred hhccccccceEEEEEE----------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 162 KDKLGQGGFGGVYKGK----------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~----------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.++||.|+||+||+|- +.+|+-.+.+++|||+++++|+|..+. ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 3589999999999994 345677889999999999999998776 88999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
+.|+|.++++.++.. +.-...+.|..|||+||.|||+ ++++||||-.+|||+..-..+||.|||+++.....
T Consensus 780 P~G~LlDyvr~hr~~-----igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 780 PLGCLLDYVREHRDN-----IGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred ccchHHHHHHHhhcc-----ccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999875532 7888999999999999999995 99999999999999999999999999999988665
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
...... ....-.+.|||-|.+... .+++++|||||||.+||++| |..|.+.....+ |.+. .
T Consensus 852 ~~ey~~-~~gK~pikwmale~i~~~--~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e--------I~dl-------l 913 (1177)
T KOG1025|consen 852 EKEYSA-PGGKVPIKWMALESIRIR--KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE--------IPDL-------L 913 (1177)
T ss_pred cccccc-cccccCcHHHHHHHhhcc--CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH--------hhHH-------H
Confidence 443321 222235789999998774 89999999999999999985 666665332110 1111 1
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
..+.+.+.+.-+..++..++.+||..|+..||+++++.+.+.....
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 2233345666778899999999999999999999999887765443
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=259.91 Aligned_cols=235 Identities=22% Similarity=0.263 Sum_probs=172.9
Q ss_pred HhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCc------eEE
Q 013074 160 SFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNN------RAL 208 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~------~~l 208 (450)
.+.+.||+|+||.||+|+.. +|+.++++++|+||+++++++..+.. .++
T Consensus 18 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07851 18 QNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97 (343)
T ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence 34678999999999998521 25778888999999999998876554 899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
|+||+ +++|.+++... .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.++|+|||++.
T Consensus 98 v~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 98 VTHLM-GADLNNIVKCQ-------KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred EEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccccc
Confidence 99999 67999888642 28999999999999999999994 899999999999999999999999999988
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccc--------hhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY--------FPHW 360 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~--------~~~~ 360 (450)
..... .....++..|+|||.+.+. ...+.++||||||+++++|++|+.||........... -+.+
T Consensus 167 ~~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 167 HTDDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred ccccc------ccCCcccccccCHHHHhCC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 66432 1233478899999998653 3678999999999999999999999864322100000 0000
Q ss_pred hhhhhhhhhh-hh--hccc----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 361 IYRHVEQDRE-FK--LLGV----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 361 i~~~~~~~~~-~~--~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..+....... .. .... ........+.++.+++.+||+.+|++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000000 00 0000 000011235789999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=244.09 Aligned_cols=203 Identities=19% Similarity=0.152 Sum_probs=159.8
Q ss_pred ccceEEEEEEEc------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCC
Q 013074 168 GGFGGVYKGKLL------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK 229 (450)
Q Consensus 168 G~fg~Vy~~~~~------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~ 229 (450)
|.||.||+++.. .+...+....||||+++++++.+....++||||+++++|.+++.....
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-- 81 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN-- 81 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhhhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC--
Confidence 788899987532 234444555799999999999999999999999999999999865432
Q ss_pred CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCcccc
Q 013074 230 PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309 (450)
Q Consensus 230 ~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y 309 (450)
+++..+..++.|++.||+|||+ .+++|+||||+||+++.++.++++|||.+....... ....++..|
T Consensus 82 ----l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~------~~~~~~~~y 148 (237)
T cd05576 82 ----IPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC------DGEAVENMY 148 (237)
T ss_pred ----CCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc------ccCCcCccc
Confidence 8899999999999999999995 899999999999999999999999999876654321 223456789
Q ss_pred ccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHH
Q 013074 310 IALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMI 389 (450)
Q Consensus 310 ~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 389 (450)
+|||.+... .++.++|+||+|+++|||++|..++........ ..... ..+...+..+.
T Consensus 149 ~aPE~~~~~--~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------------~~~~~-------~~~~~~~~~~~ 206 (237)
T cd05576 149 CAPEVGGIS--EETEACDWWSLGAILFELLTGKTLVECHPSGIN-------------THTTL-------NIPEWVSEEAR 206 (237)
T ss_pred cCCcccCCC--CCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------------ccccc-------CCcccCCHHHH
Confidence 999998663 678999999999999999999987653211100 00000 11123456788
Q ss_pred HHHHHccccCCCCCCCHH
Q 013074 390 IVGLWCIQARPYDRPPMN 407 (450)
Q Consensus 390 ~l~~~Cl~~dP~~RPs~~ 407 (450)
+++.+|++.||++||++.
T Consensus 207 ~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 207 SLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHccCCHHHhcCCC
Confidence 999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=274.91 Aligned_cols=234 Identities=21% Similarity=0.234 Sum_probs=176.8
Q ss_pred HHHhhHhhhccccccceEEEEEEEcc--------------------------hhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 155 KKITNSFKDKLGQGGFGGVYKGKLLD--------------------------GLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 155 ~~~~~~~~~~LG~G~fg~Vy~~~~~~--------------------------e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
+..++.+.+.||+|+||.|..++... |-.++..-+.+=|+.+.-.|.++.++|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 34456678899999999999987532 2233333356668999989999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
|||||+||+|...+...+. +++..+..++..|+.||+-+|+ .|+|||||||+|||||..|++||+|||.+-
T Consensus 153 VMdY~pGGDlltLlSk~~~------~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDR------LPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred EEecccCchHHHHHhhcCC------ChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHH
Confidence 9999999999999987652 8999999999999999999994 999999999999999999999999999987
Q ss_pred cccCCCCccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
.+....... ....+|||.|++||++... .+.|.+..|.||+||++|||+.|..||....-.. .+.++
T Consensus 224 km~~dG~V~--s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve--------TY~KI 293 (1317)
T KOG0612|consen 224 KMDADGTVR--SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE--------TYGKI 293 (1317)
T ss_pred hcCCCCcEE--eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH--------HHHHH
Confidence 765433222 3566799999999998632 2578999999999999999999999997542110 12222
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP---MNEVIEM 412 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~~ 412 (450)
...... .. .+ ....++.+..+++.+.+. +|+.|-. ++++-..
T Consensus 294 m~hk~~--l~-FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 294 MNHKES--LS-FP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred hchhhh--cC-CC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 111110 00 11 223466777777776554 6778877 8877654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=248.40 Aligned_cols=240 Identities=20% Similarity=0.273 Sum_probs=178.5
Q ss_pred cccchhHHHHHhhHhhhccccccceEEEEEEEcc------------------------hh-hhhhhcCCCceeeeeeEEE
Q 013074 147 KRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLD------------------------GL-ASISRTSHVNVVTLLGFCL 201 (450)
Q Consensus 147 ~~~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~~~~------------------------e~-~~l~~l~HpnIv~l~~~~~ 201 (450)
..|+-++++.. ..||.|+||+|++..+.. |. .+++.-+.||||+++|.+.
T Consensus 59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 44555555543 469999999999864221 11 2234447899999999999
Q ss_pred eCCceEEEEEecCCCChhhhhh---cCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC
Q 013074 202 EGNNRALIYEFMPNGSLEKFVY---NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC 278 (450)
Q Consensus 202 ~~~~~~lV~E~~~~gsL~~~l~---~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~ 278 (450)
.++..++.||.| ..||+.+.. .-.. ..+++.-+-+|......||.||-+ ...|+|||+||+|||++..|.
T Consensus 134 ~EGdcWiCMELM-d~SlDklYk~vy~vq~----~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~ 206 (361)
T KOG1006|consen 134 SEGDCWICMELM-DISLDKLYKRVYSVQK----SRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGD 206 (361)
T ss_pred cCCceeeeHHHH-hhhHHHHHHHHHHHHh----ccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCC
Confidence 999999999999 567765542 2221 238888888899999999999997 689999999999999999999
Q ss_pred eEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchh
Q 013074 279 PKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP 358 (450)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 358 (450)
+||+|||.+........ .+.-.|-..|||||.+......++.+|||||||+.|+|+.||+.|+..-.+
T Consensus 207 vKLCDFGIcGqLv~SiA----kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------- 274 (361)
T KOG1006|consen 207 VKLCDFGICGQLVDSIA----KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------- 274 (361)
T ss_pred EeeecccchHhHHHHHH----hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--------
Confidence 99999999876654322 223348889999999987655699999999999999999999998752111
Q ss_pred hhhhhhhhhhhhhhhcccc-cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 359 HWIYRHVEQDREFKLLGVV-TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 359 ~~i~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+.+++.+.......... .....+....|+.++..|+..|-.+||..+++.++
T Consensus 275 --vfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 275 --VFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --HHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 22222222111111111 22234577889999999999999999999998754
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=239.17 Aligned_cols=248 Identities=20% Similarity=0.306 Sum_probs=186.0
Q ss_pred ccchhHHHHHhhHhhhccccccceEEEEEE-----------------------Ecchhhhhhhc-CCCceeeeeeEEEeC
Q 013074 148 RYNFSDVKKITNSFKDKLGQGGFGGVYKGK-----------------------LLDGLASISRT-SHVNVVTLLGFCLEG 203 (450)
Q Consensus 148 ~~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~-----------------------~~~e~~~l~~l-~HpnIv~l~~~~~~~ 203 (450)
.-.|.|+.+.|. +.||+|+|+.|--+. ..+|++++... .|+||++++++|+++
T Consensus 72 ~g~F~d~YkLt~---e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 72 SGKFEDMYKLTS---ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred cchHHHHHHhHH---HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 345778777765 569999999996653 23456666665 599999999999999
Q ss_pred CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC---CeE
Q 013074 204 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF---CPK 280 (450)
Q Consensus 204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~k 280 (450)
..+|||||.|.||.|..++..+.. +++.++..+..+|+.||++||. .+|.|||+||+|||-.+.. -+|
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~~------F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRKH------FNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhhh------ccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCcee
Confidence 999999999999999999976543 9999999999999999999994 9999999999999997544 479
Q ss_pred EeeccccccccCCCC----ccccccCCCCcccccccccccc---ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCC--
Q 013074 281 ISDFGLAKLCTTKKG----IVSSLLGARGTIGYIALEVFSR---NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN-- 351 (450)
Q Consensus 281 l~DFGla~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~---~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~-- 351 (450)
|+||.+......... ......+.+|+..|||||+..- ....|+.+.|.|||||++|-||.|-+||......
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 999988765432111 1223456789999999998642 2236899999999999999999999999754321
Q ss_pred ---CCc--cchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 352 ---SSE--VYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 352 ---~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+++ ....+.+.+.++++.- +.+ ...-..++.+..+++...+..++.+|-++..++.
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkY-eFP---dkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKY-EFP---DKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCC-cCC---hhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111 1223334444433321 111 1112345667778888888999999999998886
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=247.03 Aligned_cols=247 Identities=23% Similarity=0.303 Sum_probs=177.7
Q ss_pred hhhccccccceEEEEEEEcch------------------hhhhh--hcCCCceeeeeeEEEeCC----ceEEEEEecCCC
Q 013074 161 FKDKLGQGGFGGVYKGKLLDG------------------LASIS--RTSHVNVVTLLGFCLEGN----NRALIYEFMPNG 216 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~~e------------------~~~l~--~l~HpnIv~l~~~~~~~~----~~~lV~E~~~~g 216 (450)
+.+.||+|.||.||+|+++.| .++.+ -++|+||+.+++.=..++ .++||.+|.++|
T Consensus 215 L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~G 294 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHG 294 (513)
T ss_pred EEEEecCccccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCC
Confidence 356899999999999986544 33332 358999999998654433 578999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhc-----CCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHR-----GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~-----~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
||.+||.... ++.+..++++..+|.||++||- .....|.|||||.+|||+.+++...|+|+|||....
T Consensus 295 SL~DyL~r~t-------v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~ 367 (513)
T KOG2052|consen 295 SLYDYLNRNT-------VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 367 (513)
T ss_pred cHHHHHhhcc-------CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEec
Confidence 9999997633 8999999999999999999995 223469999999999999999999999999998765
Q ss_pred CC-CCccccccCCCCccccccccccccccC----CCCccCchHhHHHHHHHHHc----CC------CCCCCCCCCCCccc
Q 013074 292 TK-KGIVSSLLGARGTIGYIALEVFSRNFG----EVSHKSDVYSFGMMIMELVG----CK------NNLDSGVDNSSEVY 356 (450)
Q Consensus 292 ~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~s~~sDiwSlGvvl~ellt----g~------~p~~~~~~~~~~~~ 356 (450)
.. ..........+||..|||||++..... .--..+||||||.|+||++- |. .||..-...+. .
T Consensus 368 ~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP--s 445 (513)
T KOG2052|consen 368 SDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP--S 445 (513)
T ss_pred ccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC--C
Confidence 54 222333456779999999999975311 11246899999999999983 21 34433222211 1
Q ss_pred hhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 357 FPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 357 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
+.++ .+-+-..+ ............+....|.+++..||..||..|-|+=.+-+.|.++.+
T Consensus 446 ~eeM-rkVVCv~~-~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 446 FEEM-RKVVCVQK-LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred HHHH-hcceeecc-cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1111 00000000 000011122345677889999999999999999999988888887664
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=239.56 Aligned_cols=238 Identities=21% Similarity=0.301 Sum_probs=185.8
Q ss_pred hhhccccccceEEEEEEEcch-----------------------------hhhhhhcCCCceeeeeeEEEeC-CceEEEE
Q 013074 161 FKDKLGQGGFGGVYKGKLLDG-----------------------------LASISRTSHVNVVTLLGFCLEG-NNRALIY 210 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~~e-----------------------------~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~ 210 (450)
.+..+-+|.||.||+|-+++| .-.+-.+.|||++.+.+++.++ ...+++|
T Consensus 288 l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y 367 (563)
T KOG1024|consen 288 LSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLY 367 (563)
T ss_pred chhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEE
Confidence 345789999999999976655 1123345899999999999875 4667889
Q ss_pred EecCCCChhhhhhc--CCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 211 EFMPNGSLEKFVYN--GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 211 E~~~~gsL~~~l~~--~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
.++.-|+|..|+.. +...+..+.++-.+...++.|++.|++||| ..++||.||..+|.+||+.-++||+|-.+++
T Consensus 368 ~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSR 444 (563)
T KOG1024|consen 368 PATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSR 444 (563)
T ss_pred eccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhcc
Confidence 99989999999973 222223345778889999999999999999 4999999999999999999999999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
.....+...- -........||+||.+..+ .++.++|||||||++|||+| |+.|...-.. ..+.
T Consensus 445 DLFP~DYhcL-GDnEnRPvkWMslEal~n~--~yssasDvWsfGVllWELmtlg~~PyaeIDP--------fEm~----- 508 (563)
T KOG1024|consen 445 DLFPGDYHCL-GDNENRPVKWMSLEALQNS--HYSSASDVWSFGVLLWELMTLGKLPYAEIDP--------FEME----- 508 (563)
T ss_pred ccCccccccc-CCCCCCcccccCHHHHhhh--hhcchhhhHHHHHHHHHHHhcCCCCccccCH--------HHHH-----
Confidence 7655443322 1233356789999999986 89999999999999999996 5555532211 1111
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
.....+.+...+.+++.++..++..||...|++||++++++..|.+....
T Consensus 509 --~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q 558 (563)
T KOG1024|consen 509 --HYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ 558 (563)
T ss_pred --HHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence 12234455667788999999999999999999999999999999876543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=254.09 Aligned_cols=221 Identities=24% Similarity=0.326 Sum_probs=178.8
Q ss_pred hccccccceEEEEEE-------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 163 DKLGQGGFGGVYKGK-------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~-------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
+.||.|.||+||-|+ +++|+.+|+++.||.||.+.-.|++.+..++|||.+ +|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 579999999999885 456799999999999999999999999999999999 667
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC---CCeEEeeccccccccCCC
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD---FCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGla~~~~~~~ 294 (450)
..+.+...... .|+++....++.||+.||+|||. .+|+|.||||+|||+... -++||+|||.|+....+.
T Consensus 649 MLEMILSsEkg----RL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 649 MLEMILSSEKG----RLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred HHHHHHHhhcc----cchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 76666554432 28998888999999999999995 999999999999999743 489999999999987764
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
. .....||+.|+|||++..+ .|+..-|+||.||++|--++|..||..+.+. .++++...-.-..
T Consensus 722 F----RrsVVGTPAYLaPEVLrnk--GyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI----------ndQIQNAaFMyPp 785 (888)
T KOG4236|consen 722 F----RRSVVGTPAYLAPEVLRNK--GYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI----------NDQIQNAAFMYPP 785 (888)
T ss_pred h----hhhhcCCccccCHHHHhhc--cccccccceeeeEEEEEEecccccCCCccch----------hHHhhccccccCC
Confidence 3 2456699999999999986 8999999999999999999999999755432 2222221111111
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..-.+++...++++...||.+-++|-|.++.+.
T Consensus 786 ----~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 786 ----NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ----CchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 112456677888999999999999999887653
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-30 Score=243.53 Aligned_cols=249 Identities=18% Similarity=0.242 Sum_probs=185.7
Q ss_pred ccchhHHHHHhhHhhhccccccceEEEEEEEc----------------------chhhhhhhcCC--C----ceeeeeeE
Q 013074 148 RYNFSDVKKITNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRTSH--V----NVVTLLGF 199 (450)
Q Consensus 148 ~~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l~H--p----nIv~l~~~ 199 (450)
.|...|....+|.+.+.+|+|+||.|-+.... -|+++|.++.+ | -+|.+.++
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~w 159 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDW 159 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehh
Confidence 35556666777788899999999999887422 23666667632 2 37888999
Q ss_pred EEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc-----
Q 013074 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD----- 274 (450)
Q Consensus 200 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~----- 274 (450)
|.-.++.|+|+|.+ |.|+.+++..++- .+++...+..++.|++.++++||+ .+++|.||||+|||+.
T Consensus 160 FdyrghiCivfell-G~S~~dFlk~N~y----~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 160 FDYRGHICIVFELL-GLSTFDFLKENNY----IPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhccCceEEEEecc-ChhHHHHhccCCc----cccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceE
Confidence 99999999999999 7799999976553 448999999999999999999995 9999999999999993
Q ss_pred ---------------CCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHH
Q 013074 275 ---------------QDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339 (450)
Q Consensus 275 ---------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ell 339 (450)
++..++|+|||.|....... .....|..|+|||++.+- +++..+||||+||+|+|+.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h------s~iVsTRHYRAPEViLgL--GwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH------STIVSTRHYRAPEVILGL--GWSQPCDVWSIGCILVELY 303 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc------ceeeeccccCCchheecc--CcCCccCceeeeeEEEEee
Confidence 13468999999998776554 334579999999999986 8999999999999999999
Q ss_pred cCCCCCCCCCCCCCcc-------chhhhhhhhhhhhh-----hhh------------------hcccccchhHHHHHHHH
Q 013074 340 GCKNNLDSGVDNSSEV-------YFPHWIYRHVEQDR-----EFK------------------LLGVVTKKENEIAKKMI 389 (450)
Q Consensus 340 tg~~p~~~~~~~~~~~-------~~~~~i~~~~~~~~-----~~~------------------~~~~~~~~~~~~~~~l~ 389 (450)
+|...|....+.+... .+|..+........ ... ..............+++
T Consensus 304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 9999998765332110 11111111110000 000 00000111234567899
Q ss_pred HHHHHccccCCCCCCCHHHHHHH
Q 013074 390 IVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 390 ~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+++.+||..||.+|+|+.|++..
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHccCccccccHHHHhcC
Confidence 99999999999999999998853
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=243.79 Aligned_cols=223 Identities=21% Similarity=0.289 Sum_probs=175.4
Q ss_pred HHHHHhhHhhhccccccceEEEEEEEc--ch------------------------hhhhhhc-CCCceeeeeeEEEeCCc
Q 013074 153 DVKKITNSFKDKLGQGGFGGVYKGKLL--DG------------------------LASISRT-SHVNVVTLLGFCLEGNN 205 (450)
Q Consensus 153 ei~~~~~~~~~~LG~G~fg~Vy~~~~~--~e------------------------~~~l~~l-~HpnIv~l~~~~~~~~~ 205 (450)
-++...++|...||+|+||+|.+|.-+ +| -++|+-. +-|.++++..++++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 455666788999999999999998522 22 1222211 45678888888999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
+|+||||+.||+|--.+.+-+. +.+..+.-++..||-||-+|| +.+|+.||||.+||++|.+|++||+|||
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~Gk------FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFG 495 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGK------FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFG 495 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcc------cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecc
Confidence 9999999999999888876654 667788889999999999999 5999999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
+.+..-... ....+.+||+.|+|||.+.-+ .|...+|.|||||+||||+.|++||+...+.. +.+.+
T Consensus 496 mcKEni~~~---~TTkTFCGTPdYiAPEIi~Yq--PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--------lF~aI 562 (683)
T KOG0696|consen 496 MCKENIFDG---VTTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--------LFQAI 562 (683)
T ss_pred cccccccCC---cceeeecCCCcccccceEEec--ccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHH
Confidence 988543322 124578899999999999875 89999999999999999999999998754321 12222
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCC
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP 405 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 405 (450)
.+. -...+...+++..+++...+...|.+|..
T Consensus 563 ~eh--------nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 MEH--------NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHc--------cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 111 11334566778888888899999999963
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=268.98 Aligned_cols=120 Identities=28% Similarity=0.464 Sum_probs=106.7
Q ss_pred HhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 160 SFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.+.++||+|+||+||+|+.. .|+.+++.++||||+++++++......++||||+
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 45678999999999999532 2355677889999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
.+++|.+++...+ .+++..++.++.||+.||+|||. .+|+||||||+|||++.++.+||+|||+++
T Consensus 87 ~g~~L~~li~~~~------~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHIYG------YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999986543 27889999999999999999995 899999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=250.84 Aligned_cols=222 Identities=22% Similarity=0.245 Sum_probs=181.8
Q ss_pred hhccccccceEEEEEEEcch--------------------------hhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 162 KDKLGQGGFGGVYKGKLLDG--------------------------LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~~~e--------------------------~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
...||-|+||.|-+.+...+ -.++...+.|.||++|..|.++...|+.||-|-|
T Consensus 425 iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 425 IATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 45799999999998865432 3455566789999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|.|...+..++. ++..+...++..++.|++||| ..+||.|||||+|.+++.+|-+||.|||.|+.......
T Consensus 505 GElWTiLrdRg~------Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 505 GELWTILRDRGS------FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred chhhhhhhhcCC------cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 999999987764 888889999999999999999 49999999999999999999999999999998876543
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
..++|||+.|.|||++.+. ..+.++|.||||++++||++|++||....... .+..+..+.+.
T Consensus 576 ----TwTFcGTpEYVAPEIILnK--GHD~avDyWaLGIli~ELL~G~pPFs~~dpmk--------tYn~ILkGid~---- 637 (732)
T KOG0614|consen 576 ----TWTFCGTPEYVAPEIILNK--GHDRAVDYWALGILIYELLTGSPPFSGVDPMK--------TYNLILKGIDK---- 637 (732)
T ss_pred ----eeeecCCcccccchhhhcc--CcchhhHHHHHHHHHHHHHcCCCCCCCCchHH--------HHHHHHhhhhh----
Confidence 4568899999999999886 78999999999999999999999997654321 23333222221
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIEM 412 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 412 (450)
...+..+.+...+++++....+|.+|.. +.++-+.
T Consensus 638 --i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 638 --IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred --hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 1233456677788888888999999975 5666543
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=233.79 Aligned_cols=241 Identities=22% Similarity=0.355 Sum_probs=175.1
Q ss_pred hhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC--------CceEE
Q 013074 162 KDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG--------NNRAL 208 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--------~~~~l 208 (450)
..+||+|.||.||+|+. .+|+++|..++|+|++.++.+|... ..+|+
T Consensus 22 ~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 22 LAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 35799999999999852 2358889999999999999988642 35899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
|+.+|++ +|...+.+.. ..++..++.+++.++..||.|+|+ ..|+|||+|+.|+||+.+|.+||+|||+++
T Consensus 102 Vf~~ceh-DLaGlLsn~~-----vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRK-----VRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eHHHhhh-hHHHHhcCcc-----ccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence 9999965 8988886553 238889999999999999999995 899999999999999999999999999997
Q ss_pred cccCCC-CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchh-------hh
Q 013074 289 LCTTKK-GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP-------HW 360 (450)
Q Consensus 289 ~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~-------~~ 360 (450)
.+.... ......+...-|..|++||.+.+. ..++++.|||+-||++.||.++.+.+....+...-..+. +.
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~-r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGD-REYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcc-cccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence 664332 222223344468999999999885 589999999999999999999998876554322100000 00
Q ss_pred hhhhhhhhhhhh------hcccccchhHHHH------HHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 361 IYRHVEQDREFK------LLGVVTKKENEIA------KKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 361 i~~~~~~~~~~~------~~~~~~~~~~~~~------~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
++..+..-.... +...-.....+.. .+..+++..++..||.+|+++++++..
T Consensus 252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 111111100000 0000000111111 267788999999999999999988743
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.3e-30 Score=243.70 Aligned_cols=232 Identities=22% Similarity=0.325 Sum_probs=176.0
Q ss_pred hhccccccceEEEEEEE------------------c------------chhhhhhhcCCCceeeeeeEEE-eCCceEEEE
Q 013074 162 KDKLGQGGFGGVYKGKL------------------L------------DGLASISRTSHVNVVTLLGFCL-EGNNRALIY 210 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~------------------~------------~e~~~l~~l~HpnIv~l~~~~~-~~~~~~lV~ 210 (450)
...||+|||+.||++-. + +|.++-+.|.||.||++|+++. +.+.+|-|+
T Consensus 468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL 547 (775)
T KOG1151|consen 468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL 547 (775)
T ss_pred HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence 46799999999999831 1 2466778899999999999986 456889999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---CCCeEEeecccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ---DFCPKISDFGLA 287 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla 287 (450)
|||+|.+|+-+|..+.. ++++.+..|+.||+.||.||.+ .+.+|||.||||.|||+.. -|.+||.|||++
T Consensus 548 EYceGNDLDFYLKQhkl------mSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 548 EYCEGNDLDFYLKQHKL------MSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eecCCCchhHHHHhhhh------hhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 99999999999976543 8999999999999999999997 3468999999999999953 478999999999
Q ss_pred ccccCCCCc----cccccCCCCccccccccccccc--cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhh
Q 013074 288 KLCTTKKGI----VSSLLGARGTIGYIALEVFSRN--FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI 361 (450)
Q Consensus 288 ~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i 361 (450)
+.+...... ........||..|++||.+... ...++.|.||||.||++|..+.|+.||.......
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--------- 691 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--------- 691 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---------
Confidence 988653221 1123445699999999998643 3578999999999999999999999997553221
Q ss_pred hhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013074 362 YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410 (450)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 410 (450)
..+..+..........+.-..++.+..+++++||+..-++|....++.
T Consensus 692 -dILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 -DILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -HHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 011111111101111111233456788899999999999998877765
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=258.29 Aligned_cols=230 Identities=25% Similarity=0.343 Sum_probs=183.8
Q ss_pred HhhhccccccceEEEEEEEcc----------------------hhhhhhhc-CCCceeeeeeEEEe-----CCceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKLLD----------------------GLASISRT-SHVNVVTLLGFCLE-----GNNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~----------------------e~~~l~~l-~HpnIv~l~~~~~~-----~~~~~lV~E 211 (450)
+|.+.||.|.+|.||+++-++ |..+++.. .|||++.++|++.- ++.++||||
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVME 101 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVME 101 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEee
Confidence 456789999999999996321 24455544 69999999999863 568999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
||.+||..+++.+..+ ..+.|..+.-|++.++.||.+||. +.++|||||-.|||++.++.||+.|||++....
T Consensus 102 fC~gGSVTDLVKn~~g----~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 102 FCGGGSVTDLVKNTKG----NRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred ccCCccHHHHHhhhcc----cchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 9999999999976553 449999999999999999999994 899999999999999999999999999998776
Q ss_pred CCCCccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
..... ..+..||+.|||||++... ...++.++|+||||++..||.-|.+|+.+.........+
T Consensus 175 sT~gr---RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I----------- 240 (953)
T KOG0587|consen 175 STVGR---RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----------- 240 (953)
T ss_pred ccccc---ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-----------
Confidence 54432 3455699999999999753 235788999999999999999999999765432211111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
...+......+....+++.+++..||..|-++||++.++++.
T Consensus 241 --pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 --PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111122223456778999999999999999999999988753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=216.87 Aligned_cols=234 Identities=22% Similarity=0.348 Sum_probs=174.3
Q ss_pred hhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 162 KDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
.++||+|.||+||+|+. .+|+-+++.++|.|||+++++...+..+-+|+||| ..
T Consensus 7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hH
Confidence 36899999999999963 23577889999999999999999999999999999 56
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|..+....++ .++.+....++.|+++||.++| +.+++|||+||.|.||+.+|.+|++|||+++.+.-...
T Consensus 86 dlkkyfdslng-----~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipvr- 156 (292)
T KOG0662|consen 86 DLKKYFDSLNG-----DLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR- 156 (292)
T ss_pred HHHHHHHhcCC-----cCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence 89888866543 2888999999999999999999 69999999999999999999999999999998754321
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh-------
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR------- 369 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~------- 369 (450)
......-|..|++|+++-+. .-++...|+||-||++.|+.....|...+.+-..+ + +.+.+.+....
T Consensus 157 --cysaevvtlwyrppdvlfga-kly~tsidmwsagcifaelanagrplfpg~dvddq--l-krif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 157 --CYSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--L-KRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred --eeeceeeeeeccCcceeeee-ehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH--H-HHHHHHhCCCccccCCcc
Confidence 12334468899999999886 47899999999999999999766665554332111 1 11222111100
Q ss_pred ----hhhhccc------ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 370 ----EFKLLGV------VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 370 ----~~~~~~~------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+...... ...........-.+++...+.-+|..|.++++.++
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 00111222334567778888889999999988765
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.3e-29 Score=261.42 Aligned_cols=247 Identities=18% Similarity=0.168 Sum_probs=152.6
Q ss_pred hHhhhccccccceEEEEEEEcch------hhhhh--------------hc---CCCceeeeeeE------EEeCCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLDG------LASIS--------------RT---SHVNVVTLLGF------CLEGNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~e------~~~l~--------------~l---~HpnIv~l~~~------~~~~~~~~lV 209 (450)
+.+.++||+|+||.||+|+..+. ..+++ ++ .+.++..+... +.++...++|
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV 213 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLV 213 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCceEEE
Confidence 44678999999999999986532 11111 11 22222222221 2355678999
Q ss_pred EEecCCCChhhhhhcCCCCC--------------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC
Q 013074 210 YEFMPNGSLEKFVYNGDTSK--------------PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~ 275 (450)
+||+.+++|.+++....... ......+..+..++.|++.||+|||+ .+|+||||||+|||+++
T Consensus 214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLKP~NILl~~ 290 (566)
T PLN03225 214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVKPQNIIFSE 290 (566)
T ss_pred EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCCHHHEEEeC
Confidence 99999999999886542100 00012234566799999999999995 89999999999999985
Q ss_pred -CCCeEEeeccccccccCCCCccccccCCCCccccccccccccccC--------------------CCCccCchHhHHHH
Q 013074 276 -DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFG--------------------EVSHKSDVYSFGMM 334 (450)
Q Consensus 276 -~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--------------------~~s~~sDiwSlGvv 334 (450)
++.+||+|||+++......... .....+++.|+|||.+..... .++.++|||||||+
T Consensus 291 ~~~~~KL~DFGlA~~l~~~~~~~--~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi 368 (566)
T PLN03225 291 GSGSFKIIDLGAAADLRVGINYI--PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI 368 (566)
T ss_pred CCCcEEEEeCCCccccccccccC--CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence 5799999999998654332221 234568899999997643211 23456799999999
Q ss_pred HHHHHcCCCCCCCCCCC------CCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHH
Q 013074 335 IMELVGCKNNLDSGVDN------SSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNE 408 (450)
Q Consensus 335 l~elltg~~p~~~~~~~------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 408 (450)
+|||+++..+.+..... .....+..|... .......... ..............+++.+||+.||++|||++|
T Consensus 369 L~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e 446 (566)
T PLN03225 369 FLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEPRASPDLR-RGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA 446 (566)
T ss_pred HHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hccccchhhh-hhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence 99999866543321000 000001111000 0000000000 000000011234558999999999999999999
Q ss_pred HHHH
Q 013074 409 VIEM 412 (450)
Q Consensus 409 vl~~ 412 (450)
+++.
T Consensus 447 ~L~H 450 (566)
T PLN03225 447 ALAH 450 (566)
T ss_pred HhCC
Confidence 9975
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=227.18 Aligned_cols=205 Identities=25% Similarity=0.337 Sum_probs=163.0
Q ss_pred chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 013074 180 DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259 (450)
Q Consensus 180 ~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 259 (450)
+|++.+++++|+||+++++++..+...++++|++++++|.+++..... +++..++.++.+++.++.|||+ .
T Consensus 36 ~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~l~~~l~~lh~---~ 106 (244)
T smart00220 36 REISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR------LSEDEARFYARQILSALEYLHS---N 106 (244)
T ss_pred HHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC------CCHHHHHHHHHHHHHHHHHHHH---c
Confidence 467788889999999999999999999999999999999999865432 7889999999999999999995 8
Q ss_pred ceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHH
Q 013074 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339 (450)
Q Consensus 260 ~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ell 339 (450)
+++|+||+|+||++++++.++|+|||.+....... ......++..|++||.+... .++.++||||||+++++++
T Consensus 107 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~--~~~~~~Di~slG~~l~~l~ 180 (244)
T smart00220 107 GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----LLTTFVGTPEYMAPEVLLGK--GYGKAVDVWSLGVILYELL 180 (244)
T ss_pred CeecCCcCHHHeEECCCCcEEEccccceeeecccc----ccccccCCcCCCCHHHHccC--CCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999998775532 12344578899999998753 7888999999999999999
Q ss_pred cCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 340 GCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 340 tg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+|..|+...... ..+.+....... ........++.++.+++.+|+..+|++||++.++++
T Consensus 181 ~~~~p~~~~~~~-------~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 181 TGKPPFPGDDQL-------LELFKKIGKPKP-----PFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred hCCCCCCCCCcH-------HHHHHHHhccCC-----CCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 999988653111 001111111000 000000115578999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-29 Score=254.96 Aligned_cols=226 Identities=24% Similarity=0.360 Sum_probs=168.4
Q ss_pred hhccccccceE-EEEEEEcchhhhhhhc-------------------CCCceeeeeeEEEeCCceEEEEEecCCCChhhh
Q 013074 162 KDKLGQGGFGG-VYKGKLLDGLASISRT-------------------SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF 221 (450)
Q Consensus 162 ~~~LG~G~fg~-Vy~~~~~~e~~~l~~l-------------------~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 221 (450)
.+.+|.|.-|+ ||+|.+.+.....+++ .|||||++++.-.++...|+..|.| ..+|.++
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dl 592 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDL 592 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHH
Confidence 45789998774 6999765432222222 6999999999888889999999999 6799999
Q ss_pred hhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---C--CCeEEeeccccccccCCCCc
Q 013074 222 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ---D--FCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 222 l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~--~~~kl~DFGla~~~~~~~~~ 296 (450)
+....... ........+.++.|+++||++|| +.+||||||||.||||+. + .+++|+|||+++....+...
T Consensus 593 ie~~~~d~--~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 593 IESSGLDV--EMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred Hhccccch--hhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 98741100 00111345678899999999999 599999999999999975 3 47899999999998877766
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcC-CCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGC-KNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
.....+..||.+|+|||++... .-+.++||||+|||+|+.++| ..||......+..+ . .+ ...+..
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NI--l--------~~-~~~L~~ 734 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANI--L--------TG-NYTLVH 734 (903)
T ss_pred hhcccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCchHHhhhhh--h--------cC-ccceee
Confidence 6667778899999999999875 557799999999999998876 78887553322111 0 00 011111
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 410 (450)
....... +..+++.+|+..+|..||++.+|+
T Consensus 735 -L~~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 735 -LEPLPDC---EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -eccCchH---HHHHHHHHhcCCCcccCCCHHHHh
Confidence 1111111 678899999999999999999997
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=245.38 Aligned_cols=216 Identities=18% Similarity=0.154 Sum_probs=142.9
Q ss_pred hhhhcCCCce-----eeeeeEEEe--------CCceEEEEEecCCCChhhhhhcCCCC------------------CCCc
Q 013074 184 SISRTSHVNV-----VTLLGFCLE--------GNNRALIYEFMPNGSLEKFVYNGDTS------------------KPCQ 232 (450)
Q Consensus 184 ~l~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~~~~ 232 (450)
++.+++|.++ ++++++|.. ....++||||+++++|.++++..... ....
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 3444555543 677777753 35689999999999999998753210 0112
Q ss_pred cCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccc
Q 013074 233 YLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312 (450)
Q Consensus 233 ~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aP 312 (450)
.+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++.......... .....+++.|+||
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~g~~tp~Y~aP 379 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN--PLYGMLDPRYSPP 379 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC--ccccCCCcceeCh
Confidence 35778899999999999999995 899999999999999999999999999997654322111 1122347899999
Q ss_pred ccccccc--------------------CCCCccCchHhHHHHHHHHHcCCC-CCCCCCCCCCc-----cchhhhhhhhhh
Q 013074 313 EVFSRNF--------------------GEVSHKSDVYSFGMMIMELVGCKN-NLDSGVDNSSE-----VYFPHWIYRHVE 366 (450)
Q Consensus 313 E~~~~~~--------------------~~~s~~sDiwSlGvvl~elltg~~-p~~~~~~~~~~-----~~~~~~i~~~~~ 366 (450)
|.+.... .....+.||||+||++++|+++.. |+........+ .....|. ...
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhc
Confidence 9975421 012235799999999999999875 55322111100 0001110 000
Q ss_pred hhhhhhhcccccchhHHHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 013074 367 QDREFKLLGVVTKKENEIAKKMIIVGLWCIQARP---YDRPPMNEVIEM 412 (450)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~~ 412 (450)
. . ...............+++.++|..+| .+|+|++|+++.
T Consensus 458 ~-~-----~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 G-Q-----KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred c-c-----CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0 0 00011123345678889999998765 689999999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=232.12 Aligned_cols=129 Identities=28% Similarity=0.421 Sum_probs=108.3
Q ss_pred cccCCCCCCcccchhHHHH-HhhHhhhccccccceEEEEEE----------------------EcchhhhhhhcC-----
Q 013074 138 LQNYGPLPLKRYNFSDVKK-ITNSFKDKLGQGGFGGVYKGK----------------------LLDGLASISRTS----- 189 (450)
Q Consensus 138 ~~~~~~~~~~~~~~~ei~~-~~~~~~~~LG~G~fg~Vy~~~----------------------~~~e~~~l~~l~----- 189 (450)
..+|....++.+.+.|... .+|.+.++||.|.|++||++. -.+|+++|++++
T Consensus 58 ~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~ 137 (590)
T KOG1290|consen 58 PEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPN 137 (590)
T ss_pred hhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCC
Confidence 4456666777788888877 888888999999999999984 246788888763
Q ss_pred C---CceeeeeeEEEe----CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceE
Q 013074 190 H---VNVVTLLGFCLE----GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRIL 262 (450)
Q Consensus 190 H---pnIv~l~~~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 262 (450)
| ..||+|++.|.. +.++|+|+|++ |.+|..+|..... +.++...+.+|+.||+.||.|||+ ..+||
T Consensus 138 ~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y----rGlpl~~VK~I~~qvL~GLdYLH~--ecgII 210 (590)
T KOG1290|consen 138 DPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY----RGLPLSCVKEICRQVLTGLDYLHR--ECGII 210 (590)
T ss_pred CCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC----CCCcHHHHHHHHHHHHHHHHHHHH--hcCcc
Confidence 3 369999999974 56899999999 8899999976554 238999999999999999999998 67999
Q ss_pred eeeeccccEEE
Q 013074 263 HFDIKPHNILL 273 (450)
Q Consensus 263 H~Dikp~NIll 273 (450)
|-||||+|||+
T Consensus 211 HTDlKPENvLl 221 (590)
T KOG1290|consen 211 HTDLKPENVLL 221 (590)
T ss_pred ccCCCcceeee
Confidence 99999999999
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=217.38 Aligned_cols=238 Identities=18% Similarity=0.303 Sum_probs=177.2
Q ss_pred hhHhhhccccccceEEEEEE--------------------EcchhhhhhhcC-CCceeeeeeEEEeC--CceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGK--------------------LLDGLASISRTS-HVNVVTLLGFCLEG--NNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~--------------------~~~e~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~E~~~ 214 (450)
.|++.+++|+|-|+.||.|. ..+|+.+|..+. ||||++++++..+. ....||+||+.
T Consensus 39 dYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~ 118 (338)
T KOG0668|consen 39 DYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN 118 (338)
T ss_pred hHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence 45677899999999999984 346789999997 99999999998765 45679999998
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-CCCeEEeeccccccccCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-DFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~ 293 (450)
+.+...... .++...+...+.++++||.|+| +.||.|||+||.|++||. .-.++|+|+|+|.++..+
T Consensus 119 n~Dfk~ly~---------tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 119 NTDFKQLYP---------TLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred cccHHHHhh---------hhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 877765542 2677788889999999999999 699999999999999995 457999999999998776
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCcc-chh---------hhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEV-YFP---------HWIYR 363 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~-~~~---------~~i~~ 363 (450)
..+... ..+..|--||.+..- ..++..-|+|||||++..|+..+.||..+.+...+. -+. ..+.+
T Consensus 187 ~eYnVR----VASRyfKGPELLVdy-~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 187 KEYNVR----VASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred ceeeee----eehhhcCCchheeec-hhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 654332 356788999999874 578999999999999999999999998776543210 000 00000
Q ss_pred -hhh----------hhhhhhhcccccchhHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 364 -HVE----------QDREFKLLGVVTKKENE-IAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 364 -~~~----------~~~~~~~~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+. .........-....... ...+.++++.+.|..|-++|+|++|..+.
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 000 00000000001111111 24778899999999999999999998653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=222.20 Aligned_cols=223 Identities=18% Similarity=0.262 Sum_probs=175.6
Q ss_pred hhhccccccceEEEEEEEcch-----hhhhh----------------------hcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 161 FKDKLGQGGFGGVYKGKLLDG-----LASIS----------------------RTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~~e-----~~~l~----------------------~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
+.+.||+|+|.+|..+++... +++++ .-+||.+|.+..+|.++..+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 457899999999998875432 11211 227999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++|+|--++.+.. .++++.+..+...|..||.|||+ .+|+.||||.+|+|+|..|.+||.|+|+.+.-...
T Consensus 334 ~ggdlmfhmqrqr------klpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 334 NGGDLMFHMQRQR------KLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred cCcceeeehhhhh------cCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 9999976665433 29999999999999999999995 99999999999999999999999999998864332
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
. ....+.+||+.|+|||.+.+. .|....|.|+|||+++||+.|+.||+.-.....+.+...++.+.+.+...
T Consensus 405 g---d~tstfcgtpnyiapeilrge--eygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--- 476 (593)
T KOG0695|consen 405 G---DTTSTFCGTPNYIAPEILRGE--EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--- 476 (593)
T ss_pred C---cccccccCCCcccchhhhccc--ccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc---
Confidence 2 124678899999999999986 88899999999999999999999998665555555555555555433221
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCC
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPP 405 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs 405 (450)
..+...+.+...++..-|..||.+|..
T Consensus 477 -----riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 477 -----RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred -----cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 112233445566777788999999853
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-28 Score=211.56 Aligned_cols=178 Identities=28% Similarity=0.371 Sum_probs=141.6
Q ss_pred hhccccccceEEEEEEEcc------------------------hhhhhhh-cCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 162 KDKLGQGGFGGVYKGKLLD------------------------GLASISR-TSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~~~------------------------e~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
...||+|+||.|-+.++.. |+.+..+ ..+|.+|+++|........++.||.| ..
T Consensus 51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT 129 (282)
T ss_pred hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence 4679999999986654321 2222222 26899999999999999999999999 56
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
||+.+...-- +....+++..+-+|+..+..||.|||+ ...++|||+||+|||++.+|++|+||||.+....+....
T Consensus 130 Sldkfy~~v~--~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 130 SLDKFYRKVL--KKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred hHHHHHHHHH--hcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 8877654311 112348899999999999999999998 789999999999999999999999999999877554321
Q ss_pred cccccCCCCccccccccccccc--cCCCCccCchHhHHHHHHHHHcCCCCCCCC
Q 013074 297 VSSLLGARGTIGYIALEVFSRN--FGEVSHKSDVYSFGMMIMELVGCKNNLDSG 348 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~sDiwSlGvvl~elltg~~p~~~~ 348 (450)
+...|-..|||||.+... ...|+-||||||||+.+.||.+++.|++..
T Consensus 206 ----t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 206 ----TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ----HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 223478899999998653 236899999999999999999999998754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-28 Score=237.70 Aligned_cols=170 Identities=24% Similarity=0.328 Sum_probs=148.5
Q ss_pred hhccccccceEEEEEEEc-------------------------------chhhhhhhcC---CCceeeeeeEEEeCCceE
Q 013074 162 KDKLGQGGFGGVYKGKLL-------------------------------DGLASISRTS---HVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~~-------------------------------~e~~~l~~l~---HpnIv~l~~~~~~~~~~~ 207 (450)
.+.||+|+||.|+.+... -|+.+|..++ |+||++++++|++++.+|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 468999999999998432 2477788876 999999999999999999
Q ss_pred EEEEec-CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccc
Q 013074 208 LIYEFM-PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGL 286 (450)
Q Consensus 208 lV~E~~-~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 286 (450)
|++|.. ++.+|.+++..... +++....-|+.|++.|+++|| +.+|||||||-+|+.++.+|.+||+|||.
T Consensus 646 l~te~hg~gIDLFd~IE~kp~------m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKPR------MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred EEecCCCCCcchhhhhhccCc------cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeeccc
Confidence 999985 45689999976543 899999999999999999999 59999999999999999999999999999
Q ss_pred cccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCC
Q 013074 287 AKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD 346 (450)
Q Consensus 287 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~ 346 (450)
+....++. ....+||.+|.|||++.++ ......-|||++|++||-++....|+.
T Consensus 717 aa~~ksgp-----fd~f~gtv~~aapevl~g~-~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSGP-----FDVFVGTVDYAAPEVLGGE-KYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCCC-----cceeeeeccccchhhhCCC-ccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98876654 4567799999999999986 345677899999999999998888875
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.4e-27 Score=233.49 Aligned_cols=187 Identities=22% Similarity=0.342 Sum_probs=151.8
Q ss_pred hccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 163 DKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.||-|+||+|-+++-. .|-.+|+..+.+=||+||-.|.+.+.+|+||+|++||
T Consensus 635 k~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGG 714 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG 714 (1034)
T ss_pred eeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCc
Confidence 46999999999998532 2345666667888999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC----
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT---- 292 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~---- 292 (450)
++-.+|-+.+- |.+..+..++..+..|+++.|+ .|+|||||||+|||||.+|++||.||||..-+.-
T Consensus 715 DmMSLLIrmgI------FeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds 785 (1034)
T KOG0608|consen 715 DMMSLLIRMGI------FEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 785 (1034)
T ss_pred cHHHHHHHhcc------CHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceecccc
Confidence 99988866553 7888888899999999999995 9999999999999999999999999999853321
Q ss_pred -----CC-----Cc-------------------------cccccCCCCccccccccccccccCCCCccCchHhHHHHHHH
Q 013074 293 -----KK-----GI-------------------------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIME 337 (450)
Q Consensus 293 -----~~-----~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~e 337 (450)
++ +. ........||+.|+|||++... .++...|.||.||+|||
T Consensus 786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~--g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART--GYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc--CccccchhhHhhHHHHH
Confidence 00 00 0001134599999999999885 89999999999999999
Q ss_pred HHcCCCCCCCCCCCCCccchhhh
Q 013074 338 LVGCKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 338 lltg~~p~~~~~~~~~~~~~~~~ 360 (450)
|+.|+.||.............+|
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeeh
Confidence 99999999877655544444343
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-29 Score=226.24 Aligned_cols=240 Identities=23% Similarity=0.315 Sum_probs=171.6
Q ss_pred hhccccccceEEEEEE-------------------------EcchhhhhhhcCCCceeeeeeEEEeCC-----ceEEEEE
Q 013074 162 KDKLGQGGFGGVYKGK-------------------------LLDGLASISRTSHVNVVTLLGFCLEGN-----NRALIYE 211 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~-------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~-----~~~lV~E 211 (450)
.+.||-|+||.||-.. +.+|+++|.-++|.||+..+++..-.. .+|++.|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 3579999999999653 345688888899999999998765432 4678889
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
.| ..+|.+.+-.- +.++...+.-+++||++||+||| +.+|+||||||.|.|++.|..+||+|||+++...
T Consensus 138 Lm-QSDLHKIIVSP------Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 138 LM-QSDLHKIIVSP------QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HH-HhhhhheeccC------CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccc
Confidence 88 56888777533 34888888899999999999999 5999999999999999999999999999999775
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh-------hh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY-------RH 364 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~-------~~ 364 (450)
..+... ++...-|.+|+|||.+.+. ..|+.+.||||.||++.||+..+..|...........+.+.+. +.
T Consensus 208 ~d~~~h--MTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 208 QRDRLN--MTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred hhhhhh--hHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 544322 3344568899999999886 5899999999999999999988888865433221111111100 00
Q ss_pred hhhhhhhh-hc-ccccc---------hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 365 VEQDREFK-LL-GVVTK---------KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 365 ~~~~~~~~-~~-~~~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
.-++.... +. ..... .......+-..+...++..||++|.+.++.+..+.
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 00010000 00 00000 01112234566677889999999999998887654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=201.84 Aligned_cols=190 Identities=37% Similarity=0.588 Sum_probs=162.4
Q ss_pred cccccceEEEEEEEc------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhh
Q 013074 165 LGQGGFGGVYKGKLL------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEK 220 (450)
Q Consensus 165 LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 220 (450)
||+|.+|.||+++.. +|++.+++++|++|+++++++......++++|++.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999998643 34678888999999999999999999999999999899999
Q ss_pred hhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-CCCeEEeeccccccccCCCCcccc
Q 013074 221 FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-DFCPKISDFGLAKLCTTKKGIVSS 299 (450)
Q Consensus 221 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~ 299 (450)
++.... ..+++..++.++.++++++.+||+ .+++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---~ 149 (215)
T cd00180 81 LLKENE-----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---L 149 (215)
T ss_pred HHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---h
Confidence 987542 128899999999999999999995 89999999999999999 89999999999987654321 1
Q ss_pred ccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccc
Q 013074 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379 (450)
Q Consensus 300 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 379 (450)
.....+...|++||.+... ...+.++|+|++|++++++
T Consensus 150 ~~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l----------------------------------------- 187 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL----------------------------------------- 187 (215)
T ss_pred hhcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence 2234478899999998663 3678899999999999999
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 013074 380 KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413 (450)
Q Consensus 380 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L 413 (450)
..+.+++.+|++.+|.+||++.++++.+
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5688899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-26 Score=252.16 Aligned_cols=203 Identities=19% Similarity=0.216 Sum_probs=141.7
Q ss_pred hhhhhhcCC-CceeeeeeEE-------EeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHh
Q 013074 182 LASISRTSH-VNVVTLLGFC-------LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 253 (450)
Q Consensus 182 ~~~l~~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL 253 (450)
.+..++++| +||+.++++| .+...+++++|++ +++|.+++.... ..+++..++.++.||++||+||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~l 96 (793)
T PLN00181 23 TDGSKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----RSVDAFECFHVFRQIVEIVNAA 96 (793)
T ss_pred CCccchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----ccccHHHHHHHHHHHHHHHHHH
Confidence 344567788 7899999988 3334677889988 679999996432 2389999999999999999999
Q ss_pred hcCCCCceEeeeeccccEEEcC-------------------CCCeEEeeccccccccCCCC-------------cccccc
Q 013074 254 HRGCSTRILHFDIKPHNILLDQ-------------------DFCPKISDFGLAKLCTTKKG-------------IVSSLL 301 (450)
Q Consensus 254 H~~~~~~ivH~Dikp~NIll~~-------------------~~~~kl~DFGla~~~~~~~~-------------~~~~~~ 301 (450)
| +.+|+||||||+||||+. ++.+|++|||+++....... ......
T Consensus 97 H---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (793)
T PLN00181 97 H---SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQI 173 (793)
T ss_pred H---hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccc
Confidence 9 499999999999999954 44566666666653211000 000011
Q ss_pred CCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchh
Q 013074 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKE 381 (450)
Q Consensus 302 ~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 381 (450)
...||+.|||||++.+. .++.++|||||||++|||+++..|+..... .+ ..+.. .. .....
T Consensus 174 ~~~gt~~Y~APE~~~~~--~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~-----~~~~~---~~----~~~~~ 234 (793)
T PLN00181 174 LAMEMSWYTSPEEDNGS--SSNCASDVYRLGVLLFELFCPVSSREEKSR-----TM-----SSLRH---RV----LPPQI 234 (793)
T ss_pred ccCCCcceEChhhhccC--CCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HH-----HHHHH---hh----cChhh
Confidence 23578899999998774 789999999999999999998776532110 00 00000 00 00111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 382 NEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 382 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.....+...++.+||+.+|.+||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 235 LLNWPKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 1112345678889999999999999999863
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.3e-25 Score=195.55 Aligned_cols=167 Identities=19% Similarity=0.200 Sum_probs=123.7
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++...+ ..+++..++.++.|++.||.|||+ .+ ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~- 63 (176)
T smart00750 1 VSLADILEVRG-----RPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ- 63 (176)
T ss_pred CcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-
Confidence 68899987543 239999999999999999999995 44 999999999999999 99988664321
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
..||..|+|||++.+. .++.++|||||||++|||++|+.||....... ..+..+. .... . ...
T Consensus 64 -------~~g~~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~-~~~~----~-~~~ 126 (176)
T smart00750 64 -------SRVDPYFMAPEVIQGQ--SYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILL-NGMP----A-DDP 126 (176)
T ss_pred -------CCCcccccChHHhcCC--CCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHH-HHhc----c-CCc
Confidence 2488999999999874 78999999999999999999999986432211 0011110 0000 0 000
Q ss_pred cccchhHHHHH--HHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 376 VVTKKENEIAK--KMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 376 ~~~~~~~~~~~--~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
........... ++.+++.+||+.+|.+||++.|+++.+...
T Consensus 127 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 127 RDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred cccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 00011223333 699999999999999999999999988654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.6e-26 Score=208.96 Aligned_cols=210 Identities=22% Similarity=0.256 Sum_probs=159.0
Q ss_pred cchhhhhhhcCCCceeeeeeEEEeC------CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHH
Q 013074 179 LDGLASISRTSHVNVVTLLGFCLEG------NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252 (450)
Q Consensus 179 ~~e~~~l~~l~HpnIv~l~~~~~~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~y 252 (450)
.+|...+..+.|+||++++.++.-. ...|+|||+| ..+|...+... ++-+++..++.|++.|++|
T Consensus 63 ~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~e--------lDH~tis~i~yq~~~~ik~ 133 (369)
T KOG0665|consen 63 YRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILME--------LDHETISYILYQMLCGIKH 133 (369)
T ss_pred hhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHHh--------cchHHHHHHHHHHHHHHHH
Confidence 4678889999999999999998643 3678999999 67998887621 6778899999999999999
Q ss_pred hhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHH
Q 013074 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFG 332 (450)
Q Consensus 253 LH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlG 332 (450)
|| +.+|+||||||+||++..+..+||.|||+++.-... ..++....|..|+|||++.+. .+.+.+||||+|
T Consensus 134 lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~----~~mtpyVvtRyyrapevil~~--~~ke~vdiwSvG 204 (369)
T KOG0665|consen 134 LH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD----FMMTPYVVTRYYRAPEVILGM--GYKENVDIWSVG 204 (369)
T ss_pred HH---hcceeecccCcccceecchhheeeccchhhcccCcc----cccCchhheeeccCchheecc--CCcccchhhhhh
Confidence 99 599999999999999999999999999999865433 124556689999999999986 599999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCCccchhhhh--------------hhhhhhhhhhh--------------hccc----ccch
Q 013074 333 MMIMELVGCKNNLDSGVDNSSEVYFPHWI--------------YRHVEQDREFK--------------LLGV----VTKK 380 (450)
Q Consensus 333 vvl~elltg~~p~~~~~~~~~~~~~~~~i--------------~~~~~~~~~~~--------------~~~~----~~~~ 380 (450)
|++.||++|+..|.... .+..|. .+.....+... ..+. ....
T Consensus 205 ci~gEli~~~Vlf~g~d------~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~ 278 (369)
T KOG0665|consen 205 CIMGELILGTVLFPGKD------HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEG 278 (369)
T ss_pred hHHHHHhhceEEecCch------HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccC
Confidence 99999999998886332 122221 00000000000 0000 0001
Q ss_pred hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 381 ENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 381 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+.--.....+++.+||-.||++|.+++++++.
T Consensus 279 ~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 279 SKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred CccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 11123456788999999999999999999976
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.8e-26 Score=220.02 Aligned_cols=254 Identities=19% Similarity=0.237 Sum_probs=195.3
Q ss_pred CCCcccchhHHHHHhhHhhhccccccceEEEEEEE----------------------cchhhhhhhcC------CCceee
Q 013074 144 LPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTS------HVNVVT 195 (450)
Q Consensus 144 ~~~~~~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~------HpnIv~ 195 (450)
..+.++.+.|+....|.+....|+|-|++|-+|+. +.|+++|++|+ --|+++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 35678899999999999999999999999999852 24688999885 347999
Q ss_pred eeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC
Q 013074 196 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 196 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~ 275 (450)
++..|...+++|||+|-+ ..+|.+.|...+.. ..|....+..++.|+.-||..|-. .+|+|.||||+|||+++
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~n---vGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN---VGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcc---cceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEecc
Confidence 999999999999999998 67999999876643 237788899999999999999994 99999999999999996
Q ss_pred C-CCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 013074 276 D-FCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE 354 (450)
Q Consensus 276 ~-~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~ 354 (450)
. ..+||||||.|......+. +...-+..|.|||++.+. .|+...|+||.||.||||.||+..|....+....
T Consensus 572 ~k~iLKLCDfGSA~~~~enei-----tPYLVSRFYRaPEIiLG~--~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ML 644 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI-----TPYLVSRFYRAPEIILGL--PYDYPIDTWSVGCTLYELYTGKILFPGRTNNQML 644 (752)
T ss_pred CcceeeeccCccccccccccc-----cHHHHHHhccCcceeecC--cccCCccceeeceeeEEeeccceecCCCCcHHHH
Confidence 5 4689999999987755432 222235679999999996 8999999999999999999999998766543221
Q ss_pred c-------chhhhhh-------hhhhhhh--------------------------h--hhh--cccccchhHHHHHHHHH
Q 013074 355 V-------YFPHWIY-------RHVEQDR--------------------------E--FKL--LGVVTKKENEIAKKMII 390 (450)
Q Consensus 355 ~-------~~~~~i~-------~~~~~~~--------------------------~--~~~--~~~~~~~~~~~~~~l~~ 390 (450)
. .|++.+. +++...- . ..+ ....+.........+.+
T Consensus 645 rl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rd 724 (752)
T KOG0670|consen 645 RLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRD 724 (752)
T ss_pred HHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHH
Confidence 1 1111111 1111000 0 000 01123334566788999
Q ss_pred HHHHccccCCCCCCCHHHHHH
Q 013074 391 VGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 391 l~~~Cl~~dP~~RPs~~evl~ 411 (450)
++..|+..||++|.|..+.|.
T Consensus 725 LLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 725 LLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHhccChhhcCCHHHHhc
Confidence 999999999999999998875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-25 Score=224.86 Aligned_cols=229 Identities=22% Similarity=0.296 Sum_probs=175.4
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
|+....+|.|+||.|||++. .+|+-+++..+||||+.++|.+......++.||||.+
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 34567899999999999963 3445566777999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+.-+-.+. +++.++..+.+..+.||+||| +.+-+|||||-.||++++.|.+|++|||.+..+....
T Consensus 97 gslQdiy~~Tgp------lselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 97 GSLQDIYHVTGP------LSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred Ccccceeeeccc------chhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhh-
Confidence 999987764433 889999999999999999999 6899999999999999999999999999987665432
Q ss_pred ccccccCCCCccccccccccc-cccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFS-RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.....+.||++|||||+-. ...+.+..++|||++|+...|+-.-++|...-...+. ....... .+ .
T Consensus 167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~--------l~LmTkS-~~--q 233 (829)
T KOG0576|consen 167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA--------LFLMTKS-GF--Q 233 (829)
T ss_pred --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH--------HHHhhcc-CC--C
Confidence 2234566999999999863 2336899999999999999999877766543321111 0000000 00 0
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 410 (450)
............-+-+++..|+..+|++||+++.++
T Consensus 234 pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CCcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 001111223456678899999999999999998765
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=196.01 Aligned_cols=230 Identities=19% Similarity=0.263 Sum_probs=162.0
Q ss_pred hHhhhccccccceEEEEEEEcch------------hhhhhhc-----------CCCceeeeeeE-EEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLDG------------LASISRT-----------SHVNVVTLLGF-CLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~e------------~~~l~~l-----------~HpnIv~l~~~-~~~~~~~~lV~E~~~ 214 (450)
|++.+.||+|.||++-+++.+.. ...++.+ .|.||+..|++ |++.+.+.+++||++
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP 105 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP 105 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence 45678999999999999875432 2222211 48899988775 455567778999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc--CCCCeEEeeccccccccC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD--QDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DFGla~~~~~ 292 (450)
.|+|...+...+ +.+.--.+++.|+++|+.||| +.++||||||.+||||- +...+||+|||+.+....
T Consensus 106 ~gdL~snv~~~G-------igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 106 RGDLRSNVEAAG-------IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cchhhhhcCccc-------ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999998886543 778888899999999999999 69999999999999994 345899999999886654
Q ss_pred CCCccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
...+. ..+..|.+||+.... .....+.+|||.||++++..++|..||.-..... ....+ +.......
T Consensus 176 tV~~~------~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d--~~Y~~--~~~w~~rk 245 (378)
T KOG1345|consen 176 TVKYL------EYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD--KPYWE--WEQWLKRK 245 (378)
T ss_pred eehhh------hhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC--chHHH--HHHHhccc
Confidence 32221 245678899986532 1246789999999999999999999998443222 11222 22222222
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.. ..+......+..+..+..+-+..++++|-...++.++
T Consensus 246 ~~----~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 246 NP----ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred Cc----cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 22 1222233344556666677889999998555544443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=206.75 Aligned_cols=237 Identities=22% Similarity=0.333 Sum_probs=170.7
Q ss_pred hhccccccceEEEEEEEcc------------------------hhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 162 KDKLGQGGFGGVYKGKLLD------------------------GLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~~~------------------------e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
.++||+|.|++||++.+.. |++.|..+ .+.||+++.+++..++...+|+||+++.
T Consensus 41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~ 120 (418)
T KOG1167|consen 41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHD 120 (418)
T ss_pred hccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCcc
Confidence 4689999999999985433 45556555 4789999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc-CCCCeEEeeccccccccC-C-
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD-QDFCPKISDFGLAKLCTT-K- 293 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~~~~-~- 293 (450)
...++... ++...+...+..++.||+++| ..|||||||||+|+|.+ ..+.-.|.|||+|..... .
T Consensus 121 ~f~~l~~~---------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 121 RFRDLYRS---------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred CHHHHHhc---------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 98888743 667788899999999999999 59999999999999998 456788999999972110 0
Q ss_pred -------------------------------CCc--------cccccCCCCccccccccccccccCCCCccCchHhHHHH
Q 013074 294 -------------------------------KGI--------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMM 334 (450)
Q Consensus 294 -------------------------------~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvv 334 (450)
..+ ........||+||+|||++.+- +..+.++||||.||+
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~-~~QttaiDiws~GVI 267 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC-PRQTTAIDIWSAGVI 267 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc-cCcCCccceeeccce
Confidence 000 0011234599999999999774 577899999999999
Q ss_pred HHHHHcCCCCCCCCCCCCCccchhhh------hhh------h--hhh-h---------hhhhhc--c----------ccc
Q 013074 335 IMELVGCKNNLDSGVDNSSEVYFPHW------IYR------H--VEQ-D---------REFKLL--G----------VVT 378 (450)
Q Consensus 335 l~elltg~~p~~~~~~~~~~~~~~~~------i~~------~--~~~-~---------~~~~~~--~----------~~~ 378 (450)
++.+++++.||.....+.....-.-. +.+ . +.+ . ..+... . ...
T Consensus 268 ~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~ 347 (418)
T KOG1167|consen 268 LLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTERE 347 (418)
T ss_pred eehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeec
Confidence 99999999999866544321100000 000 0 000 0 000000 0 000
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
......+..+.+++.+|+..||.+|.|++|.|+
T Consensus 348 ~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 348 IGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred cccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 111123346889999999999999999999885
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=193.04 Aligned_cols=176 Identities=30% Similarity=0.442 Sum_probs=148.0
Q ss_pred hhhccccccceEEEEEEEcc------------------------hhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 161 FKDKLGQGGFGGVYKGKLLD------------------------GLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~~------------------------e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.+.||.|++|.||+++..+ |++.+.+++|+|++++++++......++++|+++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45789999999999996432 456777889999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++...... +++..+..++.+++.++.+||+ .+++|+|++|+||+++.++.++|+|||.+.........
T Consensus 83 ~L~~~~~~~~~~-----~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 83 DLFDYLRKKGGK-----LSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CHHHHHHhcccC-----CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999998754321 7888999999999999999995 89999999999999999999999999998877554210
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCC
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS 347 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~ 347 (450)
......++..|++||.+. ....++.++|+|+||+++++|++|+.||..
T Consensus 155 --~~~~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 --LLKTVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred --cccceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 112334778899999984 224778899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.7e-22 Score=207.03 Aligned_cols=207 Identities=20% Similarity=0.259 Sum_probs=158.9
Q ss_pred hcCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeee
Q 013074 187 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDI 266 (450)
Q Consensus 187 ~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Di 266 (450)
.++|+|++..+..+.+.....-+||||++ +|..++..... +....+..++.|+..|++|+| ..+|.|||+
T Consensus 377 ~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~------~~~~e~~c~fKqL~~Gv~y~h---~~Giahrdl 446 (601)
T KOG0590|consen 377 SLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGK------LTPLEADCFFKQLLRGVKYLH---SMGLAHRDL 446 (601)
T ss_pred cccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccc------cchhhhhHHHHHHHHHHHHHH---hcCceeccC
Confidence 46899999888877776666666999999 99999876522 777888899999999999999 599999999
Q ss_pred ccccEEEcCCCCeEEeeccccccccCCCCc-cccccCCCCccccccccccccccCCCCc-cCchHhHHHHHHHHHcCCCC
Q 013074 267 KPHNILLDQDFCPKISDFGLAKLCTTKKGI-VSSLLGARGTIGYIALEVFSRNFGEVSH-KSDVYSFGMMIMELVGCKNN 344 (450)
Q Consensus 267 kp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~-~sDiwSlGvvl~elltg~~p 344 (450)
|++|++++.+|.+||+|||.+..+...... .....+.+|+..|+|||++.+. .+.+ ..||||.|+++..|++|+.|
T Consensus 447 K~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~--~ydpr~vDiwS~~ii~~~m~~~~~~ 524 (601)
T KOG0590|consen 447 KLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGK--EYDPRAVDVWSCGIIYICMILGRFP 524 (601)
T ss_pred ccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCccccccc--ccCcchhhhhhccceEEEEecCCCc
Confidence 999999999999999999999876543322 2335677899999999999886 5554 56999999999999999999
Q ss_pred CCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 345 LDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 345 ~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
|.......... ... ..................++.....++.++|+.||.+|.|+++|++.
T Consensus 525 Wk~a~~~~~~~------~~~-~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 525 WKVAKKSDNSF------KTN-NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccccccccch------hhh-ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 98664432211 000 00000111111223345667888999999999999999999999853
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=177.74 Aligned_cols=230 Identities=20% Similarity=0.379 Sum_probs=174.2
Q ss_pred HhhhccccccceEEEEEEEcc-----------------------hhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 160 SFKDKLGQGGFGGVYKGKLLD-----------------------GLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~-----------------------e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
++.-+|.+...|..|+|++.. |.-.|.-++||||+.++|.|....+..++..||+.|
T Consensus 193 nl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 345679999999999998643 233344568999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc-eEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR-ILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
+|...++..... ..+-.+..+++.++|+|++|||. -.+ |.-.-++...+++|++.+.+|+ .+-+++...
T Consensus 273 slynvlhe~t~v----vvd~sqav~faldiargmaflhs--lep~ipr~~lns~hvmidedltaris-mad~kfsfq--- 342 (448)
T KOG0195|consen 273 SLYNVLHEQTSV----VVDHSQAVRFALDIARGMAFLHS--LEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ--- 342 (448)
T ss_pred HHHHHHhcCccE----EEecchHHHHHHHHHhhHHHHhh--cchhhhhhhcccceEEecchhhhhee-cccceeeee---
Confidence 999999876542 36778899999999999999995 233 4445688999999999888875 222222211
Q ss_pred ccccccCCCCccccccccccccccCCCC-ccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVS-HKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s-~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
..+..-.+.||+||.++......+ .++|+|||++++|||.|.+.||..-....- +....+.
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec--------------gmkiale 404 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC--------------GMKIALE 404 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh--------------hhhhhhc
Confidence 122234688999999987533333 467999999999999999999975533221 1112233
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
+.+...+...+.-+..++.-|...||.+||.++.|+-.||+..
T Consensus 405 glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 4444555667788999999999999999999999999998754
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-20 Score=182.55 Aligned_cols=242 Identities=21% Similarity=0.240 Sum_probs=174.6
Q ss_pred hhHhhhccccccceEEEEEEEc------------------------chhhhhhhcCC----CceeeeeeEE-EeCCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL------------------------DGLASISRTSH----VNVVTLLGFC-LEGNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~H----pnIv~l~~~~-~~~~~~~l 208 (450)
.+.+.++||+|+||.||.+... .|..++..+.. .++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 3456789999999999998632 23455555552 5788888888 47778899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC-----CCeEEee
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD-----FCPKISD 283 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~-----~~~kl~D 283 (450)
||+.+ |.+|.+....... ..++..+...++.|++.+|++||+ .|++||||||.|+++... ..+.|.|
T Consensus 99 VM~l~-G~sL~dl~~~~~~----~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPP----GRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEecc-CccHHHHHHhCCC----CCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 99998 8899998765542 339999999999999999999994 999999999999999854 4689999
Q ss_pred ccccc--cccCCCCc----c-ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 013074 284 FGLAK--LCTTKKGI----V-SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356 (450)
Q Consensus 284 FGla~--~~~~~~~~----~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~ 356 (450)
||+++ .+...... . ......+||..|.++....+. ..+.+.|+||++.++.|++.|..||........
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~--e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--- 245 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI--EQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--- 245 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC--ccCCchhhhhHHHHHHHHhcCCCCCccccccch---
Confidence 99999 33222211 1 112345699999999999885 889999999999999999999988854432211
Q ss_pred hhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 357 FPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 357 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
...+.+......... .....+.++..+...+-..+..++|....+.+.|+......
T Consensus 246 -----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 246 -----KSKFEKDPRKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred -----HHHHHHHhhhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111111111111100 11122345555555555689999999999999988766654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-20 Score=172.99 Aligned_cols=237 Identities=19% Similarity=0.273 Sum_probs=175.3
Q ss_pred hHhhhccccccceEEEEEE---------------------Ecchhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGK---------------------LLDGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~---------------------~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
|.+.++||+|.||..+.|+ +++|.+..+.| ..++|..++-+-.++-+-.||+|.+ |-
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP 108 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP 108 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence 3467899999999999995 34555555555 4689999998888888999999999 88
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-----CCCeEEeecccccccc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-----DFCPKISDFGLAKLCT 291 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DFGla~~~~ 291 (450)
||+++..--++. |+.+++..+|.|++.-++|+|+ ...|.|||||+|.||.. ...+.++|||+|+.+.
T Consensus 109 SLEDLFD~CgR~-----FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 109 SLEDLFDLCGRR-----FSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred CHHHHHHHhcCc-----ccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 999988654432 9999999999999999999995 99999999999999963 3468899999999987
Q ss_pred CCCCccc----cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 292 TKKGIVS----SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 292 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
+..+... .....-||..||+--...+. .-+.+.|.-|||-|+++.|-|..||..-..... +.-++++.+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGr--EQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-----K~kYeKIGe 253 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-----KEKYEKIGE 253 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccc--hhhhhhhHHHhhhhhhhhccCCCccccccCcch-----HHHHHHhcc
Confidence 6654322 23455699999998888775 789999999999999999999999976543221 112233322
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
......+......++.++..-+...-..+=.+-|..+-+...+.
T Consensus 254 ---~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 254 ---TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD 297 (449)
T ss_pred ---ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 22222333334445566665555555666667777655444443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-19 Score=171.64 Aligned_cols=243 Identities=28% Similarity=0.337 Sum_probs=175.3
Q ss_pred HhhhccccccceEEEEEEEc-----------------------chhhhhhhcCCC-ceeeeeeEEEeCCceEEEEEecCC
Q 013074 160 SFKDKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHV-NVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~Hp-nIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
.+.+.||.|+||.||++... +|...++++.|+ +|+++.+.+......+++++++.+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 82 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDG 82 (384)
T ss_pred eeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCC
Confidence 34568999999999998532 235567788888 799999999777778999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-CeEEeeccccccccCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-CPKISDFGLAKLCTTKK 294 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~ 294 (450)
+++.+++...... ..+.......++.|++.+++|+|+ .+++|||+||+||+++..+ .++++|||.++......
T Consensus 83 ~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 83 GSLEDLLKKIGRK---GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CcHHHHHHhcccc---cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 9999766544311 238889999999999999999995 8899999999999999988 79999999998655443
Q ss_pred Cccc---cccCCCCcccccccccccccc-CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 295 GIVS---SLLGARGTIGYIALEVFSRNF-GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 295 ~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.... ......|+..|++||.+.+.. ...+...|+||+|+++++++++..|+......... ....+.+.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~----~~~~~~~~~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT----SQTLKIILELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccH----HHHHHHHHhcCC
Confidence 2211 234567999999999998631 37889999999999999999999996544321000 011111111110
Q ss_pred h-hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 371 F-KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 371 ~-~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
. ................+.+++..|+..+|..|.+..+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 00000000001223567888889999999999998877764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=182.61 Aligned_cols=220 Identities=24% Similarity=0.376 Sum_probs=163.4
Q ss_pred hhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEee
Q 013074 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHF 264 (450)
Q Consensus 185 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~ 264 (450)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... ..+++.....++++++.||.|||. +.-..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-----~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-----IKLDYFFILSFIRDISKGLAYLHN--SPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-----cCccHHHHHHHHHHHHHHHHHHhc--Ccceeee
Confidence 456899999999999999999999999999999999998743 238999999999999999999996 3334999
Q ss_pred eeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCcccccccccccccc--CC---CCccCchHhHHHHHHHHH
Q 013074 265 DIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF--GE---VSHKSDVYSFGMMIMELV 339 (450)
Q Consensus 265 Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~---~s~~sDiwSlGvvl~ell 339 (450)
.++..|.++|....+||+|||+.......... ..........-|.|||.+.... .. .+.+.||||||++++|++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~-~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEP-EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccc-cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 99999999999999999999998776431000 0011112346799999997631 11 578899999999999999
Q ss_pred cCCCCCCCCCCCCCccchhhhhhhhhhh-hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 340 GCKNNLDSGVDNSSEVYFPHWIYRHVEQ-DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 340 tg~~p~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
+.+.||+........ .+.+.. +.. ......+.. ....+...++..++..||..+|.+||+++.|-..++....
T Consensus 153 ~r~~~~~~~~~~~~~---~eii~~-~~~~~~~~~rP~i--~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDP---DEIILR-VKKGGSNPFRPSI--ELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred hccCccccccccCCh---HHHHHH-HHhcCCCCcCcch--hhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 999999875443321 111211 222 111111111 1111445579999999999999999999999988876553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.5e-20 Score=181.84 Aligned_cols=139 Identities=20% Similarity=0.207 Sum_probs=106.1
Q ss_pred hHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceee-eeeEEEeCCceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVT-LLGFCLEGNNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~-l~~~~~~~~~~~l 208 (450)
|.+.+.||+|+||+||+|+. .+|++++++++|+|++. +++ .+..++
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~L 95 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKDGL 95 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEE
Confidence 44567899999999999842 23567788889999985 443 246799
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeee-ccccEEEcCCCCeEEeecccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDI-KPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Di-kp~NIll~~~~~~kl~DFGla 287 (450)
||||+++++|... . . .. ...++.+++.||.|||+ .+|+|||| ||+|||++.++.+||+|||++
T Consensus 96 VmE~~~G~~L~~~-~---~------~~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 96 VRGWTEGVPLHLA-R---P------HG---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred EEEccCCCCHHHh-C---c------cc---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 9999999999622 1 0 11 13578899999999995 99999999 999999999999999999999
Q ss_pred ccccCCCCcc-----ccccCCCCcccccccccccc
Q 013074 288 KLCTTKKGIV-----SSLLGARGTIGYIALEVFSR 317 (450)
Q Consensus 288 ~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~ 317 (450)
+.+....... .......+++.|+|||.+..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9775432111 11234568888999999864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.5e-19 Score=167.26 Aligned_cols=200 Identities=18% Similarity=0.239 Sum_probs=141.7
Q ss_pred CCCceeeeeeEEEe---------------------------CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHH
Q 013074 189 SHVNVVTLLGFCLE---------------------------GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241 (450)
Q Consensus 189 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~ 241 (450)
+|||||.+.++|.+ +..+|+||... ..+|..++..+. .+.....-
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-------~s~r~~~~ 345 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-------RSYRTGRV 345 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-------CchHHHHH
Confidence 69999999998763 23578999887 459999997654 45567777
Q ss_pred HHHHHHHHHHHhhcCCCCceEeeeeccccEEEc--CCC--CeEEeeccccccccC---CCCccccccCCCCccccccccc
Q 013074 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD--QDF--CPKISDFGLAKLCTT---KKGIVSSLLGARGTIGYIALEV 314 (450)
Q Consensus 242 i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~--~~kl~DFGla~~~~~---~~~~~~~~~~~~gt~~y~aPE~ 314 (450)
++.|+++|+.|||+ ++|.|||+|.+|||+. +|+ .+.|+|||.+-.... .-.+.+.....-|...-||||+
T Consensus 346 ~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi 422 (598)
T KOG4158|consen 346 ILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEI 422 (598)
T ss_pred HHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhh
Confidence 89999999999995 9999999999999984 444 568899997643322 1112222233447788899999
Q ss_pred cccccCCC----CccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHH
Q 013074 315 FSRNFGEV----SHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMII 390 (450)
Q Consensus 315 ~~~~~~~~----s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 390 (450)
.....|.. -.|+|.|+.|.+.||+++...||.... ++.+....++ ....+..+..++..+.+
T Consensus 423 ~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG----em~L~~r~Yq----------e~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 423 ATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG----EMLLDTRTYQ----------ESQLPALPSRVPPVARQ 488 (598)
T ss_pred hhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc----hheechhhhh----------hhhCCCCcccCChHHHH
Confidence 86543322 358999999999999999999997632 2222111111 11223344456677888
Q ss_pred HHHHccccCCCCCCCHHHHHHHh
Q 013074 391 VGLWCIQARPYDRPPMNEVIEML 413 (450)
Q Consensus 391 l~~~Cl~~dP~~RPs~~evl~~L 413 (450)
++...|+.||.+|++.+-....|
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHH
Confidence 88999999999999875444443
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.2e-19 Score=158.78 Aligned_cols=238 Identities=18% Similarity=0.231 Sum_probs=170.4
Q ss_pred hHhhhccccccceEEEEEEEc---------------------chhhhhhhcCC-CceeeeeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL---------------------DGLASISRTSH-VNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~---------------------~e~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.+.++||.|+||.+|.|... .|.++...+++ ..|..+..+..+...-.+||+.+ |.
T Consensus 17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GP 95 (341)
T KOG1163|consen 17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GP 95 (341)
T ss_pred eEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-Cc
Confidence 445689999999999999532 23333333432 35667777888888999999999 88
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---CCCeEEeeccccccccCC
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ---DFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~~~~~ 293 (450)
+|++...--. ..++.++++.++-|++.-++|+|. .+++||||||+|.|..- -..+.++|||+++.+.+.
T Consensus 96 sLEdLfnfC~-----R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 96 SLEDLFNFCS-----RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cHHHHHHHHh-----hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 9998875332 228999999999999999999995 99999999999999863 347899999999987654
Q ss_pred CCccc----cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 294 KGIVS----SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 294 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
.+... ......||..|.+--...+. ..+.+.|+-|+|.+|+++.-|..||..-..... ...++++ .
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~--eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk-----~QKyEkI---~ 237 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGI--EQSRRDDMESVGYVLMYFNRGSLPWQGLKAATK-----KQKYEKI---S 237 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhh--hhhhhhhhhhhcceeeeeecCCCcccccchhhH-----HHHHHHH---H
Confidence 33211 12345589999887776654 668899999999999999999999976543221 1112222 2
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
+......+.......+.++...+..|-+.-=++-|...-+-+...-
T Consensus 238 EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri 283 (341)
T KOG1163|consen 238 EKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI 283 (341)
T ss_pred HhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence 2233333444455566777777777877777777876555544443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=6e-19 Score=177.44 Aligned_cols=193 Identities=22% Similarity=0.209 Sum_probs=150.2
Q ss_pred hhhhhhcC-CCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc
Q 013074 182 LASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR 260 (450)
Q Consensus 182 ~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 260 (450)
..++...+ ||.+|++.-.+..+...++++++..+|.|...+..... +.+.........++-+++++|+ .+
T Consensus 47 r~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~------f~~~~~~~~~aelaLald~lh~---l~ 117 (612)
T KOG0603|consen 47 RIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM------FDELDVAFYLAELALALDHLHK---LG 117 (612)
T ss_pred HHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc------hHHHHHHHHHHHHHHHHhhcch---hH
Confidence 44455555 99999999999999999999999999999888865543 6777777788899999999994 99
Q ss_pred eEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc
Q 013074 261 ILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG 340 (450)
Q Consensus 261 ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt 340 (450)
|+|+|+|++||+++.+|.+++.|||+++..-... ..|||..|||||++. ....++|.||||++++||++
T Consensus 118 iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-------~~cgt~eymApEI~~----gh~~a~D~ws~gvl~fellt 186 (612)
T KOG0603|consen 118 IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-------IACGTYEYRAPEIIN----GHLSAADWWSFGVLAFELLT 186 (612)
T ss_pred HHHhcccccceeecccCccccCCchhhhHhHhhh-------hcccchhhhhhHhhh----ccCCcccchhhhhhHHHHhh
Confidence 9999999999999999999999999998765432 227999999999996 45789999999999999999
Q ss_pred CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCH--HHHHHHhh
Q 013074 341 CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM--NEVIEMLQ 414 (450)
Q Consensus 341 g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl~~L~ 414 (450)
|..||... +-. .+.......+.+......+++..+...+|.+|--. +.+.+.++
T Consensus 187 g~~pf~~~------------~~~--------~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~ 242 (612)
T KOG0603|consen 187 GTLPFGGD------------TMK--------RILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ 242 (612)
T ss_pred CCCCCchH------------HHH--------HHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence 99999751 001 11111223345555666677777778888888644 34444443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.1e-19 Score=189.21 Aligned_cols=231 Identities=21% Similarity=0.223 Sum_probs=162.6
Q ss_pred HhhhccccccceEEEEEEEcch----------------------hhh--hhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 160 SFKDKLGQGGFGGVYKGKLLDG----------------------LAS--ISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~e----------------------~~~--l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
.+.+.||.+.|=+|.+|+..++ ++- .+..+|||++.+.-+-..+...|||-+|..
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk- 104 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK- 104 (1431)
T ss_pred eeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh-
Confidence 3467899999988888864433 111 344589999999888888888899999984
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC-
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK- 294 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~- 294 (450)
.+|.+.+..+. ++...+.+-|+.|++.||..+|+ .+|.|||||.+||||+.-..+.|+||...+..--.+
T Consensus 105 hnLyDRlSTRP------FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 105 HNLYDRLSTRP------FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred hhhhhhhccch------HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 59999997553 27777888899999999999995 999999999999999999999999998876432111
Q ss_pred ---CccccccCCCCcccccccccccccc--------C-CCCccCchHhHHHHHHHHHcC-CCCCCCCCCCCCccchhhhh
Q 013074 295 ---GIVSSLLGARGTIGYIALEVFSRNF--------G-EVSHKSDVYSFGMMIMELVGC-KNNLDSGVDNSSEVYFPHWI 361 (450)
Q Consensus 295 ---~~~~~~~~~~gt~~y~aPE~~~~~~--------~-~~s~~sDiwSlGvvl~elltg-~~p~~~~~~~~~~~~~~~~i 361 (450)
.+.--..+...-..|+|||.+.... . ..+++-||||+||++.||++. +++|.... -+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---------L~a 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---------LLA 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---------HHh
Confidence 1111122223445799999986421 1 267889999999999999865 55654210 001
Q ss_pred hhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 362 YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
++.............+. ...+.++++.|++.||.+|.++++.++.-.|
T Consensus 247 Yr~~~~~~~e~~Le~Ie------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIE------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HhccCccCHHHHHHhCc------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 11110000000001111 1367889999999999999999999988655
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.2e-17 Score=150.57 Aligned_cols=168 Identities=15% Similarity=0.108 Sum_probs=124.1
Q ss_pred hhccccccceEEEEEE-------------------------EcchhhhhhhcC-CCceeeeeeEEEeCCceEEEEEecCC
Q 013074 162 KDKLGQGGFGGVYKGK-------------------------LLDGLASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~-------------------------~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
...|++|+||+||.+. +.+|+++|+++. |++|++++++ +..+++|||+.|
T Consensus 7 ~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 7 NEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred ceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 3579999999999863 246789999995 4789999886 346999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeee-ccccEEEcCCCCeEEeeccccccccCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDI-KPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Di-kp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
.+|...+.. ....++.|++.+|+++|+ .+|+|||| ||+|||++.++.++|+|||++.......
T Consensus 83 ~~L~~~~~~-------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 83 AAMYQRPPR-------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ccHHhhhhh-------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 888643310 113467899999999995 99999999 7999999999999999999998554322
Q ss_pred Cc----c-cc-----ccCCCCccccccccccccccCCCC-ccCchHhHHHHHHHHHcCCCCCCCCCC
Q 013074 295 GI----V-SS-----LLGARGTIGYIALEVFSRNFGEVS-HKSDVYSFGMMIMELVGCKNNLDSGVD 350 (450)
Q Consensus 295 ~~----~-~~-----~~~~~gt~~y~aPE~~~~~~~~~s-~~sDiwSlGvvl~elltg~~p~~~~~~ 350 (450)
.. . .. ..-...++.|++|+...-. ...+ .+.+.++-|..+|.++|++.+.....+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l-~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL-KRTSWIRELWFATGKPVYRFVTRRVLHWEDNE 212 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh-ccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence 10 0 00 0011256778888765432 1233 567889999999999999988765543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.6e-18 Score=154.97 Aligned_cols=153 Identities=12% Similarity=0.121 Sum_probs=114.2
Q ss_pred hHHHHHhhHhhhccccccceEEEEEEE------------------------------cchhhhhhhcCCCceeeeeeEEE
Q 013074 152 SDVKKITNSFKDKLGQGGFGGVYKGKL------------------------------LDGLASISRTSHVNVVTLLGFCL 201 (450)
Q Consensus 152 ~ei~~~~~~~~~~LG~G~fg~Vy~~~~------------------------------~~e~~~l~~l~HpnIv~l~~~~~ 201 (450)
.++....+...+.||+|+||.||+... .+|+..+.++.|++|..+..++.
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 344455555678899999999998731 24456788899999999988865
Q ss_pred eC--------CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE
Q 013074 202 EG--------NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL 273 (450)
Q Consensus 202 ~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll 273 (450)
.. ...++||||++|.+|.++.. ++. ....+++.+|..+|+ .+++|+|++|+||++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili 168 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIV 168 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh----------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEE
Confidence 33 35789999999999977631 332 245689999999995 999999999999999
Q ss_pred cCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHH
Q 013074 274 DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339 (450)
Q Consensus 274 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ell 339 (450)
+.++ ++|+|||............ .+.... .+..++|+||||+.+..+.
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~d---------------~~vler--~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAKD---------------RIDLER--HYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred eCCC-EEEEECCCcccccchhhHH---------------HHHHHh--HhcccccccceeEeehHHH
Confidence 9988 9999999887553322110 022222 4557999999999887665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=6.1e-17 Score=146.58 Aligned_cols=98 Identities=17% Similarity=0.193 Sum_probs=74.3
Q ss_pred hhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHh-hcCCCC
Q 013074 181 GLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL-HRGCST 259 (450)
Q Consensus 181 e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~ 259 (450)
|.+.+.++.++++.....+.. ...++||||++++++........ .+++.....++.|++.+|.++ | ..
T Consensus 69 E~~~l~~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~------~~~~~~~~~i~~qi~~~L~~l~H---~~ 137 (190)
T cd05147 69 EMRNLKRLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA------PLSESKARELYLQVIQIMRILYQ---DC 137 (190)
T ss_pred HHHHHHHHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---hC
Confidence 556677777766643322221 23389999998877655432221 288899999999999999999 6 48
Q ss_pred ceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 260 ~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
+|+||||||+||+++ ++.++|+|||++...
T Consensus 138 giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 138 RLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 999999999999998 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=144.00 Aligned_cols=100 Identities=20% Similarity=0.179 Sum_probs=75.1
Q ss_pred hhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCce
Q 013074 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRI 261 (450)
Q Consensus 182 ~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i 261 (450)
.+.+.++.|++|.....+... ..++||||++++++........ .++......++.|++.++.++|. ..+|
T Consensus 70 ~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~------~~~~~~~~~i~~~l~~~l~~lH~--~~gi 139 (190)
T cd05145 70 FRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV------PLEEEEAEELYEQVVEQMRRLYQ--EAGL 139 (190)
T ss_pred HHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhc------cCCHHHHHHHHHHHHHHHHHHHH--hCCE
Confidence 345666777776444333322 2489999998875543322111 26778899999999999999993 3899
Q ss_pred EeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 262 LHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 262 vH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+||||||+||+++ ++.++|+|||++.....
T Consensus 140 vHrDlkP~NIll~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 140 VHGDLSEYNILYH-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred ecCCCChhhEEEE-CCCEEEEEcccceecCC
Confidence 9999999999999 88999999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.2e-16 Score=169.25 Aligned_cols=181 Identities=19% Similarity=0.221 Sum_probs=141.0
Q ss_pred hhHHHHHhhHhhhccccccceEEEEEEEcch-------------------hhhhhhcC---CCceeeeeeEEEeCCceEE
Q 013074 151 FSDVKKITNSFKDKLGQGGFGGVYKGKLLDG-------------------LASISRTS---HVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 151 ~~ei~~~~~~~~~~LG~G~fg~Vy~~~~~~e-------------------~~~l~~l~---HpnIv~l~~~~~~~~~~~l 208 (450)
.-++...++.+.+.||+|+||+||+|.-.+. .+++.||+ -+-|..+.....-.+..+|
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 3344445555678899999999999964432 45566666 2234455555555677889
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc-------CCCCeEE
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD-------QDFCPKI 281 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~-------~~~~~kl 281 (450)
|+||.+.|+|.+++... +..+|...+.++.|+++.++.||. .+|||+||||+|.||. +...++|
T Consensus 772 v~ey~~~Gtlld~~N~~------~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~l 842 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTN------KVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYL 842 (974)
T ss_pred eeeccccccHHHhhccC------CCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEE
Confidence 99999999999999733 338999999999999999999995 9999999999999994 3456899
Q ss_pred eeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCC
Q 013074 282 SDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 343 (450)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~ 343 (450)
+|||-+-.+..-... ......++|-.+-.+|...+. .++...|.|.|+.+++-||.|+.
T Consensus 843 IDfG~siDm~lfp~~-~~F~~~~~td~f~C~EM~~gr--pWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 843 IDFGRSIDMKLFPDG-TKFKAVWHTDLFDCIEMREGR--PWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EecccceeeeEcCCC-cEEeeeeccccchhHHHhcCC--CCchhhhhHHHHHHHHHHHHHHH
Confidence 999988654322111 235567789999999999986 89999999999999999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.5e-17 Score=161.83 Aligned_cols=176 Identities=23% Similarity=0.309 Sum_probs=128.2
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeec
Q 013074 205 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDF 284 (450)
Q Consensus 205 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 284 (450)
+.++.|++|...+|.+++.+.... ...++.....++.|++.|++| ++.+|+|+||.||+...+..+||.||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~---e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTG---EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcc---cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhh
Confidence 478999999999999999755432 337888899999999999999 58899999999999999999999999
Q ss_pred cccccccCCCC---ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhh
Q 013074 285 GLAKLCTTKKG---IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 285 Gla~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 360 (450)
|+........+ ....++...||..||+||.+.++ .++.++||||||++|+||+. -...+...
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~--~y~~kvdIyaLGlil~EL~~~f~T~~er~------------ 466 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ--QYSEKVDIYALGLILAELLIQFSTQFERI------------ 466 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhh--hhhhhcchhhHHHHHHHHHHHhccHHHHH------------
Confidence 99876654331 12235566799999999999986 89999999999999999995 11111100
Q ss_pred hhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHH
Q 013074 361 IYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEV 409 (450)
Q Consensus 361 i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev 409 (450)
...... ..+.+++....-..+=..++.+++.+.|.+||++.++
T Consensus 467 --~t~~d~----r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 --ATLTDI----RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --Hhhhhh----hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 000000 1112221111222334578899999999999954443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.9e-16 Score=142.95 Aligned_cols=113 Identities=22% Similarity=0.349 Sum_probs=88.1
Q ss_pred hccccccceEEEEEE--------------------Ecchhhhhhhc-----CCCceeeeeeEEEeCC---c-eEEEEEe-
Q 013074 163 DKLGQGGFGGVYKGK--------------------LLDGLASISRT-----SHVNVVTLLGFCLEGN---N-RALIYEF- 212 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~--------------------~~~e~~~l~~l-----~HpnIv~l~~~~~~~~---~-~~lV~E~- 212 (450)
+.||+|+||.||+.. ..+|+..++++ .||||++++|++.++. . ..+|+||
T Consensus 8 ~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~ 87 (210)
T PRK10345 8 SPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFD 87 (210)
T ss_pred ceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCC
Confidence 579999999999631 23467888888 6799999999998874 3 3378999
Q ss_pred -cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHH-HHhhcCCCCceEeeeeccccEEEcC----CCCeEEee-cc
Q 013074 213 -MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL-EYLHRGCSTRILHFDIKPHNILLDQ----DFCPKISD-FG 285 (450)
Q Consensus 213 -~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dikp~NIll~~----~~~~kl~D-FG 285 (450)
+.+++|.+++.+.. +++. ..++.+++.++ +|||+ .+|+||||||+|||++. ++.++|+| ||
T Consensus 88 G~~~~tL~~~l~~~~-------~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 88 GKPSITLTEFAEQCR-------YEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred CCcchhHHHHHHccc-------ccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 55799999996531 4544 35577888777 89995 99999999999999974 34799999 45
Q ss_pred cc
Q 013074 286 LA 287 (450)
Q Consensus 286 la 287 (450)
..
T Consensus 156 ~~ 157 (210)
T PRK10345 156 ES 157 (210)
T ss_pred Cc
Confidence 43
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.7e-16 Score=150.40 Aligned_cols=166 Identities=19% Similarity=0.265 Sum_probs=107.8
Q ss_pred eEEEEEecCCCChhhhhhc---CCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEe
Q 013074 206 RALIYEFMPNGSLEKFVYN---GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKIS 282 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~---~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 282 (450)
.+++|+-+ .++|.+++.. .... ...+....+..+..|+++.+++||. .|++|+||||+|++++.+|.++|+
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~--~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~~~nfll~~~G~v~Lg 187 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQT--HSPLAFAARLSLTVQMIRLVANLHS---YGLVHGDIKPENFLLDQDGGVFLG 187 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTT--SHHHHHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEE-TTS-EEE-
T ss_pred hhhccchh-hhcHHHHHHHHhhcccc--cchhHHHHHHHHHHHHHHHHHHHhh---cceEecccceeeEEEcCCCCEEEc
Confidence 36778877 5688777532 2211 1224555567777999999999995 999999999999999999999999
Q ss_pred eccccccccCCCCccccccCCCCccccccccccccc------cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccc
Q 013074 283 DFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356 (450)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~ 356 (450)
||+........... ...+..|.+||..... .-.++.+.|.|+||+++|.|.+++.||+........
T Consensus 188 ~F~~~~r~g~~~~~------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~-- 259 (288)
T PF14531_consen 188 DFSSLVRAGTRYRC------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADP-- 259 (288)
T ss_dssp -GGGEEETTEEEEG------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTS--
T ss_pred ChHHHeecCceeec------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccc--
Confidence 99877655432211 2245789999987542 124788999999999999999999999755322111
Q ss_pred hhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCC
Q 013074 357 FPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDR 403 (450)
Q Consensus 357 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 403 (450)
.+ ..... .+.++.+..++..+|+.||.+|
T Consensus 260 --~~---------------~f~~C-~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 260 --EW---------------DFSRC-RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp --GG---------------GGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred --cc---------------cchhc-CCcCHHHHHHHHHHccCCcccC
Confidence 10 11122 2678889999999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.5e-16 Score=162.16 Aligned_cols=204 Identities=21% Similarity=0.243 Sum_probs=136.5
Q ss_pred HhhhccccccceEEEEEEEcch--hhhhhhcCCCceeee-eeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCH
Q 013074 160 SFKDKLGQGGFGGVYKGKLLDG--LASISRTSHVNVVTL-LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRW 236 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~e--~~~l~~l~HpnIv~l-~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~ 236 (450)
+..+.+..|+||.||..+.... --.+ +++..|+|-= +.-+.+. .+.| |+-.+.+.+.+. ++.
T Consensus 86 ~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilRnilt~a~n--pfvv------gDc~tllk~~g~------lPv 150 (1205)
T KOG0606|consen 86 NTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILRNILTFAGN--PFVV------GDCATLLKNIGP------LPV 150 (1205)
T ss_pred ceeEeeccCCCCceeeeeccccccchhh-cccccchhhhccccccCC--ccee------chhhhhcccCCC------Ccc
Confidence 3457899999999999976532 1122 5555554311 2222221 1222 455555544332 232
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC------------CCCccccccCCC
Q 013074 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT------------KKGIVSSLLGAR 304 (450)
Q Consensus 237 ~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~------------~~~~~~~~~~~~ 304 (450)
+++.+++||| +.+|+|||+||+|.+|..-|.+|+.|||+++.... +....-.-...+
T Consensus 151 --------dmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvc 219 (1205)
T KOG0606|consen 151 --------DMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVC 219 (1205)
T ss_pred --------hhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhcccc
Confidence 2377899999 59999999999999999999999999999874321 111111224568
Q ss_pred CccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHH
Q 013074 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEI 384 (450)
Q Consensus 305 gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 384 (450)
||+.|+|||++..+ .|...+|.|++|+++||.+-|..||+.... +..|...+... ....+.....
T Consensus 220 gTPeyiaPeVilrq--gygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~visd~----------i~wpE~dea~ 284 (1205)
T KOG0606|consen 220 GTPEYIAPEVILRQ--GYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDD----------IEWPEEDEAL 284 (1205)
T ss_pred CCccccChhhhhhh--ccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhhhh----------ccccccCcCC
Confidence 99999999999885 899999999999999999999999986532 11222222111 1122333445
Q ss_pred HHHHHHHHHHccccCCCCCC
Q 013074 385 AKKMIIVGLWCIQARPYDRP 404 (450)
Q Consensus 385 ~~~l~~l~~~Cl~~dP~~RP 404 (450)
..+..+++.+.|+.+|..|-
T Consensus 285 p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 285 PPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred CHHHHHHHHHHHHhChHhhc
Confidence 57788888899999999996
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.57 E-value=4.4e-15 Score=136.69 Aligned_cols=113 Identities=21% Similarity=0.348 Sum_probs=95.2
Q ss_pred hccccccceEEEEEEEc-----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 163 DKLGQGGFGGVYKGKLL-----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~-----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
+.||+|++|.||+|+.. .|++.+.++.|++|.....++......++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 46999999999999421 2455677788898887777777778889999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+|++|.+.+... .+ ....++.+++.+|.++|. .+++|+|++|.||+++ ++.++|+|||.+..
T Consensus 82 ~G~~L~~~~~~~---------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSN---------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhc---------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999988532 12 778899999999999994 8999999999999999 78999999998875
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.57 E-value=6.6e-15 Score=154.42 Aligned_cols=111 Identities=21% Similarity=0.338 Sum_probs=94.9
Q ss_pred hhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 162 KDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
.+.||+|+||+||+|++ .+|++++++++|++++....++.+....++||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~ 417 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEY 417 (535)
T ss_pred cceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEe
Confidence 46899999999999632 1356678888999999888888777788999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
+++++|.+++. ....++.+++.+|.+||+ .+++||||||+||++ +++.++|+|||+++..
T Consensus 418 ~~g~~L~~~l~--------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 418 IGGKDLKDVLE--------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred cCCCcHHHHHH--------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999998873 345789999999999995 899999999999999 6789999999998753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.6e-14 Score=135.26 Aligned_cols=78 Identities=21% Similarity=0.180 Sum_probs=63.4
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc-eEeeeeccccEEEcCCCCeEEee
Q 013074 205 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR-ILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 205 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dikp~NIll~~~~~~kl~D 283 (450)
..++||||+++.+|........ .+.......++.|++.++.+||. .+ ++|+||||+||+++ ++.++|+|
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli~-~~~i~LiD 191 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLKDV------EPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILVH-DGKVVIID 191 (237)
T ss_pred CceEEEEEecCCcccccccccC------CcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEEE-CCCEEEEE
Confidence 3589999999888866542221 14556678899999999999995 88 99999999999999 88999999
Q ss_pred ccccccccC
Q 013074 284 FGLAKLCTT 292 (450)
Q Consensus 284 FGla~~~~~ 292 (450)
||.+.....
T Consensus 192 Fg~a~~~~~ 200 (237)
T smart00090 192 VSQSVELDH 200 (237)
T ss_pred ChhhhccCC
Confidence 999875443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.54 E-value=1.9e-14 Score=131.25 Aligned_cols=109 Identities=25% Similarity=0.428 Sum_probs=88.8
Q ss_pred ccccccceEEEEEEEc-----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 164 KLGQGGFGGVYKGKLL-----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 164 ~LG~G~fg~Vy~~~~~-----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.||+|+||.||+|.+. +|++++.++.|+++.....++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3899999999999621 25666777888876655555666777899999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+++|.+.+.... . .++.+++.+|.+||+ .+++|+|++|+||+++ ++.++++|||++..
T Consensus 81 g~~l~~~~~~~~-------~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGN-------D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcH-------H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999998874321 0 778999999999994 9999999999999999 88999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.3e-15 Score=158.03 Aligned_cols=232 Identities=22% Similarity=0.253 Sum_probs=170.7
Q ss_pred hhhccccccceEEEEEEE--------------------------cchhhhhhhcC-CCceeeeeeEEEeCCceEEEEEec
Q 013074 161 FKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTS-HVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
+.+.||+|.|+.|-.... ..|..+-+.+. |.|++++++...+.+..+++.++.
T Consensus 24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s 103 (601)
T KOG0590|consen 24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYS 103 (601)
T ss_pred ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcc
Confidence 445688888888865531 12233334445 999999999999999999999999
Q ss_pred CCCChhhhh-hcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-CeEEeecccccccc
Q 013074 214 PNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-CPKISDFGLAKLCT 291 (450)
Q Consensus 214 ~~gsL~~~l-~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~ 291 (450)
.++++.+.+ .... ...+.......+.|+..++.|+|. ..++.|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus 104 ~g~~~f~~i~~~~~-----~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 104 DGGSLFSKISHPDS-----TGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccccccccccCCc-----cCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999998877 3222 124555667789999999999993 38999999999999999999 99999999999887
Q ss_pred CCCCccccccCCCC-ccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARG-TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
............+| ++.|+|||...+. ....+..|+||.|+++.-+++|..|+........ .+..|......
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~-~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~--~~~~~~~~~~~---- 249 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGK-AYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG--RYSSWKSNKGR---- 249 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccch-hhcCCCcccccccccccccccCCCCccccccccc--cceeecccccc----
Confidence 74444444566678 9999999999874 4667899999999999999999999986644331 22222211100
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
. -............++..+++..+|..|.+.+++..
T Consensus 250 -~----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 250 -F----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -c----ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 00111233455677777888899999999888764
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.5e-13 Score=125.48 Aligned_cols=115 Identities=22% Similarity=0.217 Sum_probs=86.5
Q ss_pred hHhhhccccccceEEEEEEEcc--------------------------------------------hhhhhhhcCCCc--
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLD--------------------------------------------GLASISRTSHVN-- 192 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~--------------------------------------------e~~~l~~l~Hpn-- 192 (450)
+.+.+.||+|+||.||++...+ |...+.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 4556789999999999996421 233344455553
Q ss_pred eeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEE
Q 013074 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNIL 272 (450)
Q Consensus 193 Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIl 272 (450)
++..++ ....++||||+++++|...... .....++.+++.++.++|+ .+++|+||||+||+
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nil 157 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL------------EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNIL 157 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc------------ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEE
Confidence 333433 2345899999999988765320 2345688899999999995 89999999999999
Q ss_pred EcCCCCeEEeeccccccccC
Q 013074 273 LDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~ 292 (450)
+++++.++|+|||.+.....
T Consensus 158 l~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 158 VDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred EcCCCcEEEEECCccccCCC
Confidence 99999999999999865543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.38 E-value=6.3e-13 Score=108.48 Aligned_cols=65 Identities=34% Similarity=0.645 Sum_probs=56.1
Q ss_pred cCCCCcccCCCCCCcccccccCCCCCCCCCC-CCceeeecCCCCCCCCCCCEEeeCCceeEEEeeccCCcceeeccccc
Q 013074 37 VCSRQVDCGTLSLDIGYPFWGDGLRPQYCGR-QEFYLDCQNNPNQNPTQSPTIFMGSEAFRVLDIDDGHQTMIITPARL 114 (450)
Q Consensus 37 ~C~~~~~cg~~~~~i~~pf~~~~~~~~~Cg~-~~~~l~c~~~~~~~~~~~~~~~~~~~~~~v~~i~y~~~~i~v~d~~~ 114 (450)
.| +.+||+++ |.||||++. .||+ |+|+|+|+++.. .+.|.+.+..|+|++|+|.+++++|.++..
T Consensus 3 ~C--~~~CGnv~--IpYPFgi~~----~C~~~~~F~L~C~~~~~-----~~~l~l~~~~~~V~~I~~~~~~i~v~~~~~ 68 (106)
T PF13947_consen 3 GC--PSSCGNVS--IPYPFGIGP----GCGRDPGFELTCNNNTS-----PPKLLLSSGNYEVLSISYENGTIRVSDPIS 68 (106)
T ss_pred CC--CCccCCEe--ecCCCccCC----CCCCCCCcEEECCCCCC-----CceeEecCCcEEEEEEecCCCEEEEEeccc
Confidence 48 47899986 999999976 7999 999999988621 288888999999999999999999997553
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.3e-12 Score=120.94 Aligned_cols=96 Identities=19% Similarity=0.215 Sum_probs=75.2
Q ss_pred hhhhhhhcCCCce--eeeeeEEEeCCc----eEEEEEecCC-CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHh
Q 013074 181 GLASISRTSHVNV--VTLLGFCLEGNN----RALIYEFMPN-GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 253 (450)
Q Consensus 181 e~~~l~~l~HpnI--v~l~~~~~~~~~----~~lV~E~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL 253 (450)
|++++.++.|++| +..+++...... .++|+|++++ .+|.+++.... ++.. .+.+++.+|.+|
T Consensus 90 E~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~-------l~~~----~~~~i~~~l~~l 158 (239)
T PRK01723 90 EFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAP-------LSEE----QWQAIGQLIARF 158 (239)
T ss_pred HHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCC-------CCHH----HHHHHHHHHHHH
Confidence 6778888888875 677776544322 2599999987 68988875421 4443 356899999999
Q ss_pred hcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 254 H~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
|+ .+|+|+||||+|||++.++.++|+|||.+...
T Consensus 159 H~---~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 159 HD---AGVYHADLNAHNILLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred HH---CCCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence 95 99999999999999999899999999987754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.4e-12 Score=109.88 Aligned_cols=114 Identities=23% Similarity=0.187 Sum_probs=92.8
Q ss_pred hccccccceEEEEEEE-------------------cchhhhhhhcCC--CceeeeeeEEEeCCceEEEEEecCCCChhhh
Q 013074 163 DKLGQGGFGGVYKGKL-------------------LDGLASISRTSH--VNVVTLLGFCLEGNNRALIYEFMPNGSLEKF 221 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~-------------------~~e~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 221 (450)
+.||+|.++.||+++. ..|...+.+++| .++++++++...++..++++||++++.+..+
T Consensus 4 ~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~ 83 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV 83 (155)
T ss_pred eecccccccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC
Confidence 5799999999998853 234666777766 5889999888887889999999988766543
Q ss_pred hhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 222 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 222 l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+......++.+++.+++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 84 -------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 84 -------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred -------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 3456677889999999999963334799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.9e-12 Score=114.74 Aligned_cols=77 Identities=25% Similarity=0.204 Sum_probs=59.3
Q ss_pred ceEEEEEecCCCChhhh-hhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 205 NRALIYEFMPNGSLEKF-VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 205 ~~~lV~E~~~~gsL~~~-l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
..++||||++++.+... +.... .. .....++.+++.++.++|. ..+|+|+||||+||+++ ++.++++|
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~-------~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-~~~~~liD 157 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR-------LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-DGKVYIID 157 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh-------hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-CCcEEEEE
Confidence 45899999988554321 11100 11 5577889999999999993 38999999999999999 89999999
Q ss_pred ccccccccC
Q 013074 284 FGLAKLCTT 292 (450)
Q Consensus 284 FGla~~~~~ 292 (450)
||.+.....
T Consensus 158 fg~a~~~~~ 166 (187)
T cd05119 158 VPQAVEIDH 166 (187)
T ss_pred CcccccccC
Confidence 999875543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.27 E-value=9.5e-12 Score=125.70 Aligned_cols=237 Identities=20% Similarity=0.202 Sum_probs=169.2
Q ss_pred cchhHHHHHhhHhhhcccc--ccceEEEEEEE--cch-------------------------hhhhhhc-CCCceeeeee
Q 013074 149 YNFSDVKKITNSFKDKLGQ--GGFGGVYKGKL--LDG-------------------------LASISRT-SHVNVVTLLG 198 (450)
Q Consensus 149 ~~~~ei~~~~~~~~~~LG~--G~fg~Vy~~~~--~~e-------------------------~~~l~~l-~HpnIv~l~~ 198 (450)
-.+.+....+..+.+.+|. |.+|.||.++. .+. ...-.++ .|+|.++...
T Consensus 106 S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 106 SPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred CCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence 3445556666667788999 99999999875 211 1111111 4889999999
Q ss_pred EEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHH----HHHHhhcCCCCceEeeeeccccEEEc
Q 013074 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK----GLEYLHRGCSTRILHFDIKPHNILLD 274 (450)
Q Consensus 199 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dikp~NIll~ 274 (450)
.+.+++..++-.|++ +.+|..+.+.... .++...++..+.+... ||.++| +.+++|.|+||.||++.
T Consensus 186 ~~e~~~~lfiqtE~~-~~sl~~~~~~~~~-----~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~ 256 (524)
T KOG0601|consen 186 AWEGSGILFIQTELC-GESLQSYCHTPCN-----FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTT 256 (524)
T ss_pred ccccCCcceeeeccc-cchhHHhhhcccc-----cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecc
Confidence 999999999999999 5788888765443 3667777788888888 999999 69999999999999999
Q ss_pred CC-CCeEEeeccccccccCCCCccc--cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCC
Q 013074 275 QD-FCPKISDFGLAKLCTTKKGIVS--SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN 351 (450)
Q Consensus 275 ~~-~~~kl~DFGla~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~ 351 (450)
++ ...++.|||+...+........ ......|...|++||...+ .++..+|+|++|.+.++...+......+...
T Consensus 257 ~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~---l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~ 333 (524)
T KOG0601|consen 257 SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG---LATFASDIFSLGEVILEAILGSHLPSVGKNS 333 (524)
T ss_pred cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc---ccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence 99 8899999999988765542211 1122357889999999976 6889999999999999998877766554222
Q ss_pred CCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 352 SSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 352 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... ... ..+ ..+.......++..++..+++.+|..|++.+++...
T Consensus 334 ~W~~---------~r~---~~i---p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 334 SWSQ---------LRQ---GYI---PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred Cccc---------ccc---ccC---chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1110 000 000 001111223445557888999999999988877643
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=4.1e-12 Score=119.05 Aligned_cols=206 Identities=19% Similarity=0.223 Sum_probs=137.5
Q ss_pred hhhhhcCCCceeeeeeEEEeC-----CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 013074 183 ASISRTSHVNVVTLLGFCLEG-----NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257 (450)
Q Consensus 183 ~~l~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 257 (450)
..|..+.|.|||++..|+.+. ....++.|||..|+|..+|.+... ....+..+...+|.-||+.||.|||. |
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--NQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--hhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 346677899999999998754 357789999999999999976432 22447788888999999999999995 6
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeeccccccccCC--CCccccccCCCCccccccccccccccCCCCccCchHhHHHHH
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK--KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMI 335 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl 335 (450)
...|+|+++..+.|++..+|-+|+.- +........ ...........+.++|.+||.=.. ...+-++|||+||+..
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTGASDIYKFGMCA 272 (458)
T ss_pred CCccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcc--cccccchhhhhhhHHH
Confidence 67899999999999999999888753 211111100 000011122346789999997543 3667899999999999
Q ss_pred HHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 336 MELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 336 ~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+||.-+..-....... ...+-.... ...+ .+. ..=+.++..|++..|..||+|.+++..
T Consensus 273 lemailEiq~tnseS~----~~~ee~ia~-------~i~~----len---~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 273 LEMAILEIQSTNSESK----VEVEENIAN-------VIIG----LEN---GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHHHHheeccCCCcce----eehhhhhhh-------heee----ccC---ccccCcCcccccCCCCCCcchhhhhcC
Confidence 9998665432222111 000000000 0000 000 011345678999999999999988743
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=8.1e-10 Score=113.04 Aligned_cols=156 Identities=17% Similarity=0.204 Sum_probs=116.5
Q ss_pred ccccceEEEEEEEcch---------hhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCH
Q 013074 166 GQGGFGGVYKGKLLDG---------LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRW 236 (450)
Q Consensus 166 G~G~fg~Vy~~~~~~e---------~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~ 236 (450)
-.|++-.||..+...+ ++.++.++||||++++....++...|+|+|.+. -|..++.+ +..
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---------l~~ 103 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---------LGK 103 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------hHH
Confidence 3467777777765544 566788899999999999999999999999984 45556643 334
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccc
Q 013074 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316 (450)
Q Consensus 237 ~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 316 (450)
....-.+.||+.||.+||+ ..+++|++|....|+++..|..||++|.+......... .......-..|..|+.+.
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~---~~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA---PAKSLYLIESFDDPEEID 178 (690)
T ss_pred HHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---ccccchhhhcccChhhcC
Confidence 5555678899999999997 57899999999999999999999999988754432211 011111223466676554
Q ss_pred cccCCCCccCchHhHHHHHHHHHcC
Q 013074 317 RNFGEVSHKSDVYSFGMMIMELVGC 341 (450)
Q Consensus 317 ~~~~~~s~~sDiwSlGvvl~elltg 341 (450)
.+ .-..|.|-||++++|++.|
T Consensus 179 ~s----~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 179 PS----EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc----ccchhhhhHHHHHHHHhCc
Confidence 32 2457999999999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.95 E-value=1.2e-09 Score=111.33 Aligned_cols=78 Identities=22% Similarity=0.286 Sum_probs=59.4
Q ss_pred CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHH-HHHHhhcCCCCceEeeeeccccEEEcCCCCeEEe
Q 013074 204 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK-GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKIS 282 (450)
Q Consensus 204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 282 (450)
...++||||++|++|.+........ .. ..+++..++. .+..+|+ .+++|+|++|.||++++++.++++
T Consensus 231 ~~~vLvmE~i~G~~L~~~~~~~~~~-----~~---~~~ia~~~~~~~l~ql~~---~g~~H~D~hPgNilv~~~g~i~li 299 (437)
T TIGR01982 231 SERVLTMEWIDGIPLSDIAALDEAG-----LD---RKALAENLARSFLNQVLR---DGFFHADLHPGNIFVLKDGKIIAL 299 (437)
T ss_pred CCceEEEEeECCcccccHHHHHhcC-----CC---HHHHHHHHHHHHHHHHHh---CCceeCCCCcccEEECCCCcEEEE
Confidence 4568999999999998876432110 22 2345555555 4677884 899999999999999999999999
Q ss_pred eccccccccC
Q 013074 283 DFGLAKLCTT 292 (450)
Q Consensus 283 DFGla~~~~~ 292 (450)
|||++.....
T Consensus 300 DfG~~~~l~~ 309 (437)
T TIGR01982 300 DFGIVGRLSE 309 (437)
T ss_pred eCCCeeECCH
Confidence 9999876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.88 E-value=3.8e-09 Score=93.43 Aligned_cols=107 Identities=25% Similarity=0.217 Sum_probs=75.8
Q ss_pred hccccccceEEEEEEE--------------------cchhhhhhhcCCCcee-eeeeEEEeCCceEEEEEecCCCChhhh
Q 013074 163 DKLGQGGFGGVYKGKL--------------------LDGLASISRTSHVNVV-TLLGFCLEGNNRALIYEFMPNGSLEKF 221 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~--------------------~~e~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~~gsL~~~ 221 (450)
+.|+.|.++.||+++. ..|.+.++.+.+.+++ +++.+. ....++|||++++.++...
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~ 81 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE 81 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc
Confidence 4577888888887642 2345666666555543 455443 3345899999999877543
Q ss_pred hhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc-----eEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 222 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR-----ILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 222 l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
. .. ...++.+++++|+.||. .+ ++|+|++|.||+++ ++.++++|||.+..
T Consensus 82 ~-----------~~---~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 82 D-----------FS---DPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred c-----------cc---CHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 0 11 12346789999999995 54 59999999999999 66899999998653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.9e-09 Score=107.90 Aligned_cols=223 Identities=20% Similarity=0.203 Sum_probs=150.3
Q ss_pred hHhhhccccccceEEEEEEEcch--------------------------hhhhhh-cCCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLDG--------------------------LASISR-TSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~e--------------------------~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.....||.|.|+.|+......+ +-+... ..|.+++.....+...+..++-.|
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e 346 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE 346 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence 34456899999999988643211 111122 258889988888888888889999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC-CCeEEeeccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD-FCPKISDFGLAKLC 290 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~ 290 (450)
|++++++...+... ..+++..++.+..|++.++.++| +..++|+|+||+||++..+ +.-++.|||.+..+
T Consensus 347 ~~~~~s~~l~~~~~------~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 347 FCEGGSSSLRSVTS------QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred hhcCcchhhhhHHH------HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccccc
Confidence 99999987766322 23777888999999999999999 5999999999999999876 78899999988642
Q ss_pred cCCCCccccccCCCCccccc-cccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYI-ALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
.-.. ....+.-++. ..|.+... ..+..+.|++|||.-+.+.+++...-..+..-. . +.
T Consensus 418 ~~~~------~~~~~~~r~~p~~~~~~e~-~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~---------~--i~--- 476 (524)
T KOG0601|consen 418 AFSS------GVFHHIDRLYPIAEILLED-YPHLSKADIFSLGLSVDEAITGSPLSESGVQSL---------T--IR--- 476 (524)
T ss_pred ceec------ccccccccccccchhhccc-cccccccccccccccccccccCcccCcccccce---------e--ee---
Confidence 2111 1111233334 24444433 478899999999999999998876544332100 0 00
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.+.. .........+..+...++..++..||.+.++..+.+-.
T Consensus 477 ----~~~~-p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 477 ----SGDT-PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ----cccc-cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 0000 00111124455556668889999999998887665543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=9.1e-08 Score=93.26 Aligned_cols=209 Identities=11% Similarity=0.099 Sum_probs=132.7
Q ss_pred eEEEEEecCCCC-hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeec
Q 013074 206 RALIYEFMPNGS-LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDF 284 (450)
Q Consensus 206 ~~lV~E~~~~gs-L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 284 (450)
..+.|..+++.. ...++.........-...|...+.+++.++.+.+-||+ .|.+-+|++++|+|+.+++.|.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcc
Confidence 567788776542 33333322222333457899999999999999999995 89999999999999999999999986
Q ss_pred cccccccCCCCccccccCCCCccccccccccc-ccc--CCCCccCchHhHHHHHHHHHcC-CCCCCCCCCCC-----Ccc
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFS-RNF--GEVSHKSDVYSFGMMIMELVGC-KNNLDSGVDNS-----SEV 355 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~--~~~s~~sDiwSlGvvl~elltg-~~p~~~~~~~~-----~~~ 355 (450)
.......++.. .....|...|.+||.-. +.. ...+..+|.|.||+++++++.| +.|+..-.... .+.
T Consensus 162 Dsfqi~~ng~~----~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 162 DSFQINANGTL----HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred cceeeccCCce----EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 55444433222 34556889999999864 111 1457789999999999998865 88886432111 111
Q ss_pred chhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHcccc--CCCCCCCHHHHHHHhhccccccC
Q 013074 356 YFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQA--RPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 356 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
.+....+-...+...............-.+..+..+..+|+.. ++.-|||++.++..|..+.+.|.
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 1111111111111111111122222223344555566667643 47799999999988887666553
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.6e-08 Score=87.33 Aligned_cols=94 Identities=17% Similarity=0.308 Sum_probs=71.0
Q ss_pred chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 013074 180 DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259 (450)
Q Consensus 180 ~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 259 (450)
+|.++|.++.--.|..-.-+..+.....++|||++|..|.+.+... ...++..+-.-+.-||+ .
T Consensus 48 ~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------------~~~~~r~vG~~vg~lH~---~ 111 (204)
T COG3642 48 REARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------------RPDLLREVGRLVGKLHK---A 111 (204)
T ss_pred HHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------------chHHHHHHHHHHHHHHh---c
Confidence 3566666665444443333455667778999999988888888543 13456777778889995 9
Q ss_pred ceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 260 ~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
+|+|+||.++||++..+. +.++|||++...
T Consensus 112 givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 112 GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999999999998764 899999998744
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.1e-08 Score=87.53 Aligned_cols=97 Identities=14% Similarity=0.184 Sum_probs=70.6
Q ss_pred chhhhhhhcCC--CceeeeeeEEEeCCceEEEEEecCCCChhh-hhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHh-hc
Q 013074 180 DGLASISRTSH--VNVVTLLGFCLEGNNRALIYEFMPNGSLEK-FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL-HR 255 (450)
Q Consensus 180 ~e~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~ 255 (450)
+|.+.|+++.. -++.+.+++ ..-++||||+.+..+.. .+.+. .++......+..+++.+|..| |+
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-------~~~~~~~~~i~~~i~~~l~~l~H~ 143 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-------KLNDEEMKNAYYQVLSMMKQLYKE 143 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-------ccCHHHHHHHHHHHHHHHHHHHHh
Confidence 67777777754 355566654 45689999996644422 22211 145556677889999999999 74
Q ss_pred CCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 256 GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 256 ~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
.+++|+||++.||+++ ++.+.|+|||.+....
T Consensus 144 ---~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 144 ---CNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred ---CCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 8999999999999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=5.5e-09 Score=107.45 Aligned_cols=158 Identities=17% Similarity=0.230 Sum_probs=106.3
Q ss_pred HHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccc------cCCCCccccccc
Q 013074 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSL------LGARGTIGYIAL 312 (450)
Q Consensus 239 ~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~------~~~~gt~~y~aP 312 (450)
...-+.+++.|+.|+|+ +.++||++|.|++|.+++++.+||+.|+.+........+.... .-......|.||
T Consensus 101 ~f~nl~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap 178 (700)
T KOG2137|consen 101 GFANLGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP 178 (700)
T ss_pred hhhhhhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence 33445677799999998 7899999999999999999999999999876554421111100 011245689999
Q ss_pred cccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHH
Q 013074 313 EVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVG 392 (450)
Q Consensus 313 E~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 392 (450)
|++... ..+.++|+||+|+++|-+..++.+........... ...... ..........+++.++.+=+
T Consensus 179 E~~~~~--~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~--------~~~~~~---~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 179 EYLLGT--TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY--------SFSRNL---LNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred hhhccc--cccccccceeeeeEEEEEecCCcchhhccCCcchh--------hhhhcc---cccccccccccCcHHHHHHH
Confidence 999874 67899999999999999995544443322211110 000000 00001111245667788888
Q ss_pred HHccccCCCCCCCHHHHHH
Q 013074 393 LWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 393 ~~Cl~~dP~~RPs~~evl~ 411 (450)
.+++..++..||++.++..
T Consensus 246 ~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHhcCCcccCcchhhhhc
Confidence 8899999999998877653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=9.6e-09 Score=109.68 Aligned_cols=193 Identities=18% Similarity=0.170 Sum_probs=131.2
Q ss_pred CceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeecccc
Q 013074 191 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHN 270 (450)
Q Consensus 191 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~N 270 (450)
|-++...--+......+|+++|..+++|...+++.+. .+.+-.......+..+++||| +..+.|+|++|.|
T Consensus 864 P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~------~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~ 934 (1205)
T KOG0606|consen 864 PAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC------LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDS 934 (1205)
T ss_pred CceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC------cccccccchhHHHHhhhhccc---cchhhcccccccc
Confidence 3344333333445678999999999999998887653 333334444556778899999 4669999999999
Q ss_pred EEEcCCCCeEEeeccccccccC------C------------------CC----ccccccCCCCccccccccccccccCCC
Q 013074 271 ILLDQDFCPKISDFGLAKLCTT------K------------------KG----IVSSLLGARGTIGYIALEVFSRNFGEV 322 (450)
Q Consensus 271 Ill~~~~~~kl~DFGla~~~~~------~------------------~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ 322 (450)
+++..++..++.|||....... . .. .........||+.|.+||...+. ..
T Consensus 935 ~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~--~h 1012 (1205)
T KOG0606|consen 935 LLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR--RH 1012 (1205)
T ss_pred hhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc--cC
Confidence 9999999999999984332100 0 00 00112345689999999999885 77
Q ss_pred CccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCC
Q 013074 323 SHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYD 402 (450)
Q Consensus 323 s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~ 402 (450)
...+|.|+.|+.++|.++|.+||....... +.+.+... .......+.+.+.+..+++...+..+|.+
T Consensus 1013 gs~ad~~~~g~~l~e~l~g~pp~na~tpq~--------~f~ni~~~-----~~~~p~g~~~~s~~aq~~~~~ll~~~~~q 1079 (1205)
T KOG0606|consen 1013 GSAADWWSSGVCLFEVLTGIPPFNAETPQQ--------IFENILNR-----DIPWPEGPEEGSYEAQDLINRLLTEEPTQ 1079 (1205)
T ss_pred CCcchhhhhhhhhhhhhcCCCCCCCcchhh--------hhhccccC-----CCCCCCCccccChhhhhhhhhhhccCchh
Confidence 889999999999999999999997654322 12211111 11122223344455666777778889999
Q ss_pred CCCHH
Q 013074 403 RPPMN 407 (450)
Q Consensus 403 RPs~~ 407 (450)
|-.+.
T Consensus 1080 r~~a~ 1084 (1205)
T KOG0606|consen 1080 RLGAK 1084 (1205)
T ss_pred ccCcc
Confidence 97765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=9.5e-08 Score=83.55 Aligned_cols=121 Identities=21% Similarity=0.323 Sum_probs=83.0
Q ss_pred hccccccceEEEEEEEcch-----------------------------hhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 163 DKLGQGGFGGVYKGKLLDG-----------------------------LASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~e-----------------------------~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
..+-+|+-+.|+++.+..+ .+.|.++.--.|.--.-++.+...-.++|||+
T Consensus 13 ~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~ 92 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFI 92 (229)
T ss_pred eeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEec
Confidence 4577888889988865544 33444433222322222455666678999999
Q ss_pred CC-CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC---CeEEeecccccc
Q 013074 214 PN-GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF---CPKISDFGLAKL 289 (450)
Q Consensus 214 ~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DFGla~~ 289 (450)
++ .++.+++....... ........++..+-+.+.-|| .++|+|+||..+||++..++ .+.++|||++..
T Consensus 93 ~g~~~vk~~i~~~~~~~----~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 93 DGASTVKDFILSTMEDE----SEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cchhHHHHHHHHHccCc----ccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 65 37888876543211 223334678888999999999 49999999999999997655 347999999764
Q ss_pred c
Q 013074 290 C 290 (450)
Q Consensus 290 ~ 290 (450)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 4
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.6e-08 Score=101.33 Aligned_cols=77 Identities=17% Similarity=0.199 Sum_probs=52.0
Q ss_pred CceEEEEEecCCCChhhhh--hcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC----
Q 013074 204 NNRALIYEFMPNGSLEKFV--YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF---- 277 (450)
Q Consensus 204 ~~~~lV~E~~~~gsL~~~l--~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---- 277 (450)
...+|||||++|+.+.+.- ...+. . ...+....+..++.|+ + ..+++|+|++|.||+++.++
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l~~~g~-d-~~~la~~~v~~~~~Qi-------f---~~GffHaDpHPGNIlv~~~g~~~~ 301 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAALRAAGT-D-MKLLAERGVEVFFTQV-------F---RDGFFHADMHPGNIFVSYDPPENP 301 (537)
T ss_pred CCceEEEeeecCccHHhHHHHHhcCC-C-HHHHHHHHHHHHHHHH-------H---hCCeeeCCCChHHeEEecCCCCCC
Confidence 3456999999999997642 22110 0 0113333333333333 3 27999999999999999888
Q ss_pred CeEEeeccccccccC
Q 013074 278 CPKISDFGLAKLCTT 292 (450)
Q Consensus 278 ~~kl~DFGla~~~~~ 292 (450)
.++++|||+......
T Consensus 302 ~i~llDFGivg~l~~ 316 (537)
T PRK04750 302 RYIALDFGIVGSLNK 316 (537)
T ss_pred eEEEEecceEEECCH
Confidence 999999999876643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.61 E-value=6.5e-07 Score=89.50 Aligned_cols=137 Identities=16% Similarity=0.293 Sum_probs=106.4
Q ss_pred hhhhhhcCCCceeeeeeEEEe----CCceEEEEEecCC-CChhhhhhcCCCCC---------CCccCCHHHHHHHHHHHH
Q 013074 182 LASISRTSHVNVVTLLGFCLE----GNNRALIYEFMPN-GSLEKFVYNGDTSK---------PCQYLRWEKMYEIVIGIA 247 (450)
Q Consensus 182 ~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~~-gsL~~~l~~~~~~~---------~~~~l~~~~~~~i~~~ia 247 (450)
++.++++.|.|||++..++.. +..+++||+|.++ ++|.+......... .....+++.+|.++.|+.
T Consensus 324 ve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLt 403 (655)
T KOG3741|consen 324 VEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLT 403 (655)
T ss_pred HHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHH
Confidence 788999999999999998873 5678999999875 57776654322111 123368899999999999
Q ss_pred HHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCc
Q 013074 248 KGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSD 327 (450)
Q Consensus 248 ~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sD 327 (450)
.||.++| +.|..=+-|.+.+|+++.+.+++|+..|.......... |.+. --.+-|
T Consensus 404 aaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~-----------------~~le-----~~Qq~D 458 (655)
T KOG3741|consen 404 AALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT-----------------EPLE-----SQQQND 458 (655)
T ss_pred HHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCCC-----------------cchh-----HHhhhh
Confidence 9999999 48888899999999999999999999988766544320 1121 124668
Q ss_pred hHhHHHHHHHHHcCCC
Q 013074 328 VYSFGMMIMELVGCKN 343 (450)
Q Consensus 328 iwSlGvvl~elltg~~ 343 (450)
.=.||.+++.|.+|..
T Consensus 459 ~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 459 LRDLGLLLLALATGTE 474 (655)
T ss_pred HHHHHHHHHHHhhccc
Confidence 8899999999999864
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.55 E-value=4.7e-07 Score=83.44 Aligned_cols=120 Identities=19% Similarity=0.184 Sum_probs=84.1
Q ss_pred hccccccceEEEEEEEcc-----------------------hhhhhhhcCC--CceeeeeeEEEeCC---ceEEEEEecC
Q 013074 163 DKLGQGGFGGVYKGKLLD-----------------------GLASISRTSH--VNVVTLLGFCLEGN---NRALIYEFMP 214 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~-----------------------e~~~l~~l~H--pnIv~l~~~~~~~~---~~~lV~E~~~ 214 (450)
+.||.|..+.||+++..+ |.++++.+.+ .++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 357778788888764332 3445555554 34567777766542 5689999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC------------------------------------- 257 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------- 257 (450)
+.++.+.+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 84 GRVLRDRLLR-------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CEecCCCCCC-------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 9888765431 11566677777778888888887510
Q ss_pred ----------------CCceEeeeeccccEEEcC--CCCeEEeecccccc
Q 013074 258 ----------------STRILHFDIKPHNILLDQ--DFCPKISDFGLAKL 289 (450)
Q Consensus 258 ----------------~~~ivH~Dikp~NIll~~--~~~~kl~DFGla~~ 289 (450)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 56789999987653
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=6.5e-07 Score=85.19 Aligned_cols=104 Identities=21% Similarity=0.156 Sum_probs=76.7
Q ss_pred cchhhhhhhcCCCce--eeeeeEEEe-----CCceEEEEEecCCC-ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHH
Q 013074 179 LDGLASISRTSHVNV--VTLLGFCLE-----GNNRALIYEFMPNG-SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 250 (450)
Q Consensus 179 ~~e~~~l~~l~HpnI--v~l~~~~~~-----~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L 250 (450)
..|...+.++..-+| +..+++... ....++|+|++++. +|.+++..... ...+......++.+++..+
T Consensus 76 ~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~----~~~~~~~~~~ll~~la~~i 151 (268)
T PRK15123 76 DREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWAT----NPPDPRLKRMLIKRVATMV 151 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcc----cCCCHHHHHHHHHHHHHHH
Confidence 466677766644444 344555543 23468999999875 78888753221 1145667778999999999
Q ss_pred HHhhcCCCCceEeeeeccccEEEcC-------CCCeEEeecccccc
Q 013074 251 EYLHRGCSTRILHFDIKPHNILLDQ-------DFCPKISDFGLAKL 289 (450)
Q Consensus 251 ~yLH~~~~~~ivH~Dikp~NIll~~-------~~~~kl~DFGla~~ 289 (450)
.-||+ .||+|+|++++|||++. +..+.++||+.+..
T Consensus 152 ~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 152 RDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHH---CcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99995 99999999999999985 46889999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.33 E-value=8.9e-07 Score=79.60 Aligned_cols=97 Identities=24% Similarity=0.296 Sum_probs=61.8
Q ss_pred cchhhhhhhcCCC--ceeeeeeEEEeCCceEEEEEecC--CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHH-h
Q 013074 179 LDGLASISRTSHV--NVVTLLGFCLEGNNRALIYEFMP--NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY-L 253 (450)
Q Consensus 179 ~~e~~~l~~l~Hp--nIv~l~~~~~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~y-L 253 (450)
.+|.+.|.++..- ++.+.+++- .-.+||||++ +..+.. +.... ++......++.+++..+.. +
T Consensus 56 ~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~-l~~~~-------~~~~~~~~~~~~il~~~~~~~ 123 (188)
T PF01163_consen 56 KKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPR-LKDVD-------LSPEEPKELLEEILEEIIKML 123 (188)
T ss_dssp HHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGC-HHHCG-------GGGSTHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhh-HHhcc-------ccchhHHHHHHHHHHHHHHHH
Confidence 4678889888766 456666542 4479999997 444433 32221 1123345567777775555 5
Q ss_pred hcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 254 H~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
| ..+++|+|+++.||+++++ .+.|+|||.+....
T Consensus 124 ~---~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 124 H---KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp H---CTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred H---hcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 6 4899999999999999987 99999999887554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.22 E-value=3e-06 Score=77.72 Aligned_cols=103 Identities=20% Similarity=0.255 Sum_probs=77.0
Q ss_pred cchhhhhhhcCCCc--eeeeeeEEEeC----CceEEEEEecCCC-ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHH
Q 013074 179 LDGLASISRTSHVN--VVTLLGFCLEG----NNRALIYEFMPNG-SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251 (450)
Q Consensus 179 ~~e~~~l~~l~Hpn--Iv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~ 251 (450)
..|...+.++..-. +.+.+++.... ...++|+|++++. +|.+++..... .+......++.+++..++
T Consensus 59 ~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~------~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 59 KREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ------LDPSQRRELLRALARLIA 132 (206)
T ss_pred HHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc------cchhhHHHHHHHHHHHHH
Confidence 34555555554333 44566665542 2457999999874 79988865332 445667789999999999
Q ss_pred HhhcCCCCceEeeeeccccEEEcCCC---CeEEeeccccccc
Q 013074 252 YLHRGCSTRILHFDIKPHNILLDQDF---CPKISDFGLAKLC 290 (450)
Q Consensus 252 yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DFGla~~~ 290 (450)
-||+ .+|+|+|+++.|||++.++ .+.++||+.++..
T Consensus 133 ~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9995 9999999999999999887 8999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.07 E-value=2.1e-05 Score=70.85 Aligned_cols=105 Identities=21% Similarity=0.186 Sum_probs=81.2
Q ss_pred cchhhhhhhcCC-CceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 013074 179 LDGLASISRTSH-VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257 (450)
Q Consensus 179 ~~e~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 257 (450)
.+|..+++.+.+ +++++++|+|- ..+|.||...+++.+..... ......+|..+.+|+.++++.+++|+.+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l---~~~~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPL---SQFLQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccccc---ccccccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 457777777776 58999999993 36789999777664321000 00011689999999999999999999766
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
...+.-.|++++|+-+++++.+|++|...+...
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred CCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 667888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=6.5e-05 Score=68.27 Aligned_cols=103 Identities=15% Similarity=0.074 Sum_probs=74.1
Q ss_pred cchhhhhhhcCCCc--eeeeeeEEE-eC----CceEEEEEecCC-CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHH
Q 013074 179 LDGLASISRTSHVN--VVTLLGFCL-EG----NNRALIYEFMPN-GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 250 (450)
Q Consensus 179 ~~e~~~l~~l~Hpn--Iv~l~~~~~-~~----~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L 250 (450)
..|...|.++..-+ +.+.. ++. .. ..-.||+|-+.+ .+|.+++.+.... ..+......++.+++..+
T Consensus 67 ~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~----~~~~~~k~~il~~va~~i 141 (216)
T PRK09902 67 VREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVS----PYSDEVRQAMLKAVALAF 141 (216)
T ss_pred HHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcC----CcchHHHHHHHHHHHHHH
Confidence 34566666664333 44444 332 11 235789997753 5888888654321 256777889999999999
Q ss_pred HHhhcCCCCceEeeeeccccEEEcCCCC--eEEeecccccc
Q 013074 251 EYLHRGCSTRILHFDIKPHNILLDQDFC--PKISDFGLAKL 289 (450)
Q Consensus 251 ~yLH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DFGla~~ 289 (450)
+-||+ .++.|+|+.+.||+++.++. ++++||.-++.
T Consensus 142 a~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 142 KKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 99995 99999999999999986666 99999987654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.00 E-value=1.6e-05 Score=74.15 Aligned_cols=113 Identities=22% Similarity=0.233 Sum_probs=72.2
Q ss_pred HhhhccccccceEEEEEEE--------------------------------------------cchhhhhhhcCCC--ce
Q 013074 160 SFKDKLGQGGFGGVYKGKL--------------------------------------------LDGLASISRTSHV--NV 193 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~--------------------------------------------~~e~~~l~~l~Hp--nI 193 (450)
.+..+||-|--+.||.|.. .+|.+.|.++.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4567899999999999842 1234555555433 44
Q ss_pred eeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE
Q 013074 194 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL 273 (450)
Q Consensus 194 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll 273 (450)
.+-+++ +.-++|||++++-.|...-- +.+..-.++..|+.-+...-+ .|+||+|+++-||++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~-----------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV 235 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL-----------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV 235 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC-----------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence 444443 35579999998866643321 112222233333333332222 899999999999999
Q ss_pred cCCCCeEEeeccccccc
Q 013074 274 DQDFCPKISDFGLAKLC 290 (450)
Q Consensus 274 ~~~~~~kl~DFGla~~~ 290 (450)
++||.+.++||--+...
T Consensus 236 ~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 236 TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ecCCCEEEEeCcccccC
Confidence 99999999999665433
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.79 E-value=4.3e-06 Score=85.74 Aligned_cols=165 Identities=18% Similarity=0.080 Sum_probs=118.0
Q ss_pred hccccccceEEEEEEEc-----------------chhhhhhhcCCCc-eeeeeeEEEeCCceEEEEEecCCC-Chhhhhh
Q 013074 163 DKLGQGGFGGVYKGKLL-----------------DGLASISRTSHVN-VVTLLGFCLEGNNRALIYEFMPNG-SLEKFVY 223 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~-----------------~e~~~l~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~ 223 (450)
..+++|++++++|.+-. -++++|.+.+||| .+..++-+..+....++++++..+ +......
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~ 327 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT 327 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCC
Confidence 45788999999998622 2378899999999 677777777777888999999766 2221111
Q ss_pred cCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCC
Q 013074 224 NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA 303 (450)
Q Consensus 224 ~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 303 (450)
.. ...+...+...+.+.-+++++++|+ ..-+|+| ||+..+ +..|..||+....+.... .....
T Consensus 328 ~s-----e~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~----~~~t~ 390 (829)
T KOG0576|consen 328 VS-----EIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM----KPRTA 390 (829)
T ss_pred hh-----hHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc----ccccC
Confidence 00 0113334445556667789999994 4458888 777665 688999999988776543 23455
Q ss_pred CCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCC
Q 013074 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD 346 (450)
Q Consensus 304 ~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~ 346 (450)
.+++.++|||+...+ .+..+.|+|++|+-..++.-|.+|-.
T Consensus 391 ~~~~~~~~pev~~~~--~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQEN--TIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhccc--ccccCCCccCCCcchhhcCCCCCCCC
Confidence 689999999988775 78899999999987777776665543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00017 Score=67.04 Aligned_cols=123 Identities=15% Similarity=0.249 Sum_probs=68.9
Q ss_pred hccccccceEEEEEE-----------------EcchhhhhhhcCCCc--eeeeeeEEEeCCceEEEEEecCCCC-hhhh-
Q 013074 163 DKLGQGGFGGVYKGK-----------------LLDGLASISRTSHVN--VVTLLGFCLEGNNRALIYEFMPNGS-LEKF- 221 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~-----------------~~~e~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gs-L~~~- 221 (450)
..||+|..+.||+.. ..+|.+.++.+..-. +.+.+++...++...+|||+++|.. +...
T Consensus 7 ~~i~~G~t~~~y~~~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~ 86 (226)
T TIGR02172 7 TQTGEGGNGESYTHKTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRII 86 (226)
T ss_pred eeecCCCCcceeEecCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhh
Confidence 368889888888831 124566666665333 4677888777777889999998863 1111
Q ss_pred --------------------hhcCCCCCCCccCCH--HHHHHHHH-------HHHH-HHHHhhc-CCCCceEeeeecccc
Q 013074 222 --------------------VYNGDTSKPCQYLRW--EKMYEIVI-------GIAK-GLEYLHR-GCSTRILHFDIKPHN 270 (450)
Q Consensus 222 --------------------l~~~~~~~~~~~l~~--~~~~~i~~-------~ia~-~L~yLH~-~~~~~ivH~Dikp~N 270 (450)
++..... ...+.. ......+. .+.. ...+|.. .....++|+|+.|.|
T Consensus 87 ~~~~~~~~~l~~~la~~l~~lH~~~~~--~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~N 164 (226)
T TIGR02172 87 SDNPSRLEEIAKIFAEMAKKLHSTKCD--TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGN 164 (226)
T ss_pred cCCHHHHHHHHHHHHHHHHHHhCCCCC--CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCc
Confidence 1211110 011110 00000000 0001 1112211 112457899999999
Q ss_pred EEEcCCCCeEEeeccccc
Q 013074 271 ILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 271 Ill~~~~~~kl~DFGla~ 288 (450)
|++++++ +.|+||+.+.
T Consensus 165 ii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 165 LITSGKG-TYWIDLGDFG 181 (226)
T ss_pred EEEcCCC-cEEEechhcC
Confidence 9999888 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.71 E-value=7.3e-05 Score=81.77 Aligned_cols=196 Identities=18% Similarity=0.198 Sum_probs=135.9
Q ss_pred hhhhhhhcCCCceeeeeeEEEeCCceE----EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcC
Q 013074 181 GLASISRTSHVNVVTLLGFCLEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256 (450)
Q Consensus 181 e~~~l~~l~HpnIv~l~~~~~~~~~~~----lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~ 256 (450)
|...+.+..|+|++.+++|-.+....- +..|++..-++...+..-+. .+.++.+.+..++..||+|+|.
T Consensus 232 e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~------i~~~~~r~~~~~~~~GL~~~h~- 304 (1351)
T KOG1035|consen 232 ELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS------IPLETLRILHQKLLEGLAYLHS- 304 (1351)
T ss_pred HHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc------cCHHHHHHHHHHHhhhHHHHHH-
Confidence 467788899999999999887654433 44577877788777765543 7788888899999999999995
Q ss_pred CCCceEeeeeccc---cEEEcCCCCeEEe--eccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhH
Q 013074 257 CSTRILHFDIKPH---NILLDQDFCPKIS--DFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSF 331 (450)
Q Consensus 257 ~~~~ivH~Dikp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSl 331 (450)
....|.-+..+ +...+.++.+.++ ||+..+......... ....+..+.++|....+........|+|.+
T Consensus 305 --~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~----~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 --LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF----SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred --hccceeEEecccccccccCccceeecchhhhcccccCCCcccch----hhcCccccccccccccccchhhhhhHHHHH
Confidence 55555555554 4445566677777 888887665543221 122456678888887765566667899999
Q ss_pred HHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 332 GMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 332 Gvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
|..+..+..+..+........ .... ......+.+...+|+..++++|+++.++++
T Consensus 379 gll~~~~~~~~~i~~~~~~~~-------------------~~l~------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAVPV-------------------SLLD------VLSTSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHHhhhhhcCcccccccchh-------------------hhhc------cccchhhhhhhhhhcchhhhhccchhhhhh
Confidence 999999987765433221100 0000 001115667778899999999999999998
Q ss_pred Hhh
Q 013074 412 MLQ 414 (450)
Q Consensus 412 ~L~ 414 (450)
..-
T Consensus 434 ~~f 436 (1351)
T KOG1035|consen 434 HPF 436 (1351)
T ss_pred chh
Confidence 743
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.60 E-value=7.4e-05 Score=77.26 Aligned_cols=80 Identities=20% Similarity=0.279 Sum_probs=53.1
Q ss_pred CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEe
Q 013074 203 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKIS 282 (450)
Q Consensus 203 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 282 (450)
.+...|+|||++|-.+.+........ ++.+.+.....++. +..+- ..+++|.|..|.||+++.+|.+.+.
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~~g-----~d~k~ia~~~~~~f--~~q~~---~dgffHaDpHpGNi~v~~~g~i~~l 307 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKSAG-----IDRKELAELLVRAF--LRQLL---RDGFFHADPHPGNILVRSDGRIVLL 307 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHhcC-----CCHHHHHHHHHHHH--HHHHH---hcCccccCCCccceEEecCCcEEEE
Confidence 35668999999998888774222111 33222222221111 12222 1689999999999999999999999
Q ss_pred eccccccccC
Q 013074 283 DFGLAKLCTT 292 (450)
Q Consensus 283 DFGla~~~~~ 292 (450)
|||+......
T Consensus 308 DfGi~g~l~~ 317 (517)
T COG0661 308 DFGIVGRLDP 317 (517)
T ss_pred cCcceecCCH
Confidence 9999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00011 Score=67.05 Aligned_cols=67 Identities=19% Similarity=0.295 Sum_probs=51.7
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeec
Q 013074 205 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDF 284 (450)
Q Consensus 205 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 284 (450)
...++|||++|..|.+... +++ .++..+..++.-+|+ .|++|+|..|.|+++++++ ++++||
T Consensus 117 ~~~ll~EYIeG~~l~d~~~----------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i~iID~ 178 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED----------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-IRIIDT 178 (229)
T ss_pred EEEEEEEEecCeecccchh----------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-EEEEEC
Confidence 4568999999988866532 232 244567778999995 9999999999999999654 999999
Q ss_pred ccccc
Q 013074 285 GLAKL 289 (450)
Q Consensus 285 Gla~~ 289 (450)
+..+.
T Consensus 179 ~~k~~ 183 (229)
T PF06176_consen 179 QGKRM 183 (229)
T ss_pred ccccc
Confidence 76553
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.004 Score=57.75 Aligned_cols=77 Identities=23% Similarity=0.265 Sum_probs=52.9
Q ss_pred ceEEEEEecCCCCh-hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 205 NRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 205 ~~~lV~E~~~~gsL-~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
.-.|||||+..... .-.|..- .+..+....+..++++.+.-|-. ..++||+||+.-|||+. ++.+.|+|
T Consensus 140 ~nVLvMEfIg~~g~pAP~LkDv-------~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~-~~~p~iID 209 (268)
T COG1718 140 NNVLVMEFIGDDGLPAPRLKDV-------PLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH-DGEPYIID 209 (268)
T ss_pred CCeEEEEeccCCCCCCCCcccC-------CcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE-CCeEEEEE
Confidence 34699999844311 1111111 12333456666777777777764 47999999999999999 78999999
Q ss_pred cccccccc
Q 013074 284 FGLAKLCT 291 (450)
Q Consensus 284 FGla~~~~ 291 (450)
||-|....
T Consensus 210 ~~QaV~~~ 217 (268)
T COG1718 210 VSQAVTID 217 (268)
T ss_pred CccccccC
Confidence 99887554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=96.83 E-value=0.0052 Score=68.22 Aligned_cols=31 Identities=29% Similarity=0.386 Sum_probs=24.7
Q ss_pred CceEeeeeccccEEEcC-CCC-eEEeecccccc
Q 013074 259 TRILHFDIKPHNILLDQ-DFC-PKISDFGLAKL 289 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~-~~~-~kl~DFGla~~ 289 (450)
..++|+|+++.||+++. ++. .-|.||+++..
T Consensus 225 ~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 225 TGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred cceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 35999999999999985 333 57899998754
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0047 Score=64.01 Aligned_cols=77 Identities=18% Similarity=0.220 Sum_probs=51.7
Q ss_pred CceEEEEEecCCCChhhhh--hcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC----CC
Q 013074 204 NNRALIYEFMPNGSLEKFV--YNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ----DF 277 (450)
Q Consensus 204 ~~~~lV~E~~~~gsL~~~l--~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~----~~ 277 (450)
....|+||||+|.-+.+.- ...+ ++...+..-+.+...-+- ++ .|++|.|-.|.||+++. ++
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~g-------i~~~~i~~~l~~~~~~qI-f~----~GffHaDPHPGNilv~~~~~~~~ 342 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKRG-------ISPHDILNKLVEAYLEQI-FK----TGFFHADPHPGNILVRPNPEGDE 342 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHcC-------CCHHHHHHHHHHHHHHHH-Hh----cCCccCCCCCCcEEEecCCCCCc
Confidence 4678999999998776543 3322 444444333333222111 22 68999999999999994 66
Q ss_pred CeEEeeccccccccC
Q 013074 278 CPKISDFGLAKLCTT 292 (450)
Q Consensus 278 ~~kl~DFGla~~~~~ 292 (450)
.+.+.|||+......
T Consensus 343 ~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 343 EIVLLDHGLYAVISH 357 (538)
T ss_pred cEEEEcccccccccH
Confidence 889999999876543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=96.79 E-value=0.0073 Score=54.82 Aligned_cols=86 Identities=22% Similarity=0.371 Sum_probs=59.9
Q ss_pred CCCceeeeeeEEEeCCceEEEEEecCC--C----ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceE
Q 013074 189 SHVNVVTLLGFCLEGNNRALIYEFMPN--G----SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRIL 262 (450)
Q Consensus 189 ~HpnIv~l~~~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv 262 (450)
.+.+|.+++|+.+++.-..+|+|.+.+ | +|.+++.... ++. ...+.+. +-.+||-+ .+|+
T Consensus 75 ~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~-------~~~-~~~~~L~---~f~~~l~~---~~Iv 140 (199)
T PF10707_consen 75 DWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG-------LTE-ELRQALD---EFKRYLLD---HHIV 140 (199)
T ss_pred cccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC-------ccH-HHHHHHH---HHHHHHHH---cCCe
Confidence 377899999999999999999998643 2 5777774432 444 3333333 33456663 7899
Q ss_pred eeeeccccEEEcCC--C--CeEEee-ccccc
Q 013074 263 HFDIKPHNILLDQD--F--CPKISD-FGLAK 288 (450)
Q Consensus 263 H~Dikp~NIll~~~--~--~~kl~D-FGla~ 288 (450)
.+|++|+||++..+ + .+.|+| ||...
T Consensus 141 ~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 141 IRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence 99999999999633 2 467776 56544
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.008 Score=56.38 Aligned_cols=30 Identities=23% Similarity=0.193 Sum_probs=26.4
Q ss_pred CceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 259 TRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 468999999999999998778899998654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.016 Score=53.25 Aligned_cols=31 Identities=39% Similarity=0.449 Sum_probs=21.6
Q ss_pred CCceEeeeeccccEEEc-CCCCeEEeeccccc
Q 013074 258 STRILHFDIKPHNILLD-QDFCPKISDFGLAK 288 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~ 288 (450)
...++|+|+.+.||+++ +++.+.|+||+.+.
T Consensus 165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp CEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred CcEEEEeccccccceeeeccceeEEEecccce
Confidence 46799999999999999 66666899998654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.011 Score=55.29 Aligned_cols=31 Identities=26% Similarity=0.412 Sum_probs=25.9
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
...++|+|+.+.||+++++....|+||+.+.
T Consensus 163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 3458999999999999977666799998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.19 E-value=0.014 Score=51.44 Aligned_cols=108 Identities=18% Similarity=0.199 Sum_probs=68.0
Q ss_pred hhccccccceEEEEEEEc-------------------chhhhhhhcCCCcee-eeeeEEEeCCceEEEEEecCCCChhhh
Q 013074 162 KDKLGQGGFGGVYKGKLL-------------------DGLASISRTSHVNVV-TLLGFCLEGNNRALIYEFMPNGSLEKF 221 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~~-------------------~e~~~l~~l~HpnIv-~l~~~~~~~~~~~lV~E~~~~gsL~~~ 221 (450)
.+.||+|++|.||+|.+. .|+++|..+.-.++- +++.|-. ..+.|||+.|-.|.+.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~~ 102 (201)
T COG2112 27 EKELAKGTTSVVYLGEWRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGKL 102 (201)
T ss_pred hhhhhcccccEEEEeeccCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhhh
Confidence 467999999999998543 456777666655553 3444322 2345999988788765
Q ss_pred hhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeecc--ccEEEcCCCCeEEeeccccccc
Q 013074 222 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKP--HNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 222 l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp--~NIll~~~~~~kl~DFGla~~~ 290 (450)
.... +.+.+. .++..-.-|- ..+|-|+.|+- +||++.+ ..+.|+||..|..-
T Consensus 103 ~~~~---------~rk~l~----~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~-~~~~iIDFd~At~k 156 (201)
T COG2112 103 EIGG---------DRKHLL----RVLEKAYKLD---RLGIEHGELSRPWKNVLVND-RDVYIIDFDSATFK 156 (201)
T ss_pred hhcc---------cHHHHH----HHHHHHHHHH---HhccchhhhcCCceeEEecC-CcEEEEEccchhhc
Confidence 4321 122333 3344323333 47888888864 4566554 48999999988743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.068 Score=51.85 Aligned_cols=56 Identities=13% Similarity=0.146 Sum_probs=38.2
Q ss_pred hccccccceEEEEEE-------------------EcchhhhhhhcCC---CceeeeeeEEEe---CCceEEEEEecCCCC
Q 013074 163 DKLGQGGFGGVYKGK-------------------LLDGLASISRTSH---VNVVTLLGFCLE---GNNRALIYEFMPNGS 217 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~-------------------~~~e~~~l~~l~H---pnIv~l~~~~~~---~~~~~lV~E~~~~gs 217 (450)
+.||.|..+.||+.. +..|.+.|+.+.- ..|.+++++|.. .+..++|||++++.+
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~ 99 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVS 99 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEe
Confidence 368889898888732 1234555555532 457788887754 356899999998865
Q ss_pred h
Q 013074 218 L 218 (450)
Q Consensus 218 L 218 (450)
+
T Consensus 100 ~ 100 (297)
T PRK10593 100 V 100 (297)
T ss_pred c
Confidence 4
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.11 Score=52.48 Aligned_cols=31 Identities=23% Similarity=0.331 Sum_probs=26.2
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
...++|||+.+.||++.++ .++++||..+..
T Consensus 222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~~ 252 (401)
T PRK09550 222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAFY 252 (401)
T ss_pred CCceeeccCCcccEEeeCC-CcEEEecccccc
Confidence 4679999999999999876 589999986653
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.054 Score=51.16 Aligned_cols=29 Identities=24% Similarity=0.360 Sum_probs=25.4
Q ss_pred CceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 259 TRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
..++|+|+.|.||++++++ +.|+||+.+.
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYAS 174 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccC
Confidence 4689999999999999877 7899998765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.13 Score=46.73 Aligned_cols=37 Identities=30% Similarity=0.475 Sum_probs=30.7
Q ss_pred HHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 243 VIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 243 ~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+.+|.+-+..+|+ .+|+-+|+++.|.. .-||+|||.+
T Consensus 170 ~~~~~~dl~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 4566777888995 99999999999987 5689999864
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.98 E-value=0.037 Score=56.50 Aligned_cols=44 Identities=20% Similarity=0.312 Sum_probs=34.1
Q ss_pred hhhhhhcCCCceeeeeeEEEeC-CceEEEEEecCCCChhhhhhcCC
Q 013074 182 LASISRTSHVNVVTLLGFCLEG-NNRALIYEFMPNGSLEKFVYNGD 226 (450)
Q Consensus 182 ~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~ 226 (450)
...++.+.|+|....+++.... ....+|+|++ +.||++.+..+.
T Consensus 33 ~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 33 FQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred hHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 5677888999999998877654 3466889998 779999886544
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.92 E-value=0.052 Score=52.86 Aligned_cols=32 Identities=28% Similarity=0.448 Sum_probs=28.7
Q ss_pred CceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
..++|+|+.+.|++++.++-+-|.||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 46899999999999999888999999998754
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.79 E-value=0.005 Score=69.69 Aligned_cols=155 Identities=8% Similarity=-0.023 Sum_probs=103.3
Q ss_pred hhhhcCCCceeeeeeEEEe--CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhc--CCCC
Q 013074 184 SISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHR--GCST 259 (450)
Q Consensus 184 ~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~--~~~~ 259 (450)
.++...|+++.....-... +...+.+++++..|.+.+.+.++-... .++...-+...-.+......-.|. +-+.
T Consensus 1282 e~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~--~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~ 1359 (2724)
T KOG1826|consen 1282 ELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES--PDLDRSPVHLRHKVSVLNRNVILSLTNLGN 1359 (2724)
T ss_pred hhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC--CcchhchHHHHHHHHHhccchhhhcccCCc
Confidence 3444578887765554432 335678899999999999886654322 223333222222222444444443 2234
Q ss_pred ceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHH
Q 013074 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339 (450)
Q Consensus 260 ~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ell 339 (450)
-.+|+++|+-|.+|..+..+|+.++|+.+........ .....+++.|+.|+....- .++.++|+|..|+.+|+.-
T Consensus 1360 T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf---~Gl~l~sp~~v~qli~N~i--k~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1360 TNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF---FGLELCSPIYVLQLIKNEI--KFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cchhhhhhhhccceecCCcccccccccccccCchHhh---hhhhhCCHHHHHHHHHHHH--hhhhHHHHHHHHHHHHHHh
Confidence 5799999999999999999999999999833222111 2334577889999988764 7788899999999999988
Q ss_pred cCCCCC
Q 013074 340 GCKNNL 345 (450)
Q Consensus 340 tg~~p~ 345 (450)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 766554
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.35 E-value=0.093 Score=51.52 Aligned_cols=55 Identities=24% Similarity=0.262 Sum_probs=48.6
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 234 LRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 234 l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
-.+++...++.+.+..++-+.. .-..=|||+.-.||||+ +|++.|+||-+++...
T Consensus 318 ~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~~ 372 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY 372 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeeccc
Confidence 5788899999999998888886 56789999999999999 9999999999998543
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.86 E-value=0.14 Score=47.01 Aligned_cols=118 Identities=18% Similarity=0.173 Sum_probs=70.4
Q ss_pred chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC
Q 013074 180 DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259 (450)
Q Consensus 180 ~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~ 259 (450)
++.++++++. .|+++..= ....+.++.|+|-.... .. ..++..-+++|.-.|+. ..
T Consensus 107 nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------------~~----~N~i~agi~~L~~fH~~-~~ 162 (308)
T PF07387_consen 107 NKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------------NF----SNFITAGIKDLMDFHSE-NQ 162 (308)
T ss_pred hhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------------ch----hHHHHHhHHHHHHhhcc-CC
Confidence 3455555553 36666521 34456789999832110 11 11222224677888842 56
Q ss_pred ceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHH
Q 013074 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339 (450)
Q Consensus 260 ~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ell 339 (450)
+.+|+|..|+||+-|+.|.+||.|=+..-. . +.-|.--| + ...+.++.+-+|=.-++++.
T Consensus 163 ~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~-------------~V~~vN~~-Y----~~lT~~aE~~~fv~s~l~~v 222 (308)
T PF07387_consen 163 HCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N-------------QVNMVNIE-Y----ESLTQEAEVKVFVKSCLKLV 222 (308)
T ss_pred CeecCCCChhheeecCCCCEEecChhhhhh--h-------------eeeEEeee-c----cccChHHHHHHHHHHHHHHH
Confidence 899999999999999999999999764321 1 11122211 1 24567777777776677666
Q ss_pred cC
Q 013074 340 GC 341 (450)
Q Consensus 340 tg 341 (450)
..
T Consensus 223 ~~ 224 (308)
T PF07387_consen 223 EK 224 (308)
T ss_pred HH
Confidence 43
|
The function of this family is unknown. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=92.97 E-value=0.17 Score=49.04 Aligned_cols=68 Identities=18% Similarity=0.266 Sum_probs=46.7
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeec
Q 013074 205 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDF 284 (450)
Q Consensus 205 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 284 (450)
.-++|||++.+..|...-+- .+..++..-+.++ +.-|- ..|+||+|.+-=||++++++.++++||
T Consensus 182 RH~Vvmelv~g~Pl~~v~~v---------~d~~~ly~~lm~~---Iv~la---~~GlIHgDFNEFNimv~dd~~i~vIDF 246 (465)
T KOG2268|consen 182 RHCVVMELVDGYPLRQVRHV---------EDPPTLYDDLMGL---IVRLA---NHGLIHGDFNEFNIMVKDDDKIVVIDF 246 (465)
T ss_pred ceeeHHHhhcccceeeeeec---------CChHHHHHHHHHH---HHHHH---HcCceecccchheeEEecCCCEEEeec
Confidence 45789999987776543211 2333444333333 23333 389999999999999999999999999
Q ss_pred ccc
Q 013074 285 GLA 287 (450)
Q Consensus 285 Gla 287 (450)
--.
T Consensus 247 PQm 249 (465)
T KOG2268|consen 247 PQM 249 (465)
T ss_pred hHh
Confidence 643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.88 E-value=0.32 Score=47.10 Aligned_cols=31 Identities=29% Similarity=0.260 Sum_probs=27.2
Q ss_pred CCceEeeeeccccEEEcCC----CCeEEeeccccc
Q 013074 258 STRILHFDIKPHNILLDQD----FCPKISDFGLAK 288 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~----~~~kl~DFGla~ 288 (450)
...++|+|+.+.||+++++ +.+.++||..+.
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 4679999999999999985 889999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=91.88 E-value=0.25 Score=45.77 Aligned_cols=31 Identities=23% Similarity=0.297 Sum_probs=26.7
Q ss_pred CCceEeeeeccccEEEcC-CCCeEEeeccccc
Q 013074 258 STRILHFDIKPHNILLDQ-DFCPKISDFGLAK 288 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~ 288 (450)
...++|+|+.+.|||+++ ++.+.++||..+.
T Consensus 169 ~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 169 PIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred CEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 357999999999999998 5789999997654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=91.45 E-value=0.77 Score=44.26 Aligned_cols=53 Identities=13% Similarity=0.285 Sum_probs=29.2
Q ss_pred ccccccceEEEEEE------------------Ecchhhhhhhc---CCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 164 KLGQGGFGGVYKGK------------------LLDGLASISRT---SHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 164 ~LG~G~fg~Vy~~~------------------~~~e~~~l~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
.++.|....+|+.+ +..|.+.|+.+ .--.+.+.+++....+..+||+||++.+
T Consensus 24 ~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 24 PVSGGDINEAYRLDTDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EE--SSSSEEEEEETTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred ecCCCChhheEEEECCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 57778788887763 12234444444 4556788999888777789999998766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=90.34 E-value=2.5 Score=42.72 Aligned_cols=30 Identities=17% Similarity=0.303 Sum_probs=24.8
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
....+|+|+.+.||++++++ .+++|...+.
T Consensus 229 ~~~L~HGDl~~g~i~~~~~~-~~~id~ef~~ 258 (418)
T PLN02756 229 AQALVHGDLHTGSVMVTPDS-TQVIDPEFAF 258 (418)
T ss_pred ccceeecCCCCCcEEEcCCC-ceEecchhhc
Confidence 46799999999999999875 8888876543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=90.25 E-value=0.42 Score=43.66 Aligned_cols=31 Identities=35% Similarity=0.463 Sum_probs=22.0
Q ss_pred CceEeeeeccccEEE-cCCCCeEEeecccccc
Q 013074 259 TRILHFDIKPHNILL-DQDFCPKISDFGLAKL 289 (450)
Q Consensus 259 ~~ivH~Dikp~NIll-~~~~~~kl~DFGla~~ 289 (450)
..+.|+|+.+.||++ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 578999999999999 8889999999987653
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=89.92 E-value=0.48 Score=46.24 Aligned_cols=31 Identities=26% Similarity=0.376 Sum_probs=26.3
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
..+++|+|+.+.||+++++....|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 3589999999999999976656899998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=89.41 E-value=0.6 Score=45.37 Aligned_cols=31 Identities=32% Similarity=0.521 Sum_probs=27.2
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
..+++|+|+.+.||++++++...|+||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 4689999999999999988777899998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=88.29 E-value=0.79 Score=43.73 Aligned_cols=54 Identities=20% Similarity=0.193 Sum_probs=41.9
Q ss_pred CHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 235 RWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 235 ~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+.....+.+..+-.++.-.+... .-++|+|+.|+|++.++.+.++|+||.-|..
T Consensus 130 ~~~~~~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 130 DNHLLRKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred hhHHHHHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 34455556777778888777411 4699999999999999999999999976653
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=88.20 E-value=0.57 Score=45.11 Aligned_cols=30 Identities=30% Similarity=0.422 Sum_probs=26.5
Q ss_pred CceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 259 TRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
.+++|+|+.|.||++++++...|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 579999999999999998777899998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=87.83 E-value=1 Score=44.24 Aligned_cols=28 Identities=39% Similarity=0.585 Sum_probs=25.0
Q ss_pred eEeeeeccccEEEcCCCC-eEEeeccccc
Q 013074 261 ILHFDIKPHNILLDQDFC-PKISDFGLAK 288 (450)
Q Consensus 261 ivH~Dikp~NIll~~~~~-~kl~DFGla~ 288 (450)
+||+|+.|.||+++.+.. ..++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 999999999999998875 8899998654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=87.36 E-value=1.1 Score=43.31 Aligned_cols=29 Identities=31% Similarity=0.336 Sum_probs=25.2
Q ss_pred CceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 259 TRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 67999999999999987 578899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.26 E-value=0.41 Score=42.88 Aligned_cols=30 Identities=20% Similarity=0.254 Sum_probs=25.8
Q ss_pred CceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
...+|+|+.|.|+++++++ ++|+||+.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 4569999999999998877 88999997653
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=85.95 E-value=0.84 Score=44.67 Aligned_cols=37 Identities=35% Similarity=0.462 Sum_probs=23.8
Q ss_pred HHHHHHHHHHHHHHhhc-CCCCceEeeeeccccEEEcC
Q 013074 239 MYEIVIGIAKGLEYLHR-GCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 239 ~~~i~~~ia~~L~yLH~-~~~~~ivH~Dikp~NIll~~ 275 (450)
+..++.|+|--.--.-+ .+-...+|-||||+|||+-+
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd 314 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFD 314 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEec
Confidence 45567777543311322 12367999999999999943
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=85.85 E-value=1.1 Score=43.55 Aligned_cols=31 Identities=19% Similarity=0.199 Sum_probs=27.8
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
..+++|+|+.++|+++++++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4589999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=85.43 E-value=3.5 Score=38.29 Aligned_cols=38 Identities=21% Similarity=0.531 Sum_probs=30.6
Q ss_pred hhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChh
Q 013074 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219 (450)
Q Consensus 182 ~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 219 (450)
++.+.+.+--+|.+++.+-.+..+.|+|+||++-+.+.
T Consensus 62 L~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 62 LELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred HHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 55566666677888888888899999999999876664
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=84.75 E-value=1.4 Score=43.57 Aligned_cols=32 Identities=25% Similarity=0.353 Sum_probs=26.9
Q ss_pred CCceEeeeeccccEEEcC-CCCeEEeecccccc
Q 013074 258 STRILHFDIKPHNILLDQ-DFCPKISDFGLAKL 289 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~ 289 (450)
...++|+|+++.||++++ ++.+.++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 357899999999999986 46899999987653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=84.47 E-value=1.3 Score=50.58 Aligned_cols=31 Identities=35% Similarity=0.435 Sum_probs=26.0
Q ss_pred CceEeeeeccccEEEcCCC--CeE-Eeecccccc
Q 013074 259 TRILHFDIKPHNILLDQDF--CPK-ISDFGLAKL 289 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~--~~k-l~DFGla~~ 289 (450)
.++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 6899999999999999775 454 999997653
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=82.80 E-value=0.97 Score=40.83 Aligned_cols=30 Identities=27% Similarity=0.315 Sum_probs=25.1
Q ss_pred CceEeeeeccccEEEcCCC-----CeEEeeccccc
Q 013074 259 TRILHFDIKPHNILLDQDF-----CPKISDFGLAK 288 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~-----~~kl~DFGla~ 288 (450)
..++|||+.+.||++..++ .+.++||..++
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 5799999999999998543 58899998754
|
subfamily of choline kinases |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=82.21 E-value=0.9 Score=43.52 Aligned_cols=31 Identities=35% Similarity=0.545 Sum_probs=25.5
Q ss_pred CceEeeeeccccEEEcCCCC-eEEeecccccc
Q 013074 259 TRILHFDIKPHNILLDQDFC-PKISDFGLAKL 289 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~-~kl~DFGla~~ 289 (450)
..++|+|+.+.||++++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 46999999999999997555 46999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=82.17 E-value=2.6 Score=41.13 Aligned_cols=40 Identities=30% Similarity=0.364 Sum_probs=27.1
Q ss_pred HHHHHHHHHHHHHHHhhc-CCCCceEeeeeccccEEEcCCC
Q 013074 238 KMYEIVIGIAKGLEYLHR-GCSTRILHFDIKPHNILLDQDF 277 (450)
Q Consensus 238 ~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dikp~NIll~~~~ 277 (450)
-+..++.|++--.-..-+ .|-...+|-||||+|||+-+..
T Consensus 280 YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 280 YIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 355677788765433422 2246799999999999995443
|
|
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=81.68 E-value=13 Score=36.59 Aligned_cols=83 Identities=18% Similarity=0.211 Sum_probs=60.4
Q ss_pred CCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCcccccccc
Q 013074 234 LRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALE 313 (450)
Q Consensus 234 l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE 313 (450)
+.....++++.+....|.-+- +.-.|.=+.|+||+++.++.+.+..+|+-...+ |.=+.||
T Consensus 82 ~~k~~Klr~a~~~I~~l~e~~----~tr~~~~laPeNilf~~~l~p~~vH~Glk~~lp---------------Pye~tee 142 (434)
T COG4499 82 KEKTRKLRLALQNIATLSELN----NTRYTFFLAPENILFDGGLTPFFVHRGLKNSLP---------------PYEMTEE 142 (434)
T ss_pred HHHHHHHHHHHHHHHHHHHhh----ccceeEEecchheEEcCCCceEEEecchhccCC---------------CCCCCHH
Confidence 455667777888877777765 566788899999999999999999999854332 2335666
Q ss_pred ccccccCCCCccCchHhHHHHHHHHHcCCCCCCC
Q 013074 314 VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS 347 (450)
Q Consensus 314 ~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~ 347 (450)
.+.. .+-+++..++.|+.+|..
T Consensus 143 ~f~~------------~ykA~~~~~fn~k~~Fe~ 164 (434)
T COG4499 143 RFLK------------EYKALAIYAFNGKFSFES 164 (434)
T ss_pred HHHH------------HHHHHHHHHHcCCccHHH
Confidence 6544 356677778888887753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 450 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-35 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-29 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-22 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-22 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-22 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 5e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-12 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-12 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-12 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-12 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-12 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-12 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-11 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-11 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-11 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-11 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-11 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 5e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 6e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 6e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-11 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 7e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 7e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-11 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-11 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 8e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 9e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-10 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-10 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-09 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-09 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-09 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 9e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 9e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 8e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 8e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-08 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 8e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-07 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-07 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-07 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-07 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-07 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-07 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-07 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-07 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-07 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-07 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 7e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 7e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 7e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 7e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-07 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-07 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-07 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 9e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-07 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-06 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-06 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-06 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-06 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-06 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-06 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-06 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-06 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-06 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-06 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-06 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-06 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-06 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-06 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-06 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-06 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-06 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-06 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-06 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 8e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 9e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-05 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-05 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-05 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 4e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 8e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 9e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-04 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-04 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-04 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-04 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-04 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-04 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-04 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-04 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-04 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-04 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-04 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 3e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 3e-04 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-04 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 3e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-04 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-04 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-04 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-04 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-04 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-04 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-04 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-04 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-04 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-04 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 7e-04 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-04 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 1e-92
Identities = 105/301 (34%), Positives = 164/301 (54%), Gaps = 40/301 (13%)
Query: 146 LKRYNFSDVKKITNSF--KDKLGQGGFGGVYKGKLLDG---------------------- 181
LKR++ +++ +++F K+ LG+GGFG VYKG+L DG
Sbjct: 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76
Query: 182 -LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 240
+ IS H N++ L GFC+ R L+Y +M NGS+ + S+P L W K
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP--PLDWPKRQ 134
Query: 241 EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSL 300
I +G A+GL YLH C +I+H D+K NILLD++F + DFGLAKL K V++
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTA 194
Query: 301 LGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD-SGVDNSSEVYFPH 359
+ RGTIG+IA E S G+ S K+DV+ +G+M++EL+ + D + + N +V
Sbjct: 195 V--RGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 360 WIYRHVEQDREFKLL-----GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
W+ +++ + L+ G +E +++I V L C Q+ P +RP M+EV+ ML+
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEE---VEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
Query: 415 G 415
G
Sbjct: 308 G 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 5e-82
Identities = 89/316 (28%), Positives = 147/316 (46%), Gaps = 62/316 (19%)
Query: 146 LKRYNFSDVKKITNSFKD--------KLGQGGFGGVYKGKLLDG-------LAS------ 184
++F ++K +TN+F + K+G+GGFG VYKG ++ LA+
Sbjct: 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVKKLAAMVDITT 70
Query: 185 -------------ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPC 231
+++ H N+V LLGF +G++ L+Y +MPNGSL + D + P
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP- 129
Query: 232 QYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291
L W +I G A G+ +LH +H DIK NILLD+ F KISDFGLA+
Sbjct: 130 --LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 292 T-KKGIVSSLLGAR--GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 348
+ +++S R GT Y+A E GE++ KSD+YSFG++++E++ +D
Sbjct: 185 KFAQTVMTS----RIVGTTAYMAPEALR---GEITPKSDIYSFGVVLLEIITGLPAVDE- 236
Query: 349 VDNSSEVYFPHWIYRHVEQDREF-----KLLGVVTKKENEIAKKMIIVGLWCIQARPYDR 403
+ ++++ K + + M V C+ + R
Sbjct: 237 --HREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTS---VEAMYSVASQCLHEKKNKR 291
Query: 404 PPMNEVIEMLQGSTEA 419
P + +V ++LQ T +
Sbjct: 292 PDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 252 bits (647), Expect = 3e-81
Identities = 97/311 (31%), Positives = 157/311 (50%), Gaps = 48/311 (15%)
Query: 143 PLPLKRYNFSDVKKITNSFKDK--LGQGGFGGVYKGKLLDG------------------- 181
P R D+++ TN+F K +G G FG VYKG L DG
Sbjct: 23 PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 182 ---LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK 238
+ ++S H ++V+L+GFC E N LIY++M NG+L++ +Y + P + WE+
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQ 140
Query: 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK-KGIV 297
EI IG A+GL YLH I+H D+K NILLD++F PKI+DFG++K T + +
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197
Query: 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF 357
S+++ +GT+GYI E F + G ++ KSDVYSFG+++ E++ ++ + + V
Sbjct: 198 STVV--KGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR-EMVNL 252
Query: 358 PHWIYRHVEQDREF------KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
W + + L + + +K + C+ DRP M +V+
Sbjct: 253 AEWA-VESHNNGQLEQIVDPNLADKIRPES---LRKFGDTAVKCLALSSEDRPSMGDVLW 308
Query: 412 MLQGSTEALQI 422
L+ AL++
Sbjct: 309 KLEY---ALRL 316
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 3e-51
Identities = 68/299 (22%), Positives = 105/299 (35%), Gaps = 55/299 (18%)
Query: 160 SFKDKLGQGGFGGVYKG---------KLLDG-----------LASISRTSHVNVVTLLGF 199
+ +G FG V+K K+ + S+ H N++ +G
Sbjct: 27 QLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGA 86
Query: 200 CLEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH- 254
G + LI F GSL F+ + W ++ I +A+GL YLH
Sbjct: 87 EKRGTSVDVDLWLITAFHEKGSLSDFLKA-------NVVSWNELCHIAETMARGLAYLHE 139
Query: 255 ------RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG 308
G I H DIK N+LL + I+DFGLA K + G GT
Sbjct: 140 DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT-HGQVGTRR 198
Query: 309 YIALEVFS---RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365
Y+A EV + + D+Y+ G+++ EL D VD + F I +H
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD-EYMLPFEEEIGQHP 257
Query: 366 EQDREFKLLGVVTKK----------ENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ ++ VV KK ++ + C R V E +
Sbjct: 258 SLEDMQEV--VVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-47
Identities = 71/306 (23%), Positives = 129/306 (42%), Gaps = 67/306 (21%)
Query: 150 NFSDVKKITNSFKDKLGQGGFGGVYKG---------KLLDG--------------LASIS 186
+ D+ K+K+G G FG V++ K+L +A +
Sbjct: 35 PWCDLN-----IKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMK 89
Query: 187 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 246
R H N+V +G + N +++ E++ GSL + ++ + L + + +
Sbjct: 90 RLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ---LDERRRLSMAYDV 146
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT 306
AKG+ YLH + I+H ++K N+L+D+ + K+ DFGL++L K S A GT
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGT 202
Query: 307 IGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK---NNLDSGVDNSSEVYFPHWIYR 363
++A EV + KSDVYSFG+++ EL + NL N ++V
Sbjct: 203 PEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNL-----NPAQVVA------ 249
Query: 364 HVEQDREFKLLGVVTKKE-----NEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418
V K + + ++ + C P+ RP ++++L+ +
Sbjct: 250 -----------AVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298
Query: 419 ALQIPP 424
+ PP
Sbjct: 299 SAVPPP 304
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-45
Identities = 66/306 (21%), Positives = 121/306 (39%), Gaps = 61/306 (19%)
Query: 150 NFSDVKKITNSFKDKLGQGGFGGVYKG---------KLLDG----------LASISRTSH 190
++ +++ ++ +G+G FG V K K ++ L +SR +H
Sbjct: 6 DYKEIE-----VEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNH 60
Query: 191 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 250
N+V L G CL N L+ E+ GSL ++ ++P Y + ++G+
Sbjct: 61 PNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHG---AEPLPYYTAAHAMSWCLQCSQGV 115
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDF-CPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
YLH ++H D+KP N+LL KI DFG A T + +G+ +
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT------HMTNNKGSAAW 169
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369
+A EVF + S K DV+S+G+++ E++ + P + +
Sbjct: 170 MAPEVFEGS--NYSEKCDVFSWGIILWEVITRRK--------------P---FDEIGGP- 209
Query: 370 EFKLLGVVTKKE-----NEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPP 424
F+++ V + K + + C P RP M E+++++
Sbjct: 210 AFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269
Query: 425 TPFLSS 430
P
Sbjct: 270 EPLQYP 275
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-43
Identities = 64/277 (23%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 161 FKDKLGQGGFGGVYKG--------KLLDG--------------LASISRTSHVNVVTLLG 198
++G G FG VYKG K+L+ + + +T HVN++ +G
Sbjct: 28 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
+ A++ ++ SL ++ +T +K+ +I A+G++YLH +
Sbjct: 88 YSTAPQ-LAIVTQWCEGSSLYHHLHASETK-----FEMKKLIDIARQTARGMDYLH---A 138
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF-SR 317
I+H D+K +NI L +D KI DFGLA ++ G+I ++A EV +
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE-KSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 318 NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVV 377
+ S +SDVY+FG+++ EL+ + S ++N ++ I L V
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPY-SNINNRDQI-----IEMVGRGSLSPDLSKVR 251
Query: 378 TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ + + M C++ + +RP ++ ++
Sbjct: 252 SNCPKRMKRLM----AECLKKKRDERPSFPRILAEIE 284
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 59/327 (18%), Positives = 104/327 (31%), Gaps = 64/327 (19%)
Query: 153 DVKKITNSFKDKLGQGGFGGVYKGKLLD--------------------GLASISRTSHVN 192
D+ + + +G+G +G VYKG L + + + H N
Sbjct: 11 DLDNLK--LLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDN 68
Query: 193 VVTLLGFCLEGN-----NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 247
+ + L+ E+ PNGSL K++ W + +
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-------HTSDWVSSCRLAHSVT 121
Query: 248 KGLEYLH------RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
+GL YLH I H D+ N+L+ D ISDFGL+ T + +
Sbjct: 122 RGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEE 181
Query: 302 -----GARGTIGYIALEVFS-----RNFGEVSHKSDVYSFGMMIMELV-GCKNNLDSGVD 350
GTI Y+A EV R+ + D+Y+ G++ E+ C +
Sbjct: 182 DNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
Query: 351 NSSEVYFPHWIYRHVEQDREFKLLGVVTKKE-----------NEIAKKMIIVGLWCIQAR 399
++ F + H + L V +K+ + + + C
Sbjct: 242 PEYQMAFQTEVGNHPTFEDMQVL--VSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD 299
Query: 400 PYDRPPMNEVIEMLQGSTEALQIPPTP 426
R E + + +
Sbjct: 300 AEARLTAQXAEERMAELMMIWERNKSV 326
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 61/302 (20%), Positives = 113/302 (37%), Gaps = 71/302 (23%)
Query: 150 NFSDVKKITNSFKDKLGQGGFGGVYKG--------KLLDG--------------LASISR 187
F ++ + +G+G FG VY G +L+D + + +
Sbjct: 31 PFEQLE-----IGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQ 85
Query: 188 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 247
T H NVV +G C+ + A+I +L V + L K +I I
Sbjct: 86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV-----LDVNKTRQIAQEIV 140
Query: 248 KGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL--CTTKKGIVSSLLGARG 305
KG+ YLH + ILH D+K N+ D I+DFGL + L G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 306 TIGYIALEVFSRNFGEV-------SHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP 358
+ ++A E+ + + S SDV++ G + EL + +P
Sbjct: 197 WLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE--------------WP 242
Query: 359 HWIYRHVEQDREFKLLGVVTKK------ENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412
++ + ++ + + + K++ + L+C +RP ++++M
Sbjct: 243 ---FKTQPAEA---IIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296
Query: 413 LQ 414
L+
Sbjct: 297 LE 298
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-42
Identities = 59/316 (18%), Positives = 119/316 (37%), Gaps = 74/316 (23%)
Query: 142 GPLPLKRYNFSDVKKITNS---FKDKLGQGGFGGVYKGKLLDG----------------- 181
G + + S + + ++ ++ ++G+GGFG V+KG+L+
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 182 -------------LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTS 228
+ +S +H N+V L G ++ EF+P G L + +
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD---- 114
Query: 229 KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-----DFCPKISD 283
++W +++ IA G+EY+ + I+H D++ NI L C K++D
Sbjct: 115 -KAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 343
FGL++ V S+ G G ++A E + K+D YSF M++ ++ +
Sbjct: 173 FGLSQQ------SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 344 NLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKE-----NEIAKKMIIVGLWCIQA 398
P + + + + + + ++ V C
Sbjct: 227 --------------P---FDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSG 269
Query: 399 RPYDRPPMNEVIEMLQ 414
P RP + +++ L
Sbjct: 270 DPKKRPHFSYIVKELS 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 3e-41
Identities = 54/300 (18%), Positives = 105/300 (35%), Gaps = 76/300 (25%)
Query: 150 NFSDVKKITNSFKDKLGQGGFGGVYKG---------KLLDG--------------LASIS 186
+F + F KL + G ++KG K+L +
Sbjct: 8 DFKQLN-----FLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 187 RTSHVNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 244
SH NV+ +LG C + LI +MP GSL ++ G + + + +
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV----VDQSQAVKFAL 118
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR 304
+A+G+ +LH I + ++++D+D +IS + + G
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP--------GRM 169
Query: 305 GTIGYIALEVF-SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363
++A E + +D++SF +++ ELV + EV F
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV------------TREVPFADLSNM 217
Query: 364 HVEQDREFKLLGVVTKKE---------NEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ + V + ++K M I C+ P RP + ++ +L+
Sbjct: 218 EI-------GMKVALEGLRPTIPPGISPHVSKLMKI----CMNEDPAKRPKFDMIVPILE 266
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-40
Identities = 70/307 (22%), Positives = 114/307 (37%), Gaps = 84/307 (27%)
Query: 150 NFSDVKKITNSFKDKLGQGGFGGVYKG---------KLLDGLAS---------------- 184
+F+++ ++ +G GGFG VY+ K
Sbjct: 5 DFAELT-----LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 185 ISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 244
+ H N++ L G CL+ N L+ EF G L + + + + + + +
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-------KRIPPDILVNWAV 112
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP--------KISDFGLAKLCTTKKGI 296
IA+G+ YLH I+H D+K NIL+ Q KI+DFGLA+
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR---- 168
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356
++ + A G ++A EV + S SDV+S+G+++ EL+ + EV
Sbjct: 169 -TTKMSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELL------------TGEVP 213
Query: 357 FPHWIYRHVEQDREFKLLGVVTKKE---------NEIAKKMIIVGLWCIQARPYDRPPMN 407
F V GV K AK M C P+ RP
Sbjct: 214 FRGIDGLAV-------AYGVAMNKLALPIPSTCPEPFAKLM----EDCWNPDPHSRPSFT 262
Query: 408 EVIEMLQ 414
+++ L
Sbjct: 263 NILDQLT 269
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 66/325 (20%), Positives = 115/325 (35%), Gaps = 62/325 (19%)
Query: 143 PLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKG---------KLLDG-----------L 182
PL ++R ++ ++G+G +G V+ G K+ +
Sbjct: 28 PLLVQRTIAKQIQ-----MVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEI 82
Query: 183 ASISRTSHVNVVTLLGFCLEGNNR----ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEK 238
H N++ + ++G LI ++ NGSL ++ + L +
Sbjct: 83 YQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-------TTLDAKS 135
Query: 239 MYEIVIGIAKGLEYLH-----RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293
M ++ GL +LH I H D+K NIL+ ++ I+D GLA +
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195
Query: 294 KGIVSSLLGAR-GTIGYIALEVF----SRNFGEVSHKSDVYSFGMMIMELV-GCKNNLDS 347
V R GT Y+ EV +RN + +D+YSFG+++ E+ C +
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG--- 252
Query: 348 GVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKE-----NEIAKKMIIVGLW-----CIQ 397
E P+ + E V KK N + + + C
Sbjct: 253 --GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWA 310
Query: 398 ARPYDRPPMNEVIEMLQGSTEALQI 422
P R V + L +E+ I
Sbjct: 311 HNPASRLTALRVKKTLAKMSESQDI 335
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 68/333 (20%), Positives = 111/333 (33%), Gaps = 78/333 (23%)
Query: 150 NFSDVKKITNSFKDKLGQGGFGGVYKG-----------KLLDGL-----------ASI-S 186
SD+ + LG+G FG K K L +
Sbjct: 8 RPSDLI-----HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 187 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 246
H NV+ +G + I E++ G+L + + D+ W + I
Sbjct: 63 CLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ-----YPWSQRVSFAKDI 117
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL-----------CTTKKG 295
A G+ YLH S I+H D+ HN L+ ++ ++DFGLA+L + KK
Sbjct: 118 ASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174
Query: 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEV 355
G ++A E+ N K DV+SFG+++ E++G N
Sbjct: 175 DRKKRYTVVGNPYWMAPEMI--NGRSYDEKVDVFSFGIVLCEIIGRVNA----------- 221
Query: 356 YFPHWIYRHVE---QDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412
P ++ R ++ R F + C P RP ++
Sbjct: 222 -DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPIT----VRCCDLDPEKRPSFVKLEHW 276
Query: 413 LQGSTEAL--QIPPTP--------FLSSPPRAS 435
L+ L +P P F + R
Sbjct: 277 LETLRMHLAGHLPLGPQLEQLDRGFWETYRRGE 309
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-38
Identities = 56/300 (18%), Positives = 105/300 (35%), Gaps = 59/300 (19%)
Query: 161 FKDKLGQGGFGGVYKG---------KLLDG-----------LASISRTSHVNVVTLLGFC 200
+ +G+G +G V++G K+ L + H N++ +
Sbjct: 12 LLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 201 LEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH-- 254
+ + + LI + GSL ++ L IV+ IA GL +LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQL-------TTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 255 ---RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT-TKKGIVSSLLGARGTIGYI 310
I H D+K NIL+ ++ I+D GLA + + + + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 311 ALEVF----SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH-- 364
A EV + + + D+++FG+++ E+ +G+ + F +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV--SNGIVEDYKPPFYDVVPNDPS 242
Query: 365 VEQDREFKLLGVVTKKE-----NEIAKKMIIVGLW-----CIQARPYDRPPMNEVIEMLQ 414
E R+ V ++ N + L C P R + + L
Sbjct: 243 FEDMRK----VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 61/321 (19%), Positives = 109/321 (33%), Gaps = 70/321 (21%)
Query: 143 PLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKG---------KLLDG-----------L 182
PL ++R + ++ +G+G FG V++G K+ +
Sbjct: 33 PLLVQRTIARTIV-----LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEI 87
Query: 183 ASISRTSHVNVVTLLGFCLEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLR--- 235
H N++ + + N L+ ++ +GSL YL
Sbjct: 88 YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL------------FDYLNRYT 135
Query: 236 --WEKMYEIVIGIAKGLEYLH-----RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
E M ++ + A GL +LH I H D+K NIL+ ++ I+D GLA
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195
Query: 289 LCTTKKGIVSSLLGAR-GTIGYIALEVF----SRNFGEVSHKSDVYSFGMMIMELVGCKN 343
+ + R GT Y+A EV + E ++D+Y+ G++ E+
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA---- 251
Query: 344 NLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKK----------ENEIAKKMIIVGL 393
S + P++ + E V +K E + M +
Sbjct: 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 311
Query: 394 WCIQARPYDRPPMNEVIEMLQ 414
C A R + + L
Sbjct: 312 ECWYANGAARLTALRIKKTLS 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 64/295 (21%), Positives = 107/295 (36%), Gaps = 81/295 (27%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL-----------------------ASISRT-SHVNVVT 195
+++G+G FG V+ G+L A I + SH N+V
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 196 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHR 255
L+G C + ++ E + G F+ LR + + ++V A G+EYL
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR-----LRVKTLLQMVGDAAAGMEYLE- 230
Query: 256 GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI----- 310
S +H D+ N L+ + KISDFG+++ + A G + +
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSRE------EADGVYAASGGLRQVPVKWT 282
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDNSSEVYFPHWIY 362
A E N+G S +SDV+SFG+++ E N +
Sbjct: 283 APEAL--NYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---------QQT------R 325
Query: 363 RHVEQDREFKLLGVVTKKEN---EIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
VE+ G + E + + M C P RP + + + LQ
Sbjct: 326 EFVEKG------GRLPCPELCPDAVFRLM----EQCWAYEPGQRPSFSTIYQELQ 370
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 60/331 (18%), Positives = 106/331 (32%), Gaps = 42/331 (12%)
Query: 40 RQVDCGTLSLDIGYPFWG-DGLRPQYCGRQEFYLDCQNNPNQNPTQSPTIFMGSEAFRVL 98
Q G + G F L + + + C N + S +
Sbjct: 214 SQDKAGKYCIPEGTKFDTLWQLVEYLKLKADGLIYCLKEACPNSSASNASGAAAPTLPAH 273
Query: 99 DIDDGHQTMIITPARLDLLSSY----CPSVQWPQAIINHTLFSLQNYGPLPLKRYNFSDV 154
H I D + + ++ ++F P LK
Sbjct: 274 PSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLK 333
Query: 155 KKITNSFKDKLGQGGFGGVYKGKLL--------------DGLASISRT------------ 188
+ +LG G FG V +G G
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393
Query: 189 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAK 248
+ +V L+G C L+ E G L KF+ + + + E++ ++
Sbjct: 394 DNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL-----VGKREEIPVSNVAELLHQVSM 447
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG 308
G++YL +H ++ N+LL KISDFGL+K ++ + +
Sbjct: 448 GMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 504
Query: 309 YIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ A E NF + S +SDV+S+G+ + E +
Sbjct: 505 WYAPECI--NFRKFSSRSDVWSYGVTMWEAL 533
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 59/209 (28%), Positives = 89/209 (42%), Gaps = 42/209 (20%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL---------------------------ASI-SRTSHV 191
LG G FG VYKG + A + + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGL 250
+V LLG CL + LI + MP G L +V + D L W + IAKG+
Sbjct: 78 HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310
YL R++H D+ N+L+ KI+DFGLAKL ++ + G + I ++
Sbjct: 131 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWM 186
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
ALE +H+SDV+S+G+ + EL+
Sbjct: 187 ALESI--LHRIYTHQSDVWSYGVTVWELM 213
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 47/204 (23%), Positives = 80/204 (39%), Gaps = 37/204 (18%)
Query: 162 KDKLGQGGFGGVYKGKLLDGL-------------------------ASI-SRTSHVNVVT 195
+LG G FG V +G A I + + +V
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 196 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHR 255
L+G C L+ E G L KF+ + + + E++ ++ G++YL
Sbjct: 75 LIGVCQA-EALMLVMEMAGGGPLHKFL-----VGKREEIPVSNVAELLHQVSMGMKYL-- 126
Query: 256 GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF 315
+H D+ N+LL KISDFGL+K ++ + + + A E
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 316 SRNFGEVSHKSDVYSFGMMIMELV 339
NF + S +SDV+S+G+ + E +
Sbjct: 186 --NFRKFSSRSDVWSYGVTMWEAL 207
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 37/206 (17%)
Query: 161 FKDKLGQGGFGGVYKGKLL---------------DGLASISRT------------SHVNV 193
+ +G G G V G+L G R H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 194 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 253
+ L G G ++ E+M NGSL+ F+ D ++ ++ G+ G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-----FTIMQLVGMLRGVGAGMRYL 167
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALE 313
+H D+ N+L+D + K+SDFGL+++ + G + I + A E
Sbjct: 168 S---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPE 224
Query: 314 VFSRNFGEVSHKSDVYSFGMMIMELV 339
F S SDV+SFG+++ E++
Sbjct: 225 AI--AFRTFSSASDVWSFGVVMWEVL 248
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 38/207 (18%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGL---------------------------ASI-SRTSHVN 192
+ +G G FG VYKG L A I + SH N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
++ L G + +I E+M NG+L+KF+ D ++ ++ GIA G++Y
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE-----FSVLQLVGMLRGIAAGMKY 162
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
L + +H D+ NIL++ + K+SDFGL+++ + G + I + A
Sbjct: 163 LA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMELV 339
E ++ + + SDV+SFG+++ E++
Sbjct: 220 EAI--SYRKFTSASDVWSFGIVMWEVM 244
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 60/282 (21%), Positives = 99/282 (35%), Gaps = 74/282 (26%)
Query: 161 FKDKLGQGGFGGVYKG---------------------KLLDGLAS----ISRTSHVNVVT 195
F ++G+G F VYKG + H N+V
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 196 LLGFCLEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----I 246
L+ E M +G+L+ ++ R++ M V+ I
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYL-----------KRFKVMKIKVLRSWCRQI 138
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLD-QDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
KGL++LH + I+H D+K NI + KI D GLA L ++ G
Sbjct: 139 LKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF--AKAV---IG 192
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK---NNLDSGVDNSSEVYFPHWIY 362
T ++A E++ + E DVY+FGM ++E+ + + + IY
Sbjct: 193 TPEFMAPEMYEEKYDE---SVDVYAFGMCMLEMATSEYPYSECQN----------AAQIY 239
Query: 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRP 404
R V + K K++I CI+ +R
Sbjct: 240 RRVTSGVKPASFD---KVAIPEVKEII---EGCIRQNKDERY 275
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 60/295 (20%), Positives = 107/295 (36%), Gaps = 62/295 (21%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLASISRTS-----------------------------HV 191
LG+G FG V + D + H
Sbjct: 25 RIRDLGEGHFGKVELCRY-DPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHE 83
Query: 192 NVVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
N+V G C E LI EF+P+GSL++++ + ++ + + I KG
Sbjct: 84 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-----INLKQQLKYAVQICKG 138
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
++YL S + +H D+ N+L++ + KI DFGL K T K + + +
Sbjct: 139 MDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQD 368
A E + SDV+SFG+ + EL+ C ++ + H
Sbjct: 196 YAPE--CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR-- 251
Query: 369 REFKLLGVVTKKE---------NEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
L+ + + + +E+ + M C + +P +R +IE +
Sbjct: 252 ----LVNTLKEGKRLPCPPNCPDEVYQLM----RKCWEFQPSNRTSFQNLIEGFE 298
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 67/279 (24%), Positives = 119/279 (42%), Gaps = 53/279 (18%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGL---------------------ASISRT-SHVNVVTLLG 198
K KLG G +G VY+G A++ + H N+V LLG
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
C +I EFM G+L ++ + Q + + + I+ +EYL
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE---K 336
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
+H ++ N L+ ++ K++DFGL++L T + GA+ I + A E
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAKFPIKWTAPESL--A 392
Query: 319 FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378
+ + S KSDV++FG+++ E+ + G+D S+V Y +E+D +++
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQV------YELLEKD--YRME---- 439
Query: 379 KKEN---EIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ E ++ + M C Q P DRP E+ + +
Sbjct: 440 RPEGCPEKVYELM----RACWQWNPSDRPSFAEIHQAFE 474
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 55/209 (26%), Positives = 81/209 (38%), Gaps = 41/209 (19%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLASISRT----------------------------SHVN 192
F +LG+G FG V + D L + H N
Sbjct: 14 FLQQLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 72
Query: 193 VVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 250
+V G C R LI E++P GSL ++ + K+ + I KG+
Sbjct: 73 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGM 127
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310
EYL + R +H D+ NIL++ + KI DFGL K+ K I +
Sbjct: 128 EYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
A E + S SDV+SFG+++ EL
Sbjct: 185 APESL--TESKFSVASDVWSFGVVLYELF 211
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 42/209 (20%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRT----------------------------SHV 191
LG G FG VYKG + + +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKGL 250
+V LLG CL + LI + MP G L +V + D L W + IAKG+
Sbjct: 78 HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGM 130
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310
YL R++H D+ N+L+ KI+DFGLAKL ++ + G + I ++
Sbjct: 131 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWM 186
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
ALE +H+SDV+S+G+ + EL+
Sbjct: 187 ALESI--LHRIYTHQSDVWSYGVTVWELM 213
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-24
Identities = 47/210 (22%), Positives = 72/210 (34%), Gaps = 42/210 (20%)
Query: 160 SFKDKLGQGGFGGVYKGK---------------LLDGLASISRT--------------SH 190
+KLG G FG V +G+ L + S H
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 191 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKG 249
N++ L G L ++ E P GSL + + R+ + +A+G
Sbjct: 81 RNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY------AVQVAEG 133
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
+ YL S R +H D+ N+LL KI DFGL + + +
Sbjct: 134 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
A E SH SD + FG+ + E+
Sbjct: 191 CAPESL--KTRTFSHASDTWMFGVTLWEMF 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 51/201 (25%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL--------------------ASI-SRTSHVNVVTLLG 198
+F ++G G FG V+ G L+ A + + SH +V L G
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
CLE L+ EFM +G L ++ E + + + + +G+ YL
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRTQRGL-----FAAETLLGMCLDVCEGMAYL---EE 122
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
++H D+ N L+ ++ K+SDFG+ + +S G + + + + EVF +
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFPVKWASPEVF--S 178
Query: 319 FGEVSHKSDVYSFGMMIMELV 339
F S KSDV+SFG+++ E+
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVF 199
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 56/209 (26%), Positives = 82/209 (39%), Gaps = 41/209 (19%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLASISRT----------------------------SHVN 192
F +LG+G FG V + D L + H N
Sbjct: 45 FLQQLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDN 103
Query: 193 VVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 250
+V G C R LI E++P GSL ++ + K+ + I KG+
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-----IDHIKLLQYTSQICKGM 158
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310
EYL + R +H D+ NIL++ + KI DFGL K+ K I +
Sbjct: 159 EYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY 215
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
A E S + S SDV+SFG+++ EL
Sbjct: 216 APE--SLTESKFSVASDVWSFGVVLYELF 242
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 50/203 (24%), Positives = 79/203 (38%), Gaps = 42/203 (20%)
Query: 162 KDKLGQGGFGGVYKGK------------------LLDGLASISRTSHVNVVTLLGFCLEG 203
+ ++G+G FG V++ K ++ L + + S +V L G EG
Sbjct: 63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREG 122
Query: 204 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEYLHRGCS 258
+ E + GSL + + + + E +GLEYLH +
Sbjct: 123 PWVNIFMELLEGGSLGQLI-----------KQMGCLPEDRALYYLGQALEGLEYLH---T 168
Query: 259 TRILHFDIKPHNILLDQDFCP-KISDFGLAKLCTTKKGIVSSLLGA--RGTIGYIALEVF 315
RILH D+K N+LL D + DFG A S L G GT ++A EV
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVV 228
Query: 316 SRNFGEVSHKSDVYSFGMMIMEL 338
K D++S M++ +
Sbjct: 229 MGK--PCDAKVDIWSSCCMMLHM 249
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 53/278 (19%)
Query: 161 FKDKLGQGGFGGVYKG---------------------KLLDGLASISRTSHVNVVTLLGF 199
+ KLGQG FG V+ G L + + H +V L
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259
E ++ E+M GSL F+ +YLR ++ ++ IA G+ Y+
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVE---RM 299
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF 319
+H D++ NIL+ ++ K++DFGLA+L + ++ GA+ I + A E +
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA--LY 355
Query: 320 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379
G + KSDV+SFG+++ EL G+ N EV VE+ +++
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REV------LDQVERG--YRMP----C 402
Query: 380 KEN---EIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ M C + P +RP + L+
Sbjct: 403 PPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLE 436
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 54/207 (26%), Positives = 89/207 (42%), Gaps = 40/207 (19%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLASISRT----------------------------SHVN 192
LG G FG V+KG + SI H +
Sbjct: 17 KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
+V LLG C ++ L+ +++P GSL V + Q L + IAKG+ Y
Sbjct: 77 IVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-----LNWGVQIAKGMYY 130
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
L ++H ++ N+LL +++DFG+A L + A+ I ++AL
Sbjct: 131 LE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY-SEAKTPIKWMAL 186
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMELV 339
E +FG+ +H+SDV+S+G+ + EL+
Sbjct: 187 ESI--HFGKYTHQSDVWSYGVTVWELM 211
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 52/212 (24%), Positives = 82/212 (38%), Gaps = 35/212 (16%)
Query: 153 DVKKITNSFKDKLGQGGFGGVYKGKLLDG------------LASISR--------TSHVN 192
V KI+ KD LG G G + + D + R H N
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPN 79
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
V+ + + + E +L+++V D + + ++ GL +
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA-----HLGLEPITLLQQTTSGLAH 133
Query: 253 LHRGCSTRILHFDIKPHNILL-----DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTI 307
LH S I+H D+KPHNIL+ ISDFGL K + S G GT
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190
Query: 308 GYIALEVFSRNFGE-VSHKSDVYSFGMMIMEL 338
G+IA E+ S + E ++ D++S G + +
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 48/207 (23%), Positives = 86/207 (41%), Gaps = 37/207 (17%)
Query: 160 SFKDKLGQGGFGGVYKGKLL---------------DGLASISRT------------SHVN 192
S +G G FG V G+L G R H N
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPN 107
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
++ L G + ++ E+M NGSL+ F+ D ++ ++ GIA G++Y
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ-----FTVIQLVGMLRGIASGMKY 162
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
L +H D+ NIL++ + K+SDFGL ++ + G + I + +
Sbjct: 163 LS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSP 219
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMELV 339
E + + + SDV+S+G+++ E++
Sbjct: 220 EAI--AYRKFTSASDVWSYGIVLWEVM 244
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 55/235 (23%), Positives = 89/235 (37%), Gaps = 44/235 (18%)
Query: 138 LQNYGPLPLKRYNFSDVKKITNS---FKDKLGQGGFGGVYKGKLLDGLASISRTS----- 189
+ ++ + Y D + +LG+G FG V + D L +
Sbjct: 1 MGHHHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRY-DPLGDNTGALVAVKQ 59
Query: 190 -----------------------HVNVVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYN 224
+V G ++ L+ E++P+G L F+
Sbjct: 60 LQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR 119
Query: 225 GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDF 284
L ++ I KG+EYL S R +H D+ NIL++ + KI+DF
Sbjct: 120 HRAR-----LDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADF 171
Query: 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
GLAKL K + I + A E S + S +SDV+SFG+++ EL
Sbjct: 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPE--SLSDNIFSRQSDVWSFGVVLYELF 224
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-24
Identities = 46/203 (22%), Positives = 78/203 (38%), Gaps = 39/203 (19%)
Query: 164 KLGQGGFGGVYKGKLLDGLASIS---------------------------RTSHVNVVTL 196
+LG G FG V KG + + + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
+G C + L+ E G L K++ K + V ++ G++YL
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL------VHQVSMGMKYLE-- 134
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
+ +H D+ N+LL KISDFGL+K + + + + + A E
Sbjct: 135 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI- 192
Query: 317 RNFGEVSHKSDVYSFGMMIMELV 339
N+ + S KSDV+SFG+++ E
Sbjct: 193 -NYYKFSSKSDVWSFGVLMWEAF 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 33/200 (16%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGL--------------------ASI-SRTSHVNVVTLLGF 199
+ KLG G FG V+ A++ H +V L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259
+ +I EFM GSL F+ + + K+ + IA+G+ ++
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIE---QR 303
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF 319
+H D++ NIL+ KI+DFGLA++ + GA+ I + A E NF
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWTAPEAI--NF 359
Query: 320 GEVSHKSDVYSFGMMIMELV 339
G + KSDV+SFG+++ME+V
Sbjct: 360 GSFTIKSDVWSFGILLMEIV 379
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 57/295 (19%), Positives = 98/295 (33%), Gaps = 64/295 (21%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLASISRT-----------------------------SHV 191
LG+G FG V D + H
Sbjct: 35 KIRDLGEGHFGKVSLY-CYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHE 93
Query: 192 NVVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
+++ G C + + L+ E++P GSL ++ P + ++ I +G
Sbjct: 94 HIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-------PRHSIGLAQLLLFAQQICEG 146
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
+ YLH + +H D+ N+LLD D KI DFGLAK + +
Sbjct: 147 MAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFW 203
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMIMELV-GCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368
A E + + SDV+SFG+ + EL+ C ++ + +
Sbjct: 204 YAPE--CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-- 259
Query: 369 REFKLLGVVTKKE---------NEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
L ++ + E E+ M C + RP +I +L+
Sbjct: 260 ----LTELLERGERLPRPDKCPAEVYHLM----KNCWETEASFRPTFENLIPILK 306
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-24
Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 53/278 (19%)
Query: 161 FKDKLGQGGFGGVYKG---------------------KLLDGLASISRTSHVNVVTLLGF 199
+ KLGQG FG V+ G L + + H +V L
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259
E ++ E+M GSL F+ +YLR ++ ++ IA G+ Y+
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVE---RM 382
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF 319
+H D++ NIL+ ++ K++DFGLA+L + ++ GA+ I + A E +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKFPIKWTAPEAA--LY 438
Query: 320 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379
G + KSDV+SFG+++ EL G+ N EV VE+ +++
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REV------LDQVERG--YRMP----C 485
Query: 380 KEN---EIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ M C + P +RP + L+
Sbjct: 486 PPECPESLHDLM----CQCWRKEPEERPTFEYLQAFLE 519
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-24
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 33/201 (16%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL--------------------ASI-SRTSHVNVVTLLG 198
+ +LG G FG V GK A + SH +V G
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYG 70
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
C + ++ E++ NG L ++ + L ++ E+ + +G+ +L S
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRSHGKG-----LEPSQLLEMCYDVCEGMAFLE---S 122
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
+ +H D+ N L+D+D C K+SDFG+ + S +G + + + A EVF +
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFPVKWSAPEVF--H 178
Query: 319 FGEVSHKSDVYSFGMMIMELV 339
+ + S KSDV++FG+++ E+
Sbjct: 179 YFKYSSKSDVWAFGILMWEVF 199
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-24
Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 39/201 (19%)
Query: 161 FKDKLGQGGFGGVYKGK----------LLDGL--------ASISRT-SHVNVVTLLGFCL 201
+G+G FG V G + + AS+ H N+V LLG +
Sbjct: 197 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 202 EGNNRALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
E + +Y E+M GSL ++ S+ L + + + + + + +EYL
Sbjct: 257 E--EKGGLYIVTEYMAKGSLVDYL----RSRGRSVLGGDCLLKFSLDVCEAMEYLE---G 307
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
+H D+ N+L+ +D K+SDFGL K ++ + + + + A E
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKLPVKWTAPEAL--R 359
Query: 319 FGEVSHKSDVYSFGMMIMELV 339
+ S KSDV+SFG+++ E+
Sbjct: 360 EKKFSTKSDVWSFGILLWEIY 380
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 49/213 (23%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGL--------------------------ASI-SRTSHVNV 193
+G+G FG VY G+ +D + +H NV
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 194 VTLLGFCLEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
+ L+G L + +M +G L +F+ + + + + + +A+G+EY
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-----PTVKDLISFGLQVARGMEY 139
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL------CTTKKGIVSSLLGARGT 306
L + +H D+ N +LD+ F K++DFGLA+ + ++ AR
Sbjct: 140 LA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR-----HARLP 191
Query: 307 IGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ + ALE S + KSDV+SFG+++ EL+
Sbjct: 192 VKWTALE--SLQTYRFTTKSDVWSFGVLLWELL 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-23
Identities = 47/207 (22%), Positives = 78/207 (37%), Gaps = 40/207 (19%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL--------------------------ASI-SRTSHVN 192
+G+G FG V++G + A + H +
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
+V L+G E N +I E G L F+ S L + ++ L Y
Sbjct: 78 IVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS-----LDLASLILYAYQLSTALAY 131
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
L S R +H DI N+L+ + C K+ DFGL++ + + I ++A
Sbjct: 132 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAP 186
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMELV 339
E NF + SDV+ FG+ + E++
Sbjct: 187 ESI--NFRRFTSASDVWMFGVCMWEIL 211
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-23
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 33/202 (16%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL---------------------ASI-SRTSHVNVVTLL 197
+ K KLG G +G VY+G A++ H N+V LL
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
G C +I EFM G+L ++ + Q + + + I+ +EYL
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLE--- 128
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
+H D+ N L+ ++ K++DFGL++L T + GA+ I + A E
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAKFPIKWTAPESL-- 184
Query: 318 NFGEVSHKSDVYSFGMMIMELV 339
+ + S KSDV++FG+++ E+
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIA 206
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 67/305 (21%), Positives = 109/305 (35%), Gaps = 77/305 (25%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRT------------------------------S 189
SF LG G FG V + + S + +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF------------VYNGDTSKPCQYLRWE 237
H+N+V LLG C G +I E+ G L F L E
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 238 KMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT-----T 292
+ +AKG+ +L S +H D+ NILL KI DFGLA+
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS 352
KG AR + ++A E S + +SDV+S+G+ + EL ++ G+
Sbjct: 203 VKG------NARLPVKWMAPE--SIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254
Query: 353 SEVYFPHWIYRHVEQDREFKLLGVVTKKEN---EIAKKMIIVGLWCIQARPYDRPPMNEV 409
S+ Y+ +++ + E+ E+ M C A P RP ++
Sbjct: 255 SKF------YKMIKEG------FRMLSPEHAPAEMYDIM----KTCWDADPLKRPTFKQI 298
Query: 410 IEMLQ 414
+++++
Sbjct: 299 VQLIE 303
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 62/301 (20%), Positives = 98/301 (32%), Gaps = 73/301 (24%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRT------------------------------S 189
F LG G FG V + +
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF--------VYNGDTSKPCQYLRWEKMYE 241
H N+V LLG C G +I E+ G L F + + +
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT-----TKKGI 296
+A+G+ +L S +H D+ N+LL KI DFGLA+ KG
Sbjct: 169 FSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG- 224
Query: 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY 356
AR + ++A E S + +SDV+S+G+++ E+ N G+ +S+
Sbjct: 225 -----NARLPVKWMAPE--SIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF- 276
Query: 357 FPHWIYRHVEQDREFKLLGVVTKKEN---EIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413
Y+ V+ + + I M C P RP ++ L
Sbjct: 277 -----YKLVKDG------YQMAQPAFAPKNIYSIM----QACWALEPTHRPTFQQICSFL 321
Query: 414 Q 414
Q
Sbjct: 322 Q 322
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 48/200 (24%), Positives = 86/200 (43%), Gaps = 35/200 (17%)
Query: 160 SFKDKLGQGGFGGVYKGK----------LLDGL--------ASI-SRTSHVNVVTLLGFC 200
+G+G FG V G + + AS+ ++ H N+V LLG
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 201 LEGNNRALI-YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259
+E I E+M GSL ++ + L + + + + + + +EYL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLE---GN 136
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF 319
+H D+ N+L+ +D K+SDFGL K ++ + + + + A E
Sbjct: 137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD------TGKLPVKWTAPEAL--RE 188
Query: 320 GEVSHKSDVYSFGMMIMELV 339
+ S KSDV+SFG+++ E+
Sbjct: 189 KKFSTKSDVWSFGILLWEIY 208
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 5e-23
Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 33/201 (16%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL--------------------ASI-SRTSHVNVVTLLG 198
+F +LG G FG V GK A + SH +V L G
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYG 86
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
C + +I E+M NG L ++ + +++ E+ + + +EYL S
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLREMRHR-----FQTQQLLEMCKDVCEAMEYLE---S 138
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
+ LH D+ N L++ K+SDFGL++ +S +G++ + + EV
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY--VLDDEYTSSVGSKFPVRWSPPEVL--M 194
Query: 319 FGEVSHKSDVYSFGMMIMELV 339
+ + S KSD+++FG+++ E+
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIY 215
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 7e-23
Identities = 50/211 (23%), Positives = 77/211 (36%), Gaps = 48/211 (22%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL--------------------------ASI-SRTSHVN 192
LG+G FG VY+G + A I H +
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPH 74
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
+V L+G E +I E P G L ++ S L+ + + I K + Y
Sbjct: 75 IVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNS-----LKVLTLVLYSLQICKAMAY 128
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL----CTTKKGIVSSLLGARGTIG 308
L S +H DI NIL+ C K+ DFGL++ K R I
Sbjct: 129 LE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKAS------VTRLPIK 179
Query: 309 YIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+++ E NF + SDV+ F + + E++
Sbjct: 180 WMSPESI--NFRRFTTASDVWMFAVCMWEIL 208
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-22
Identities = 53/203 (26%), Positives = 80/203 (39%), Gaps = 43/203 (21%)
Query: 165 LGQGGFGGVYKG-----------------------KLLDGLASISRTSHVNVVTLLGFCL 201
LG+G +G VY G L + +A H N+V LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 202 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEYLHRG 256
E + E +P GSL + + E IG I +GL+YLH
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDN--------EQTIGFYTKQILEGLKYLH-- 139
Query: 257 CSTRILHFDIKPHNILLDQ-DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF 315
+I+H DIK N+L++ KISDFG +K + GT+ Y+A E+
Sbjct: 140 -DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF---TGTLQYMAPEII 195
Query: 316 SRNFGEVSHKSDVYSFGMMIMEL 338
+ +D++S G I+E+
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEM 218
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-22
Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 33/201 (16%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL--------------------ASI-SRTSHVNVVTLLG 198
++LG G FG V+ G A++ + H +V L
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
+ +I E+M NGSL F+ K L K+ ++ IA+G+ ++
Sbjct: 76 VVTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIE---E 127
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
+H D++ NIL+ KI+DFGLA+L + ++ GA+ I + A E N
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREGAKFPIKWTAPEAI--N 183
Query: 319 FGEVSHKSDVYSFGMMIMELV 339
+G + KSDV+SFG+++ E+V
Sbjct: 184 YGTFTIKSDVWSFGILLTEIV 204
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 49/218 (22%)
Query: 160 SFKDKLGQGGFGGVYKGKLLD---------------GLAS-------------ISRTSHV 191
LG+G FG V +G L +S + SH
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96
Query: 192 NVVTLLGFCLEGNNRA-----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 246
NV+ LLG C+E +++ +I FM G L ++ +++ + + + ++ I
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC-----TTKKGIVSSLL 301
A G+EYL + LH D+ N +L D ++DFGL+K +
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGR------ 207
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
A+ + +IA+E S + KSDV++FG+ + E+
Sbjct: 208 IAKMPVKWIAIE--SLADRVYTSKSDVWAFGVTMWEIA 243
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 67/324 (20%), Positives = 106/324 (32%), Gaps = 87/324 (26%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRT-----------------------------SH 190
+ LG G FG VY+G++ S +H
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 191 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKG 249
N+V +G L+ R ++ E M G L+ F+ L + + IA G
Sbjct: 93 QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 250 LEYLHRGCSTRILHFDIKPHNILLD---QDFCPKISDFGLAKL-----CTTKKGIVSSLL 301
+YL +H DI N LL KI DFG+A+ K G ++L
Sbjct: 153 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGG--CAML 207
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDNSS 353
+ E F G + K+D +SFG+++ E+ N
Sbjct: 208 PVKWM----PPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------- 252
Query: 354 EVYFPHWIYRHVEQDREFKLLGVVTKKEN---EIAKKMIIVGLWCIQARPYDRPPMNEVI 410
EV V G + +N + + M C Q +P DRP ++
Sbjct: 253 EV------LEFVTSG------GRMDPPKNCPGPVYRIM----TQCWQHQPEDRPNFAIIL 296
Query: 411 EMLQGSTEALQI--PPTPFLSSPP 432
E ++ T+ + P P
Sbjct: 297 ERIEYCTQDPDVINTALPIEYGPL 320
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-22
Identities = 57/226 (25%), Positives = 85/226 (37%), Gaps = 57/226 (25%)
Query: 161 FKDKLGQGGFGGVYKGK-LLDG---------------------LASISRTSHVNVVTLLG 198
LGQG FG V K + LD + ++ +H VV
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA 69
Query: 199 FCLEGNNRAL----------IY---EFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYEIVI 244
LE N ++ E+ NG+L + + +Y R +I+
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL--FRQIL- 126
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR 304
+ L Y+H S I+H D+KP NI +D+ KI DFGLAK I+
Sbjct: 127 ---EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 305 -----------GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
GT Y+A EV G + K D+YS G++ E++
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMI 225
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 48/216 (22%), Positives = 91/216 (42%), Gaps = 46/216 (21%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLASI---------------------------SRTSHVNV 193
F+D +G+G FG V K ++ + H N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 194 VTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWEKMYEIV 243
+ LLG C L E+ P+G+L F + L +++
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA 303
+A+G++YL + +H D+ NIL+ +++ KI+DFGL++ + +
Sbjct: 149 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 201
Query: 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
R + ++A+E S N+ + SDV+S+G+++ E+V
Sbjct: 202 RLPVRWMAIE--SLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 3e-22
Identities = 51/237 (21%), Positives = 93/237 (39%), Gaps = 57/237 (24%)
Query: 149 YNFSDVKKITNS---FKDKLGQGGFGGVYKGKLLDGL----------------------- 182
++ V+ I K +LG+G FG V+ + +
Sbjct: 4 HSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD 63
Query: 183 ----ASI-SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDT 227
A + + H ++V G C +G+ +++E+M +G L KF + +G
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 228 SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287
+ L +M I IA G+ YL S +H D+ N L+ + KI DFG++
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 288 KLC-----TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ G ++L R E + + + +SDV+SFG+++ E+
Sbjct: 181 RDVYSTDYYRVGG--HTMLPIRWM----PPESI--MYRKFTTESDVWSFGVILWEIF 229
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-22
Identities = 50/221 (22%), Positives = 85/221 (38%), Gaps = 53/221 (23%)
Query: 163 DKLGQGGFGGVYKGK-LLDG-----------------------LASISRTSHVNVVTLLG 198
LG+GGFG V++ K +D + ++++ H +V
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 199 FCLEGNN---------RALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 246
LE N + +Y + +L+ ++ + + I + I
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCLHIFLQI 127
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT---------TKKGIV 297
A+ +E+LH S ++H D+KP NI D K+ DFGL T
Sbjct: 128 AEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+ G GT Y++ E N SHK D++S G+++ EL
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFEL 223
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-22
Identities = 46/219 (21%), Positives = 85/219 (38%), Gaps = 50/219 (22%)
Query: 160 SFKDKLGQGGFGGVYKGKLLD---------------GLASISRT-------------SHV 191
+ LG+G FG V + +L + + S H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHP 85
Query: 192 NVVTLLGFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG 245
+V L+G L + +I FM +G L F+ + L + + ++
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC-----TTKKGIVSSL 300
IA G+EYL S +H D+ N +L +D ++DFGL++ +
Sbjct: 146 IACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGC----- 197
Query: 301 LGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
++ + ++ALE S + SDV++FG+ + E++
Sbjct: 198 -ASKLPVKWLALE--SLADNLYTVHSDVWAFGVTMWEIM 233
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-22
Identities = 62/310 (20%), Positives = 98/310 (31%), Gaps = 82/310 (26%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRT------------------------------S 189
F LG G FG V + S
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS 107
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF-----------------VYNGDTSKPCQ 232
H N+V LLG C LI+E+ G L + + +
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 233 YLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT- 291
L +E + +AKG+E+L +H D+ N+L+ KI DFGLA+
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 292 ----TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS 347
+G AR + ++A E S G + KSDV+S+G+++ E+ N
Sbjct: 225 DSNYVVRG------NARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276
Query: 348 GVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKEN---EIAKKMIIVGLWCIQARPYDRP 404
G+ + Y+ ++ + + EI M C RP
Sbjct: 277 GIPVDANF------YKLIQNG------FKMDQPFYATEEIYIIM----QSCWAFDSRKRP 320
Query: 405 PMNEVIEMLQ 414
+ L
Sbjct: 321 SFPNLTSFLG 330
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 47/222 (21%), Positives = 85/222 (38%), Gaps = 53/222 (23%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL---------------------------ASI-SRTSHV 191
K +LG+G FG V+ + + L A + + H
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQ 103
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKF---------VYNGDTSKPCQYLRWEKMYEI 242
++V G C EG +++E+M +G L +F + G L ++ +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 243 VIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC-----TTKKGIV 297
+A G+ YL +H D+ N L+ Q KI DFG+++ G
Sbjct: 164 ASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG-- 218
Query: 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
++L R E + + + +SDV+SFG+++ E+
Sbjct: 219 RTMLPIRWM----PPESI--LYRKFTTESDVWSFGVVLWEIF 254
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 6e-22
Identities = 48/207 (23%), Positives = 79/207 (38%), Gaps = 40/207 (19%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL--------------------------ASI-SRTSHVN 192
+G+G FG V++G + A + H +
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 452
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
+V L+G E N +I E G L F+ S L + ++ L Y
Sbjct: 453 IVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFS-----LDLASLILYAYQLSTALAY 506
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
L S R +H DI N+L+ + C K+ DFGL++ + + I ++A
Sbjct: 507 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAP 561
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMELV 339
E S NF + SDV+ FG+ + E++
Sbjct: 562 E--SINFRRFTSASDVWMFGVCMWEIL 586
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-22
Identities = 57/224 (25%), Positives = 88/224 (39%), Gaps = 55/224 (24%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL----------------------------ASI-SRTSH 190
F ++LG+ FG VYKG L A + +R H
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 191 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWEKMY 240
NVV LLG + ++I+ + +G L +F D L
Sbjct: 72 PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131
Query: 241 EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC-----TTKKG 295
+V IA G+EYL S ++H D+ N+L+ KISD GL + G
Sbjct: 132 HLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+SLL R A E + +G+ S SD++S+G+++ E+
Sbjct: 189 --NSLLPIRWM----APE--AIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-22
Identities = 48/206 (23%), Positives = 84/206 (40%), Gaps = 40/206 (19%)
Query: 164 KLGQGGFGGVYKGK-LLDG------------------LASISRTSHVNVVTLLGFCLEGN 204
+G GGFG V+K K +DG + ++++ HVN+V G +
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 205 NRALIYEFMPNGSLEKFVY-------NGD-----TSKPCQYLRWEKMYEIVIGIAKGLEY 252
+ S K ++ G + + L E+ I KG++Y
Sbjct: 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDY 137
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
+H S ++++ D+KP NI L KI DFGL ++GT+ Y++
Sbjct: 138 IH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND----GKRTRSKGTLRYMSP 190
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMEL 338
E S + + D+Y+ G+++ EL
Sbjct: 191 EQISSQ--DYGKEVDLYALGLILAEL 214
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 64/331 (19%), Positives = 114/331 (34%), Gaps = 78/331 (23%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRT------------------------------- 188
LG+G FG V + +
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 189 -SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWE 237
H N++ LLG C + +I E+ G+L ++ + P + L +
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 238 KMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT-----T 292
+ +A+G+EYL S + +H D+ N+L+ +D KI+DFGLA+
Sbjct: 192 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248
Query: 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS 352
K R + ++A E + +H+SDV+SFG+++ E+ + GV
Sbjct: 249 KTT------NGRLPVKWMAPE--ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 299
Query: 353 SEVYFPHWIYRHVEQDREFKLLGVVTKKEN---EIAKKMIIVGLWCIQARPYDRPPMNEV 409
E+ ++ +++ + K N E+ M C A P RP ++
Sbjct: 300 EEL------FKLLKEG------HRMDKPSNCTNELYMMM----RDCWHAVPSQRPTFKQL 343
Query: 410 IEMLQGSTEALQIPPTPFLSSPPRASIDSST 440
+E L + D T
Sbjct: 344 VEDLDRIVALTSNQEMGYYHHHHHHDYDIPT 374
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 66/303 (21%), Positives = 110/303 (36%), Gaps = 85/303 (28%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLASISRT-----------------------------SHV 191
+LGQG FG VY+G + T +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFV----YNGDTSKPCQYLRWEKMYEIVIGIA 247
+VV LLG +G +I E M G L+ ++ + KM ++ IA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 248 KGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC-----TTKKGIVSSLLG 302
G+ YL+ + + +H D+ N ++ +DF KI DFG+ + K G
Sbjct: 149 DGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG------K 199
Query: 303 ARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDNSSE 354
+ +++ E S G + SDV+SFG+++ E+ G N +
Sbjct: 200 GLLPVRWMSPE--SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---------Q 248
Query: 355 VYFPHWIYRHVEQDREFKLLGVVTKKEN---EIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
V R V + G++ K +N + + M C Q P RP E+I
Sbjct: 249 V------LRFVMEG------GLLDKPDNCPDMLFELM----RMCWQYNPKMRPSFLEIIS 292
Query: 412 MLQ 414
++
Sbjct: 293 SIK 295
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-21
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 47/213 (22%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL--------------------------ASI-SRTSHVN 192
F + +G+G FG VY G LLD I SH N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 193 VVTLLGFCLEGNNRAL-IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251
V++LLG CL L + +M +G L F+ N + + + + +AKG++
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAKGMK 142
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC-----TTKKGIVSSLLGARGT 306
YL S + +H D+ N +LD+ F K++DFGLA+ + + L +
Sbjct: 143 YLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM 199
Query: 307 IGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
ALE S + + KSDV+SFG+++ EL+
Sbjct: 200 ----ALE--SLQTQKFTTKSDVWSFGVLLWELM 226
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 67/324 (20%), Positives = 106/324 (32%), Gaps = 87/324 (26%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRT-----------------------------SH 190
+ LG G FG VY+G++ S +H
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 191 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAKG 249
N+V +G L+ R ++ E M G L+ F+ L + + IA G
Sbjct: 134 QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 250 LEYLHRGCSTRILHFDIKPHNILLD---QDFCPKISDFGLAKL-----CTTKKGIVSSLL 301
+YL +H DI N LL KI DFG+A+ K G ++L
Sbjct: 194 CQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG--CAML 248
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDNSS 353
+ E F G + K+D +SFG+++ E+ N
Sbjct: 249 PVKWM----PPEAF--MEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ--------- 293
Query: 354 EVYFPHWIYRHVEQDREFKLLGVVTKKEN---EIAKKMIIVGLWCIQARPYDRPPMNEVI 410
EV V G + +N + + M C Q +P DRP ++
Sbjct: 294 EV------LEFVTSG------GRMDPPKNCPGPVYRIM----TQCWQHQPEDRPNFAIIL 337
Query: 411 EMLQGSTEALQI--PPTPFLSSPP 432
E ++ T+ + P P
Sbjct: 338 ERIEYCTQDPDVINTALPIEYGPL 361
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 39/209 (18%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL--------------------------ASI-SRTSHVN 192
F + +G+G FG VY G LLD I SH N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 193 VVTLLGFCLEGNN-RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251
V++LLG CL ++ +M +G L F+ N + + + + +AKG++
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGLQVAKGMK 206
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK-KGIVSSLLGARGTIGYI 310
+L S + +H D+ N +LD+ F K++DFGLA+ K V + GA+ + ++
Sbjct: 207 FLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 263
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
ALE S + + KSDV+SFG+++ EL+
Sbjct: 264 ALE--SLQTQKFTTKSDVWSFGVLLWELM 290
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 45/202 (22%), Positives = 85/202 (42%), Gaps = 36/202 (17%)
Query: 163 DKLGQGGFGGVYKGK-------------LLDGLAS-------------ISRTSHVNVVTL 196
K+G+G F VY+ + L + + +H NV+
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
+E N ++ E G L + + + K + + +++ + + LE++H
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKH--FKKQKRLIPERTVWKYFVQLCSALEHMH-- 153
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
S R++H DIKP N+ + K+ D GL + ++K SL+ GT Y++ E
Sbjct: 154 -SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---GTPYYMSPERIH 209
Query: 317 RNFGEVSHKSDVYSFGMMIMEL 338
N + KSD++S G ++ E+
Sbjct: 210 EN--GYNFKSDIWSLGCLLYEM 229
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 43/201 (21%), Positives = 87/201 (43%), Gaps = 37/201 (18%)
Query: 163 DKLGQGGFGGVYKGK-LLDG---------LASISRT---------------SHVNVVTLL 197
K+G+G FG K DG ++ +S H N+V
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
E + ++ ++ G L K + ++ + +++ + + I L+++H
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRI----NAQKGVLFQEDQILDWFVQICLALKHVH--- 142
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
+ILH DIK NI L +D ++ DFG+A++ + + + + GT Y++ E+
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI---GTPYYLSPEICEN 199
Query: 318 NFGEVSHKSDVYSFGMMIMEL 338
++KSD+++ G ++ EL
Sbjct: 200 K--PYNNKSDIWALGCVLYEL 218
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 54/259 (20%), Positives = 86/259 (33%), Gaps = 49/259 (18%)
Query: 111 PARLDLLSSYCPSVQWPQAIINHTLFSLQNYGPLPLKRYNFSDVKKITNS-FK--DKLGQ 167
+ +DL + Q F + L Y+ S + F+ +LG
Sbjct: 8 SSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGH 67
Query: 168 GGFGGVYKG-KLLDG---------------------------LASISRTSHVNVVTLLGF 199
G +G V+K DG + + H V L
Sbjct: 68 GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ--HPCCVRLEQA 125
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259
EG L E SL++ L +++ + L +LH S
Sbjct: 126 WEEGGILYLQTELC-GPSLQQHC-----EAWGASLPEAQVWGYLRDTLLALAHLH---SQ 176
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF 319
++H D+KP NI L K+ DFGL T G Y+A E+ ++
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE----GDPRYMAPELLQGSY 232
Query: 320 GEVSHKSDVYSFGMMIMEL 338
G +DV+S G+ I+E+
Sbjct: 233 G---TAADVFSLGLTILEV 248
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 47/227 (20%), Positives = 89/227 (39%), Gaps = 58/227 (25%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRTS------------------------------ 189
+ LG+G FG V + + + +
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 190 --HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWE 237
H N++ LLG C + +I E+ G+L ++ P + + ++
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 238 KMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297
+ +A+G+EYL S + +H D+ N+L+ ++ KI+DFGLA+ I
Sbjct: 158 DLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD------IN 208
Query: 298 SSLLGARGTIGYI-----ALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ + T G + A E + +H+SDV+SFG+++ E+
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 68/312 (21%), Positives = 109/312 (34%), Gaps = 92/312 (29%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRT------------------------------S 189
LG+G FG V + + +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 89
Query: 190 HVNVVTLLGFCL-EGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWEK 238
H+NVV LLG C G +I EF G+L + +L E
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT-----TK 293
+ +AKG+E+L S + +H D+ NILL + KI DFGLA+ +
Sbjct: 150 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNL 345
KG AR + ++A E + + +SDV+SFG+++ E+ G K +
Sbjct: 207 KG------DARLPLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID- 257
Query: 346 DSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKEN---EIAKKMIIVGLWCIQARPYD 402
E R +++ + + E+ + M L C P
Sbjct: 258 -------EEF------CRRLKEG------TRMRAPDYTTPEMYQTM----LDCWHGEPSQ 294
Query: 403 RPPMNEVIEMLQ 414
RP +E++E L
Sbjct: 295 RPTFSELVEHLG 306
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 46/226 (20%), Positives = 87/226 (38%), Gaps = 58/226 (25%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLASISRTS------------------------------- 189
LG+G FG V + + + +
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 190 -HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF----------VYNGDTSKPCQYLRWEK 238
H N++ LLG C + +I E+ G+L ++ P + + ++
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT-----TK 293
+ +A+G+EYL S + +H D+ N+L+ ++ KI+DFGLA+ K
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKK 261
Query: 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
R + ++A E + +H+SDV+SFG+++ E+
Sbjct: 262 TT------NGRLPVKWMAPE--ALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 44/218 (20%), Positives = 82/218 (37%), Gaps = 54/218 (24%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGL-----------------------------ASI-SRTS 189
F + LGQG F ++KG + AS+ S+ S
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
H ++V G C+ G+ L+ EF+ GSL+ ++ + E+ +A
Sbjct: 71 HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-----INILWKLEVAKQLAAA 125
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCP--------KISDFGLAKLCTTKKGIVSSLL 301
+ +L ++H ++ NILL ++ K+SD G++ V
Sbjct: 126 MHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLPKD 175
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ I ++ E N ++ +D +SFG + E+
Sbjct: 176 ILQERIPWVPPECIE-NPKNLNLATDKWSFGTTLWEIC 212
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 1e-20
Identities = 46/226 (20%), Positives = 76/226 (33%), Gaps = 44/226 (19%)
Query: 150 NFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG------------LASISR--------TS 189
NF K + LG G G V G
Sbjct: 8 NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD 67
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVIGIAK 248
H NV+ + E N +L+ V + + + + ++ IA
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLD-------------QDFCPKISDFGLAKLCTTKKG 295
G+ +LH S +I+H D+KP NIL+ ++ ISDFGL K + +
Sbjct: 127 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183
Query: 296 IVSSLLGAR-GTIGYIALEVFSRNFGEVSHKS-----DVYSFGMMI 335
+ L GT G+ A E+ + + + D++S G +
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 50/231 (21%), Positives = 83/231 (35%), Gaps = 63/231 (27%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLASISRT-----------------------------SHV 191
LG+G FG V K T +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKF------------------VYNGDTSKPCQY 233
+V+ L G C + LI E+ GSL F + +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 234 LRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT-- 291
L + I++G++YL +++H D+ NIL+ + KISDFGL++
Sbjct: 147 LTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 292 ---TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
K+ R + ++A+E S + +SDV+SFG+++ E+V
Sbjct: 204 DSYVKRS------QGRIPVKWMAIE--SLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-20
Identities = 46/227 (20%), Positives = 87/227 (38%), Gaps = 62/227 (27%)
Query: 163 DKLGQGGFGGVYKG-KLLDG---------------------------LASISRTSHVNVV 194
+K+G G FG V+K K LDG A + + H +VV
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ--HSHVV 74
Query: 195 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 254
E ++ + E+ GSL + + + Y + ++ ++++ + +GL Y+H
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAI--SENYRIMSYFKEAELKDLLLQVGRGLRYIH 132
Query: 255 RGCSTRILHFDIKPHNILLDQDFCP-------------------KISDFGLAKLCTTKKG 295
S ++H DIKP NI + + P KI D G ++ +
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189
Query: 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
G ++A EV N+ K+D+++ + ++ G +
Sbjct: 190 EE-------GDSRFLANEVLQENYTH-LPKADIFALALTVVCAAGAE 228
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-20
Identities = 68/366 (18%), Positives = 121/366 (33%), Gaps = 102/366 (27%)
Query: 115 DLLSSYCPSVQWPQAIINHTLFSLQNYGPLPLKRYNFSDVKKITNS---FKDKLGQGGFG 171
+ S+ P ++ L Y +PL + + + +G+G FG
Sbjct: 2 AMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFG 61
Query: 172 GVYKGKLLDGL----------------------------ASI-SRTSHVNVVTLLGFCLE 202
V++ + L A++ + + N+V LLG C
Sbjct: 62 RVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121
Query: 203 GNNRALIYEFMPNGSLEKF------------------VYNGDTSKPCQYLRWEKMYEIVI 244
G L++E+M G L +F +S L + I
Sbjct: 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR 181
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR 304
+A G+ YL + +H D+ N L+ ++ KI+DFGL+ + I S+
Sbjct: 182 QVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLS------RNIYSADYYKA 232
Query: 305 GTIGYI-----ALEVFSRNFGEVSHKSDVYSFGMMIMELV--------GCKNNLDSGVDN 351
I E S + + +SDV+++G+++ E+ G +
Sbjct: 233 DGNDAIPIRWMPPE--SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE------- 283
Query: 352 SSEVYFPHWIYRHVEQDREFKLLGVVTKKEN---EIAKKMIIVGLWCIQARPYDRPPMNE 408
EV +V ++ EN E+ M C P DRP
Sbjct: 284 --EV------IYYVRDG------NILACPENCPLELYNLM----RLCWSKLPADRPSFCS 325
Query: 409 VIEMLQ 414
+ +LQ
Sbjct: 326 IHRILQ 331
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-20
Identities = 59/296 (19%), Positives = 108/296 (36%), Gaps = 68/296 (22%)
Query: 161 FKDKLGQGGFGGVYKGK-LLDGL---------------------ASISRT-SHVNVVTLL 197
F KLG+GGF V + L DG A + R +H N++ L+
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLV 92
Query: 198 GFCLEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 253
+CL L+ F G+L + +L +++ +++GI +GLE +
Sbjct: 93 AYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG--NFLTEDQILWLLLGICRGLEAI 150
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT------TKKGIVSSLLGARGTI 307
H + H D+KP NILL + P + D G + + R TI
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 308 GYIALEVFS-RNFGEVSHKSDVYSFGMMIMELV-------GCKNNLDSGVDN-SSEVYFP 358
Y A E+FS ++ + ++DV+S G ++ ++ DS +++ P
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIP 267
Query: 359 HWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+++ + P+ RP + ++ L+
Sbjct: 268 --QSPRHSSA----------------LWQLLN---SMMTVDPHQRPHIPLLLSQLE 302
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-20
Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 36/205 (17%)
Query: 164 KLGQGGFGGVYKGK-LLDG---------LASISRT---------------SHVNVVTLLG 198
+G G +G K + DG S++ H N+V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 199 -FCLEGNNRALIY-EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH-- 254
N I E+ G L + G + QYL E + ++ + L+ H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKER--QYLDEEFVLRVMTQLTLALKECHRR 130
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEV 314
+LH D+KP N+ LD K+ DFGLA++ + + GT Y++ E
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV---GTPYYMSPEQ 187
Query: 315 FSRNFGEVSHKSDVYSFGMMIMELV 339
+R + KSD++S G ++ EL
Sbjct: 188 MNRM--SYNEKSDIWSLGCLLYELC 210
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 46/221 (20%), Positives = 77/221 (34%), Gaps = 54/221 (24%)
Query: 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHN 270
+ +L+ ++ + I I IA+ +E+LH S ++H D+KP N
Sbjct: 141 QLCRKENLKDWMNRR---CSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSN 194
Query: 271 ILLDQDFCPKISDFGLAKLCT---------TKKGIVSSLLGARGTIGYIALEVFSRNFGE 321
I D K+ DFGL T ++ G GT Y++ E N
Sbjct: 195 IFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN--N 252
Query: 322 VSHKSDVYSFGMMI----------MELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371
SHK D++S G+++ ME V ++ + FP + Q
Sbjct: 253 YSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLK-------FPLLFTQKYPQ---- 301
Query: 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412
M+ + P +RP ++IE
Sbjct: 302 -------------EHMMV---QDMLSPSPTERPEATDIIEN 326
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-19
Identities = 53/278 (19%), Positives = 94/278 (33%), Gaps = 60/278 (21%)
Query: 163 DKLGQGGFGGVYKGK------------------------LLDGLASISRTSHVNVVTLLG 198
+LG G G V+K ++ L + + +V G
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 98
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
++ E M GSL++ P Q L ++ I + KGL YL
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQV-LKKAGRIPEQILG-----KVSIAVIKGLTYLRE--K 150
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLA-KLCTTK-KGIVSSLLGARGTIGYIALEVFS 316
+I+H D+KP NIL++ K+ DFG++ +L + V GT Y++ E
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-------GTRSYMSPERLQ 203
Query: 317 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376
S +SD++S G+ ++E+ +P + + G
Sbjct: 204 GT--HYSVQSDIWSMGLSLVEMA--------------VGRYP---IPPPDAKELELMFGC 244
Query: 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ + + D P + E+L
Sbjct: 245 QVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLD 282
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 6e-19
Identities = 45/217 (20%), Positives = 72/217 (33%), Gaps = 48/217 (22%)
Query: 160 SFKDKLGQGGFGGVYKG-----------------KLLDGLASISR-------TSHVNVVT 195
D LGQG V++G L + R +H N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 196 LLGFCLEGNNRALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
L E EF P GSL + + L + ++ + G+ +
Sbjct: 72 LFAI-EEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 253 LHRGCSTRILHFDIKPHNILL----DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG 308
L I+H +IKP NI+ D K++DFG A+ + VS GT
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY----GTEE 180
Query: 309 YIALEVFSRNFGEV------SHKSDVYSFGMMIMELV 339
Y+ +++ R D++S G+
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 9e-19
Identities = 48/210 (22%), Positives = 83/210 (39%), Gaps = 44/210 (20%)
Query: 163 DKLGQGGFGGVYKG-----------KLLD------GLASI-------SRTSHVNVVTLLG 198
+ +G G V K ++ + + S+ H N+V+
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA-----KGLEYL 253
+ + L+ + + GS+ + + + E I +GLEYL
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDII---KHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGL-AKLCTTKKGIVSSLLGARGT-IG--- 308
H +H D+K NILL +D +I+DFG+ A L T + R T +G
Sbjct: 138 H---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNK---VRKTFVGTPC 191
Query: 309 YIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
++A EV + G K+D++SFG+ +EL
Sbjct: 192 WMAPEVMEQVRG-YDFKADIWSFGITAIEL 220
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-18
Identities = 51/224 (22%), Positives = 82/224 (36%), Gaps = 58/224 (25%)
Query: 147 KRYNFSDVKKITN--SFKDKLGQGGFGGVYKGK-LLDGLA----SISRT----------- 188
R N + LG+G FG V K K + I++
Sbjct: 10 GRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL 69
Query: 189 ---------SHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYL 234
H N++ L + ++ ++ E G L ++ ++
Sbjct: 70 REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS---------- 119
Query: 235 RWEKM-YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLC 290
E I+ + G+ Y+H I+H D+KP NILL ++D KI DFGL+
Sbjct: 120 --EHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174
Query: 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMM 334
+ + GT YIA EV + E K DV+S G++
Sbjct: 175 QQNTKMKDRI----GTAYYIAPEVLRGTYDE---KCDVWSAGVI 211
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 83/323 (25%), Positives = 114/323 (35%), Gaps = 95/323 (29%)
Query: 165 LGQGGFGGVY-----------------KGKLLDGLA--------SI-SRTSHVNVVTLLG 198
LG+GGF + K LL SI +H +VV G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 199 FCLEGNNRALIY---EFMPNGSL-EKFVYNGDTSKP--CQYLRWEKMYEIVIGIAKGLEY 252
E N+ ++ E SL E ++P YLR I G +Y
Sbjct: 109 -FFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLR---------QIVLGCQY 156
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR-GTIGYIA 311
LH R++H D+K N+ L++D KI DFGLA GT YIA
Sbjct: 157 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD----GERKKVLCGTPNYIA 209
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIME-LVGCKNNL---DSGVDN------SSEVYFPHWI 361
EV S+ S + DV+S G ++ LVG S + +E P I
Sbjct: 210 PEVLSKK--GHSFEVDVWSIGCIMYTLLVG---KPPFETSCLKETYLRIKKNEYSIPKHI 264
Query: 362 YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE---MLQGSTE 418
N +A +I +Q P RP +NE++ G
Sbjct: 265 --------------------NPVAASLIQ---KMLQTDPTARPTINELLNDEFFTSGYIP 301
Query: 419 ALQIPPTPFLSSPPRASIDSSTL 441
A P L+ PPR SI S+L
Sbjct: 302 AR--LPITCLTIPPRFSIAPSSL 322
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 52/207 (25%), Positives = 81/207 (39%), Gaps = 49/207 (23%)
Query: 160 SFKDKLGQGGFGGVYKGK-LLDGLA----SISRT---------------------SHVNV 193
+ LG+G FG V K + G IS+ H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 194 VTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGLE 251
+ L F + L+ E G L ++ + S E I+ + G+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS--------EVDAARIIRQVLSGIT 140
Query: 252 YLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG 308
Y+H +I+H D+KP N+LL +D +I DFGL+ K + + GT
Sbjct: 141 YMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI----GTAY 193
Query: 309 YIALEVFSRNFGEVSHKSDVYSFGMMI 335
YIA EV + E K DV+S G+++
Sbjct: 194 YIAPEVLHGTYDE---KCDVWSTGVIL 217
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 3e-18
Identities = 26/211 (12%), Positives = 53/211 (25%), Gaps = 24/211 (11%)
Query: 205 NRALIYEFMPNGSLEKFVYNGDTSKPCQ-YLRWEKMYEIVIGIAKGLEYLHRGCSTRILH 263
N L+ + LE D + ++ + + + L S ++H
Sbjct: 162 NYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVH 217
Query: 264 FDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVS 323
P N+ + D + D K G + Y E + + +
Sbjct: 218 GHFTPDNLFIMPDGRLMLGDVSALW----KVGTRGPASS--VPVTYAPREFLNASTATFT 271
Query: 324 HKSDVYSFGMMIMELVGCKNNLDSGV---DNSSEVYFPHWIYRHVEQDREFKLLGVVTKK 380
H + + G+ I + + W + L
Sbjct: 272 HALNAWQLGLSIYRVW-------CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP 324
Query: 381 ENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
+ K +I + R E +E
Sbjct: 325 LPDFVKTLI---GRFLNFDRRRRLLPLEAME 352
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 46/217 (21%), Positives = 73/217 (33%), Gaps = 48/217 (22%)
Query: 160 SFKDKLGQGGFGGVYKG-----------------KLLDGLASISR-------TSHVNVVT 195
D LGQG V++G L + R +H N+V
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 196 LLGFCLEGNNRALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
L E EF P GSL + + L + ++ + G+ +
Sbjct: 72 LFAI-EEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 253 LHRGCSTRILHFDIKPHNILL----DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG 308
L I+H +IKP NI+ D K++DFG A+ + VS GT
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY----GTEE 180
Query: 309 YIALEVFSRNFGEVSH------KSDVYSFGMMIMELV 339
Y+ +++ R H D++S G+
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 4e-18
Identities = 38/207 (18%), Positives = 73/207 (35%), Gaps = 52/207 (25%)
Query: 163 DKLGQGGFGGVYKG------------KLL------DGLA-------SISRTSHVNVVTLL 197
+ GG G +Y K L + A ++ H ++V +
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 198 GFCLEGNNRA-----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
F + ++ E++ SL++ Q L + ++ I L Y
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--------QKLPVAEAIAYLLEILPALSY 197
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
LH +++ D+KP NI+L ++ K+ D G + + GT G+ A
Sbjct: 198 LHS---IGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYLY-------GTPGFQAP 246
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMELV 339
E+ + +D+Y+ G + L
Sbjct: 247 EIVR---TGPTVATDIYTVGRTLAALT 270
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 48/206 (23%)
Query: 160 SFKDKLGQGGFGGVYKGK-LLDGLA----SISRT--------------------SHVNVV 194
KLG G +G V + + + I +T H N++
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 195 TLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGLEY 252
L F + N L+ E G L ++ ++ + E I+ + G+ Y
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFN--------EVDAAVIIKQVLSGVTY 151
Query: 253 LHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
LH I+H D+KP N+LL ++D KI DFGL+ + +K + L GT Y
Sbjct: 152 LH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL----GTAYY 204
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMI 335
IA EV + + E K DV+S G+++
Sbjct: 205 IAPEVLRKKYDE---KCDVWSIGVIL 227
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 35/212 (16%), Positives = 72/212 (33%), Gaps = 48/212 (22%)
Query: 163 DKLGQG--GFGGVYKG-----------KLLD-------GLASI-------SRTSHVNVVT 195
+G+G V + ++ + + +H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 196 LLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGL 250
+ N ++ FM GS + + + M E+ I + K L
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFM---------DGMNELAIAYILQGVLKAL 141
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG-LAKLCTT---KKGIVSSLLGARGT 306
+Y+H +H +K +IL+ D +S + + ++ + +
Sbjct: 142 DYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 307 IGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+ +++ EV +N KSD+YS G+ EL
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 230
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 5e-18
Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 47/207 (22%)
Query: 163 DKLGQGGFGGVYKG-----------KLLD-GLA--------------SISRTSHVNVVTL 196
DKLG GG VY K + + S+ SH N+V++
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
+ E + L+ E++ +L +++ ++ P L + I G+++ H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGP---LSVDTAINFTNQILDGIKHAHD- 129
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT----TKKGIVSSLLGARGTIGYIAL 312
RI+H DIKP NIL+D + KI DFG+AK + T+ V GT+ Y +
Sbjct: 130 --MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL------GTVQYFSP 181
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMELV 339
E +D+YS G+++ E++
Sbjct: 182 EQAKG--EATDECTDIYSIGIVLYEML 206
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 6e-18
Identities = 82/318 (25%), Positives = 112/318 (35%), Gaps = 89/318 (27%)
Query: 165 LGQGGFGGVY-----------------KGKLLDGLA--------SI-SRTSHVNVVTLLG 198
LG+GGF + K LL SI +H +VV G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 199 FCLEGNNRALIY---EFMPNGSL-EKFVYNGDTSKP--CQYLRWEKMYEIVIGIAKGLEY 252
E N+ ++ E SL E ++P YLR I G +Y
Sbjct: 83 -FFEDNDF--VFVVLELCRRRSLLELHKRRKALTEPEARYYLR---------QIVLGCQY 130
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR-GTIGYIA 311
LH R++H D+K N+ L++D KI DFGLA GT YIA
Sbjct: 131 LH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD----GERKKVLCGTPNYIA 183
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIME-LVGCKNNLDSGVDN------SSEVYFPHWIYRH 364
EV S+ S + DV+S G ++ LVG S + +E P I
Sbjct: 184 PEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHI--- 238
Query: 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE---MLQGSTEALQ 421
N +A +I +Q P RP +NE++ G A
Sbjct: 239 -----------------NPVAASLIQ---KMLQTDPTARPTINELLNDEFFTSGYIPAR- 277
Query: 422 IPPTPFLSSPPRASIDSS 439
P L+ PPR SI S
Sbjct: 278 -LPITCLTIPPRFSIAPS 294
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 36/252 (14%), Positives = 70/252 (27%), Gaps = 51/252 (20%)
Query: 131 INHTLFSLQNYGPLPLKRYNFSDVKKITNS-----FKDKLGQGGFGGVYKGKLLDG---- 181
++ + S N K + LG+G F VY+ D
Sbjct: 34 LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93
Query: 182 ------------------------LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217
+ + + + L N L+ E G+
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF 277
L N + P + + + + + +E +H I+H DIKP N +L F
Sbjct: 154 LLN-AINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGF 209
Query: 278 CP-----------KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKS 326
+ D G + + T G+ +E+ S +++
Sbjct: 210 LEQDDEDDLSAGLALIDLGQSI-DMKLFPKGTIFTAKCETSGFQCVEMLSNK--PWNYQI 266
Query: 327 DVYSFGMMIMEL 338
D + + +
Sbjct: 267 DYFGVAATVYCM 278
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 45/211 (21%), Positives = 77/211 (36%), Gaps = 51/211 (24%)
Query: 163 DKLGQGGFGGVYKGKLL-----------------DGLASISR--------TSHVNVVTLL 197
++G+G +G V K + + +V
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFY 87
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEY 252
G + + E M + S +KF K + + + E ++G K L +
Sbjct: 88 GALFREGDCWICMELM-STSFDKFY------KYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG---Y 309
L + +I+H DIKP NILLD+ K+ DFG++ G + + G Y
Sbjct: 141 LKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGIS-------GQLVDSIAKTRDAGCRPY 191
Query: 310 IALEVFSRNFGEV--SHKSDVYSFGMMIMEL 338
+A E + +SDV+S G+ + EL
Sbjct: 192 MAPERIDPSASRQGYDVRSDVWSLGITLYEL 222
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-17
Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 48/204 (23%)
Query: 164 KLGQGGFGGVYKGK-----------------------LLDGLASISRTSHVNVVTLLGFC 200
K+GQG G VY +++ + + + N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 201 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEYLHR 255
L G+ ++ E++ GSL V M E I + LE+LH
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTET------------CMDEGQIAAVCRECLQALEFLH- 133
Query: 256 GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF 315
S +++H DIK NILL D K++DFG T ++ S+++ GT ++A EV
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTPYWMAPEVV 188
Query: 316 SRNFGEVSHKSDVYSFGMMIMELV 339
+R K D++S G+M +E++
Sbjct: 189 TRK--AYGPKVDIWSLGIMAIEMI 210
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 48/205 (23%)
Query: 163 DKLGQGGFGGVYKGK-----------------------LLDGLASISRTSHVNVVTLLGF 199
K+G+G G V + L + + + H NVV +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLEYLH 254
L G ++ EF+ G+L V ++ E I + + L YLH
Sbjct: 111 YLVGEELWVLMEFLQGGALTDIVSQV------------RLNEEQIATVCEAVLQALAYLH 158
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEV 314
+ ++H DIK +ILL D K+SDFG + SL+ GT ++A EV
Sbjct: 159 ---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV---GTPYWMAPEV 212
Query: 315 FSRNFGEVSHKSDVYSFGMMIMELV 339
SR+ + + D++S G+M++E+V
Sbjct: 213 ISRS--LYATEVDIWSLGIMVIEMV 235
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-17
Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 50/210 (23%)
Query: 163 DKLGQGGFGGVYKGK-------------------------LLDGLASISRTSHVNVVTLL 197
+LG+G +G V K + L+D S+ VT
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72
Query: 198 GFCLEGNNRALIYEFMPNGSLEKF---VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 254
G + + E M + SL+KF V + + P L +I + I K LE+LH
Sbjct: 73 GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG-----KIAVSIVKALEHLH 126
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR----GTIGYI 310
++H D+KP N+L++ K+ DFG++ +V + A+ G Y+
Sbjct: 127 S--KLSVIHRDVKPSNVLINALGQVKMCDFGIS------GYLVDDV--AKDIDAGCKPYM 176
Query: 311 ALEVFSRNFGEV--SHKSDVYSFGMMIMEL 338
A E + + S KSD++S G+ ++EL
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 55/230 (23%), Positives = 82/230 (35%), Gaps = 53/230 (23%)
Query: 138 LQNYGPLPLKRYNFSDVKKITN--SFKDKLGQGGFGGVY-----------------KGKL 178
+ ++ R N I + FK KLG G FG V+ K +
Sbjct: 1 MHHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60
Query: 179 LDGLASISR-------TSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGD 226
+ I H N++ + + +N ++ E G L
Sbjct: 61 QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA 120
Query: 227 TSKPCQYLRWEKM-YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKIS 282
S E E++ + L Y H S ++H D+KP NIL KI
Sbjct: 121 LS--------EGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKII 169
Query: 283 DFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFG 332
DFGLA+L + + A GT Y+A EVF R+ K D++S G
Sbjct: 170 DFGLAELFKSDE----HSTNAAGTALYMAPEVFKRDVTF---KCDIWSAG 212
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 45/196 (22%), Positives = 77/196 (39%), Gaps = 18/196 (9%)
Query: 154 VKKITNSFKDKLGQGGFGGVYKGKLLDGLASISR-------TSHVNVVTLLGFCLEGNNR 206
+KK S +K K + + +T G + +
Sbjct: 59 LKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDE 117
Query: 207 A-LIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMY-EIVIGIAKGLEYLHRGCSTRILH 263
+IYE+M N S+ + Y K ++ I+ + Y+H I H
Sbjct: 118 VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICH 175
Query: 264 FDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVS 323
D+KP NIL+D++ K+SDFG ++ KK + G+RGT ++ E FS
Sbjct: 176 RDVKPSNILMDKNGRVKLSDFGESEYMVDKK-----IKGSRGTYEFMPPEFFSNESSYNG 230
Query: 324 HKSDVYSFGMMIMELV 339
K D++S G+ + +
Sbjct: 231 AKVDIWSLGICLYVMF 246
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-17
Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 42/202 (20%)
Query: 163 DKLGQGGFGGVYKG--------------KLLDGLASI-------SRTSHVNVVTLLGFCL 201
+KLG+G +G VYK + L I + +VV G
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 202 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRI 261
+ + ++ E+ GS+ + + L +++ I+ KGLEYLH R
Sbjct: 95 KNTDLWIVMEYCGAGSVSDII-----RLRNKTLTEDEIATILQSTLKGLEYLH---FMRK 146
Query: 262 LHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT-IG---YIALEVFSR 317
+H DIK NILL+ + K++DFG+A G ++ + R T IG ++A EV
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVA-------GQLTDTMAKRNTVIGTPFWMAPEVIQE 199
Query: 318 NFGEVSHKSDVYSFGMMIMELV 339
+ +D++S G+ +E+
Sbjct: 200 --IGYNCVADIWSLGITAIEMA 219
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 50/219 (22%), Positives = 80/219 (36%), Gaps = 71/219 (32%)
Query: 163 DKLGQGGFGGVYKG-----------KLLDG-LA--------------SISRTSHVNVVTL 196
+G+GG G VY+ KL+ L+ + R +VV
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP- 98
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVY------NGDTSKPCQYLR------WEKMYEIVI 244
I++F G ++ +Y NG LR + IV
Sbjct: 99 ------------IHDF---GEIDGQLYVDMRLINGVDLA--AMLRRQGPLAPPRAVAIVR 141
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT----TKKGIVSSL 300
I L+ H H D+KP NIL+ D + DFG+A T T+ G
Sbjct: 142 QIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-- 196
Query: 301 LGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
GT+ Y+A E FS ++++D+Y+ ++ E +
Sbjct: 197 ----GTLYYMAPERFSE--SHATYRADIYALTCVLYECL 229
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 54/209 (25%), Positives = 87/209 (41%), Gaps = 57/209 (27%)
Query: 163 DKLGQGGFGGVYKG-----------KLL------DGLASI-------SRTSHVNVVTLLG 198
+K+G+G FG V+KG K++ D + I S+ V G
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 87
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI-----AKGLEYL 253
L+ +I E++ GS + G + E I KGL+YL
Sbjct: 88 SYLKDTKLWIIMEYLGGGSALDLLEPG------------PLDETQIATILREILKGLDYL 135
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT-IG---Y 309
H S + +H DIK N+LL + K++DFG+A G ++ R T +G +
Sbjct: 136 H---SEKKIHRDIKAANVLLSEHGEVKLADFGVA-------GQLTDTQIKRNTFVGTPFW 185
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
+A EV + K+D++S G+ +EL
Sbjct: 186 MAPEVIKQ--SAYDSKADIWSLGITAIEL 212
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 55/216 (25%), Positives = 75/216 (34%), Gaps = 59/216 (27%)
Query: 160 SFKDKLGQGGFGGVY-----------------KGKLLDGLASISRT-------------- 188
KLG G +G V K + G S
Sbjct: 39 FKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 189 -----SHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YE 241
H N++ L + L+ EF G L E+ + E
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD--------ECDAAN 150
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVS 298
I+ I G+ YLH I+H DIKP NILL + KI DFGL+ + +
Sbjct: 151 IMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD 207
Query: 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMM 334
L GT YIA EV + + E K DV+S G++
Sbjct: 208 RL----GTAYYIAPEVLKKKYNE---KCDVWSCGVI 236
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-17
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 50/205 (24%)
Query: 165 LGQGGFGGVYKG-----------KLLD-------GLA-------SI-SRTSHVNVVTLLG 198
LG+G FG VY K+L G+ I S H N++ L G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
+ + LI E+ P G++ + + + ++ + +A L Y H S
Sbjct: 77 YFHDATRVYLILEYAPLGTVYREL------QKLSKFDEQRTATYITELANALSYCH---S 127
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR----GTIGYIALEV 314
R++H DIKP N+LL KI+DFG + + + R GT+ Y+ E+
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---------RTDLCGTLDYLPPEM 178
Query: 315 FSRNFGEVSHKSDVYSFGMMIMELV 339
K D++S G++ E +
Sbjct: 179 IEGR--MHDEKVDLWSLGVLCYEFL 201
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 35/219 (15%), Positives = 69/219 (31%), Gaps = 61/219 (27%)
Query: 163 DKLGQGGFGGVYKGKLLDG---------LASISRTS-----------------HVNVVTL 196
++G GG V++ L + ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 251
+ + ++ E N L ++ + + + + +
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKKK-----------KSIDPWERKSYWKNMLEAVH 122
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT--TKKGIVSSLLGARGTIGY 309
+H I+H D+KP N L+ K+ DFG+A T + S GT+ Y
Sbjct: 123 TIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQ---VGTVNY 175
Query: 310 IALEVFSR---------NFGEVSHKSDVYSFGMMIMELV 339
+ E + ++S KSDV+S G ++ +
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 51/207 (24%), Positives = 89/207 (42%), Gaps = 47/207 (22%)
Query: 163 DKLGQGGFGGVYKG--KLLDGLASI---------------------SRTSHVNVVTLLGF 199
+LG G FG VYK K LA+ + H +V LLG
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259
++ EF P G+++ + D L ++ + + + L +LH S
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDRG-----LTEPQIQVVCRQMLEALNFLH---SK 136
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGL-AKLCTTKKGIVSSLLGARGT-IG---YIALEV 314
RI+H D+K N+L+ + +++DFG+ AK T L R + IG ++A EV
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--------LQKRDSFIGTPYWMAPEV 188
Query: 315 FSRNFGEVS---HKSDVYSFGMMIMEL 338
+ + +K+D++S G+ ++E+
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEM 215
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 63/314 (20%), Positives = 112/314 (35%), Gaps = 72/314 (22%)
Query: 163 DKLGQGGFGGVYKG-----------KLLDG-LA--------------SISRTSHVNVVTL 196
+ LG GG V+ K+L LA + + +H +V +
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 197 L--GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR------WEKMYEIVIGIAK 248
G E L Y M ++V +G T + + ++ E++ +
Sbjct: 78 YDTG-EAETPAGPLPYIVM------EYV-DGVTLR--DIVHTEGPMTPKRAIEVIADACQ 127
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG 308
L + H+ I+H D+KP NI++ K+ DFG+A+ V+ GT
Sbjct: 128 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 309 YIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV-----DNSSEVYFPHWIYR 363
Y++ E V +SDVYS G ++ E++ +G D+ V Y+
Sbjct: 185 YLSPEQARG--DSVDARSDVYSLGCVLYEVL-------TGEPPFTGDSPVSV-----AYQ 230
Query: 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-MNEVIEMLQGSTEALQI 422
HV +D + + ++ + V L + P +R E+ L
Sbjct: 231 HVRED-----PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPP 285
Query: 423 PPTPFLSSPPRASI 436
L+ R S+
Sbjct: 286 EAPKVLTDAERTSL 299
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 52/213 (24%), Positives = 83/213 (38%), Gaps = 47/213 (22%)
Query: 161 FKDKLGQGGFGGVYKG--------------------KLLDGLA---SISRT-SHVNVVTL 196
K++LG GGFG V + K + I + +H NVV+
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSA 77
Query: 197 L------GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 250
+ L E+ G L K++ + + C L+ + ++ I+ L
Sbjct: 78 REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCGLKEGPIRTLLSDISSAL 134
Query: 251 EYLHRGCSTRILHFDIKPHNILLD---QDFCPKISDFGLAKLCTTKKGIVSSLLGARGTI 307
YLH RI+H D+KP NI+L Q KI D G AK + + GT+
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV----GTL 187
Query: 308 GYIALEVFS-RNFGEVSHKSDVYSFGMMIMELV 339
Y+A E+ + + D +SFG + E +
Sbjct: 188 QYLAPELLEQKKYTV---TVDYWSFGTLAFECI 217
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 51/227 (22%), Positives = 82/227 (36%), Gaps = 50/227 (22%)
Query: 138 LQNYGPLPLKRYNFSDVKKITN--SFKDKLGQGGFGGVYKG------------------- 176
+ ++ R N + LG+G FG V K
Sbjct: 1 MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60
Query: 177 ------KLLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSK 229
+L + + + H N++ L + ++ ++ E G L ++ + S
Sbjct: 61 KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS- 119
Query: 230 PCQYLRWEKM-YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFG 285
E I+ + G+ Y+H I+H D+KP NILL ++D KI DFG
Sbjct: 120 -------EHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFG 332
L+ + GT YIA EV + E K DV+S G
Sbjct: 170 LSTCFQQNT----KMKDRIGTAYYIAPEVLRGTYDE---KCDVWSAG 209
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 34/217 (15%), Positives = 65/217 (29%), Gaps = 57/217 (26%)
Query: 163 DKLGQGGFGGVYKGKLLDG---------LASISRTS-----------------HVNVVTL 196
++G GG V++ L + ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 251
+ + ++ E N L ++ + + + + +
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLKKK-----------KSIDPWERKSYWKNMLEAVH 141
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
+H I+H D+KP N L+ K+ DFG+A V GT+ Y+
Sbjct: 142 TIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSV-VKDSQVGTVNYMP 196
Query: 312 LEVFSRNFGE---------VSHKSDVYSFGMMIMELV 339
E +S KSDV+S G ++ +
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 27/219 (12%), Positives = 70/219 (31%), Gaps = 45/219 (20%)
Query: 205 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHF 264
+R +Y M + S + L ++ + + + L LH ++H
Sbjct: 174 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHT 230
Query: 265 DIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGE--- 321
++P +I+LDQ ++ F + + + + G+ E+ +R
Sbjct: 231 YLRPVDIVLDQRGGVFLTGFEHLVR-------DGARVVSSVSRGFEPPELEARRATISYH 283
Query: 322 ------VSHKSDVYSFGMMIMELVGCKNNLDSGV---DNSSEVYFPHWIYRHVEQDREFK 372
++ D ++ G++I + + + WI+R +
Sbjct: 284 RDRRTLMTFSFDAWALGLVIYWIW-------CADLPITKDAALGGSEWIFRSCKN----- 331
Query: 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
+ + ++ ++ DR + +E
Sbjct: 332 --------IPQPVRALL---EGFLRYPKEDRLLPLQAME 359
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 34/219 (15%), Positives = 66/219 (30%), Gaps = 61/219 (27%)
Query: 163 DKLGQGGFGGVYKGKLLDG---------LASISRTS-----------------HVNVVTL 196
++G GG V++ L + ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----IAKGLE 251
+ + ++ E N L ++ + + + + +
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKK-----------KSIDPWERKSYWKNMLEAVH 169
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL--CTTKKGIVSSLLGARGTIGY 309
+H I+H D+KP N L+ K+ DFG+A T + S G + Y
Sbjct: 170 TIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQ---VGAVNY 222
Query: 310 IALEVFSRNFGE---------VSHKSDVYSFGMMIMELV 339
+ E +S KSDV+S G ++ +
Sbjct: 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 64/219 (29%)
Query: 163 DKLGQGGFGGVYKG-----------KLLDG--------------LASISRTSHVNVVTLL 197
+ +G G +G VYKG K++D L S H N+ T
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSH--HRNIATYY 87
Query: 198 GFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIG-----I 246
G ++ N L+ EF GS+ + + + + E I I
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---------KNTKGNTLKEEWIAYICREI 138
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT 306
+GL +LH +++H DIK N+LL ++ K+ DFG++ + +G R T
Sbjct: 139 LRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS-------AQLDRTVGRRNT 188
Query: 307 -IG---YIALEVFSRNFGEVS---HKSDVYSFGMMIMEL 338
IG ++A EV + + + KSD++S G+ +E+
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 5e-16
Identities = 39/200 (19%), Positives = 68/200 (34%), Gaps = 46/200 (23%)
Query: 161 FKDKLGQGGFGGVYKG----------------KLLDGLASISR-------TSHVNVVTLL 197
++ +G+G +G V ++ + + H N++ L
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 198 GFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGLEYLHR 255
+ + L+ E G L E+ V+ E I+ + + Y H
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFR--------ESDAARIMKDVLSAVAYCH- 123
Query: 256 GCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
+ H D+KP N L D K+ DFGLA K + GT Y++
Sbjct: 124 --KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK----MMRTKVGTPYYVSP 177
Query: 313 EVFSRNFGEVSHKSDVYSFG 332
+V +G + D +S G
Sbjct: 178 QVLEGLYGP---ECDEWSAG 194
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 8e-16
Identities = 39/217 (17%), Positives = 77/217 (35%), Gaps = 45/217 (20%)
Query: 164 KLGQGGFGGVYKGK----------------LLDGLASISR--------TSHVNVVTLLGF 199
L +GGF VY+ + + +I + + H N+V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 200 CLEGNNRA-------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEY 252
G + L+ + G L +F+ + L + + +I + +++
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKK---MESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT---------TKKGIVSSLLGA 303
+HR I+H D+K N+LL K+ DFG A + ++ +V +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 304 RGTIGYIALEVFSRNFGE-VSHKSDVYSFGMMIMELV 339
T Y E+ + K D+++ G ++ L
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 54/230 (23%), Positives = 80/230 (34%), Gaps = 64/230 (27%)
Query: 142 GPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVY-----------------KGKLLDGLAS 184
G P K+ D I ++LG G F V K +
Sbjct: 1 GMEPFKQQKVEDFYDI----GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRG 56
Query: 185 ISRT------------SHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDT 227
+SR H NV+TL + LI E + G L +K +
Sbjct: 57 VSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS--- 113
Query: 228 SKPCQYLRWEKMYEIVIG-IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP----KIS 282
E+ I I G+ YLH + +I HFD+KP NI+L P K+
Sbjct: 114 ---------EEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLI 161
Query: 283 DFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFG 332
DFGLA GT ++A E+ + + ++D++S G
Sbjct: 162 DFGLAHEIEDGV----EFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIG 205
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 1e-15
Identities = 50/207 (24%), Positives = 81/207 (39%), Gaps = 51/207 (24%)
Query: 165 LGQGGFGGVY----------------------KGKLLDGLA---SI-SRTSHVNVVTLLG 198
LG+G F GVY K ++ + I + H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 199 FCLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
E +N L+ E NG + +++ + + + I G+ YLH
Sbjct: 79 -YFEDSNYVYLVLEMCHNGEMNRYL-----KNRVKPFSENEARHFMHQIITGMLYLH--- 129
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR-----GTIGYIAL 312
S ILH D+ N+LL ++ KI+DFGLA + GT YI+
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP--------HEKHYTLCGTPNYISP 181
Query: 313 EVFSRNFGEVSHKSDVYSFGMMIMELV 339
E+ +R+ +SDV+S G M L+
Sbjct: 182 EIATRS--AHGLESDVWSLGCMFYTLL 206
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 43/207 (20%), Positives = 72/207 (34%), Gaps = 46/207 (22%)
Query: 163 DKLGQGGFGGVYKGKLL-----------------DGLASISR--------TSHVNVVTLL 197
++G G G V+K + + I +V
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
G + + + E M EK P + L ++ + I K L YL
Sbjct: 91 GTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKE-- 142
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG---YIALEV 314
++H D+KP NILLD+ K+ DFG++ G + + G Y+A E
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGIS-------GRLVDDKAKDRSAGCAAYMAPER 195
Query: 315 FSRNFGEV---SHKSDVYSFGMMIMEL 338
++DV+S G+ ++EL
Sbjct: 196 IDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 47/237 (19%), Positives = 68/237 (28%), Gaps = 68/237 (28%)
Query: 161 FKDKLGQGGFGGVYKG----------------KLLDGLASISRT------------SHVN 192
K +GQG +G V + + H N
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMY----------- 240
+ L + L+ E G L +K D S + K
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 241 ----------------------EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL--DQD 276
I+ I L YLH + I H DIKP N L ++
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKS 206
Query: 277 FCPKISDFGLAKLCTTKKGIVSSLLGAR-GTIGYIALEVFSRNFGEVSHKSDVYSFG 332
F K+ DFGL+K + + GT ++A EV + K D +S G
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 51/230 (22%), Positives = 85/230 (36%), Gaps = 61/230 (26%)
Query: 143 PLPLKRYNFSDVKKITNSFKDK--------LGQGGFGGVYKG----------------KL 178
P P ++ V + LG G FG V+K +
Sbjct: 67 PAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG 126
Query: 179 LDGLASISR-------TSHVNVVTLLGFCLEGNNRALIYEFMPNGSL------EKFVYNG 225
+ + H N++ L N+ L+ E++ G L E +
Sbjct: 127 MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLT- 185
Query: 226 DTSKPCQYLRWEKM-YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL-DQDFCP-KIS 282
E + I +G+ ++H ILH D+KP NIL ++D KI
Sbjct: 186 -----------ELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKII 231
Query: 283 DFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFG 332
DFGLA+ ++ + + GT ++A EV + +F VS +D++S G
Sbjct: 232 DFGLARRYKPREKLKVNF----GTPEFLAPEVVNYDF--VSFPTDMWSVG 275
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 47/229 (20%), Positives = 82/229 (35%), Gaps = 56/229 (24%)
Query: 146 LKRYNFSDVKKITNSFKDKLGQGGFGGVYKG-----------KLLD--GLASISR----- 187
+K F + + LG+G F K K++ A+ +
Sbjct: 1 MKDSPFYQHYDL-DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITAL 59
Query: 188 ---TSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM 239
H N+V L + + L+ E + G L +K ++ E
Sbjct: 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFS------------ETE 107
Query: 240 -YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKG 295
I+ + + ++H ++H D+KP N+L + + KI DFG A+L
Sbjct: 108 ASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 296 IVSSLLGARGTIGYIALEVFSRNF-GEVSHKSDVYSFG--MMIMELVGC 341
L T+ Y A E+ ++N E D++S G + M L G
Sbjct: 165 P---LKTPCFTLHYAAPELLNQNGYDE---SCDLWSLGVILYTM-LSGQ 206
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 32/248 (12%), Positives = 74/248 (29%), Gaps = 45/248 (18%)
Query: 205 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHF 264
+R +Y M + S + L ++ + + + L LH ++H
Sbjct: 179 SRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHT 235
Query: 265 DIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR---NFGE 321
++P +I+LDQ ++ F VS + A + +
Sbjct: 236 YLRPVDIVLDQRGGVFLTGFEHLVR--DGASAVSPIGRGFAPPETTAERMLPFGQHHPTL 293
Query: 322 VSHKSDVYSFGMMIMELVGCKNNLDSGV---DNSSEVYFPHWIYRHVEQDREFKLLGVVT 378
++ D ++ G+ I + + + + WI+R +
Sbjct: 294 MTFAFDTWTLGLAIYWIW-------CADLPNTDDAALGGSEWIFRSCKN----------- 335
Query: 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE---------MLQGSTEAL--QIPPTPF 427
+ + ++ ++ DR + +E L + PT
Sbjct: 336 --IPQPVRALL---EGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPLYQTDGEPTRE 390
Query: 428 LSSPPRAS 435
+PP +
Sbjct: 391 GGAPPSGT 398
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 50/167 (29%), Positives = 73/167 (43%), Gaps = 41/167 (24%)
Query: 153 DVKKITNSFK--DKLGQGGFGGVYKGK--------------------LLDGLAS-----I 185
DVK ++ D LG+G F VYK + DG+ I
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 186 S---RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYE 241
SH N++ LL +N +L+++FM LE + + P + M
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM-- 120
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
+GLEYLH ILH D+KP+N+LLD++ K++DFGLAK
Sbjct: 121 ----TLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 46/207 (22%), Positives = 81/207 (39%), Gaps = 51/207 (24%)
Query: 163 DKLGQGGFGGVYKG-----------KLL--------DGLASI-------SRTSHVNVVTL 196
++G G FG VY K + + I + H N +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
G L + L+ E+ + + + L+ ++ + G +GL YLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP------LQEVEIAAVTHGALQGLAYLH-- 171
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT-IG---YIAL 312
S ++H D+K NILL + K+ DFG +S++ + +G ++A
Sbjct: 172 -SHNMIHRDVKAGNILLSEPGLVKLGDFG-----------SASIMAPANSFVGTPYWMAP 219
Query: 313 EV-FSRNFGEVSHKSDVYSFGMMIMEL 338
EV + + G+ K DV+S G+ +EL
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 7e-15
Identities = 42/149 (28%), Positives = 64/149 (42%), Gaps = 28/149 (18%)
Query: 163 DKLGQGGFGGVYKGKLL----------------DGLAS-----IS---RTSHVNVVTLLG 198
+KLG G + VYKG +G S IS H N+V L
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYD 70
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
N L++EFM N L+K++ + + L + + +GL + H
Sbjct: 71 VIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-- 127
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLA 287
+ILH D+KP N+L+++ K+ DFGLA
Sbjct: 128 -KILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 47/187 (25%), Positives = 74/187 (39%), Gaps = 52/187 (27%)
Query: 134 TLFSLQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG------------ 181
T+ + GP + +++D K I G G FG VY+ KL D
Sbjct: 39 TVVATPGQGPDRPQEVSYTDTKVI--------GNGSFGVVYQAKLCDSGELVAIKKVLQD 90
Query: 182 -------LASISRTSHVNVVTLLGFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTS 228
L + + H N+V L F + L+ +++P ++ + + +
Sbjct: 91 KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRA 149
Query: 229 KP------CQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP-KI 281
K + MY++ + L Y+H S I H DIKP N+LLD D K+
Sbjct: 150 KQTLPVIYVKLY----MYQL----FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKL 198
Query: 282 SDFGLAK 288
DFG AK
Sbjct: 199 CDFGSAK 205
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 47/212 (22%), Positives = 73/212 (34%), Gaps = 60/212 (28%)
Query: 160 SFKDKLGQGGFGGVY-----------------KGKLLDGLASISRT------------SH 190
++LG G F V K + + R H
Sbjct: 15 DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 191 VNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKMYEIVIG 245
N++TL + LI E + G L +K + E+ I
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS------------EEEATSFIK 122
Query: 246 -IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP----KISDFGLAKLCTTKKGIVSSL 300
I G+ YLH + +I HFD+KP NI+L P K+ DFGLA
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV----EF 175
Query: 301 LGARGTIGYIALEVFSRNFGEVSHKSDVYSFG 332
GT ++A E+ + + ++D++S G
Sbjct: 176 KNIFGTPEFVAPEIVNYEP--LGLEADMWSIG 205
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 47/226 (20%), Positives = 80/226 (35%), Gaps = 65/226 (28%)
Query: 161 FKDKLGQGGFGGVYKG-------------------------KLLDGLASISR-------- 187
K+ LG+G V + ++ + + +
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 188 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYN-GDTSKPCQYLRWEKMYE 241
+ H N++ L L+++ M G L EK + +T K
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK------------ 128
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
I+ + + + LH I+H D+KP NILLD D K++DFG + G L
Sbjct: 129 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPG--EKLR 181
Query: 302 GARGTIGYIALEVFSRNFGEVSH----KSDVYSFG--MMIMELVGC 341
GT Y+A E+ + + + D++S G M + L G
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTL-LAGS 226
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 40/157 (25%), Positives = 62/157 (39%), Gaps = 43/157 (27%)
Query: 163 DKLGQGGFGGVYKGKLLDG------------------LASISRTSHVNVVTLLGFCLEGN 204
+G G FG V++ KL++ L + H NVV L F
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNG 105
Query: 205 NRA------LIYEFMPNGSLEKFVYNGDTSKP------CQYLRWEKMYEIVIGIAKGLEY 252
++ L+ E++P ++ + + K + MY++ + L Y
Sbjct: 106 DKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLY----MYQL----LRSLAY 156
Query: 253 LHRGCSTRILHFDIKPHNILLDQDFCP-KISDFGLAK 288
+H S I H DIKP N+LLD K+ DFG AK
Sbjct: 157 IH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 56/233 (24%), Positives = 86/233 (36%), Gaps = 61/233 (26%)
Query: 150 NFSDVKKITNSFKDKLGQGGFGGVYKG----------------KLLDGLASISR------ 187
F DV ++ +D LG+G V + + + R
Sbjct: 9 RFEDVYQLQ---EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLY 65
Query: 188 --TSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM- 239
H NV+ L+ F E + L++E M GS+ ++ +N E
Sbjct: 66 QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFN------------ELEA 113
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLC----TT 292
+V +A L++LH + I H D+KP NIL +Q KI DF L
Sbjct: 114 SVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170
Query: 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSH---KSDVYSFG--MMIMELVG 340
LL G+ Y+A EV E S + D++S G + I+ L G
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYIL-LSG 222
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 41/205 (20%), Positives = 66/205 (32%), Gaps = 45/205 (21%)
Query: 161 FKDKLGQGGFGGVYKG----------------KLLDGLASISRT------------SHVN 192
+ +G+G F V + +S H +
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 193 VVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGL 250
+V LL +++EFM L + V Y E + + I + L
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA--DAGFVYS--EAVASHYMRQILEAL 143
Query: 251 EYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTI 307
Y H I+H D+KPH +LL + K+ FG+A + + GT
Sbjct: 144 RYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV---GTP 197
Query: 308 GYIALEVFSRNFGEVSHKSDVYSFG 332
++A EV R DV+ G
Sbjct: 198 HFMAPEVVKRE--PYGKPVDVWGCG 220
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 45/240 (18%), Positives = 83/240 (34%), Gaps = 71/240 (29%)
Query: 150 NFSDVKKITNSFKD--KLGQGGFGGVYKGKLLDG----------------------LASI 185
+K + F+ GQG FG V GK + +
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDL 73
Query: 186 SRTSHVNVVTLLGFCLEGNNRA-------LIYEFMPNGSLEKFVYNGDTSKP------CQ 232
+ H N+V L + R ++ E++P+ +L + N + +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIK 132
Query: 233 YLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP-KISDFGLAKLCT 291
++++ + + LH S + H DIKPHN+L+++ K+ DFG AK
Sbjct: 133 VF----LFQL----IRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--- 180
Query: 292 TKKGIVSSLLGARGTIGYIALEVFSR---------NFGEVSHKSDVYSFGMMIMELVGCK 342
L + + YI SR + D++S G + E++ +
Sbjct: 181 -------KLSPSEPNVAYIC----SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 45/222 (20%), Positives = 78/222 (35%), Gaps = 57/222 (25%)
Query: 143 PLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKG----------------KLLDGLASIS 186
P+ +K+ + D I ++LG G FG V++ ++
Sbjct: 41 PVEVKQGSVYDYYDI----LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK 96
Query: 187 R-------TSHVNVVTLLGFCLEGNNRALIYEFMPNGSL------EKFVYNGDTSKPCQY 233
H ++ L + LI EF+ G L E + +
Sbjct: 97 NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMS--------- 147
Query: 234 LRWEKMYEIVIG-IAKGLEYLHRGCSTRILHFDIKPHNILL--DQDFCPKISDFGLAKLC 290
E + +GL+++H I+H DIKP NI+ + KI DFGLA
Sbjct: 148 ---EAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 201
Query: 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFG 332
+ + + T + A E+ R V +D+++ G
Sbjct: 202 NPDEIVKVTT----ATAEFAAPEIVDREP--VGFYTDMWAIG 237
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 3e-14
Identities = 45/205 (21%), Positives = 72/205 (35%), Gaps = 53/205 (25%)
Query: 160 SFKDKLGQGGFGGVYKG----------------KLLDGLASISR-------TSHVNVVTL 196
++LG G FG V++ ++ + H +V L
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 197 LGFCLEGNNRALIYEFMPNGSL------EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKG 249
+ N +IYEFM G L E + E E + + KG
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS------------EDEAVEYMRQVCKG 267
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCP--KISDFGLAKLCTTKKGIVSSLLGARGTI 307
L ++H +H D+KP NI+ K+ DFGL K+ + + GT
Sbjct: 268 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT----GTA 320
Query: 308 GYIALEVFSRNFGEVSHKSDVYSFG 332
+ A EV V + +D++S G
Sbjct: 321 EFAAPEVA--EGKPVGYYTDMWSVG 343
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 56/225 (24%), Positives = 90/225 (40%), Gaps = 52/225 (23%)
Query: 147 KRYNFSDVKKITNSFKDKLGQGGFGGVYKG-----------KLLDGLASISR-------- 187
K+Y +D +++ K LG G G V + KLL +
Sbjct: 22 KKYAVTDDYQLS---KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQA 78
Query: 188 TSHVNVVTLLGFCLEGNNRA----LIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YE 241
+ ++V +L ++ +I E M G L + GD + + E+ E
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----FT--EREAAE 132
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVS 298
I+ I +++LH S I H D+KP N+L ++D K++DFG AK T
Sbjct: 133 IMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---- 185
Query: 299 SLLGARGTIGYIALEVFSR-NFGEVSHKSDVYSFG--MMIMELVG 340
L T Y+A EV + + D++S G M I+ L G
Sbjct: 186 -LQTPCYTPYYVAPEVLGPEKYDK---SCDMWSLGVIMYIL-LCG 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 45/205 (21%), Positives = 76/205 (37%), Gaps = 50/205 (24%)
Query: 165 LGQGGFGGVY----------------------KGKLLDGLA---SI-SRTSHVNVVTLLG 198
LG+G FG VY K + L I S H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
+ + L+ EF P G L K + + ++ + +A L Y H
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKEL------QKHGRFDEQRSATFMEELADALHYCH---E 132
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR----GTIGYIALEV 314
+++H DIKP N+L+ KI+DFG + + + R GT+ Y+ E+
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR---------RRTMCGTLDYLPPEM 183
Query: 315 FSRNFGEVSHKSDVYSFGMMIMELV 339
K D++ G++ E +
Sbjct: 184 IEGK--THDEKVDLWCAGVLCYEFL 206
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 43/213 (20%), Positives = 77/213 (36%), Gaps = 50/213 (23%)
Query: 138 LQNYGPLPLKRYNFSDVKKITN--SFKDKLGQGGFGGVYKG----------------KLL 179
+Q G + + + + T+ K+ +G G + +
Sbjct: 1 MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60
Query: 180 DGLASISR----TSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKP 230
D I H N++TL +G ++ E M G L + ++
Sbjct: 61 DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS------ 114
Query: 231 CQYLRWEKM-YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCP-KISDFG 285
E+ ++ I K +EYLH + ++H D+KP NIL + +I DFG
Sbjct: 115 ------EREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
AK + G++ + T ++A EV R
Sbjct: 166 FAKQLRAENGLLMTPC---YTANFVAPEVLERQ 195
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 7e-14
Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 33/151 (21%)
Query: 163 DKLGQGGFGGVYKGKLL-----------------DGLAS-----IS---RTSHVNVVTLL 197
+K+G+G +G VYK + +G+ S IS +H N+V LL
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 68
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
N L++EF+ L+KF+ + + + + + +GL + H
Sbjct: 69 DVIHTENKLYLVFEFLHQ-DLKKFM----DASALTGIPLPLIKSYLFQLLQGLAFCH--- 120
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK 288
S R+LH D+KP N+L++ + K++DFGLA+
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 48/201 (23%)
Query: 161 FKDKLGQGGFGGVYKGK-----------------------LLDGLASISRTSHVNVVTLL 197
F + LG G F V+ K L + +A + + H N+VTL
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 198 GFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGLEYLHR 255
+ L+ + + G L ++ + G + EK ++ + ++YLH
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYT--------EKDASLVIQQVLSAVKYLH- 123
Query: 256 GCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL 312
I+H D+KP N+L +++ I+DFGL+K+ + GI+S+ GT GY+A
Sbjct: 124 --ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTAC---GTPGYVAP 176
Query: 313 EVFSRN-FGEVSHKSDVYSFG 332
EV ++ + + D +S G
Sbjct: 177 EVLAQKPYSK---AVDCWSIG 194
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 47/207 (22%), Positives = 79/207 (38%), Gaps = 57/207 (27%)
Query: 161 FKDKLGQGGFGGVYKG----------------KLLDGL--------ASISRT-SHVNVVT 195
K++LG+G F V + K L A I R H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92
Query: 196 LLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKG 249
L E + L+++ + G L + Y+ E + I +
Sbjct: 93 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS------------EADASHCIQQILES 140
Query: 250 LEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT 306
+ Y H S I+H ++KP N+LL + K++DFGLA + G GT
Sbjct: 141 IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDS--EAWHGFAGT 193
Query: 307 IGYIALEVFSRN-FGEVSHKSDVYSFG 332
GY++ EV ++ + + D+++ G
Sbjct: 194 PGYLSPEVLKKDPYSK---PVDIWACG 217
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 33/150 (22%)
Query: 163 DKLGQGGFGGVYKGK----------------LLDGLAS-----IS---RTSHVNVVTLLG 198
+K+G+G +G VYK K +G+ S IS H N+V+L+
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
L++EFM L+K + T ++ +Y+++ +G+ + H
Sbjct: 87 VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK-IYLYQLL----RGVAHCH---Q 137
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAK 288
RILH D+KP N+L++ D K++DFGLA+
Sbjct: 138 HRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 28/150 (18%), Positives = 57/150 (38%), Gaps = 34/150 (22%)
Query: 163 DKLGQGGFGGVYKGKLL-----------------DGLASIS--------RTSHVNVVTLL 197
K+G+G +G V+K + + I+ + H N+V LL
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
L++E+ + ++ + P ++ ++ + + + + H
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK-SITWQTL----QAVNFCH--- 119
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLA 287
+H D+KP NIL+ + K+ DFG A
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFA 149
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 43/214 (20%), Positives = 78/214 (36%), Gaps = 61/214 (28%)
Query: 161 FKDKLGQGGFGGVYKGK------------------------LLDGLASISR--------T 188
KD +G+G V + L + + R
Sbjct: 98 PKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157
Query: 189 SHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNG-----DTSKPCQYLRWEKMYEI 242
H +++TL+ + L+++ M G L + +T I
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRS------------I 205
Query: 243 VIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLG 302
+ + + + +LH + I+H D+KP NILLD + ++SDFG + + G L
Sbjct: 206 MRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPG--EKLRE 258
Query: 303 ARGTIGYIALEVFSRNFGEV----SHKSDVYSFG 332
GT GY+A E+ + E + D+++ G
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 50/212 (23%), Positives = 74/212 (34%), Gaps = 60/212 (28%)
Query: 160 SFKDKLGQGGFGGVY-----------------KGKLLDGLASISRT------------SH 190
++LG G F V K +L +SR H
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 191 VNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM-YEIVI 244
N++TL + LI E + G L EK E + +
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLT------------EDEATQFLK 115
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP----KISDFGLAKLCTTKKGIVSSL 300
I G+ YLH S RI HFD+KP NI+L P K+ DFG+A
Sbjct: 116 QILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN----EF 168
Query: 301 LGARGTIGYIALEVFSRNFGEVSHKSDVYSFG 332
GT ++A E+ + + ++D++S G
Sbjct: 169 KNIFGTPEFVAPEIVNYEP--LGLEADMWSIG 198
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 70.2 bits (173), Expect = 1e-13
Identities = 37/150 (24%), Positives = 66/150 (44%), Gaps = 33/150 (22%)
Query: 163 DKLGQGGFGGVYKGK----------------LLDGLAS-----IS---RTSHVNVVTLLG 198
+K+G+G +G VYK + +G+ S IS H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
L++E + L+K + + + + +++ G+ Y H
Sbjct: 68 VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAK-SFLLQLL----NGIAYCH---D 118
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAK 288
R+LH D+KP N+L++++ KI+DFGLA+
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 53/227 (23%), Positives = 77/227 (33%), Gaps = 64/227 (28%)
Query: 145 PLKRYNFSDVKKITNSFKDKLGQGGFGGVY-----------------KGKLLDGLASISR 187
++ N D ++LG G F V K + +SR
Sbjct: 3 VFRQENVDDYYDT----GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSR 58
Query: 188 T------------SHVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKP 230
H NV+TL + LI E + G L EK
Sbjct: 59 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLT------ 112
Query: 231 CQYLRWEKM-YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL----DQDFCPKISDFG 285
E+ E + I G+ YLH S +I HFD+KP NI+L KI DFG
Sbjct: 113 ------EEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163
Query: 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFG 332
LA GT ++A E+ + + ++D++S G
Sbjct: 164 LAHKIDFGN----EFKNIFGTPEFVAPEIVNYEP--LGLEADMWSIG 204
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 44/208 (21%), Positives = 78/208 (37%), Gaps = 56/208 (26%)
Query: 160 SFKDKLGQGGFGGVYKG----------------KLLDGL--------ASISRT-SHVNVV 194
++LG+G F V + K L A I R H N+V
Sbjct: 14 QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 195 TLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAK 248
L E + LI++ + G L + Y+ E + I +
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS------------EADASHCIQQILE 121
Query: 249 GLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
+ + H ++H ++KP N+LL + K++DFGLA ++ G
Sbjct: 122 AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA---G 175
Query: 306 TIGYIALEVFSRN-FGEVSHKSDVYSFG 332
T GY++ EV ++ +G+ D+++ G
Sbjct: 176 TPGYLSPEVLRKDPYGK---PVDLWACG 200
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 47/207 (22%), Positives = 79/207 (38%), Gaps = 57/207 (27%)
Query: 161 FKDKLGQGGFGGVYKG----------------KLLDGL--------ASISRT-SHVNVVT 195
K++LG+G F V + K L A I R H N+V
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69
Query: 196 LLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKG 249
L E + L+++ + G L + Y+ E + I +
Sbjct: 70 LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYS------------EADASHCIQQILES 117
Query: 250 LEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT 306
+ Y H S I+H ++KP N+LL + K++DFGLA + G GT
Sbjct: 118 IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDS--EAWHGFAGT 170
Query: 307 IGYIALEVFSRN-FGEVSHKSDVYSFG 332
GY++ EV ++ + + D+++ G
Sbjct: 171 PGYLSPEVLKKDPYSK---PVDIWACG 194
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 54/196 (27%), Positives = 82/196 (41%), Gaps = 43/196 (21%)
Query: 165 LGQGGFGGVY-----------------KGKLLDGLASISR-------TSHVNVVTLLGFC 200
LG+G +G V + +D +I + +H NVV G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 201 LEGNNRALIYEFMPNGSL-EKFVYNGDTSKP--CQYLRWEKMYEIVIGIAKGLEYLHRGC 257
EGN + L E+ G L ++ + +P ++ +++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-----QLMAGV----VYLH--- 122
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR-GTIGYIALEVFS 316
I H DIKP N+LLD+ KISDFGLA + + LL GT+ Y+A E+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATV--FRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 317 RNFGEVSHKSDVYSFG 332
R + DV+S G
Sbjct: 181 RR-EFHAEPVDVWSCG 195
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 50/203 (24%), Positives = 80/203 (39%), Gaps = 53/203 (26%)
Query: 161 FKDKLGQGGFGGVYKGK-----LLDGLASISRT----------------SHVNVVTLLGF 199
+ +LG+G VY+ K L + +T SH N++ L
Sbjct: 57 VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 200 CLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGLEYL 253
+L+ E + G L EK Y+ E+ + V I + + YL
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVEKGYYS------------ERDAADAVKQILEAVAYL 164
Query: 254 HRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310
H I+H D+KP N+L D KI+DFGL+K+ + + + GT GY
Sbjct: 165 H---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC----GTPGYC 217
Query: 311 ALEVFSR-NFGEVSHKSDVYSFG 332
A E+ +G + D++S G
Sbjct: 218 APEILRGCAYGP---EVDMWSVG 237
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 36/151 (23%), Positives = 70/151 (46%), Gaps = 34/151 (22%)
Query: 163 DKLGQGGFGGVYKGKLL-----------------DGLAS-----IS---RTSHVNVVTLL 197
+K+G+G +G V+K K +G+ S I H N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
L++EF L+K+ + + + ++ +++++ KGL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVK-SFLFQLL----KGLGFCH--- 118
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK 288
S +LH D+KP N+L++++ K+++FGLA+
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 2e-13
Identities = 37/162 (22%), Positives = 64/162 (39%), Gaps = 44/162 (27%)
Query: 163 DKLGQGGFGGVYKGKLL-----------------DGLASISRTS--------------HV 191
++G G +G VYK + G + ++ H
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHP 74
Query: 192 NVVTLLGFCLEGNNRA-----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 246
NVV L+ C L++E + L ++ P L E + +++
Sbjct: 75 NVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL----DKAPPPGLPAETIKDLMRQF 129
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
+GL++LH + I+H D+KP NIL+ K++DFGLA+
Sbjct: 130 LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
+ L+YL + RI+H D+KP NILLD+ I+DF +A + + I + G
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA----G 176
Query: 306 TIGYIALEVFSRNFGEVSHKS-DVYSFGMMIMEL 338
T Y+A E+FS G + D +S G+ EL
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 3e-13
Identities = 47/227 (20%), Positives = 82/227 (36%), Gaps = 47/227 (20%)
Query: 136 FSLQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYK------GKLL---------- 179
L NF++ +T +LG+G F V + G+
Sbjct: 11 VDLGTENLYFQSMENFNNFYILT---SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67
Query: 180 --DGLASISR--------TSHVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTS 228
D A I S V+ L + LI E+ G + +
Sbjct: 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCL-----P 122
Query: 229 KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFG 285
+ + + + ++ I +G+ YLH I+H D+KP NILL KI DFG
Sbjct: 123 ELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFG 332
+++ L GT Y+A E+ + + ++ +D+++ G
Sbjct: 180 MSRKIGHAC----ELREIMGTPEYLAPEILNYDP--ITTATDMWNIG 220
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 54/196 (27%), Positives = 82/196 (41%), Gaps = 43/196 (21%)
Query: 165 LGQGGFGGVY-----------------KGKLLDGLASISR-------TSHVNVVTLLGFC 200
LG+G +G V + +D +I + +H NVV G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 201 LEGNNRALIYEFMPNGSL-EKFVYNGDTSKP--CQYLRWEKMYEIVIGIAKGLEYLHRGC 257
EGN + L E+ G L ++ + +P ++ +++ G+ YLH
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFH-----QLMAGV----VYLH--- 122
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR-GTIGYIALEVFS 316
I H DIKP N+LLD+ KISDFGLA + + LL GT+ Y+A E+
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATV--FRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 317 RNFGEVSHKSDVYSFG 332
R + DV+S G
Sbjct: 181 RR-EFHAEPVDVWSCG 195
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 37/150 (24%), Positives = 70/150 (46%), Gaps = 33/150 (22%)
Query: 163 DKLGQGGFGGVYKGKLL----------------DGLAS-----IS---RTSHVNVVTLLG 198
DKLG+G + VYKGK +G +S H N+VTL
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
+ L++E++ L++++ + ++ +++++ +GL Y H
Sbjct: 68 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVK-LFLFQLL----RGLAYCH---R 118
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAK 288
++LH D+KP N+L+++ K++DFGLA+
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 50/228 (21%), Positives = 87/228 (38%), Gaps = 73/228 (32%)
Query: 164 KLGQGGFGGVYKG--------------------------KLLDGLASISRTSHVNVVTLL 197
KLG+G + V++ K+L+ L N++TL
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENL-----RGGPNIITLA 97
Query: 198 GFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHR 255
+ +R AL++E + N ++ +Y T ++ MYEI+ K L+Y H
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQ-LYQTLTDYDIRFY----MYEIL----KALDYCH- 147
Query: 256 GCSTRILHFDIKPHNILLDQDFCP-KISDFGLAKLCTTKKGIVSSLLGARGTIGYIAL-- 312
S I+H D+KPHN+++D + ++ D+GLA
Sbjct: 148 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA----------------EFYHPGQEYNV 189
Query: 313 EVFSR---------NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN 351
V SR ++ + D++S G M+ ++ K G DN
Sbjct: 190 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 43/204 (21%), Positives = 70/204 (34%), Gaps = 52/204 (25%)
Query: 160 SFKDKLGQGGFGGVYK------GKLL---------DGLASISR-------TSHVNVVTLL 197
+ LG+G FG V++ K + + H N++ L
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLH 67
Query: 198 GFCLEGNNRALIYEFMPNGSL------EKFVYNGDTSKPCQYLRWEKM-YEIVIGIAKGL 250
+I+EF+ + F N E+ V + + L
Sbjct: 68 ESFESMEELVMIFEFISGLDIFERINTSAFELN------------EREIVSYVHQVCEAL 115
Query: 251 EYLHRGCSTRILHFDIKPHNILL--DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIG 308
++LH S I HFDI+P NI+ + KI +FG A+ +
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD----NFRLLFTAPE 168
Query: 309 YIALEVFSRNFGEVSHKSDVYSFG 332
Y A EV + VS +D++S G
Sbjct: 169 YYAPEVHQHDV--VSTATDMWSLG 190
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 5e-13
Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 42/163 (25%)
Query: 162 KDKLGQGGFGGVYKGKLLDGL------------ASISRTS-----------HVNVVTLLG 198
K+G+G +G VYK K DG IS ++ H NV++L
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 85
Query: 199 FCLEGNNRA--LIYEFMPN---GSLEKFVYNGDTSKPCQYLRWEK---MYEIVIGIAKGL 250
L +R L++++ + ++ + KP Q R +Y+I+ G+
Sbjct: 86 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL----DGI 141
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDF----CPKISDFGLAKL 289
YLH + +LH D+KP NIL+ + KI+D G A+L
Sbjct: 142 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 53/228 (23%), Positives = 85/228 (37%), Gaps = 51/228 (22%)
Query: 144 LPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKG-----------KLLDGLASISR----- 187
L +K+ D K+ LG G G V + K+L R
Sbjct: 52 LQIKKNAIIDDYKV---TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELH 108
Query: 188 ---TSHVNVVTLLGFCLEGNNRA----LIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKM 239
+ ++V ++ ++ E + G L + GD + E+
Sbjct: 109 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFT------ERE 162
Query: 240 -YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKG 295
EI+ I + ++YLH S I H D+KP N+L + K++DFG AK T+
Sbjct: 163 ASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 219
Query: 296 IVSSLLGARGTIGYIALEVFSR-NFGEVSHKSDVYSFG--MMIMELVG 340
L T Y+A EV + + D++S G M I+ L G
Sbjct: 220 ----LTTPCYTPYYVAPEVLGPEKYDK---SCDMWSLGVIMYIL-LCG 259
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 39/163 (23%), Positives = 69/163 (42%), Gaps = 48/163 (29%)
Query: 163 DKLGQGGFGGVYKGKLL------------------DG-----------LASISRTSHVNV 193
++G+G +G V+K + L +G L + H NV
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 194 VTLLGFCLEGNNRA-----LIYEFMPN---GSLEKFVYNGDTSKPCQYLRWEKMYEIVIG 245
V L C L++E + L+K G ++ + + M++++
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM----MFQLL-- 130
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288
+GL++LH S R++H D+KP NIL+ K++DFGLA+
Sbjct: 131 --RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 41/149 (27%), Positives = 64/149 (42%), Gaps = 22/149 (14%)
Query: 190 HVNVVTLLGFCLEGNNRALIY---EFMPNGSLEKFVYNG--DTSKPCQYLRWEKMYEIVI 244
H NVV L+ L+ N +Y E + G + + + Y +
Sbjct: 95 HPNVVKLVEV-LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQ--------- 144
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR 304
+ KG+EYLH +I+H DIKP N+L+ +D KI+DFG++ + L
Sbjct: 145 DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL---LSNTV 198
Query: 305 GTIGYIALEVFSRNFGEVS-HKSDVYSFG 332
GT ++A E S S DV++ G
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMG 227
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 45/212 (21%), Positives = 69/212 (32%), Gaps = 59/212 (27%)
Query: 161 FKDKLGQGGFGGVY-----------------KGKLLDGLASISRT--------------S 189
LG G G V K K G A + +
Sbjct: 139 MSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSL-----EKFVYNGDTSKPCQYLRWEKMYEIVI 244
H ++ + F + + ++ E M G L T K
Sbjct: 199 HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK-----------LYFY 246
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVSSLL 301
+ ++YLH I+H D+KP N+LL ++D KI+DFG +K+ S +
Sbjct: 247 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLMR 299
Query: 302 GARGTIGYIALEVFSRNFGEV-SHKSDVYSFG 332
GT Y+A EV + D +S G
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 39/156 (25%), Positives = 62/156 (39%), Gaps = 40/156 (25%)
Query: 163 DKLGQGGFGGVYKGKLL-----------------DGLAS-----IS---RTSHVNVVTLL 197
KLG+G +G VYK +G+ +S H N++ L
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
+ LI+E+ N L+K++ + +Y+++ G+ + H
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF--LYQLI----NGVNFCH--- 149
Query: 258 STRILHFDIKPHNILLDQDFCP-----KISDFGLAK 288
S R LH D+KP N+LL KI DFGLA+
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 34/150 (22%)
Query: 163 DKLGQGGFGGVYKGK-------------LLD----GLASIS--------RTSHVNVVTLL 197
+G+G +G V K + L + I+ + H N+V LL
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
C + L++EF+ + ++ + Q ++ + +++I+ G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQ-KYLFQII----NGIGFCH--- 141
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLA 287
S I+H DIKP NIL+ Q K+ DFG A
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 34/98 (34%), Positives = 51/98 (52%), Gaps = 17/98 (17%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK--GIVSSLLGA 303
I GLE++H + +++ D+KP NILLD+ +ISD GLA + KK V
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV------ 351
Query: 304 RGTIGYIALEVFSRNFGEVSHKSDV--YSFGMMIMELV 339
GT GY+A EV + + S +S G M+ +L+
Sbjct: 352 -GTHGYMAPEVLQKGVA---YDSSADWFSLGCMLFKLL 385
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 39/138 (28%), Positives = 64/138 (46%), Gaps = 19/138 (13%)
Query: 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY--EIVIGIAKGLEYLHRGCSTRILHFD 265
++ E+MP G L + N D + W + Y E+V+ L+ +H S +H D
Sbjct: 146 MVMEYMPGGDLVNLMSNYDVPEK-----WARFYTAEVVLA----LDAIH---SMGFIHRD 193
Query: 266 IKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHK 325
+KP N+LLD+ K++DFG + + GT YI+ EV G+ +
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV--GTPDYISPEVLKSQGGDGYYG 251
Query: 326 SDV--YSFGMMIME-LVG 340
+ +S G+ + E LVG
Sbjct: 252 RECDWWSVGVFLYEMLVG 269
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 35/151 (23%), Positives = 62/151 (41%), Gaps = 42/151 (27%)
Query: 208 LIYEFMPNGSLEKFVYNGDTSKP------CQYLRWEKMYEIVIGIAKGLEYLHRGCSTRI 261
+I E++P+ +L K + + S +Y++ + + ++H S I
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIY----IYQL----FRAVGFIH---SLGI 162
Query: 262 LHFDIKPHNILLDQDFCP-KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR--- 317
H DIKP N+L++ K+ DFG AK L+ + ++ YI SR
Sbjct: 163 CHRDIKPQNLLVNSKDNTLKLCDFGSAK----------KLIPSEPSVAYIC----SRFYR 208
Query: 318 ------NFGEVSHKSDVYSFGMMIMELVGCK 342
E + D++S G + EL+ K
Sbjct: 209 APELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 32/301 (10%), Positives = 70/301 (23%), Gaps = 82/301 (27%)
Query: 163 DKLGQGGFGGVYKG-----------KLLD-GLA--------------SISRTSHVNVVTL 196
G ++ +D +SR V +
Sbjct: 37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHR- 255
L ++ E++ GSL++ + +A + HR
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHRA 148
Query: 256 GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF 315
G + P + + D G L +
Sbjct: 149 G----VALSIDHPSRVRVSID--------GDVVL---------------AYPATMP---- 177
Query: 316 SRNFGEVSHKSDVYSFGMMIMELV-GCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374
+ + + D+ G + L+ ++GV + R
Sbjct: 178 -----DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-----AERDTAGQ-----P 222
Query: 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPPTPFLSSPPRA 434
+ +I ++ V +Q R + M Q + A + + P +
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGPIDEAPVS 282
Query: 435 S 435
+
Sbjct: 283 A 283
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 40/159 (25%), Positives = 62/159 (38%), Gaps = 44/159 (27%)
Query: 163 DKLGQGGFGGVYKGKLL-----------------DGLAS-----IS---RTSHVNVVTLL 197
K+GQG FG V+K + +G I H NVV L+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 82
Query: 198 GFCLEGNNRA--------LIYEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYEIVIGIAK 248
C + L+++F + L + N + R M ++
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV--MQMLL----N 135
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287
GL Y+H +ILH D+K N+L+ +D K++DFGLA
Sbjct: 136 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 12/96 (12%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I GLE+LH I++ D+KP N+LLD D +ISD GLA + G
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA---G 351
Query: 306 TIGYIALEVFSRNFGEVSHKSDV--YSFGMMIMELV 339
T G++A E+ + V ++ G+ + E++
Sbjct: 352 TPGFMAPELLLGE----EYDFSVDYFALGVTLYEMI 383
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 46/204 (22%), Positives = 73/204 (35%), Gaps = 52/204 (25%)
Query: 165 LGQGGFGGVY-----------------KGKLL---DGLASISR-------TSHVNVVTLL 197
LG+G +G V K KL +G A++ + H NV+ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 198 GFCLEGNNRALIY---EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV-----IGIAKG 249
L + +Y E+ G E + ++ + G
Sbjct: 73 DV-LYNEEKQKMYMVMEYCVCGMQEML----------DSVPEKRFPVCQAHGYFCQLIDG 121
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLG-ARGTIG 308
LEYLH S I+H DIKP N+LL KIS G+A+ ++G+
Sbjct: 122 LEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA--DDTCRTSQGSPA 176
Query: 309 YIALEVFSRNFGEVSHKSDVYSFG 332
+ E+ + K D++S G
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAG 200
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 47/216 (21%), Positives = 74/216 (34%), Gaps = 67/216 (31%)
Query: 161 FKDKLGQGGFGGVY-----------------KGKLLDGLASISRT--------------S 189
LG G G V K K G A + +
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEKMYE-----IV 243
H ++ + F + + ++ E M G L +K V N ++ E
Sbjct: 74 HPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNK------------RLKEATCKLYF 120
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTKKGIVSSL 300
+ ++YLH I+H D+KP N+LL ++D KI+DFG +K+ S +
Sbjct: 121 YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET----SLM 173
Query: 301 LGARGTIGYIALEVFS----RNFGEVSHKSDVYSFG 332
GT Y+A EV + D +S G
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNR---AVDCWSLG 206
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I GLE LH RI++ D+KP NILLD +ISD GLA + I + G
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV----G 347
Query: 306 TIGYIALEVFSRNFGEVSHKSDV--YSFGMMIMELV 339
T+GY+A EV + ++ G ++ E++
Sbjct: 348 TVGYMAPEVVKNE----RYTFSPDWWALGCLLYEMI 379
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 25/177 (14%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
+AKG+E+L S + +H D+ NILL + KI DFGLA+ V AR
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK-GDARL 257
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365
+ ++A E + + +SDV+SFG+++ E+ + GV E R +
Sbjct: 258 PLKWMAPE--TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRL 309
Query: 366 EQDREFKLLGVVTKKEN---EIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419
++ + + E+ + M L C P RP +E++E L +A
Sbjct: 310 KEG------TRMRAPDYTTPEMYQTM----LDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 19/96 (19%), Positives = 30/96 (31%), Gaps = 31/96 (32%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRT------------------------------S 189
LG+G FG V + + +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 190 HVNVVTLLGFCLEGNNRA-LIYEFMPNGSLEKFVYN 224
H+NVV LLG C + +I EF G+L ++ +
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 38/159 (23%), Positives = 68/159 (42%), Gaps = 19/159 (11%)
Query: 190 HVNVVTLLGFCLEGNNRA-----LIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEIV 243
H N++ + ++ + M L K + ++ Y +Y+I+
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYF----LYQIL 138
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA 303
+GL+Y+H S +LH D+KP N+LL+ KI DFGLA++ L
Sbjct: 139 ----RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
T Y A E+ N + D++S G ++ E++ +
Sbjct: 192 VATRWYRAPEIML-NSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 10/96 (10%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT--TKKGIVSSLLGA 303
I LEYLH I+H D+KP NILL++D +I+DFG AK+ + +K+ +S +
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-- 193
Query: 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
GT Y++ E+ + SD+++ G +I +LV
Sbjct: 194 -GTAQYVSPELLTEK--SACKSSDLWALGCIIYQLV 226
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 4e-10
Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 13/104 (12%)
Query: 241 EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSL 300
E+VI ++ +H +H DIKP NIL+D + +++DFG + SS+
Sbjct: 183 EMVIA----IDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV 235
Query: 301 LGARGTIGYIALEVF-SRNFGEVSHKSDV--YSFGMMIME-LVG 340
GT YI+ E+ + G+ + + +S G+ + E L G
Sbjct: 236 AV--GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 37/146 (25%), Positives = 61/146 (41%), Gaps = 37/146 (25%)
Query: 154 VKKITNSFKDKLGQGGFGGVYKG-----KLLDGLASISRTSHVNVVTLLGFCLEGNNRA- 207
+KKI F+D K +L +R +H +VV +L + +
Sbjct: 83 IKKILRVFEDL-------IDCKRILREIAIL------NRLNHDHVVKVLDIVIPKDVEKF 129
Query: 208 ----LIYEFMPNGSLEKFVYNGD--TSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRI 261
++ E + +K T + L +Y ++ G++Y+H S I
Sbjct: 130 DELYVVLEIADS-DFKKLFRTPVYLTELHIKTL----LYNLL----VGVKYVH---SAGI 177
Query: 262 LHFDIKPHNILLDQDFCPKISDFGLA 287
LH D+KP N L++QD K+ DFGLA
Sbjct: 178 LHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 45/160 (28%), Positives = 72/160 (45%), Gaps = 26/160 (16%)
Query: 190 HVNVVTLLGFCLEGNNRA------LIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEI 242
H NV+ LL L+ FM L K + + Q+L +Y++
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFL----VYQM 137
Query: 243 VIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLG 302
+ KGL Y+H + I+H D+KP N+ +++D KI DFGLA + S + G
Sbjct: 138 L----KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMTG 184
Query: 303 ARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
T Y A EV N+ + D++S G ++ E++ K
Sbjct: 185 YVVTRWYRAPEVIL-NWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
+ + YL I+H DIK NI++ +DF K+ DFG A ++G G
Sbjct: 139 LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAY--LERG--KLFYTFCG 191
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFG 332
TI Y A EV N + +++S G
Sbjct: 192 TIEYCAPEVLMGN-PYRGPELEMWSLG 217
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-10
Identities = 31/137 (22%), Positives = 61/137 (44%), Gaps = 15/137 (10%)
Query: 208 LIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDI 266
++ E+M L + G + + MY+++ +GL+Y+H S +LH D+
Sbjct: 99 IVQEYMET-DLANVLEQGPLLEEHARLF----MYQLL----RGLKYIH---SANVLHRDL 146
Query: 267 KPHNILLDQDFCP-KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHK 325
KP N+ ++ + KI DFGLA++ L T Y + + + +
Sbjct: 147 KPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLL-SPNNYTKA 205
Query: 326 SDVYSFGMMIMELVGCK 342
D+++ G + E++ K
Sbjct: 206 IDMWAAGCIFAEMLTGK 222
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 51/200 (25%), Positives = 75/200 (37%), Gaps = 50/200 (25%)
Query: 165 LGQGGFGGVY-----------------KGKLLDGLASISR-------TSHVNVVTLLGFC 200
+G G FG +G +D ++ R H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE--NVQREIINHRSLRHPNIVRFKEVI 85
Query: 201 LEGNNRALIYEFMPNGSL-EKFVYNGDTSKP--CQYLRWEKMYEIVIGIAKGLEYLHRGC 257
L + A+I E+ G L E+ G S+ + + +++ G+ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ-----QLLSGV----SYCH--- 133
Query: 258 STRILHFDIKPHNILLDQDFCP--KISDFGLAKLCTTKKGIVSSLLGAR-GTIGYIALEV 314
S +I H D+K N LLD P KI DFG +K S + GT YIA EV
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----HSQPKSTVGTPAYIAPEV 188
Query: 315 FSRNFGEVSHKSDVYSFGMM 334
R +DV+S G+
Sbjct: 189 LLRQ-EYDGKIADVWSCGVT 207
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 29/114 (25%), Positives = 47/114 (41%), Gaps = 17/114 (14%)
Query: 236 WEKMY--EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293
+ Y EIV+ ++ +H +H DIKP NILLD+ +++DFG
Sbjct: 163 MARFYLAEIVMA----IDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215
Query: 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKS-----DVYSFGMMIME-LVGC 341
+ S + GT Y++ E+ G S D ++ G+ E G
Sbjct: 216 GTVRSLVAV--GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 39/135 (28%), Positives = 69/135 (51%), Gaps = 19/135 (14%)
Query: 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIK 267
L+ FM L+K + + + QYL +Y+++ KGL+Y+H S ++H D+K
Sbjct: 106 LVMPFMQT-DLQKIMGLKFSEEKIQYL----VYQML----KGLKYIH---SAGVVHRDLK 153
Query: 268 PHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSD 327
P N+ +++D KI DFGLA + + + G T Y A EV ++ + D
Sbjct: 154 PGNLAVNEDCELKILDFGLA------RHADAEMTGYVVTRWYRAPEVIL-SWMHYNQTVD 206
Query: 328 VYSFGMMIMELVGCK 342
++S G ++ E++ K
Sbjct: 207 IWSVGCIMAEMLTGK 221
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 24/105 (22%), Positives = 45/105 (42%), Gaps = 19/105 (18%)
Query: 190 HVNVVTLLGFCLEGNNRA-----LIYEFMPNGSLEKFVYNGD--TSKPCQYLRWEKMYEI 242
++ L + + ++ E + L+K T + + + +Y +
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTI----LYNL 138
Query: 243 VIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287
+ G ++H + I+H D+KP N LL+QD K+ DFGLA
Sbjct: 139 L----LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 34/152 (22%), Positives = 54/152 (35%), Gaps = 39/152 (25%)
Query: 154 VKKITNSFKDKLGQGGFGGVYKGKLLDGLASISRT----------SHVNVVTLLGFCLEG 203
+K++ N+ D + K R H N++ L +
Sbjct: 51 IKRVFNTVSDGRTVNILSDSFLCK---------RVLREIRLLNHFHHPNILGLRDIFVHF 101
Query: 204 NNRA-----LIYEFMPNGSLEKFVYNGD---TSKPCQYLRWEKMYEIVIGIAKGLEYLHR 255
A L+ E M L + +++ + + QY MY I+ GL LH
Sbjct: 102 EEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF----MYHIL----LGLHVLH- 151
Query: 256 GCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287
++H D+ P NILL + I DF LA
Sbjct: 152 --EAGVVHRDLHPGNILLADNNDITICDFNLA 181
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 44/160 (27%), Positives = 71/160 (44%), Gaps = 26/160 (16%)
Query: 190 HVNVVTLLGFCLEGNNRA------LIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEI 242
H NV+ LL + L+ M L V T Q+L +Y+I
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFL----IYQI 141
Query: 243 VIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLG 302
+ +GL+Y+H S I+H D+KP N+ +++D KI DFGLA + + G
Sbjct: 142 L----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA------RHTADEMTG 188
Query: 303 ARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
T Y A E+ N+ + D++S G ++ EL+ +
Sbjct: 189 YVATRWYRAPEIML-NWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 32/101 (31%), Positives = 53/101 (52%), Gaps = 15/101 (14%)
Query: 190 HVNVVTLLGFCLEGNNRA--LIYEFMPNGSLEKFVYNGD-TSKPCQYLRWEKMYEIVIGI 246
H N+V LL N+R L++++M L + QY+ +Y+++
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYV----VYQLI--- 119
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287
K ++YLH S +LH D+KP NILL+ + K++DFGL+
Sbjct: 120 -KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLS 156
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 3e-09
Identities = 40/199 (20%), Positives = 74/199 (37%), Gaps = 42/199 (21%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP-KISDFGLAKLCTTKKGIVSSLLGAR 304
+ +++ H S ++H DIK NIL+D K+ DFG L
Sbjct: 148 VVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEP---YTDFD 199
Query: 305 GTIGYIALEVFSRN--FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD--NSSEVYFPHW 360
GT Y E SR+ + V+S G+++ ++V C + +E++FP
Sbjct: 200 GTRVYSPPEWISRHQYHAL---PATVWSLGILLYDMV-CGDIPFERDQEILEAELHFPAH 255
Query: 361 IYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGSTE 418
+ + +I C+ +P RP + E++ +Q E
Sbjct: 256 V--------------------SPDCCALI---RRCLAPKPSSRPSLEEILLDPWMQTPAE 292
Query: 419 ALQIPPTPFLSSPPRASID 437
+ + P+ +P S+
Sbjct: 293 DVPLNPSKGGPAPLAWSLL 311
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 39/159 (24%), Positives = 67/159 (42%), Gaps = 24/159 (15%)
Query: 190 HVNVVTLLGFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV 243
H N++ LL + ++ E M +L + + + YL +Y+++
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYL----LYQML 137
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA 303
G+++LH S I+H D+KP NI++ D KI DFGLA+ T +
Sbjct: 138 ----CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPY 186
Query: 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
T Y A EV D++S G ++ E++
Sbjct: 187 VVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGG 223
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 29/89 (32%), Positives = 41/89 (46%), Gaps = 12/89 (13%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I ++Y H+ I+H D+K N+LLD D KI+DFG + T L G
Sbjct: 123 IVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG----KLDAFCG 175
Query: 306 TIGYIALEVFSRNFGEVSH--KSDVYSFG 332
Y A E+F G+ + DV+S G
Sbjct: 176 APPYAAPELFQ---GKKYDGPEVDVWSLG 201
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 5e-09
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 13/98 (13%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
+A L++LH S I++ D+KP NILLD++ K++DFGL+K + S G
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC---G 188
Query: 306 TIGYIALEVFSRNFGEVSHKSDV--YSFGMMIME-LVG 340
T+ Y+A EV +R H +SFG+++ E L G
Sbjct: 189 TVEYMAPEVVNRR----GHTQSADWWSFGVLMFEMLTG 222
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 38/179 (21%), Positives = 63/179 (35%), Gaps = 50/179 (27%)
Query: 143 PLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKG-----------KLLDGLASISR---- 187
L +K+ D K+ LG G G V + K+L R
Sbjct: 7 GLQIKKNAIIDDYKV---TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL 63
Query: 188 ----TSHVNVVTLLGFC----LEGNNRALIYEFMPNGSL-EKFVYNGDTSKPCQYLRWEK 238
+ ++V ++ ++ E + G L + GD +
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-----------Q 112
Query: 239 MY------EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAK 288
+ EI+ I + ++YLH S I H D+KP N+L + K++DFG AK
Sbjct: 113 AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 7e-09
Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 13/98 (13%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I+ L +LH I++ D+KP NI+L+ K++DFGL K + + G
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---G 183
Query: 306 TIGYIALEVFSRNFGEVSHKSDV--YSFGMMIME-LVG 340
TI Y+A E+ R+ H V +S G ++ + L G
Sbjct: 184 TIEYMAPEILMRS----GHNRAVDWWSLGALMYDMLTG 217
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 28/122 (22%), Positives = 55/122 (45%), Gaps = 25/122 (20%)
Query: 231 CQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290
QY +Y+ + + ++ LH + ++H D+KP N+L++ + K+ DFGLA++
Sbjct: 114 IQYF----IYQTL----RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 291 TTKKGIVSSLLGARGTI-GYIALEVFSR---------NFGEVSHKSDVYSFGMMIMELVG 340
S G + + ++A +R + S DV+S G ++ EL
Sbjct: 163 DESAADNSEPTGQQSGMVEFVA----TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL 218
Query: 341 CK 342
+
Sbjct: 219 RR 220
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 29/96 (30%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I L+YLH + +++ D+K N++LD+D KI+DFGL K + + G
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC---G 311
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIME-LVG 340
T Y+A EV N + D + G+++ E + G
Sbjct: 312 TPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCG 345
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 26/160 (16%)
Query: 190 HVNVVTLLGFCLEGNNRA------LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV 243
H N+++LL L+ E M +L + + + YL +Y+++
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYL----LYQML 174
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA 303
G+++LH S I+H D+KP NI++ D KI DFGLA+ T +
Sbjct: 175 ----CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS----FMMTPY 223
Query: 304 RGTIGYIALEV-FSRNFGEVSHKSDVYSFGMMIMELVGCK 342
T Y A EV + D++S G ++ E+V K
Sbjct: 224 VVTRYYRAPEVILGMGY---KENVDIWSVGCIMGEMVRHK 260
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 13/98 (13%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I LEYLH S +++ DIK N++LD+D KI+DFGL K + + + G
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---G 167
Query: 306 TIGYIALEVFSRNFGEVSHKSDV--YSFGMMIME-LVG 340
T Y+A EV N + V + G+++ E + G
Sbjct: 168 TPEYLAPEVLEDN----DYGRAVDWWGLGVVMYEMMCG 201
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-08
Identities = 33/98 (33%), Positives = 45/98 (45%), Gaps = 13/98 (13%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
IA L YLH S I++ D+KP NILLD ++DFGL K S+ G
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC---G 201
Query: 306 TIGYIALEVFSRNFGEVSHKSDV--YSFGMMIME-LVG 340
T Y+A EV + + V + G ++ E L G
Sbjct: 202 TPEYLAPEVLHKQ----PYDRTVDWWCLGAVLYEMLYG 235
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 24/90 (26%), Positives = 36/90 (40%), Gaps = 14/90 (15%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP-KISDFGLAKLCTTKKGIVSSLLGAR 304
+ + + + H +LH DIK NIL+D + K+ DFG L K +
Sbjct: 158 VLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTV---YTDFD 209
Query: 305 GTIGYIALEVFSRN--FGEVSHKSDVYSFG 332
GT Y E + G + V+S G
Sbjct: 210 GTRVYSPPEWIRYHRYHG---RSAAVWSLG 236
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 7/94 (7%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV-SSLLGAR 304
I LE+LH I++ DIK NILLD + ++DFGL+K +
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC--- 221
Query: 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMEL 338
GTI Y+A ++ D +S G+++ EL
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 35/97 (36%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQD-FCPKISDFGLAKLCTTKKGIVSSLLGAR 304
I GL++LH S I++ D+K NILLD+D KI+DFG+ K ++
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFC--- 179
Query: 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIME-LVG 340
GT YIA E+ + +H D +SFG+++ E L+G
Sbjct: 180 GTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIG 214
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 27/98 (27%), Positives = 46/98 (46%), Gaps = 13/98 (13%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I L +LH I++ D+K N+LLD + K++DFG+ K ++ G
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---G 186
Query: 306 TIGYIALEVFSRNFGEVSH-KS-DVYSFGMMIME-LVG 340
T YIA E+ + + D ++ G+++ E L G
Sbjct: 187 TPDYIAPEILQEM----LYGPAVDWWAMGVLLYEMLCG 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 5e-08
Identities = 32/98 (32%), Positives = 50/98 (51%), Gaps = 13/98 (13%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
IA GL +L S I++ D+K N++LD + KI+DFG+ K + G
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---G 183
Query: 306 TIGYIALEVFSRNFGEVSH-KS-DVYSFGMMIME-LVG 340
T YIA E+ + + KS D ++FG+++ E L G
Sbjct: 184 TPDYIAPEIIAYQ----PYGKSVDWWAFGVLLYEMLAG 217
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 15/96 (15%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I EYLH S +++ D+KP N+L+DQ +++DFG AK + +L G
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TWTL---CG 200
Query: 306 TIGYIALEVFSRNFGEVSH-KS-DVYSFGMMIMELV 339
T +A E+ + K+ D ++ G++I E+
Sbjct: 201 TPEALAPEIILSK----GYNKAVDWWALGVLIYEMA 232
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-08
Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I+ L YLH I++ D+K N+LLD + K++D+G+ K S+ G
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---G 172
Query: 306 TIGYIALEVFSRNFGEVSH-KS-DVYSFGMMIME-LVG 340
T YIA E+ + S D ++ G+++ E + G
Sbjct: 173 TPNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAG 206
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 7e-08
Identities = 41/98 (41%), Positives = 53/98 (54%), Gaps = 16/98 (16%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
+ LEYLH S I++ D+KP NILLD++ KI+DFG AK +L G
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTL---CG 165
Query: 306 TIGYIALEVFSRNFGEVSH-KS-DVYSFGMMIME-LVG 340
T YIA EV S + KS D +SFG++I E L G
Sbjct: 166 TPDYIAPEVVSTK----PYNKSIDWWSFGILIYEMLAG 199
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 13/98 (13%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I+ L YLH I++ D+K N+LLD + K++D+G+ K S+ G
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---G 215
Query: 306 TIGYIALEVFSRNFGEVSH-KS-DVYSFGMMIME-LVG 340
T YIA E+ + S D ++ G+++ E + G
Sbjct: 216 TPNYIAPEILRGE----DYGFSVDWWALGVLMFEMMAG 249
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 27/87 (31%), Positives = 44/87 (50%), Gaps = 8/87 (9%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I ++Y H ++H D+KP N+LLD KI+DFGL+ + + + + +S G
Sbjct: 120 ILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC----G 172
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFG 332
+ Y A EV S + D++S G
Sbjct: 173 SPNYAAPEVISGR-LYAGPEVDIWSCG 198
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 30/96 (31%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
IA GL +L S I++ D+K N++LD + KI+DFG+ K + G
Sbjct: 451 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---G 504
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIME-LVG 340
T YIA E+ + D ++FG+++ E L G
Sbjct: 505 TPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAG 538
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 8/87 (9%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARG 305
I +EY HR +I+H D+KP N+LLD + KI+DFGL+ + T + +S G
Sbjct: 117 IICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC----G 169
Query: 306 TIGYIALEVFSRNFGEVSHKSDVYSFG 332
+ Y A EV + + DV+S G
Sbjct: 170 SPNYAAPEVINGK-LYAGPEVDVWSCG 195
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 45/227 (19%), Positives = 75/227 (33%), Gaps = 69/227 (30%)
Query: 164 KLGQGGFGGVYKG-------------------------------KLLDGLASISRTSHVN 192
K+G GGFG +Y + + I +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 193 VVTLLGF----------CLEGNNRALIYEFMPNG-SLEK-FVYNGDTSKPCQYLRWEKMY 240
+ LG + R ++ E + G L+K NG K +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKST-------VL 154
Query: 241 EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKI--SDFGLAKL-CTTKKGIV 297
++ I + LEY+H +H DIK N+LL ++ +D+GL+ C
Sbjct: 155 QLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 298 ---SSLLGARGTIGYIALEVFSRN--FG-EVSHKSDVYSFGMMIMEL 338
+ G GTI + S + G +S +SDV G ++
Sbjct: 212 YQENPRKGHNGTIEFT-----SLDAHKGVALSRRSDVEILGYCMLRW 253
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 50/222 (22%), Positives = 82/222 (36%), Gaps = 62/222 (27%)
Query: 163 DKLGQGGFGGVYKG----------------------------KLLDGLASISRTSHV--- 191
KLG G F V+ KLL + T
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 192 --NVVTLLG-FCLEGNNRA---LIYEFMPNGSLEKFV-YNGDTSKPCQYLRWEKMYEIVI 244
+++ LL F +G N +++E + +L + P Y++ +I
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK-----QISK 138
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP------KISDFGLAKLCTTKKGIVS 298
+ GL+Y+HR C I+H DIKP N+L++ P KI+D G A +
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYT 193
Query: 299 SLLGARGTIGYIALEVFSRNFG-EVSHKSDVYSFGMMIMELV 339
+ + R Y + EV G +D++S +I EL+
Sbjct: 194 NSIQTR---EYRSPEVL---LGAPWGCGADIWSTACLIFELI 229
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 30/88 (34%), Positives = 43/88 (48%), Gaps = 10/88 (11%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR- 304
I G++Y HR ++H D+KP N+LLD KI+DFGL+ + G L
Sbjct: 125 ILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDG---EFLRTSC 176
Query: 305 GTIGYIALEVFSRNFGEVSHKSDVYSFG 332
G+ Y A EV S + D++S G
Sbjct: 177 GSPNYAAPEVISGR-LYAGPEVDIWSSG 203
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 34/231 (14%), Positives = 66/231 (28%), Gaps = 74/231 (32%)
Query: 164 KLGQGGFGGVYKGKLLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY 223
+ G +Y+ L S L+ + L E +
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSL----KLDAKDGRLFNEQN--------FF 96
Query: 224 NGDTSKPCQYLRWEKMYEI-VIGIAK-------------------G--LEYLHRGCSTR- 260
+KP Q +W+K+Y ++ I G L+
Sbjct: 97 Q-RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHV 155
Query: 261 ------------------------ILHFDIKPHNILLDQDFCPKI--SDFGLAKL-CTTK 293
+H ++ NI +D + ++ + +G A C +
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 294 KGIV---SSLLGARGTIGYIALEVFSRN--FG-EVSHKSDVYSFGMMIMEL 338
K + S G + +I S + G S +SD+ S G +++
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI-----SMDLHKGCGPSRRSDLQSLGYCMLKW 261
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 44.5 bits (104), Expect = 4e-05
Identities = 25/194 (12%), Positives = 43/194 (22%), Gaps = 79/194 (40%)
Query: 164 KLGQGGFGGVYKG--------------------------------------KLLDGLASI 185
K+G+G FG V++ K L L+
Sbjct: 27 KIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 186 SRTSHVNVVTLLGFCL------------------------------EGNNRALIYEFMPN 215
+ L + + ++ EF
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 216 G-SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD 274
G LE+ + I+ + L R H D+ N+LL
Sbjct: 147 GIDLEQMRTKLSS--------LATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVLLK 196
Query: 275 QDFCPKISDFGLAK 288
+ K+ K
Sbjct: 197 KTSLKKLHYTLNGK 210
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 1e-04
Identities = 23/101 (22%), Positives = 38/101 (37%), Gaps = 23/101 (22%)
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKI--SDFGLAKLCTTKKGIV-------SSL 300
LEY+H +H DIK N+LL+ ++ D+GLA +
Sbjct: 165 LEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCH 221
Query: 301 LGARGTIGYIALEVFSRN--FG-EVSHKSDVYSFGMMIMEL 338
GTI + S + G S + D+ G +++
Sbjct: 222 ---DGTIEFT-----SIDAHNGVAPSRRGDLEILGYCMIQW 254
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 15/96 (15%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP--KISDFGLAKLCTTKKGIVSSLLGA 303
I + L+ LH RI+H D+KP NILL Q K+ DFG + C + V + + +
Sbjct: 209 ILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQ-RVYTYIQS 262
Query: 304 RGTIGYIALEVFSRNFG-EVSHKSDVYSFGMMIMEL 338
R Y A EV G D++S G ++ EL
Sbjct: 263 R---FYRAPEVI---LGARYGMPIDMWSLGCILAEL 292
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 2e-04
Identities = 70/394 (17%), Positives = 121/394 (30%), Gaps = 109/394 (27%)
Query: 92 SEAFRVLDI-----DDGHQTMIITPARLD---LLSSYCPSVQWPQAIINHTLFS-----L 138
S R+ ++ Q + R++ L+S + Q + ++ L
Sbjct: 62 SGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPI--KTEQRQPSMMTRMYIEQRDRL 119
Query: 139 QNYGPLPLKRYNFSDVKKITNSFKDKL------------GQGGFGGVYKGKL-LDGLASI 185
N +YN S ++ + L G G G K + LD S
Sbjct: 120 YNDNQ-VFAKYNVSRLQPYLK-LRQALLELRPAKNVLIDGVLGSG---KTWVALDVCLSY 174
Query: 186 SRTSHVNV----VTLLGFC------LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLR 235
++ + L C LE + L+Y+ PN + D S
Sbjct: 175 KVQCKMDFKIFWLN-LKNCNSPETVLEMLQK-LLYQIDPN-----WTSRSDHSSN----- 222
Query: 236 WEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHN---ILLDQDFC-PKISD-FGL-AK- 288
++ I + L R KP+ ++L + K + F L K
Sbjct: 223 ----IKLRIHSIQ--AELRR-------LLKSKPYENCLLVLL-NVQNAKAWNAFNLSCKI 268
Query: 289 LCTTK-KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSF-GMMIMEL--VGCKNN 344
L TT+ K + L A T +I+L+ S KS + + +L N
Sbjct: 269 LLTTRFKQVTDFLSAATTT--HISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTN 326
Query: 345 --LDSGVDNSSEVYFPHWI-YRHVEQD------------------RE-FKLLGVVTKKEN 382
S + S W ++HV D R+ F L V +
Sbjct: 327 PRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAH 386
Query: 383 EIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416
I ++ + +W D M V ++ + S
Sbjct: 387 -IPTILLSL-IWF-DVIKSD--VMVVVNKLHKYS 415
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 19/106 (17%)
Query: 177 KLLDGLASISRTSHVN---VVTLLG-FCLEGNN---RALIYEFMPNG-SLEKFV-YNGDT 227
+LL + + S + N VV LL F + G N +++E + G L K++ +
Sbjct: 85 RLLKSVRN-SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQ 141
Query: 228 SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL 273
P ++ I+ + +GL+YLH C RI+H DIKP NILL
Sbjct: 142 GLPLPCVKK-----IIQQVLQGLDYLHTKC--RIIHTDIKPENILL 180
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 25/96 (26%), Positives = 40/96 (41%), Gaps = 13/96 (13%)
Query: 246 IAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP--KISDFGLAKLCTTKKGIVSSLLGA 303
+ L +L I+H D+KP NILL KI DFG + + + +
Sbjct: 166 MCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS---CQLGQRIYQYIQS 221
Query: 304 RGTIGYIALEVFSRNFG-EVSHKSDVYSFGMMIMEL 338
R Y + EV G D++S G +++E+
Sbjct: 222 R---FYRSPEVL---LGMPYDLAIDMWSLGCILVEM 251
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 31/158 (19%), Positives = 54/158 (34%), Gaps = 48/158 (30%)
Query: 164 KLGQGGFGGVYKGK--------------------LLDGLASI--SRTSHVNVVTLLGFCL 201
++G+G FG +++G L + + F
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ 76
Query: 202 EGNNRALIYEFMPNG-SLEKFVYNGDTSKPCQYLRWEKM-YEIVIGIAK----GLEYLHR 255
EG + L+ + + G SLE D C K + V AK ++ +H
Sbjct: 77 EGLHNVLVIDLL--GPSLE------DLLDLCG----RKFSVKTVAMAAKQMLARVQSIH- 123
Query: 256 GCSTRILHFDIKPHNILLDQDFCPK-----ISDFGLAK 288
+++ DIKP N L+ + + DFG+ K
Sbjct: 124 --EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 450 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.56 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.38 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.86 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.62 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.61 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.46 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.02 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.64 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.42 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.08 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 96.85 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.66 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.5 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 95.7 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 94.81 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 94.03 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 93.43 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 91.87 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 88.8 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 87.39 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 86.98 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 86.72 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 85.17 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.99 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.38 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 83.37 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 83.11 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-52 Score=402.50 Aligned_cols=241 Identities=27% Similarity=0.430 Sum_probs=187.5
Q ss_pred HhhhccccccceEEEEEEE----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 160 SFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
.+.++||+|+||+||+|++ .+|+.++++++|||||+++|+|.+ +..++|||||++|+
T Consensus 39 ~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs 117 (307)
T 3omv_A 39 MLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS 117 (307)
T ss_dssp CEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred EEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence 3678999999999999963 357889999999999999998865 56899999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++..... .++|..+..++.|+|.||+|||+ .+||||||||+||||++++.+||+|||+|+........
T Consensus 118 L~~~l~~~~~-----~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~- 188 (307)
T 3omv_A 118 LYKHLHVQET-----KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS- 188 (307)
T ss_dssp HHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred HHHHHhhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcc-
Confidence 9999976542 29999999999999999999995 89999999999999999999999999999876433221
Q ss_pred ccccCCCCccccccccccccc-cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 298 SSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
......+||+.|||||++.+. .+.++.++|||||||++|||++|+.||...... ..+...+..... ...
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~-------~~~~~~~~~~~~---~p~ 258 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR-------DQIIFMVGRGYA---SPD 258 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHTTCC---CCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCC---CCC
Confidence 123456799999999999653 246899999999999999999999999643211 111111111110 011
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
.......++.++.+++.+||+.||++||||+||++.|+.+..++
T Consensus 259 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 259 LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 11223345678999999999999999999999999998876654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=402.83 Aligned_cols=239 Identities=23% Similarity=0.344 Sum_probs=194.2
Q ss_pred HhhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
.+..|.++||+|+||+||+|++ .+|+.++++++|||||+++|+|.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 3445788999999999999863 23578899999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC
Q 013074 208 LIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF 277 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 277 (450)
+|||||++|+|.++|...... .....++|..++.++.|||+||+|||+ .+||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence 999999999999999754321 112358999999999999999999995 8999999999999999999
Q ss_pred CeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccc
Q 013074 278 CPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVY 356 (450)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~ 356 (450)
.+||+|||+++......... ......||+.|||||++.+. .++.++|||||||++|||+| |+.||.....
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~-~~~~~~gt~~ymAPE~l~~~--~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------ 253 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYK-LLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------ 253 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBC-SSSSSCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------
T ss_pred CEEECCcccceeccCCCcee-EecccccCCcccCHHHHhCC--CCCccchhhhHHHHHHHHHhCCCCCCCCCCH------
Confidence 99999999998765433222 23456799999999999874 89999999999999999998 7888864321
Q ss_pred hhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 357 FPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 357 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
..+...+... .....+..++.++.+++.+||+.||++||||+||++.|+..
T Consensus 254 --~~~~~~i~~~-------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 254 --QDVVEMIRNR-------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp --HHHHHHHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred --HHHHHHHHcC-------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1122222211 12223345677899999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=402.42 Aligned_cols=240 Identities=23% Similarity=0.382 Sum_probs=193.0
Q ss_pred hHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
+.+.++||+|+||+||+|++ .+|++++++++|||||+++|+|.+++..++||
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~ 94 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 94 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 34678999999999999953 24688999999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCC-------CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 211 EFMPNGSLEKFVYNGDT-------SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~-------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
|||++|+|.+++...+. ......++|..++.++.|+++||+|||+ .+|+||||||+|||+++++.+||+|
T Consensus 95 Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~D 171 (299)
T 4asz_A 95 EYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGD 171 (299)
T ss_dssp ECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred EcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECC
Confidence 99999999999976431 1223459999999999999999999995 8999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~ 362 (450)
||+++.......... .....||+.|||||++.+. .++.++|||||||++|||+| |+.||..... ..+.
T Consensus 172 FGla~~~~~~~~~~~-~~~~~gt~~ymAPE~~~~~--~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~~ 240 (299)
T 4asz_A 172 FGMSRDVYSTDYYRV-GGHTMLPIRWMPPESIMYR--KFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVI 240 (299)
T ss_dssp CSCHHHHTGGGCEEE-TTTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHH
T ss_pred cccceecCCCCceee-cCceecChhhcCHHHHcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence 999987654432221 2334589999999999874 89999999999999999998 8999864321 1122
Q ss_pred hhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
..+..+ .....+..++.++.+++.+||+.||++|||++||++.|+.+.++
T Consensus 241 ~~i~~~-------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 241 ECITQG-------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcC-------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 222221 12223345667899999999999999999999999999987654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=399.74 Aligned_cols=239 Identities=22% Similarity=0.350 Sum_probs=186.7
Q ss_pred HhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
.+.++||+|+||+||+|++ .+|++++++++|||||+++|+|.+++..++|||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4678999999999999853 246889999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCC---------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEe
Q 013074 212 FMPNGSLEKFVYNGDTS---------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKIS 282 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~---------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 282 (450)
||++|+|.+++...... .....++|..++.++.|+++||+|||+ .+|+||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEc
Confidence 99999999999764321 112359999999999999999999995 899999999999999999999999
Q ss_pred eccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhh
Q 013074 283 DFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWI 361 (450)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i 361 (450)
|||+++.......... .....||+.|||||++.+. .++.++|||||||++|||+| |+.||..... ..+
T Consensus 201 DFGla~~~~~~~~~~~-~~~~~gt~~ymAPE~~~~~--~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--------~~~ 269 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRV-GGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--------TEA 269 (329)
T ss_dssp CCC-----------------CCCCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--------HHH
T ss_pred ccccceeccCCCccee-cCcccccccccChhhhcCC--CCCccccccchHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence 9999987654332221 2345699999999999874 89999999999999999998 8999864321 112
Q ss_pred hhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 362 YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
...+..+. ....+..++.++.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 270 ~~~i~~g~-------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 270 IDCITQGR-------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHTC-------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHcCC-------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 22222211 1222344567899999999999999999999999999987754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=391.37 Aligned_cols=237 Identities=22% Similarity=0.246 Sum_probs=189.2
Q ss_pred HhhhccccccceEEEEEEE------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhhh
Q 013074 160 SFKDKLGQGGFGGVYKGKL------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF 221 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 221 (450)
.+.++||+|+||+||+|+. .+|+.++++++|||||++++++.+++.+|+|||||++|+|.++
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~ 140 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 140 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHH
T ss_pred EeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHH
Confidence 4467899999999999963 3578999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-CeEEeeccccccccCCCCcc--c
Q 013074 222 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-CPKISDFGLAKLCTTKKGIV--S 298 (450)
Q Consensus 222 l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~~~~~--~ 298 (450)
+...+. +++..+..++.|++.||+||| +.+|+||||||+||||+.++ .+||+|||+|+......... .
T Consensus 141 l~~~~~------l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 141 IKQMGC------LPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp HHHHSS------CCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred HHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 976542 999999999999999999999 59999999999999999987 69999999998765432211 1
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....+||+.|||||++.+. .++.++|||||||++|||++|+.||....... +...+..... ...
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~-----~~~ 276 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGK--PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP--------LCLKIASEPP-----PIR 276 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC--------CHHHHHHSCC-----GGG
T ss_pred cCCccccCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--------HHHHHHcCCC-----Cch
Confidence 12345799999999999875 78999999999999999999999997543221 1111111100 011
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
..+..++..+.+++.+||+.||++|||++|+++.|.......
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 122345678899999999999999999999999887765543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=377.29 Aligned_cols=221 Identities=24% Similarity=0.375 Sum_probs=177.5
Q ss_pred hhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe----CCceEEEEE
Q 013074 161 FKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE----GNNRALIYE 211 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E 211 (450)
|.++||+|+||+||+|+. .+|++++++++|||||++++++.+ +..+++|||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmE 109 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109 (290)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEe
Confidence 456899999999999952 357889999999999999999875 346899999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc--eEeeeeccccEEEc-CCCCeEEeeccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR--ILHFDIKPHNILLD-QDFCPKISDFGLAK 288 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dikp~NIll~-~~~~~kl~DFGla~ 288 (450)
||++|+|.+++...+. +++..+..++.||+.||+|||+ .+ |+||||||+||||+ +++.+||+|||+|+
T Consensus 110 y~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 110 LMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 9999999999976432 8999999999999999999994 66 99999999999998 47999999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
...... ....+||+.|||||++.+ .++.++|||||||++|||++|+.||...... ..+...+...
T Consensus 181 ~~~~~~-----~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~~~~-------~~~~~~i~~~ 245 (290)
T 3fpq_A 181 LKRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTSG 245 (290)
T ss_dssp GCCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTTT
T ss_pred eCCCCc-----cCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH-------HHHHHHHHcC
Confidence 654322 235679999999999864 6899999999999999999999999643211 1122222211
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
... .......+.++.+++.+||+.||++|||++|+++
T Consensus 246 ~~~------~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 246 VKP------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCC------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 110 1111223456889999999999999999999986
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-49 Score=384.26 Aligned_cols=226 Identities=22% Similarity=0.300 Sum_probs=186.3
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
|++.++||+|+||+||+|+. .+|++++++++|||||++++++.+++.+|+|||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 155 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence 44567899999999999952 3578999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++.... +++..+..++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++.......
T Consensus 156 g~L~~~l~~~~-------l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 225 (346)
T 4fih_A 156 GALTDIVTHTR-------MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 225 (346)
T ss_dssp EEHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC
T ss_pred CcHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC
Confidence 99999997532 8999999999999999999995 9999999999999999999999999999987754332
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. ....+||+.|||||++.+. .++.++|||||||++|||++|+.||..... . .+...+.... .
T Consensus 226 ~---~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~----~~~~~i~~~~-----~ 287 (346)
T 4fih_A 226 R---RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----L----KAMKMIRDNL-----P 287 (346)
T ss_dssp C---BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----H----HHHHHHHHSS-----C
T ss_pred c---ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----H----HHHHHHHcCC-----C
Confidence 2 3456799999999999874 789999999999999999999999964321 0 0111111110 0
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........++.++.+++.+||+.||++|||++|+++.
T Consensus 288 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 288 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1112223456789999999999999999999999874
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=388.77 Aligned_cols=226 Identities=22% Similarity=0.346 Sum_probs=180.2
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.++||+|+||+||+|+. .+|++++++++|||||++++++.+++.+|+|||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~ 105 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYC 105 (350)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 45678999999999999952 34788999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++|+|.+++...+. ..+++..++.++.||+.||+|||+ .+|+||||||+||||++++.+||+|||+|+.....
T Consensus 106 ~gg~L~~~i~~~~~----~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 106 EGGDLFKRINAQKG----VLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp TTCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCcHHHHHHHcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999976543 237899999999999999999995 99999999999999999999999999999876543
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
... ....+||+.|||||++.+. .++.++|||||||++|||++|+.||..... .. +...+...
T Consensus 179 ~~~---~~~~~GT~~YmAPE~l~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~-~~~~i~~~----- 240 (350)
T 4b9d_A 179 VEL---ARACIGTPYYLSPEICENK--PYNNKSDIWALGCVLYELCTLKHAFEAGSM-------KN-LVLKIISG----- 240 (350)
T ss_dssp HHH---HHHHHSCCTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HH-HHHHHHHT-----
T ss_pred ccc---ccccCCCccccCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HH-HHHHHHcC-----
Confidence 211 2345699999999999875 789999999999999999999999965321 11 11111111
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
........++.++.+++.+||+.||++|||++|+++
T Consensus 241 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 241 --SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111222345678999999999999999999999986
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=379.24 Aligned_cols=251 Identities=21% Similarity=0.242 Sum_probs=184.5
Q ss_pred HhhhccccccceEEEEEEEcc--------------------hhhhhhhcCCCceeeeeeEEEeCC----ceEEEEEecCC
Q 013074 160 SFKDKLGQGGFGGVYKGKLLD--------------------GLASISRTSHVNVVTLLGFCLEGN----NRALIYEFMPN 215 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~--------------------e~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~~ 215 (450)
.+.++||+|+||+||+|++.. |+..+.+++|||||+++|+|.+++ .+++|||||++
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~ 85 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCC
Confidence 456789999999999997532 244566789999999999998764 57999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC-----CCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC-----STRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
|+|.++++... ++|..+.+++.|+++||+|||..+ ..+|+||||||+||||+.++.+||+|||+++..
T Consensus 86 gsL~~~l~~~~-------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 86 GSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CcHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 99999997542 899999999999999999999521 238999999999999999999999999999876
Q ss_pred cCCCCcc-ccccCCCCcccccccccccccc----CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCcc-------chh
Q 013074 291 TTKKGIV-SSLLGARGTIGYIALEVFSRNF----GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEV-------YFP 358 (450)
Q Consensus 291 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~----~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~-------~~~ 358 (450)
....... ......+||+.|||||++.+.. +.++.++|||||||++|||+||+.|+.......... ...
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~ 238 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence 5443221 1223457999999999997531 136789999999999999999998875443221100 000
Q ss_pred hhhhhhhhhh-hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 359 HWIYRHVEQD-REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 359 ~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
..+.+.+... ...... ......+.++.+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 239 ~~~~~~~~~~~~rp~~p--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 239 EEMRKVVCEQKLRPNIP--NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCCCCCCC--GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHhcccCCCCCC--ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 0111111100 000000 0112235667899999999999999999999999999987643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=391.66 Aligned_cols=243 Identities=26% Similarity=0.387 Sum_probs=192.7
Q ss_pred HhhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCC-CceeeeeeEEEeC-Cc
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSH-VNVVTLLGFCLEG-NN 205 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~H-pnIv~l~~~~~~~-~~ 205 (450)
..+.+.++||+|+||+||+|++ .+|++++++++| ||||+++|+|.+. +.
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 3456778999999999999852 235778888876 8999999999764 56
Q ss_pred eEEEEEecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~ 275 (450)
+++|||||++|+|.++|...... .....+++..+..++.|||+||+|||+ .+||||||||+|||+++
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECG
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCC
Confidence 89999999999999999754311 112348999999999999999999995 99999999999999999
Q ss_pred CCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 013074 276 DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSE 354 (450)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~ 354 (450)
++.+||+|||+|+.......... ....+||+.|||||++.+. .++.++|||||||++|||+| |+.||......
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~-~~~~~gt~~ymAPE~l~~~--~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~--- 294 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--- 294 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEE-ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS---
T ss_pred CCCEEECcchhhhhcccCCCcee-eccccccccccCHHHHhcC--CCCCcccEeehHHHHHHHHhCCCCCCCCCCHH---
Confidence 99999999999987654433222 3445689999999999874 89999999999999999998 89998653211
Q ss_pred cchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 355 VYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 355 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
..+...+..+. ....+..++.++.+++.+||+.||++|||++||++.|+.+.++
T Consensus 295 ----~~~~~~i~~g~-------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 295 ----EEFCRRLKEGT-------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp ----HHHHHHHHHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCC-------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 11222222221 1222334567899999999999999999999999999887643
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=380.30 Aligned_cols=224 Identities=23% Similarity=0.304 Sum_probs=185.5
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|++.+.||+|+||+||+|+. .+|++++++++|||||++++++.+++.+|+||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 66788999999999999952 3468889999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++...+. +++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 114 ~~gG~L~~~i~~~~~------l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 114 AKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999976543 8999999999999999999995 9999999999999999999999999999997653
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... ......+||+.|||||++.+. .++.++||||+||++|||++|+.||..... ..+...+.... .
T Consensus 185 ~~~~-~~~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~--------~~~~~~i~~~~-~- 251 (311)
T 4aw0_A 185 ESKQ-ARANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------GLIFAKIIKLE-Y- 251 (311)
T ss_dssp TTTC-CCBCCCCSCGGGCCHHHHHHS--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC-C-
T ss_pred CCCc-ccccCcccCcccCCHHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCC-C-
Confidence 3221 123566899999999999875 789999999999999999999999964321 11112211111 0
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 410 (450)
..+..++.++.+++.+||+.||++|||++|++
T Consensus 252 ------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 ------DFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ------CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 11223557789999999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=385.72 Aligned_cols=226 Identities=22% Similarity=0.293 Sum_probs=186.0
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
|.+.++||+|+||+||+|+. .+|+.++++++|||||++++++.+++.+|+|||||++
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~g 232 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCC
Confidence 44567899999999999952 3578999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++.... +++..+..++.||+.||+|||+ .+|+||||||+||||+.+|.+||+|||+++.......
T Consensus 233 G~L~~~i~~~~-------l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 233 GALTDIVTHTR-------MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp EEHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CcHHHHHhccC-------CCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 99999996532 8999999999999999999995 9999999999999999999999999999987754332
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. ....+||+.|||||++.+. .++.++|||||||++|||++|+.||...... .+...+.... .
T Consensus 303 ~---~~~~~GTp~YmAPEvl~~~--~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--------~~~~~i~~~~-----~ 364 (423)
T 4fie_A 303 R---RKSLVGTPYWMAPELISRL--PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--------KAMKMIRDNL-----P 364 (423)
T ss_dssp C---BCCCEECTTTCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--------HHHHHHHHSC-----C
T ss_pred c---ccccccCcCcCCHHHHCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--------HHHHHHHcCC-----C
Confidence 2 3456799999999999875 7899999999999999999999999643210 0111111110 0
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........++.++.+++.+||+.||++|||++|+++.
T Consensus 365 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 365 PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0111223456788999999999999999999999874
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=367.98 Aligned_cols=224 Identities=21% Similarity=0.355 Sum_probs=172.3
Q ss_pred hhHhhhccccccceEEEEEE--------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGK--------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~--------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
.|.+.+.||+|+||+||+|+ +.+|++++++++|||||++++++.+++..|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 35567899999999999994 2346889999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+ +|+|.+++...+. +++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 94 y~-~g~L~~~l~~~~~------l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDK------MSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp CC-CEEHHHHHHHSCS------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred CC-CCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 99 7899999976543 9999999999999999999995 999999999999999999999999999998765
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.... ....+||+.|||||++.+. ...+.++||||+||++|||++|+.||..... .. +.+.+....
T Consensus 164 ~~~~----~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~~~-------~~-~~~~i~~~~-- 228 (275)
T 3hyh_A 164 DGNF----LKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDESI-------PV-LFKNISNGV-- 228 (275)
T ss_dssp ---------------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHTC--
T ss_pred CCCc----cCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHHcCC--
Confidence 4322 2346799999999999875 2346899999999999999999999964311 11 112211111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
...+..++.++.+++.+||+.||++|||++|+++.
T Consensus 229 ------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 ------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 11122356778999999999999999999999873
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=373.66 Aligned_cols=223 Identities=23% Similarity=0.275 Sum_probs=179.1
Q ss_pred hHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
|++.+.||+|+||+||+|+. ..|++++++++|||||++++++.+++..|+||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 56778999999999999842 34677899999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++|+|.+++...+. +++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+|+..
T Consensus 106 Ey~~gg~L~~~l~~~~~------l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEVM------FTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp CCCTTCEEHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EcCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999976543 8999999999999999999995 99999999999999999999999999999865
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
..... .....+||+.|||||++.+. .++.++|||||||++|||++|+.||..... .. +...+...
T Consensus 177 ~~~~~---~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~-~~~~i~~~-- 241 (304)
T 3ubd_A 177 IDHEK---KAYSFCGTVEYMAPEVVNRR--GHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------KE-TMTMILKA-- 241 (304)
T ss_dssp ----C---CCCSCCCCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHC--
T ss_pred cCCCc---cccccccCcccCCHHHhccC--CCCCCCcccchHHHHHHHHhCCCCCCCcCH-------HH-HHHHHHcC--
Confidence 44322 13456799999999999875 789999999999999999999999964321 01 11111111
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM-----NEVIE 411 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 411 (450)
....+..++.++.+++.+||+.||++|||+ +|+++
T Consensus 242 ------~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 242 ------KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ------CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 011123356788999999999999999984 67764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=361.64 Aligned_cols=228 Identities=23% Similarity=0.337 Sum_probs=168.4
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCC----------
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGN---------- 204 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~---------- 204 (450)
|++.+.||+|+||+||+|+. .+|++++++++|||||++++++.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~ 86 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSP 86 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCC
Confidence 45678999999999999952 34788999999999999999987654
Q ss_pred --ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEe
Q 013074 205 --NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKIS 282 (450)
Q Consensus 205 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 282 (450)
.+|+|||||++|+|.+++...... ....+..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+
T Consensus 87 ~~~l~ivmE~~~gg~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 87 KVYLYIQMQLCRKENLKDWMNGRCTI---EERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp CEEEEEEEECCCSCCHHHHHHTCCSG---GGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred CcEEEEEEecCCCCcHHHHHHhcCCC---ChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEc
Confidence 368999999999999999765432 235677789999999999999995 899999999999999999999999
Q ss_pred eccccccccCCCCcc---------ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCC
Q 013074 283 DFGLAKLCTTKKGIV---------SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSS 353 (450)
Q Consensus 283 DFGla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~ 353 (450)
|||+|+......... ......+||+.|||||++.+. .++.++|||||||++|||++ ||....
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~--~y~~~~DiwSlGvilyell~---Pf~~~~---- 231 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN--SYSHKVDIFSLGLILFELLY---PFSTQM---- 231 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHS---CCSSHH----
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCC--CCCCHHHHHHHHHHHHHHcc---CCCCcc----
Confidence 999998765432211 123445799999999999875 79999999999999999996 553210
Q ss_pred ccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 354 EVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 354 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+ ....+... .....+...........+++.+||+.||++|||+.|+++
T Consensus 232 -----~-~~~~~~~~----~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 232 -----E-RVRTLTDV----RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -----H-HHHHHHHH----HTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----H-HHHHHHHH----hcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00000000 011122233444556788999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=354.97 Aligned_cols=244 Identities=18% Similarity=0.238 Sum_probs=182.0
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe------CCceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE------GNNRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~------~~~~~ 207 (450)
|.+.+.||+|+||+||+|+. .+|+++|++++|||||++++++.. .+.+|
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ 135 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY 135 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEE
Confidence 55678999999999999952 247889999999999999998764 35789
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+|||||+ |+|.+++...+ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 136 ivmE~~~-g~L~~~i~~~~------~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 136 VVLDLME-SDLHQIIHSSQ------PLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEECCS-EEHHHHHTSSS------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEeCCC-CCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeeccee
Confidence 9999995 78999997543 39999999999999999999995 99999999999999999999999999999
Q ss_pred ccccCCCC-ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh
Q 013074 288 KLCTTKKG-IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE 366 (450)
Q Consensus 288 ~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~ 366 (450)
+....... ........+||+.|||||++.+. ..++.++||||+||++|||++|+.||....... ....+.....
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~----~l~~I~~~~g 280 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH----QLQLIMMVLG 280 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH----HHHHHHHHHC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCCHHH----HHHHHHHhcC
Confidence 87643321 12224567899999999998764 367999999999999999999999997542110 0000100000
Q ss_pred hh-----------hhh----hhccccc----chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccc
Q 013074 367 QD-----------REF----KLLGVVT----KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGST 417 (450)
Q Consensus 367 ~~-----------~~~----~~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 417 (450)
.. ... ....... ......+.++.+++.+||+.||++|||++|+++. +++..
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 00 000 0000000 0011235678899999999999999999999874 55443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=348.06 Aligned_cols=178 Identities=22% Similarity=0.350 Sum_probs=149.7
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhc-CCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.++||+|+||+||+|+. .+|+++++++ +||||+++++++.+.+..++||||+
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~ 102 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYL 102 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECC
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCC
Confidence 45678999999999999952 1356777777 6999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC-CCeEEeeccccccccC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD-FCPKISDFGLAKLCTT 292 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~~~ 292 (450)
++|+|.+++. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||+|+....
T Consensus 103 ~g~~L~~~~~---------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 103 EHESFLDILN---------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp CCCCHHHHHT---------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CcccHHHHHc---------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 9999999983 18899999999999999999995 999999999999999876 7999999999986543
Q ss_pred CCCc-------------------------cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCC
Q 013074 293 KKGI-------------------------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDS 347 (450)
Q Consensus 293 ~~~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~ 347 (450)
.... .......+||+.|+|||++.+. ..++.++||||+||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC-PNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 2211 0112345799999999999764 3589999999999999999999999976
Q ss_pred CC
Q 013074 348 GV 349 (450)
Q Consensus 348 ~~ 349 (450)
+.
T Consensus 250 ~~ 251 (361)
T 4f9c_A 250 AS 251 (361)
T ss_dssp CS
T ss_pred CC
Confidence 54
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=367.49 Aligned_cols=225 Identities=26% Similarity=0.306 Sum_probs=181.0
Q ss_pred hHhhhccccccceEEEEEEEcc-----------------------------hhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLD-----------------------------GLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~-----------------------------e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
|.+.+.||+|+||+||+|+... ++.+++.++|||||++++++.+.+.+|+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 4456889999999999996321 13455677999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||++||+|.+++...+. +++..+..++.||+.||+||| +.+||||||||+||||+.+|.+||+|||+|+.
T Consensus 271 mEy~~GGdL~~~l~~~~~------l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGV------FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp ECCCCSCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeee
Confidence 999999999999976543 899999999999999999999 59999999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
..... ....+||+.|||||++.+. ..++.++|+|||||++|||++|+.||........ ..+......
T Consensus 342 ~~~~~-----~~t~~GTp~YmAPEvl~~~-~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~-----~~i~~~i~~-- 408 (689)
T 3v5w_A 342 FSKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMTLT-- 408 (689)
T ss_dssp CSSCC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH-----HHHHHHHHH--
T ss_pred cCCCC-----CCCccCCcCccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHHhhcC--
Confidence 65433 3456799999999999642 3689999999999999999999999965322110 001111110
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIE 411 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 411 (450)
.....+..++.++.+++.+||+.||.+|++ ++||++
T Consensus 409 ------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 409 ------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 011122345678899999999999999998 677764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=363.75 Aligned_cols=229 Identities=24% Similarity=0.319 Sum_probs=185.8
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.|.+.+.||+|+||+||+|+. .+|+.+|++++|||||++++++.++..+++|||||+
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 456788999999999999952 346889999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC--CCeEEeeccccccccC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD--FCPKISDFGLAKLCTT 292 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DFGla~~~~~ 292 (450)
+|+|.+++.... ..+++..+..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+++....
T Consensus 238 gg~L~~~i~~~~-----~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 238 GGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCBHHHHHTCTT-----SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred CCcHHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999986443 238999999999999999999995 999999999999999854 8999999999998755
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... ....+||+.|||||++.+. .++.++|||||||++|||++|+.||...... . ....+....
T Consensus 310 ~~~----~~~~~GT~~y~APEv~~~~--~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~-------~-~~~~i~~~~--- 372 (573)
T 3uto_A 310 KQS----VKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGENDD-------E-TLRNVKSCD--- 372 (573)
T ss_dssp TSE----EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHHHTTC---
T ss_pred CCc----eeeeEECccccCHHHhCCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-------H-HHHHHHhCC---
Confidence 432 2345699999999999885 7899999999999999999999999654211 0 111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........++.++.+++.+||+.||.+|||++|+++.
T Consensus 373 -~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 373 -WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp -CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001112223456778999999999999999999999873
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=329.94 Aligned_cols=266 Identities=38% Similarity=0.679 Sum_probs=206.9
Q ss_pred CcccchhHHHHHhhHh--hhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEE
Q 013074 146 LKRYNFSDVKKITNSF--KDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFC 200 (450)
Q Consensus 146 ~~~~~~~ei~~~~~~~--~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~ 200 (450)
.+.+++.++.....+| .+.||+|+||.||+|+. .+|++++++++||||+++++++
T Consensus 17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 96 (326)
T 3uim_A 17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96 (326)
T ss_dssp CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence 4567777877766655 56899999999999852 2457888999999999999999
Q ss_pred EeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeE
Q 013074 201 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPK 280 (450)
Q Consensus 201 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 280 (450)
.++...++||||+++|+|.+++...... ...+++..++.++.|++.||+|||+.+..+|+||||||+|||++.++.+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 97 MTPTERLLVYPYMANGSVASCLRERPES--QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp CCSSCCEEEEECCTTCBHHHHHHCCSTT--CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred ecCCceEEEEEeccCCCHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999865432 23489999999999999999999962222999999999999999999999
Q ss_pred EeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCC-CCCccchhh
Q 013074 281 ISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD-NSSEVYFPH 359 (450)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~-~~~~~~~~~ 359 (450)
|+|||+++......... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||..... .........
T Consensus 175 l~Dfg~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHV--TTAVRGTIGHIAPEYLSTG--KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp ECCCSSCEECCSSSSCE--ECCCCSCGGGCCHHHHHHS--EECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred eccCccccccCcccccc--cccccCCcCccCHHHhccC--CCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 99999998765443322 2345599999999999764 689999999999999999999999963211 112223333
Q ss_pred hhhhhhhhhhhhhh--cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 360 WIYRHVEQDREFKL--LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 360 ~i~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
|+............ ...........+..+.+++.+||+.||.+|||++||+++|++..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 33332222111111 11122334667889999999999999999999999999999743
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=323.17 Aligned_cols=260 Identities=33% Similarity=0.568 Sum_probs=205.0
Q ss_pred CCcccchhHHHHHhhHhh--------hccccccceEEEEEEE-------------------------cchhhhhhhcCCC
Q 013074 145 PLKRYNFSDVKKITNSFK--------DKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHV 191 (450)
Q Consensus 145 ~~~~~~~~ei~~~~~~~~--------~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~Hp 191 (450)
..+.|++.++.+++.+|. +.||+|+||.||+|+. .+|+.++++++||
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 356789999999999885 4599999999999852 2357788999999
Q ss_pred ceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccE
Q 013074 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNI 271 (450)
Q Consensus 192 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NI 271 (450)
||+++++++.+++..++||||+++++|.+++...... ..+++..++.++.|++.||.|||+ .+|+|+||||+||
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Ni 164 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGT---PPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANI 164 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGC---CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHE
Confidence 9999999999999999999999999999998753321 238999999999999999999995 8999999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCC
Q 013074 272 LLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN 351 (450)
Q Consensus 272 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~ 351 (450)
+++.++.+||+|||++.......... ......||..|+|||.+.+ .++.++||||||+++|+|++|..||......
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 240 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTV-MTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVDEHREP 240 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCE-ECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred EEcCCCcEEEeecccccccccccccc-cccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence 99999999999999998765432221 1234568999999999865 5789999999999999999999999765432
Q ss_pred CCccchhhhhhhhhhhhh---hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 352 SSEVYFPHWIYRHVEQDR---EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 352 ~~~~~~~~~i~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.. +..+ .+...... ...............+..+.+++.+||+.||.+|||++|+++.|+++.+
T Consensus 241 ~~---~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 241 QL---LLDI-KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SB---TTHH-HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HH---HHHH-HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 21 1111 11111100 0111122233456678889999999999999999999999999998653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=332.23 Aligned_cols=239 Identities=25% Similarity=0.437 Sum_probs=182.1
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.+.||+|+||+||+|+. .+|++++++++||||+++++++.+....++||||++
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 117 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCT
T ss_pred HceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCC
Confidence 345678999999999999952 246888999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc--eEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR--ILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|.+++..... ...+++..++.++.|++.||+|||+ .+ |+||||||+||+++.++.+||+|||+++....
T Consensus 118 ~~~L~~~l~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 118 RGSLYRLLHKSGA---REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp TCBHHHHHHSTTH---HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred CCcHHHHHhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999976432 1238999999999999999999994 78 99999999999999999999999999986543
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...... . ....+.
T Consensus 192 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~Pf~~~~~~-------~-~~~~~~------ 252 (309)
T 3p86_A 192 TFLS---SKSAAGTPEWMAPEVLRDE--PSNEKSDVYSFGVILWELATLQQPWGNLNPA-------Q-VVAAVG------ 252 (309)
T ss_dssp -------------CCTTSCHHHHTTC--CCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-------H-HHHHHH------
T ss_pred cccc---cccCCCCccccChhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHH------
Confidence 3211 2345689999999999874 7899999999999999999999999643210 0 111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
........+..++.++.+++.+||+.||.+|||++|+++.|+...+...
T Consensus 253 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 253 FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 0111112223455778999999999999999999999999999887654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=331.96 Aligned_cols=238 Identities=22% Similarity=0.376 Sum_probs=189.3
Q ss_pred HhhHhhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
..+.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 34556789999999999998642 357888999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 129 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDG-----QFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred eeCCCCCcHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 999999999999965432 28999999999999999999995 8999999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
...............+|..|+|||++.+. .++.++||||||+++|||++ |..||...... .+...+...
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~--------~~~~~~~~~ 270 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNR--------DVISSVEEG 270 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--------HHHHHHHTT
T ss_pred cccCccceeeccCCCCcccccCHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcC
Confidence 75543322223344567889999999764 78999999999999999998 99998643210 111111111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
........++..+.+++.+||+.||++|||++|+++.|+.+...
T Consensus 271 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 271 -------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp -------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred -------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 11122234567899999999999999999999999999987764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=326.38 Aligned_cols=248 Identities=27% Similarity=0.356 Sum_probs=187.4
Q ss_pred HhhhccccccceEEEEEEEc--------------------chhhhhhhcCCCceeeeeeEEEeCCc----eEEEEEecCC
Q 013074 160 SFKDKLGQGGFGGVYKGKLL--------------------DGLASISRTSHVNVVTLLGFCLEGNN----RALIYEFMPN 215 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~--------------------~e~~~l~~l~HpnIv~l~~~~~~~~~----~~lV~E~~~~ 215 (450)
.+.+.||+|+||+||+|+.. .|+.++++++||||+++++++.+... .++||||+++
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~ 106 (322)
T 3soc_A 27 QLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106 (322)
T ss_dssp EEEEEEECSTTCEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred hhhheecccCceEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCC
Confidence 45678999999999999643 24667888999999999999987553 6999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC----------ceEeeeeccccEEEcCCCCeEEeecc
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST----------RILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~----------~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
|+|.+++.... +++..++.++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||
T Consensus 107 g~L~~~l~~~~-------~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 107 GSLSDFLKANV-------VSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp CBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCHHHHHHhcC-------CCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 99999997532 8999999999999999999995 7 99999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCCcccccccccccccc---CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF---GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~ 362 (450)
+++......... ......||+.|+|||++.+.. ..++.++|||||||++|||++|+.||........ ..+.....
T Consensus 177 ~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-~~~~~~~~ 254 (322)
T 3soc_A 177 LALKFEAGKSAG-DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM-LPFEEEIG 254 (322)
T ss_dssp TCEEECTTSCCC-CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC-CTTHHHHC
T ss_pred cccccccccCcc-ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc-cchhhhhc
Confidence 998765443221 133456999999999987521 1456788999999999999999999976543221 11111100
Q ss_pred hhhhhhh--hhh----hcccc--cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 363 RHVEQDR--EFK----LLGVV--TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 363 ~~~~~~~--~~~----~~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
....... ... ..... .......+.++.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000 000 00000 011234567799999999999999999999999999987654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=324.16 Aligned_cols=250 Identities=35% Similarity=0.596 Sum_probs=195.8
Q ss_pred hhhccccccceEEEEEEE----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 161 FKDKLGQGGFGGVYKGKL----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
+.+.||+|+||.||+|+. .+|++++++++||||+++++++.+++..++||||+++++|
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 122 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122 (321)
T ss_dssp CCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBT
T ss_pred ccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcH
Confidence 456899999999999963 2457888999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
.+++..... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.........
T Consensus 123 ~~~l~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~- 196 (321)
T 2qkw_B 123 KRHLYGSDL--PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH- 196 (321)
T ss_dssp GGGSSSSCC--CSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCC-
T ss_pred HHHHhccCC--CccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccccc-
Confidence 999865432 12348999999999999999999995 899999999999999999999999999998654322211
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh--hccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK--LLGV 376 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~--~~~~ 376 (450)
......||..|+|||++.+. .++.++||||||+++|||++|+.||....... ......|............ ....
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (321)
T 2qkw_B 197 LSTVVKGTLGYIDPEYFIKG--RLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVNLAEWAVESHNNGQLEQIVDPNL 273 (321)
T ss_dssp CBCCCEEETTTCCHHHHHHC--BCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS-CCCHHHHTHHHHTTTCCCSSSSSSC
T ss_pred cccccCCCccccCHHHhcCC--CCCcccchHhHHHHHHHHHhCCCcccccCcHH-HHHHHHHhhhccccccHHHhcChhh
Confidence 12334589999999999764 78999999999999999999999997654322 1222233222111111000 0111
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
........+..+.+++.+||+.||++|||++|+++.|+.....
T Consensus 274 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 2233467788999999999999999999999999999987643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=326.90 Aligned_cols=240 Identities=23% Similarity=0.369 Sum_probs=189.6
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
+.+.+.||+|+||+||+|+. .+|++++++++||||+++++++.++...++||||+++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 91 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKG 91 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCC
Confidence 34567899999999999963 2468889999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 92 ~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 92 GTLRGIIKSMDS-----QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CBHHHHHHHCCT-----TSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999976432 28999999999999999999995 8999999999999999999999999999987644322
Q ss_pred ccc-----------cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 296 IVS-----------SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 296 ~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
... ......||+.|+|||++.+. .++.++||||||+++|||++|..|+............ .....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~--~~~~~ 239 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGR--SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL--NVRGF 239 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB--CHHHH
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh--hhhcc
Confidence 110 11245699999999999874 7899999999999999999999988654332211100 00000
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
.. . ..+..++..+.+++.+||+.||++|||++|+++.|+.+...+.
T Consensus 240 ~~----~-------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 240 LD----R-------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp HH----H-------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred cc----c-------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 00 0 0112334668899999999999999999999999998876653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=331.97 Aligned_cols=241 Identities=22% Similarity=0.396 Sum_probs=190.8
Q ss_pred hhHhhhccccccceEEEEEEE-------------------------------cchhhhhhhc-CCCceeeeeeEEEeCCc
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-------------------------------LDGLASISRT-SHVNVVTLLGFCLEGNN 205 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-------------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~ 205 (450)
.+.+.+.||+|+||.||+|+. .+|+.+++++ +||||+++++++.+++.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 345678899999999999853 1357778888 89999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~ 275 (450)
.++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECC
Confidence 99999999999999999765421 112348999999999999999999995 89999999999999999
Q ss_pred CCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 013074 276 DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSE 354 (450)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~ 354 (450)
++.+||+|||+++.......... .....+|+.|+|||++.+. .++.++|||||||++|||++ |+.||......
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~p~~~~~~~--- 312 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKK-TTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 312 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCT-TTTTTSCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---
T ss_pred CCCEEEccccCCcccCcccceec-ccCCCcccceECHhHhcCC--CCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999987654332211 2334578899999999774 78999999999999999998 88888643210
Q ss_pred cchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 355 VYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 355 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
. +...+... .....+..++.++.+++.+||+.||++||++.|+++.|+.+...
T Consensus 313 ----~-~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 313 ----E-LFKLLKEG-------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp ----G-HHHHHHTT-------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----H-HHHHHhcC-------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0 11111111 11122234567899999999999999999999999999987643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=319.25 Aligned_cols=226 Identities=23% Similarity=0.327 Sum_probs=183.5
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
|.+.+.||+|+||+||+|+. .+|+.++++++||||+++++++.+++..++||||+++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 101 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCC
Confidence 34567899999999999952 2467888999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++.... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++........
T Consensus 102 ~~L~~~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 102 GSLTDVVTETC-------MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CBHHHHHHHSC-------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCHHHHHhhcC-------CCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 99999997542 8899999999999999999995 8999999999999999999999999999987654332
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....||+.|+|||++.+. .++.++||||||+++|||++|+.||...... ....... .. ..
T Consensus 172 ~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~~-~~-----~~ 233 (297)
T 3fxz_A 172 K---RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIA-TN-----GT 233 (297)
T ss_dssp C---BCCCCSCGGGCCHHHHHCS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHH-HH-----CS
T ss_pred c---cCCccCCcCccChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHH-hC-----CC
Confidence 2 2345699999999999874 7899999999999999999999999643210 0011100 00 01
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........++..+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 234 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1112233456778999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=320.92 Aligned_cols=243 Identities=19% Similarity=0.238 Sum_probs=189.3
Q ss_pred hHhhhccccccceEEEEEEE---------------------cchhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
|.+.+.||+|+||.||+|+. ..|+.+++++ +||||+++++++.++...++||||+ ++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GP 89 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CC
T ss_pred eEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CC
Confidence 34567899999999999962 3468889999 9999999999999999999999999 99
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC-----eEEeecccccccc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC-----PKISDFGLAKLCT 291 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~DFGla~~~~ 291 (450)
+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++...
T Consensus 90 ~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 90 SLEDLFDLCD-----RTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp BHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred CHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 9999997643 238999999999999999999995 89999999999999998887 9999999998765
Q ss_pred CCCCccc----cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 292 TKKGIVS----SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 292 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||........ .. ....+..
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~----~~-~~~~i~~ 234 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGK--EQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL----KE-RYQKIGD 234 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH----HH-HHHHHHH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCC--CCCchhHHHHHHHHHHHHhcCCCCccccccccH----HH-HHHHHHh
Confidence 4332111 12356799999999999874 789999999999999999999999976532211 11 1111111
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
. .............+ ++.+++.+||+.||.+||++++|++.|+...+.+.
T Consensus 235 ~---~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~ 284 (330)
T 2izr_A 235 T---KRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284 (330)
T ss_dssp H---HHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred h---hccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcC
Confidence 1 00000001111233 89999999999999999999999999987766543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=331.65 Aligned_cols=257 Identities=21% Similarity=0.363 Sum_probs=197.4
Q ss_pred HHHhhHhhhccccccceEEEEEEE-------------------------------cchhhhhhhc-CCCceeeeeeEEEe
Q 013074 155 KKITNSFKDKLGQGGFGGVYKGKL-------------------------------LDGLASISRT-SHVNVVTLLGFCLE 202 (450)
Q Consensus 155 ~~~~~~~~~~LG~G~fg~Vy~~~~-------------------------------~~e~~~l~~l-~HpnIv~l~~~~~~ 202 (450)
....+.+.+.||+|+||.||+|+. .+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 334556778999999999999863 1357778888 99999999999999
Q ss_pred CCceEEEEEecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEE
Q 013074 203 GNNRALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNIL 272 (450)
Q Consensus 203 ~~~~~lV~E~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIl 272 (450)
++..++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+ .+|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 99999999999999999999765421 112348999999999999999999995 89999999999999
Q ss_pred EcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCC
Q 013074 273 LDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDN 351 (450)
Q Consensus 273 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~ 351 (450)
+++++.+||+|||+++.......... .....+|..|+|||++.+. .++.++||||||++++||++ |..||.....
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt~g~~p~~~~~~- 299 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKK-TTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV- 299 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCC-CTTCCCGGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred EcCCCcEEEcccCccccccccccccc-ccCCCCCcceeCHHHhcCC--CCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence 99999999999999987654332211 2344578899999999874 78999999999999999999 8888864321
Q ss_pred CCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCCCCCCCCC
Q 013074 352 SSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPPTPFLSSP 431 (450)
Q Consensus 352 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~p~~~~~ 431 (450)
..+.+.+.... .......++.++.+++.+||+.||++|||++||++.|+.+.........+..++.
T Consensus 300 -------~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~ 365 (382)
T 3tt0_A 300 -------EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMGYYHHH 365 (382)
T ss_dssp -------HHHHHHHHTTC-------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-------
T ss_pred -------HHHHHHHHcCC-------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCCCCCcc
Confidence 11111111111 1112233457799999999999999999999999999998877665555554443
Q ss_pred C
Q 013074 432 P 432 (450)
Q Consensus 432 ~ 432 (450)
.
T Consensus 366 ~ 366 (382)
T 3tt0_A 366 H 366 (382)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=333.26 Aligned_cols=237 Identities=22% Similarity=0.403 Sum_probs=176.6
Q ss_pred hhHhhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
.+.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++.++...++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 3446788999999999998532 3577888999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 126 e~~~~~sL~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 126 EYMENGSLDSFLRKHDA-----QFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp ECCTTCBHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred eCCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999975432 38999999999999999999995 89999999999999999999999999999876
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
..............++..|+|||++.+. .++.++||||||+++|||++ |+.||..... ..+...+...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~i~~~- 266 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKAVDEG- 266 (373)
T ss_dssp ----------------CTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHHHHTT-
T ss_pred ccCCccceeccCCCcCCCccChhhhccC--CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC-
Confidence 5433222212233457789999999874 78999999999999999997 9999864321 0111111111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
........++..+.+++.+||+.||++||+++||++.|+.+...
T Consensus 267 ------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 267 ------YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp ------EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11112234557799999999999999999999999999886543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=329.39 Aligned_cols=260 Identities=23% Similarity=0.271 Sum_probs=188.8
Q ss_pred hHhhhccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEE--eCCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCL--EGNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~--~~~~~~lV 209 (450)
+.+.+.||+|+||.||++++ .+|++++++++||||+++++++. +....++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 104 (327)
T 3lxl_A 25 LKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLV 104 (327)
T ss_dssp EEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEE
T ss_pred hhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEE
Confidence 44678999999999999862 24678899999999999999987 44668999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++++|.+++..... .+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++..
T Consensus 105 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 105 MEYLPSGCLRDFLQRHRA-----RLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EECCTTCBHHHHHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EeecCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence 999999999999975332 38999999999999999999995 8999999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
...............+|..|+|||++.+. .++.++||||||+++++|++|+.||........................
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDN--IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccC--CCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 76544333333445688899999999774 6899999999999999999999988643110000000000000000000
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCCCCCC
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPPTPFL 428 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~p~~ 428 (450)
.....+........++..+.+++.+||+.||++|||++|+++.|+.+......-..+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~~~ 313 (327)
T 3lxl_A 255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAF 313 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------------
T ss_pred HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccccc
Confidence 00011111222334567899999999999999999999999999988766544433333
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=323.83 Aligned_cols=224 Identities=21% Similarity=0.299 Sum_probs=182.5
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.+++..++||||+
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 96 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYA 96 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECC
Confidence 34567899999999999952 24678899999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++...+. +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~L~~~l~~~~~------l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 97 SGGEVFDYLVAHGR------MKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp TTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred CCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999976543 8999999999999999999995 89999999999999999999999999999876543
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
.. ....+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||..... .. +...+...
T Consensus 168 ~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~-~~~~i~~~----- 229 (328)
T 3fe3_A 168 GK----LDAFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-------KE-LRERVLRG----- 229 (328)
T ss_dssp CG----GGTTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHC-----
T ss_pred Cc----cccccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-------HH-HHHHHHhC-----
Confidence 22 3455799999999999875 2335899999999999999999999965321 11 11111111
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
....+...+.++.+++.+||+.||.+|||++|+++.
T Consensus 230 ---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 230 ---KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001122345678899999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=322.96 Aligned_cols=234 Identities=28% Similarity=0.416 Sum_probs=184.8
Q ss_pred hhHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
.+.+.+.||+|+||+||+|+. .+|+.++++++||||+++++++.++. .++|
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v 94 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEE
T ss_pred HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEE
Confidence 345568999999999999853 13577888999999999999998754 7899
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
+||+.+|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 95 ~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 95 TQLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EECCTTCBHHHHHHHSTT-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 999999999999976542 28999999999999999999995 8999999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
......... .....+|..|+|||++.+. .++.++||||||+++|||++ |+.||...... . +...+...
T Consensus 167 ~~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~----~~~~~~~~ 235 (327)
T 3poz_A 167 LGAEEKEYH-AEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----E----ISSILEKG 235 (327)
T ss_dssp HTTTCC--------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----G----HHHHHHTT
T ss_pred ccCCccccc-ccCCCccccccChHHhccC--CCCchhhhhhhHHHHHHHHhcCCCCccCCCHH----H----HHHHHHcC
Confidence 654432222 2334578899999999874 78999999999999999999 99998643211 1 11111111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
........++..+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 236 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 236 -------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp -------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred -------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111223345678999999999999999999999999987654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=324.00 Aligned_cols=233 Identities=25% Similarity=0.367 Sum_probs=182.8
Q ss_pred hHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
+.+.+.||+|+||+||+|+. .+|+.++++++||||+++++++. +...++||
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~ 93 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVT 93 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEE
Confidence 34567899999999999953 23467888899999999999886 56789999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+.+|+|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 94 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 94 QYLPLGSLLDHVRQHR-----GALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp ECCTTCBSHHHHHSSG-----GGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EeCCCCCHHHHHHHcc-----ccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999997542 238889999999999999999995 89999999999999999999999999999877
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
........ .....+|..|+|||++.+. .++.++||||||+++|+|++ |+.||....... +...+....
T Consensus 166 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~ 234 (325)
T 3kex_A 166 PPDDKQLL-YSEAKTPIKWMALESIHFG--KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--------VPDLLEKGE 234 (325)
T ss_dssp CCCTTCCC------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--------HHHHHHTTC
T ss_pred Cccccccc-ccCCCCcccccChHHhccC--CCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--------HHHHHHcCC
Confidence 54432211 2344578899999999874 78999999999999999999 999987542211 111111111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
....+..++..+.+++.+||+.||.+|||++|+++.|+.+..
T Consensus 235 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 235 -------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 111112234568889999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=334.33 Aligned_cols=243 Identities=24% Similarity=0.336 Sum_probs=189.2
Q ss_pred hhHhhhccccccceEEEEEEEc-----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL-----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~-----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
.+.+.+.||+|+||+||+|++. .|+.++++++||||+++++++.++...++
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 151 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 151 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEE
Confidence 4456789999999999998732 34678889999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCC-CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC---CeEEeec
Q 013074 209 IYEFMPNGSLEKFVYNGDTS-KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF---CPKISDF 284 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DF 284 (450)
||||+++|+|.+++...... .....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 152 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DF 228 (367)
T 3l9p_A 152 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDF 228 (367)
T ss_dssp EEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCC
Confidence 99999999999999764321 122348999999999999999999995 8999999999999999554 5999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
|+++......... ......||+.|+|||++.+. .++.++|||||||++|||++ |..||..... ..+..
T Consensus 229 G~a~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt~g~~pf~~~~~--------~~~~~ 297 (367)
T 3l9p_A 229 GMARDIYRAGYYR-KGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLE 297 (367)
T ss_dssp HHHHHHHHHSSCT-TCCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHH
T ss_pred ccccccccccccc-cCCCcCCcccEECHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH
Confidence 9998653322111 12234578999999999774 78999999999999999998 8888864321 01111
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
.+... ........++..+.+++.+||+.||++|||++||++.|+...+...
T Consensus 298 ~i~~~-------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 298 FVTSG-------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp HHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred HHHcC-------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 11111 1111223345678999999999999999999999999988766543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=321.59 Aligned_cols=250 Identities=24% Similarity=0.362 Sum_probs=185.0
Q ss_pred hhHhhhccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEeC--CceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLEG--NNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~l 208 (450)
.+.+.++||+|+||+||++++ .+|++++++++||||+++++++... ...++
T Consensus 11 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 90 (295)
T 3ugc_A 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 90 (295)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEE
T ss_pred HhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEE
Confidence 445678999999999999863 2357889999999999999998653 56899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
||||+++++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 91 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 91 IMEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEECCTTCBHHHHHHHCGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEeCCCCCHHHHHHhccc-----ccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999976532 38999999999999999999995 899999999999999999999999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCC----Cccchhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS----SEVYFPHWIYRH 364 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~----~~~~~~~~i~~~ 364 (450)
................++..|+|||.+.+. .++.++||||||+++|||++|..|+....... ............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCC--CCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 775543322223344578889999999874 78999999999999999999998875421000 000000000000
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
... ..........+..++.++.+++.+||+.||++|||++|+++.|+.+.+.+
T Consensus 241 ~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 241 LIE---LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHH---HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHH---HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 000 00111112223345678999999999999999999999999999877654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=312.36 Aligned_cols=247 Identities=15% Similarity=0.212 Sum_probs=193.6
Q ss_pred hHhhhccccccceEEEEEEE---------------------cchhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
|.+.+.||+|+||.||+|+. .+|+..++++ +|+|++++++++.++...++||||+ ++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 90 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 90 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CC
Confidence 44567899999999999962 2357788888 8999999999999999999999999 99
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC-----eEEeecccccccc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC-----PKISDFGLAKLCT 291 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-----~kl~DFGla~~~~ 291 (450)
+|.+++...+. .+++..++.++.|++.||+||| +.+|+||||||+||+++.++. +||+|||+++...
T Consensus 91 ~L~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 91 SLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp BHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CHHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99999976532 2899999999999999999999 489999999999999987776 9999999998765
Q ss_pred CCCCcc----ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 292 TKKGIV----SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 292 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
...... .......||..|+|||++.+. .++.++||||||+++|||++|+.||......... .....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~-----~~~~~~~~ 235 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK-----QKYERIGE 235 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH-----HHHHHHHH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHcCCCCcchhhccccH-----HHHHHHHh
Confidence 432211 112455699999999999774 7899999999999999999999999764322211 11111111
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCC
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPP 424 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~ 424 (450)
.. ...........++.++.+++.+||+.||++||++++|++.|+.+.+.+....
T Consensus 236 ~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~ 289 (298)
T 1csn_A 236 KK---QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 289 (298)
T ss_dssp HH---HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred hc---cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence 10 0011111112346789999999999999999999999999999888765443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=318.98 Aligned_cols=242 Identities=27% Similarity=0.446 Sum_probs=183.8
Q ss_pred HhhhccccccceEEEEEEE-------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChhh
Q 013074 160 SFKDKLGQGGFGGVYKGKL-------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEK 220 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 220 (450)
.+.+.||+|+||.||+|+. .+|++++++++||||+++++++. +..++||||+++++|.+
T Consensus 11 ~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~ 88 (307)
T 2eva_A 11 EVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN 88 (307)
T ss_dssp EEEEEEECCSSSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHH
T ss_pred eeeeEeecCCCceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHH
Confidence 4567899999999999963 24678899999999999999876 45899999999999999
Q ss_pred hhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC-eEEeeccccccccCCCCcccc
Q 013074 221 FVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC-PKISDFGLAKLCTTKKGIVSS 299 (450)
Q Consensus 221 ~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-~kl~DFGla~~~~~~~~~~~~ 299 (450)
++..... ...+++..++.++.|++.||+|||+....+|+||||||+||+++.++. +||+|||++.......
T Consensus 89 ~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~----- 160 (307)
T 2eva_A 89 VLHGAEP---LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM----- 160 (307)
T ss_dssp HHHCSSS---EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------
T ss_pred HHhccCC---CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-----
Confidence 9976542 123788999999999999999999532278999999999999998886 7999999997654321
Q ss_pred ccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccc
Q 013074 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379 (450)
Q Consensus 300 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 379 (450)
....||..|+|||++.+. .++.++||||||+++|||++|+.||....... .. +...... .....
T Consensus 161 -~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~-~~~~~~~-------~~~~~ 224 (307)
T 2eva_A 161 -TNNKGSAAWMAPEVFEGS--NYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-----FR-IMWAVHN-------GTRPP 224 (307)
T ss_dssp -----CCTTSSCHHHHTCC--CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-----HH-HHHHHHT-------TCCCC
T ss_pred -ccCCCCCceEChhhhCCC--CCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-----HH-HHHHHhc-------CCCCC
Confidence 233589999999999874 78999999999999999999999996432210 00 0001100 11112
Q ss_pred hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCCCCC
Q 013074 380 KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPPTPF 427 (450)
Q Consensus 380 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~p~ 427 (450)
....++..+.+++.+||+.||++|||++|+++.|+.+.+.++....|.
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~ 272 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPL 272 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSCC
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCcc
Confidence 223345778999999999999999999999999999887765554444
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=316.36 Aligned_cols=238 Identities=23% Similarity=0.291 Sum_probs=189.1
Q ss_pred cccchhHHHHHhhH------------hhhccccccceEEEEEEEc-----------------------chhhhhhhcCCC
Q 013074 147 KRYNFSDVKKITNS------------FKDKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHV 191 (450)
Q Consensus 147 ~~~~~~ei~~~~~~------------~~~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~Hp 191 (450)
..+++++++.++.. +.+.||+|+||.||+|+.. +|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45677777777643 2457999999999999632 457888999999
Q ss_pred ceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccE
Q 013074 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNI 271 (450)
Q Consensus 192 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NI 271 (450)
||+++++++..++..++||||+++++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NI 172 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-------RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI 172 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHE
Confidence 9999999999999999999999999999998642 28999999999999999999995 8999999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCC
Q 013074 272 LLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN 351 (450)
Q Consensus 272 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~ 351 (450)
+++.++.+||+|||++......... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||......
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~slG~il~el~~g~~pf~~~~~~ 247 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVPK---RKSLVGTPYWMAPEVISRS--LYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSCC---BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH
T ss_pred EECCCCcEEEeeeeeeeecccCccc---cccccCCccccCHhhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999876543221 2345699999999999764 7899999999999999999999999643210
Q ss_pred CCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 352 SSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 352 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.....+.... ..........+..+.+++.+||+.||++|||++|+++.
T Consensus 248 --------~~~~~~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 --------QAMKRLRDSP-----PPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp --------HHHHHHHHSS-----CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred --------HHHHHHhcCC-----CCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111100 00111122345678999999999999999999999874
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=312.76 Aligned_cols=233 Identities=25% Similarity=0.462 Sum_probs=188.1
Q ss_pred hHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
+.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.++...++||||+++++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 91 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 91 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCB
T ss_pred ceeeheecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCc
Confidence 44578899999999999963 246888999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++..... .+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||+++.......
T Consensus 92 L~~~l~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 161 (269)
T 4hcu_A 92 LSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-- 161 (269)
T ss_dssp HHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH--
T ss_pred HHHHHHhcCc-----ccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc--
Confidence 9999975432 38999999999999999999995 8999999999999999999999999999986644321
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.......+|..|+|||++.+. .++.++||||||+++++|++ |+.||..... ..+...+... .
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--------~~~~~~~~~~-------~ 224 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--------SEVVEDISTG-------F 224 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTT-------C
T ss_pred ccccCcccccccCCHHHhcCC--CCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhcC-------c
Confidence 112344577889999999764 78999999999999999999 8888864321 0111111111 1
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
....+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 111122345678999999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=313.16 Aligned_cols=236 Identities=23% Similarity=0.429 Sum_probs=188.8
Q ss_pred HhhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
..+.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.++...++||||+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISN 87 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCC
Confidence 3455678999999999999963 2457889999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++.... ..+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 88 ~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 88 GCLLNYLRSHG-----KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred CcHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 99999997543 238999999999999999999995 8999999999999999999999999999987654432
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .....+|..|+|||.+.+. .++.++||||||+++++|++ |+.||...... . ....+...
T Consensus 160 ~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~-~~~~~~~~------ 221 (268)
T 3sxs_A 160 VS--SVGTKFPVKWSAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-------E-VVLKVSQG------ 221 (268)
T ss_dssp EE--CCSCCCCGGGCCHHHHHHS--EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-------H-HHHHHHTT------
T ss_pred hc--ccCCCcCcccCCHHHHhcc--CCchhhhhHHHHHHHHHHHcCCCCCccccChH-------H-HHHHHHcC------
Confidence 21 2344567889999999774 78899999999999999998 88888643211 0 11111111
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
.....+...+..+.+++.+||+.||++|||++|+++.|+.+.+.
T Consensus 222 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 222 -HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp -CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred -CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 01111222346789999999999999999999999999987653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=316.45 Aligned_cols=237 Identities=24% Similarity=0.355 Sum_probs=183.9
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++. .+|+..+++++||||+++++++.+++..++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 92 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEY 92 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeC
Confidence 45678999999999999952 2357788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++...+. +++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 93 ~~g~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 93 IEGPTLSEYIESHGP------LSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp CCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred CCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999976532 8999999999999999999995 8999999999999999999999999999987643
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... ......||+.|+|||.+.+. .++.++||||||+++|+|++|+.||...... ...........
T Consensus 164 ~~~~--~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~--- 229 (294)
T 4eqm_A 164 TSLT--QTNHVLGTVQYFSPEQAKGE--ATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDSV--- 229 (294)
T ss_dssp -------------CCSSCCHHHHHTC--CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSCC---
T ss_pred cccc--ccCccccCccccCHhHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhccC---
Confidence 3211 12334689999999999874 7899999999999999999999999653210 01111111100
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhccccc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-PMNEVIEMLQGSTEA 419 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~~ 419 (450)
..........++..+.+++.+||+.||.+|| +++++.+.|+.....
T Consensus 230 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 230 -PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 0000111223457799999999999999998 999999999986654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=322.58 Aligned_cols=237 Identities=25% Similarity=0.416 Sum_probs=181.3
Q ss_pred HhhhccccccceEEEEEEEc----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKLL----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++.+.+..++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 34578999999999998531 35778889999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 127 ~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 127 YMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp CCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CCCCCcHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999976432 28999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.............+|..|+|||++.+. .++.++||||||+++|||++ |+.||..... ..+...+...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~-- 266 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDG-- 266 (333)
T ss_dssp ------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTT--
T ss_pred cccccccccCCCCccccccCchhcccC--CCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHCC--
Confidence 433222222333467899999999764 78999999999999999998 9998854321 1111111111
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
........++..+.+++.+||+.||++||+++|+++.|+.+.....
T Consensus 267 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 267 -----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp -----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 0111123345778999999999999999999999999998765543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=314.92 Aligned_cols=248 Identities=21% Similarity=0.268 Sum_probs=181.3
Q ss_pred hhHhhhccccccceEEEEEEEcc------------------hhhhhhh--cCCCceeeeeeEEEeC----CceEEEEEec
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLLD------------------GLASISR--TSHVNVVTLLGFCLEG----NNRALIYEFM 213 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~~------------------e~~~l~~--l~HpnIv~l~~~~~~~----~~~~lV~E~~ 213 (450)
.+.+.+.||+|+||+||+|+... |.+++.. ++||||+++++++.+. ...++||||+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~ 88 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred cEEEEEeeccCCCcEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhc
Confidence 34567899999999999996422 2344444 7999999999987653 4588999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC-----CCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC-----STRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
++|+|.+++... .+++..++.++.|++.||+|||... ..+|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~g~L~~~l~~~-------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 161 (301)
T 3q4u_A 89 EMGSLYDYLQLT-------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161 (301)
T ss_dssp TTCBHHHHHTTC-------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCHHHHHhhc-------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence 999999999532 2899999999999999999999210 2899999999999999999999999999998
Q ss_pred cccCCCCccc-cccCCCCccccccccccccccC----CCCccCchHhHHHHHHHHHcC----------CCCCCCCCCCCC
Q 013074 289 LCTTKKGIVS-SLLGARGTIGYIALEVFSRNFG----EVSHKSDVYSFGMMIMELVGC----------KNNLDSGVDNSS 353 (450)
Q Consensus 289 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~----~~s~~sDiwSlGvvl~elltg----------~~p~~~~~~~~~ 353 (450)
.......... ......||+.|+|||++.+... .++.++||||||+++|||++| +.||........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~ 241 (301)
T 3q4u_A 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241 (301)
T ss_dssp EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence 6654332211 1233469999999999976411 244799999999999999999 666654332211
Q ss_pred ccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 354 EVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 354 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
. ... +........ ..............+..+.+++.+||+.||++|||++||++.|+++
T Consensus 242 ~--~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 242 S--FED-MRKVVCVDQ-QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp C--HHH-HHHHHTTSC-CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred c--hhh-hhHHHhccC-CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1 111 111110000 0000001112345678899999999999999999999999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-40 Score=320.20 Aligned_cols=228 Identities=20% Similarity=0.265 Sum_probs=183.2
Q ss_pred hHhhhccccccceEEEEEEE----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+.+..++||||++++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~ 86 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCC
Confidence 44678899999999999852 24688899999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC--CCCeEEeeccccccccCCC
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ--DFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DFGla~~~~~~~ 294 (450)
+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 87 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 87 DIFERINTSA-----FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp BHHHHHTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred CHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence 9999996543 238999999999999999999995 89999999999999987 7899999999998775443
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
. .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...... . +...+.... .
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~-~~~~i~~~~----~ 220 (321)
T 1tki_A 159 N----FRLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ-------Q-IIENIMNAE----Y 220 (321)
T ss_dssp E----EEEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHHTC----C
T ss_pred c----cccccCChhhcCcHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-------H-HHHHHHcCC----C
Confidence 2 2234589999999999774 6789999999999999999999999653210 1 111111100 0
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.........++.++.+++.+||+.||++|||+.|+++.
T Consensus 221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00011112346788999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=320.21 Aligned_cols=230 Identities=24% Similarity=0.311 Sum_probs=183.0
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|.+.+.||+|+||+||+|+. .+|+.++++++||||+++++++.+++..++||||++
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 88 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred ceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCC
Confidence 34577899999999999952 246788899999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 89 GGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp TEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCcHHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999986543 28999999999999999999995 999999999999999999999999999998664322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .......||+.|+|||++.+. ...+.++||||||+++|+|++|+.||....... ..+..+...
T Consensus 160 ~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~~~~~~----------- 224 (323)
T 3tki_A 160 RE-RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEK----------- 224 (323)
T ss_dssp EE-CCBCSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS--HHHHHHHTT-----------
T ss_pred cc-cccCCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHHhcc-----------
Confidence 11 113355799999999999764 234789999999999999999999997543221 111111100
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.........++..+.+++.+||+.||++|||++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00111123345678899999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=330.59 Aligned_cols=235 Identities=23% Similarity=0.356 Sum_probs=186.6
Q ss_pred hhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.+.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.+++..++||||+
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 194 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcC
Confidence 345678999999999999964 23578899999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++|+|.+++...+ ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 195 ~~g~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 195 QGGDFLTFLRTEG-----ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp TTCBHHHHHHHHG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred CCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999997543 238999999999999999999995 89999999999999999999999999999865432
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... .......++..|+|||.+... .++.++||||||+++|||++ |..||..... ..+.+.+...
T Consensus 267 ~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~~~~~~~~~---- 331 (377)
T 3cbl_A 267 VYA-ASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQTREFVEKG---- 331 (377)
T ss_dssp EEE-CCSSCCEEEGGGSCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HHHHHHHHTT----
T ss_pred cee-ecCCCCCCCcCcCCHhHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC----
Confidence 111 111122357789999999764 78999999999999999998 8888864321 1111111111
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.....+..++..+.+++.+||+.||++|||++++++.|+.+..
T Consensus 332 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 332 ---GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 1111223345778999999999999999999999999987653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=321.49 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=179.4
Q ss_pred hhHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCce---
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNR--- 206 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~--- 206 (450)
.+.+.+.||+|+||.||+|+. .+|++++++++||||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 345678999999999999852 2357788899999999999999887655
Q ss_pred ---EEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 207 ---ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 207 ---~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
++||||+++++|.+++...........+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEee
Confidence 9999999999999998654322222348999999999999999999995 8999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~ 362 (450)
||+++.......... .....++..|+|||.+.+. .++.++||||||+++|||++ |..||....... +.
T Consensus 181 fg~a~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~ 249 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQ-GCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--------IY 249 (323)
T ss_dssp CCC------------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HH
T ss_pred ccccccccccccccc-cccccCcccccCchhhcCC--CCCCccchhhHHHHHHHHHhCCCCCccccChHH--------HH
Confidence 999987654332211 2234467899999999874 78999999999999999999 888886432110 11
Q ss_pred hhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCC
Q 013074 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIP 423 (450)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p 423 (450)
..+.. .........++..+.+++.+||+.||++|||+.|+++.|+.+...+...
T Consensus 250 ~~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~ 303 (323)
T 3qup_A 250 NYLIG-------GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303 (323)
T ss_dssp HHHHT-------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred HHHhc-------CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhc
Confidence 11111 1111222345577999999999999999999999999999887764433
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=321.84 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=189.0
Q ss_pred HHhhHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeC--Cc
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEG--NN 205 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~ 205 (450)
...+.+.+.||+|+||.||++++ .+|+.++++++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 33345678999999999999862 2357888999999999999999876 67
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
.++||||+++++|.+++..... .+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN-----KINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EEEEEEeCCCCcHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccc
Confidence 8999999999999999965432 28999999999999999999995 899999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc---cchhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE---VYFPHWIY 362 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~---~~~~~~i~ 362 (450)
++.................||..|+|||++.+. .++.++||||||+++|+|++|..|+......... ........
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS--KFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCC--CCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence 998776554433334455688899999999774 7889999999999999999999876422100000 00000000
Q ss_pred hhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
.... ..............++..+.+++.+||+.||.+|||++|+++.|+.+.
T Consensus 250 ~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 250 TRLV---NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHH---HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHH---HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0000 000111111223345678999999999999999999999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=320.80 Aligned_cols=257 Identities=16% Similarity=0.195 Sum_probs=189.9
Q ss_pred hhHhhhccccccceEEEEEEEcc------------------------h---------------hhhhhhcCCCceeeeee
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLLD------------------------G---------------LASISRTSHVNVVTLLG 198 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~~------------------------e---------------~~~l~~l~HpnIv~l~~ 198 (450)
.|.+.+.||+|+||.||+|+... | +..+.+++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 44567899999999999996422 1 12345567999999999
Q ss_pred EEEeC----CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc
Q 013074 199 FCLEG----NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD 274 (450)
Q Consensus 199 ~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~ 274 (450)
++... ...++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~ 186 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-----KRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEE
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEe
Confidence 99875 4589999999 999999997643 238999999999999999999995 8999999999999999
Q ss_pred --CCCCeEEeeccccccccCCCCcc----ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCC
Q 013074 275 --QDFCPKISDFGLAKLCTTKKGIV----SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 348 (450)
Q Consensus 275 --~~~~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~ 348 (450)
.++.+||+|||+++......... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV--APSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 88999999999998765432211 112344599999999999875 7899999999999999999999999743
Q ss_pred CCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCCCCCC
Q 013074 349 VDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPPTPFL 428 (450)
Q Consensus 349 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~p~~ 428 (450)
.... .............. ....... ......+.++.+++.+||+.||.+||+++++++.|+...+.+..+....+
T Consensus 265 ~~~~---~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~ 339 (364)
T 3op5_A 265 LKDP---KYVRDSKIRYRENI-ASLMDKC-FPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKL 339 (364)
T ss_dssp TTCH---HHHHHHHHHHHHCH-HHHHHHH-SCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred ccCH---HHHHHHHHHhhhhH-HHHHHHh-cccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCcc
Confidence 2211 11111111000000 0000000 00022357899999999999999999999999999998887776654444
Q ss_pred CC
Q 013074 429 SS 430 (450)
Q Consensus 429 ~~ 430 (450)
.+
T Consensus 340 dw 341 (364)
T 3op5_A 340 DL 341 (364)
T ss_dssp CC
T ss_pred ce
Confidence 33
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=314.75 Aligned_cols=256 Identities=21% Similarity=0.262 Sum_probs=185.7
Q ss_pred chhHHHHHhhHhhhccccccceEEEEEEEcch------------------hhhh--hhcCCCceeeeeeEEEeC----Cc
Q 013074 150 NFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG------------------LASI--SRTSHVNVVTLLGFCLEG----NN 205 (450)
Q Consensus 150 ~~~ei~~~~~~~~~~LG~G~fg~Vy~~~~~~e------------------~~~l--~~l~HpnIv~l~~~~~~~----~~ 205 (450)
...+.....+.+.+.||+|+||.||+|+...+ .+++ ..++||||+++++++... ..
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 33444455667788999999999999975422 2222 234899999999999887 67
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC--------ceEeeeeccccEEEcCCC
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST--------RILHFDIKPHNILLDQDF 277 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~--------~ivH~Dikp~NIll~~~~ 277 (450)
.++||||+++|+|.+++.... +++..++.++.|++.||+|||. . +|+||||||+|||++.++
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKSTT-------LDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred eEEEEeccCCCcHHHHhhccC-------CCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCC
Confidence 899999999999999996542 8999999999999999999995 6 999999999999999999
Q ss_pred CeEEeeccccccccCCCCcc-ccccCCCCccccccccccccccCCCCc------cCchHhHHHHHHHHHcCCCC------
Q 013074 278 CPKISDFGLAKLCTTKKGIV-SSLLGARGTIGYIALEVFSRNFGEVSH------KSDVYSFGMMIMELVGCKNN------ 344 (450)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~------~sDiwSlGvvl~elltg~~p------ 344 (450)
.+||+|||+++......... .......||..|+|||++.+. .... ++|||||||++|||++|..+
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 99999999997664432221 112345699999999999764 3344 38999999999999999544
Q ss_pred ----CCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 345 ----LDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 345 ----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
|........ .... ........ ..............++.++.+++.+||+.||++|||++|+++.|+.+.+..
T Consensus 258 ~~~p~~~~~~~~~--~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 258 YQLPYHDLVPSDP--SYED-MREIVCIK-KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CCCTTTTTSCSSC--CHHH-HHHHHTTS-CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ccccHhhhcCCCC--chhh-hHHHHhhh-ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 432211111 0000 00100000 000000011123367888999999999999999999999999999987764
Q ss_pred C
Q 013074 421 Q 421 (450)
Q Consensus 421 ~ 421 (450)
+
T Consensus 334 ~ 334 (337)
T 3mdy_A 334 D 334 (337)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=323.44 Aligned_cols=250 Identities=22% Similarity=0.306 Sum_probs=190.3
Q ss_pred HhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeC--CceEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEG--NNRALI 209 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV 209 (450)
.+.++||+|+||+||++.+ .+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 4567899999999987642 2468889999999999999999884 578999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++++|.+++.... +++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++..
T Consensus 114 ~e~~~~~~L~~~l~~~~-------~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRHS-------IGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp ECCCTTCBHHHHGGGSC-------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EecccCCcHHHHHhhCC-------CCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 99999999999996542 8999999999999999999995 8999999999999999999999999999988
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh--h
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE--Q 367 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~--~ 367 (450)
...............+|..|+|||++.+. .++.++||||||+++++|++|+.||........ ....+...... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~~~~ 259 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEY--KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL--ELIGIAQGQMTVLR 259 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH--HHHCSCCHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCcccccchhhh--hhhcccccchhHHH
Confidence 76544333323445588899999999874 788999999999999999999998864211000 00000000000 0
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCC
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIP 423 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p 423 (450)
................++..+.+++.+||+.||++|||++|+++.|+.+.+.++-+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 260 LTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 00000111122223445678999999999999999999999999999988776543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=321.41 Aligned_cols=226 Identities=21% Similarity=0.296 Sum_probs=182.0
Q ss_pred hHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.++...++|
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 93 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLI 93 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEE
Confidence 45678999999999999852 2467889999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC----CeEEeecc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF----CPKISDFG 285 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DFG 285 (450)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++ .+||+|||
T Consensus 94 ~e~~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 94 LELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EECCCSCBHHHHHTTCS------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 99999999999996543 28999999999999999999995 8999999999999998777 79999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...... . ....+
T Consensus 165 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-------~-~~~~i 230 (361)
T 2yab_A 165 LAHEIEDGVE----FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------E-TLANI 230 (361)
T ss_dssp SCEECCTTCC----CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHH
T ss_pred CceEcCCCCc----cccCCCCccEECchHHcCC--CCCccccHHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHH
Confidence 9987654322 2345699999999999774 7899999999999999999999999653210 0 11111
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.... ...........+..+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 231 TAVS----YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HTTC----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhcC----CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100 00001111234567899999999999999999999985
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=319.72 Aligned_cols=238 Identities=20% Similarity=0.309 Sum_probs=174.1
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCce----EE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNR----AL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~----~l 208 (450)
|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++...... ++
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~l 93 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 93 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEE
Confidence 45678999999999999962 2356678888999999999998876544 99
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
||||+++++|.+++...+. +++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 94 v~e~~~g~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 94 VMEYVDGVTLRDIVHTEGP------MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEECCCEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred EEecCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 9999999999999975432 8999999999999999999995 899999999999999999999999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
................||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ...........
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-------~~~~~~~~~~~ 235 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVRED 235 (311)
T ss_dssp -----------------CCTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHhcCC
Confidence 765443322223445689999999999874 789999999999999999999999964321 01111111110
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHhhccccc
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI-EMLQGSTEA 419 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl-~~L~~~~~~ 419 (450)
.. ........++.++.+++.+||+.||++||+..+++ +.|......
T Consensus 236 ~~-----~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~ 282 (311)
T 3ork_A 236 PI-----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 282 (311)
T ss_dssp CC-----CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred CC-----CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence 00 00011123457789999999999999999665554 556554433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=338.70 Aligned_cols=240 Identities=26% Similarity=0.420 Sum_probs=192.8
Q ss_pred HHHHhhHhhhccccccceEEEEEEEc----------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 154 VKKITNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 154 i~~~~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+....+.+.++||+|+||.||+|+.. +|+.++++++||||++++++|.++...++|||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 34445567789999999999999642 45788999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 297 ~~~~g~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 297 FMTYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp CCTTCBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred ccCCCCHHHHHHhcCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999976443 238999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.... .......++..|+|||++... .++.++||||||+++|||++ |..||...... .+.+.+...
T Consensus 370 ~~~~--~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~-- 435 (495)
T 1opk_A 370 GDTY--TAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--------QVYELLEKD-- 435 (495)
T ss_dssp TCCE--ECCTTCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG--------GHHHHHHTT--
T ss_pred CCce--eecCCCcCCcceeCHhHHhcC--CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHcC--
Confidence 4321 112334567899999999764 78999999999999999998 88888643211 111211111
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
.....+..++..+.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 436 -----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 436 -----YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 11122234567899999999999999999999999999987543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=318.84 Aligned_cols=232 Identities=22% Similarity=0.344 Sum_probs=182.2
Q ss_pred HhhHhhhccccccceEEEEEEE------------------------------cchhhhhhhcCCCceeeeeeEEEeCCce
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL------------------------------LDGLASISRTSHVNVVTLLGFCLEGNNR 206 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~------------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 206 (450)
..+.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 3455678999999999999842 1347788899999999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC--------
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC-------- 278 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~-------- 278 (450)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~ 159 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNK-----NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPF 159 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred EEEEECCCCCCHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccce
Confidence 99999999999999997643 238999999999999999999995 89999999999999998887
Q ss_pred eEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchh
Q 013074 279 PKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP 358 (450)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 358 (450)
+||+|||++....... ...||..|+|||++.+. ..++.++||||||+++|||++|+.++........
T Consensus 160 ~kl~Dfg~~~~~~~~~-------~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~----- 226 (289)
T 4fvq_A 160 IKLSDPGISITVLPKD-------ILQERIPWVPPECIENP-KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR----- 226 (289)
T ss_dssp EEECCCCSCTTTSCHH-------HHHHTTTTSCHHHHHCG-GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----
T ss_pred eeeccCcccccccCcc-------ccCCcCcccCHHHhCCC-CCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-----
Confidence 9999999987654321 12378899999999763 3689999999999999999997666543321100
Q ss_pred hhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 359 HWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 359 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
....... ....+...+.++.+++.+||+.||++|||++|+++.|+.+..+-
T Consensus 227 --~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~ 277 (289)
T 4fvq_A 227 --KLQFYED---------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD 277 (289)
T ss_dssp --HHHHHHT---------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred --HHHHhhc---------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 0000000 00111112456889999999999999999999999999877643
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=324.09 Aligned_cols=242 Identities=26% Similarity=0.391 Sum_probs=188.3
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeCC-ce
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEGN-NR 206 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~-~~ 206 (450)
.+.+.+.||+|+||.||+|+. .+|+++++++ +||||+++++++.+.+ ..
T Consensus 23 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~ 102 (359)
T 3vhe_A 23 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 102 (359)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCC
T ss_pred ceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCce
Confidence 445678999999999999952 2357778888 7899999999998765 48
Q ss_pred EEEEEecCCCChhhhhhcCCCCC---------------------------------------------------------
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSK--------------------------------------------------------- 229 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~--------------------------------------------------------- 229 (450)
++||||+++|+|.+++.......
T Consensus 103 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (359)
T 3vhe_A 103 MVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182 (359)
T ss_dssp EEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------------
T ss_pred EEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccc
Confidence 99999999999999997654210
Q ss_pred ---CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCc
Q 013074 230 ---PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT 306 (450)
Q Consensus 230 ---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt 306 (450)
....+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......... .....||
T Consensus 183 ~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~~~t 258 (359)
T 3vhe_A 183 EDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR-KGDARLP 258 (359)
T ss_dssp -CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE-C--CEEC
T ss_pred cchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh-ccccCCC
Confidence 01228999999999999999999995 8999999999999999999999999999986644332221 2345588
Q ss_pred cccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHH
Q 013074 307 IGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIA 385 (450)
Q Consensus 307 ~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 385 (450)
..|+|||++.+. .++.++||||||+++|||++ |+.||...... ..+...+.... ....+...+
T Consensus 259 ~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~~-------~~~~~~~~~ 322 (359)
T 3vhe_A 259 LKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGT-------RMRAPDYTT 322 (359)
T ss_dssp GGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-------HHHHHHHHHTC-------CCCCCTTCC
T ss_pred ceeEChhhhcCC--CCCchhhhhhHHHHHHHHHhcCCCCCCccchh-------HHHHHHHHcCC-------CCCCCCCCC
Confidence 999999999874 78999999999999999998 99998654221 11111111111 111122345
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 386 KKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 386 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
.++.+++.+||+.||.+|||++|+++.|+.+.++
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 6789999999999999999999999999987654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=318.78 Aligned_cols=242 Identities=21% Similarity=0.349 Sum_probs=189.4
Q ss_pred hhHhhhccccccceEEEEEEEc-----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL-----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~-----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
.+.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++.+++..++
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 127 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCL 127 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEE
Confidence 3445778999999999998643 25778889999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCC------------------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeecccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSK------------------PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHN 270 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~N 270 (450)
||||+++++|.+++....... ....+++..++.++.|++.||.|||+ .+|+||||||+|
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~N 204 (343)
T 1luf_A 128 LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRN 204 (343)
T ss_dssp EEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGG
T ss_pred EEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcce
Confidence 999999999999997643210 11348999999999999999999995 899999999999
Q ss_pred EEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCC
Q 013074 271 ILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGV 349 (450)
Q Consensus 271 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~ 349 (450)
|+++.++.+||+|||+++......... ......+|..|+|||++.+. .++.++||||||+++|||++ |..||....
T Consensus 205 Il~~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 205 CLVGENMVVKIADFGLSRNIYSADYYK-ADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp EEECGGGCEEECCCSCHHHHTGGGCBC-----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred EEECCCCeEEEeecCCCcccccCcccc-ccCCCcccceecChhhhccC--CcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 999999999999999998664432211 12344578999999999874 78999999999999999998 888886432
Q ss_pred CCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 350 DNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 350 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
. ..+...+... .....+..++..+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 282 ~--------~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 282 H--------EEVIYYVRDG-------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp H--------HHHHHHHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred h--------HHHHHHHhCC-------CcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 1 1111111111 111222345578999999999999999999999999999887654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=315.39 Aligned_cols=243 Identities=26% Similarity=0.435 Sum_probs=178.3
Q ss_pred HHhhHhhhccccccceEEEEEEE----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
...+.+.++||+|+||.||+|+. .+|+.++++++||||+++++++ .....++||||+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~ 101 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC 101 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred ccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEec
Confidence 33455678999999999999852 3468889999999999999965 556789999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++......
T Consensus 102 ~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 173 (289)
T 3og7_A 102 EGSSLYHHLHASE-----TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173 (289)
T ss_dssp CEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC--------
T ss_pred CCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccc
Confidence 9999999996543 238999999999999999999995 89999999999999999999999999999765432
Q ss_pred CCccccccCCCCccccccccccccc-cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... ......||..|+|||.+... ...++.++||||||+++|+|++|+.||...... ..+.+.+....
T Consensus 174 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~--- 242 (289)
T 3og7_A 174 SGSH-QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIEMVGRGS--- 242 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-------HHHHHHHHHTS---
T ss_pred cccc-cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcccc---
Confidence 2111 12345689999999998621 136788999999999999999999999654221 11111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
...........++..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 243 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 243 LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0111111223456789999999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=315.06 Aligned_cols=228 Identities=23% Similarity=0.291 Sum_probs=182.7
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
.|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.++...++
T Consensus 12 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 91 (326)
T 2y0a_A 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 91 (326)
T ss_dssp HEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 456678999999999999852 246788999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC----CeEEeec
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF----CPKISDF 284 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DF 284 (450)
||||+++++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+||+++.++ .+||+||
T Consensus 92 v~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 92 ILELVAGGELFDFLAEKE------SLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEECCCSCBHHHHHTTSS------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEcCCCCCHHHHHHhcC------CcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999996543 28999999999999999999995 8999999999999999887 8999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
|+++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|..||...... . ....
T Consensus 163 g~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~-~~~~ 228 (326)
T 2y0a_A 163 GLAHKIDFGNE----FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------E-TLAN 228 (326)
T ss_dssp TTCEECCTTSC----CCCCCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHH
T ss_pred CCCeECCCCCc----cccccCCcCcCCceeecCC--CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-------H-HHHH
Confidence 99987654322 2345699999999999764 7899999999999999999999999643210 0 1111
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+.... ...........+..+.+++.+||+.||++|||++|+++.
T Consensus 229 ~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 229 VSAVN----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHTC----CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhcC----CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10000 000011112345678899999999999999999999974
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.56 Aligned_cols=239 Identities=24% Similarity=0.394 Sum_probs=190.3
Q ss_pred hHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
+.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.+++..++|
T Consensus 25 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 104 (314)
T 2ivs_A 25 LVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104 (314)
T ss_dssp EEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred eeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEE
Confidence 44568899999999999853 1357788999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCC------------------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccE
Q 013074 210 YEFMPNGSLEKFVYNGDTSK------------------PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNI 271 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NI 271 (450)
|||+++++|.+++....... ....+++..++.++.|++.||.|||+ .+|+||||||+||
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NI 181 (314)
T 2ivs_A 105 VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNI 181 (314)
T ss_dssp EECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred EeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheE
Confidence 99999999999997654311 11348999999999999999999995 8999999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCC
Q 013074 272 LLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVD 350 (450)
Q Consensus 272 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~ 350 (450)
+++.++.+||+|||+++.......... .....+|..|+|||.+.+. .++.++||||||+++|||++ |+.||.....
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVK-RSQGRIPVKWMAIESLFDH--IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEEC-SSCCCSCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred EEcCCCCEEEcccccccccccccccee-ccCCCCcccccChhhhcCC--CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999987654433222 2344578899999999774 78999999999999999999 8888864321
Q ss_pred CCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 351 NSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 351 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
. .+...+... ........++..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 259 ~--------~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 259 E--------RLFNLLKTG-------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp G--------GHHHHHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--------HHHHHhhcC-------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 111111111 1112223456789999999999999999999999999998654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=314.19 Aligned_cols=233 Identities=21% Similarity=0.333 Sum_probs=175.1
Q ss_pred hhHhhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
.+.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++ .++..++||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 94 (281)
T 1mp8_A 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIM 94 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred HeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEE
Confidence 4456789999999999998532 356778889999999999987 456789999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++++|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 95 e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 95 ELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp ECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred ecCCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccccc
Confidence 99999999999976532 28999999999999999999995 89999999999999999999999999999876
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
....... .....+++.|+|||++.+. .++.++||||||+++|||++ |..||....... +...+...
T Consensus 167 ~~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~--------~~~~i~~~- 233 (281)
T 1mp8_A 167 EDSTYYK--ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENG- 233 (281)
T ss_dssp --------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTT-
T ss_pred Ccccccc--cccCCCcccccChhhcccC--CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH--------HHHHHHcC-
Confidence 5432211 1233467899999999764 78999999999999999996 888886432110 11111111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
........++..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 234 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 234 ------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1111223456788999999999999999999999999998654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=328.43 Aligned_cols=230 Identities=19% Similarity=0.267 Sum_probs=183.1
Q ss_pred HhhHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
..|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+++..++|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 3456678999999999999842 346888999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc---CCCCeEEeeccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD---QDFCPKISDFGLAK 288 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~ 288 (450)
|+++|+|.+.+..... +++..+..++.|++.||+|||+ .+|+||||||+|||++ +++.+||+|||++.
T Consensus 91 ~~~gg~L~~~i~~~~~------~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 91 LVTGGELFEDIVAREY------YSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp CCBCCBHHHHHHHCSC------CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred eCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 9999999999976543 8999999999999999999995 8999999999999998 46789999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ..+...+...
T Consensus 162 ~~~~~~~~---~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~ 228 (444)
T 3soa_A 162 EVEGEQQA---WFGFAGTPGYLSPEVLRKD--PYGKPVDLWACGVILYILLVGYPPFWDEDQ--------HRLYQQIKAG 228 (444)
T ss_dssp CCCTTCCB---CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHT
T ss_pred EecCCCce---eecccCCcccCCHHHhcCC--CCCCccccHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhC
Confidence 76543321 2345699999999999774 789999999999999999999999964321 1111111111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
. ..........++.++.+++.+||+.||++|||+.|+++.
T Consensus 229 ~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 229 A----YDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp C----CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred C----CCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 000111112345778999999999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-39 Score=312.70 Aligned_cols=247 Identities=19% Similarity=0.254 Sum_probs=190.3
Q ss_pred hHhhhccccccceEEEEEEEc------------------------chhhhhhhcCCCceeeeeeEEEeCC--ceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL------------------------DGLASISRTSHVNVVTLLGFCLEGN--NRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~E~ 212 (450)
|.+.+.||+|+||+||+|+.. +|++++++++||||+++++++.... ..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 90 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEEC
T ss_pred EEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeC
Confidence 445778999999999999632 4577899999999999999998765 77999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE----cCCCCeEEeeccccc
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL----DQDFCPKISDFGLAK 288 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla~ 288 (450)
+++++|.+++...... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 91 ~~~~~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 91 CPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp CTTCBHHHHHHSGGGT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred CCCCCHHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 9999999999764332 238999999999999999999995 899999999999999 778889999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccc------cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRN------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~ 362 (450)
....... .....||..|+|||++... ...++.++|||||||++|||++|+.||......... ...+.
T Consensus 165 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~ 237 (319)
T 4euu_A 165 ELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMY 237 (319)
T ss_dssp ECCTTCC----BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC---HHHHH
T ss_pred ecCCCCc----eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh---HHHHH
Confidence 7654432 2344699999999998631 247889999999999999999999999654322111 11111
Q ss_pred hhhhhhhhhh----------------hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 363 RHVEQDREFK----------------LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 363 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.......... ...............+.+++.+||+.||++|||++|+++..++...
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~ 309 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence 1111100000 0001112345677889999999999999999999999999886543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.12 Aligned_cols=255 Identities=22% Similarity=0.312 Sum_probs=183.5
Q ss_pred HhhhccccccceEEEEEEEcch--------------------hhhhhhcCCCceeeeeeEEEe-----CCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKLLDG--------------------LASISRTSHVNVVTLLGFCLE-----GNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~e--------------------~~~l~~l~HpnIv~l~~~~~~-----~~~~~lV~E~~~ 214 (450)
.+.+.||+|+||.||+|+..++ +..+..++||||+++++.+.. ....++||||++
T Consensus 16 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~ 95 (336)
T 3g2f_A 16 KLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP 95 (336)
T ss_dssp EEEEEEEECSSEEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCT
T ss_pred heeeecccCCCeEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCC
Confidence 4567899999999999964321 233445799999999986643 235689999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC---------ceEeeeeccccEEEcCCCCeEEeecc
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST---------RILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~---------~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
+|+|.+++.... .++..++.++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||
T Consensus 96 ~g~L~~~l~~~~-------~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 96 NGSLXKYLSLHT-------SDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp TCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred CCcHHHHHhhcc-------cchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 999999996543 6889999999999999999995 6 99999999999999999999999999
Q ss_pred ccccccCCCCc-----cccccCCCCcccccccccccccc-----CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc-
Q 013074 286 LAKLCTTKKGI-----VSSLLGARGTIGYIALEVFSRNF-----GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE- 354 (450)
Q Consensus 286 la~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-----~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~- 354 (450)
+++........ ........||..|+|||++.+.. ..++.++|||||||++|||++|+.|+.........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 99876543211 11123456999999999987521 14567899999999999999998887655432221
Q ss_pred cchhhhh---------hhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCC
Q 013074 355 VYFPHWI---------YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPP 424 (450)
Q Consensus 355 ~~~~~~i---------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~ 424 (450)
..+.... .......................+..+.+++.+||+.||++|||++|+++.|+.+.+......
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 1110000 000000000000000111123467789999999999999999999999999999887765443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=312.04 Aligned_cols=238 Identities=28% Similarity=0.459 Sum_probs=183.8
Q ss_pred hHhhhccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEe-CCceEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLE-GNNRALIY 210 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~ 210 (450)
+.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+ ++..++||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 106 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 106 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEE
Confidence 34568899999999999863 135778889999999999998754 56789999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 107 e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 107 PYMKHGDLRNFIRNET-----HNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp ECCTTCBHHHHHHCTT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred eCCCCCCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999997543 238899999999999999999995 89999999999999999999999999999866
Q ss_pred cCCCCc-cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 291 TTKKGI-VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 291 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
...... ........+|..|+|||.+.+. .++.++||||||+++++|++|+.|+........ ........
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-------~~~~~~~~- 248 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQG- 248 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-------HHHHHHTT-
T ss_pred cccchhccccccCCCCCccccChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhcC-
Confidence 443221 1122344578899999999774 789999999999999999995555433322111 11111111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
.....+..++..+.+++.+||+.||++|||++|+++.|+++...+
T Consensus 249 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 249 ------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred ------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111112234567899999999999999999999999999987654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=317.07 Aligned_cols=224 Identities=21% Similarity=0.266 Sum_probs=181.4
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||+||+++.. +|..++++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 446788999999999998632 246778889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|..++...+. +++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 87 ANGGELFFHLSRERV------FTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp CTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999875432 8999999999999999999995 8999999999999999999999999999986433
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... .....+||+.|+|||++.+. .++.++||||||+++|||++|+.||..... ..+.+.+...
T Consensus 158 ~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~---- 220 (337)
T 1o6l_A 158 DGA---TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILME---- 220 (337)
T ss_dssp TTC---CBCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC----
T ss_pred CCC---cccccccChhhCChhhhcCC--CCCchhhcccchhHHHHHhcCCCCCCCCCH--------HHHHHHHHcC----
Confidence 221 13445699999999999874 789999999999999999999999964321 0111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
....+...+.++.+++.+||+.||++|| +++|+++.
T Consensus 221 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 221 ----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0011223457789999999999999999 89999864
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=308.75 Aligned_cols=227 Identities=26% Similarity=0.419 Sum_probs=174.1
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
+.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.+++..++||||+
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFA 88 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECC
T ss_pred eeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcC
Confidence 34567899999999999852 23577888999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc---eEeeeeccccEEEcC--------CCCeEEe
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR---ILHFDIKPHNILLDQ--------DFCPKIS 282 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~---ivH~Dikp~NIll~~--------~~~~kl~ 282 (450)
++++|.+++... .+++..++.++.|++.||+|||+ .+ |+||||||+||+++. ++.+||+
T Consensus 89 ~~~~L~~~~~~~-------~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 89 RGGPLNRVLSGK-------RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp TTEEHHHHHTSS-------CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred CCCCHHHHhhcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999998532 28999999999999999999996 66 999999999999986 7789999
Q ss_pred eccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh
Q 013074 283 DFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 283 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~ 362 (450)
|||++........ ....||..|+|||.+.+. .++.++||||||+++++|++|+.||...... ....
T Consensus 159 Dfg~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~ 224 (271)
T 3dtc_A 159 DFGLAREWHRTTK-----MSAAGAYAWMAPEVIRAS--MFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-------AVAY 224 (271)
T ss_dssp CCCC------------------CCGGGSCHHHHHHC--CCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-------HHHH
T ss_pred cCCcccccccccc-----cCCCCccceeCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHH
Confidence 9999986644321 234589999999999874 7899999999999999999999999643210 0000
Q ss_pred hhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.... .......+..++..+.+++.+||+.||++|||++|+++.|+.+
T Consensus 225 ~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 225 GVAM-------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HHHT-------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hhhc-------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 0000 0111112234457799999999999999999999999999863
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=310.55 Aligned_cols=234 Identities=23% Similarity=0.411 Sum_probs=185.0
Q ss_pred hhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
.+.+.+.||+|+||.||+++. .+|++++++++||||+++++++.+++..++||||++++
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 104 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTC
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCC
Confidence 344578999999999999863 24678899999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++.... ..+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++........
T Consensus 105 ~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 175 (283)
T 3gen_A 105 CLLNYLREMR-----HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 175 (283)
T ss_dssp BHHHHHHCGG-----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-
T ss_pred cHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-
Confidence 9999997532 238999999999999999999995 8999999999999999999999999999986644321
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
.......+|..|+|||++.+. .++.++||||||+++|+|++ |+.||...... .....+...
T Consensus 176 -~~~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--------~~~~~~~~~------- 237 (283)
T 3gen_A 176 -TSSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--------ETAEHIAQG------- 237 (283)
T ss_dssp -HSTTSTTSCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHTT-------
T ss_pred -ccccCCccCcccCCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCccccChh--------HHHHHHhcc-------
Confidence 112334577889999999874 78999999999999999998 99888643210 111111111
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.....+...+..+.+++.+||+.||.+|||++|+++.|+.+.+
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 238 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 1111122234678999999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=329.94 Aligned_cols=230 Identities=23% Similarity=0.388 Sum_probs=185.4
Q ss_pred hHhhhccccccceEEEEEEE-------------------cchhhhhhhcCCCceeeeeeEEEeCC-ceEEEEEecCCCCh
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------LDGLASISRTSHVNVVTLLGFCLEGN-NRALIYEFMPNGSL 218 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------~~e~~~l~~l~HpnIv~l~~~~~~~~-~~~lV~E~~~~gsL 218 (450)
+.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+.. ..++||||+++|+|
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L 274 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 274 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBH
T ss_pred eEEEeeecCcCCeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcH
Confidence 34567899999999999963 34688999999999999999988765 78999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
.+++...+. ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 275 ~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---- 343 (450)
T 1k9a_A 275 VDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 343 (450)
T ss_dssp HHHHHHHCT----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred HHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc----
Confidence 999976543 227899999999999999999995 899999999999999999999999999998553321
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVV 377 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 377 (450)
....++..|+|||.+.+. .++.++||||||+++|||++ |+.||....... +...+... ..
T Consensus 344 --~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~-------~~ 404 (450)
T 1k9a_A 344 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKG-------YK 404 (450)
T ss_dssp -----CCCTTTSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT--------HHHHHHTT-------CC
T ss_pred --cCCCCCcceeCHHHhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcC-------CC
Confidence 122478899999999774 79999999999999999998 999986543211 11122111 11
Q ss_pred cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 378 TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 378 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
...+..++..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 405 ~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 12233456789999999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=323.28 Aligned_cols=231 Identities=18% Similarity=0.258 Sum_probs=179.5
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||+||+++.. .|..++.++ +||||+++++++.+++..++|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 346789999999999999632 234556555 89999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|..++...+. +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 134 ~~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQRK------LPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp CCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred cCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 9999999999876432 8999999999999999999995 899999999999999999999999999998633
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCC-ccchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSS-EVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~-~~~~~~~i~~~~~~~~~ 370 (450)
.... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||........ .......+.+.+...
T Consensus 205 ~~~~---~~~~~~gt~~Y~aPE~l~~~--~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-- 277 (396)
T 4dc2_A 205 RPGD---TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-- 277 (396)
T ss_dssp CTTC---CBCCCCBCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC--
T ss_pred cCCC---ccccccCCcccCCchhhcCC--CCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc--
Confidence 2221 13456799999999999875 789999999999999999999999964432111 011111122211111
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM------NEVIE 411 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 411 (450)
....+..++.++.+++.+||+.||++||++ +|+++
T Consensus 278 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 278 ------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 111223356778999999999999999986 56654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=318.77 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=189.2
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeCCceE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~ 207 (450)
.+.+.+.||+|+||.||+|+. .+|+.+++++ +||||+++++++..++..+
T Consensus 46 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 125 (344)
T 1rjb_A 46 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 125 (344)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccE
Confidence 345678999999999999863 1357788889 8999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCC-----------------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSK-----------------PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHN 270 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~-----------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~N 270 (450)
+||||+++|+|.+++....... ....+++..++.++.|++.||+|||+ .+|+||||||+|
T Consensus 126 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~N 202 (344)
T 1rjb_A 126 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARN 202 (344)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGG
T ss_pred EEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhh
Confidence 9999999999999997654210 11237999999999999999999995 899999999999
Q ss_pred EEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCC
Q 013074 271 ILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGV 349 (450)
Q Consensus 271 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~ 349 (450)
|+++.++.+||+|||++........... .....+|+.|+|||.+.+. .++.++||||||+++|+|++ |..||....
T Consensus 203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 203 VLVTHGKVVKICDFGLARDIMSDSNYVV-RGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEE-ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred EEEcCCCcEEeCCCccCcccccCcccee-ccCccCccCccCHHHhccC--CCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999987654332211 2334478899999999774 78999999999999999998 988986543
Q ss_pred CCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 350 DNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 350 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
... .....+... .....+...+.++.+++.+||+.||.+|||+.|+++.|+.....
T Consensus 280 ~~~-------~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 VDA-------NFYKLIQNG-------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CSH-------HHHHHHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cHH-------HHHHHHhcC-------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 211 111111111 01111223457799999999999999999999999999987654
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=310.98 Aligned_cols=230 Identities=21% Similarity=0.257 Sum_probs=178.5
Q ss_pred chhHHHHHhhHhhhccccccceEEEEEEEcc-------------------------hhhhhhhc-CCCceeeeeeEEEeC
Q 013074 150 NFSDVKKITNSFKDKLGQGGFGGVYKGKLLD-------------------------GLASISRT-SHVNVVTLLGFCLEG 203 (450)
Q Consensus 150 ~~~ei~~~~~~~~~~LG~G~fg~Vy~~~~~~-------------------------e~~~l~~l-~HpnIv~l~~~~~~~ 203 (450)
...++....+.+.++||+|+||+||+|+... |+..+.++ +||||+++++++.++
T Consensus 50 ~~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 50 RPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred CccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 3445556667778899999999999997531 12222333 899999999999999
Q ss_pred CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 204 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
+..++||||+ +++|.+++...+. .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~D 200 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGA-----SLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGD 200 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECC
T ss_pred CEEEEEEecc-CCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEcc
Confidence 9999999999 7799998876432 38999999999999999999995 8999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
||++........ .....||+.|+|||++.+ .++.++||||||+++|||++|..++.... ...
T Consensus 201 FG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~ 262 (311)
T 3p1a_A 201 FGLLVELGTAGA----GEVQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHGGE-----------GWQ 262 (311)
T ss_dssp CTTCEECC----------CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------HHH
T ss_pred ceeeeecccCCC----CcccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHH
Confidence 999887644322 234458999999999875 68999999999999999999977664321 011
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+.... ........++.++.+++.+||+.||++|||++|+++.
T Consensus 263 ~~~~~~------~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 263 QLRQGY------LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp HHTTTC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhccC------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 111100 0111122345789999999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=308.91 Aligned_cols=230 Identities=24% Similarity=0.446 Sum_probs=181.0
Q ss_pred hHhhhccccccceEEEEEEEc------------------------------chhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL------------------------------DGLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~------------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
+.+.+.||+|+||+||+|+.. +|+.++++++||||+++++++.+.. ++
T Consensus 21 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~l 98 (287)
T 4f0f_A 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RM 98 (287)
T ss_dssp EEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EE
T ss_pred ceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eE
Confidence 445778999999999999631 3567788899999999999986554 79
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc--eEeeeeccccEEEcCCCC-----eEE
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR--ILHFDIKPHNILLDQDFC-----PKI 281 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dikp~NIll~~~~~-----~kl 281 (450)
||||+++++|.+++..... .+++..++.++.|++.||+|||+ .+ |+|+||||+||+++.++. +||
T Consensus 99 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 99 VMEFVPCGDLYHRLLDKAH-----PIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp EEECCTTCBHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred EEEecCCCCHHHHHhcccC-----CccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence 9999999999998865432 38999999999999999999994 78 999999999999988776 999
Q ss_pred eeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhh
Q 013074 282 SDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI 361 (450)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i 361 (450)
+|||+++..... .....||..|+|||++......++.++||||||+++|||++|+.||....... . ...
T Consensus 171 ~Dfg~~~~~~~~------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~---~~~ 239 (287)
T 4f0f_A 171 ADFGLSQQSVHS------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK--I---KFI 239 (287)
T ss_dssp CCCTTCBCCSSC------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH--H---HHH
T ss_pred CCCCcccccccc------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH--H---HHH
Confidence 999999754432 23456899999999985443467899999999999999999999996543211 0 000
Q ss_pred hhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 362 YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.... ...........++..+.+++.+||+.||++|||++|+++.|+.+
T Consensus 240 ~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 NMIR-------EEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHHH-------HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHHh-------ccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 0000 01111122234567899999999999999999999999999863
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=319.88 Aligned_cols=230 Identities=20% Similarity=0.310 Sum_probs=183.2
Q ss_pred HHhhHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
...|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+++..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 34566778999999999999852 24688899999999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC---CCeEEeecccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD---FCPKISDFGLA 287 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DFGla 287 (450)
||+++|+|.+++.... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.+ +.+||+|||++
T Consensus 108 e~~~gg~L~~~l~~~~------~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE------FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp CCCCSCBHHHHHTTCS------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ecCCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 9999999999986543 28999999999999999999995 899999999999999865 45999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
........ .....||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ..+...+..
T Consensus 179 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~Pf~~~~~--------~~~~~~i~~ 244 (362)
T 2bdw_A 179 IEVNDSEA----WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQIKA 244 (362)
T ss_dssp BCCTTCCS----CCCSCSCTTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHH
T ss_pred eEecCCcc----cccCCCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHh
Confidence 87654322 2345699999999999774 789999999999999999999999964321 011111111
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.. ..........++.++.+++.+||+.||++|||+.|+++.
T Consensus 245 ~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 245 GA----YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp TC----CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CC----CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 10 000111112345778999999999999999999998754
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=323.26 Aligned_cols=237 Identities=26% Similarity=0.429 Sum_probs=175.7
Q ss_pred HhhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEe-CCceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLE-GNNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E 211 (450)
.+.+.||+|+||+||+|+.. +|+.++++++||||+++++++.+ ++..++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 45678999999999998631 34677888999999999998765 457899999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 172 ~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp CCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CCCCCCHHHHHhhccc-----CCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999975432 27899999999999999999995 899999999999999999999999999998664
Q ss_pred CCCCcc-ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 292 TKKGIV-SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 292 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
...... .......+|..|+|||++.+. .++.++||||||+++|||++ |.+||....... . ...+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~----~----~~~~~~~- 312 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD----I----TVYLLQG- 312 (373)
T ss_dssp --------------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC----H----HHHHHTT-
T ss_pred ccccccccccCCCCCcccccChHHhcCC--CCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH----H----HHHHHcC-
Confidence 332111 112334578899999999874 78999999999999999999 555554332111 1 1111111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
.....+..++..+.+++.+||+.||++|||++|+++.|+.+...+.
T Consensus 313 ------~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 313 ------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 1111122345678999999999999999999999999999877653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.26 Aligned_cols=242 Identities=26% Similarity=0.403 Sum_probs=191.1
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeCCceE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~ 207 (450)
.+.+.+.||+|+||.||+|+. .+|+.+++++ +||||+++++++.+++..+
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 103 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL 103 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcE
Confidence 445678999999999999863 1357788888 9999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCC------------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC
Q 013074 208 LIYEFMPNGSLEKFVYNGDTS------------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~ 275 (450)
+||||+++|+|.+++...... .....+++..++.++.|++.||.|||+ .+|+|+||||+||+++.
T Consensus 104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~ 180 (313)
T 1t46_A 104 VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTH 180 (313)
T ss_dssp EEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEET
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcC
Confidence 999999999999999765421 112248999999999999999999995 89999999999999999
Q ss_pred CCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 013074 276 DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSE 354 (450)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~ 354 (450)
++.+||+|||+++.......... .....+|..|+|||++.+. .++.++||||||+++++|++ |+.||.......
T Consensus 181 ~~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 255 (313)
T 1t46_A 181 GRITKICDFGLARDIKNDSNYVV-KGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255 (313)
T ss_dssp TTEEEECCCGGGSCTTSCTTSEE-CSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred CCCEEEcccccccccccccccee-ccCCCCcceeeChHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCCCcccchh--
Confidence 99999999999987755433221 2334578899999999774 78999999999999999998 888886542211
Q ss_pred cchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 355 VYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 355 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
.......... ........+..+.+++.+||+.||.+|||++|+++.|+...+.
T Consensus 256 -----~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 256 -----KFYKMIKEGF-------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -----HHHHHHHHTC-------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHhccCC-------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111111110 1111223457789999999999999999999999999987654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.32 Aligned_cols=238 Identities=25% Similarity=0.406 Sum_probs=189.6
Q ss_pred HHhhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
...+.+.+.||+|+||+||+|+. .+|+.++++++||||+++++++. ++..++||||++
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~ 265 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMA 265 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecC
Confidence 34455678999999999999964 24688899999999999999986 667899999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+|+|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 266 ~g~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 266 KGSLLDFLKSDEG----SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp TCBHHHHHHSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred CCcHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 9999999975421 237889999999999999999995 899999999999999999999999999998764322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
. .......++..|+|||++... .++.++||||||+++|||++ |+.||..... ..+...+...
T Consensus 339 ~--~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~----- 401 (454)
T 1qcf_A 339 Y--TAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALERG----- 401 (454)
T ss_dssp H--HTTCSSSSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHHHHHHT-----
T ss_pred e--eccCCCcccccccCHHHhccC--CCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC-----
Confidence 1 112334467899999999764 79999999999999999999 9988864321 0111111111
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
.....+..++.++.+++.+||+.||++|||+++|++.|+.+....
T Consensus 402 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 402 --YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 111222345678999999999999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=320.67 Aligned_cols=227 Identities=23% Similarity=0.325 Sum_probs=182.8
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+....++||||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~ 96 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEec
Confidence 44678999999999999852 2367889999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+.+|+|..++..... +++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 97 LLGGDLRYHLQQNVH------FKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CTTEEHHHHHHTTCC------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999976432 8999999999999999999995 8999999999999999999999999999987654
Q ss_pred CCCccccccCCCCccccccccccccc-cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
... ....+||+.|+|||++... ...++.++|||||||++|||++|+.||........ .. +.....
T Consensus 168 ~~~----~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~----~~-~~~~~~----- 233 (384)
T 4fr4_A 168 ETQ----ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS----KE-IVHTFE----- 233 (384)
T ss_dssp TCC----BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCH----HH-HHHHHH-----
T ss_pred CCc----eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccH----HH-HHHHHh-----
Confidence 322 3456799999999999753 13588999999999999999999999975432211 01 111110
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-MNEVIE 411 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~ 411 (450)
......+..++..+.+++.+||+.||.+||+ ++++.+
T Consensus 234 ---~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 234 ---TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111122335578999999999999999998 777764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=309.68 Aligned_cols=237 Identities=26% Similarity=0.402 Sum_probs=186.8
Q ss_pred hhhccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEeCCce-EEEEEe
Q 013074 161 FKDKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLEGNNR-ALIYEF 212 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~-~lV~E~ 212 (450)
..+.||+|+||+||+|+. .+|+.++++++||||+++++++.+.+.. ++||||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 347899999999999852 2357788899999999999999876655 999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+.+++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 105 ~~~~~L~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 105 MCHGDLLQFIRSPQ-----RNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CTTCBHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ccCCCHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999997643 238999999999999999999995 8999999999999999999999999999986544
Q ss_pred CCCc-cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 293 KKGI-VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 293 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.... ........++..|+|||.+.+. .++.++||||||+++|+|++|+.|+....... . +...+....
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~---~----~~~~~~~~~-- 245 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTY--RFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF---D----LTHFLAQGR-- 245 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG---G----HHHHHHTTC--
T ss_pred CcccccccCcCCCCCccccChhhhccC--CCChhhchhhHHHHHHHHhhCCCCCCccCCHH---H----HHHHhhcCC--
Confidence 3211 1122345588999999999774 78999999999999999999777665432211 1 111111111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
........+..+.+++.+||+.||.+|||++|+++.|+.+.+.+.
T Consensus 246 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 246 -----RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred -----CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111222345678999999999999999999999999999887754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=308.73 Aligned_cols=236 Identities=22% Similarity=0.351 Sum_probs=189.8
Q ss_pred ccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 164 KLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 164 ~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
.||+|+||.||+|+. .+|++++++++||||+++++++ +.+..++||||+++++
T Consensus 17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~ 95 (287)
T 1u59_A 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP 95 (287)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence 899999999999853 1357888999999999999999 5667999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++.... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++..........
T Consensus 96 L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 167 (287)
T 1u59_A 96 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 167 (287)
T ss_dssp HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred HHHHHHhCC-----ccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence 999996433 238999999999999999999995 899999999999999999999999999998775444333
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.......+|..|+|||++.+. .++.++||||||+++|||++ |+.||...... . +...+... .
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~-~~~~i~~~-------~ 230 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------E-VMAFIEQG-------K 230 (287)
T ss_dssp CCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------H-HHHHHHTT-------C
T ss_pred eccccccccccccCHHHhccC--CCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-------H-HHHHHhcC-------C
Confidence 323444578999999999764 78999999999999999998 99998653211 0 11111111 1
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCCC
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPPT 425 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~ 425 (450)
....+..++..+.+++.+||+.||++||++.|+++.|+.+..+...+..
T Consensus 231 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~~ 279 (287)
T 1u59_A 231 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 279 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTCS
T ss_pred cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCccc
Confidence 1122234567899999999999999999999999999998877665543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=311.14 Aligned_cols=230 Identities=22% Similarity=0.312 Sum_probs=177.6
Q ss_pred hhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCc--------
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNN-------- 205 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~-------- 205 (450)
.|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.+...
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 345678999999999999963 236788999999999999999876542
Q ss_pred -------------------------------------------------eEEEEEecCCCChhhhhhcCCCCCCCccCCH
Q 013074 206 -------------------------------------------------RALIYEFMPNGSLEKFVYNGDTSKPCQYLRW 236 (450)
Q Consensus 206 -------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~ 236 (450)
.++||||+++++|.+++...... ...++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~ 163 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---EDREH 163 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---GGSCH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---cchhh
Confidence 79999999999999999875432 33677
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc---------ccccCCCCcc
Q 013074 237 EKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV---------SSLLGARGTI 307 (450)
Q Consensus 237 ~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~---------~~~~~~~gt~ 307 (450)
..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 8899999999999999995 899999999999999999999999999998765432111 1123456999
Q ss_pred ccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHH
Q 013074 308 GYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKK 387 (450)
Q Consensus 308 ~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (450)
.|+|||++.+. .++.++||||||+++|||++|..++... ..... .................
T Consensus 241 ~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~~~~~~~~-------------~~~~~----~~~~~~~~~~~~~~~~~ 301 (332)
T 3qd2_B 241 LYMSPEQIHGN--NYSHKVDIFSLGLILFELLYSFSTQMER-------------VRIIT----DVRNLKFPLLFTQKYPQ 301 (332)
T ss_dssp GGSCHHHHHCC--CCCTHHHHHHHHHHHHHHHSCCCCHHHH-------------HHHHH----HHHTTCCCHHHHHHCHH
T ss_pred CccChHHhcCC--CCcchhhHHHHHHHHHHHHHcCCChhHH-------------HHHHH----HhhccCCCcccccCChh
Confidence 99999999874 7899999999999999999976543110 00000 00111222333455677
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 013074 388 MIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 388 l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+.+++.+||+.||++|||++|+++.
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 8899999999999999999999863
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=312.94 Aligned_cols=221 Identities=24% Similarity=0.291 Sum_probs=180.8
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||+||+++.. +|..++++++||||+++++++.+....++||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 345788999999999998632 246678889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 88 IEGGELFSLLRKSQR------FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCSCBHHHHHHHTSS------CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred CCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999976542 899999999999999999999 49999999999999999999999999999987643
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
. ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .. ....+...
T Consensus 159 ~------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~-~~~~i~~~---- 218 (318)
T 1fot_A 159 V------TYTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MK-TYEKILNA---- 218 (318)
T ss_dssp C------BCCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHHC----
T ss_pred c------cccccCCccccCHhHhcCC--CCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HH-HHHHHHhC----
Confidence 2 2345699999999999874 789999999999999999999999964321 00 11111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
....+...+.++.+++.+||+.||++|| +++|+++.
T Consensus 219 ----~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 219 ----ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 0011223457789999999999999999 88998843
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=316.84 Aligned_cols=234 Identities=28% Similarity=0.410 Sum_probs=179.6
Q ss_pred hHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.++. .++|+
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~ 95 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLIT 95 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEE
Confidence 44567899999999999963 13577889999999999999998764 88999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
|++.+|+|.+++..... .+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~~~g~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 96 QLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp CCCSSCBHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EecCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999976542 28999999999999999999995 89999999999999999999999999999876
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
........ .....+|..|+|||++.+. .++.++||||||+++|||++ |+.||...... . +...+...
T Consensus 168 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~~g~~p~~~~~~~----~----~~~~~~~~- 235 (327)
T 3lzb_A 168 GAEEKEYH-AEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----E----ISSILEKG- 235 (327)
T ss_dssp -------------CCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG----G----HHHHHHTT-
T ss_pred cCcccccc-ccCCCccccccCHHHHcCC--CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH----H----HHHHHHcC-
Confidence 44332211 2334478899999999874 78999999999999999999 99998643211 1 11111111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
........++.++.+++.+||+.||.+|||++|+++.|+.+...
T Consensus 236 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 236 ------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp ------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred ------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11112233456789999999999999999999999999987643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=312.47 Aligned_cols=241 Identities=25% Similarity=0.405 Sum_probs=179.9
Q ss_pred hHhhhccccccceEEEEEEEc----------------------------chhhhhhhcCCCceeeeeeEEEeCC-----c
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL----------------------------DGLASISRTSHVNVVTLLGFCLEGN-----N 205 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~-----~ 205 (450)
+.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++.+.. .
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 115 (313)
T 3brb_A 36 LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115 (313)
T ss_dssp EEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------C
T ss_pred eeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcc
Confidence 445678999999999988532 3477888999999999999998765 3
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
.++||||+++++|.+++...........+++..++.++.|++.||.||| +.+|+||||||+||+++.++.+||+|||
T Consensus 116 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Dfg 192 (313)
T 3brb_A 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFG 192 (313)
T ss_dssp EEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSCS
T ss_pred cEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeecC
Confidence 5999999999999999864432222345999999999999999999999 4899999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
+++.......... .....++..|+|||.+.+. .++.++||||||+++|+|++ |..||...... . +...
T Consensus 193 ~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~----~~~~ 261 (313)
T 3brb_A 193 LSKKIYSGDYYRQ-GRIAKMPVKWIAIESLADR--VYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH----E----MYDY 261 (313)
T ss_dssp CC-----------------CCGGGSCHHHHHSS--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----G----HHHH
T ss_pred cceecccccccCc-ccccCCCccccCchhhcCC--CccchhhhHHHHHHHHHHHhcCCCCCccCCHH----H----HHHH
Confidence 9987644322111 2234478899999999774 78999999999999999999 77787543211 0 1111
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
.... ........++..+.+++.+||+.||.+|||++++++.|+.+.+.+
T Consensus 262 ~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 262 LLHG-------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHTT-------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHcC-------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1111 111222345577999999999999999999999999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=324.84 Aligned_cols=232 Identities=19% Similarity=0.233 Sum_probs=182.2
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.++||+|+||+||+|+.. +|..++++++||||+++++++.+++..++||||
T Consensus 76 y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 344578999999999999632 346678888999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 156 ~~gg~L~~~l~~~~~-----~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 156 YVGGDLLTLLSKFED-----RLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp CTTCBHHHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHHccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 999999999976432 28999999999999999999995 9999999999999999999999999999987654
Q ss_pred CCCccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh-
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD- 368 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~- 368 (450)
..... ....+||+.|+|||++... .+.++.++|||||||++|||++|+.||...... + ....+...
T Consensus 228 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-------~-~~~~i~~~~ 297 (437)
T 4aw2_A 228 DGTVQ--SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------E-TYGKIMNHK 297 (437)
T ss_dssp TSCEE--CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHTHH
T ss_pred CCCcc--cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-------H-HHHhhhhcc
Confidence 33221 2345799999999998721 246899999999999999999999999753210 1 11111111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYD--RPPMNEVIEM 412 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 412 (450)
.... .+.....++.++.+++.+||+.+|++ ||+++|+++.
T Consensus 298 ~~~~----~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 298 ERFQ----FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHCC----CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred cccc----CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0111 11111234577889999999888888 9999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=316.52 Aligned_cols=233 Identities=18% Similarity=0.223 Sum_probs=182.6
Q ss_pred HHhhHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
...|.+.+.||+|+||+||+++. .+|+.++++++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34566778999999999999852 24577888999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC---eEEeec
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC---PKISDF 284 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DF 284 (450)
+||||+++++|.+++...... ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred EEEeCCCCCCHHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecC
Confidence 999999999998887543211 1238999999999999999999995 89999999999999986654 999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
|++......... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.... ..+...
T Consensus 178 g~a~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~ 243 (351)
T 3c0i_A 178 GVAIQLGESGLV---AGGRVGTPHFMAPEVVKRE--PYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEG 243 (351)
T ss_dssp TTCEECCTTSCB---CCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHH
T ss_pred cceeEecCCCee---ecCCcCCcCccCHHHHcCC--CCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHH
Confidence 999876543221 2345699999999999874 78999999999999999999999996431 011111
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+.... ..........++.++.+++.+||+.||++|||+.|+++
T Consensus 244 i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 244 IIKGK----YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHTC----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCC----CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11110 00001111234578899999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=318.65 Aligned_cols=248 Identities=17% Similarity=0.181 Sum_probs=184.2
Q ss_pred hHhhhccccc--cceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQG--GFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G--~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
|.+.++||+| +||+||+++.. +|+.++++++||||+++++++.+++..++|||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 106 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 106 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEE
Confidence 4467899999 99999999632 36788999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||.+....
T Consensus 107 ~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 107 FMAYGSAKDLICTHFM----DGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp CCTTCBHHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred ccCCCCHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 9999999999976532 228999999999999999999995 899999999999999999999999999886543
Q ss_pred CCCCc----cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 292 TKKGI----VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 292 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
..... ........||..|+|||++.+....++.++|||||||++|||++|+.||........ +...+......
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~ 256 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM---LLEKLNGTVPC 256 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH---HHHC-------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH---HHHHhcCCCCc
Confidence 22111 111223468999999999987434789999999999999999999999975432211 00000000000
Q ss_pred h--------hhh-------------------------hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--
Q 013074 368 D--------REF-------------------------KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM-- 412 (450)
Q Consensus 368 ~--------~~~-------------------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~-- 412 (450)
. ... ............++..+.+++.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 0 000 00000001123345679999999999999999999999965
Q ss_pred hhcc
Q 013074 413 LQGS 416 (450)
Q Consensus 413 L~~~ 416 (450)
++..
T Consensus 337 f~~~ 340 (389)
T 3gni_B 337 FKQI 340 (389)
T ss_dssp GGGC
T ss_pred HHHH
Confidence 5443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=311.77 Aligned_cols=237 Identities=23% Similarity=0.326 Sum_probs=180.5
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|.+.++||+|+||+||+|+. .+|++++++++||||+++++++.++...++||||++
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 102 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME 102 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS
T ss_pred hHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC
Confidence 34567899999999999963 246788999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++|.+.+..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 103 -~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 103 -KDLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp -EEHHHHHHTCTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred -CCHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 588888865432 28999999999999999999995 899999999999999999999999999998764332
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh--
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK-- 372 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~-- 372 (450)
.. .....||+.|+|||++.+. ..++.++|||||||++|+|++|+.||........ +.. +...........
T Consensus 174 ~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~-i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 174 RS---YTHEVVTLWYRAPDVLMGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ---LPK-IFSILGTPNPREWP 245 (311)
T ss_dssp C------CCCCCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH---HHH-HHHHHCCCCTTTSG
T ss_pred cc---ccCCcccCCcCCHHHhcCC-CCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH---HHH-HHHHHCCCChHHhh
Confidence 21 2334689999999998764 3689999999999999999999999975433221 111 111000000000
Q ss_pred --------------h--cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 --------------L--LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 --------------~--~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
. ...........+.++.+++.+||+.||++|||++|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 000000112234678899999999999999999999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=304.34 Aligned_cols=231 Identities=20% Similarity=0.340 Sum_probs=182.8
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeC--CceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEG--NNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~--~~~~lV~E~~ 213 (450)
+.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+. ...++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 91 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWM 91 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECC
T ss_pred hHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeeccc
Confidence 34577899999999999963 2457788899999999999999887 7889999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc--eEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR--ILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
++|+|.+++..... ..+++..++.++.|++.||+|||+ .+ ++|+||||+||+++.++.++|+|||++....
T Consensus 92 ~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 92 PYGSLYNVLHEGTN----FVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp TTCBHHHHHHSCSS----CCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred CCCcHHHHHhhccc----CCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999986543 238999999999999999999994 78 9999999999999999999999988865432
Q ss_pred CCCCccccccCCCCccccccccccccc-cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
. ....||+.|+|||.+.+. ...++.++||||||+++|||++|+.||...... ........
T Consensus 165 ~--------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~---- 225 (271)
T 3kmu_A 165 S--------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM-------EIGMKVAL---- 225 (271)
T ss_dssp C--------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH-------HHHHHHHH----
T ss_pred c--------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH-------HHHHHHHh----
Confidence 2 233589999999998763 123344899999999999999999999643210 00111110
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.......+..++..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 226 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 226 ---EGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ---SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ---cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111112223456779999999999999999999999999987653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=322.84 Aligned_cols=230 Identities=21% Similarity=0.261 Sum_probs=182.2
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||+||+++.. +|..+++.++||||+++++++.++...++||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 344678999999999999632 357788889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++.... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 151 ~~gg~L~~~l~~~~-------~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 151 MPGGDLVNLMSNYD-------VPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp CTTEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHcCC-------CCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 99999999987532 8899999999999999999995 8999999999999999999999999999987654
Q ss_pred CCCccccccCCCCccccccccccccccC--CCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFG--EVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.... .....+||+.|+|||++.+... .++.++|||||||++|||++|+.||..... ......+.....
T Consensus 221 ~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~~ 290 (410)
T 3v8s_A 221 EGMV--RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMNHKN 290 (410)
T ss_dssp TSEE--ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTHHH
T ss_pred CCcc--cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh--------hhHHHHHHhccc
Confidence 3211 1245679999999999976411 278999999999999999999999974321 011111111100
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYD--RPPMNEVIEM 412 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~ 412 (450)
. ........++.++.+++.+||+.+|.+ ||+++|+++.
T Consensus 291 ~----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 291 S----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp H----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred c----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 0 001111234577899999999999988 9999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=332.07 Aligned_cols=238 Identities=26% Similarity=0.418 Sum_probs=184.3
Q ss_pred HhhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
..+.+.++||+|+||.||+|+. .+|++++++++||||+++++++.+ +..++||||+++
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~ 262 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 262 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcC
Confidence 3445678999999999999963 246888999999999999999876 678999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 263 gsL~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 263 GSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CBHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 999999964321 238999999999999999999995 8999999999999999999999999999987653321
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
. ......++..|+|||.+... .++.++||||||+++|||++ |+.||..... ..+...+...
T Consensus 336 ~--~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i~~~------ 397 (452)
T 1fmk_A 336 T--ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERG------ 397 (452)
T ss_dssp ---------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTT------
T ss_pred e--cccCCcccccccCHhHHhcC--CCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC------
Confidence 1 12234467899999999764 78999999999999999999 8888864321 1111111111
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
.....+..++..+.+++.+||+.||++|||++++++.|+.......
T Consensus 398 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 398 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred -CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 1112223456789999999999999999999999999999876543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=308.35 Aligned_cols=233 Identities=24% Similarity=0.371 Sum_probs=185.3
Q ss_pred Hhhh-ccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 160 SFKD-KLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 160 ~~~~-~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
.+.+ .||+|+||.||+|.. .+|+.++++++||||+++++++ +.+..++|||
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 3445 899999999999832 2357788999999999999998 6678899999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++..... +++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++....
T Consensus 98 ~~~~~~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 98 MAELGPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp CCTTEEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHhCcC------CCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999976532 8999999999999999999995 899999999999999999999999999998775
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.............++..|+|||.+.+. .++.++||||||+++|+|++ |+.||..... ..+...+...
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~-- 236 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKG-- 236 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTT--
T ss_pred cCCCcccccccCCCCceeeChHHhccC--CCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcC--
Confidence 544333323334567899999999764 68899999999999999999 9999865321 0111111111
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
.....+..++..+.+++.+||+.||++||++.|+++.|+.+...
T Consensus 237 -----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 237 -----ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11122234567899999999999999999999999999986554
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=318.38 Aligned_cols=223 Identities=22% Similarity=0.340 Sum_probs=180.6
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+....++||||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~ 90 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY 90 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEEC
Confidence 44578899999999999963 2357788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+ +|+|.+++...+. +++..++.++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||++.....
T Consensus 91 ~-~g~l~~~l~~~~~------l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 91 A-GGELFDYIVEKKR------MTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp C-CEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred C-CCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9 7899998865432 8999999999999999999995 8999999999999999999999999999987654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... ....+||+.|+|||++.+. ...+.++||||||+++|+|++|+.||........ .+.+...
T Consensus 161 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------~~~i~~~---- 223 (336)
T 3h4j_B 161 GNF----LKTSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------FKKVNSC---- 223 (336)
T ss_dssp SBT----TCCCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC--------BCCCCSS----
T ss_pred Ccc----cccccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH--------HHHHHcC----
Confidence 332 2345699999999999764 2237899999999999999999999975432211 0111000
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
....+...+..+.+++.+||+.||.+|||++|+++.
T Consensus 224 ----~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 224 ----VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp ----CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred ----CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 011122345678899999999999999999999864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=315.37 Aligned_cols=221 Identities=19% Similarity=0.220 Sum_probs=181.6
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||.||+++.. +|+.++++++||||+++++++.++...++||||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 345678999999999999632 256778899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++...+. +++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 123 ~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 123 VAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp CTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999976432 8999999999999999999995 9999999999999999999999999999987644
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
. ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+.+.+....
T Consensus 194 ~------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~~--- 254 (350)
T 1rdq_E 194 R------TWTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSGK--- 254 (350)
T ss_dssp C------BCCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC---
T ss_pred C------cccccCCccccCHHHhcCC--CCCCcCCEecccHhHhHHhhCCCCCCCCCH--------HHHHHHHHcCC---
Confidence 3 2345699999999999874 789999999999999999999999964321 11111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 412 (450)
...+..++..+.+++.+||+.||.+||+ ++|+++.
T Consensus 255 -----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 -----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1112234577899999999999999998 8888753
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=316.09 Aligned_cols=228 Identities=22% Similarity=0.307 Sum_probs=173.1
Q ss_pred hHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.++...++||||+++++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 134 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCC
Confidence 45567899999999999853 347889999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---CCCeEEeeccccccccCCC
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ---DFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~~~~~~ 294 (450)
|.+++...+ .+++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++......
T Consensus 135 L~~~l~~~~------~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 135 LFDRIVEKG------YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV 205 (349)
T ss_dssp HHHHHTTCS------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred HHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc
Confidence 999996543 28999999999999999999995 89999999999999975 8899999999998664432
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+...+.....
T Consensus 206 ~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i~~~~~---- 268 (349)
T 2w4o_A 206 L----MKTVCGTPGYCAPEILRGC--AYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRILNCEY---- 268 (349)
T ss_dssp -----------CGGGSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHHHTTCC----
T ss_pred c----cccccCCCCccCHHHhcCC--CCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHHHhCCC----
Confidence 1 2345689999999999874 7899999999999999999999999654221 111111111100
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........+.++.+++.+||+.||++|||+.|+++.
T Consensus 269 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 269 YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111123455778999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=305.81 Aligned_cols=248 Identities=17% Similarity=0.232 Sum_probs=191.0
Q ss_pred hhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEE-EeCCceEEEEEecCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFC-LEGNNRALIYEFMPN 215 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~E~~~~ 215 (450)
.|.+.+.||+|+||.||+|+. ..|+.++++++|++++..++.+ .++...++||||+ +
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~ 88 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-G 88 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-C
T ss_pred ceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-C
Confidence 345678999999999999962 2457788899998877776666 5667889999999 9
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE---cCCCCeEEeeccccccccC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~~ 292 (450)
++|.+++..... .+++..++.++.|++.||.|||+ .+|+||||||+|||+ ++++.+||+|||+++....
T Consensus 89 ~~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 89 PSLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CBHHHHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999999975432 28999999999999999999995 899999999999999 7899999999999987654
Q ss_pred CCCcc----ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 293 KKGIV----SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 293 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
..... .......||..|+|||.+.+. .++.++||||||+++|+|++|+.||...........+........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 235 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM--- 235 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH---
T ss_pred cccCccCCCCcccccCCCccccchHHhcCC--CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc---
Confidence 33211 112345699999999999875 789999999999999999999999976543322221111111110
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCC
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPP 424 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~ 424 (450)
..........++..+.+++.+||+.||++|||++++++.|+.+.+....+.
T Consensus 236 -----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 236 -----STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp -----HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred -----cchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 011111112235789999999999999999999999999999887765543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=309.99 Aligned_cols=238 Identities=27% Similarity=0.420 Sum_probs=190.9
Q ss_pred HHhhHhhhccccccceEEEEEEEc----------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
...+.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++.++...++||||+
T Consensus 12 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 91 (288)
T 3kfa_A 12 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91 (288)
T ss_dssp GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcC
Confidence 344556789999999999999632 4578899999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++..... ..+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++......
T Consensus 92 ~~~~L~~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 92 TYGNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp TTEEHHHHHHHCCT----TTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred CCCcHHHHHHhccc----CCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999976543 238999999999999999999995 89999999999999999999999999999876543
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... .....+|..|+|||.+.+. .++.++||||||+++|+|++ |..||...... . +.+.+...
T Consensus 165 ~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----~----~~~~~~~~---- 228 (288)
T 3kfa_A 165 TYTA--HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----Q----VYELLEKD---- 228 (288)
T ss_dssp SSEE--ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----G----HHHHHHTT----
T ss_pred cccc--ccCCccccCcCChhhhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----H----HHHHHhcc----
Confidence 3221 2334467899999999874 78999999999999999999 88888643211 0 11111111
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
........++..+.+++.+||+.||.+|||++|+++.|+.....
T Consensus 229 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 229 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11112234457899999999999999999999999999876543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=319.35 Aligned_cols=223 Identities=19% Similarity=0.244 Sum_probs=175.9
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||+||+++.. .|..+++++ +||||+++++++.+.+..++|||
T Consensus 25 y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E 104 (353)
T 3txo_A 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVME 104 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEe
Confidence 456789999999999999632 235566666 79999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|..++..... +++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 105 ~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 105 FVNGGDLMFHIQKSRR------FDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred CCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999976532 8999999999999999999995 899999999999999999999999999998543
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+...
T Consensus 176 ~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~--- 239 (353)
T 3txo_A 176 CNGV---TTATFCGTPDYIAPEILQEM--LYGPAVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAILND--- 239 (353)
T ss_dssp C------------CCGGGCCHHHHHHH--HCTTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC---
T ss_pred cCCc---cccccCCCcCeEChhhcCCC--CcCCccCCCcchHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC---
Confidence 2221 13445799999999999875 789999999999999999999999965421 0111111111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM------NEVIE 411 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 411 (450)
....+...+..+.+++.+||+.||++||++ +|+++
T Consensus 240 -----~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 240 -----EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 011122345678899999999999999998 77764
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=312.34 Aligned_cols=242 Identities=21% Similarity=0.322 Sum_probs=172.3
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 86 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD 86 (317)
T ss_dssp ------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC
T ss_pred eeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC
Confidence 45677899999999999952 246888999999999999999999999999999997
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++|.+++...........+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 87 -~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 162 (317)
T 2pmi_A 87 -NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV 162 (317)
T ss_dssp -CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC
T ss_pred -CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc
Confidence 6999988654322222348999999999999999999995 899999999999999999999999999998764332
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh------
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD------ 368 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~------ 368 (450)
.. .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||....... ....+.+.....
T Consensus 163 ~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 163 NT---FSSEVVTLWYRAPDVLMGS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE----QLKLIFDIMGTPNESLWP 234 (317)
T ss_dssp CC---CCCCCSCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCSCCTTTCG
T ss_pred cc---CCCCcccccccCchHhhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChhHhh
Confidence 11 2344689999999998763 368999999999999999999999996542110 001111100000
Q ss_pred -----hhh--hhccc---------ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 369 -----REF--KLLGV---------VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 369 -----~~~--~~~~~---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... ..... ........+.++.+++.+||+.||++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 00000 000011235678999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=312.80 Aligned_cols=231 Identities=18% Similarity=0.249 Sum_probs=162.6
Q ss_pred hccccccceEEEEEEEc--------------------chhhhhhhcC-CCceeeeeeEEEeCCceEEEEEecCCCChhhh
Q 013074 163 DKLGQGGFGGVYKGKLL--------------------DGLASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF 221 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~--------------------~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 221 (450)
+.||+|+||.||+++.. +|+.+++++. ||||+++++++.++...++||||+++|+|.++
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 96 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFER 96 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHH
Confidence 57999999999999642 3577788887 99999999999999999999999999999999
Q ss_pred hhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC---CeEEeeccccccccCCCCccc
Q 013074 222 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF---CPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 222 l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~kl~DFGla~~~~~~~~~~~ 298 (450)
+..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++........
T Consensus 97 l~~~~~------~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~-- 165 (325)
T 3kn6_A 97 IKKKKH------FSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-- 165 (325)
T ss_dssp HHHCSC------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc--
Confidence 976532 8999999999999999999995 8999999999999998765 8999999999866443221
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....||..|+|||++.+. .++.++||||||+++|+|++|+.||.............+ +...+.... .....
T Consensus 166 -~~~~~~t~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~----~~~~~ 237 (325)
T 3kn6_A 166 -LKTPCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGD----FSFEG 237 (325)
T ss_dssp -------------------C--CCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTC----CCCCS
T ss_pred -ccccCCCcCccCHHHhcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCC----CCCCc
Confidence 2345689999999999774 789999999999999999999999975433211111111 111111110 00111
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.....++.++.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1223456789999999999999999999999854
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=304.31 Aligned_cols=233 Identities=25% Similarity=0.459 Sum_probs=187.1
Q ss_pred hHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
+.+.+.||+|+||.||+++. .+|++++++++||||+++++++.+++..++||||+++++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 89 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGC 89 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCB
T ss_pred eeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCc
Confidence 34567899999999999963 245788899999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++..... .+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 90 L~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 159 (267)
T 3t9t_A 90 LSDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-- 159 (267)
T ss_dssp HHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH--
T ss_pred HHHHHhhCcc-----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc--
Confidence 9999976532 28999999999999999999995 8999999999999999999999999999986643211
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.......++..|+|||++.+. .++.++||||||+++|+|++ |+.||..... .. +...+... .
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~-~~~~i~~~-------~ 222 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SE-VVEDISTG-------F 222 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-HHHHHHTT-------C
T ss_pred cccccccccccccChhhhcCC--CccchhchhhhHHHHHHHhccCCCCCCCCCH-------HH-HHHHHhcC-------C
Confidence 112334578899999999764 78999999999999999999 8888864321 00 11111111 0
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
....+...+..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111122345678999999999999999999999999998764
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=319.57 Aligned_cols=229 Identities=21% Similarity=0.285 Sum_probs=182.8
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.++...++||||++
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 355678999999999999852 246888999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC--CCCeEEeeccccccccC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ--DFCPKISDFGLAKLCTT 292 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~--~~~~kl~DFGla~~~~~ 292 (450)
+++|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++....
T Consensus 132 gg~L~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 132 GGELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCcHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999986543 238999999999999999999995 89999999999999974 57899999999987654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... ....||+.|+|||++.+. .++.++|||||||++|||++|..||...... . ....+....
T Consensus 204 ~~~~----~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-------~-~~~~i~~~~--- 266 (387)
T 1kob_A 204 DEIV----KVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------E-TLQNVKRCD--- 266 (387)
T ss_dssp TSCE----EEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHHHHCC---
T ss_pred Ccce----eeeccCCCccCchhccCC--CCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhCC---
Confidence 3321 233589999999999874 7899999999999999999999999653210 0 111111000
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........++.++.+++.+||+.||++|||++|+++.
T Consensus 267 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 267 -WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp -CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred -CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000111122456788999999999999999999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=312.68 Aligned_cols=242 Identities=21% Similarity=0.390 Sum_probs=190.2
Q ss_pred hhHhhhccccccceEEEEEEEc-------------------------------chhhhhhhc-CCCceeeeeeEEEeCCc
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL-------------------------------DGLASISRT-SHVNVVTLLGFCLEGNN 205 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~-------------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~ 205 (450)
.+.+.+.||+|+||.||+|+.. +|+++++++ +||||+++++++.+++.
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 115 (334)
T 2pvf_A 36 KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 115 (334)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred HeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCc
Confidence 3446788999999999998632 246778888 89999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCCC----------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSK----------PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~ 275 (450)
.++||||+++++|.+++....... ....+++..++.++.|++.||+|||+ .+|+|+||||+||+++.
T Consensus 116 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~ 192 (334)
T 2pvf_A 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTE 192 (334)
T ss_dssp CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECT
T ss_pred eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEcC
Confidence 999999999999999997654210 12348999999999999999999995 89999999999999999
Q ss_pred CCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 013074 276 DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSE 354 (450)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~ 354 (450)
++.+||+|||+++.......... .....+|..|+|||++.+. .++.++||||||+++|||++ |+.||.....
T Consensus 193 ~~~~kL~Dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~---- 265 (334)
T 2pvf_A 193 NNVMKIADFGLARDINNIDYYKK-TTNGRLPVKWMAPEALFDR--VYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV---- 265 (334)
T ss_dssp TCCEEECCCTTCEECTTTSSEEC-CSCCCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred CCCEEEccccccccccccccccc-cCCCCcccceeChHHhcCC--CcChHHHHHHHHHHHHHHHhCCCCCcCcCCH----
Confidence 99999999999987654332221 2334578899999999764 68999999999999999999 8888864321
Q ss_pred cchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 355 VYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 355 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
..+...+... ........++..+.+++.+||+.||.+|||++|+++.|+.+....
T Consensus 266 ----~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 266 ----EELFKLLKEG-------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp ----HHHHHHHHHT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHhcC-------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 1111111111 111122344577899999999999999999999999999887654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=315.32 Aligned_cols=244 Identities=17% Similarity=0.225 Sum_probs=178.1
Q ss_pred HhhHhhhccccccceEEEEEEEcc-------------------------------------hhhhhhhcCCCceeeeeeE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLLD-------------------------------------GLASISRTSHVNVVTLLGF 199 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~~-------------------------------------e~~~l~~l~HpnIv~l~~~ 199 (450)
..|.+.+.||+|+||.||+|+... |+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 345567899999999999997532 1234556799999999999
Q ss_pred EEe----CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC
Q 013074 200 CLE----GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 200 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~ 275 (450)
+.+ +...++||||+ +++|.+++...+ .+++..++.++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG------TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEES
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEcc
Confidence 988 67899999999 999999986543 38999999999999999999995 89999999999999998
Q ss_pred CC--CeEEeeccccccccCCCCc----cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCC
Q 013074 276 DF--CPKISDFGLAKLCTTKKGI----VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV 349 (450)
Q Consensus 276 ~~--~~kl~DFGla~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~ 349 (450)
++ .+||+|||+++........ ........||..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV--ALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC--CCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 87 9999999999876432211 1112445699999999999874 78999999999999999999999996432
Q ss_pred CCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 350 DNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 350 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
.... .... ................ .....++.++.+++.+||+.||++||++++|++.|+...
T Consensus 265 ~~~~--~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 265 KDPV--AVQT-AKTNLLDELPQSVLKW--APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp TCHH--HHHH-HHHHHHHTTTHHHHHH--SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cccH--HHHH-HHHhhcccccHHHHhh--ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 1110 0000 0000000000000000 000134568999999999999999999999999998754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=305.76 Aligned_cols=226 Identities=22% Similarity=0.317 Sum_probs=175.2
Q ss_pred hHhhhccccccceEEEEEEE-------------------------------------------------cchhhhhhhcC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------------------------------LDGLASISRTS 189 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------------------------------~~e~~~l~~l~ 189 (450)
|.+.+.||+|+||.||+|+. .+|++++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 94 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD 94 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCC
T ss_pred eEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCC
Confidence 34577899999999999941 13678899999
Q ss_pred CCceeeeeeEEEe--CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeec
Q 013074 190 HVNVVTLLGFCLE--GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIK 267 (450)
Q Consensus 190 HpnIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik 267 (450)
||||+++++++.+ +...++||||+++++|.+++.. ..+++..++.++.|++.||+|||+ .+|+|||||
T Consensus 95 h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlk 164 (298)
T 2zv2_A 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-------KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIK 164 (298)
T ss_dssp CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCC
T ss_pred CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCC
Confidence 9999999999987 5678999999999999876532 238999999999999999999995 899999999
Q ss_pred cccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCC-CCccCchHhHHHHHHHHHcCCCCCC
Q 013074 268 PHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGE-VSHKSDVYSFGMMIMELVGCKNNLD 346 (450)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~s~~sDiwSlGvvl~elltg~~p~~ 346 (450)
|+||+++.++.+||+|||+++........ .....||+.|+|||++.+.... .+.++||||||+++|+|++|+.||.
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL---LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCE---ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred HHHEEECCCCCEEEecCCCcccccccccc---ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999999999999999876543322 2345699999999999764111 3788999999999999999999996
Q ss_pred CCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 347 SGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 347 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.... .. +...+... .........++..+.+++.+||+.||++|||++|+++
T Consensus 242 ~~~~-------~~-~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 242 DERI-------MC-LHSKIKSQ------ALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CSSH-------HH-HHHHHHHC------CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CccH-------HH-HHHHHhcc------cCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 4311 01 11111110 0001111234567899999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=324.46 Aligned_cols=227 Identities=22% Similarity=0.383 Sum_probs=183.6
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+.+..++||||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~ 97 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEY 97 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 34567899999999999953 2357788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++...+ .+++..++.++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~~gg~L~~~l~~~~------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 98 VSGGELFDYICKNG------RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp CSSEEHHHHTTSSS------SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999996543 2899999999999999999999 48999999999999999999999999999987654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... ....+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||..... .. +...+...
T Consensus 169 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~-~~~~i~~~---- 231 (476)
T 2y94_A 169 GEF----LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PT-LFKKICDG---- 231 (476)
T ss_dssp TCC----BCCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HH-HHHHHHTT----
T ss_pred ccc----ccccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HH-HHHHHhcC----
Confidence 322 2345699999999999874 2347899999999999999999999974321 11 11111111
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQG 415 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 415 (450)
....+...+.++.+++.+||+.||++|||++|+++. +..
T Consensus 232 ----~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 232 ----IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred ----CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 011122345678999999999999999999999973 554
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.26 Aligned_cols=238 Identities=22% Similarity=0.290 Sum_probs=179.0
Q ss_pred hHhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.++||+|+||+||+|+.. +|+.++++++||||+++++++.+++..++||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecC
Confidence 345678999999999999631 3678899999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++ +|.+.+..... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 84 ~~-~l~~~~~~~~~-----~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 84 DQ-DLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp SE-EHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred CC-CHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 65 66666654332 28999999999999999999995 89999999999999999999999999999876433
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh-
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK- 372 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~- 372 (450)
... .....||..|+|||++.+. ..++.++||||||+++++|++|+.|+....... .....+.+.........
T Consensus 155 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~---~~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 155 VRC---YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD---DQLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp CSC---CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH---HHHHHHHHHHCCCCTTTC
T ss_pred ccc---ccCCccccCCcChHHHcCC-CCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH---HHHHHHHHHhCCCChhhh
Confidence 221 2345689999999999764 347999999999999999999988875443211 00011111000000000
Q ss_pred ----------------hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 ----------------LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ----------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
............+..+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000011112345778899999999999999999999863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=301.90 Aligned_cols=226 Identities=19% Similarity=0.267 Sum_probs=181.4
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.++...++||||++
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 89 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCT 89 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred hEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccC
Confidence 355678999999999999852 246888999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE---cCCCCeEEeecccccccc
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~ 291 (450)
+++|.+++..... +++..++.++.|++.||+|||+ .+|+|+||||+||++ +.++.+||+|||++....
T Consensus 90 ~~~L~~~~~~~~~------~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 90 GGELFERVVHKRV------FRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp SCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred CCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999998876432 8999999999999999999995 899999999999999 788999999999998765
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.... .....||+.|+|||.+.+ .++.++||||||+++++|++|+.||...... .....+....
T Consensus 161 ~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~-- 223 (277)
T 3f3z_A 161 PGKM----MRTKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS--------EVMLKIREGT-- 223 (277)
T ss_dssp TTSC----BCCCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHCC--
T ss_pred Cccc----hhccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCCHH--------HHHHHHHhCC--
Confidence 4332 234468999999999865 5899999999999999999999999653210 0111111100
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..........++..+.+++.+||+.||++|||+.|+++
T Consensus 224 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 --FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp --CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000111134678999999999999999999999985
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=310.47 Aligned_cols=219 Identities=25% Similarity=0.294 Sum_probs=179.8
Q ss_pred hhHhhhccccccceEEEEEEE-------------------------------cchhhhhhhcCCCceeeeeeEEEeCCce
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-------------------------------LDGLASISRTSHVNVVTLLGFCLEGNNR 206 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-------------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~ 206 (450)
.|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+.+..
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~ 104 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFF 104 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred ceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEE
Confidence 344567899999999999941 2378899999999999999999999999
Q ss_pred EEEEEecCCC-ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 207 ALIYEFMPNG-SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 207 ~lV~E~~~~g-sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
++||||+.+| +|.+++..... +++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 105 ~lv~e~~~~g~~l~~~~~~~~~------l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 105 QLVMEKHGSGLDLFAFIDRHPR------LDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEECCTTSCBHHHHHHTCCC------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEeCCCCccHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999776 99999876542 8999999999999999999995 899999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
++........ .....||+.|+|||++.+. ...+.++||||||+++|+|++|+.||.......
T Consensus 176 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------------- 237 (335)
T 3dls_A 176 SAAYLERGKL----FYTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCELEETV------------- 237 (335)
T ss_dssp TCEECCTTCC----BCEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-------------
T ss_pred cceECCCCCc----eeccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-------------
Confidence 9987654432 2234589999999999774 234889999999999999999999996421100
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.. ....+..++.++.+++.+||+.||++|||++|+++.
T Consensus 238 ~~---------~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 EA---------AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp TT---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred hh---------ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 000111234678999999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=307.96 Aligned_cols=244 Identities=21% Similarity=0.345 Sum_probs=180.3
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|.+.+.||+|+||+||+|+. .+|++++++++||||+++++++.+++..++||||++
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc
Confidence 34567899999999999952 256889999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++|.+++...+. .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 84 -~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 84 -KDLKQYLDDCGN-----IINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp -EEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred -cCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 699998876542 38999999999999999999995 899999999999999999999999999998654332
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh----
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE---- 370 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~---- 370 (450)
.. .....||..|+|||++.+. ..++.++||||||+++|+|++|+.||....... ....+.+.......
T Consensus 155 ~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~ 226 (324)
T 3mtl_A 155 KT---YDNEVVTLWYRPPDILLGS-TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTPTEETWP 226 (324)
T ss_dssp -----------CGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTST
T ss_pred cc---cccccCcccccChhhhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHhch
Confidence 11 2334589999999998764 368999999999999999999999996542110 00111110000000
Q ss_pred -------hhh---c----ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccccc
Q 013074 371 -------FKL---L----GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGSTEA 419 (450)
Q Consensus 371 -------~~~---~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~~ 419 (450)
... . .........++.++.+++.+||+.||++|||++|+++. +.+..+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 227 GILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp TGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 000 0 00001112345678899999999999999999999974 5554443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=303.57 Aligned_cols=248 Identities=17% Similarity=0.232 Sum_probs=190.6
Q ss_pred hHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEE-EeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFC-LEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~-~~~~~~~lV~E~~~~g 216 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++|++++..+.++ .++...++||||+ ++
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~ 89 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 89 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CC
Confidence 34567899999999999963 2457888999998877666655 5667789999999 99
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE---cCCCCeEEeeccccccccCC
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~~~ 293 (450)
+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+||++ ++++.+||+|||+++.....
T Consensus 90 ~L~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 90 SLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp BHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999974432 28999999999999999999995 899999999999999 48899999999999876544
Q ss_pred CCcc----ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 294 KGIV----SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 294 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
.... .......||..|+|||.+.+. .++.++||||||+++|||++|+.||...........+........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---- 235 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM---- 235 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH----
T ss_pred ccccccccccccccccccccCChhhhcCC--CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc----
Confidence 3211 112345699999999999874 789999999999999999999999976543222221111111111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCCC
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPPT 425 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~ 425 (450)
..........++.++.+++.+||+.||++|||++++++.|+.+......+..
T Consensus 236 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 287 (296)
T 3uzp_A 236 ----STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 287 (296)
T ss_dssp ----HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSS
T ss_pred ----CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccc
Confidence 0011111123457799999999999999999999999999998877665533
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=313.36 Aligned_cols=231 Identities=18% Similarity=0.254 Sum_probs=179.3
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||.||+++.. .|..+++++ +||||+++++++.+....++|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 345788999999999999632 235566666 89999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++..... +++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 91 ~~~gg~L~~~l~~~~~------l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQRK------LPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred CCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999975432 8999999999999999999995 899999999999999999999999999998643
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc-cchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE-VYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~-~~~~~~i~~~~~~~~~ 370 (450)
.... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ......+.+.+...
T Consensus 162 ~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~-- 234 (345)
T 3a8x_A 162 RPGD---TTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-- 234 (345)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC--
T ss_pred CCCC---cccccCCCccccCccccCCC--CCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC--
Confidence 2221 13455799999999999874 7899999999999999999999999643221110 01111122211111
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM------NEVIE 411 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~ 411 (450)
....+...+.++.+++.+||+.||++||++ +|+++
T Consensus 235 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 235 ------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 011122355778999999999999999996 56664
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=313.37 Aligned_cols=232 Identities=21% Similarity=0.344 Sum_probs=182.1
Q ss_pred hhHhhhccccccceEEEEEEE-------------------cchhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-------------------LDGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
.|.+.+.||+|+||.||+++. .+|++++.++ +||||+++++++.++...++||||+++|+
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 102 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCc
Confidence 455678999999999999963 2457777777 79999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC----CCeEEeeccccccccCC
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD----FCPKISDFGLAKLCTTK 293 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~----~~~kl~DFGla~~~~~~ 293 (450)
|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||+.++ +.+||+|||+++.....
T Consensus 103 L~~~i~~~~------~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 103 LLDKILRQK------FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp HHHHHHTCT------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred HHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 999997543 28999999999999999999995 899999999999998543 35999999999876543
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
... ....+||+.|+|||++.+. .++.++|||||||++|||++|..||........ ..+...+.....
T Consensus 174 ~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-----~~~~~~i~~~~~--- 240 (342)
T 2qr7_A 174 NGL---LMTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP-----EEILARIGSGKF--- 240 (342)
T ss_dssp TCC---BCCSSCCSSCCCHHHHHHH--HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH-----HHHHHHHHHCCC---
T ss_pred CCc---eeccCCCccccCHHHhcCC--CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH-----HHHHHHHccCCc---
Confidence 321 2345689999999999874 688999999999999999999999975422111 111121111110
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.........++.++.+++.+||+.||++|||+.|+++.
T Consensus 241 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 241 -SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp -CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00111123456788999999999999999999999863
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=314.82 Aligned_cols=240 Identities=25% Similarity=0.382 Sum_probs=186.6
Q ss_pred hHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeCCceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~l 208 (450)
+.+.+.||+|+||.||+|+. .+|+.+++++ +||||+++++++.+++..++
T Consensus 48 ~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 127 (333)
T 2i1m_A 48 LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLV 127 (333)
T ss_dssp EEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEE
Confidence 44578899999999999863 2357788888 89999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCC--------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeE
Q 013074 209 IYEFMPNGSLEKFVYNGDTS--------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPK 280 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 280 (450)
||||+++|+|.+++...... .....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+|
T Consensus 128 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 128 ITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp EEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEE
T ss_pred EEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEE
Confidence 99999999999998653210 001237999999999999999999995 8999999999999999999999
Q ss_pred EeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhh
Q 013074 281 ISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPH 359 (450)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~ 359 (450)
|+|||++.......... ......+|..|+|||++.+. .++.++||||||+++|||++ |..||.......
T Consensus 205 l~Dfg~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------- 274 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYI-VKGNARLPVKWMAPESIFDC--VYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------- 274 (333)
T ss_dssp BCCCGGGCCGGGCTTSE-ECSSCEECGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-------
T ss_pred ECcccccccccccccee-ecCCCCCCccccCHHHhccC--CCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-------
Confidence 99999998664433221 12334578899999999874 78999999999999999998 888886432211
Q ss_pred hhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 360 WIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 360 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
......... .....+...+..+.+++.+||+.||.+|||++|+++.|+....
T Consensus 275 ~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 275 KFYKLVKDG-------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp HHHHHHHHT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhcC-------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 111111111 0111122235678999999999999999999999999987653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=305.62 Aligned_cols=239 Identities=26% Similarity=0.426 Sum_probs=186.9
Q ss_pred hhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
.+.+.+.||+|+||.||+|+. .+|++++++++||||+++++++. ++..++||||++++
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~ 92 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENG 92 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTC
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCC
Confidence 345678999999999999853 24578899999999999999876 45689999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++..... ..+++..++.++.|++.||+|||+ .+|+|+||||+||++++++.+||+|||++.........
T Consensus 93 ~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 93 SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp BHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CHHHHHhcCCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 99999864321 238999999999999999999995 89999999999999999999999999999876543221
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
......++..|+|||.+.+. .++.++||||||++++||++ |+.||..... .. +...+...
T Consensus 166 --~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~-~~~~~~~~------- 226 (279)
T 1qpc_A 166 --AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PE-VIQNLERG------- 226 (279)
T ss_dssp --CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HH-HHHHHHTT-------
T ss_pred --cccCCCCccCccChhhhccC--CCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HH-HHHHHhcc-------
Confidence 12334577899999999764 78899999999999999999 8888864321 01 11111111
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCC
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIP 423 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p 423 (450)
........++..+.+++.+||+.||++|||++++++.|+........+
T Consensus 227 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 274 (279)
T 1qpc_A 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQ 274 (279)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC---
T ss_pred cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccCC
Confidence 011112344578999999999999999999999999999887665443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=303.70 Aligned_cols=222 Identities=24% Similarity=0.377 Sum_probs=177.8
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+....++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 34567899999999999952 2357788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++..... +++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++.....
T Consensus 91 ~~~~~l~~~l~~~~~------~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 91 APLGTVYRELQKLSK------FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp CTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred CCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 999999999876432 8999999999999999999994 8999999999999999999999999999865543
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.. .....||..|+|||.+.+. .++.++||||||+++|+|++|+.||..... . .....+..
T Consensus 162 ~~-----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~-~~~~~~~~----- 221 (279)
T 3fdn_A 162 SR-----RTDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------Q-ETYKRISR----- 221 (279)
T ss_dssp -----------CCCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------H-HHHHHHHH-----
T ss_pred cc-----ccccCCCCCccCHhHhccC--CCCccchhHhHHHHHHHHHHCCCCCCCCcH-------H-HHHHHHHh-----
Confidence 32 2334589999999999774 788999999999999999999999964321 0 01111111
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.....+...+..+.+++.+||+.||++|||++|+++.
T Consensus 222 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 ---VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0011122345678899999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=309.36 Aligned_cols=241 Identities=24% Similarity=0.441 Sum_probs=188.1
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhc-CCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRT-SHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||.||+|+. .+|+++++++ +||||+++++++.+++..++|||
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 106 (327)
T 1fvr_A 27 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 106 (327)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEe
Confidence 34678899999999999852 1357788899 89999999999999999999999
Q ss_pred ecCCCChhhhhhcCCC----------CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEE
Q 013074 212 FMPNGSLEKFVYNGDT----------SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKI 281 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 281 (450)
|+++++|.+++..... ......+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 107 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL 183 (327)
T 1fvr_A 107 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKI 183 (327)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEE
T ss_pred cCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEE
Confidence 9999999999976530 0111348999999999999999999995 89999999999999999999999
Q ss_pred eeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhh
Q 013074 282 SDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 360 (450)
+|||+++....... .....++..|+|||++.+. .++.++||||||+++|||++ |+.||..... ..
T Consensus 184 ~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~ 249 (327)
T 1fvr_A 184 ADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AE 249 (327)
T ss_dssp CCTTCEESSCEECC----C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HH
T ss_pred cccCcCcccccccc----ccCCCCCccccChhhhccc--cCCchhcchHHHHHHHHHHcCCCCCCCCCcH--------HH
Confidence 99999874432211 1233468899999999764 68899999999999999998 9999864321 01
Q ss_pred hhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCC
Q 013074 361 IYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIP 423 (450)
Q Consensus 361 i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p 423 (450)
+...+... ........++..+.+++.+||+.||.+|||++|+++.|+.+.+.....
T Consensus 250 ~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 305 (327)
T 1fvr_A 250 LYEKLPQG-------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 305 (327)
T ss_dssp HHHHGGGT-------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCS
T ss_pred HHHHhhcC-------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCc
Confidence 11111111 111122334577999999999999999999999999999877665433
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=335.47 Aligned_cols=232 Identities=22% Similarity=0.347 Sum_probs=181.4
Q ss_pred ccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 164 KLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 164 ~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
+||+|+||.||+|.+ .+|++++++++||||+++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 699999999999853 235788999999999999999976 56899999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcc
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~ 297 (450)
|.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.........
T Consensus 422 L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 493 (613)
T 2ozo_A 422 LHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493 (613)
T ss_dssp HHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred HHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCcee
Confidence 999996543 238999999999999999999995 899999999999999999999999999998765433322
Q ss_pred ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 298 ~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.......++..|+|||++.+. .++.++|||||||++|||++ |+.||...... .+...+... .
T Consensus 494 ~~~~~~~~~~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~--------~~~~~i~~~-------~ 556 (613)
T 2ozo_A 494 TARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--------EVMAFIEQG-------K 556 (613)
T ss_dssp --------CCTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH--------HHHHHHHTT-------C
T ss_pred eeccCCCCccceeCHhhhcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH--------HHHHHHHcC-------C
Confidence 222333467899999999764 89999999999999999998 99998654221 011222111 1
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
....+..++.++.+++.+||+.||++||++++|++.|+.....+.
T Consensus 557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 112233456789999999999999999999999999998765543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=307.70 Aligned_cols=237 Identities=21% Similarity=0.303 Sum_probs=177.3
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+++..++||||++
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC
Confidence 34567899999999999953 146788999999999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++|.+++..... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++......
T Consensus 84 -~~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 84 -QDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp -EEHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred -CCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 499988875432 28999999999999999999995 899999999999999999999999999998664322
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh-----
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR----- 369 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~----- 369 (450)
.. .....||+.|+|||++.+. ..++.++||||||+++|||++|+.||....... .+ ..+.+......
T Consensus 155 ~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~-~~~~~~~~~~~~~~~~ 226 (288)
T 1ob3_A 155 RK---YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QL-MRIFRILGTPNSKNWP 226 (288)
T ss_dssp ----------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH-HHHHHHHCCCCTTTST
T ss_pred cc---cccccccccccCchheeCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH-HHHHHHHCCCChhhch
Confidence 11 2334589999999998753 368999999999999999999999996532110 00 00110000000
Q ss_pred ------hh--hh----cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 370 ------EF--KL----LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 370 ------~~--~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.. .. ...........+.++.+++.+||+.||++|||++|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00 00 000001112345778899999999999999999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=315.52 Aligned_cols=224 Identities=23% Similarity=0.286 Sum_probs=174.8
Q ss_pred hhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 162 KDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
.+.||+|+||.||+|+. .+|++++++++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 35799999999999852 2468889999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE--cCCCCeEEeeccccccccCCCCc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL--DQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll--~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
.+++.... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 174 ~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~- 244 (373)
T 2x4f_A 174 FDRIIDES-----YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK- 244 (373)
T ss_dssp HHHHHHTG-----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-
T ss_pred HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-
Confidence 99886543 238999999999999999999995 899999999999999 5678999999999987654332
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ..+....... ...
T Consensus 245 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~-----~~~ 307 (373)
T 2x4f_A 245 ---LKVNFGTPEFLAPEVVNYD--FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACR-----WDL 307 (373)
T ss_dssp ---CCCCCSSCTTCCHHHHTTC--BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTC-----CCS
T ss_pred ---cccccCCCcEeChhhccCC--CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcc-----CCC
Confidence 2334599999999999764 7899999999999999999999999653210 1111111000 001
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.......++.++.+++.+||+.||.+|||++|+++
T Consensus 308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11112345678999999999999999999999997
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=304.93 Aligned_cols=261 Identities=20% Similarity=0.246 Sum_probs=192.6
Q ss_pred cccchhHHHHHhhHhhhccccccceEEEEEEEc------------------chhhhhhh--cCCCceeeeeeEEEeCC--
Q 013074 147 KRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLL------------------DGLASISR--TSHVNVVTLLGFCLEGN-- 204 (450)
Q Consensus 147 ~~~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~~~------------------~e~~~l~~--l~HpnIv~l~~~~~~~~-- 204 (450)
..+...+.....+.+.+.||+|+||.||+|+.. .|.+++.. ++||||+++++++....
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~ 111 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence 344455566667778889999999999999642 23555555 79999999999998876
Q ss_pred --ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC-----CCceEeeeeccccEEEcCCC
Q 013074 205 --NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC-----STRILHFDIKPHNILLDQDF 277 (450)
Q Consensus 205 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dikp~NIll~~~~ 277 (450)
..++||||+++|+|.+++.... +++..++.++.|++.||.|||... ..+|+||||||+||+++.++
T Consensus 112 ~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 112 WTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCCEEEEECCCTTCBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred cceeEEEEeecCCCcHHHHHhccC-------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 7899999999999999997532 899999999999999999999210 27999999999999999999
Q ss_pred CeEEeeccccccccCCCCccc-cccCCCCccccccccccccccC----CCCccCchHhHHHHHHHHHcC----------C
Q 013074 278 CPKISDFGLAKLCTTKKGIVS-SLLGARGTIGYIALEVFSRNFG----EVSHKSDVYSFGMMIMELVGC----------K 342 (450)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~----~~s~~sDiwSlGvvl~elltg----------~ 342 (450)
.+||+|||++........... ......||..|+|||++.+... .++.++||||||+++|||++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 999999999987654432211 1234569999999999876311 123689999999999999999 5
Q ss_pred CCCCCCCCCCCccchhhhhhhhhhhh-hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 343 NNLDSGVDNSSEVYFPHWIYRHVEQD-REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 343 ~p~~~~~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
.||........ ....+ .+.+... ...... ...........+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 265 ~p~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 265 LPYYDLVPSDP--SVEEM-RKVVCEQKLRPNIP--NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CTTTTTSCSSC--CHHHH-HHHHTTSCCCCCCC--GGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCccccCcCcc--cHHHH-HHHHHHHHhCCCCc--ccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 55543322111 11111 1111100 000000 0011235678899999999999999999999999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=304.75 Aligned_cols=232 Identities=23% Similarity=0.341 Sum_probs=181.0
Q ss_pred hHhhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++.+ +..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEe
Confidence 345678999999999998521 25778889999999999998765 45789999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++..... .+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 93 LYPYGELGHYLERNKN-----SLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp CCTTCBHHHHHHHHTT-----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred cCCCCCHHHHHHhccc-----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999975432 28999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
...... .....++..|+|||++.+. .++.++||||||+++|+|++ |+.||....... ....+...
T Consensus 165 ~~~~~~--~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--------~~~~~~~~-- 230 (281)
T 3cc6_A 165 DEDYYK--ASVTRLPIKWMSPESINFR--RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--------VIGVLEKG-- 230 (281)
T ss_dssp ----------CCCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--------HHHHHHHT--
T ss_pred cccccc--cccCCCCcceeCchhhccC--CCCchhccHHHHHHHHHHHhCCCCCcccCChHH--------HHHHHhcC--
Confidence 432211 2334578899999999764 78999999999999999998 999986432111 11111111
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.....+..++..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 231 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 231 -----DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 0111122345778999999999999999999999999987643
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=317.93 Aligned_cols=232 Identities=18% Similarity=0.191 Sum_probs=180.5
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||+||+++.. +|..++.+++||||+++++++.+++..++||||
T Consensus 63 f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 344678999999999999632 346677888999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++...+. .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 143 ~~gg~L~~~l~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 143 YVGGDLLTLLSKFGE-----RIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp CCSCBHHHHHHHHSS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 999999999975431 28999999999999999999995 8999999999999999999999999999987654
Q ss_pred CCCccccccCCCCccccccccccccc-----cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRN-----FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
..... ....+||+.|+|||++... .+.++.++|||||||++|||++|+.||...... .....+..
T Consensus 215 ~~~~~--~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--------~~~~~i~~ 284 (412)
T 2vd5_A 215 DGTVR--SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--------ETYGKIVH 284 (412)
T ss_dssp TSCEE--CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHT
T ss_pred CCccc--cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--------HHHHHHHh
Confidence 33211 2345799999999999731 136889999999999999999999999653210 11111111
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDR---PPMNEVIEM 412 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~~ 412 (450)
.... .........++.++.+++.+||+ +|.+| |+++|+++.
T Consensus 285 ~~~~---~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 285 YKEH---LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHHH---CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred cccC---cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1000 00111123456789999999999 99998 589999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=315.74 Aligned_cols=222 Identities=22% Similarity=0.287 Sum_probs=178.2
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||+||+|+.. .|..+++++ +||||+++++++.+.+..++|||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E 98 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 98 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 445788999999999999642 134455555 89999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++..... +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 99 ~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 99 YLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp CCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999976432 8999999999999999999995 899999999999999999999999999998653
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
..... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+...
T Consensus 170 ~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------~~~~~~i~~~--- 233 (345)
T 1xjd_A 170 LGDAK---TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMD--- 233 (345)
T ss_dssp CTTCC---BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC---
T ss_pred cCCCc---ccCCCCCcccCChhhhcCC--CCCChhhhHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHhC---
Confidence 32211 3456799999999999874 789999999999999999999999964321 1111111111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMN-EVI 410 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl 410 (450)
....+...+.++.+++.+||+.||++||++. |++
T Consensus 234 -----~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 -----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0111223457789999999999999999997 665
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=307.50 Aligned_cols=240 Identities=24% Similarity=0.373 Sum_probs=187.7
Q ss_pred hhHhhhccccccceEEEEEEEc-----------------------------chhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL-----------------------------DGLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~-----------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
.+.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++.+++..++
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 105 (322)
T 1p4o_A 26 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 105 (322)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEE
Confidence 3456789999999999997422 35778899999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCC----CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeec
Q 013074 209 IYEFMPNGSLEKFVYNGDT----SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDF 284 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 284 (450)
||||+++++|.+++..... ......+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+||
T Consensus 106 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Df 182 (322)
T 1p4o_A 106 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 182 (322)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcC
Confidence 9999999999999865321 0011237899999999999999999995 89999999999999999999999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
|+++.......... .....+|..|+|||++.+. .++.++||||||+++|+|++ |+.||..... ..+..
T Consensus 183 g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~ 251 (322)
T 1p4o_A 183 GMTRDIYETDYYRK-GGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLR 251 (322)
T ss_dssp TCCCGGGGGGCEEG-GGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH--------HHHHH
T ss_pred cccccccccccccc-ccCCCCCCCccChhhhccC--CCCchhhHHHHHHHHHHHHhcCCCccccCCH--------HHHHH
Confidence 99986644332211 2334468899999999774 78999999999999999998 7777754311 00111
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.+.. .........++..+.+++.+||+.||.+|||+.|+++.|+...+
T Consensus 252 ~~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 252 FVME-------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHT-------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHc-------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111 11112223455778999999999999999999999999998654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=301.95 Aligned_cols=227 Identities=19% Similarity=0.296 Sum_probs=181.1
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+++..++||||+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 87 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 87 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecC
Confidence 44567899999999999852 23577889999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC---eEEeeccccccc
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC---PKISDFGLAKLC 290 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFGla~~~ 290 (450)
++++|.+.+..... +++..+..++.|++.||.|||+ .+|+||||||+||+++.++. +||+|||++...
T Consensus 88 ~~~~l~~~~~~~~~------~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 88 TGGELFEDIVAREF------YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred CCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999988875432 8999999999999999999995 89999999999999986655 999999999766
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
..... .....||+.|+|||++.+. .++.++||||||+++++|++|+.||...... .....+....
T Consensus 159 ~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--------~~~~~~~~~~- 223 (284)
T 3kk8_A 159 NDSEA----WHGFAGTPGYLSPEVLKKD--PYSKPVDIWACGVILYILLVGYPPFWDEDQH--------RLYAQIKAGA- 223 (284)
T ss_dssp CSSCB----CCCSCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--------HHHHHHHHTC-
T ss_pred ccCcc----ccCCCCCcCCcCchhhcCC--CCCcccchHHHHHHHHHHHHCCCCCCCCchh--------HHHHHHHhcc-
Confidence 54332 2345689999999999874 7899999999999999999999999653210 0111111100
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
...........+.++.+++.+||+.||++|||++|+++.
T Consensus 224 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 224 ---YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---ccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 001111112345778999999999999999999999974
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=337.54 Aligned_cols=229 Identities=23% Similarity=0.355 Sum_probs=179.7
Q ss_pred hccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
++||+|+||.||+|.+ .+|++++++++|||||++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 3799999999999832 23577899999999999999986 4568999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++..... +++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~~~~------l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~ 524 (635)
T 4fl3_A 454 GPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 524 (635)
T ss_dssp EEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred CCHHHHHhhCCC------CCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence 999999975432 8999999999999999999995 8999999999999999999999999999987755443
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.........+|..|+|||++.+. .++.++|||||||++|||++ |+.||..... ..+...+...
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~--~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~i~~~------ 588 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKG------ 588 (635)
T ss_dssp ----------CGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTT------
T ss_pred ccccccCCCCceeeeChhhhcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC------
Confidence 32223344578899999999764 89999999999999999998 9999865321 1112222111
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.....+..++.++.+++.+||+.||++||++++|++.|+....
T Consensus 589 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 589 -ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1112233456789999999999999999999999999987543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=324.67 Aligned_cols=225 Identities=20% Similarity=0.262 Sum_probs=177.9
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+.+..++||||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 229 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEY 229 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEee
Confidence 45678999999999999852 2356778889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++..... +++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+++....
T Consensus 230 ~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 230 ANGGELFFHLSRERV------FSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp CSSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred CCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999876432 8999999999999999999993 27899999999999999999999999999986433
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .. +...+...
T Consensus 302 ~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~-~~~~i~~~---- 364 (446)
T 4ejn_A 302 DGA---TMKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EK-LFELILME---- 364 (446)
T ss_dssp --------CCSSSCGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHC----
T ss_pred CCc---ccccccCCccccCHhhcCCC--CCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HH-HHHHHHhC----
Confidence 221 13456799999999999774 789999999999999999999999965321 00 11111100
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
....+...+.++.+++.+||+.||.+|| +++|+++.
T Consensus 365 ----~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 365 ----EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 0011223457789999999999999999 99999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=315.78 Aligned_cols=229 Identities=23% Similarity=0.285 Sum_probs=171.2
Q ss_pred hHhhhccccccceEEEEEEE----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
|.+.+.||+|+||+||+++. .+|+.++++++||||+++++++.+....++||||+++|
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~ 101 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGG 101 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCC
Confidence 45678999999999999963 24578889999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC--eEEeeccccccccCCC
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC--PKISDFGLAKLCTTKK 294 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DFGla~~~~~~~ 294 (450)
+|.+++...+. +++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||+++......
T Consensus 102 ~L~~~l~~~~~------~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 102 ELYERICNAGR------FSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp BHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999875432 8999999999999999999995 99999999999999987765 9999999987543222
Q ss_pred CccccccCCCCccccccccccccccCCCC-ccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVS-HKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s-~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
. .....||+.|+|||++.+. .++ .++|||||||++|+|++|+.||........ +...+.......
T Consensus 173 ~----~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~~----- 238 (361)
T 3uc3_A 173 Q----PKSTVGTPAYIAPEVLLRQ--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSVK----- 238 (361)
T ss_dssp ------------CTTSCHHHHHCS--SCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHHHTTC-----
T ss_pred C----CCCCcCCCCcCChhhhcCC--CCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcCC-----
Confidence 1 2334599999999999774 444 448999999999999999999975433211 111111111100
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........++..+.+++.+||+.||++|||+.|+++.
T Consensus 239 --~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 239 --YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0001111245678999999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=318.04 Aligned_cols=229 Identities=20% Similarity=0.263 Sum_probs=171.7
Q ss_pred hccccccceEEEEEEEc------------------chhhhh-hhcCCCceeeeeeEEEe----CCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKLL------------------DGLASI-SRTSHVNVVTLLGFCLE----GNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~------------------~e~~~l-~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~ 219 (450)
+.||+|+||+||+++.. +|+.++ +..+||||+++++++.. ....++||||+++|+|.
T Consensus 68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~ 147 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 147 (400)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHH
T ss_pred ceeeeccCeEEEEEEECCCCCEEEEEEeCcchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHH
Confidence 57999999999999643 345555 34589999999999876 56789999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---CCCeEEeeccccccccCCCCc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ---DFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~~~~~~~~ 296 (450)
+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||+++.......
T Consensus 148 ~~l~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~- 219 (400)
T 1nxk_A 148 SRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 219 (400)
T ss_dssp HHHHCC-------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----
T ss_pred HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc-
Confidence 99976542 238999999999999999999995 89999999999999997 78999999999986643321
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||............ ...+.... .. .
T Consensus 220 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~i~~~~-~~---~ 286 (400)
T 1nxk_A 220 ---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQ-YE---F 286 (400)
T ss_dssp ----------CTTCCGGGSCCC--CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH----HHHHHHTC-CC---C
T ss_pred ---cccCCCCCCccCHhhcCCC--CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH----HHHHHcCc-cc---C
Confidence 2345689999999999764 7899999999999999999999999755332211111 11111000 00 0
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.......++.++.+++.+||+.||++|||++|+++.
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001112356778999999999999999999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=310.59 Aligned_cols=245 Identities=20% Similarity=0.175 Sum_probs=181.9
Q ss_pred hhHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
.|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.+++..++|
T Consensus 27 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 106 (345)
T 3hko_A 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLV 106 (345)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred heeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEE
Confidence 355678999999999999952 1367889999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCC----------------------------------CCCccCCHHHHHHHHHHHHHHHHHhhc
Q 013074 210 YEFMPNGSLEKFVYNGDTS----------------------------------KPCQYLRWEKMYEIVIGIAKGLEYLHR 255 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~----------------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~ 255 (450)
|||+++|+|.+++...... .....+++..++.++.|++.||+|||+
T Consensus 107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 186 (345)
T 3hko_A 107 MELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN 186 (345)
T ss_dssp EECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999988521100 001224677888999999999999995
Q ss_pred CCCCceEeeeeccccEEEcCCC--CeEEeeccccccccCCCC-ccccccCCCCccccccccccccccCCCCccCchHhHH
Q 013074 256 GCSTRILHFDIKPHNILLDQDF--CPKISDFGLAKLCTTKKG-IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFG 332 (450)
Q Consensus 256 ~~~~~ivH~Dikp~NIll~~~~--~~kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlG 332 (450)
.+|+||||||+||+++.++ .+||+|||+++....... .........||+.|+|||++.+....++.++||||||
T Consensus 187 ---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG 263 (345)
T 3hko_A 187 ---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263 (345)
T ss_dssp ---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred ---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence 8999999999999998776 899999999986543221 1111234569999999999976435789999999999
Q ss_pred HHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 333 MMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 333 vvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+++|||++|+.||...... ..+........ ..........+..+.+++.+||+.||.+||++.|+++.
T Consensus 264 ~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 264 VLLHLLLMGAVPFPGVNDA-------DTISQVLNKKL-----CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCC-----CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred HHHHHHHHCCCCCCCCChH-------HHHHHHHhccc-----ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 9999999999999643211 11111111100 00111122345778999999999999999999999874
Q ss_pred --hhccc
Q 013074 413 --LQGST 417 (450)
Q Consensus 413 --L~~~~ 417 (450)
+++..
T Consensus 332 p~~~~~~ 338 (345)
T 3hko_A 332 PWISQFS 338 (345)
T ss_dssp HHHHTTS
T ss_pred hhhccCh
Confidence 54443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=306.34 Aligned_cols=229 Identities=21% Similarity=0.280 Sum_probs=183.2
Q ss_pred HhhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
..|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.++...+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 3456778999999999999952 24677889999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC----CeEEee
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF----CPKISD 283 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~D 283 (450)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++ .+||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKE------SLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEECCCCSCBHHHHHHTCS------CEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEcCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999997543 28999999999999999999995 8999999999999999887 799999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
||++........ .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...... . ...
T Consensus 163 fg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~-~~~ 228 (321)
T 2a2a_A 163 FGLAHEIEDGVE----FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------E-TLA 228 (321)
T ss_dssp CTTCEECCTTCC----CCCCCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHH
T ss_pred CccceecCcccc----ccccCCCCCccCcccccCC--CCCCccccHHHHHHHHHHHHCCCCCCCCCHH-------H-HHH
Confidence 999987654322 2344589999999999764 7899999999999999999999999643210 0 111
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+.... ...........+..+.+++.+||+.||++|||++|+++.
T Consensus 229 ~i~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 229 NITSVS----YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHTTC----CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHhcc----cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111000 000011112345678999999999999999999999873
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=301.67 Aligned_cols=225 Identities=22% Similarity=0.322 Sum_probs=182.3
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.+++..++||||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 95 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEF 95 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEe
Confidence 44678899999999999953 2357788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++...+. +++..++.++.|++.||.||| +.+|+|+||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 96 APRGELYKELQKHGR------FDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred CCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999976432 899999999999999999999 48999999999999999999999999999876543
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.. .....|+..|+|||++.+. .++.++||||||+++|+|++|+.||...... . ....+...
T Consensus 167 ~~-----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~-~~~~~~~~---- 227 (284)
T 2vgo_A 167 LR-----RRTMCGTLDYLPPEMIEGK--THDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-------E-THRRIVNV---- 227 (284)
T ss_dssp SC-----BCCCCSCGGGCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHHHHHTT----
T ss_pred cc-----cccccCCCCcCCHHHhccC--CCCcccchhhHHHHHHHHHHCCCCCCCCCHh-------H-HHHHHhcc----
Confidence 22 2344689999999999874 7899999999999999999999999643210 0 11111100
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQG 415 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 415 (450)
....+...+..+.+++.+||+.||.+|||++|+++. ++.
T Consensus 228 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 228 ----DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred ----ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 011112345678999999999999999999999963 544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=308.86 Aligned_cols=244 Identities=20% Similarity=0.365 Sum_probs=178.4
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+++..++||||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 113 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 113 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEec
Confidence 45678999999999999852 2357788999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++...... ...+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 114 ~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 114 ADAGDLSRMIKHFKKQ--KRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp CCSCBHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred CCCCCHHHHHHHhccc--ccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999998642111 1238999999999999999999995 8999999999999999999999999999886644
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... .....|+..|+|||++.+. .++.++||||||+++|+|++|+.||...... ... +...+....
T Consensus 189 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~~--- 254 (310)
T 2wqm_A 189 KTTA---AHSLVGTPYYMSPERIHEN--GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYS-LCKKIEQCD--- 254 (310)
T ss_dssp -------------CCSSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTC---CC-----HHH-HHHHHHTTC---
T ss_pred CCcc---ccccCCCeeEeChHHhCCC--CCCchhhHHHHHHHHHHHHhCCCCCcccchh-----HHH-HHHHhhccc---
Confidence 3221 2234589999999999774 7899999999999999999999998643211 001 111111100
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCC
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPP 424 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~ 424 (450)
.........+.++.+++.+||+.||++|||++||++.|+.+.+....|+
T Consensus 255 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 255 ---YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp ---SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred ---CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 0011112345679999999999999999999999999999887765544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=314.72 Aligned_cols=222 Identities=20% Similarity=0.227 Sum_probs=175.7
Q ss_pred hHhhhccccccceEEEEEEEcc--------------------------hhhh-hhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLD--------------------------GLAS-ISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~--------------------------e~~~-l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||+||+++... |..+ ++.++||||+++++++.+.+..++|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 4567899999999999996321 1222 466899999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++..... +++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 120 YINGGELFYHLQRERC------FLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred CCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999976432 8899999999999999999995 899999999999999999999999999998643
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.... .....+||+.|+|||++.+. .++.++|||||||++|||++|..||..... ..+.+.+...
T Consensus 191 ~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~--- 254 (373)
T 2r5t_A 191 EHNS---TTSTFCGTPEYLAPEVLHKQ--PYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNK--- 254 (373)
T ss_dssp CCCC---CCCSBSCCCCCCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSBH--------HHHHHHHHHS---
T ss_pred cCCC---ccccccCCccccCHHHhCCC--CCCchhhhHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhc---
Confidence 3221 13455799999999999874 789999999999999999999999964321 0111111111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 410 (450)
.......++..+.+++.+||+.||.+||++.+.+
T Consensus 255 -----~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 255 -----PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp -----CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred -----ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 0011123456789999999999999999985433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=303.23 Aligned_cols=236 Identities=24% Similarity=0.398 Sum_probs=186.8
Q ss_pred HHHHHhhHhhhccccccceEEEEEEEc-------------------chhhhhhhcCCCceeeeeeEEEe-----------
Q 013074 153 DVKKITNSFKDKLGQGGFGGVYKGKLL-------------------DGLASISRTSHVNVVTLLGFCLE----------- 202 (450)
Q Consensus 153 ei~~~~~~~~~~LG~G~fg~Vy~~~~~-------------------~e~~~l~~l~HpnIv~l~~~~~~----------- 202 (450)
+.....+.+.+.||+|+||.||+|+.. +|++++++++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 344455667789999999999999642 46888999999999999998864
Q ss_pred -----CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC
Q 013074 203 -----GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF 277 (450)
Q Consensus 203 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 277 (450)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+ .+|+|+||||+||++++++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRG----EKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETT
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCC
Confidence 4458999999999999999975432 238999999999999999999995 8999999999999999999
Q ss_pred CeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 013074 278 CPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF 357 (450)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~ 357 (450)
.+||+|||++........ .....||..|+|||++.+. .++.++||||||+++|+|++|..|+...
T Consensus 160 ~~kl~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~~~~~~~~--------- 224 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK----RTRSKGTLRYMSPEQISSQ--DYGKEVDLYALGLILAELLHVCDTAFET--------- 224 (284)
T ss_dssp EEEECCCTTCEESSCCSC----CCCCCSCCTTSCHHHHHCS--CCCTHHHHHHHHHHHHHHHSCCSSHHHH---------
T ss_pred CEEECcchhheecccccc----ccccCCcccccChhhhccC--CCcchhhhHHHHHHHHHHHhcCCcchhH---------
Confidence 999999999987654322 2334589999999999774 7899999999999999999998776321
Q ss_pred hhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 358 PHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 358 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
.. ....+.. ... ....+..+.+++.+||+.||.+|||+.|+++.|+.......
T Consensus 225 ~~-~~~~~~~-------~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 225 SK-FFTDLRD-------GII---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HH-HHHHHHT-------TCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HH-HHHHhhc-------ccc---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 00 1111110 001 12234668899999999999999999999999998776543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=308.27 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=180.5
Q ss_pred HhhhccccccceEEEEEEE----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCC
Q 013074 160 SFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGS 217 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gs 217 (450)
.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+....++||||+++++
T Consensus 36 ~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 115 (319)
T 2y4i_B 36 EIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT 115 (319)
T ss_dssp ECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred EEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence 4567899999999999852 356888999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC--
Q 013074 218 LEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG-- 295 (450)
Q Consensus 218 L~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~-- 295 (450)
|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++ ++.+||+|||++........
T Consensus 116 L~~~l~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 116 LYSVVRDAK-----IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp HHHHTTSSC-----CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred HHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 999996543 238899999999999999999995 8999999999999998 67999999999876532111
Q ss_pred ccccccCCCCccccccccccccc-------cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 296 IVSSLLGARGTIGYIALEVFSRN-------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~-------~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
.........||..|+|||++... ...++.++||||||+++|||++|+.||..... ..+...+...
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~ 258 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--------EAIIWQMGTG 258 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--------HHHHHHHHTT
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHhccC
Confidence 11112344589999999998652 13578999999999999999999999964321 0111111111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCCCCCC
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPPTPFL 428 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~p~~ 428 (450)
... ......++.++.+++.+||+.||++|||+++++++|+.+.......+.|..
T Consensus 259 ~~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~ 312 (319)
T 2y4i_B 259 MKP------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGH 312 (319)
T ss_dssp CCC------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------------
T ss_pred CCC------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCcc
Confidence 000 001112446788999999999999999999999999998876554444443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=308.44 Aligned_cols=237 Identities=20% Similarity=0.285 Sum_probs=177.1
Q ss_pred hHhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.++||+|+||+||+|+.. +|++++++++||||+++++++.+++..++||||+
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeC
Confidence 345678999999999999532 3678899999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++..... +++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++......
T Consensus 85 ~~~~l~~~~~~~~~------~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 85 DHTVLHELDRYQRG------VPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp SEEHHHHHHHTSSC------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred CCchHHHHHhhhcC------CCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999888765432 8999999999999999999995 89999999999999999999999999999876543
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh------
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ------ 367 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~------ 367 (450)
... .....||..|+|||++.+. ..++.++||||||+++++|++|+.||........ ...+.+....
T Consensus 156 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~ 227 (311)
T 4agu_A 156 SDY---YDDEVATRWYRSPELLVGD-TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ----LYLIRKTLGDLIPRHQ 227 (311)
T ss_dssp -------------GGGCCHHHHHTC-SCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCSCCHHHH
T ss_pred ccc---cCCCcCCccccChHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHHhcccccccc
Confidence 221 2334589999999999763 4689999999999999999999999965422110 0001000000
Q ss_pred -----hhhh---hhcc-----cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 368 -----DREF---KLLG-----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 368 -----~~~~---~~~~-----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... .... ........++..+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 228 QVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 0000 0000012345678999999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=312.27 Aligned_cols=259 Identities=15% Similarity=0.185 Sum_probs=194.9
Q ss_pred hhHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceee---------------e
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVT---------------L 196 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~---------------l 196 (450)
.|.+.+.||+|+||.||+|+.. +|++++++++||||++ +
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~ 122 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC 122 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETTSTHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEecccchHHHHHHHHHHhcccchhhhhhhhccCCccCccch
Confidence 3456789999999999999643 3577888999999987 6
Q ss_pred eeEEEe-CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC
Q 013074 197 LGFCLE-GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 197 ~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~ 275 (450)
++++.. +...++||||+ +++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 123 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~~ 194 (352)
T 2jii_A 123 MGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK----HVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDP 194 (352)
T ss_dssp CEEEEETTTEEEEEEECC-CEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEET
T ss_pred hhccccCCcEEEEEecCC-CcCHHHHHHhCCc----CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEcC
Confidence 777776 67889999999 9999999976521 239999999999999999999995 89999999999999999
Q ss_pred CC--CeEEeeccccccccCCCCcc----ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCC
Q 013074 276 DF--CPKISDFGLAKLCTTKKGIV----SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV 349 (450)
Q Consensus 276 ~~--~~kl~DFGla~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~ 349 (450)
++ .+||+|||+++......... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC--GPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccC--CCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 98 99999999998765432211 112334699999999999874 78999999999999999999999997543
Q ss_pred CCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCCCCCCC
Q 013074 350 DNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPPTPFLS 429 (450)
Q Consensus 350 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~p~~~ 429 (450)
.... .+...... ..... ..... .......++.++.+++.+||+.||++|||++|+++.|+.+.+.....+...+.
T Consensus 273 ~~~~--~~~~~~~~-~~~~~-~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~d 347 (352)
T 2jii_A 273 PNTE--DIMKQKQK-FVDKP-GPFVG-PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIG 347 (352)
T ss_dssp TCHH--HHHHHHHH-HHHSC-CCEEC-TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCC
T ss_pred cCHH--HHHHHHHh-ccCCh-hhhhh-hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCcccc
Confidence 1110 01000000 00000 00000 00000123577999999999999999999999999999999887766555444
Q ss_pred CC
Q 013074 430 SP 431 (450)
Q Consensus 430 ~~ 431 (450)
++
T Consensus 348 w~ 349 (352)
T 2jii_A 348 LP 349 (352)
T ss_dssp CC
T ss_pred Cc
Confidence 43
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=302.28 Aligned_cols=229 Identities=24% Similarity=0.324 Sum_probs=175.2
Q ss_pred hhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.|.+.++||+|+||.||+++. .+|++++++++||||+++++++.+....++||||+
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 102 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETC 102 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeC
Confidence 456678999999999999852 24678899999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE---cCCCCeEEeeccccccc
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLC 290 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~ 290 (450)
++++|.+++...... ...+++..++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++...
T Consensus 103 ~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 103 EGGELLERIVSAQAR--GKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp SCCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred CCCcHHHHHHhhhhc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999988543110 1238999999999999999999995 899999999999999 45678999999999866
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
..... .....||..|+|||++.+ .++.++||||||+++++|++|+.||..... .. +.......
T Consensus 178 ~~~~~----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~il~~ll~g~~pf~~~~~-------~~-~~~~~~~~-- 240 (285)
T 3is5_A 178 KSDEH----STNAAGTALYMAPEVFKR---DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-------EE-VQQKATYK-- 240 (285)
T ss_dssp -------------CTTGGGCCHHHHTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHC--
T ss_pred CCccc----CcCcccccCcCChHHhcc---CCCcccCeehHHHHHHHHHhCCCCCCCCCH-------HH-HHhhhccC--
Confidence 54322 234458999999999864 688999999999999999999999964321 00 11110000
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
...........+.++.+++.+||+.||++|||++|+++
T Consensus 241 ---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 241 ---EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00001111123567889999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=309.35 Aligned_cols=225 Identities=20% Similarity=0.251 Sum_probs=176.6
Q ss_pred hhHhhhccccccceEEEEEEE------------------------------cchhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL------------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~------------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
.|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+++..+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 345678999999999998753 23577889999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+++++|.+++...+. +++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREGI------FMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEECCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEeCCCCCcHHHHHHhCCC------CCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999975432 8899999999999999999995 89999999999999999999999999998
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
+........ .....||+.|+|||++.+. .++.++||||||+++|||++|+.||..... .. ....+..
T Consensus 169 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~-~~~~i~~ 235 (327)
T 3a62_A 169 KESIHDGTV---THTFCGTIEYMAPEILMRS--GHNRAVDWWSLGALMYDMLTGAPPFTGENR-------KK-TIDKILK 235 (327)
T ss_dssp -------------CTTSSCCTTSCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HH-HHHHHHH
T ss_pred cccccCCcc---ccccCCCcCccCHhhCcCC--CCCCcccchhHHHHHHHHHHCCCCCCCCCH-------HH-HHHHHHh
Confidence 764332211 2345699999999999774 789999999999999999999999964321 01 1111111
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
. ....+...+.++.+++.+||+.||++|| +++|+++.
T Consensus 236 ~--------~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 236 C--------KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp T--------CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred C--------CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 0 0111223457789999999999999999 77788753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=312.81 Aligned_cols=232 Identities=22% Similarity=0.245 Sum_probs=182.1
Q ss_pred hHhhhccccccceEEEEEEE------------------------------cchhhhhhhc-CCCceeeeeeEEEeCCceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------------LDGLASISRT-SHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~ 207 (450)
|.+.+.||+|+||.||+++. .+|+++++++ +||||+++++++.++...+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 44678899999999998853 2357778888 6999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+++++|.+++..... +++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 136 lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEeecCCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999976432 8999999999999999999995 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
+......... .....||+.|+|||++.+....++.++|||||||++|||++|+.||......... .. +.....
T Consensus 207 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~-~~~~~~- 279 (355)
T 1vzo_A 207 KEFVADETER--AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AE-ISRRIL- 279 (355)
T ss_dssp EECCGGGGGG--GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HH-HHHHHH-
T ss_pred eecccCCCCc--ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH---HH-HHHHHh-
Confidence 8664332211 2344699999999999864346789999999999999999999999754322211 11 111110
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHHh
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEML 413 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L 413 (450)
......+..++..+.+++.+||+.||++|| +++|+++..
T Consensus 280 -------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 280 -------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -------ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 011122234556788999999999999999 999998763
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=298.71 Aligned_cols=230 Identities=24% Similarity=0.317 Sum_probs=181.6
Q ss_pred hhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.+.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+++..++||||+
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEec
Confidence 345678999999999999953 23577788899999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++.... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++......
T Consensus 88 ~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 88 SGGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp TTEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred CCCcHHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999986432 38999999999999999999995 89999999999999999999999999999865432
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
... .......||..|+|||.+.+. ...+.++||||||+++++|++|+.||....... ..+..+.. ..
T Consensus 159 ~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~-----~~---- 225 (276)
T 2yex_A 159 NRE-RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKE-----KK---- 225 (276)
T ss_dssp TEE-CCBCCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS--HHHHHHHT-----TC----
T ss_pred cch-hcccCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH--HHHHHhhh-----cc----
Confidence 211 112345689999999999764 234789999999999999999999997543221 11111110 00
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.........+..+.+++.+||+.||++|||++|+++
T Consensus 226 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000111234567889999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=334.52 Aligned_cols=238 Identities=26% Similarity=0.421 Sum_probs=189.1
Q ss_pred HhhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
..+.+.++||+|+||.||+|+. .+|++++++++||||+++++++.+ +..++||||+++
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~ 345 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSK 345 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTT
T ss_pred hhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcC
Confidence 3445678899999999999963 246888999999999999999876 678999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 346 gsL~~~l~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 346 GSLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp EEHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred CcHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 999999964321 238999999999999999999995 8999999999999999999999999999987643211
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.......++..|+|||++... .++.++||||||+++|||++ |+.||..... ..+...+...
T Consensus 419 --~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~--------~~~~~~i~~~------ 480 (535)
T 2h8h_A 419 --TARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERG------ 480 (535)
T ss_dssp --HTTCSTTSCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH--------HHHHHHHHTT------
T ss_pred --ecccCCcCcccccCHHHhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcC------
Confidence 112334477899999999764 79999999999999999999 8888864321 1111111111
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
........++..+.+++.+||+.||++|||+++|++.|+.+.....
T Consensus 481 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 481 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 1111223456789999999999999999999999999999876543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=312.15 Aligned_cols=224 Identities=19% Similarity=0.245 Sum_probs=178.5
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+.+.+.||+|+||+||+++.. .|..+++.+ +||||+++++++.+.+..++|||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E 101 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 101 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEe
Confidence 456789999999999999632 234556665 79999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++...+. +++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 102 YVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred CCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999975432 8999999999999999999995 899999999999999999999999999998643
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+.+.+...
T Consensus 173 ~~~~---~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~--- 236 (353)
T 2i0e_A 173 WDGV---TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH--- 236 (353)
T ss_dssp CTTC---CBCCCCSCGGGCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC---
T ss_pred cCCc---ccccccCCccccChhhhcCC--CcCCcccccchHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhC---
Confidence 2221 13456799999999999874 789999999999999999999999964321 1111111111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIEM 412 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 412 (450)
....+...+.++.+++.+||+.||.+||+ ++|+++.
T Consensus 237 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 -----NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 01112245678899999999999999995 4677643
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=313.06 Aligned_cols=242 Identities=24% Similarity=0.349 Sum_probs=184.7
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
.+.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+....++
T Consensus 31 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (327)
T 2yfx_A 31 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFI 110 (327)
T ss_dssp GCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred heEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEE
Confidence 345678999999999999862 135778889999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCC-CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---CCCeEEeec
Q 013074 209 IYEFMPNGSLEKFVYNGDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ---DFCPKISDF 284 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DF 284 (450)
||||+++++|.+++....... ....+++..++.++.|++.||.|||+ .+|+||||||+||+++. +..+||+||
T Consensus 111 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~Df 187 (327)
T 2yfx_A 111 LMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDF 187 (327)
T ss_dssp EEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred EEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECcc
Confidence 999999999999998654321 12348999999999999999999995 89999999999999984 456999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
|++........... .....+|..|+|||++.+. .++.++||||||+++|+|++ |..||..... ..+..
T Consensus 188 g~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~ 256 (327)
T 2yfx_A 188 GMARDIYRASYYRK-GGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN--------QEVLE 256 (327)
T ss_dssp HHHHHHHC-------CCGGGSCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--------HHHHH
T ss_pred cccccccccccccc-CCCcCCCcceeCHhHhcCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCcCH--------HHHHH
Confidence 99986543322111 2234478899999999764 78999999999999999998 8888864321 00111
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
.+... ........++..+.+++.+||+.||.+||+++|+++.|+......
T Consensus 257 ~~~~~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 257 FVTSG-------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HHhcC-------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 11111 111122334567899999999999999999999999999866543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=302.84 Aligned_cols=237 Identities=21% Similarity=0.264 Sum_probs=173.8
Q ss_pred hccccccceEEEEEEE-----------------------cchhhhhhh-cCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 163 DKLGQGGFGGVYKGKL-----------------------LDGLASISR-TSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
+.||+|+||.||+|+. .+|++++.+ .+||||+++++++.+++..++||||+++++|
T Consensus 19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 98 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI 98 (316)
T ss_dssp CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence 5799999999999852 235777777 4799999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC---eEEeeccccccccCCCC
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC---PKISDFGLAKLCTTKKG 295 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DFGla~~~~~~~~ 295 (450)
.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++........
T Consensus 99 ~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 99 LSHIHKRR------HFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp HHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred HHHHhccC------CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 99997643 28999999999999999999995 89999999999999998776 99999999876542211
Q ss_pred c----cccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch-------hhhh
Q 013074 296 I----VSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF-------PHWI 361 (450)
Q Consensus 296 ~----~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~-------~~~i 361 (450)
. ........||..|+|||++.+. ...++.++||||||+++|||++|+.||............ ...+
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 249 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML 249 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence 0 1112344599999999998641 125788999999999999999999999765432211000 0001
Q ss_pred hhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 362 YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+.+.... ..........++..+.+++.+||+.||++|||++|+++.
T Consensus 250 ~~~i~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 250 FESIQEGK----YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHCC----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhccC----cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11111100 000001112345789999999999999999999999984
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=300.70 Aligned_cols=223 Identities=24% Similarity=0.373 Sum_probs=176.0
Q ss_pred HhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe----CCceEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE----GNNRALIY 210 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~ 210 (450)
.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.. ....++||
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 108 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEE
Confidence 3456899999999999952 235788899999999999999876 35689999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc--eEeeeeccccEEEc-CCCCeEEeecccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR--ILHFDIKPHNILLD-QDFCPKISDFGLA 287 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dikp~NIll~-~~~~~kl~DFGla 287 (450)
||+++++|.+++..... +++..++.++.|++.||.|||+ .+ |+|+||||+||+++ +++.+||+|||++
T Consensus 109 e~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~ 179 (290)
T 1t4h_A 109 ELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 179 (290)
T ss_dssp ECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred EecCCCCHHHHHHHccC------CCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence 99999999999976432 8899999999999999999995 77 99999999999998 7899999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
....... .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...... ..+......
T Consensus 180 ~~~~~~~-----~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~ 244 (290)
T 1t4h_A 180 TLKRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTS 244 (290)
T ss_dssp GGCCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTT
T ss_pred ccccccc-----cccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-------HHHHHHHhc
Confidence 7654332 223458999999998864 6899999999999999999999999653211 111111111
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... ........+.++.+++.+||+.||.+|||++|+++.
T Consensus 245 ~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 245 GVK------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TCC------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCC------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 100 011112233578999999999999999999999863
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=311.55 Aligned_cols=224 Identities=25% Similarity=0.344 Sum_probs=178.1
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+...+.||+|+||.||+|+. .+|++++++++||||+++++++.+++..++||||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 135 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 135 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEec
Confidence 44567899999999999952 2457888999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+. |+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 136 ~~-g~l~~~l~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 136 CL-GSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp CS-EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred CC-CCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 96 68888875432 238999999999999999999995 8999999999999999999999999999986643
Q ss_pred CCCccccccCCCCcccccccccccc-ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
. ....||+.|+|||++.. ..+.++.++||||||+++|||++|+.||..... ...+..... ..
T Consensus 207 ~-------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~~-~~-- 269 (348)
T 1u5q_A 207 A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQ-NE-- 269 (348)
T ss_dssp B-------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHH-SC--
T ss_pred C-------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHh-cC--
Confidence 2 23458999999999853 124789999999999999999999999864321 111111111 00
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.........+..+.+++.+||+.||++|||++++++.
T Consensus 270 ----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 ----SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0011112345678899999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=299.75 Aligned_cols=224 Identities=24% Similarity=0.357 Sum_probs=161.3
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+.+..++||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 34567899999999999963 2356778889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++.... ..+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 93 CHNGEMNRYLKNRV-----KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp CTTEEHHHHHHTCS-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred CCCCcHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999997543 238999999999999999999995 8999999999999999999999999999987643
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... .....||+.|+|||.+.+. .++.++||||||+++++|++|+.||........ .......
T Consensus 165 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~----- 227 (278)
T 3cok_A 165 PHEK---HYTLCGTPNYISPEIATRS--AHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------LNKVVLA----- 227 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS-----
T ss_pred CCCc---ceeccCCCCcCCcchhcCC--CCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-------HHHHhhc-----
Confidence 3211 1234589999999999774 788999999999999999999999975432211 0000000
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
....+...+.++.+++.+||+.||++|||++++++
T Consensus 228 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 ----DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ----ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 00111224567889999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=307.93 Aligned_cols=242 Identities=26% Similarity=0.391 Sum_probs=187.5
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeCC-ce
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEGN-NR 206 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~-~~ 206 (450)
.+.+.+.||+|+||.||+|+. .+|+.+++++ +||||+++++++.+.+ ..
T Consensus 28 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 107 (316)
T 2xir_A 28 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPL 107 (316)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCC
T ss_pred heeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCce
Confidence 445678999999999999952 1356778888 7999999999988754 58
Q ss_pred EEEEEecCCCChhhhhhcCCCCC----------CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSK----------PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD 276 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~ 276 (450)
++||||+++++|.+++....... ....+++..++.++.|++.||.|||+ .+|+||||||+||+++.+
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~ 184 (316)
T 2xir_A 108 MVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK 184 (316)
T ss_dssp EEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCC
Confidence 99999999999999997654210 01237899999999999999999995 899999999999999999
Q ss_pred CCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCcc
Q 013074 277 FCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEV 355 (450)
Q Consensus 277 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~ 355 (450)
+.+||+|||+++.......... .....+|..|+|||++.+. .++.++||||||+++|+|++ |..||.......
T Consensus 185 ~~~kl~Dfg~~~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--- 258 (316)
T 2xir_A 185 NVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--- 258 (316)
T ss_dssp GCEEECCCGGGSCTTTCTTSEE-ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH---
T ss_pred CCEEECCCccccccccCcccee-ccCCCcceeecCchhhccc--cccchhHHHHHHHHHHHHHhCCCCCCcccchhH---
Confidence 9999999999987644332211 2334578899999999774 78999999999999999998 888886542211
Q ss_pred chhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 356 YFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 356 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
.+...+.... ........+.++.+++.+||+.||.+|||+.|+++.|+.+.+.
T Consensus 259 ----~~~~~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 259 ----EFCRRLKEGT-------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp ----HHHHHHHHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHhccCc-------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 1111111111 1111223456789999999999999999999999999987654
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=309.93 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=187.5
Q ss_pred hHhhhccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEeCC--ceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLEGN--NRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~--~~~lV 209 (450)
+.+.+.||+|+||.||++++ .+|++++++++||||+++++++...+ ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 44678999999999999863 23577899999999999999987654 78999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++++|.+++..... .+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++..
T Consensus 123 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKE-----RIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp ECCCTTCBHHHHHHHSTT-----SSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EECCCCCCHHHHHHhccc-----CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 999999999999976532 28999999999999999999995 8999999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCC----Cccchhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS----SEVYFPHWIYRHV 365 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~----~~~~~~~~i~~~~ 365 (450)
...............++..|+|||.+.+. .++.++||||||++++||++|..|+....... .......+....+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTES--KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL 272 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred ccccccccccccCCCCceeEECchhhcCC--CCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence 76544332222334577889999999774 68899999999999999999998875321000 0000000000000
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
.. .............++.++.+++.+||+.||++|||+.|+++.|+.+.+.
T Consensus 273 ~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 273 IE---LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HH---HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH---HhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 00 0000111122334567899999999999999999999999999987654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=319.78 Aligned_cols=241 Identities=20% Similarity=0.260 Sum_probs=186.0
Q ss_pred hHhhhccccccceEEEEEEE---------------------cchhhhhhhcCC-CceeeeeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSH-VNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
|.+.++||+|+||.||+|+. ..|+++++.++| ++|..+..++.++...++||||+ ++
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~ 87 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GP 87 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CC
Confidence 44578899999999999963 235778888887 55666667777888899999999 99
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE---cCCCCeEEeeccccccccCC
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~~~~ 293 (450)
+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.....
T Consensus 88 sL~~ll~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 88 SLEDLFNFCSR-----KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp BHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CHHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999975432 28999999999999999999995 899999999999999 68899999999999876544
Q ss_pred CCcc----ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 294 KGIV----SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 294 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
.... .......||..|+|||++.+. .++.++|||||||++|||++|+.||...........+ ..+..
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~-----~~i~~-- 230 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-----EKISE-- 230 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH-----HHHHH--
T ss_pred ccccccccccccccCCCccccCHHHhcCC--CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH-----HHHhh--
Confidence 3211 112355699999999999875 7899999999999999999999999764332211111 11111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.............++.++.+++.+||+.||++||++++|+++|+.+..
T Consensus 231 -~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 231 -KKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp -HHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred -ccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111111112223346789999999999999999999999999987644
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=307.64 Aligned_cols=227 Identities=25% Similarity=0.319 Sum_probs=182.3
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+++..++||||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 122 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 122 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEec
Confidence 34567899999999999852 2357788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++.....
T Consensus 123 ~~~~~L~~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 123 CRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999886543 28999999999999999999995 8999999999999999999999999999987643
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... .....||..|+|||++.+. .++.++||||||+++|+|++|+.||..... .. ....+...
T Consensus 194 ~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~-~~~~~~~~---- 256 (335)
T 2owb_A 194 DGER---KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KE-TYLRIKKN---- 256 (335)
T ss_dssp TTCC---BCCCCSCCSSCCHHHHHTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHHT----
T ss_pred Cccc---ccccCCCccccCHHHhccC--CCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HH-HHHHHhcC----
Confidence 3221 2345689999999999774 788999999999999999999999964321 01 11111100
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQG 415 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 415 (450)
....+..+...+.+++.+||+.||++|||++|+++. +..
T Consensus 257 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~ 297 (335)
T 2owb_A 257 ----EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS 297 (335)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred ----CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 001112344678899999999999999999999973 544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=304.41 Aligned_cols=236 Identities=21% Similarity=0.257 Sum_probs=178.1
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++.. +|+.++++++||||+++++++.+++..++||||
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRL 115 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEe
Confidence 345778999999999999521 357788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++.... .+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||++.....
T Consensus 116 ~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 116 INGVDLAAMLRRQG------PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp CCCEEHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred cCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999997643 28999999999999999999995 8999999999999999999999999999886654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... ......|+..|+|||++.+. .++.++||||||+++|+|++|+.||..... ..+...+...
T Consensus 187 ~~~~--~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~~---- 250 (309)
T 2h34_A 187 EKLT--QLGNTVGTLYYMAPERFSES--HATYRADIYALTCVLYECLTGSPPYQGDQL--------SVMGAHINQA---- 250 (309)
T ss_dssp ------------CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSCHH--------HHHHHHHHSC----
T ss_pred cccc--cccccCCCcCccCHHHHcCC--CCCchHhHHHHHHHHHHHHHCCCCCCCchH--------HHHHHHhccC----
Confidence 3211 12344589999999999774 789999999999999999999999964311 0111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcccccc
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-PMNEVIEMLQGSTEAL 420 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~~l 420 (450)
..........++.++.+++.+||+.||++|| +++++++.|+......
T Consensus 251 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 251 -IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp -CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred -CCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0001112234556789999999999999999 9999999999876553
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=304.40 Aligned_cols=236 Identities=22% Similarity=0.368 Sum_probs=179.7
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
.+.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.++. .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 345678899999999999852 13467788899999999999987764 899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
|+||+++++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.
T Consensus 98 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEecccCCCHHHHHHhcc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence 999999999999997542 238999999999999999999995 899999999999999999999999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
................+|..|+|||++.+. .++.++||||||+++|+|++ |+.||..... .. +...+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~-~~~~~~~ 239 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQ-ILHKIDK 239 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HH-HHHHHHT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCC--CCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------HH-HHHHHHc
Confidence 775544332223344578899999999764 67899999999999999999 9998864321 01 1111110
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
. .........++..+.+++.+||+.||++|||++++++.|++...
T Consensus 240 ~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 240 E------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp S------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred c------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0 01111223456789999999999999999999999999987653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=304.86 Aligned_cols=241 Identities=23% Similarity=0.321 Sum_probs=177.6
Q ss_pred HHHHhhHhhhccccccceEEEEEEEc----------------------------chhhhhhhc---CCCceeeeeeEEEe
Q 013074 154 VKKITNSFKDKLGQGGFGGVYKGKLL----------------------------DGLASISRT---SHVNVVTLLGFCLE 202 (450)
Q Consensus 154 i~~~~~~~~~~LG~G~fg~Vy~~~~~----------------------------~e~~~l~~l---~HpnIv~l~~~~~~ 202 (450)
+....|.+.++||+|+||+||+|+.. +|+.+++++ +||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 33445667789999999999999521 234455544 59999999999987
Q ss_pred CC-----ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC
Q 013074 203 GN-----NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF 277 (450)
Q Consensus 203 ~~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~ 277 (450)
.. ..++||||+. ++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPP----PGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGG 157 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTS
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCC
Confidence 65 4789999995 699999976543 228999999999999999999995 8999999999999999999
Q ss_pred CeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch
Q 013074 278 CPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF 357 (450)
Q Consensus 278 ~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~ 357 (450)
.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||....... .
T Consensus 158 ~~kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~ 227 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMA----LTPVVVTLWYRAPEVLLQS--TYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD----Q 227 (308)
T ss_dssp CEEECSCSCTTTSTTCCC----SGGGGCCCSSCCHHHHHTS--CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH----H
T ss_pred CEEEeeCccccccCCCcc----cCCccccccccCchHHcCC--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH----H
Confidence 999999999986644322 2334589999999999774 78999999999999999999999996542110 0
Q ss_pred hhhhhhhhhhhhhhh-----------hc----ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 358 PHWIYRHVEQDREFK-----------LL----GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 358 ~~~i~~~~~~~~~~~-----------~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
...+.+......... .. ........+++..+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 011111100000000 00 00000112345778999999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=322.34 Aligned_cols=227 Identities=26% Similarity=0.361 Sum_probs=179.0
Q ss_pred hhHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
.|.+.++||+|+||+||+|+. .+|+.++++++||||+++++++.+....++||||
T Consensus 38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 117 (494)
T 3lij_A 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMEC 117 (494)
T ss_dssp HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 456678999999999999852 2468889999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---CCCeEEeecccccc
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ---DFCPKISDFGLAKL 289 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~ 289 (450)
+++|+|.+++..... +++..++.++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||++..
T Consensus 118 ~~~g~L~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 118 YKGGELFDEIIHRMK------FNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp CCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred CCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 999999998865432 8999999999999999999995 89999999999999976 45599999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
...... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ..+...+....
T Consensus 189 ~~~~~~----~~~~~gt~~y~aPE~l~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~~ 253 (494)
T 3lij_A 189 FENQKK----MKERLGTAYYIAPEVLRK---KYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKVEKGK 253 (494)
T ss_dssp CBTTBC----BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHTC
T ss_pred CCCCcc----ccccCCCcCeeCHHHHcc---cCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC
Confidence 654332 234569999999999864 689999999999999999999999965321 11111111110
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
. .........++..+.+++.+||+.||.+|||+.|+++.
T Consensus 254 ~----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 254 Y----TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp C----CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred C----CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 0 00111122355778999999999999999999999853
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=316.20 Aligned_cols=248 Identities=19% Similarity=0.250 Sum_probs=189.8
Q ss_pred hHhhhccccccceEEEEEEEc------------------------chhhhhhhcCCCceeeeeeEEEeCC--ceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL------------------------DGLASISRTSHVNVVTLLGFCLEGN--NRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~HpnIv~l~~~~~~~~--~~~lV~E~ 212 (450)
|.+.+.||+|+||+||+|+.. +|++++++++||||+++++++.+.. ..++||||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~ 90 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEF 90 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECC
T ss_pred eEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEec
Confidence 445778999999999999632 4577899999999999999998765 77999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE----cCCCCeEEeeccccc
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL----DQDFCPKISDFGLAK 288 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla~ 288 (450)
+++|+|.+++...... ..+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++
T Consensus 91 ~~~g~L~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 91 CPCGSLYTVLEEPSNA---YGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CTTEEHHHHTTSGGGT---TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred CCCCCHHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 9999999999754322 238999999999999999999995 899999999999999 777889999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccc------cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRN------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~ 362 (450)
....... .....||..|+|||++.+. ...++.++|||||||++|||++|+.||.......... ..+.
T Consensus 165 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~---~~~~ 237 (396)
T 4eut_A 165 ELEDDEQ----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK---EVMY 237 (396)
T ss_dssp ECCCGGG----SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH---HHHH
T ss_pred EccCCCc----cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH---HHHH
Confidence 7654332 2345699999999998641 0256789999999999999999999997543322111 1111
Q ss_pred hhhhhhhhhh----------------hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 363 RHVEQDREFK----------------LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 363 ~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
.......... ...........+...+.+++.+||+.||++||+++|+++.++.+.+.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1111110000 00011122356778899999999999999999999999998876543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=307.50 Aligned_cols=175 Identities=27% Similarity=0.326 Sum_probs=151.0
Q ss_pred hhHhhhccccccceEEEEEEEc----------------------chhhhhhhcC-----CCceeeeeeEEEeCCceEEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRTS-----HVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l~-----HpnIv~l~~~~~~~~~~~lV~ 210 (450)
.|.+.++||+|+||+||+|+.. .|+.+++++. ||||+++++++...+..++||
T Consensus 36 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~ 115 (360)
T 3llt_A 36 AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIF 115 (360)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEE
Confidence 4456789999999999999642 2466677775 999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---------------
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ--------------- 275 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~--------------- 275 (450)
||+ +++|.+++...... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 116 e~~-~~~L~~~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~ 187 (360)
T 3llt_A 116 EPL-GPSLYEIITRNNYN----GFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTD 187 (360)
T ss_dssp CCC-CCBHHHHHHHTTTC----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTT
T ss_pred cCC-CCCHHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhcccc
Confidence 999 99999999765432 38999999999999999999995 99999999999999975
Q ss_pred ----------CCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCC
Q 013074 276 ----------DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNL 345 (450)
Q Consensus 276 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~ 345 (450)
++.+||+|||+++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus 188 ~~~~~~~~~~~~~~kl~DFG~a~~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 188 GKKIQIYRTKSTGIKLIDFGCATFKSDYH------GSIINTRQYRAPEVILNL--GWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp CCEEEEEEESCCCEEECCCTTCEETTSCC------CSCCSCGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccccCCCCEEEEeccCceecCCCC------cCccCcccccCcHHHcCC--CCCCccchHHHHHHHHHHHHCCCCC
Confidence 7899999999998654332 344689999999999874 7899999999999999999999999
Q ss_pred CCC
Q 013074 346 DSG 348 (450)
Q Consensus 346 ~~~ 348 (450)
...
T Consensus 260 ~~~ 262 (360)
T 3llt_A 260 RTH 262 (360)
T ss_dssp CCS
T ss_pred CCC
Confidence 754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-38 Score=300.80 Aligned_cols=224 Identities=25% Similarity=0.321 Sum_probs=180.8
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++.. +|+.++++++||||+++++++.+++..++||||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 96 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLEL 96 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEec
Confidence 345678999999999998532 357788899999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++.... .+++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~L~~~~~~~~------~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 97 CRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp CTTCBHHHHHHHHC------SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999886543 28999999999999999999995 8999999999999999999999999999987643
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... .....||..|+|||.+.+. .++.++||||||+++++|++|+.||..... .+ ....+...
T Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~-~~~~~~~~---- 230 (294)
T 2rku_A 168 DGER---KKVLCGTPNYIAPEVLSKK--GHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KE-TYLRIKKN---- 230 (294)
T ss_dssp TTCC---BCCCCSCCSSCCHHHHTTS--CBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HH-HHHHHHTT----
T ss_pred Cccc---cccccCCCCcCCcchhccC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HH-HHHHHhhc----
Confidence 2221 2334589999999999764 688999999999999999999999964321 01 01111100
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
....+...+..+.+++.+||+.||++|||++|+++.
T Consensus 231 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 231 ----EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 001112344678899999999999999999999974
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=306.30 Aligned_cols=234 Identities=20% Similarity=0.272 Sum_probs=178.9
Q ss_pred HHHHhhHhh-hccccccceEEEEEEEc-------------------------chhhhhhhc-CCCceeeeeeEEEeCCce
Q 013074 154 VKKITNSFK-DKLGQGGFGGVYKGKLL-------------------------DGLASISRT-SHVNVVTLLGFCLEGNNR 206 (450)
Q Consensus 154 i~~~~~~~~-~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~ 206 (450)
.....|.+. +.||+|+||.||+|+.. +|+.+++++ .||||+++++++.+....
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 333344444 78999999999998532 346667777 569999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---CCCeEEee
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ---DFCPKISD 283 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~D 283 (450)
++||||+++++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|
T Consensus 105 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPELA----EMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp EEEEECCTTEEGGGGGSSCC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred EEEEEecCCCcHHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEee
Confidence 999999999999999865322 238999999999999999999995 89999999999999997 78999999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
||+++....... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...... . ...
T Consensus 178 fg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~-~~~ 243 (327)
T 3lm5_A 178 FGMSRKIGHACE----LREIMGTPEYLAPEILNYD--PITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------E-TYL 243 (327)
T ss_dssp GGGCEEC-------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHH
T ss_pred CccccccCCccc----cccccCCcCccCCeeecCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------H-HHH
Confidence 999987654322 2334699999999999764 7899999999999999999999999653210 0 111
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+... ...........++..+.+++.+||+.||++|||++|+++.
T Consensus 244 ~i~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 244 NISQV----NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHT----CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHhc----ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11000 0111112223455778999999999999999999999875
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=312.74 Aligned_cols=243 Identities=21% Similarity=0.289 Sum_probs=170.9
Q ss_pred hhHhhhccccccceEEEEEEE-------------------------cchhhhhhhcC-CCceeeeeeEEEeCC--ceEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTS-HVNVVTLLGFCLEGN--NRALI 209 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~-HpnIv~l~~~~~~~~--~~~lV 209 (450)
.|.+.+.||+|+||.||+|+. .+|+.+++++. ||||+++++++...+ ..++|
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv 89 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLV 89 (388)
T ss_dssp TEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEE
Confidence 455678999999999999952 13567788887 999999999997654 68999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||++ ++|..++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~e~~~-~~L~~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 90 FDYME-TDLHAVIRAN-------ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EECCS-EEHHHHHHHT-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecccC-cCHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 99996 6999988753 28899999999999999999995 8999999999999999999999999999986
Q ss_pred ccCCCC------------------ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCC
Q 013074 290 CTTKKG------------------IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN 351 (450)
Q Consensus 290 ~~~~~~------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~ 351 (450)
...... ........+||+.|+|||++.+. ..++.++|||||||+++||++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS-TKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCC-CCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 533110 01113345799999999999763 47899999999999999999999999754211
Q ss_pred CCccchhhhhhhhhhhhhhhhh----------------------cccccch-------------hHHHHHHHHHHHHHcc
Q 013074 352 SSEVYFPHWIYRHVEQDREFKL----------------------LGVVTKK-------------ENEIAKKMIIVGLWCI 396 (450)
Q Consensus 352 ~~~~~~~~~i~~~~~~~~~~~~----------------------~~~~~~~-------------~~~~~~~l~~l~~~Cl 396 (450)
. .+ ..+...+........ ....... ....+.++.+++.+||
T Consensus 238 ~---~~-~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 238 N---QL-ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp H---HH-HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred H---HH-HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 0 00 000000000000000 0000000 0023467899999999
Q ss_pred ccCCCCCCCHHHHHHH--hhcc
Q 013074 397 QARPYDRPPMNEVIEM--LQGS 416 (450)
Q Consensus 397 ~~dP~~RPs~~evl~~--L~~~ 416 (450)
+.||++|||++|+++. ++..
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTTTTT
T ss_pred ccCcccCCCHHHHhCCHHHHHh
Confidence 9999999999999976 5443
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-38 Score=316.64 Aligned_cols=234 Identities=19% Similarity=0.265 Sum_probs=175.0
Q ss_pred HHHHhhHhhhccccccceEEEEEEE-------------------------------cchhhhhhhcCCCceeeeeeEEEe
Q 013074 154 VKKITNSFKDKLGQGGFGGVYKGKL-------------------------------LDGLASISRTSHVNVVTLLGFCLE 202 (450)
Q Consensus 154 i~~~~~~~~~~LG~G~fg~Vy~~~~-------------------------------~~e~~~l~~l~HpnIv~l~~~~~~ 202 (450)
.....|.+.+.||+|+||+||+|+. .+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 3344566778999999999999842 24688899999999999999975
Q ss_pred CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC---CCe
Q 013074 203 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD---FCP 279 (450)
Q Consensus 203 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~ 279 (450)
.+..++||||+++|+|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.+ ..+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCE
T ss_pred cCceEEEEEcCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceE
Confidence 456899999999999999886543 28999999999999999999995 899999999999999754 459
Q ss_pred EEeeccccccccCCCCccccccCCCCcccccccccccc-ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchh
Q 013074 280 KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP 358 (450)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 358 (450)
||+|||+++....... .....||+.|+|||++.+ ....++.++||||||+++|+|++|+.||....... .+.
T Consensus 282 kl~DFG~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~ 354 (419)
T 3i6u_A 282 KITDFGHSKILGETSL----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLK 354 (419)
T ss_dssp EECCSSTTTSCC---------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC---CHH
T ss_pred EEeecccceecCCCcc----ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH---HHH
Confidence 9999999987654321 234569999999999864 22468899999999999999999999997543221 111
Q ss_pred hhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 359 HWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 359 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..+.... ..........++..+.+++.+||+.||++|||++|+++.
T Consensus 355 ----~~i~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 355 ----DQITSGK----YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ----HHHHTTC----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----HHHhcCC----CCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1111110 000111122346788999999999999999999999863
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=310.67 Aligned_cols=229 Identities=19% Similarity=0.270 Sum_probs=172.5
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCC--CceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSH--VNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~H--pnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++. .+|+.++++++| |||+++++++.++...++|||+
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~ 90 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC 90 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC
Confidence 44678999999999999842 246788888887 9999999999999999999995
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
.+++|.+++..... +++..+..++.|++.||.|||+ .+|+||||||+|||++ ++.+||+|||+++....
T Consensus 91 -~~~~L~~~l~~~~~------~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 91 -GNIDLNSWLKKKKS------IDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp -CSEEHHHHHHHSCC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred -CCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 58899999976543 8999999999999999999995 8999999999999997 57899999999987654
Q ss_pred CCCccccccCCCCccccccccccccc---------cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRN---------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
..... ......||+.|+|||++.+. ...++.++|||||||++|||++|+.||...... ...+..
T Consensus 160 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~ 232 (343)
T 3dbq_A 160 DTTSV-VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHA 232 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHH
T ss_pred ccccc-cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH------HHHHHH
Confidence 32211 12345699999999998641 136889999999999999999999999643211 000111
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
...... ....+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 233 ~~~~~~-------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 IIDPNH-------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHCTTS-------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhcCCc-------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111000 001111223568899999999999999999999865
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=319.88 Aligned_cols=172 Identities=27% Similarity=0.419 Sum_probs=133.8
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC-----CceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG-----NNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~-----~~~~l 208 (450)
|.+.+.||+|+||+||+|+. .+|++++++++||||+++++++... ...|+
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~l 134 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYV 134 (458)
T ss_dssp EEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred eEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEE
Confidence 45678999999999999942 2468889999999999999998543 56899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
||||+ +++|.+++.... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 135 v~e~~-~~~L~~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 135 VLEIA-DSDFKKLFRTPV------YLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EECCC-SEEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEecc-ccchhhhcccCC------CCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccch
Confidence 99998 679999987543 28999999999999999999995 899999999999999999999999999998
Q ss_pred cccCCCCc------------------------cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcC
Q 013074 289 LCTTKKGI------------------------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGC 341 (450)
Q Consensus 289 ~~~~~~~~------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg 341 (450)
........ .......+||+.|+|||++... ..++.++|||||||++|||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ-ENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCC-CCCCcHhHHHHHHHHHHHHHHh
Confidence 76432111 0123455689999999987543 4789999999999999999984
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=326.95 Aligned_cols=229 Identities=25% Similarity=0.328 Sum_probs=184.3
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
+.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+.+..++||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 34457899999999999863 2357788999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++...+. ..+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 266 ~~gg~L~~~l~~~~~----~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQ----AGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp CCSCBHHHHHHSSSS----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999976543 238999999999999999999995 8999999999999999999999999999987654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ...+...+...
T Consensus 339 ~~~----~~~~~GT~~Y~APEvl~~~--~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~----~~~i~~~i~~~---- 404 (576)
T 2acx_A 339 GQT----IKGRVGTVGYMAPEVVKNE--RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK----REEVERLVKEV---- 404 (576)
T ss_dssp TCC----EECCCSCGGGCCHHHHTTC--EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC----HHHHHHHHHHC----
T ss_pred Ccc----ccccCCCccccCHHHHcCC--CCCccchHHHHHHHHHHHHhCCCCCcccccchh----HHHHHHHhhcc----
Confidence 332 2345799999999999874 789999999999999999999999976432211 11111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
.......++.++.+++.+||+.||.+|| +++|+++.
T Consensus 405 ----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 ----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred ----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1111233567899999999999999999 78888754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=298.09 Aligned_cols=228 Identities=21% Similarity=0.304 Sum_probs=179.3
Q ss_pred HhhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
..|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.++...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 3456678999999999999952 23577889999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC----CeEEee
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF----CPKISD 283 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~D 283 (450)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||||+||+++.++ .+||+|
T Consensus 85 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~d 155 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE------SLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLID 155 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEeecCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEe
Confidence 9999999999999997543 28999999999999999999995 8999999999999998877 899999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
||++........ .....|++.|+|||++.+. .++.++||||||+++++|++|+.||...... . ...
T Consensus 156 fg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~-~~~ 221 (283)
T 3bhy_A 156 FGIAHKIEAGNE----FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGETKQ-------E-TLT 221 (283)
T ss_dssp CTTCEECC------------CCCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------H-HHH
T ss_pred cccceeccCCCc----ccccCCCcCccCcceecCC--CCCcchhhhhHHHHHHHHHHCCCCCCCcchH-------H-HHH
Confidence 999987654322 2334589999999999764 7899999999999999999999999653210 0 111
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.+.... ...........+..+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 222 NISAVN----YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHTTC----CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhHhcc----cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 110000 00011111234567899999999999999999999997
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=320.14 Aligned_cols=228 Identities=24% Similarity=0.319 Sum_probs=182.2
Q ss_pred HhhHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
..|.+.++||+|+||+||+++. .+|++++++++||||+++++++.+....++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 4566788999999999999852 246888999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc---CCCCeEEeeccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD---QDFCPKISDFGLAK 288 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~ 288 (450)
|+.+++|.+.+..... +++..+..++.|++.||.|||+ .+|+||||||+|||++ .++.+||+|||+++
T Consensus 102 ~~~~~~L~~~~~~~~~------~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKR------FSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred cCCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999998865432 8999999999999999999995 8999999999999995 45689999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ..+...+...
T Consensus 173 ~~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~~~ 237 (486)
T 3mwu_A 173 CFQQNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNE--------YDILKRVETG 237 (486)
T ss_dssp TBCCC--------CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHT
T ss_pred ECCCCCc----cCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhC
Confidence 6654322 234569999999999875 689999999999999999999999965321 0011111111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
. ..........++.++.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~----~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 238 K----YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp C----CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C----CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 000111223456778999999999999999999999975
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=302.97 Aligned_cols=230 Identities=23% Similarity=0.385 Sum_probs=178.0
Q ss_pred hHhhhccccccceEEEEEEE-------------------cchhhhhhhcCCCceeeeeeEEEeC-CceEEEEEecCCCCh
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------LDGLASISRTSHVNVVTLLGFCLEG-NNRALIYEFMPNGSL 218 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------~~e~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~~gsL 218 (450)
+.+.+.||+|+||.||+++. .+|++++++++||||+++++++.+. +..++||||+++++|
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L 102 (278)
T 1byg_A 23 LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL 102 (278)
T ss_dssp EEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEH
T ss_pred ceEEeEEecCCCceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCH
Confidence 34578899999999999863 2468889999999999999997654 478999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
.+++..... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.......
T Consensus 103 ~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 171 (278)
T 1byg_A 103 VDYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---- 171 (278)
T ss_dssp HHHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred HHHHHhccc----ccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc----
Confidence 999965421 237889999999999999999995 899999999999999999999999999988654332
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVV 377 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 377 (450)
....++..|+|||.+.+. .++.++||||||+++++|++ |+.||...... . +...+... ..
T Consensus 172 --~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~-~~~~~~~~-------~~ 232 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------D-VVPRVEKG-------YK 232 (278)
T ss_dssp ------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------G-HHHHHTTT-------CC
T ss_pred --cCCCccccccCHHHhCCC--CCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------H-HHHHHhcC-------CC
Confidence 223478899999999764 78999999999999999998 88888643211 0 11111111 01
Q ss_pred cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 378 TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 378 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
......++..+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 11223445789999999999999999999999999998654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=297.85 Aligned_cols=225 Identities=20% Similarity=0.356 Sum_probs=176.2
Q ss_pred HhhHhhhccccccceEEEEEEEc-------------------------chhhhhhhc-CCCceeeeeeEEEeCCceEEEE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRT-SHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
..|.+.+.||+|+||.||+|+.. +|+..+.++ +||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 34556789999999999999642 235566677 9999999999999999999999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC--------------
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD-------------- 276 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~-------------- 276 (450)
||+++++|.+++...... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRI--MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp ECCTTCBHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred EecCCCcHHHHHHhhccc--ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 999999999999754210 1238999999999999999999995 899999999999999844
Q ss_pred -----CCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCC
Q 013074 277 -----FCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN 351 (450)
Q Consensus 277 -----~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~ 351 (450)
..+||+|||++....... ...||..|+|||++.+. ..++.++||||||+++++|++|.+++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-------~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~-- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-------VEEGDSRFLANEVLQEN-YTHLPKADIFALALTVVCAAGAEPLPRNGD-- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-------CCCCCGGGCCHHHHTTC-CTTHHHHHHHHHHHHHHHHTTCCCCCSSSH--
T ss_pred ccCCceEEEEcccccccccCCcc-------ccCCCccccChhHhcCC-CCCCchhhHHHHHHHHHHHhcCCCCCcchh--
Confidence 479999999998765432 23489999999999764 356789999999999999999987764321
Q ss_pred CCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 352 SSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 352 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
....+... .....+..++..+.+++.+||+.||++|||++|+++.
T Consensus 236 ---------~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 ---------QWHEIRQG-------RLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---------HHHHHHTT-------CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---------HHHHHHcC-------CCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 01111111 1111222345778999999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=305.16 Aligned_cols=242 Identities=22% Similarity=0.319 Sum_probs=180.7
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEe----CCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLE----GNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E 211 (450)
|.+.+.||+|+||.||+++. .+|++++++++||||+++++++.. ....++|||
T Consensus 31 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e 110 (317)
T 2buj_A 31 YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110 (317)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEE
Confidence 44578899999999999962 246788899999999999999873 347889999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++...... ...+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++....
T Consensus 111 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 111 FFKRGTLWNEIERLKDK--GNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp CCTTCBHHHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred eCCCCcHHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 99999999998753211 1338999999999999999999995 899999999999999999999999999987653
Q ss_pred CCCCc------cccccCCCCcccccccccccccc-CCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 292 TKKGI------VSSLLGARGTIGYIALEVFSRNF-GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 292 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~-~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
..... ........||..|+|||++.+.. ..++.++||||||+++|+|++|+.||......... +...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~ 259 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS------VALA 259 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC------HHHH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch------hhHH
Confidence 21110 00012234789999999986531 13688999999999999999999998532110000 0000
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
... ..........+..+.+++.+||+.||.+|||++|+++.|+.+..
T Consensus 260 ~~~-------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 260 VQN-------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HHC-------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hhc-------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 000 00011122345779999999999999999999999999998654
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=308.86 Aligned_cols=246 Identities=20% Similarity=0.275 Sum_probs=170.1
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------cchhhhhhhcC-CCceeeeeeEEEe--------CCc
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTS-HVNVVTLLGFCLE--------GNN 205 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~-HpnIv~l~~~~~~--------~~~ 205 (450)
.+.+.++||+|+||.||+++. .+|+.+++++. ||||+++++++.. ...
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~ 108 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAE 108 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEE
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCce
Confidence 445678999999999999963 23467788885 9999999999953 335
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc--eEeeeeccccEEEcCCCCeEEee
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR--ILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dikp~NIll~~~~~~kl~D 283 (450)
.++||||+. |+|.+++...... ..+++..++.++.|++.||+|||+ .+ |+|+||||+|||++.++.+||+|
T Consensus 109 ~~lv~e~~~-g~L~~~l~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 109 FLLLTELCK-GQLVEFLKKMESR---GPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp EEEEEECCS-EEHHHHHHHHHTT---CSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred EEEEEEecC-CCHHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEec
Confidence 789999994 7999988652211 238999999999999999999994 77 99999999999999999999999
Q ss_pred ccccccccCCCCcc---------ccccCCCCcccccccccccc-ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCC
Q 013074 284 FGLAKLCTTKKGIV---------SSLLGARGTIGYIALEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSS 353 (450)
Q Consensus 284 FGla~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~ 353 (450)
||+++......... .......||+.|+|||++.. ....++.++||||||+++|+|++|+.||........
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 99998765432211 01123458999999999842 113688999999999999999999999965422110
Q ss_pred ccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCCCCCC
Q 013074 354 EVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPPTPFL 428 (450)
Q Consensus 354 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~~p~~ 428 (450)
..... . ..........+.+++.+||+.||.+|||++|+++.|+.+......++.+..
T Consensus 262 -------~~~~~----~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~ 318 (337)
T 3ll6_A 262 -------VNGKY----S-------IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI 318 (337)
T ss_dssp -----------C----C-------CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred -------hcCcc----c-------CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccH
Confidence 00000 0 000111224478899999999999999999999999998887666655443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.22 Aligned_cols=229 Identities=19% Similarity=0.273 Sum_probs=173.1
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcC--CCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTS--HVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++. .+|+.++++++ ||||+++++++..++..++|||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E- 136 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 136 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-
T ss_pred eEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-
Confidence 45678899999999999842 24577888886 5999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+.+++|.+++..... +++..++.++.|++.||.||| +.+|+||||||+|||++ ++.+||+|||+++....
T Consensus 137 ~~~~~L~~~l~~~~~------~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 137 CGNIDLNSWLKKKKS------IDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp CCSEEHHHHHHHCSS------CCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred cCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 458899999976542 888999999999999999999 48999999999999996 57999999999987654
Q ss_pred CCCccccccCCCCccccccccccccc---------cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRN---------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
..... ......||+.|+|||++.+. ...++.++|||||||++|||++|+.||...... ...+..
T Consensus 207 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~~~~~~ 279 (390)
T 2zmd_A 207 DTTSV-VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHA 279 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHH
T ss_pred CCccc-cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH------HHHHHH
Confidence 32211 12345699999999998641 136889999999999999999999999643211 011111
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+...... ..+...+.++.+++.+||+.||++|||++|+++.
T Consensus 280 ~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 IIDPNHEI-------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHCTTSCC-------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCccccC-------CCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11110000 1111124678899999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=300.61 Aligned_cols=231 Identities=19% Similarity=0.264 Sum_probs=178.8
Q ss_pred HHhhHhhhccccccceEEEEEEE-------------------------------cchhhhhhhcCCCceeeeeeEEEeCC
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL-------------------------------LDGLASISRTSHVNVVTLLGFCLEGN 204 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~-------------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~ 204 (450)
...|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 34566788999999999999842 24678899999999999999987654
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC---eEE
Q 013074 205 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC---PKI 281 (450)
Q Consensus 205 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl 281 (450)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .+|+||||||+||+++.++. +||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK------RLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEE
T ss_pred -eEEEEecCCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEE
Confidence 899999999999999986543 28999999999999999999995 89999999999999987654 999
Q ss_pred eeccccccccCCCCccccccCCCCcccccccccccc-ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhh
Q 013074 282 SDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR-NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 360 (450)
+|||+++....... .....||..|+|||++.. ....++.++||||||+++|+|++|..||....... .+..
T Consensus 159 ~Dfg~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~- 230 (322)
T 2ycf_A 159 TDFGHSKILGETSL----MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV---SLKD- 230 (322)
T ss_dssp CCCTTCEECCCCHH----HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS---CHHH-
T ss_pred ccCccceecccccc----cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH---HHHH-
Confidence 99999987644321 122348999999999752 12468899999999999999999999997543221 1111
Q ss_pred hhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 361 IYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 361 i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.+.... ...........+..+.+++.+||+.||++|||++|+++
T Consensus 231 ---~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 231 ---QITSGK----YNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---HHHHTC----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHhCc----cccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111100 00011111234578899999999999999999999984
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.08 Aligned_cols=229 Identities=23% Similarity=0.307 Sum_probs=184.0
Q ss_pred HHhhHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
...|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 34566778999999999999852 2468889999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE---cCCCCeEEeeccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGL 286 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGl 286 (450)
|||+.+++|.+++..... +++..++.++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+
T Consensus 105 ~e~~~~~~L~~~~~~~~~------~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKR------FSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp ECCCCSCBHHHHHHTCSC------CBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EecCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 999999999999876532 8999999999999999999995 899999999999999 5678999999999
Q ss_pred cccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh
Q 013074 287 AKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE 366 (450)
Q Consensus 287 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~ 366 (450)
++....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ..+...+.
T Consensus 176 a~~~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~ 240 (484)
T 3nyv_A 176 STHFEASKK----MKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGANE--------YDILKKVE 240 (484)
T ss_dssp HHHBCCCCS----HHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH
T ss_pred eEEcccccc----cccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH
Confidence 987654432 223459999999999865 689999999999999999999999965321 01111111
Q ss_pred hhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 367 QDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... .........++..+.+++.+||+.||.+|||++|+++.
T Consensus 241 ~~~~----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 241 KGKY----TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HCCC----CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred cCCC----CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 1100 00111123456788999999999999999999999964
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=301.06 Aligned_cols=231 Identities=22% Similarity=0.338 Sum_probs=183.5
Q ss_pred HhhHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
..|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.++...++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 3455678999999999999852 24678899999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE---cCCCCeEEeeccccccc
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL---DQDFCPKISDFGLAKLC 290 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll---~~~~~~kl~DFGla~~~ 290 (450)
++++|.+++...+. +++..++.++.|++.||.|||+ .+|+|+||||+||++ ++++.+||+|||++...
T Consensus 89 ~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 89 SGGELFDRILERGV------YTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred CCccHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 99999999865432 8999999999999999999995 899999999999999 78899999999998765
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.... .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||..... ..+...+....
T Consensus 160 ~~~~-----~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~- 223 (304)
T 2jam_A 160 QNGI-----MSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVITYILLCGYPPFYEETE--------SKLFEKIKEGY- 223 (304)
T ss_dssp CCBT-----THHHHSCCCBCCTTTBSSC--SCCHHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHCC-
T ss_pred CCCc-----cccccCCCCccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHcCC-
Confidence 4322 1223489999999999774 789999999999999999999999964321 00111111110
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhc
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQG 415 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 415 (450)
..........++..+.+++.+||+.||++|||++|+++. +++
T Consensus 224 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 267 (304)
T 2jam_A 224 ---YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267 (304)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred ---CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence 000111122345778999999999999999999999963 544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=311.83 Aligned_cols=241 Identities=20% Similarity=0.283 Sum_probs=180.3
Q ss_pred HhhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
..+.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 3445667899999999999863 2457888999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++..... +++..+..++.|++.||.|||+ ..+|+|+||||+||+++.++.+||+|||++.....
T Consensus 113 ~~~~~L~~~l~~~~~------~~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 113 MDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH--hCCEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 999999999976432 8999999999999999999995 23899999999999999999999999999876533
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch---------------
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF--------------- 357 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~--------------- 357 (450)
.. .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+
T Consensus 185 ~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 185 SM-----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HC---------CCCCTTCCHHHHTTC--CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cc-----ccCCCCCCCeECHHHHcCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 21 2334689999999999874 7899999999999999999999999753211000000
Q ss_pred -------hhhhhhh-----hhhhhhhhh-cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 358 -------PHWIYRH-----VEQDREFKL-LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 358 -------~~~i~~~-----~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..+.... ......... ..........++.++.+++.+||+.||++|||++|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 0000000 000000000 000001112245679999999999999999999999863
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=297.82 Aligned_cols=232 Identities=18% Similarity=0.234 Sum_probs=177.4
Q ss_pred hHhhhccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEE--eCCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCL--EGNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~--~~~~~~lV 209 (450)
|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++. +....++|
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMV 86 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEE
T ss_pred eeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEE
Confidence 44678899999999999852 23577888999999999999984 45688999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||++++ |.+++..... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++..
T Consensus 87 ~e~~~~~-l~~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 87 MEYCVCG-MQEMLDSVPE----KRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EECCSEE-HHHHHHHSTT----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ehhccCC-HHHHHHhCcc----cccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999765 7777765432 238999999999999999999995 8999999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
........ ......||..|+|||++.+.....+.++||||||+++|||++|+.||..... .. +...+...
T Consensus 159 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~-~~~~i~~~- 228 (305)
T 2wtk_C 159 LHPFAADD-TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-------YK-LFENIGKG- 228 (305)
T ss_dssp CCTTCSSC-EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HH-HHHHHHHC-
T ss_pred cCcccccc-ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-------HH-HHHHHhcC-
Confidence 64322111 1234568999999999876423457899999999999999999999964311 01 11111111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQG 415 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 415 (450)
.......++..+.+++.+||+.||.+|||++|+++. +++
T Consensus 229 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 269 (305)
T 2wtk_C 229 -------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269 (305)
T ss_dssp -------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred -------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence 001112345678899999999999999999999964 544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=303.95 Aligned_cols=238 Identities=19% Similarity=0.270 Sum_probs=180.5
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeC-----CceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEG-----NNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV 209 (450)
|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++... ...++|
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv 108 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIV 108 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEE
Confidence 44577899999999999952 2468889999999999999999765 368999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+. ++|.+++.... +++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 109 ~e~~~-~~L~~~l~~~~-------~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 109 QDLME-TDLYKLLKTQH-------LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EECCS-EEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EcccC-cCHHHHHHhCC-------CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99996 69999886532 8999999999999999999995 8999999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
...............||+.|+|||++.+. ..++.++||||||+++|+|++|+.||....... .+ ..+........
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~-~~i~~~~~~~~ 252 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD---QL-NHILGILGSPS 252 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTB-CSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG---HH-HHHHHHHCSCC
T ss_pred cCCCCCccccccccccccCCCCCHHhcCC-CCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH---HH-HHHHHHhCCCC
Confidence 65443333223455799999999987654 358999999999999999999999996543211 00 11110000000
Q ss_pred h-------------hh--hcc----cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 370 E-------------FK--LLG----VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 370 ~-------------~~--~~~----~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
. .. ... .........+.++.+++.+||+.||++|||++|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00 000 0000012235678999999999999999999999975
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=303.73 Aligned_cols=240 Identities=21% Similarity=0.305 Sum_probs=178.2
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC--------Cc
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG--------NN 205 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--------~~ 205 (450)
|.+.++||+|+||.||+|+. .+|+.++++++||||+++++++.+. +.
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (351)
T 3mi9_A 19 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 98 (351)
T ss_dssp EEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CE
T ss_pred eeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCce
Confidence 44578899999999999963 1468889999999999999999873 46
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
.++||||++ ++|.+.+..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 99 ~~lv~e~~~-~~l~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 99 IYLVFDFCE-HDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp EEEEEECCS-EEHHHHHHCTTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccch
Confidence 899999996 588877765432 28999999999999999999995 899999999999999999999999999
Q ss_pred ccccccCCCC-ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 286 LAKLCTTKKG-IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 286 la~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
+++....... .........||+.|+|||++.+. ..++.++|||||||++|+|++|+.||....... ....+...
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~ 244 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQL 244 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHH
T ss_pred hcccccccccccccccCCcccccCccCchhhcCC-CCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHH
Confidence 9987643221 11223445689999999998764 367999999999999999999999997542110 00000000
Q ss_pred hhh-----------hhhhh---hc-ccccchhH-----HHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 365 VEQ-----------DREFK---LL-GVVTKKEN-----EIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 365 ~~~-----------~~~~~---~~-~~~~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... ..... .. ........ .....+.+++.+||+.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000 00000 00 00000000 113568899999999999999999999974
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=308.70 Aligned_cols=238 Identities=22% Similarity=0.369 Sum_probs=176.4
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.++...++||||+
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 106 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred heeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecC
Confidence 34567899999999999853 24678889999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++++|.+++..... +++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+|||+++.....
T Consensus 107 ~~~~l~~~~~~~~~------~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 107 DHTILDDLELFPNG------LDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp SEEHHHHHHHSTTC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred CcchHHHHHhhccC------CCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 99888887654432 8999999999999999999995 89999999999999999999999999999865443
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh----------h
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY----------R 363 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~----------~ 363 (450)
... .....||..|+|||++.+. ..++.++||||||+++|+|++|+.||....... .+..... .
T Consensus 178 ~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~ 250 (331)
T 4aaa_A 178 GEV---YDDEVATRWYRAPELLVGD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID---QLYHIMMCLGNLIPRHQE 250 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCHHHHH
T ss_pred ccc---cCCCcCCccccCcccccCC-CCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhCCCChhhhh
Confidence 221 2334589999999998764 368899999999999999999999996543211 0000000 0
Q ss_pred hhhhhhhh---hhc-----ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 364 HVEQDREF---KLL-----GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 364 ~~~~~~~~---~~~-----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........ ... .........++..+.+++.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 000 00000112346789999999999999999999999853
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=297.07 Aligned_cols=228 Identities=25% Similarity=0.326 Sum_probs=178.7
Q ss_pred hccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~ 219 (450)
..||+|+||.||+|+. .+|+.++++++||||+++++++.+.+..++||||+++++|.
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 107 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence 4799999999999962 24578889999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-CCCeEEeeccccccccCCCCccc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-DFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
+++...... ..+++..+..++.|++.||+|||+ .+++|+||||+||+++. ++.+||+|||++.........
T Consensus 108 ~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~-- 179 (295)
T 2clq_A 108 ALLRSKWGP---LKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC-- 179 (295)
T ss_dssp HHHHHTTCC---CTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred HHHHhhccC---CCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc--
Confidence 999765322 237789999999999999999995 89999999999999987 899999999999876443211
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....||..|+|||++.+....++.++||||||+++|+|++|+.||....... ...... .......
T Consensus 180 -~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~-------~~~~~~~ 245 (295)
T 2clq_A 180 -TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ------AAMFKV-------GMFKVHP 245 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH------HHHHHH-------HHHCCCC
T ss_pred -ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh------HHHHhh-------ccccccc
Confidence 23446899999999997642347899999999999999999999986321100 000000 0001111
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..+...+.++.+++.+||+.||++||+++|+++.
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2223455788999999999999999999999863
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=304.49 Aligned_cols=235 Identities=19% Similarity=0.281 Sum_probs=173.5
Q ss_pred hHhhhccccccceEEEEEE-------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGK-------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~-------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.++||+|+||+||+|+ +.+|+.++++++||||+++++++.++...++||||+
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 115 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYA 115 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecC
Confidence 4456799999999999994 225688999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc-----CCCCeEEeeccccc
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD-----QDFCPKISDFGLAK 288 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~-----~~~~~kl~DFGla~ 288 (450)
+ ++|.+++..... +++..++.++.|++.||+|||+ .+|+||||||+|||++ +++.+||+|||+++
T Consensus 116 ~-~~L~~~~~~~~~------~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 116 E-NDLKKYMDKNPD------VSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp S-EEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred C-CCHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 6 599999976543 8999999999999999999995 8999999999999994 45569999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
........ .....||..|+|||++.+. ..++.++|||||||++|||++|+.||....... .+.. +.......
T Consensus 186 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~-~~~~~~~~ 257 (329)
T 3gbz_A 186 AFGIPIRQ---FTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFK-IFEVLGLP 257 (329)
T ss_dssp HHC--------------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-HHHHHCCC
T ss_pred ccCCcccc---cCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHH-HHHHhCCC
Confidence 76433221 2334589999999999764 358999999999999999999999996542110 0000 00000000
Q ss_pred hhh-------------hhccccc-----chhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 369 REF-------------KLLGVVT-----KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 369 ~~~-------------~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
... ....... .....+..++.+++.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000 0000000 001113467899999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=318.09 Aligned_cols=226 Identities=26% Similarity=0.323 Sum_probs=179.3
Q ss_pred hHhhhccccccceEEEEEEEc------------------------------------chhhhhhhcCCCceeeeeeEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL------------------------------------DGLASISRTSHVNVVTLLGFCLE 202 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~------------------------------------~e~~~l~~l~HpnIv~l~~~~~~ 202 (450)
|.+.++||+|+||+||+|+.. +|+.++++++||||+++++++.+
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 117 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED 117 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred eEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 456789999999999998521 35778899999999999999999
Q ss_pred CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC---Ce
Q 013074 203 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF---CP 279 (450)
Q Consensus 203 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~---~~ 279 (450)
+...++||||+++|+|.+++..... +++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+
T Consensus 118 ~~~~~lv~e~~~gg~L~~~l~~~~~------~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 118 KKYFYLVTEFYEGGELFEQIINRHK------FDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSE
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999876432 8999999999999999999995 8999999999999999776 69
Q ss_pred EEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhh
Q 013074 280 KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPH 359 (450)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~ 359 (450)
||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... .
T Consensus 189 kl~Dfg~a~~~~~~~~----~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~ 253 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDYK----LRDRLGTAYYIAPEVLKK---KYNEKCDVWSCGVIMYILLCGYPPFGGQND--------Q 253 (504)
T ss_dssp EECCCTTCEECCTTSC----BCCCCSCTTTCCHHHHTT---CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------H
T ss_pred EEEECCCCEEcCCCCc----cccccCCcCCCCHHHhcc---CCCchHHHHHHHHHHHHHHhCCCCCCCCCH--------H
Confidence 9999999987654322 234569999999999864 689999999999999999999999975321 1
Q ss_pred hhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 360 WIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 360 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+...+..... .........++.++.+++.+||+.||.+|||++|+++.
T Consensus 254 ~~~~~i~~~~~----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 254 DIIKKVEKGKY----YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHHHHCCC----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHcCCC----CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 11111111100 00001112345789999999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=309.74 Aligned_cols=246 Identities=24% Similarity=0.259 Sum_probs=182.1
Q ss_pred chhHHHHHhhHhhhccccccceEEEEEEE----------------------cchhhhhhhcC--------CCceeeeeeE
Q 013074 150 NFSDVKKITNSFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTS--------HVNVVTLLGF 199 (450)
Q Consensus 150 ~~~ei~~~~~~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~--------HpnIv~l~~~ 199 (450)
...++....|.+.++||+|+||+||+|+. .+|++++++++ |+||++++++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~ 109 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDD 109 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEE
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecc
Confidence 33343344566778999999999999953 23566777775 8889999999
Q ss_pred EE----eCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC-ceEeeeeccccEEEc
Q 013074 200 CL----EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST-RILHFDIKPHNILLD 274 (450)
Q Consensus 200 ~~----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dikp~NIll~ 274 (450)
+. ++...++||||+ +++|.+.+..... ..+++..++.++.|++.||+|||+ . +|+||||||+|||++
T Consensus 110 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~ 181 (397)
T 1wak_A 110 FKISGVNGTHICMVFEVL-GHHLLKWIIKSNY----QGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLS 181 (397)
T ss_dssp EEEEETTEEEEEEEECCC-CCBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEEC
T ss_pred eeecCCCCceEEEEEecc-CccHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEe
Confidence 87 456889999999 6777777755432 238999999999999999999995 6 999999999999999
Q ss_pred CCC-------------------------------------------------CeEEeeccccccccCCCCccccccCCCC
Q 013074 275 QDF-------------------------------------------------CPKISDFGLAKLCTTKKGIVSSLLGARG 305 (450)
Q Consensus 275 ~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~~g 305 (450)
.++ .+||+|||++...... .....|
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~------~~~~~g 255 (397)
T 1wak_A 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQ 255 (397)
T ss_dssp CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC------SCSCCS
T ss_pred ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc------CccCCC
Confidence 775 7999999999876543 233468
Q ss_pred ccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch--hhhhhhhhhhhhhh------------
Q 013074 306 TIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF--PHWIYRHVEQDREF------------ 371 (450)
Q Consensus 306 t~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~--~~~i~~~~~~~~~~------------ 371 (450)
|..|+|||++.+. .++.++|||||||++|||++|+.||............ ...+.+........
T Consensus 256 t~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 333 (397)
T 1wak_A 256 TRQYRSLEVLIGS--GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFF 333 (397)
T ss_dssp CGGGCCHHHHHTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTB
T ss_pred CCcccCChhhcCC--CCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccccccc
Confidence 9999999999875 7899999999999999999999999765432211000 00011100000000
Q ss_pred ------------------hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 372 ------------------KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 372 ------------------~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.............+..+.+++.+||+.||++|||++|+++
T Consensus 334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 334 TKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0000001123566788999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-37 Score=320.43 Aligned_cols=229 Identities=22% Similarity=0.300 Sum_probs=182.1
Q ss_pred hhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 161 FKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+.+.||+|+||.||+++.. .|..++++++||||+++++++.+....++||||++
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~ 268 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMN 268 (543)
T ss_dssp EEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCT
T ss_pred EEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEecc
Confidence 3467999999999999632 35778889999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+|+|..++...... ...+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 269 gg~L~~~l~~~~~~--~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~ 343 (543)
T 3c4z_A 269 GGDIRYHIYNVDED--NPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343 (543)
T ss_dssp TCBHHHHHHTSSTT--SCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred CCCHHHHHHHhhcc--cccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence 99999998764321 1348999999999999999999995 899999999999999999999999999998765433
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..+.+.+...
T Consensus 344 ~~---~~~~~GT~~Y~APE~l~~~--~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~----~~~~~~i~~~------ 408 (543)
T 3c4z_A 344 TK---TKGYAGTPGFMAPELLLGE--EYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN----KELKQRVLEQ------ 408 (543)
T ss_dssp CC---BCCCCSCTTTSCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH----HHHHHHHHHC------
T ss_pred cc---cccccCCccccChhhhcCC--CCChHHhcCcchHHHHHHHhCCCCCCCCccchhH----HHHHHHHhhc------
Confidence 21 2345799999999999874 7899999999999999999999999764322111 1111111110
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPM-----NEVIE 411 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 411 (450)
....+..++..+.+++.+||+.||++||++ +++++
T Consensus 409 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 409 --AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred --ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 111223456788999999999999999975 56663
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=306.79 Aligned_cols=235 Identities=15% Similarity=0.149 Sum_probs=181.4
Q ss_pred hhHhhhccccccceEEEEEEE-------------------------cchhhhhhhcC---CCceeeeeeEEEeCCceEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTS---HVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~---HpnIv~l~~~~~~~~~~~lV 209 (450)
.|.+.+.||+|+||+||+|.. ..|.+++++++ |+||+++++++..++..++|
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv 145 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEE
Confidence 345567899999999999931 12345555555 99999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-----------CCC
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-----------DFC 278 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-----------~~~ 278 (450)
|||+++|+|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.
T Consensus 146 ~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~ 221 (365)
T 3e7e_A 146 GELYSYGTLLNAINLYKNT-PEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221 (365)
T ss_dssp ECCCCSCBHHHHHHHHHTS-TTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CTT
T ss_pred EeccCCCcHHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccCC
Confidence 9999999999999753211 11349999999999999999999994 89999999999999998 899
Q ss_pred eEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchh
Q 013074 279 PKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP 358 (450)
Q Consensus 279 ~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~ 358 (450)
+||+|||+++........ ......+||..|+|||++.+. .++.++|||||||++|||++|+.||.........
T Consensus 222 ~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---- 294 (365)
T 3e7e_A 222 LALIDLGQSIDMKLFPKG-TIFTAKCETSGFQCVEMLSNK--PWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---- 294 (365)
T ss_dssp EEECCCTTCEEGGGSCTT-EEECCSSCTTSCCCHHHHTTC--CBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE----
T ss_pred EEEeeCchhhhhhccCCC-ceeeeecCCCCCCChHHhcCC--CCCccccHHHHHHHHHHHHhCCCccccCCCCcee----
Confidence 999999999765422211 123456799999999999875 6899999999999999999999998543221100
Q ss_pred hhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHhhccccc
Q 013074 359 HWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDR-PPMNEVIEMLQGSTEA 419 (450)
Q Consensus 359 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~~~~~ 419 (450)
... ..... .....+.+++..|++.+|.+| |+++++.+.|++..+.
T Consensus 295 ------~~~-----~~~~~-----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 295 ------PEG-----LFRRL-----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp ------ECS-----CCTTC-----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ------ech-----hcccc-----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 000 00000 123567788889999999999 5788888888876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=314.62 Aligned_cols=232 Identities=22% Similarity=0.264 Sum_probs=170.5
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCC------ceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGN------NRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~------~~~ 207 (450)
|.+.++||+|+||+||+|+. .+|+.++++++||||+++++++.... ..+
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 143 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 143 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEE
Confidence 34567899999999999952 24578899999999999999997553 569
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+++ +|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 144 lv~E~~~~-~l~~~~~~--------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 144 LVMELMDA-NLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEECCSE-EHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred EEEeCCCC-CHHHHHhh--------cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 99999965 56666632 28899999999999999999995 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh--
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV-- 365 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~-- 365 (450)
+....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+ ..+.+.+
T Consensus 212 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~---~~-~~i~~~lg~ 281 (464)
T 3ttj_A 212 RTAGTSFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYID---QW-NKVIEQLGT 281 (464)
T ss_dssp -----CCC----C----CCCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH-HHHHHHHCS
T ss_pred eecCCCcc----cCCCcccccccCHHHHcCC--CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HH-HHHHHhcCC
Confidence 87654321 2345699999999999875 78999999999999999999999996532100 00 0000000
Q ss_pred ---------hhh-hhh-------------h-----hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 366 ---------EQD-REF-------------K-----LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 366 ---------~~~-~~~-------------~-----~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... ... . ............+.++.+++.+||+.||++|||++|+++.
T Consensus 282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 000 0 0000111122336789999999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=299.73 Aligned_cols=233 Identities=21% Similarity=0.338 Sum_probs=180.4
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe--CCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE--GNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E 211 (450)
|.+.+.||+|+||.||+++. .+|+.++++++||||+++++++.+ +...++|||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 87 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 87 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEe
Confidence 34567899999999999853 235778899999999999998864 567899999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc-----eEeeeeccccEEEcCCCCeEEeeccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR-----ILHFDIKPHNILLDQDFCPKISDFGL 286 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----ivH~Dikp~NIll~~~~~~kl~DFGl 286 (450)
|+++++|.+++...... ...+++..++.++.|++.||+|||+ .+ |+|+||||+||+++.++.+||+|||+
T Consensus 88 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 88 YCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp CCTTEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred CCCCCCHHHHHHhhccc--CCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 99999999998753211 1338999999999999999999996 66 99999999999999999999999999
Q ss_pred cccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh
Q 013074 287 AKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE 366 (450)
Q Consensus 287 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~ 366 (450)
+......... .....|+..|+|||.+.+. .++.++||||||+++|+|++|+.||..... ..+...+.
T Consensus 163 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~i~ 229 (279)
T 2w5a_A 163 ARILNHDTSF---AKTFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIR 229 (279)
T ss_dssp HHHC---CHH---HHHHHSCCTTCCHHHHHCC---CCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH
T ss_pred heeecccccc---ccccCCCccccChHHhccC--CCCchhhHHHHHHHHHHHHHCCCCCcccCH--------HHHHHHHh
Confidence 9876543221 1223489999999999774 789999999999999999999999864321 11111111
Q ss_pred hhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 367 QDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.. .....+..++.++.+++.+||+.||++|||++|+++.+...
T Consensus 230 ~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 230 EG-------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp HT-------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred hc-------ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 11 11112223557899999999999999999999999987653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=311.28 Aligned_cols=176 Identities=25% Similarity=0.386 Sum_probs=143.8
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC-----CceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG-----NNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~-----~~~~l 208 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++... ...++
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~l 107 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEE
T ss_pred EEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEE
Confidence 44578999999999999952 2468889999999999999999776 57899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
||||+. ++|.+++.... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 108 v~e~~~-~~L~~~~~~~~------~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 108 VLEIAD-SDLKKLFKTPI------FLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEECCS-EEHHHHHHSSC------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEecCC-cCHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 999995 69999997543 28999999999999999999995 899999999999999999999999999998
Q ss_pred cccCCCCc-------------------cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCC
Q 013074 289 LCTTKKGI-------------------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNL 345 (450)
Q Consensus 289 ~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~ 345 (450)
........ ........||+.|+|||++... ..++.++|||||||++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQ-ENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcC-CCCCcccccchHHHHHHHHHhccccc
Confidence 76443211 0113456799999999987543 47899999999999999999865444
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=297.34 Aligned_cols=229 Identities=23% Similarity=0.335 Sum_probs=178.2
Q ss_pred HhhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
..+.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+++..++||||+++
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGA 108 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCC
Confidence 3445677899999999999953 2467889999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++.... ..+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 109 ~~L~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 109 GSVSDIIRLRN-----KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp EEHHHHHHHHT-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999986432 228999999999999999999995 8999999999999999999999999999986644322
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....||..|+|||.+.+. .++.++||||||+++|+|++|+.||...... ..+. ..... ..
T Consensus 181 ~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~-~~~~~-----~~ 242 (314)
T 3com_A 181 K---RNTVIGTPFWMAPEVIQEI--GYNCVADIWSLGITAIEMAEGKPPYADIHPM-------RAIF-MIPTN-----PP 242 (314)
T ss_dssp C---BCCCCSCGGGCCHHHHSSS--CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHH-HHHHS-----CC
T ss_pred c---cCccCCCCCccChhhcCCC--CCCccccHHHHHHHHHHHHhCCCCCCCCChH-------HHHH-HHhcC-----CC
Confidence 1 2344689999999999774 7899999999999999999999999643210 0000 00000 00
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.........+..+.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011112234577899999999999999999999986
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=294.96 Aligned_cols=224 Identities=22% Similarity=0.377 Sum_probs=173.1
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+|+.. +|+..+++++||||+++++++.+....++||||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEY 92 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEec
Confidence 345678999999999999632 357778889999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++..... +++..++.++.|++.||+|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 93 ~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 93 VSGGELFDYICKHGR------VEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp CCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred cCCCcHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999976432 8999999999999999999995 8999999999999999999999999999987654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... .....|++.|+|||.+.+. ...+.++||||||+++++|++|+.||..... . .+.+.+...
T Consensus 164 ~~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~-~~~~~~~~~---- 226 (276)
T 2h6d_A 164 GEF----LRTSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------P-TLFKKIRGG---- 226 (276)
T ss_dssp -----------------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------H-HHHHHHHHC----
T ss_pred Ccc----eecccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------H-HHHHHhhcC----
Confidence 321 2234589999999999764 2346899999999999999999999964311 0 111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
....+...+..+.+++.+||+.||++|||++|+++.
T Consensus 227 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 227 ----VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011122345678899999999999999999999974
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=303.86 Aligned_cols=238 Identities=25% Similarity=0.307 Sum_probs=179.7
Q ss_pred hhHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
.|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+....++|
T Consensus 11 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp --CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred ccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 345678899999999999852 1367888999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++ +|..++.... ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~e~~~~-~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EECCSE-EHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEcCCC-CHHHHHHhcC-----cCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 999965 8988886543 238888999999999999999995 8999999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
....... .....||+.|+|||++.+. ..++.++|||||||++|||++|.+||...... ..+ ..+.+......
T Consensus 162 ~~~~~~~---~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~~~~~~~~~---~~~-~~i~~~~~~~~ 233 (346)
T 1ua2_A 162 FGSPNRA---YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---DQL-TRIFETLGTPT 233 (346)
T ss_dssp TTSCCCC---CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH-HHHHHHHCCCC
T ss_pred ccCCccc---CCcccccccccCchHhhCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH---HHH-HHHHHHcCCCC
Confidence 6443221 2345689999999998753 35889999999999999999999888653210 000 00111000000
Q ss_pred hhhhc-----------cccc-----chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 370 EFKLL-----------GVVT-----KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 370 ~~~~~-----------~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..... .... ......+..+.+++.+||+.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000 0000 0012345789999999999999999999999976
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=299.81 Aligned_cols=235 Identities=19% Similarity=0.277 Sum_probs=179.5
Q ss_pred hhHhhhccccccceEEEEEEE--------------------cchhhhhhhcC-CCceeeeeeEEEe--CCceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL--------------------LDGLASISRTS-HVNVVTLLGFCLE--GNNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~--------------------~~e~~~l~~l~-HpnIv~l~~~~~~--~~~~~lV~E~~~ 214 (450)
.|.+.+.||+|+||.||+|+. .+|+.++++++ ||||+++++++.+ ....++||||++
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~ 116 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 116 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCC
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccC
Confidence 345678999999999999953 34688889997 9999999999988 667899999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-CeEEeeccccccccCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-CPKISDFGLAKLCTTK 293 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~ 293 (450)
+++|.+++.. +++..+..++.|++.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 117 ~~~l~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 117 NTDFKQLYQT---------LTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp CCCHHHHGGG---------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred chhHHHHHHh---------CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 9999988742 7889999999999999999995 8999999999999999776 8999999999876543
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
.. .....||..|+|||++.+. ..++.++|||||||++|+|++|+.||..+..... .+.. +............
T Consensus 185 ~~----~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~-~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 185 QE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVR-IAKVLGTEDLYDY 256 (330)
T ss_dssp CC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHH-HHHHHCHHHHHHH
T ss_pred Cc----cccccccccccChhhhcCC-CcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHH-HHHhcCCchhhhH
Confidence 32 2344689999999998763 4689999999999999999999999965432111 0000 0000000000000
Q ss_pred ------------------------cc-cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 374 ------------------------LG-VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 374 ------------------------~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.. ........++.++.+++.+||+.||++|||++|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00 0001112246789999999999999999999999874
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.66 Aligned_cols=244 Identities=21% Similarity=0.241 Sum_probs=177.4
Q ss_pred hHhhhccccccceEEEEEEE------------------cchhhhhhhcCCCceeeeeeEEEeCCc------eEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------LDGLASISRTSHVNVVTLLGFCLEGNN------RALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~------~~lV~E~~~ 214 (450)
|.+.+.||+|+||+||+|+. .+|++++++++||||+++++++..... .++||||++
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~ 121 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccC
Confidence 44567899999999999964 247899999999999999999976543 789999997
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc-CCCCeEEeeccccccccCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD-QDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DFGla~~~~~~ 293 (450)
++ +...+..... ....+++..++.++.|++.||+|||+ .+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 122 ~~-l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~ 195 (394)
T 4e7w_A 122 ET-VYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG 195 (394)
T ss_dssp EE-HHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred cc-HHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC
Confidence 64 4433321110 01238999999999999999999995 8999999999999999 7999999999999876443
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh----
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR---- 369 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~---- 369 (450)
.. .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||....... .+.. +.+......
T Consensus 196 ~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~l~~-i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 196 EP----NVSYICSRYYRAPELIFGA-TNYTTNIDIWSTGCVMAELMQGQPLFPGESGID---QLVE-IIKVLGTPSREQI 266 (394)
T ss_dssp CC----CCSSCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH-HHHHHCCCCHHHH
T ss_pred CC----CcccccCcCccCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH-HHHHhCCCCHHHH
Confidence 32 2344589999999998764 368999999999999999999999997542110 0100 000000000
Q ss_pred -----h---hhhcccccc-----hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccc
Q 013074 370 -----E---FKLLGVVTK-----KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGST 417 (450)
Q Consensus 370 -----~---~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 417 (450)
. ......... .....+.++.+++.+||+.||.+|||+.|+++. +++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 0 000000000 011245689999999999999999999999975 55443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=297.60 Aligned_cols=224 Identities=25% Similarity=0.340 Sum_probs=180.9
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.++...++||||++
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 103 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred HHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCC
Confidence 34567899999999999952 235778889999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+++|.+++... .+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++.......
T Consensus 104 ~~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 104 GGSALDLLEPG-------PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp TEEHHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCcHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999998542 28999999999999999999995 899999999999999999999999999998765432
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. .....||..|+|||++.+. .++.++||||||+++++|++|+.||..... ......+...
T Consensus 174 ~~---~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~------ 234 (303)
T 3a7i_A 174 IK---RNTFVGTPFWMAPEVIKQS--AYDSKADIWSLGITAIELARGEPPHSELHP--------MKVLFLIPKN------ 234 (303)
T ss_dssp CC---BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHS------
T ss_pred cc---cCccCCCcCccCHHHHhcC--CCCchhhhHHHHHHHHHHccCCCCCCCcCH--------HHHHHHhhcC------
Confidence 11 2345689999999999774 788999999999999999999999864321 0011111110
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........++..+.+++.+||+.||++|||++|+++.
T Consensus 235 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 235 -NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp -CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred -CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1111122345678999999999999999999999874
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=303.65 Aligned_cols=238 Identities=22% Similarity=0.270 Sum_probs=174.9
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCC------ceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGN------NRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~------~~~ 207 (450)
|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.... ..+
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~ 106 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 106 (367)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEE
Confidence 34567899999999999952 24678899999999999999998653 469
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 107 lv~e~~-~~~L~~~~~~~-------~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 107 LVMPFM-GTDLGKLMKHE-------KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp EEEECC-SEEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecC-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 999999 88999998753 28999999999999999999995 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh--
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV-- 365 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~-- 365 (450)
+..... .....+|..|+|||++.+. ..++.++|||||||+++||++|+.||....... ....+.+..
T Consensus 176 ~~~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~l~~i~~~~g~ 244 (367)
T 1cm8_A 176 RQADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD----QLKEIMKVTGT 244 (367)
T ss_dssp EECCSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCC
T ss_pred cccccc------cCcCcCCCCcCCHHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCC
Confidence 876432 2345689999999998763 378999999999999999999999997542110 000010000
Q ss_pred ---------hhhhhh----hhc----ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcccc
Q 013074 366 ---------EQDREF----KLL----GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGSTE 418 (450)
Q Consensus 366 ---------~~~~~~----~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~ 418 (450)
...... ... ..........+..+.+++.+||+.||++|||++|+++. ++...+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 000000 000 00011112345678999999999999999999999984 555443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=303.95 Aligned_cols=228 Identities=19% Similarity=0.302 Sum_probs=179.0
Q ss_pred hHhhhccccccceEEEEEEEc-------------------------------chhhhhhhc-CCCceeeeeeEEEeCCce
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-------------------------------DGLASISRT-SHVNVVTLLGFCLEGNNR 206 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-------------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~~ 206 (450)
|.+.+.||+|+||.||+|+.. +|+.+++++ +||||+++++++......
T Consensus 96 y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 175 (365)
T 2y7j_A 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFM 175 (365)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEE
T ss_pred cccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEE
Confidence 444578999999999999642 235566777 799999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccc
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGL 286 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGl 286 (450)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||+
T Consensus 176 ~lv~e~~~g~~L~~~l~~~~------~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~ 246 (365)
T 2y7j_A 176 FLVFDLMRKGELFDYLTEKV------ALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGF 246 (365)
T ss_dssp EEEECCCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCc
Confidence 99999999999999997543 28999999999999999999995 8999999999999999999999999999
Q ss_pred cccccCCCCccccccCCCCccccccccccccc----cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh
Q 013074 287 AKLCTTKKGIVSSLLGARGTIGYIALEVFSRN----FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 287 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~ 362 (450)
+........ .....||+.|+|||++.+. ...++.++||||||+++|+|++|+.||..... . ...
T Consensus 247 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~----~~~ 314 (365)
T 2y7j_A 247 SCHLEPGEK----LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----I----LML 314 (365)
T ss_dssp CEECCTTCC----BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----H----HHH
T ss_pred ccccCCCcc----cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----H----HHH
Confidence 987654322 2345699999999998642 12578899999999999999999999964321 0 011
Q ss_pred hhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..+.... ...........+..+.+++.+||+.||++|||++|+++
T Consensus 315 ~~i~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 315 RMIMEGQ----YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHHHTC----CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHhCC----CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111100 00000111123567899999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=307.48 Aligned_cols=246 Identities=21% Similarity=0.272 Sum_probs=163.4
Q ss_pred hhccccccceEEEEEEEc-----------------------chhhhhhhcCCCceeeeeeEEEe--CCceEEEEEecCCC
Q 013074 162 KDKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHVNVVTLLGFCLE--GNNRALIYEFMPNG 216 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~~g 216 (450)
.++||+|+||+||+|+.. +|+.++++++||||+++++++.. +...++||||+. +
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~ 104 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 104 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-E
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-C
Confidence 457999999999999743 36888999999999999999965 678899999995 5
Q ss_pred ChhhhhhcCC---CCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE----cCCCCeEEeecccccc
Q 013074 217 SLEKFVYNGD---TSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL----DQDFCPKISDFGLAKL 289 (450)
Q Consensus 217 sL~~~l~~~~---~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll----~~~~~~kl~DFGla~~ 289 (450)
+|.+++.... .......+++..++.++.|++.||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.
T Consensus 105 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~ 181 (405)
T 3rgf_A 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181 (405)
T ss_dssp EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-
T ss_pred CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCcee
Confidence 8887775321 11112348999999999999999999995 899999999999999 6788999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc--cchhhhhhhh---
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE--VYFPHWIYRH--- 364 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~--~~~~~~i~~~--- 364 (450)
...............||+.|+|||++.+. ..++.++|||||||++|||++|+.||......... ......+...
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~ 260 (405)
T 3rgf_A 182 FNSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260 (405)
T ss_dssp ---------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred cCCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence 65433222223456789999999999764 35899999999999999999999999754332100 0000000000
Q ss_pred hhhhhhh------------h----hc-ccc-cch--------hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 365 VEQDREF------------K----LL-GVV-TKK--------ENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 365 ~~~~~~~------------~----~~-~~~-~~~--------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+...... . .. ... ... .......+.+++.+||+.||.+|||++|+++.
T Consensus 261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000 0 00 000 000 00114568899999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=316.12 Aligned_cols=221 Identities=14% Similarity=0.162 Sum_probs=167.8
Q ss_pred HhhhccccccceEEEEEEE--------------------------cchh---hhhhhcCCCceeeee-------eEEEeC
Q 013074 160 SFKDKLGQGGFGGVYKGKL--------------------------LDGL---ASISRTSHVNVVTLL-------GFCLEG 203 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~--------------------------~~e~---~~l~~l~HpnIv~l~-------~~~~~~ 203 (450)
.+.+.||+|+||.||+|+. .+|+ +.+++++||||++++ +++.+.
T Consensus 76 ~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~ 155 (377)
T 3byv_A 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155 (377)
T ss_dssp EEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred EEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence 3467899999999999952 1345 566777999999998 666555
Q ss_pred C-----------------ceEEEEEecCCCChhhhhhcCCCCC-CCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeee
Q 013074 204 N-----------------NRALIYEFMPNGSLEKFVYNGDTSK-PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFD 265 (450)
Q Consensus 204 ~-----------------~~~lV~E~~~~gsL~~~l~~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D 265 (450)
+ ..++||||+ +|+|.+++...+... ....+++..++.++.|++.||+|||+ .+|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrD 231 (377)
T 3byv_A 156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTY 231 (377)
T ss_dssp TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSC
T ss_pred CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCC
Confidence 3 278999999 689999997532211 11235578899999999999999995 8999999
Q ss_pred eccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccc---------cCCCCccCchHhHHHHHH
Q 013074 266 IKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN---------FGEVSHKSDVYSFGMMIM 336 (450)
Q Consensus 266 ikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~sDiwSlGvvl~ 336 (450)
|||+|||++.++.+||+|||+++..... .....| +.|+|||++.+. ...++.++|||||||++|
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ 304 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGAR------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTCE------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCCc------ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence 9999999999999999999999864331 234457 999999999763 015899999999999999
Q ss_pred HHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 337 ELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 337 elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
||++|+.||......... ..+.. ....++.++.+++.+||+.||++|||+.|+++
T Consensus 305 elltg~~Pf~~~~~~~~~----~~~~~----------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 305 WIWCADLPITKDAALGGS----EWIFR----------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHSSCCC------CCS----GGGGS----------------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHCCCCCcccccccch----hhhhh----------------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999654322110 00000 00123467889999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=298.11 Aligned_cols=242 Identities=22% Similarity=0.298 Sum_probs=171.4
Q ss_pred hHhhhccccccceEEEEEE------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGK------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+.+.+.||+|+||.||+|+ +.+|+.++++++||||+++++++..++..++||||++
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 96 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLS 96 (303)
T ss_dssp CEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCT
T ss_pred hhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhcc
Confidence 3456789999999999984 2346778888999999999999999999999999999
Q ss_pred CCChhhhhhcCC--CCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 215 NGSLEKFVYNGD--TSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 215 ~gsL~~~l~~~~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|.+++.... .......+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 97 GGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp TCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred CCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 999999986410 01112348999999999999999999995 8999999999999999999999999999876643
Q ss_pred CCCc--cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 293 KKGI--VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 293 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
.... ........||+.|+|||++.+. ..++.++||||||+++|+|++|+.||....... ...........
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~ 245 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKYPPMK-------VLMLTLQNDPP 245 (303)
T ss_dssp --------------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHTSSCC
T ss_pred CCCccchhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccCchhh-------HHHHHhccCCC
Confidence 2211 1112334689999999998753 268899999999999999999999997542211 00001000000
Q ss_pred h-hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 371 F-KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 371 ~-~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
. .............+..+.+++.+||+.||.+|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 0000000111223467899999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=327.97 Aligned_cols=235 Identities=21% Similarity=0.328 Sum_probs=183.5
Q ss_pred HHhhHhhhccccccceEEEEEEEc---------------------------chhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKLL---------------------------DGLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~~---------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
...+.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++. ++..++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 345566788999999999998642 3577888999999999999985 567899
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++
T Consensus 468 v~E~~~~g~L~~~l~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKF-----SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEECCTTCBHHHHHHHTTT-----TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEcCCCCcHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence 9999999999999975432 28999999999999999999995 899999999999999999999999999998
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
......... .....+|+.|+|||++.+. .++.++||||||+++|||++ |..||...... . +...+..
T Consensus 540 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-------~-~~~~i~~ 607 (656)
T 2j0j_A 540 YMEDSTYYK--ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------D-VIGRIEN 607 (656)
T ss_dssp SCCC------------CCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------H-HHHHHHH
T ss_pred ecCCCccee--ccCCCCCcceeCHHHhcCC--CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-------H-HHHHHHc
Confidence 765433221 1233467899999999764 78999999999999999997 88888643210 0 1111111
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
. .....+..++..+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 608 ~-------~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 608 G-------ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp T-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-------CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1 1111223456788999999999999999999999999998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=308.03 Aligned_cols=175 Identities=24% Similarity=0.311 Sum_probs=148.9
Q ss_pred hhHhhhccccccceEEEEEEEc----------------------chhhhhhhc------CCCceeeeeeEEEeCCceEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRT------SHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l------~HpnIv~l~~~~~~~~~~~lV 209 (450)
.|.+.+.||+|+||.||+|+.. +|+++++.+ +|+||+++++++......++|
T Consensus 98 ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 177 (429)
T 3kvw_A 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMT 177 (429)
T ss_dssp TEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEE
T ss_pred cEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEE
Confidence 3556789999999999999532 235555555 678999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC--eEEeecccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC--PKISDFGLA 287 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--~kl~DFGla 287 (450)
|||+. ++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++. +||+|||++
T Consensus 178 ~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 178 FELLS-MNLYELIKKNKF----QGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp ECCCC-CBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EeccC-CCHHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99995 799999876543 238999999999999999999995 89999999999999999887 999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCC
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 348 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~ 348 (450)
...... .....||+.|+|||++.+. .++.++|||||||++|||++|..||...
T Consensus 250 ~~~~~~------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 250 CYEHQR------VYTYIQSRFYRAPEVILGA--RYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp EETTCC------CCSSCSCGGGCCHHHHHTB--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecCCc------ccccCCCCCccChHHHhCC--CCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 765432 2345689999999999875 7899999999999999999999999654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=327.27 Aligned_cols=223 Identities=19% Similarity=0.254 Sum_probs=179.1
Q ss_pred hHhhhccccccceEEEEEEEcc--------------------------hhhhhhhc-CCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLD--------------------------GLASISRT-SHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~--------------------------e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
+++.+.||+|+||+||+|+... |..++..+ +||||+++++++.+.+.+++|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 4456789999999999996422 24445555 79999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|..++...+. +++..++.++.||+.||+|||+ .+|+||||||+||||+.++.+||+|||+++...
T Consensus 423 ~~~gg~L~~~l~~~~~------~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 423 YVNGGDLMYHIQQVGR------FKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp CCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CcCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999976532 8999999999999999999995 899999999999999999999999999998643
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.... .....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+.+.+...
T Consensus 494 ~~~~---~~~~~~GT~~Y~APE~l~~~--~~~~~~DvwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~--- 557 (674)
T 3pfq_A 494 WDGV---TTKTFCGTPDYIAPEIIAYQ--PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEH--- 557 (674)
T ss_dssp CTTC---CBCCCCSCSSSCCHHHHTCC--CBSTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHSS---
T ss_pred cCCc---ccccccCCCcccCHhhhcCC--CCCccceEechHHHHHHHHcCCCCCCCCCH--------HHHHHHHHhC---
Confidence 3221 13456799999999999774 789999999999999999999999975321 1111111111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPM-----NEVIE 411 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~ 411 (450)
....+..++.++.+++.+||+.||++||++ +||++
T Consensus 558 -----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 -----NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred -----CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 111223456789999999999999999997 67764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=296.84 Aligned_cols=231 Identities=24% Similarity=0.292 Sum_probs=167.0
Q ss_pred hhHhhhccccccceEEEEEEEcc-------------------------hhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLLD-------------------------GLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~~-------------------------e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
.+.+.+.||+|+||.||+++... +...++.++||||+++++++.+++..++||||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~ 87 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMEL 87 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEEC
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEeh
Confidence 34567899999999999996421 12336678999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC-ceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST-RILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
++ ++|.+++...... ...+++..++.++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~~-~~l~~~l~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 88 MD-TSLDKFYKQVIDK--GQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp CS-EEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred hc-cchHHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 96 5888777542110 1238999999999999999999995 6 99999999999999999999999999998765
Q ss_pred CCCCccccccCCCCcccccccccccc--ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSR--NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
.... .....||+.|+|||++.. ....++.++||||||+++++|++|+.||...... . ..+......
T Consensus 162 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~-~~~~~~~~~-- 229 (290)
T 3fme_A 162 DDVA----KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----F-QQLKQVVEE-- 229 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----H-HHHHHHHHS--
T ss_pred cccc----ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----H-HHHHHHhcc--
Confidence 4322 123358999999999732 1136889999999999999999999999643211 0 001111100
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..........+.++.+++.+||+.||++|||++|+++
T Consensus 230 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 -----PSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 1111112234577899999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=292.25 Aligned_cols=228 Identities=20% Similarity=0.266 Sum_probs=179.8
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------------chhhhhhhcC-CCceeeeeeEEEeCCc
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------------DGLASISRTS-HVNVVTLLGFCLEGNN 205 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------------~e~~~l~~l~-HpnIv~l~~~~~~~~~ 205 (450)
|.+.+.||+|+||.||+|+.. +|+++++++. ||||+++++++.++..
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 98 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 98 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred cceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCe
Confidence 345678999999999998531 3466777885 9999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||
T Consensus 99 ~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 99 FFLVFDLMKKGELFDYLTEKV------TLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEeccCCCcHHHHHhccC------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999997543 28999999999999999999995 899999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccc----cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN----FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI 361 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i 361 (450)
++........ .....|+..|+|||++.+. ...++.++||||||+++++|++|+.||...... . .
T Consensus 170 ~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~-~ 237 (298)
T 1phk_A 170 FSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------L-M 237 (298)
T ss_dssp TCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-H
T ss_pred chhhcCCCcc----cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-------H-H
Confidence 9987654322 2344689999999998631 236788999999999999999999999643210 0 1
Q ss_pred hhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 362 YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
...+.... ..........++..+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 238 LRMIMSGN----YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHHTC----CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHhcCC----cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11111100 00011112345678999999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=296.63 Aligned_cols=229 Identities=21% Similarity=0.292 Sum_probs=176.3
Q ss_pred hHhhhccccccceEEEEEEEc-----------------------chhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
|.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++.+++..++||||+++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 100 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPG 100 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTT
T ss_pred eeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCC
Confidence 455778999999999999632 357788999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
++|.+++..... .+++..++.++.|++.||.|||+ .+++|+||||+||+++.++.+||+|||++........
T Consensus 101 ~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (302)
T 2j7t_A 101 GAVDAIMLELDR-----GLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ 172 (302)
T ss_dssp EEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred CcHHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence 999998865332 28999999999999999999995 8999999999999999999999999998764322111
Q ss_pred ccccccCCCCcccccccccccc---ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 296 IVSSLLGARGTIGYIALEVFSR---NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
......||..|+|||++.. ....++.++||||||+++|+|++|+.||..... ...... ....
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~-~~~~---- 237 (302)
T 2j7t_A 173 ---KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-------MRVLLK-IAKS---- 237 (302)
T ss_dssp ---C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHH-HHHS----
T ss_pred ---ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-------HHHHHH-Hhcc----
Confidence 1123458999999999842 114688999999999999999999999864321 011111 1000
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
...........+..+.+++.+||+.||++|||++++++
T Consensus 238 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 238 -DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp -CCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred -CCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00011122334567899999999999999999999876
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=303.74 Aligned_cols=236 Identities=21% Similarity=0.228 Sum_probs=168.8
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCC------ceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGN------NRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~------~~~ 207 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.... ..+
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 106 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 106 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEE
T ss_pred eeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceE
Confidence 34567899999999999952 23578889999999999999997665 679
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||++ ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 107 lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 107 IVMELMD-ANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEECCS-EEHHHHHHS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred EEEEcCC-CCHHHHHhh--------ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeecc
Confidence 9999996 588888752 28899999999999999999995 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCC--------ccchhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSS--------EVYFPH 359 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~--------~~~~~~ 359 (450)
+....... .....||..|+|||++.+. .++.++|||||||++|+|++|+.||........ ....+.
T Consensus 175 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 175 RTAGTSFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPE 248 (371)
T ss_dssp -------------------CTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHH
T ss_pred cccccccc----cCCceecCCccCHHHhcCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 86643321 2345689999999999874 789999999999999999999999975421100 000000
Q ss_pred hhhh-------hhhhhhh-----------hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 360 WIYR-------HVEQDRE-----------FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 360 ~i~~-------~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+... ....... ..............+..+.+++.+||+.||++|||++|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 0000000 000000111123446789999999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=302.76 Aligned_cols=240 Identities=20% Similarity=0.219 Sum_probs=176.0
Q ss_pred hhHhhhccccccceEEEEEEE-------------------cchhhhhhhcCCCceeeeeeEEEeC---------------
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-------------------LDGLASISRTSHVNVVTLLGFCLEG--------------- 203 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-------------------~~e~~~l~~l~HpnIv~l~~~~~~~--------------- 203 (450)
.|.+.+.||+|+||+||+|+. .+|++++++++||||+++++++...
T Consensus 8 ~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~ 87 (383)
T 3eb0_A 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHN 87 (383)
T ss_dssp TEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC---------------
T ss_pred eEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccc
Confidence 345678999999999999953 2478999999999999999998543
Q ss_pred -----------------------CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc
Q 013074 204 -----------------------NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR 260 (450)
Q Consensus 204 -----------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ 260 (450)
...++||||++ ++|.+.+..... ....+++..++.++.|++.||+||| +.+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH---~~g 161 (383)
T 3eb0_A 88 KLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR--SGRSIPMNLISIYIYQLFRAVGFIH---SLG 161 (383)
T ss_dssp ----------------------CCEEEEEECCCS-EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHH---TTT
T ss_pred cccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHH---HCc
Confidence 34789999997 588777653111 0123899999999999999999999 599
Q ss_pred eEeeeeccccEEEc-CCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHH
Q 013074 261 ILHFDIKPHNILLD-QDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339 (450)
Q Consensus 261 ivH~Dikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ell 339 (450)
|+||||||+|||++ +++.+||+|||+++....... .....+|..|+|||++.+. ..++.++|||||||++|||+
T Consensus 162 i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell 236 (383)
T 3eb0_A 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP----SVAYICSRFYRAPELMLGA-TEYTPSIDLWSIGCVFGELI 236 (383)
T ss_dssp EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC----CCCCCCCSSCCCHHHHTTC-SSCCTHHHHHHHHHHHHHHH
T ss_pred CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC----CcCcccCCCccCHHHhcCC-CCCCcchhhhhHHHHHHHHH
Confidence 99999999999998 688999999999987644332 2344589999999998764 35899999999999999999
Q ss_pred cCCCCCCCCCCCCCccchhhhhhhhhhhhhh------------hhhccccc-----chhHHHHHHHHHHHHHccccCCCC
Q 013074 340 GCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE------------FKLLGVVT-----KKENEIAKKMIIVGLWCIQARPYD 402 (450)
Q Consensus 340 tg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~------------~~~~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~ 402 (450)
+|+.||....... .+... .+....... ........ ..+...+..+.+++.+||+.||++
T Consensus 237 ~g~~pf~~~~~~~---~~~~i-~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 237 LGKPLFSGETSID---QLVRI-IQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HSSCSSCCSSHHH---HHHHH-HHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred hCCCCCCCCChHH---HHHHH-HHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999997542110 11110 000000000 00000000 011124567899999999999999
Q ss_pred CCCHHHHHHH
Q 013074 403 RPPMNEVIEM 412 (450)
Q Consensus 403 RPs~~evl~~ 412 (450)
|||+.|+++.
T Consensus 313 R~t~~e~l~h 322 (383)
T 3eb0_A 313 RINPYEAMAH 322 (383)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999853
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=297.65 Aligned_cols=221 Identities=22% Similarity=0.337 Sum_probs=172.8
Q ss_pred HHHhhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc----CCCceeeeeeEEE
Q 013074 155 KKITNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT----SHVNVVTLLGFCL 201 (450)
Q Consensus 155 ~~~~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l----~HpnIv~l~~~~~ 201 (450)
....|.+.+.||+|+||.||+|+. .+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 344566778999999999999952 1256777777 8999999999999
Q ss_pred eCCceEEEEEe-cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc-CCCCe
Q 013074 202 EGNNRALIYEF-MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD-QDFCP 279 (450)
Q Consensus 202 ~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~ 279 (450)
+.+..++|+|+ +.+++|.+++..... +++..++.++.|++.||+|||+ .+|+|+||||+||+++ .++.+
T Consensus 109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~------~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 109 TQEGFMLVLERPLPAQDLFDYITEKGP------LGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp ----CEEEEECCSSEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEE
T ss_pred cCCeEEEEEEecCCCCCHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeE
Confidence 99999999999 789999999976432 8999999999999999999995 8999999999999999 88999
Q ss_pred EEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhh
Q 013074 280 KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPH 359 (450)
Q Consensus 280 kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~ 359 (450)
||+|||++....... .....|+..|+|||++.+. ...+.++||||||+++|+|++|+.||.... .
T Consensus 180 kl~dfg~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~ 244 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP-----YTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFERDQ---------E 244 (312)
T ss_dssp EECCCSSCEECCSSC-----BCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H
T ss_pred EEEEcchhhhcccCc-----ccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCChH---------H
Confidence 999999998765432 2344589999999998764 233568999999999999999999985321 0
Q ss_pred hhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 360 WIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 360 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+. .. .......++..+.+++.+||+.||++|||++|+++.
T Consensus 245 -~~----~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 -IL----EA--------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -HH----HT--------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -Hh----hh--------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00 001112345678899999999999999999999984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=290.61 Aligned_cols=231 Identities=23% Similarity=0.307 Sum_probs=181.7
Q ss_pred HHHHHhhHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceE
Q 013074 153 DVKKITNSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 153 ei~~~~~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~ 207 (450)
......|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 33445566778999999999999953 23578889999999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC---CCeEEeec
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD---FCPKISDF 284 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~---~~~kl~DF 284 (450)
+|+||+++++|.+++.... .+++..++.++.|++.||.|||+ .+++|+||||+||+++.+ +.+||+||
T Consensus 98 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK------RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS------SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEecc
Confidence 9999999999999886543 28999999999999999999995 899999999999999754 47999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
|++........ .....||..|+|||.+.+ .++.++||||||+++++|++|+.||...... . +...
T Consensus 169 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~-~~~~ 233 (287)
T 2wei_A 169 GLSTCFQQNTK----MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------D-ILKR 233 (287)
T ss_dssp TGGGTBCCCSS----CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHH
T ss_pred CcceeecCCCc----cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-------H-HHHH
Confidence 99986654322 122347899999999865 5889999999999999999999999653210 0 1111
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+..... .........++.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 234 VETGKY----AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHHCCC----CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCC----CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 111100 0001111234577899999999999999999999997
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=307.16 Aligned_cols=230 Identities=10% Similarity=0.019 Sum_probs=159.2
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------ch---hhhhhhcCCCceeeee-------eEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DG---LASISRTSHVNVVTLL-------GFCLE 202 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e---~~~l~~l~HpnIv~l~-------~~~~~ 202 (450)
+.+.+.||+|+||.||+|+.. +| +..|++ +||||++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheec
Confidence 345678999999999999632 23 334455 699987754 45543
Q ss_pred CC-----------------ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHH------HHHHHHHHHHHHHhhcCCCC
Q 013074 203 GN-----------------NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM------YEIVIGIAKGLEYLHRGCST 259 (450)
Q Consensus 203 ~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~ 259 (450)
.+ ..++||||++ ++|.+++...+. .+.+..+ +.++.|++.||+|||+ .
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-----VYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-----ccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 32 3799999998 899999976422 1344445 6778999999999995 8
Q ss_pred ceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHH
Q 013074 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339 (450)
Q Consensus 260 ~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ell 339 (450)
+|+||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+....++.++|||||||++|||+
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell 287 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCCc------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence 99999999999999999999999999998664322 123467999999999762237899999999999999999
Q ss_pred cCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 340 GCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 340 tg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+|+.||........... ... ...... ...........++..+.+++.+||+.||++|||+.|+++
T Consensus 288 tg~~Pf~~~~~~~~~~~-~~~---~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 288 CLFLPFGLVTPGIKGSW-KRP---SLRVPG---TDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp HSSCSTTBCCTTCTTCC-CBC---CTTSCC---CCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred hCCCCCCCcCcccccch-hhh---hhhhcc---ccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999976533221100 000 000000 000011111234578999999999999999999999974
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=298.40 Aligned_cols=218 Identities=24% Similarity=0.330 Sum_probs=177.0
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcC--CCceeeeeeEEEeCCce
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTS--HVNVVTLLGFCLEGNNR 206 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~--HpnIv~l~~~~~~~~~~ 206 (450)
.|.+.+.||+|+||.||+|+. ..|+.++++++ |+||+++++++.+++..
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~ 123 (320)
T 3a99_A 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123 (320)
T ss_dssp TEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence 345678999999999999952 23677888886 59999999999999999
Q ss_pred EEEEEecCC-CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc-CCCCeEEeec
Q 013074 207 ALIYEFMPN-GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD-QDFCPKISDF 284 (450)
Q Consensus 207 ~lV~E~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~kl~DF 284 (450)
++|+|++.+ ++|.+++..... +++..++.++.|++.||+|||+ .+|+||||||+|||++ +++.+||+||
T Consensus 124 ~lv~e~~~~~~~L~~~l~~~~~------l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Df 194 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITERGA------LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 194 (320)
T ss_dssp EEEEECCSSEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEcCCCCccHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeC
Confidence 999999976 899999876432 8999999999999999999995 8999999999999999 7899999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
|+++...... .....||..|+|||++.+. ...+.++||||||+++|||++|+.||.... ....
T Consensus 195 g~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~~~~-- 257 (320)
T 3a99_A 195 GSGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIR-- 257 (320)
T ss_dssp TTCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHH--
T ss_pred cccccccccc-----ccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCChh---------hhhc--
Confidence 9998765432 2344589999999998764 234788999999999999999999985321 0000
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
. .......++.++.+++.+||+.||++|||++|+++.
T Consensus 258 ---~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 258 ---G--------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ---C--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---c--------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000112234678899999999999999999999874
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=297.02 Aligned_cols=228 Identities=24% Similarity=0.359 Sum_probs=171.5
Q ss_pred HhhhccccccceEEEEEEE----------------------cchhhhhhhc-CCCceeeeeeEEEe------CCceEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL----------------------LDGLASISRT-SHVNVVTLLGFCLE------GNNRALIY 210 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l-~HpnIv~l~~~~~~------~~~~~lV~ 210 (450)
.+.+.||+|+||.||+|+. .+|+.+++++ +||||+++++++.. ....++||
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~ 106 (326)
T 2x7f_A 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVM 106 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEE
T ss_pred EEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEE
Confidence 4567899999999999964 2356778888 79999999999987 46789999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++++|.+++..... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+|||++...
T Consensus 107 e~~~~~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 179 (326)
T 2x7f_A 107 EFCGAGSVTDLIKNTKG----NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179 (326)
T ss_dssp ECCTTEEHHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC--
T ss_pred EcCCCCcHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceec
Confidence 99999999999976432 238999999999999999999995 89999999999999999999999999998866
Q ss_pred cCCCCccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
...... .....||..|+|||++... ...++.++||||||+++|+|++|+.||...... .... .+..
T Consensus 180 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~-~~~~ 248 (326)
T 2x7f_A 180 DRTVGR---RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALF-LIPR 248 (326)
T ss_dssp --------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHH-HHHH
T ss_pred CcCccc---cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-------HHHH-Hhhc
Confidence 432211 2334589999999998631 136889999999999999999999998643210 0000 0000
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
. ..........+..+.+++.+||+.||.+||+++|+++
T Consensus 249 ~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 249 N------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp S------CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred C------ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 0000111234567899999999999999999999987
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=310.03 Aligned_cols=239 Identities=23% Similarity=0.277 Sum_probs=173.6
Q ss_pred hHhhhccccccceEEEEEEE-------------------cchhhhhhhcCCCceeeeeeEEEeCC------ceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------LDGLASISRTSHVNVVTLLGFCLEGN------NRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------~~e~~~l~~l~HpnIv~l~~~~~~~~------~~~lV~E~~ 213 (450)
|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.... ..++||||+
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~ 135 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECC
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcc
Confidence 34567899999999999963 24788999999999999999986421 367899999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC-CCeEEeeccccccccC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD-FCPKISDFGLAKLCTT 292 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~-~~~kl~DFGla~~~~~ 292 (450)
++ +|.+.+..... ....+++..++.++.|+++||+||| +.+|+||||||+|||++.+ +.+||+|||+++....
T Consensus 136 ~~-~l~~~~~~~~~--~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 136 PE-TVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp CE-EHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred cc-cHHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 64 66665543110 0123899999999999999999999 4999999999999999965 5789999999987644
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh---
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR--- 369 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~--- 369 (450)
... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||...... ..+.+.+ +.+....
T Consensus 210 ~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~---~~l~~i~-~~lg~p~~~~ 280 (420)
T 1j1b_A 210 GEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV---DQLVEII-KVLGTPTREQ 280 (420)
T ss_dssp TCC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH-HHHCSCCHHH
T ss_pred CCC----ceeeeeCCCcCCHHHHcCC-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH-HHhCCCCHHH
Confidence 322 2334689999999998753 36899999999999999999999999754211 1111111 1000000
Q ss_pred ---------hhhhcccccc-----hhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 370 ---------EFKLLGVVTK-----KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 370 ---------~~~~~~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.......... .....+.++.+++.+||+.||.+|||+.|+++.
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0000000000 011235779999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=301.53 Aligned_cols=237 Identities=21% Similarity=0.243 Sum_probs=161.9
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC------CceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG------NNRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~------~~~~ 207 (450)
|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++... ...+
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~ 110 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 110 (367)
T ss_dssp EEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred eEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEE
Confidence 34567899999999999952 1467889999999999999998754 5679
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+|+|++ +++|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 111 lv~e~~-~~~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 111 LVTHLM-GADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp EEEECC-CEECC-----C-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred EEeccc-CCCHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence 999999 78999888542 28999999999999999999995 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
+..... .....||..|+|||++.+. ..++.++|||||||+++||++|+.||...... .....+.+.+..
T Consensus 180 ~~~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~l~~i~~~~g~ 248 (367)
T 2fst_X 180 RHTADE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI----DQLKLILRLVGT 248 (367)
T ss_dssp -----------------CCCTTCCHHHHTTC-CSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCS
T ss_pred cccccc------CCCcCcCcCccChHHHcCC-cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCC
Confidence 865432 2344689999999998763 47899999999999999999999999654211 000111110000
Q ss_pred hhh-----------hh----hccccc----chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccc
Q 013074 368 DRE-----------FK----LLGVVT----KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGST 417 (450)
Q Consensus 368 ~~~-----------~~----~~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 417 (450)
... .. ...... .........+.+++.+||+.||++|||++|+++. ++...
T Consensus 249 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 249 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 000 00 000000 0011234678999999999999999999999975 44433
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=298.79 Aligned_cols=231 Identities=21% Similarity=0.264 Sum_probs=156.3
Q ss_pred hccccccceEEEEEEEcch-------------------hhhhhhcCCCceeeeeeEEEe----CCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKLLDG-------------------LASISRTSHVNVVTLLGFCLE----GNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~~e-------------------~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~ 219 (450)
+.||+|+||+||+|+.... ...++.+.||||+++++++.. +...++||||+++|+|.
T Consensus 35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~ 114 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELF 114 (336)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHH
T ss_pred eeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHH
Confidence 4699999999999975421 233566789999999999976 44589999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---CCCeEEeeccccccccCCCCc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ---DFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~~~~~~~~ 296 (450)
+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++. ++.+||+|||+++......
T Consensus 115 ~~l~~~~~----~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~-- 185 (336)
T 3fhr_A 115 SRIQERGD----QAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-- 185 (336)
T ss_dssp HHHHTC-C----CCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC------
T ss_pred HHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc--
Confidence 99986543 238999999999999999999995 89999999999999976 4569999999998664332
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.....||+.|+|||++.+. .++.++||||||+++|+|++|+.||........... ....... .....
T Consensus 186 ---~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----~~~~~~~----~~~~~ 252 (336)
T 3fhr_A 186 ---LQTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG----MKRRIRL----GQYGF 252 (336)
T ss_dssp ---------------------C--HHHHHHHHHHHHHHHHHHHHSSCCC-----------------------------CC
T ss_pred ---cccCCCCcCccChhhhCCC--CCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh----HHHhhhc----ccccc
Confidence 2334589999999999664 788999999999999999999999965432211000 0000000 00001
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhc
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQG 415 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 415 (450)
.......++.++.+++.+||+.||.+|||++|+++. ++.
T Consensus 253 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 293 (336)
T 3fhr_A 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293 (336)
T ss_dssp CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence 111112356778999999999999999999999974 554
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-37 Score=297.35 Aligned_cols=238 Identities=22% Similarity=0.296 Sum_probs=169.2
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEE--------------
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCL-------------- 201 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~-------------- 201 (450)
|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~ 92 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLT 92 (320)
T ss_dssp EEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CC
T ss_pred eeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccccc
Confidence 34567899999999999953 24678899999999999999873
Q ss_pred eCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc-CCCCeE
Q 013074 202 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD-QDFCPK 280 (450)
Q Consensus 202 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~-~~~~~k 280 (450)
+....++||||++ |+|.+++... .+++..++.++.|++.||+|||+ .+|+||||||+||+++ +++.+|
T Consensus 93 ~~~~~~lv~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 93 ELNSVYIVQEYME-TDLANVLEQG-------PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp SCSEEEEEEECCS-EEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEE
T ss_pred ccCceeEEeeccC-CCHHHHhhcC-------CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEE
Confidence 3467899999996 6999998542 28899999999999999999995 8999999999999997 567999
Q ss_pred EeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhh
Q 013074 281 ISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~ 360 (450)
|+|||+++................+|..|+|||.+.+. ..++.++||||||+++|||++|+.||....... ....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~~~~ 236 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSP-NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE----QMQL 236 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCc-ccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH----HHHH
Confidence 99999998764332222222334578999999998653 478999999999999999999999997543110 0000
Q ss_pred hhhhhhh---hhhhh------------hc---ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 361 IYRHVEQ---DREFK------------LL---GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 361 i~~~~~~---~~~~~------------~~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+...... ..... .. .........++.++.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 0000000 00000 00 00001112346789999999999999999999999874
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=291.85 Aligned_cols=232 Identities=26% Similarity=0.396 Sum_probs=170.8
Q ss_pred hhHhhhccccccceEEEEEEE----------------------cchhhhhhhcCCCceeeeeeEEEe-------------
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTSHVNVVTLLGFCLE------------- 202 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~HpnIv~l~~~~~~------------- 202 (450)
.|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++.+
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~ 86 (303)
T 1zy4_A 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKK 86 (303)
T ss_dssp HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------C
T ss_pred cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccccc
Confidence 345678899999999999963 246788899999999999998865
Q ss_pred CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEe
Q 013074 203 GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKIS 282 (450)
Q Consensus 203 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~ 282 (450)
....++||||+++++|.+++.... ..+++..++.++.|++.||+|||+ .+|+|+||||+||+++.++.+||+
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 87 KSTLFIQMEYCENGTLYDLIHSEN-----LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHSC-----GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEEC
T ss_pred CCceEEEEecCCCCCHHHhhhccc-----cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEe
Confidence 356789999999999999997543 237889999999999999999995 899999999999999999999999
Q ss_pred eccccccccCCCCc-----------cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCC
Q 013074 283 DFGLAKLCTTKKGI-----------VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN 351 (450)
Q Consensus 283 DFGla~~~~~~~~~-----------~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~ 351 (450)
|||++......... ........||..|+|||++.+. +.++.++||||||+++|+|++ |+.....
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~---p~~~~~~- 233 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT-GHYNEKIDMYSLGIIFFEMIY---PFSTGME- 233 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSC-SCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC-CCCcchhhHHHHHHHHHHHHh---ccCCchh-
Confidence 99999865432110 1112345689999999998754 468999999999999999997 3322100
Q ss_pred CCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 352 SSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 352 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.......+... ............+..+.+++.+||+.||.+|||++|+++.
T Consensus 234 ------~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 ------RVNILKKLRSV----SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ------HHHHHHHHHST----TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ------HHHHHHhcccc----ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00011111110 0011111223345678899999999999999999999863
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=296.01 Aligned_cols=235 Identities=20% Similarity=0.251 Sum_probs=178.7
Q ss_pred hhHhhhccccccceEEEEEEEc-----------------------chhhhhhhcCCC------ceeeeeeEEEeCCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHV------NVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~Hp------nIv~l~~~~~~~~~~~l 208 (450)
.|.+.+.||+|+||.||++... +|+.++++++|+ +++++++++.+.+..++
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~l 94 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICI 94 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEE
Confidence 4556789999999999999531 245667777665 49999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-------------
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ------------- 275 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~------------- 275 (450)
||||+ +++|.+++..... ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 95 v~e~~-~~~l~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 95 VFELL-GLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEcCC-CCCHHHHHHhcCC----CCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999 8999999976543 238999999999999999999995 89999999999999987
Q ss_pred ------CCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCC
Q 013074 276 ------DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGV 349 (450)
Q Consensus 276 ------~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~ 349 (450)
++.+||+|||+++..... .....||..|+|||++.+. .++.++||||||+++|||++|..||....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH------HSTLVSTRHYRAPEVILAL--GWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC------CCSSCSCGGGCCHHHHTTS--CCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccCCCceEeeCcccccCccc------cccccCCccccChHHhhCC--CCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999999865433 2344689999999999874 78999999999999999999999997542
Q ss_pred CCCCccchhhhhhhhhhhhhhh--------------------------------hhcccccchhHHHHHHHHHHHHHccc
Q 013074 350 DNSSEVYFPHWIYRHVEQDREF--------------------------------KLLGVVTKKENEIAKKMIIVGLWCIQ 397 (450)
Q Consensus 350 ~~~~~~~~~~~i~~~~~~~~~~--------------------------------~~~~~~~~~~~~~~~~l~~l~~~Cl~ 397 (450)
... ....+.......... .............+.++.+++.+||+
T Consensus 239 ~~~----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 314 (339)
T 1z57_A 239 SKE----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314 (339)
T ss_dssp HHH----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred hHH----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence 111 000000000000000 00000011123456789999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 013074 398 ARPYDRPPMNEVIEM 412 (450)
Q Consensus 398 ~dP~~RPs~~evl~~ 412 (450)
.||++|||++|+++.
T Consensus 315 ~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 315 YDPAKRITLREALKH 329 (339)
T ss_dssp SSTTTSCCHHHHTTS
T ss_pred cCcccccCHHHHhcC
Confidence 999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=300.19 Aligned_cols=238 Identities=22% Similarity=0.303 Sum_probs=176.4
Q ss_pred hHhhhccccccceEEEEEEEc------------------------chhhhhhhcCCCceeeeeeEEEeC-----CceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL------------------------DGLASISRTSHVNVVTLLGFCLEG-----NNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~------------------------~e~~~l~~l~HpnIv~l~~~~~~~-----~~~~lV 209 (450)
+.+.+.||+|+||.||+|+.. +|+.++++++||||+++++++..+ ...++|
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv 92 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEE
Confidence 345678999999999999632 467889999999999999988764 678999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+. ++|.+++... .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~e~~~-~~L~~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 93 QELMQ-TDLHRVISTQ-------MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp ECCCS-EEHHHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EeccC-ccHHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99996 6999988753 28999999999999999999995 8999999999999999999999999999987
Q ss_pred ccCCCCcc-------ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhh
Q 013074 290 CTTKKGIV-------SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY 362 (450)
Q Consensus 290 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~ 362 (450)
........ .......||..|+|||++.+. ..++.++||||||+++|+|++|+.||....... .+ ..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~-~~~~ 236 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTS-AKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH---QL-LLIF 236 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSC-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH-HHHH
T ss_pred cccccccccCccccccchhhccccccccCCeeeccC-CCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH---HH-HHHH
Confidence 64322111 112335689999999987653 478999999999999999999999997542100 00 0000
Q ss_pred hhhh------------hhh--hh--hhc----ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 363 RHVE------------QDR--EF--KLL----GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 363 ~~~~------------~~~--~~--~~~----~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... ... .. ... .........++.++.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 000 00 000 00001112345778999999999999999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=299.10 Aligned_cols=245 Identities=21% Similarity=0.224 Sum_probs=166.8
Q ss_pred hhHhhhccccccceEEEEEEEc----------------------chhhhhhhcCCCceeeeeeEEEeCCc-------eEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRTSHVNVVTLLGFCLEGNN-------RAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l~HpnIv~l~~~~~~~~~-------~~l 208 (450)
.|.+.+.||+|+||.||+|+.. ++++.+++++||||+++++++..... .++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~l 103 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNV 103 (360)
T ss_dssp TEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEE
Confidence 3455678999999999999642 12555677899999999999976443 789
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhh--cCCCCceEeeeeccccEEEcC-CCCeEEeecc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH--RGCSTRILHFDIKPHNILLDQ-DFCPKISDFG 285 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFG 285 (450)
||||+++ +|...+..... ....+++..+..++.|++.||.||| + .+|+||||||+|||++. ++.+||+|||
T Consensus 104 v~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 104 VMEYVPD-TLHRCCRNYYR--RQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEECCSC-BHHHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred Eeecccc-cHHHHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 9999965 65554432110 1123889999999999999999999 5 89999999999999996 8999999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
+++....... .....||..|+|||++.+. ..++.++||||||+++|+|++|+.||...... ..+.. +.+..
T Consensus 178 ~a~~~~~~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~-~~~~~ 248 (360)
T 3e3p_A 178 SAKKLSPSEP----NVAYICSRYYRAPELIFGN-QHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA---GQLHE-IVRVL 248 (360)
T ss_dssp TCBCCCTTSC----CCSTTSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH-HHHHH
T ss_pred CceecCCCCC----cccccCCcceeCHHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH---HHHHH-HHHHc
Confidence 9987654332 2344589999999998654 35899999999999999999999999754211 01111 11000
Q ss_pred hhh------------hhhhh--------cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccc
Q 013074 366 EQD------------REFKL--------LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGST 417 (450)
Q Consensus 366 ~~~------------~~~~~--------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 417 (450)
... ..... ...........+..+.+++.+||+.||.+|||+.|+++. +++..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 000 00000 000011111246789999999999999999999999975 55543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-36 Score=297.57 Aligned_cols=243 Identities=21% Similarity=0.246 Sum_probs=177.8
Q ss_pred HhhHhhhccccccceEEEEEEEc----------------------chhhhhhhcC-----------CCceeeeeeEEEeC
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRTS-----------HVNVVTLLGFCLEG 203 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l~-----------HpnIv~l~~~~~~~ 203 (450)
..|.+.+.||+|+||.||+|+.. +|+.++++++ ||||+++++++...
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~ 98 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 98 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhcc
Confidence 34556789999999999999631 3466666665 89999999999865
Q ss_pred C----ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC-ceEeeeeccccEEEc----
Q 013074 204 N----NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST-RILHFDIKPHNILLD---- 274 (450)
Q Consensus 204 ~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dikp~NIll~---- 274 (450)
. ..++|||++ +++|.+++..... ..+++..++.++.|++.||+|||+ . +|+||||||+|||++
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 99 GPNGVHVVMVFEVL-GENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp ETTEEEEEEEECCC-CEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEET
T ss_pred CCCCceEEEEEecC-CCCHHHHHHHhhc----cCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCC
Confidence 4 789999999 8999999976543 228999999999999999999995 6 999999999999995
Q ss_pred --CCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCC
Q 013074 275 --QDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNS 352 (450)
Q Consensus 275 --~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~ 352 (450)
..+.+||+|||++...... .....||+.|+|||++.+. .++.++||||||+++|||++|+.||.......
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~------~~~~~~t~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH------YTNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC------CCSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CcCcceEEEcccccccccCCC------CCCCCCCccccCcHHHhCC--CCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 3448999999999876543 2334589999999999874 78999999999999999999999997543221
Q ss_pred Cccchh--hhhhhhhhhhhh------------------------------hhhcccccchhHHHHHHHHHHHHHccccCC
Q 013074 353 SEVYFP--HWIYRHVEQDRE------------------------------FKLLGVVTKKENEIAKKMIIVGLWCIQARP 400 (450)
Q Consensus 353 ~~~~~~--~~i~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP 400 (450)
...... ..+.+.+..... ..............+.++.+++.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 110000 000000000000 000000112235677889999999999999
Q ss_pred CCCCCHHHHHHH--hhc
Q 013074 401 YDRPPMNEVIEM--LQG 415 (450)
Q Consensus 401 ~~RPs~~evl~~--L~~ 415 (450)
++|||++|+++. +.+
T Consensus 323 ~~Rpt~~ell~hp~f~~ 339 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKD 339 (373)
T ss_dssp TTCBCHHHHHTCGGGTT
T ss_pred cccCCHHHHhhChhhhc
Confidence 999999999974 544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=295.97 Aligned_cols=233 Identities=21% Similarity=0.327 Sum_probs=179.8
Q ss_pred hHhhhccccccceEEEEEEE--------------------------------------cchhhhhhhcCCCceeeeeeEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------------------LDGLASISRTSHVNVVTLLGFC 200 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------------------~~e~~~l~~l~HpnIv~l~~~~ 200 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 112 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEE
T ss_pred eEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 44577899999999999852 2356788899999999999999
Q ss_pred EeCCceEEEEEecCCCChhhh------hhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc
Q 013074 201 LEGNNRALIYEFMPNGSLEKF------VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD 274 (450)
Q Consensus 201 ~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~ 274 (450)
.+++..++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ ..+|+|+||||+||+++
T Consensus 113 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNY----TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp ESSSEEEEEEECCTTCBSSEESSSEESSCSSS----CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred eeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc----ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 999999999999999999998 44321 2349999999999999999999993 38999999999999999
Q ss_pred CCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCc-cCchHhHHHHHHHHHcCCCCCCCCCCCCC
Q 013074 275 QDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSH-KSDVYSFGMMIMELVGCKNNLDSGVDNSS 353 (450)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~-~sDiwSlGvvl~elltg~~p~~~~~~~~~ 353 (450)
.++.+||+|||++...... ......||..|+|||++.+. ..++. ++||||||++++||++|+.||.......
T Consensus 187 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 259 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK-----KIKGSRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV- 259 (348)
T ss_dssp TTSCEEECCCTTCEECBTT-----EECSSCSCGGGCCGGGGSSC-CCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred CCCcEEEeccccccccccc-----cccCCCCCcCccCchhhcCC-CCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 9999999999999876443 13445689999999999764 24555 9999999999999999999997543210
Q ss_pred ccchhhhhhhhhhhhhhhhhcc------------cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 354 EVYFPHWIYRHVEQDREFKLLG------------VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 354 ~~~~~~~i~~~~~~~~~~~~~~------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
. +...+..... .... .........+..+.+++.+||+.||.+|||++|+++
T Consensus 260 --~----~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 --E----LFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --H----HHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --H----HHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 1111111000 0000 000011335678899999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=296.73 Aligned_cols=231 Identities=22% Similarity=0.256 Sum_probs=171.9
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCce------E
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNR------A 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~------~ 207 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++...+.. +
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 123 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 123 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCE
T ss_pred EEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEE
Confidence 34567899999999999952 2357788999999999999999877655 9
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+. ++|.+.+.. .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 124 lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 124 LVMPFMQ-TDLQKIMGM--------EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp EEEECCC-EEHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred EEEcccc-ccHHHHhhc--------CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 9999996 688887731 28999999999999999999995 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh-
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE- 366 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~- 366 (450)
+..... .....||+.|+|||++.+. ..++.++||||||+++++|++|+.||....... .+. .+.....
T Consensus 192 ~~~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~-~i~~~~~~ 260 (371)
T 4exu_A 192 RHADAE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLT-QILKVTGV 260 (371)
T ss_dssp --------------CTTCCCTTSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH-HHHHHHCC
T ss_pred cccccC------cCCcccCccccCHHHhcCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH---HHH-HHHHHhCC
Confidence 865433 2345689999999998763 378999999999999999999999996532110 000 0000000
Q ss_pred ----------hhhh----hhhcccc----cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 367 ----------QDRE----FKLLGVV----TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 367 ----------~~~~----~~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... ....... .......+..+.+++.+||+.||++|||++|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 261 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 0000 0000000 00111235789999999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=293.89 Aligned_cols=236 Identities=23% Similarity=0.347 Sum_probs=177.4
Q ss_pred hHhhhccccccceEEEEEEEc--------------------------chhhhhhhc---CCCceeeeeeEEE-----eCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRT---SHVNVVTLLGFCL-----EGN 204 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l---~HpnIv~l~~~~~-----~~~ 204 (450)
|.+.+.||+|+||.||+|+.. +|+.+++++ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 445778999999999999642 234445544 8999999999987 456
Q ss_pred ceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeec
Q 013074 205 NRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDF 284 (450)
Q Consensus 205 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DF 284 (450)
..++||||+. ++|.+++..... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||+||
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred eEEEEEecCC-CCHHHHHHhccc----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecC
Confidence 7899999996 699999976543 238999999999999999999995 89999999999999999999999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
|+++...... ......||..|+|||++.+. .++.++||||||+++|+|++|+.||...... .....+...
T Consensus 165 g~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~~ 234 (326)
T 1blx_A 165 GLARIYSFQM----ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDV----DQLGKILDV 234 (326)
T ss_dssp CSCCCCCGGG----GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHH
T ss_pred cccccccCCC----CccccccccceeCHHHHhcC--CCCcchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHHH
Confidence 9998664322 12345689999999999774 7899999999999999999999999754211 000001100
Q ss_pred hhhhhhhh---------------hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 365 VEQDREFK---------------LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 365 ~~~~~~~~---------------~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
........ ...........++..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 00000000 0000111122345778999999999999999999999954
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=295.13 Aligned_cols=240 Identities=17% Similarity=0.244 Sum_probs=177.4
Q ss_pred HhhHhhhccccccceEEEEEEEc-----------------------chhhhhhhcCCCc------eeeeeeEEEeCCceE
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLL-----------------------DGLASISRTSHVN------VVTLLGFCLEGNNRA 207 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~-----------------------~e~~~l~~l~Hpn------Iv~l~~~~~~~~~~~ 207 (450)
..|.+.+.||+|+||+||+|+.. .|+.++++++|++ ++.+++++......+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 98 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMC 98 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEE
Confidence 34556789999999999998532 2466777777665 899999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEE--------------
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILL-------------- 273 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll-------------- 273 (450)
+||||+ +++|.+++..... ..+++..++.++.|++.||+||| +.+|+||||||+|||+
T Consensus 99 lv~e~~-~~~l~~~l~~~~~----~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 99 IAFELL-GKNTFEFLKENNF----QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEECC-CCBHHHHHHHTTT----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEecc-CCChHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccc
Confidence 999999 6788777765432 23899999999999999999999 4899999999999999
Q ss_pred -----cCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCC
Q 013074 274 -----DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 348 (450)
Q Consensus 274 -----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~ 348 (450)
+.++.+||+|||+++...... ....||..|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEHH------TTIVATRHYRPPEVILEL--GWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSCC------CSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccCCCcEEEeecCccccccccc------cCCcCCCcccCCeeeecC--CCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 678899999999998654332 344689999999999874 7899999999999999999999999754
Q ss_pred CCCCCccch-------hhhhhhhhhhhhhh------------------h---hcccccchhHHHHHHHHHHHHHccccCC
Q 013074 349 VDNSSEVYF-------PHWIYRHVEQDREF------------------K---LLGVVTKKENEIAKKMIIVGLWCIQARP 400 (450)
Q Consensus 349 ~~~~~~~~~-------~~~i~~~~~~~~~~------------------~---~~~~~~~~~~~~~~~l~~l~~~Cl~~dP 400 (450)
........+ +............. . ...............+.+++.+||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 321100000 00000000000000 0 0000001122345688999999999999
Q ss_pred CCCCCHHHHHHH
Q 013074 401 YDRPPMNEVIEM 412 (450)
Q Consensus 401 ~~RPs~~evl~~ 412 (450)
++|||++|+++.
T Consensus 323 ~~Rpt~~e~l~h 334 (355)
T 2eu9_A 323 AQRITLAEALLH 334 (355)
T ss_dssp TTSCCHHHHTTS
T ss_pred hhCcCHHHHhcC
Confidence 999999999853
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=294.93 Aligned_cols=240 Identities=18% Similarity=0.196 Sum_probs=171.5
Q ss_pred HhhhccccccceEEEEEEE---------------------------------cchhhhhhhcCCCceeeeeeEEEeC---
Q 013074 160 SFKDKLGQGGFGGVYKGKL---------------------------------LDGLASISRTSHVNVVTLLGFCLEG--- 203 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~---------------------------------~~e~~~l~~l~HpnIv~l~~~~~~~--- 203 (450)
.+.+.||+|+||.||+|+. .+|++++++++||||+++++++...
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (362)
T 3pg1_A 25 TVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104 (362)
T ss_dssp EEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTT
T ss_pred EEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCC
Confidence 3457899999999999841 2468889999999999999998653
Q ss_pred --CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEE
Q 013074 204 --NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKI 281 (450)
Q Consensus 204 --~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 281 (450)
...++||||+. |+|.+++.... ..+++..++.++.|++.||.|||+ .+|+|+||||+||+++.++.+||
T Consensus 105 ~~~~~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 105 AMHKLYLVTELMR-TDLAQVIHDQR-----IVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp TCCEEEEEEECCS-EEHHHHHHCTT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred CcceEEEEEccCC-CCHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEE
Confidence 35799999996 68888887543 238999999999999999999995 89999999999999999999999
Q ss_pred eeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhh
Q 013074 282 SDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI 361 (450)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i 361 (450)
+|||+++....... .....||..|+|||++.+. ..++.++||||||+++|+|++|+.||....... ....+
T Consensus 176 ~Dfg~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i 246 (362)
T 3pg1_A 176 CDFNLAREDTADAN----KTHYVTHRWYRAPELVMQF-KGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN----QLNKI 246 (362)
T ss_dssp CCTTC-------------------CGGGCCHHHHTTC-TTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHH
T ss_pred EecCcccccccccc----cceecccceecCcHHhcCC-CCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH----HHHHH
Confidence 99999975543322 2334589999999998763 368999999999999999999999997542110 00000
Q ss_pred hhhhhhhhh-------------h---hh----cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccc
Q 013074 362 YRHVEQDRE-------------F---KL----LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGST 417 (450)
Q Consensus 362 ~~~~~~~~~-------------~---~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 417 (450)
.+....... . .. ...........+..+.+++.+||+.||++|||++|+++. ++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 000000000 0 00 000001112235678999999999999999999999975 55443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-36 Score=290.14 Aligned_cols=229 Identities=18% Similarity=0.262 Sum_probs=170.7
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcC--CCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTS--HVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~--HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||.||+++. .+|++++++++ ||||+++++++.++...++|||
T Consensus 30 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e- 108 (313)
T 3cek_A 30 YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME- 108 (313)
T ss_dssp EEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-
T ss_pred EEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-
Confidence 44567899999999999852 23577788887 5999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+.+++|.+++..... +++..++.++.|++.||.|||+ .+|+||||||+||++++ +.+||+|||+++....
T Consensus 109 ~~~~~L~~~l~~~~~------~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 109 CGNIDLNSWLKKKKS------IDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp CCSEEHHHHHHHCSS------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred cCCCcHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 458899999976532 8899999999999999999995 89999999999999974 8999999999987654
Q ss_pred CCCccccccCCCCccccccccccccc---------cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRN---------FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
..... ......||..|+|||.+.+. ...++.++||||||+++|+|++|+.||...... ...+..
T Consensus 179 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~------~~~~~~ 251 (313)
T 3cek_A 179 DTTSV-VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ------ISKLHA 251 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHHHH
T ss_pred ccccc-cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH------HHHHHH
Confidence 32211 12344589999999998641 136788999999999999999999999643211 000111
Q ss_pred hhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
...... ....+...+.++.+++.+||+.||++||+++|+++.
T Consensus 252 ~~~~~~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 IIDPNH-------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHCTTS-------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHhccc-------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 111100 001111224678899999999999999999999964
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=302.61 Aligned_cols=235 Identities=22% Similarity=0.283 Sum_probs=166.3
Q ss_pred hhccccccceEEEEEE-------------------Ecchhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCCCChhhh
Q 013074 162 KDKLGQGGFGGVYKGK-------------------LLDGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKF 221 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~-------------------~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~ 221 (450)
.+.||+|+||+||.+. ..+|+++++++ +||||+++++++.++...++||||+. |+|.++
T Consensus 20 ~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~ 98 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDL 98 (434)
T ss_dssp EEEEEECSTTCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHH
T ss_pred cCeEeeCCCeEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHH
Confidence 4679999999997542 12457778776 89999999999999999999999995 699999
Q ss_pred hhcCCCCCCC-ccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC-------------CCeEEeecccc
Q 013074 222 VYNGDTSKPC-QYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD-------------FCPKISDFGLA 287 (450)
Q Consensus 222 l~~~~~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~-------------~~~kl~DFGla 287 (450)
+......... ...++..++.++.|++.||+|||+ .+|+||||||+|||++.+ +.+||+|||++
T Consensus 99 l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a 175 (434)
T 2rio_A 99 VESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175 (434)
T ss_dssp HHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTC
T ss_pred HhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEEEcccccc
Confidence 9765432111 112334567899999999999995 899999999999999754 48999999999
Q ss_pred ccccCCCCc-cccccCCCCccccccccccccc-----cCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhh
Q 013074 288 KLCTTKKGI-VSSLLGARGTIGYIALEVFSRN-----FGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHW 360 (450)
Q Consensus 288 ~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-----~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 360 (450)
+........ ........||+.|+|||++.+. ...++.++|||||||++|||++ |+.||....... ...
T Consensus 176 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-----~~i 250 (434)
T 2rio_A 176 KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-----SNI 250 (434)
T ss_dssp EECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-----HHH
T ss_pred eecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-----HHH
Confidence 877543321 1112345699999999998651 1468999999999999999998 888886432110 000
Q ss_pred hhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 361 IYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 361 i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
+... .............++.++.+++.+||+.||.+|||+.|+++
T Consensus 251 ~~~~------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 251 IRGI------FSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHTC------CCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hcCC------CCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0000 00011111223456788999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=292.54 Aligned_cols=233 Identities=22% Similarity=0.288 Sum_probs=155.3
Q ss_pred HhhhccccccceEEEEEEEcc------------------------hh-hhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKLLD------------------------GL-ASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~------------------------e~-~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.||+|+||.||+|+... |. .+++.++||||+++++++.+++..++||||++
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~ 104 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS 104 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS
T ss_pred hehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC
Confidence 346789999999999996431 12 25667799999999999999999999999996
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCC-ceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST-RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
++|.+++..... .....+++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++.....
T Consensus 105 -~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 105 -TSFDKFYKYVYS-VLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp -EEHHHHHHHHHH-TTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred -CChHHHHHHHHh-hhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 488777753110 001238999999999999999999995 6 9999999999999999999999999999876443
Q ss_pred CCccccccCCCCccccccccccccc--cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRN--FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.. .....||..|+|||++... ...++.++||||||+++|+|++|+.||......... +.... ....
T Consensus 180 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~-~~~~- 247 (327)
T 3aln_A 180 IA----KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LTQVV-KGDP- 247 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCC-CSCC-
T ss_pred cc----cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HHHHh-cCCC-
Confidence 21 1233589999999998421 136889999999999999999999999753221100 00000 0000
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..........++..+.+++.+||+.||++|||++|+++
T Consensus 248 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 --PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp --CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00001111234567999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=291.85 Aligned_cols=177 Identities=21% Similarity=0.266 Sum_probs=146.4
Q ss_pred hhHhhhccccccceEEEEEEEc----------------------chhhhhhhcC-CC-----ceeeeeeEEEeCCceEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRTS-HV-----NVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l~-Hp-----nIv~l~~~~~~~~~~~lV 209 (450)
.|.+.+.||+|+||+||+|+.. .|+.+++.++ |+ +|+++++++...+..++|
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv 134 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLV 134 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEE
Confidence 3445778999999999999632 1345555553 44 599999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc--CCCCeEEeecccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD--QDFCPKISDFGLA 287 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DFGla 287 (450)
|||+. ++|.+++..... ..+++..+..++.|++.||.|||.. ..+|+||||||+|||++ .++.+||+|||++
T Consensus 135 ~e~~~-~~L~~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 135 FEMLS-YNLYDLLRNTNF----RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EECCC-CBHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EecCC-CCHHHHHhhcCc----CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99995 699999976542 2389999999999999999999931 26899999999999995 5788999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCC
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 348 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~ 348 (450)
+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 209 ~~~~~~------~~~~~~t~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 209 CQLGQR------IYQYIQSRFYRSPEVLLGM--PYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EETTCC------CCSSCSCGGGCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccc------cccccCCccccChHHHcCC--CCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 876433 2345689999999999875 7899999999999999999999999754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=294.56 Aligned_cols=231 Identities=22% Similarity=0.254 Sum_probs=172.1
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCc------eE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNN------RA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~------~~ 207 (450)
|.+.+.||+|+||.||+|+. .+|+.++++++||||+++++++..... .+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 105 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFY 105 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCE
T ss_pred EEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEE
Confidence 34567899999999999952 235778889999999999999987654 49
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+. ++|.+++.. .+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 106 lv~e~~~-~~l~~~~~~--------~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 106 LVMPFMQ-TDLQKIMGL--------KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp EEEECCS-EEGGGTTTS--------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEecccc-CCHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 9999996 688877632 28999999999999999999995 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh--
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV-- 365 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~-- 365 (450)
+..... .....+|..|+|||++.+. ..++.++||||||+++++|++|+.||....... .+ ..+....
T Consensus 174 ~~~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~-~~i~~~~~~ 242 (353)
T 3coi_A 174 RHADAE------MTGYVVTRWYRAPEVILSW-MHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QL-TQILKVTGV 242 (353)
T ss_dssp TC--------------CCSBCCSCHHHHSCC-SCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HH-HHHHHHHCB
T ss_pred cCCCCC------ccccccCcCcCCHHHHhCc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HH-HHHHHHhCC
Confidence 865432 2334589999999998763 378999999999999999999999997542110 00 0000000
Q ss_pred ---------hhhhhh----hh----cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 366 ---------EQDREF----KL----LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 366 ---------~~~~~~----~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
...... .. ...........+..+.+++.+||+.||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 00 000111112446789999999999999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=300.49 Aligned_cols=231 Identities=23% Similarity=0.268 Sum_probs=166.5
Q ss_pred hHhhhccccccceEEE-EEE------------------Ecchhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 159 NSFKDKLGQGGFGGVY-KGK------------------LLDGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy-~~~------------------~~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
+.+.+.||+|+||+|| ++. ..+|+.+++++ +||||+++++++.++...++||||+. |+|
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L 104 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATL 104 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEH
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCH
Confidence 3456789999999854 442 23568888888 79999999999999999999999995 699
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-----CCCeEEeeccccccccCC
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-----DFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DFGla~~~~~~ 293 (450)
.+++...... +.+..++.++.|++.||+|||+ .+|+||||||+|||++. ...+||+|||+++.....
T Consensus 105 ~~~l~~~~~~-----~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 105 QEYVEQKDFA-----HLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp HHHHHSSSCC-----CCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred HHHHHhcCCC-----ccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9999765432 3444567899999999999995 89999999999999953 336789999999877544
Q ss_pred CCccccccCCCCccccccccccccc-cCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
...........||+.|+|||++.+. ...++.++|||||||++|||++ |..||...... ........ .
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~--------~~~~~~~~-~-- 245 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR--------QANILLGA-C-- 245 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH--------HHHHHTTC-C--
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH--------HHHHHhcc-C--
Confidence 3222223456799999999999742 1367889999999999999999 88887432110 00000000 0
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..............+.+++.+||+.||.+|||++|+++
T Consensus 246 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 --SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp --CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00011112234566889999999999999999999984
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=285.84 Aligned_cols=228 Identities=21% Similarity=0.278 Sum_probs=157.8
Q ss_pred HhhhccccccceEEEEEEEcc-------------------------hhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 160 SFKDKLGQGGFGGVYKGKLLD-------------------------GLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~-------------------------e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+.+.||+|+||.||+|+... +..+++.++||||+++++++.+++..++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM- 106 (318)
T ss_dssp EEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-
T ss_pred cccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-
Confidence 456789999999999996431 123466779999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++.+..+..... ..+++..++.++.|++.||.|||+ ..+|+|+||||+||+++.++.+||+|||++.......
T Consensus 107 ~~~~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 107 GTCAEKLKKRMQ-----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp SEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH--HHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred CCcHHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHh--hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 555555554322 228999999999999999999995 1389999999999999999999999999997664432
Q ss_pred CccccccCCCCcccccccccccc---ccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSR---NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
. .....||..|+|||++.. ....++.++||||||+++|+|++|+.||...... ...+ ........
T Consensus 180 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~-~~~~~~~~- 247 (318)
T 2dyl_A 180 A----KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD------FEVL-TKVLQEEP- 247 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH------HHHH-HHHHHSCC-
T ss_pred c----ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc------HHHH-HHHhccCC-
Confidence 2 223458999999999853 1136889999999999999999999999753211 0111 11111000
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
........++..+.+++.+||+.||.+||+++|+++
T Consensus 248 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 ----PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp ----CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000111124567899999999999999999999986
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=308.58 Aligned_cols=215 Identities=20% Similarity=0.247 Sum_probs=171.0
Q ss_pred hhHhhhccccccceEEEEEEEc-------------------------chhhhhhhcCCCceeeeeeEEEeCCc-----eE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL-------------------------DGLASISRTSHVNVVTLLGFCLEGNN-----RA 207 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~-------------------------~e~~~l~~l~HpnIv~l~~~~~~~~~-----~~ 207 (450)
.|.+.+.||+|+||.||+|+.. .|+.++++++||||+++++++.+.+. .+
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~ 160 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence 3456788999999999999642 34677889999999999999988765 79
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+++++|.+++.. .+++..++.++.|++.||.|||+ .+|+||||||+|||++.+ .+||+|||++
T Consensus 161 lv~E~~~g~~L~~~~~~--------~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ--------KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEECCCCEECC----C--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHhC--------CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence 99999999999887643 28999999999999999999995 899999999999999986 8999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
+..... ....||+.|+|||++.+ ..+.++|||||||++++|++|..|+........ +
T Consensus 229 ~~~~~~-------~~~~gt~~y~aPE~~~~---~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----~--------- 285 (681)
T 2pzi_A 229 SRINSF-------GYLYGTPGFQAPEIVRT---GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----P--------- 285 (681)
T ss_dssp EETTCC-------SCCCCCTTTSCTTHHHH---CSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----C---------
T ss_pred hhcccC-------CccCCCccccCHHHHcC---CCCCceehhhhHHHHHHHHhCCCCCcccccccc----c---------
Confidence 876443 33459999999999876 348999999999999999999888753211100 0
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcc
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-PMNEVIEMLQGS 416 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~ 416 (450)
...........+.+++.+||+.||++|| +++++.+.|.+.
T Consensus 286 ---------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 ---------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0011123346788999999999999999 566676666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=276.05 Aligned_cols=209 Identities=13% Similarity=0.069 Sum_probs=161.6
Q ss_pred hhHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
.|.+.+.||+|+||.||+|+. .+|+..+++++||||+++++++.+++..++|||
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 111 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAE 111 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEE
Confidence 345678999999999999963 234667888999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++++|.+++... .....+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+++|
T Consensus 112 ~~~g~~L~~~l~~~--------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 112 WIRGGSLQEVADTS--------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp CCCEEEHHHHHTTC--------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred ecCCCCHHHHHhcC--------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc------
Confidence 99999999998532 3455688899999999999995 899999999999999999999997443
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
|++ .++.++||||||+++|||++|+.||............ .......
T Consensus 175 -----------------~~~---------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~----~~~~~~~--- 221 (286)
T 3uqc_A 175 -----------------TMP---------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA----ERDTAGQ--- 221 (286)
T ss_dssp -----------------CCT---------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC----CBCTTSC---
T ss_pred -----------------ccC---------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH----HHHhccC---
Confidence 222 4688999999999999999999999765432110000 0000000
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
..........++.++.+++.+||+.||++| |++|+++.|+.....
T Consensus 222 --~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 222 --PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp --BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred --CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 000001112345778999999999999999 999999999986654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-34 Score=275.06 Aligned_cols=213 Identities=19% Similarity=0.249 Sum_probs=161.0
Q ss_pred hccccccceEEEEEEEc------------------chhhhh-hhcCCCceeeeeeEEEe----CCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKLL------------------DGLASI-SRTSHVNVVTLLGFCLE----GNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~~------------------~e~~~l-~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~ 219 (450)
+.||+|+||.||+++.. +|+.++ +..+||||+++++++.. +...++||||+++++|.
T Consensus 24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 103 (299)
T ss_dssp EEEEEETTEEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHH
T ss_pred cccccCCCeEEEEEEEcCCCcEEEEEEecccHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHH
Confidence 67999999999999642 245555 55699999999999987 67789999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---CCCeEEeeccccccccCCCCc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ---DFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~~~~~~~~ 296 (450)
+++..... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||++.....
T Consensus 104 ~~l~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---- 172 (299)
T 3m2w_A 104 SRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG---- 172 (299)
T ss_dssp HHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT----
T ss_pred HHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccccccc----
Confidence 99987543 238999999999999999999995 89999999999999998 78999999999864321
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
..++.++||||||+++|||++|+.||............. ..... .....
T Consensus 173 -----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~----~~~~~----~~~~~ 221 (299)
T 3m2w_A 173 -----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----TRIRM----GQYEF 221 (299)
T ss_dssp -----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC----CSSCT----TCCSS
T ss_pred -----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH----HHHhh----ccccC
Confidence 246789999999999999999999996543211100000 00000 00000
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccc
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGST 417 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 417 (450)
.......++.++.+++.+||+.||++|||++|+++. +....
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 001112346789999999999999999999999974 55433
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-34 Score=302.84 Aligned_cols=239 Identities=23% Similarity=0.287 Sum_probs=174.9
Q ss_pred hhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEe------CCceE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLE------GNNRA 207 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~------~~~~~ 207 (450)
.|.+.+.||+|+||.||+|+. .+|++++++++||||+++++++.. ++..+
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~ 94 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCC
T ss_pred CeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEE
Confidence 455678999999999999742 236889999999999999998765 66789
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC---eEEeec
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC---PKISDF 284 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~---~kl~DF 284 (450)
+||||+++|+|.+++...... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++. +||+||
T Consensus 95 LVmEy~~ggsL~~~L~~~~~~---~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 95 LAMEYCEGGDLRKYLNQFENC---CGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CEEECCSSCBHHHHHHSSSCT---TCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEeCCCCCHHHHHHhcccC---CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence 999999999999999765432 238889999999999999999995 89999999999999997665 899999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCC------ccchh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSS------EVYFP 358 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~------~~~~~ 358 (450)
|++........ .....||..|+|||++.+. .++.++||||||+++|+|++|..||........ ...-.
T Consensus 169 G~a~~~~~~~~----~~~~~gt~~Y~APE~l~~~--~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 169 GYAKELDQGEL----CTEFVGTLQYLAPELLEQK--KYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CCCCBTTSCCC----CCCCCSCCTTCSSCSSCCS--CCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred ccccccccccc----cccccCCcccCChHHhccC--CCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 99987654332 2345689999999999764 789999999999999999999999965311000 00000
Q ss_pred h-hhhhhhhhhhhh-hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHH
Q 013074 359 H-WIYRHVEQDREF-KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNE 408 (450)
Q Consensus 359 ~-~i~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e 408 (450)
. ............ ............++..+.+++.+||+.||++|||++|
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 0 000000000000 0000011123346788999999999999999999977
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-34 Score=288.97 Aligned_cols=218 Identities=14% Similarity=0.107 Sum_probs=154.2
Q ss_pred hhccccccceEEEEEEEc--------------------------chhhhhhhcCC-Ccee---------------e----
Q 013074 162 KDKLGQGGFGGVYKGKLL--------------------------DGLASISRTSH-VNVV---------------T---- 195 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l~H-pnIv---------------~---- 195 (450)
.+.||+|+||+||+|+.. +|+.+++.++| +|.. .
T Consensus 83 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (413)
T 3dzo_A 83 GTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162 (413)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC-
T ss_pred ecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCC
Confidence 568999999999999732 44566667766 2111 1
Q ss_pred --eeeEEEe-----CCceEEEEEecCCCChhhhhhcCCC-CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeec
Q 013074 196 --LLGFCLE-----GNNRALIYEFMPNGSLEKFVYNGDT-SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIK 267 (450)
Q Consensus 196 --l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~-~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik 267 (450)
+..++.. ....+++|+++ +++|.+++..... ......+++..++.++.|++.||+|||+ .+|+|||||
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiK 238 (413)
T 3dzo_A 163 KKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLR 238 (413)
T ss_dssp --------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCC
T ss_pred CccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcc
Confidence 1111111 22456777776 7899988842100 0112348889999999999999999995 999999999
Q ss_pred cccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccc--------cCCCCccCchHhHHHHHHHHH
Q 013074 268 PHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN--------FGEVSHKSDVYSFGMMIMELV 339 (450)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~s~~sDiwSlGvvl~ell 339 (450)
|+|||++.++.+||+|||+++..... .....| +.|+|||++... ...++.++|||||||++|||+
T Consensus 239 p~NILl~~~~~~kL~DFG~a~~~~~~------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 239 PVDIVLDQRGGVFLTGFEHLVRDGAS------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp GGGEEECTTCCEEECCGGGCEETTEE------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cceEEEecCCeEEEEeccceeecCCc------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999998865433 234457 999999999421 125788999999999999999
Q ss_pred cCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013074 340 GCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410 (450)
Q Consensus 340 tg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 410 (450)
+|+.||........ .... .. ....++..+.+++.+||+.||++||++.|++
T Consensus 312 tg~~Pf~~~~~~~~--------~~~~-------~~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 312 CADLPNTDDAALGG--------SEWI-------FR-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HSSCCCCTTGGGSC--------SGGG-------GS-----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HCCCCCCCcchhhh--------HHHH-------Hh-----hcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 99999965422110 0000 00 0012346799999999999999999976654
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-32 Score=270.51 Aligned_cols=221 Identities=15% Similarity=0.127 Sum_probs=161.2
Q ss_pred HHhhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcC---------CCceeeee
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTS---------HVNVVTLL 197 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~---------HpnIv~l~ 197 (450)
...|.+.+.||+|+||+||+|+. .+|+.++++++ ||||+++.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 34566788999999999999952 12455666665 66666666
Q ss_pred eEE-----------------Ee-------------CCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHH
Q 013074 198 GFC-----------------LE-------------GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 247 (450)
Q Consensus 198 ~~~-----------------~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia 247 (450)
+++ .+ +...++||||+++|++.+.+.. ..+++..++.++.|++
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------TCCCHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------cCCCHHHHHHHHHHHH
Confidence 553 32 6789999999999977766633 2289999999999999
Q ss_pred HHHHHhh-cCCCCceEeeeeccccEEEcCCC--------------------CeEEeeccccccccCCCCccccccCCCCc
Q 013074 248 KGLEYLH-RGCSTRILHFDIKPHNILLDQDF--------------------CPKISDFGLAKLCTTKKGIVSSLLGARGT 306 (450)
Q Consensus 248 ~~L~yLH-~~~~~~ivH~Dikp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~~gt 306 (450)
.||+||| + .+|+||||||+|||++.++ .+||+|||+++..... ...||
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--------~~~gt 240 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--------IVVFC 240 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--------EEECC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--------cEEEe
Confidence 9999999 6 8999999999999999887 8999999999876542 22589
Q ss_pred cccccccccccccCCCCccCchHhHHHH-HHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHH
Q 013074 307 IGYIALEVFSRNFGEVSHKSDVYSFGMM-IMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIA 385 (450)
Q Consensus 307 ~~y~aPE~~~~~~~~~s~~sDiwSlGvv-l~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 385 (450)
+.|+|||++.+. .+.++||||+|++ .+++++|..||... .....+...+...... ...........++
T Consensus 241 ~~y~aPE~~~g~---~~~~~Diwsl~~~~~~~~~~g~~p~~~~-------~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s 309 (336)
T 2vuw_A 241 DVSMDEDLFTGD---GDYQFDIYRLMKKENNNRWGEYHPYSNV-------LWLHYLTDKMLKQMTF-KTKCNTPAMKQIK 309 (336)
T ss_dssp CCTTCSGGGCCC---SSHHHHHHHHHHHHHTTCTTSCCTHHHH-------HHHHHHHHHHHHTCCC-SSCCCSHHHHHHH
T ss_pred ecccChhhhcCC---CccceehhhhhCCCCcccccccCCCcch-------hhhhHHHHhhhhhhcc-CcccchhhhhhcC
Confidence 999999999874 3889999998777 66778887776321 0000011111100000 0111222345678
Q ss_pred HHHHHHHHHccccCCCCCCCHHHHH
Q 013074 386 KKMIIVGLWCIQARPYDRPPMNEVI 410 (450)
Q Consensus 386 ~~l~~l~~~Cl~~dP~~RPs~~evl 410 (450)
.++.+++.+||+.| |++|++
T Consensus 310 ~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 310 RKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHHhccC-----CHHHHH
Confidence 89999999999976 899888
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.4e-29 Score=260.47 Aligned_cols=148 Identities=16% Similarity=0.205 Sum_probs=110.5
Q ss_pred cchhhhhhhc-CCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 013074 179 LDGLASISRT-SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257 (450)
Q Consensus 179 ~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 257 (450)
.+|+++|+++ .|+||+++++++++++..||||||++|++|.+.+...+. ++.. +|+.||+.||+|+|+
T Consensus 289 ~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~------l~~~---~I~~QIl~AL~ylH~-- 357 (569)
T 4azs_A 289 HNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE------IDRE---KILGSLLRSLAALEK-- 357 (569)
T ss_dssp HHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC------CCHH---HHHHHHHHHHHHHHH--
T ss_pred HHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC------CCHH---HHHHHHHHHHHHHHH--
Confidence 4578899999 799999999999999999999999999999999986543 5554 478999999999995
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHH
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIME 337 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~e 337 (450)
++||||||||+|||++++|.+||+|||+++........ ....+||++|||||++.+ ....++|+||+|+++++
T Consensus 358 -~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~---~~t~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~ 430 (569)
T 4azs_A 358 -QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW---PTNLVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFN 430 (569)
T ss_dssp -TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC---SHHHHHHHHHHHHHHC--------------------CC
T ss_pred -CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc---ccCceechhhccHHHhCC---CCCCcccccccccchhh
Confidence 99999999999999999999999999999876543322 234569999999999976 56788999999999888
Q ss_pred HHcCCCC
Q 013074 338 LVGCKNN 344 (450)
Q Consensus 338 lltg~~p 344 (450)
+.++..+
T Consensus 431 l~~~~~~ 437 (569)
T 4azs_A 431 LPQPWSN 437 (569)
T ss_dssp CCTTHHH
T ss_pred hccccch
Confidence 7655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.2e-25 Score=230.21 Aligned_cols=165 Identities=15% Similarity=0.207 Sum_probs=129.5
Q ss_pred hhccccccceEEEEEE-----------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 162 KDKLGQGGFGGVYKGK-----------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~-----------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
.+.||+|+||.||+|+ +.+|++++++++||||+++..++...+..++||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~ 420 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSY 420 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEEC
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEEC
Confidence 4589999999999773 14568889999999999777777788888999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++++|.+++.. +..++.|++.||+|||+ .+|+||||||+|||+++ .+||+|||+++....
T Consensus 421 ~~ggsL~~~l~~--------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 421 INGKLAKDVIED--------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp CCSEEHHHHSTT--------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred CCCCCHHHHHHH--------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999854 44789999999999995 89999999999999998 999999999998755
Q ss_pred CCCccc----cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCC
Q 013074 293 KKGIVS----SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNL 345 (450)
Q Consensus 293 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~ 345 (450)
...... ......||+.|+|||++......|+..+|+||...-.++-+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 322110 11245699999999999874346788999999998888877655443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=3.1e-19 Score=170.79 Aligned_cols=119 Identities=17% Similarity=0.154 Sum_probs=95.4
Q ss_pred hhccccccceEEEEEEE----------------------------------------cchhhhhhhcCCCceeeeeeEEE
Q 013074 162 KDKLGQGGFGGVYKGKL----------------------------------------LDGLASISRTSHVNVVTLLGFCL 201 (450)
Q Consensus 162 ~~~LG~G~fg~Vy~~~~----------------------------------------~~e~~~l~~l~HpnIv~l~~~~~ 201 (450)
.+.||+|+||.||+|+. .+|+.++++++ | +++.+++.
T Consensus 95 ~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~ 171 (282)
T 1zar_A 95 GKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA 171 (282)
T ss_dssp EEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred cCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence 47899999999999853 14566677777 5 67777554
Q ss_pred eCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEE
Q 013074 202 EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKI 281 (450)
Q Consensus 202 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl 281 (450)
. +..++||||+++++|.+ +.. .....++.|++.||.|||+ .+|+||||||+|||++ ++.+||
T Consensus 172 ~-~~~~lvmE~~~g~~L~~-l~~------------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl 233 (282)
T 1zar_A 172 W-EGNAVLMELIDAKELYR-VRV------------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWI 233 (282)
T ss_dssp E-ETTEEEEECCCCEEGGG-CCC------------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEE
T ss_pred c-cceEEEEEecCCCcHHH-cch------------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEE
Confidence 4 56799999999999988 421 1234689999999999995 9999999999999999 999999
Q ss_pred eeccccccccCCCCccccccCCCCcccccccccccc
Q 013074 282 SDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317 (450)
Q Consensus 282 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 317 (450)
+|||+++. +..++|||++.+
T Consensus 234 ~DFG~a~~----------------~~~~~a~e~l~r 253 (282)
T 1zar_A 234 IDFPQSVE----------------VGEEGWREILER 253 (282)
T ss_dssp CCCTTCEE----------------TTSTTHHHHHHH
T ss_pred EECCCCeE----------------CCCCCHHHHHHH
Confidence 99999863 344678998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.56 E-value=2e-15 Score=142.27 Aligned_cols=90 Identities=18% Similarity=0.239 Sum_probs=66.9
Q ss_pred hhhhhcCCCce--eeeeeEEEeCCceEEEEEecCC-C----ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhh-
Q 013074 183 ASISRTSHVNV--VTLLGFCLEGNNRALIYEFMPN-G----SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH- 254 (450)
Q Consensus 183 ~~l~~l~HpnI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH- 254 (450)
..++++.|+++ +.++++ ...++||||+.+ | +|.+.... .++..+..++.|++.||.|||
T Consensus 122 ~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---------~~~~~~~~i~~qi~~~l~~lH~ 188 (258)
T 1zth_A 122 RNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---------LKELDVEGIFNDVVENVKRLYQ 188 (258)
T ss_dssp HHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---------cChHHHHHHHHHHHHHHHHHHH
Confidence 34555666653 333332 357899999942 4 56655421 223456789999999999999
Q ss_pred cCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 255 ~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
+ .+|+||||||+|||+++ .++|+|||++...
T Consensus 189 ~---~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 189 E---AELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp T---SCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred H---CCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 6 89999999999999998 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.38 E-value=4.6e-14 Score=139.30 Aligned_cols=70 Identities=13% Similarity=0.191 Sum_probs=56.5
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC--------
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-------- 277 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-------- 277 (450)
.++||||++++.|..... . .....++.|++.+|.+||+ .+||||||||.|||+++++
T Consensus 186 ~~LVME~i~G~~L~~l~~----------~--~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~~d~~~~ 250 (397)
T 4gyi_A 186 HTIVMSLVDALPMRQVSS----------V--PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDAEDPSSI 250 (397)
T ss_dssp TEEEEECCSCEEGGGCCC----------C--SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECSSCTTSE
T ss_pred ceEEEEecCCccHhhhcc----------c--HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCccccccc
Confidence 379999999888865431 1 1234678999999999996 8999999999999998776
Q ss_pred --CeEEeeccccccc
Q 013074 278 --CPKISDFGLAKLC 290 (450)
Q Consensus 278 --~~kl~DFGla~~~ 290 (450)
.+.|+||+-+...
T Consensus 251 ~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 251 TLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEEEEECCCTTCEET
T ss_pred ccceEEEEeCCcccC
Confidence 3889999977654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.86 E-value=1.9e-09 Score=100.96 Aligned_cols=117 Identities=14% Similarity=0.015 Sum_probs=88.1
Q ss_pred hhhccccccceEEEEEE---------------------EcchhhhhhhcC-CCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 161 FKDKLGQGGFGGVYKGK---------------------LLDGLASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~---------------------~~~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
+...+|.|+.+.||+.. +..|.++++.+. +..+.++++++.+.+..++|||+++|.+|
T Consensus 18 ~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 97 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLC 97 (263)
T ss_dssp EEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEH
T ss_pred eEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeeh
Confidence 34567778888898874 123567777764 67788999999988899999999999998
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC-----------------------------------------
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC----------------------------------------- 257 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----------------------------------------- 257 (450)
.+.+.. ......++.+++++|..||+-.
T Consensus 98 ~~~~~~-----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T 3tm0_A 98 SEEYED-----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp HHHCCT-----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred hhccCC-----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence 775311 1123467888999999999610
Q ss_pred ---------------CCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 258 ---------------STRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 258 ---------------~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
...++|+|+++.||+++++..+.|+||+.+.
T Consensus 167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876666799998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.62 E-value=9.7e-08 Score=93.73 Aligned_cols=119 Identities=16% Similarity=0.169 Sum_probs=88.3
Q ss_pred hccccccceEEEEEEE------------------------cchhhhhhhcC--CCceeeeeeEEEeC---CceEEEEEec
Q 013074 163 DKLGQGGFGGVYKGKL------------------------LDGLASISRTS--HVNVVTLLGFCLEG---NNRALIYEFM 213 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~--HpnIv~l~~~~~~~---~~~~lV~E~~ 213 (450)
+.|+.|.++.||+.+. ..|.++++.+. +..+.+++.++.+. +..++||||+
T Consensus 44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v 123 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV 123 (359)
T ss_dssp EECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred EEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence 4578888888887631 12466666665 45678899988776 3478999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC------------------------------------
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC------------------------------------ 257 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------ 257 (450)
+|..+.+... ..++......++.++++.|..||...
T Consensus 124 ~G~~l~~~~~--------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 124 SGRVLWDQSL--------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCBCCCCTTC--------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred CCeecCCCcc--------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9877743211 12677888889999999999999620
Q ss_pred -------------------CCceEeeeeccccEEEcCCCC--eEEeecccccc
Q 013074 258 -------------------STRILHFDIKPHNILLDQDFC--PKISDFGLAKL 289 (450)
Q Consensus 258 -------------------~~~ivH~Dikp~NIll~~~~~--~kl~DFGla~~ 289 (450)
...++|+|+++.||+++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.61 E-value=6.8e-08 Score=89.78 Aligned_cols=95 Identities=21% Similarity=0.163 Sum_probs=68.7
Q ss_pred chhhhhhhcCCCc--eeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC
Q 013074 180 DGLASISRTSHVN--VVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257 (450)
Q Consensus 180 ~e~~~l~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~ 257 (450)
.|+++++.+.+.+ +.+++++..+++..++||||++|.+|. ... .. ...++.++++.|..||...
T Consensus 62 ~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~---------~~---~~~~~~~l~~~l~~lh~~~ 127 (264)
T 1nd4_A 62 DEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH---------LA---PAEKVSIMADAMRRLHTLD 127 (264)
T ss_dssp HHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC---------CC---HHHHHHHHHHHHHHHTTSC
T ss_pred HHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc---------CC---HhHHHHHHHHHHHHHhCCC
Confidence 4566777775544 566888888878889999999998874 211 11 1245677777777777521
Q ss_pred -------------------------------------------------------CCceEeeeeccccEEEcCCCCeEEe
Q 013074 258 -------------------------------------------------------STRILHFDIKPHNILLDQDFCPKIS 282 (450)
Q Consensus 258 -------------------------------------------------------~~~ivH~Dikp~NIll~~~~~~kl~ 282 (450)
...++|+|++|.||++++++.++|+
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~li 207 (264)
T 1nd4_A 128 PATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFI 207 (264)
T ss_dssp GGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEEC
T ss_pred CCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEE
Confidence 1139999999999999877667799
Q ss_pred eccccc
Q 013074 283 DFGLAK 288 (450)
Q Consensus 283 DFGla~ 288 (450)
||+.+.
T Consensus 208 D~~~a~ 213 (264)
T 1nd4_A 208 DCGRLG 213 (264)
T ss_dssp CCTTCE
T ss_pred cchhcc
Confidence 999865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.46 E-value=6.9e-08 Score=92.56 Aligned_cols=169 Identities=18% Similarity=0.187 Sum_probs=102.0
Q ss_pred ccccccceEEEEE------E----------EcchhhhhhhcC-CCc--eeeeeeEEEeCC---ceEEEEEecCCCChhhh
Q 013074 164 KLGQGGFGGVYKG------K----------LLDGLASISRTS-HVN--VVTLLGFCLEGN---NRALIYEFMPNGSLEKF 221 (450)
Q Consensus 164 ~LG~G~fg~Vy~~------~----------~~~e~~~l~~l~-Hpn--Iv~l~~~~~~~~---~~~lV~E~~~~gsL~~~ 221 (450)
.++.|....||+. | +..|.+.++.+. +.. +.+++.....+. ..++|||+++|.+|.+.
T Consensus 27 ~~~~G~~n~v~~v~~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~ 106 (304)
T 3sg8_A 27 ISGEGNDCIAYEINRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPL 106 (304)
T ss_dssp EEEECSSEEEEESTTSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHH
T ss_pred ecCCCCcceEEEECCEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcc
Confidence 4788888888864 2 234667777663 322 344554433333 34789999999888653
Q ss_pred hhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcC---------------------------------------------
Q 013074 222 VYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG--------------------------------------------- 256 (450)
Q Consensus 222 l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~--------------------------------------------- 256 (450)
... .++......++.++++.|..||..
T Consensus 107 ~~~--------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 178 (304)
T 3sg8_A 107 LLN--------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR 178 (304)
T ss_dssp HHH--------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred ccc--------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence 321 156666677777777777777741
Q ss_pred ----------CCCceEeeeeccccEEEcC--CCCeEEeeccccccccCCCCccccccCC---CCc---------ccccc-
Q 013074 257 ----------CSTRILHFDIKPHNILLDQ--DFCPKISDFGLAKLCTTKKGIVSSLLGA---RGT---------IGYIA- 311 (450)
Q Consensus 257 ----------~~~~ivH~Dikp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~---~gt---------~~y~a- 311 (450)
....++|+|+++.||++++ +..+.|+||+.+........... .... .+. .+...
T Consensus 179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~-~~~~~~~~~~~~~~~~l~~Y~~~~~ 257 (304)
T 3sg8_A 179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFIS-LMEDDEEYGMEFVSKILNHYKHKDI 257 (304)
T ss_dssp HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHT-TCCTTTSCCHHHHHHHHHHHTCSCH
T ss_pred HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHH-HHhhccccCHHHHHHHHHHcCCCCc
Confidence 1135899999999999998 45678999998765322110000 0000 000 01111
Q ss_pred ccccccccCCCCccCchHhHHHHHHHHHcCCCCC
Q 013074 312 LEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNL 345 (450)
Q Consensus 312 PE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~ 345 (450)
|+.... .....+.|++|.+++.+.+|..++
T Consensus 258 ~~~~~r----~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 258 PTVLEK----YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHH----HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHH----HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 222211 122358999999999999887544
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.66 E-value=8.6e-05 Score=69.25 Aligned_cols=99 Identities=17% Similarity=0.152 Sum_probs=67.1
Q ss_pred chhhhhhhcC-CCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcC--
Q 013074 180 DGLASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG-- 256 (450)
Q Consensus 180 ~e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-- 256 (450)
.|...|+.+. +--|.++++++.+++..++|||++++.++.+...... .....+..+++..|..||.-
T Consensus 68 ~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~----------~~~~~~~~~l~~~L~~Lh~~~~ 137 (272)
T 4gkh_A 68 DEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP----------DSGENIVDALAVFLRRLHSIPV 137 (272)
T ss_dssp HHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG----------GGHHHHHHHHHHHHHHHHTSCG
T ss_pred HHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH----------HHHHHHHHHHHHHHHHhcCCCc
Confidence 4566666553 2336788999999999999999999887765442211 11223444555555555530
Q ss_pred -----------------------------------------------------CCCceEeeeeccccEEEcCCCCeEEee
Q 013074 257 -----------------------------------------------------CSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 257 -----------------------------------------------------~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
....++|+|+.+.||++++++.+-|+|
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viD 217 (272)
T 4gkh_A 138 CNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCID 217 (272)
T ss_dssp GGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECC
T ss_pred ccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEE
Confidence 012479999999999999877778999
Q ss_pred ccccc
Q 013074 284 FGLAK 288 (450)
Q Consensus 284 FGla~ 288 (450)
|+.+.
T Consensus 218 we~a~ 222 (272)
T 4gkh_A 218 VGRVG 222 (272)
T ss_dssp CTTCE
T ss_pred Ccccc
Confidence 98765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00012 Score=69.90 Aligned_cols=118 Identities=18% Similarity=0.137 Sum_probs=73.6
Q ss_pred ccccccceEEEEE------E----------EcchhhhhhhcCCC---ceeeeeeEEE-eCCceEEEEEecCCCChhhhhh
Q 013074 164 KLGQGGFGGVYKG------K----------LLDGLASISRTSHV---NVVTLLGFCL-EGNNRALIYEFMPNGSLEKFVY 223 (450)
Q Consensus 164 ~LG~G~fg~Vy~~------~----------~~~e~~~l~~l~Hp---nIv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~ 223 (450)
.++.|....||+. | +..|.+++..+.+. .|.+.+.+.. ..+..++|||+++|..|.+...
T Consensus 26 ~l~~G~~n~v~~vg~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~ 105 (306)
T 3tdw_A 26 SLGEGFRNYAILVNGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM 105 (306)
T ss_dssp EEEECSSEEEEEETTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH
T ss_pred ecCCCcceeEEEECCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh
Confidence 4677777777765 1 23467777777652 3566676664 3455789999999887765321
Q ss_pred cCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcC-----------------------------------------------
Q 013074 224 NGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG----------------------------------------------- 256 (450)
Q Consensus 224 ~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------------- 256 (450)
.. ++......++.++++.|..||.-
T Consensus 106 ~~--------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 106 AV--------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp TT--------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred hh--------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 00 23333333333444443333320
Q ss_pred ----------CCCceEeeeeccccEEEcC---CCC-eEEeecccccc
Q 013074 257 ----------CSTRILHFDIKPHNILLDQ---DFC-PKISDFGLAKL 289 (450)
Q Consensus 257 ----------~~~~ivH~Dikp~NIll~~---~~~-~kl~DFGla~~ 289 (450)
....++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1346799999999999987 455 48999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00096 Score=59.73 Aligned_cols=101 Identities=15% Similarity=0.077 Sum_probs=65.4
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
-+|.+.|...+ .+++++++|.++.|.+.+|.-+-.. ..-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~-----~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------- 97 (229)
T 2yle_A 33 LSLEEILRLYN-----QPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD------- 97 (229)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred ccHHHHHHHcC-----CCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-------
Confidence 37888887655 3499999999999999998776210 1111334457899999999987653 1110
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCC
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~ 342 (450)
.....+.|||.... ..+.+.=|||||+++|.-+--.
T Consensus 98 --------~~~~~~~~pe~~~~---~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 --------AGEPPPVAGKLGYS---QCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp -----------------CCSSS---SSCHHHHHHHHHHHHHHHHTTT
T ss_pred --------ccccCCCChhhccc---cchHHHHHHHHHHHHHHHhhcC
Confidence 02234568887642 4567888999999999998544
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0016 Score=63.17 Aligned_cols=31 Identities=19% Similarity=0.178 Sum_probs=26.1
Q ss_pred CceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
..++|+|+.+.||+++++..+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 5799999999999999654578999987653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.66 E-value=0.012 Score=56.24 Aligned_cols=31 Identities=23% Similarity=0.203 Sum_probs=27.6
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
...++|+|+++.||+++.++.+.|+||+.+.
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 4789999999999999888889999998654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0083 Score=59.10 Aligned_cols=31 Identities=19% Similarity=0.271 Sum_probs=26.3
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
...++|+|+.+.||+++.+ .++++||..+..
T Consensus 226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 3689999999999999876 489999987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.042 Score=52.32 Aligned_cols=121 Identities=16% Similarity=0.107 Sum_probs=72.9
Q ss_pred ccccccceEEEEEEE------------------cchhhhhhhcC---CCceeeeeeEEEeCCceEEEEEecCCCChh---
Q 013074 164 KLGQGGFGGVYKGKL------------------LDGLASISRTS---HVNVVTLLGFCLEGNNRALIYEFMPNGSLE--- 219 (450)
Q Consensus 164 ~LG~G~fg~Vy~~~~------------------~~e~~~l~~l~---HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~--- 219 (450)
.|+.|....+|+... ..|.+.|+.+. ...+.++++++...+..++|||++++..+.
T Consensus 43 ~l~gG~~n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~~~~ 122 (312)
T 3jr1_A 43 KLYSGEMNEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNKQSS 122 (312)
T ss_dssp EECCSSSSEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCCTTH
T ss_pred EeCCccceeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCCchh
Confidence 578888888988641 23445555553 356888898888778899999999887652
Q ss_pred --------hhhhcCCC-CCCC---------------ccCCHHHHHH---HH----------------HHHHHH-HHHhhc
Q 013074 220 --------KFVYNGDT-SKPC---------------QYLRWEKMYE---IV----------------IGIAKG-LEYLHR 255 (450)
Q Consensus 220 --------~~l~~~~~-~~~~---------------~~l~~~~~~~---i~----------------~~ia~~-L~yLH~ 255 (450)
..++.... ...+ ..-+|...+. +. ..+... ...|..
T Consensus 123 ~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~ 202 (312)
T 3jr1_A 123 FTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSK 202 (312)
T ss_dssp HHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhcc
Confidence 12333221 0000 0124543221 11 111111 223321
Q ss_pred -CCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 256 -GCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 256 -~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
.....++|+|+.+.|++++.++ +.|.|+.
T Consensus 203 ~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 203 HNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp CCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred CCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1235799999999999999887 8899974
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=94.81 E-value=0.05 Score=51.20 Aligned_cols=31 Identities=23% Similarity=0.148 Sum_probs=25.9
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
...++|+|+.+.||+ ..++.+.++||..+..
T Consensus 172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 356899999999999 5667789999987764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=94.03 E-value=0.15 Score=47.56 Aligned_cols=25 Identities=24% Similarity=0.256 Sum_probs=20.4
Q ss_pred CCceEeeeeccccEEEcCCCCeEEee
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
...++|+|+.+.||+++.++. .+.|
T Consensus 187 ~p~LvHGDlw~gNvl~~~~g~-~~iD 211 (288)
T 3f7w_A 187 PPARIHGDLWNGNVLWQDDGA-VVID 211 (288)
T ss_dssp CCEEECSCCSGGGEEEETTEE-EECS
T ss_pred CCeeeecCCCCCcEEEcCCCe-EEEe
Confidence 347999999999999998874 4555
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=93.43 E-value=0.096 Score=51.28 Aligned_cols=31 Identities=29% Similarity=0.320 Sum_probs=26.9
Q ss_pred CCceEeeeeccccEEEcCC----CCeEEeeccccc
Q 013074 258 STRILHFDIKPHNILLDQD----FCPKISDFGLAK 288 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~----~~~kl~DFGla~ 288 (450)
...++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 219 ~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 219 PVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp CEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred CcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3579999999999999876 789999998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=91.87 E-value=0.18 Score=49.95 Aligned_cols=81 Identities=12% Similarity=0.062 Sum_probs=46.4
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccC-CCCccCchHhHHHHHH
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFG-EVSHKSDVYSFGMMIM 336 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~s~~sDiwSlGvvl~ 336 (450)
...++|+|+++.||+++.++ ++|+||+.+..-............ -...|.+|+......+ ......++.+....+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN--LILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH--HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH--HHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 47899999999999999876 999999987654321110000000 0134555554431100 1112344557777777
Q ss_pred HHHcC
Q 013074 337 ELVGC 341 (450)
Q Consensus 337 elltg 341 (450)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 76644
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.41 E-value=0.16 Score=49.94 Aligned_cols=30 Identities=27% Similarity=0.292 Sum_probs=25.0
Q ss_pred ceEeeeeccccEEE------cCCCCeEEeecccccc
Q 013074 260 RILHFDIKPHNILL------DQDFCPKISDFGLAKL 289 (450)
Q Consensus 260 ~ivH~Dikp~NIll------~~~~~~kl~DFGla~~ 289 (450)
.++|+|+.+.||++ +++..+.++||..+..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567899999988754
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=88.80 E-value=0.51 Score=44.78 Aligned_cols=33 Identities=27% Similarity=0.283 Sum_probs=28.1
Q ss_pred CCceEeeeeccccEEEcCC----CCeEEeeccccccc
Q 013074 258 STRILHFDIKPHNILLDQD----FCPKISDFGLAKLC 290 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~----~~~kl~DFGla~~~ 290 (450)
...++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4689999999999999874 67899999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=87.39 E-value=0.2 Score=47.27 Aligned_cols=30 Identities=23% Similarity=0.317 Sum_probs=25.7
Q ss_pred CceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 259 TRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
.+++|+|+.+.||+++++..+.|+||+.+.
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 579999999999999987666899998654
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=86.98 E-value=0.67 Score=46.44 Aligned_cols=17 Identities=24% Similarity=0.344 Sum_probs=15.2
Q ss_pred CCceEeeeeccccEEEc
Q 013074 258 STRILHFDIKPHNILLD 274 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~ 274 (450)
...++|+|+.+.|||++
T Consensus 289 ~~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 289 PIVLCHCDLLSSNIINT 305 (458)
T ss_dssp CEEEECSCCCGGGEEEC
T ss_pred CeeEEecCCCCCcEEee
Confidence 35789999999999998
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=86.72 E-value=0.7 Score=43.57 Aligned_cols=30 Identities=33% Similarity=0.328 Sum_probs=25.5
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
...++|+|+++.||+++ + .+.|+||+.+..
T Consensus 194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 36789999999999999 4 889999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=85.17 E-value=0.46 Score=45.47 Aligned_cols=31 Identities=26% Similarity=0.294 Sum_probs=27.6
Q ss_pred CceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5799999999999999888899999987654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.99 E-value=2.4 Score=37.65 Aligned_cols=117 Identities=12% Similarity=0.136 Sum_probs=75.8
Q ss_pred cCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeec
Q 013074 188 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIK 267 (450)
Q Consensus 188 l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dik 267 (450)
..||+.+.. .+-.+++.+.+.++.-+ +...+-. ...++...+++++.+|+....+++ .-+|.-+.
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~-------ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~ 106 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDN-------IKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLA 106 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGG-------GGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCS
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCc--ccCCHHH-------HHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEe
Confidence 468888866 45556665555555433 2222211 122778899999999998776555 34788999
Q ss_pred cccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCC
Q 013074 268 PHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLD 346 (450)
Q Consensus 268 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~ 346 (450)
|+|++++.++.+++.-.|+-... +|. ..++..=.-.+=+++..+++++..|.
T Consensus 107 P~NL~f~~~~~p~i~~RGik~~l--------------------~P~-------~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 107 PDELFFTRDGLPIAKTRGLQNVV--------------------DPL-------PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GGGEEECTTSCEEESCCEETTTB--------------------SCC-------CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred cceEEEcCCCCEEEEEccCccCC--------------------CCC-------CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999999877763322 221 11112223346778888998877664
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.38 E-value=3.7 Score=36.47 Aligned_cols=84 Identities=10% Similarity=0.076 Sum_probs=58.3
Q ss_pred cCCCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHH-HhhcCCCCceEeeee
Q 013074 188 TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE-YLHRGCSTRILHFDI 266 (450)
Q Consensus 188 l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~ivH~Di 266 (450)
..||+. -..+-.+++.+.+.++.-+++.=...+. .++...+++++.+++.... +++ .-+|.-+
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l 110 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIV 110 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCC
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEE
Confidence 367777 3333456666666666653332222332 1778889999999988666 444 5678899
Q ss_pred ccccEEEcCCCCeEEeecccc
Q 013074 267 KPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 267 kp~NIll~~~~~~kl~DFGla 287 (450)
.|+|++++.++.+++.-.|+-
T Consensus 111 ~P~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 111 CPENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp CGGGEEECTTCCEEESCCEET
T ss_pred eCceEEEeCCCcEEEEEcCCc
Confidence 999999999999999887763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=83.37 E-value=0.76 Score=45.57 Aligned_cols=30 Identities=30% Similarity=0.335 Sum_probs=24.2
Q ss_pred CceEeeeeccccEEEcCC----------------------------CCeEEeeccccc
Q 013074 259 TRILHFDIKPHNILLDQD----------------------------FCPKISDFGLAK 288 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~----------------------------~~~kl~DFGla~ 288 (450)
..++|+|+.+.|||++++ +.+.|+||..+.
T Consensus 249 ~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~ 306 (429)
T 1nw1_A 249 VTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYAS 306 (429)
T ss_dssp EEEECSCCCGGGEEEEC------------------------------CCEECCCTTCE
T ss_pred eEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCC
Confidence 468999999999999875 678888887665
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=83.11 E-value=1.5 Score=42.26 Aligned_cols=29 Identities=21% Similarity=0.344 Sum_probs=24.5
Q ss_pred CceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 259 TRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
..++|+|+.+.|||++++. +.|+||..+.
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~ 240 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 240 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence 5799999999999998654 8999998765
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 450 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 9e-46 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-45 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-43 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-43 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-42 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-41 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-40 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-39 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-39 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-37 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-33 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-30 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-30 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-28 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 9e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-28 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-27 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-26 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-23 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-23 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-23 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-23 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-22 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-22 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-21 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-20 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-19 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-18 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-17 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-14 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-14 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-13 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-12 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-53
Identities = 68/283 (24%), Positives = 122/283 (43%), Gaps = 43/283 (15%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLA----------------------SISRTSHVNVVTLLG 198
++G G FG VYKGK +A + +T HVN++ +G
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
+ A++ ++ SL ++ +T K+ +I A+G++YLH
Sbjct: 72 YS-TAPQLAIVTQWCEGSSLYHHLHIIETK-----FEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF-SR 317
I+H D+K +NI L +D KI DFGLA + + G G+I ++A EV +
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS-HQFEQLSGSILWMAPEVIRMQ 181
Query: 318 NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVV 377
+ S +SDVY+FG+++ EL+ +G S + I V + L
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELM-------TGQLPYSNINNRDQIIFMVGRGYLSPDL--- 231
Query: 378 TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420
+K + K M + C++ + +RP +++ ++ +L
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 9e-46
Identities = 56/294 (19%), Positives = 102/294 (34%), Gaps = 47/294 (15%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG--------------------LASISRTSHVNVVTLLGFC 200
++ +G+G FG V++GK + H N++ +
Sbjct: 7 LQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 201 LEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
+ N L+ ++ +GSL ++ + E M ++ + A GL +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHME 119
Query: 257 C-----STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGAR-GTIGYI 310
I H D+K NIL+ ++ I+D GLA + + R GT Y+
Sbjct: 120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 311 ALEVFSRNF----GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE 366
A EV + E ++D+Y+ G++ E+ + D Y VE
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 367 QDREFKLLGVVTKK------ENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ R+ + E + M + C A R + + L
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-45
Identities = 63/280 (22%), Positives = 112/280 (40%), Gaps = 47/280 (16%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG---------------------LASISRTSHVNVVTLLGF 199
F ++G G FG V+ G L+ + + SH +V L G
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259
CLE L++EFM +G L ++ E + + + + +G+ YL C
Sbjct: 69 CLEQAPICLVFEFMEHGCLSDYLR-----TQRGLFAAETLLGMCLDVCEGMAYLEEAC-- 121
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF 319
++H D+ N L+ ++ K+SDFG+ + + +S G + + + + EVF +F
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVF--SF 176
Query: 320 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379
S KSDV+SFG+++ E+ + R + E G
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEG--------------KIPYENRSNSEVVEDISTGFRLY 222
Query: 380 KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419
K + + + C + RP DRP + ++ L E+
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-45
Identities = 56/275 (20%), Positives = 107/275 (38%), Gaps = 47/275 (17%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG---------------------LASISRTSHVNVVTLLGF 199
F +LG G FG V GK + SH +V L G
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259
C + +I E+M NG L ++ + +++ E+ + + +EYL
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLRE-----MRHRFQTQQLLEMCKDVCEAMEYLES---K 119
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF 319
+ LH D+ N L++ K+SDFGL++ + +S +G++ + + EV
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMY-- 175
Query: 320 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379
+ S KSD+++FG+++ E+ NS H+ Q G+
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-------ETAEHIAQ-------GLRLY 221
Query: 380 KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ + ++K+ + C + +RP ++ +
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-44
Identities = 65/282 (23%), Positives = 115/282 (40%), Gaps = 50/282 (17%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG---------------------LASISRTSHVNVVTLLGF 199
++LG G FG V+ G + + H +V L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259
+ +I E+M NGSL F+ K L K+ ++ IA+G+ ++
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIK----LTINKLLDMAAQIAEGMAFIEERN-- 129
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF 319
+H D++ NIL+ KI+DFGLA+L + GA+ I + A E N+
Sbjct: 130 -YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKWTAPEAI--NY 184
Query: 320 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379
G + KSDV+SFG+++ E+V G+ N + +++E+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGYRMVR------ 231
Query: 380 KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG---STE 418
+ +++ + C + RP DRP + + +L+ +TE
Sbjct: 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-44
Identities = 63/287 (21%), Positives = 109/287 (37%), Gaps = 47/287 (16%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG---------------------LASISRTSHVNVVTLLGF 199
+ KLGQG FG V+ G + + H +V L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 200 CLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCST 259
++ E+M GSL F+ + +YLR ++ ++ IA G+ Y+ R
Sbjct: 81 V-SEEPIYIVTEYMSKGSLLDFLKG----ETGKYLRLPQLVDMAAQIASGMAYVERMN-- 133
Query: 260 RILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNF 319
+H D++ NIL+ ++ K++DFGLA+L + GA+ I + A E
Sbjct: 134 -YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ--GAKFPIKWTAPEAALY-- 188
Query: 320 GEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTK 379
G + KSDV+SFG+++ EL G+ + VE+
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVERGYRMPC------ 235
Query: 380 KENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPPTP 426
E + + + C + P +RP + L+ + + P
Sbjct: 236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 154 bits (390), Expect = 3e-44
Identities = 64/306 (20%), Positives = 113/306 (36%), Gaps = 64/306 (20%)
Query: 149 YNFSDVKKITNSF-----------KDKLGQGGFGGVYKGKLLDG---------------- 181
+ F D + F + +G G FG V G L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 182 -----------LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKP 230
+ + + H NV+ L G + +I EFM NGSL+ F+ +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-----QN 121
Query: 231 CQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290
++ ++ GIA G++YL +H D+ NIL++ + K+SDFGL++
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 291 T--TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 348
T +S LG + I + A E + + + SDV+S+G+++ E++
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAI--QYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236
Query: 349 VDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNE 408
+ N + +EQD + + + L C Q RP +
Sbjct: 237 MTNQD-------VINAIEQDYRL-------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 409 VIEMLQ 414
++ L
Sbjct: 283 IVNTLD 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-43
Identities = 53/274 (19%), Positives = 102/274 (37%), Gaps = 49/274 (17%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLASI-------------------SRTSHVNVVTLLGFCL 201
+G+G FG V G ++ ++ H N+V LLG +
Sbjct: 11 LLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70
Query: 202 EGNNR-ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR 260
E ++ E+M GSL ++ + + L + + + + + + +EYL
Sbjct: 71 EEKGGLYIVTEYMAKGSLVDYLRS----RGRSVLGGDCLLKFSLDVCEAMEYLE---GNN 123
Query: 261 ILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFG 320
+H D+ N+L+ +D K+SDFGL K ++ + + + + A E
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG------KLPVKWTAPEALRE--K 175
Query: 321 EVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKK 380
+ S KSDV+SFG+++ E+ + + VE+ +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIP-------LKDVVPRVEKGYKMDA------- 221
Query: 381 ENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ + V C RP ++ E L+
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-43
Identities = 58/297 (19%), Positives = 105/297 (35%), Gaps = 58/297 (19%)
Query: 144 LPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------------- 181
L LKR N +LG G FG V +G
Sbjct: 3 LFLKRDNLLIADI-------ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE 55
Query: 182 ----LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE 237
+ + + +V L+G C + L+ E G L KF+ + +
Sbjct: 56 MMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV-----GKREEIPVS 109
Query: 238 KMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297
+ E++ ++ G++YL +H D+ N+LL KISDFGL+K
Sbjct: 110 NVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166
Query: 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF 357
++ + + + A E NF + S +SDV+S+G+ + E + +
Sbjct: 167 TARSAGKWPLKWYAPECI--NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK------- 217
Query: 358 PHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ +EQ + + E ++ + C + DRP V + ++
Sbjct: 218 GPEVMAFIEQGKRMEC-------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (377), Expect = 2e-42
Identities = 66/277 (23%), Positives = 113/277 (40%), Gaps = 47/277 (16%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDG----------------------LASISRTSHVNVVTLL 197
+ K KLG G +G VY+G A + H N+V LL
Sbjct: 20 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
G C +I EFM G+L ++ Q + + + I+ +EYL
Sbjct: 80 GVCTREPPFYIITEFMTYGNLLDYLRE----CNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
+H D+ N L+ ++ K++DFGL++L T + GA+ I + A E +
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAKFPIKWTAPESLAY 190
Query: 318 NFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVV 377
+ S KSDV++FG+++ E+ + G+D S +Y +E+D
Sbjct: 191 --NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKDYRM------ 235
Query: 378 TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
++ +K+ + C Q P DRP E+ + +
Sbjct: 236 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-42
Identities = 67/337 (19%), Positives = 127/337 (37%), Gaps = 70/337 (20%)
Query: 143 PLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG--------------------- 181
P +++D+K F+D +G+G FG V K ++
Sbjct: 1 PTIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR 55
Query: 182 --------LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN--------- 224
L + H N++ LLG C L E+ P+G+L F+
Sbjct: 56 DFAGELEVLCKLGH--HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA 113
Query: 225 -GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283
+ L +++ +A+G++YL + +H D+ NIL+ +++ KI+D
Sbjct: 114 FAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIAD 170
Query: 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN 343
FGL++ R + ++A+E N+ + SDV+S+G+++ E+V
Sbjct: 171 FGLSRGQEVY----VKKTMGRLPVRWMAIESL--NYSVYTTNSDVWSYGVLLWEIVSLGG 224
Query: 344 NLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDR 403
G+ +Y + Q +K ++ + C + +PY+R
Sbjct: 225 TPYCGMT-------CAELYEKLPQGYRL-------EKPLNCDDEVYDLMRQCWREKPYER 270
Query: 404 PPMNEVIEMLQGSTEALQ-IPPTPFLSSPPRASIDSS 439
P +++ L E + T A ID S
Sbjct: 271 PSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGIDCS 307
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-42
Identities = 67/291 (23%), Positives = 116/291 (39%), Gaps = 53/291 (18%)
Query: 153 DVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------------------LASI 185
+ F + +G+G FG VY G LLD +
Sbjct: 23 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 186 SRTSHVNVVTLLGFCLEGNNRA-LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVI 244
SH NV++LLG CL ++ +M +G L F+ N + + + +
Sbjct: 83 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-----PTVKDLIGFGL 137
Query: 245 GIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG-IVSSLLGA 303
+AKG+ S + +H D+ N +LD+ F K++DFGLA+ K+ V + GA
Sbjct: 138 QVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363
+ + ++ALE + + KSDV+SFG+++ EL+ V+ I
Sbjct: 195 KLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITV 245
Query: 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
++ Q R + + V L C + RP +E++ +
Sbjct: 246 YLLQGRRL-------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 9e-42
Identities = 58/291 (19%), Positives = 107/291 (36%), Gaps = 54/291 (18%)
Query: 151 FSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------------------LA 183
+ D K +T K +LG G FG V KG
Sbjct: 2 YLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEAN 60
Query: 184 SISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIV 243
+ + + +V ++G C E + L+ E G L K++ ++++ + + E+V
Sbjct: 61 VMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ------NRHVKDKNIIELV 113
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA 303
++ G++YL + +H D+ N+LL KISDFGL+K + +
Sbjct: 114 HQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170
Query: 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363
+ + + A E + + S KSDV+SFG+++ E G+ +
Sbjct: 171 KWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-------GSEVTA 221
Query: 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+E+ ++M + C +RP V L+
Sbjct: 222 MLEKGERMGC-------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-41
Identities = 63/328 (19%), Positives = 111/328 (33%), Gaps = 69/328 (21%)
Query: 137 SLQNYGPLPLKRYNFSDVKKITNS---FKDKLGQGGFGGVYKGKLLDG------------ 181
S Y + + Y + + F LG G FG V
Sbjct: 14 SDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVK 73
Query: 182 -----------------LASISR-TSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVY 223
L +++ SH N+V LLG C LI+E+ G L ++
Sbjct: 74 MLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLR 133
Query: 224 N-----------------GDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDI 266
+ + + L +E + +AKG+E+L +H D+
Sbjct: 134 SKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL 190
Query: 267 KPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKS 326
N+L+ KI DFGLA+ + V AR + ++A E G + KS
Sbjct: 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVR-GNARLPVKWMAPESLFE--GIYTIKS 247
Query: 327 DVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAK 386
DV+S+G+++ E+ N G+ + Y+ ++ + + +
Sbjct: 248 DVWSYGILLWEIFSLGVNPYPGIPVDAN------FYKLIQNGFKM-------DQPFYATE 294
Query: 387 KMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
++ I+ C RP + L
Sbjct: 295 EIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 6e-41
Identities = 65/298 (21%), Positives = 106/298 (35%), Gaps = 61/298 (20%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDGLASISRT------------------------------S 189
SF LG G FG V + + S + +
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY------------LRWE 237
H+N+V LLG C G +I E+ G L F+ S C L E
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 238 KMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297
+ +AKG+ +L S +H D+ NILL KI DFGLA+ V
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF 357
AR + ++A E + +SDV+S+G+ + EL ++ G+ S
Sbjct: 203 VK-GNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---- 255
Query: 358 PHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415
Y+ +++ +M + C A P RP +++++++
Sbjct: 256 --KFYKMIKEGFRM-------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 8e-41
Identities = 59/294 (20%), Positives = 115/294 (39%), Gaps = 55/294 (18%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDG----------------------------LASISRTSHV 191
+ + +G G FG VYKG L + + SH
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 69
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251
N++ L G + +I E+M NG+L+KF+ + ++ ++ GIA G++
Sbjct: 70 NIIRLEGVISKYKPMMIITEYMENGALDKFLR-----EKDGEFSVLQLVGMLRGIAAGMK 124
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
YL +H D+ NIL++ + K+SDFGL+++ + G + I + A
Sbjct: 125 YLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371
E S + + SDV+SFG+++ E++ + N H + + +
Sbjct: 182 PEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFRL 232
Query: 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPPT 425
+ + + + C Q RP +++ +L + ++ P +
Sbjct: 233 PT-------PMDCPSAIYQLMMQCWQQERARRPKFADIVSILD---KLIRAPDS 276
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 9e-41
Identities = 54/301 (17%), Positives = 104/301 (34%), Gaps = 67/301 (22%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLAS-----------------------------ISRTSHV 191
+ +G+G FG V++ + L ++ +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQY------------------ 233
N+V LLG C G L++E+M G L +F+ + C
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 234 LRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293
L + I +A G+ YL + +H D+ N L+ ++ KI+DFGL++ +
Sbjct: 137 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSS 353
+ I ++ E N + +SDV+++G+++ E+ G+
Sbjct: 194 DYYKAD-GNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMA--- 247
Query: 354 EVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEML 413
+ +V G + ++ + C P DRP + +L
Sbjct: 248 ----HEEVIYYVRD-------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
Query: 414 Q 414
Q
Sbjct: 297 Q 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 1e-40
Identities = 58/275 (21%), Positives = 104/275 (37%), Gaps = 57/275 (20%)
Query: 164 KLGQGGFGGVYKGKLLDG--------------------------LASISRTSHVNVVTLL 197
++G G FG VY + + + + + H N +
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
G L + L+ E+ + + + + L+ ++ + G +GL YLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLH--- 132
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF-S 316
S ++H D+K NILL + K+ DFG A + V GT ++A EV +
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-------GTPYWMAPEVILA 185
Query: 317 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376
+ G+ K DV+S G+ +EL K L + N+ +Y + + G
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFN--MNAMSA-----LYHIAQNESPALQSGH 238
Query: 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
+ E + + C+Q P DRP +++
Sbjct: 239 WS----EYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 8e-40
Identities = 55/280 (19%), Positives = 103/280 (36%), Gaps = 51/280 (18%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG-------------------------LASISRTSHVNVVT 195
+G G +G K + + + H N+V
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 196 LLGFCLEGNNRAL--IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 253
++ N L + E+ G L + G +K QYL E + ++ + L+
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKG--TKERQYLDEEFVLRVMTQLTLALKEC 125
Query: 254 HR--GCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
HR +LH D+KP N+ LD K+ DFGLA++ + GT Y++
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAF---VGTPYYMS 182
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371
E +R + KSD++S G ++ EL + + + + + +
Sbjct: 183 PEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTA--------FSQKELAGKIREGKFR 232
Query: 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
++ + + NEI + + + Y RP + E++E
Sbjct: 233 RIPYRYSDELNEIITR-------MLNLKDYHRPSVEEILE 265
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-39
Identities = 55/283 (19%), Positives = 97/283 (34%), Gaps = 53/283 (18%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG-----------------------------LASISRTSHV 191
+KLG G FG V +G+ + ++ H
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251
N++ L G L + ++ E P GSL + K + + + +A+G+
Sbjct: 72 NLIRLYGVVLTPPMK-MVTELAPLGSLLDRLR-----KHQGHFLLGTLSRYAVQVAEGMG 125
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
YL S R +H D+ N+LL KI DFGL + + + A
Sbjct: 126 YLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371
E SH SD + FG+ + E+ G++ I ++++
Sbjct: 183 PESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-------GSQILHKIDKE--- 230
Query: 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
G + + + + V + C +P DRP + + L
Sbjct: 231 ---GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 2e-39
Identities = 60/281 (21%), Positives = 102/281 (36%), Gaps = 58/281 (20%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG-------------------------LASISRTSHVNVVT 195
F ++G+G F VYKG + + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 196 LLGFCLE----GNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251
L+ E M +G+L+ ++ + ++ + + I KGL+
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF------KVMKIKVLRSWCRQILKGLQ 126
Query: 252 YLHRGCSTRILHFDIKPHNILL-DQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310
+LH + I+H D+K NI + KI D GLA L S GT ++
Sbjct: 127 FLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-----SFAKAVIGTPEFM 180
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370
A E++ + DVY+FGM ++E+ + SE IYR V +
Sbjct: 181 APEMYE---EKYDESVDVYAFGMCMLEMA-------TSEYPYSECQNAAQIYRRVTSGVK 230
Query: 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
V E K++I CI+ +R + +++
Sbjct: 231 PASFDKVAIPE---VKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (355), Expect = 6e-39
Identities = 49/286 (17%), Positives = 96/286 (33%), Gaps = 47/286 (16%)
Query: 144 LPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG---------------------- 181
+ LK +F + ++ G G G V+K
Sbjct: 1 MELKDDDFEKISEL--------GAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII 52
Query: 182 --LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 239
L + + +V G ++ E M GSL++ + + + +
Sbjct: 53 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA------GRIPEQIL 106
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
++ I + KGL YL +I+H D+KP NIL++ K+ DFG++ S
Sbjct: 107 GKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SM 159
Query: 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPH 359
GT Y++ E S +SD++S G+ ++E+ + + E+ F
Sbjct: 160 ANSFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217
Query: 360 WIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP 405
+ + + + + + + PP
Sbjct: 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPP 263
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 1e-37
Identities = 59/291 (20%), Positives = 106/291 (36%), Gaps = 63/291 (21%)
Query: 147 KRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG------------------------- 181
+++ D + LG+G FG VY +
Sbjct: 1 RQWALEDFEIG-----RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 55
Query: 182 -LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 240
+ S H N++ L G+ + LI E+ P G++ + + + ++
Sbjct: 56 EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL------QKLSKFDEQRTA 109
Query: 241 EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSL 300
+ +A L Y H S R++H DIKP N+LL KI+DFG + + +
Sbjct: 110 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-----R 161
Query: 301 LGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHW 360
GT+ Y+ E+ K D++S G++ E + K ++ + E Y
Sbjct: 162 TTLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEA--NTYQETY---- 213
Query: 361 IYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
R ++ E A+ +I ++ P RP + EV+E
Sbjct: 214 -------KRISRVEFTFPDFVTEGARDLI---SRLLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-37
Identities = 68/317 (21%), Positives = 115/317 (36%), Gaps = 60/317 (18%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDG----------------------------LASISRTSHV 191
LG G FG VYKG + ++ +
Sbjct: 12 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 71
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251
+V LLG CL + LI + MP G L +V + + + + IAKG+
Sbjct: 72 HVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIG-----SQYLLNWCVQIAKGMN 125
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
YL R++H D+ N+L+ KI+DFGLAKL ++ + G + I ++A
Sbjct: 126 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-EGGKVPIKWMA 181
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371
LE +H+SDV+S+G+ + EL+ + G+ S I +E+
Sbjct: 182 LESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERL 232
Query: 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE------ALQIPPT 425
+ + ++ + C RP E+I +Q
Sbjct: 233 -------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 285
Query: 426 PFLSSPPRASIDSSTLR 442
L SP ++ + +
Sbjct: 286 MHLPSPTDSNFYRALMD 302
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-37
Identities = 67/300 (22%), Positives = 108/300 (36%), Gaps = 60/300 (20%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLAS------------------------------ISRTSH 190
LG+G FG V + + I H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 191 VNVVTLLGFCLE-GNNRALIYEFMPNGSLEKFVYN----------GDTSKPCQYLRWEKM 239
+NVV LLG C + G +I EF G+L ++ + +L E +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299
+AKG+E+L S + +H D+ NILL + KI DFGLA+ V
Sbjct: 137 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPH 359
AR + ++A E + +SDV+SFG+++ E+ + GV
Sbjct: 194 -GDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI------DE 244
Query: 360 WIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419
R +++ + + +M L C P RP +E++E L +A
Sbjct: 245 EFCRRLKEGTRMRA-------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-37
Identities = 55/281 (19%), Positives = 94/281 (33%), Gaps = 54/281 (19%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG---------------------------LASISRTSHVNV 193
+G+G FG V++G + ++ + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 194 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 253
V L+G E N +I E G L F+ L + ++ L YL
Sbjct: 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYL 124
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALE 313
R +H DI N+L+ + C K+ DFGL++ +S + I ++A E
Sbjct: 125 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS--KGKLPIKWMAPE 179
Query: 314 VFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373
NF + SDV+ FG+ + E++ GV + + +E +
Sbjct: 180 SI--NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-------NNDVIGRIENGERLPM 230
Query: 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+ K C P RP E+ L
Sbjct: 231 PPNCPPTLYSLMTK-------CWAYDPSRRPRFTELKAQLS 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 5e-37
Identities = 53/277 (19%), Positives = 102/277 (36%), Gaps = 50/277 (18%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG-----------------------LASISRTSHVNVVTLL 197
+LG G FG VYK + + + ++ H N+V LL
Sbjct: 16 IIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 75
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
NN ++ EF G+++ + + + L ++ + L YLH
Sbjct: 76 DAFYYENNLWILIEFCAGGAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLH--- 127
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF-- 315
+I+H D+K NIL D K++DFG++ T S GT ++A EV
Sbjct: 128 DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF---IGTPYWMAPEVVMC 184
Query: 316 -SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374
+ +K+DV+S G+ ++E+ + P + + + L
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE--------LNPMRVLLKIAKSEPPTL- 235
Query: 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
+ + K + C++ R +++++
Sbjct: 236 -AQPSRWSSNFKDFL---KKCLEKNVDARWTTSQLLQ 268
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-36
Identities = 56/296 (18%), Positives = 109/296 (36%), Gaps = 62/296 (20%)
Query: 161 FKDKLGQGGFGGVYKGKLLDGLASISR--------------------------------T 188
LG+G FG V + +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 189 SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN----------GDTSKPCQYLRWEK 238
H N++ LLG C + +I E+ G+L +++ + P + L +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 239 MYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298
+ +A+G+EYL S + +H D+ N+L+ +D KI+DFGLA+
Sbjct: 137 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFP 358
+ R + ++A E +H+SDV+SFG+++ E+ + GV
Sbjct: 194 T-TNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV------- 243
Query: 359 HWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
+++ +++ + ++ ++ C A P RP +++E L
Sbjct: 244 EELFKLLKEGHRMDK-------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-35
Identities = 63/292 (21%), Positives = 110/292 (37%), Gaps = 53/292 (18%)
Query: 160 SFKDKLGQGGFGGVYKG----------------KLLDGLAS-------------ISRTSH 190
+ +LGQG FG VY+G K ++ AS + +
Sbjct: 23 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 82
Query: 191 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYN----GDTSKPCQYLRWEKMYEIVIGI 246
+VV LLG +G +I E M G L+ ++ + + KM ++ I
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT 306
A G+ YL + + +H D+ N ++ +DF KI DFG+ + G
Sbjct: 143 ADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG-LLP 198
Query: 307 IGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE 366
+ +++ E G + SDV+SFG+++ E+ G+ + R V
Sbjct: 199 VRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQVLRFVM 249
Query: 367 QDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418
+ G + K + + + C Q P RP E+I ++ E
Sbjct: 250 E-------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 4e-35
Identities = 57/275 (20%), Positives = 95/275 (34%), Gaps = 48/275 (17%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG------------------------LASISRTSHVNVVTL 196
LG+G +G V + +H NVV
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF 68
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
G EGN + L E+ G L + +P + + G+ YLH
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRI------EPDIGMPEPDAQRFFHQLMAGVVYLH-- 120
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
I H DIKP N+LLD+ KISDFGLA + L GT+ Y+A E+
Sbjct: 121 -GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY-NNRERLLNKMCGTLPYVAPELLK 178
Query: 317 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376
R + DV+S G+++ ++ + D + S + W + + K+
Sbjct: 179 RR-EFHAEPVDVWSCGIVLTAMLAGELPWDQ--PSDSCQEYSDWKEKKTYLNPWKKI--- 232
Query: 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
+ ++ + P R + ++ +
Sbjct: 233 -----DSAPLALL---HKILVENPSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-33
Identities = 60/290 (20%), Positives = 110/290 (37%), Gaps = 61/290 (21%)
Query: 145 PLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGK-----------------------LLDG 181
P K+Y + +K+GQG G VY +++
Sbjct: 18 PKKKY----------TRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 182 LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYE 241
+ + + N+V L L G+ ++ E++ GSL V ++
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-------EGQIAA 120
Query: 242 IVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLL 301
+ + LE+LH S +++H DIK NILL D K++DFG T ++ S++
Sbjct: 121 VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM- 176
Query: 302 GARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI 361
GT ++A EV +R K D++S G+M +E++ + + +N +
Sbjct: 177 --VGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLN--ENPLRALYLIAT 230
Query: 362 YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
E KL + I + + C+ R E+++
Sbjct: 231 NGTPELQNPEKL--------SAIFRDFL---NRCLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 119 bits (299), Expect = 1e-30
Identities = 55/276 (19%), Positives = 100/276 (36%), Gaps = 51/276 (18%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG-----------------------LASISRTSHVNVVTLL 197
++LG G FG V++ + ++S H +V L
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLH 89
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
+ N +IYEFM G L + V + ++ E + + KGL ++H
Sbjct: 90 DAFEDDNEMVMIYEFMSGGELFEKVA-----DEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 258 STRILHFDIKPHNILLDQDFCP--KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVF 315
+H D+KP NI+ K+ DFGL K+ + + GT + A EV
Sbjct: 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT----TGTAEFAAPEVA 197
Query: 316 SRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375
V + +D++S G++ L+ + +N E + ++ +
Sbjct: 198 EG--KPVGYYTDMWSVGVLSYILLSGLSPFGG--ENDDETLRNV-------KSCDWNMDD 246
Query: 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
+E K I + A P R +++ +E
Sbjct: 247 SAFSGISEDGKDFI---RKLLLADPNTRMTIHQALE 279
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 118 bits (297), Expect = 2e-30
Identities = 59/293 (20%), Positives = 98/293 (33%), Gaps = 62/293 (21%)
Query: 160 SFKDKLGQGGFGGVYKGKLLDG-----------------------------LASISRTSH 190
S +G+GGFG VY + D L+ +S
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 191 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 250
+V + + + I + M G L + M I GL
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL------SQHGVFSEADMRFYAAEIILGL 120
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310
E++H + +++ D+KP NILLD+ +ISD GLA + KK S GT GY+
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYM 172
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370
A EV + +D +S G M+ +L+ + + VE
Sbjct: 173 APEVLQKGVA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS 231
Query: 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIP 423
F + + ++ +Q R + +G+ E + P
Sbjct: 232 F----------SPELRSLL---EGLLQRDVNRRLGC-----LGRGAQEVKESP 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 2e-29
Identities = 53/275 (19%), Positives = 94/275 (34%), Gaps = 54/275 (19%)
Query: 161 FKDKLGQGGFGGVYKGK--------------------------LLDGLASISRTSHVNVV 194
F LG+G F V + + +SR H V
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 195 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 254
L + + NG L K++ I LEYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRK------IGSFDETCTRFYTAEIVSALEYLH 125
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEV 314
I+H D+KP NILL++D +I+DFG AK+ + + + GT Y++ E+
Sbjct: 126 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP-ESKQARANSFVGTAQYVSPEL 181
Query: 315 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374
+ SD+++ G +I +LV + N ++ + ++ + +F
Sbjct: 182 LTE--KSACKSSDLWALGCIIYQLVAGLPPFRA--GNEYLIF-----QKIIKLEYDF--- 229
Query: 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEV 409
+K A+ ++ + R E+
Sbjct: 230 ---PEKFFPKARDLV---EKLLVLDATKRLGCEEM 258
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 114 bits (285), Expect = 9e-29
Identities = 60/320 (18%), Positives = 114/320 (35%), Gaps = 59/320 (18%)
Query: 143 PLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG--------------------- 181
P+ +K+ + D I ++LG G FG V++
Sbjct: 19 PVEVKQGSVYDYYDI----LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK 74
Query: 182 --LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKM 239
++ +++ H ++ L + LI EF+ G L + + + ++
Sbjct: 75 NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI-----AAEDYKMSEAEV 129
Query: 240 YEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP--KISDFGLAKLCTTKKGIV 297
+ +GL+++H I+H DIKP NI+ + KI DFGLA
Sbjct: 130 INYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD---- 182
Query: 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF 357
+ T + A E+ R V +D+++ G++ L+ + ++ E
Sbjct: 183 EIVKVTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAG--EDDLETL- 237
Query: 358 PHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQG 415
D EF + AK I +Q P R +++ +E L+G
Sbjct: 238 ----QNVKRCDWEFDED--AFSSVSPEAKDFI---KNLLQKEPRKRLTVHDALEHPWLKG 288
Query: 416 STEAL--QIPPTPFLSSPPR 433
L +IP + + +
Sbjct: 289 DHSNLTSRIPSSRYNKIRQK 308
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (279), Expect = 3e-28
Identities = 57/308 (18%), Positives = 106/308 (34%), Gaps = 51/308 (16%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG------------------------LASISRTSHVNVVTL 196
F+D LG G F V + +A + + H N+V L
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
G + LI + + G L + + ++ + ++YLH
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVE------KGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
LD+D ISDFGL+K+ S L A GT GY+A EV +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG----SVLSTACGTPGYVAPEVLA 182
Query: 317 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376
+ S D +S G++ L+ +N ++++ + ++ + EF
Sbjct: 183 Q--KPYSKAVDCWSIGVIAYILLCGYPPFYD--ENDAKLF-----EQILKAEYEFD---- 229
Query: 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGSTEALQIPPTPFLSSPPRA 434
+ ++I+ ++ P R + ++ + G T AL +S +
Sbjct: 230 -SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT-ALDKNIHQSVSEQIKK 287
Query: 435 SIDSSTLR 442
+ S +
Sbjct: 288 NFAKSKWK 295
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 5e-28
Identities = 61/315 (19%), Positives = 115/315 (36%), Gaps = 51/315 (16%)
Query: 144 LPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKG-----------KLLDGLASISR----- 187
L +K+ D K+T LG G G V + K+L R
Sbjct: 2 LQIKKNAIIDDYKVT---SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELH 58
Query: 188 ---TSHVNVVTLLGFC----LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMY 240
+ ++V ++ ++ E + G L + + + Q +
Sbjct: 59 WRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTEREAS 114
Query: 241 EIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP---KISDFGLAKLCTTKKGIV 297
EI+ I + ++YLH S I H D+KP N+L K++DFG AK T+ +
Sbjct: 115 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT 171
Query: 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF 357
+ T Y+A EV + D++S G+++ L+ N
Sbjct: 172 TP----CYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAIS 222
Query: 358 PHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417
P R EF + +E+++++ ++ ++ P R + E +
Sbjct: 223 PGMKTRIRMGQYEFP-----NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH-PWIM 276
Query: 418 EALQIPPTPFLSSPP 432
++ ++P TP +S
Sbjct: 277 QSTKVPQTPLHTSRV 291
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 109 bits (273), Expect = 9e-28
Identities = 49/288 (17%), Positives = 97/288 (33%), Gaps = 62/288 (21%)
Query: 161 FKDKLGQGGFGGVYKG-----------KLLDGLASISRT--------------------- 188
K+ LG+G V + K++D S +
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 189 -SHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIA 247
H N++ L L+++ M G L ++ L ++ +I+ +
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK------VTLSEKETRKIMRALL 120
Query: 248 KGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTI 307
+ + LH I+H D+KP NILLD D K++DFG + L GT
Sbjct: 121 EVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG----EKLREVCGTP 173
Query: 308 GYIALEVFS----RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363
Y+A E+ N + D++S G+++ L+ +
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH--RKQMLMLR-----M 226
Query: 364 HVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
+ + +F + + ++ + + + + +P R E +
Sbjct: 227 IMSGNYQFG-----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 109 bits (273), Expect = 9e-28
Identities = 50/293 (17%), Positives = 102/293 (34%), Gaps = 56/293 (19%)
Query: 155 KKITNSFK--DKLGQGGFGGVYKGKLLDG--------------------------LASIS 186
+++ ++ + LG GG V+ + L + +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 187 RTSHVNVVTLLGFCLEGNNRA----LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEI 242
+H +V + ++ E++ +L V+ + ++ E+
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT------EGPMTPKRAIEV 116
Query: 243 VIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLG 302
+ + L + I+H D+KP NI++ K+ DFG+A+ V+
Sbjct: 117 IADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173
Query: 303 ARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIY 362
GT Y++ E V +SDVYS G ++ E++ + D+ V Y
Sbjct: 174 VIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTG--DSPVSV-----AY 224
Query: 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-MNEVIEMLQ 414
+HV +D + ++ + V L + P +R E+ L
Sbjct: 225 QHVREDPIPPS-----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-27
Identities = 47/275 (17%), Positives = 94/275 (34%), Gaps = 50/275 (18%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG----------------------LASISRTSHVNVVTLLG 198
+ LG+G FG V++ ++ ++ H N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
+I+EF+ + + + + L ++ V + + L++LH S
Sbjct: 69 SFESMEELVMIFEFISGLDIFERI-----NTSAFELNEREIVSYVHQVCEALQFLH---S 120
Query: 259 TRILHFDIKPHNILLDQDFCP--KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
I HFDI+P NI+ KI +FG A+ Y A EV
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL----FTAPEYYAPEVHQ 176
Query: 317 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376
VS +D++S G ++ L+ N + + + ++ + E+
Sbjct: 177 H--DVVSTATDMWSLGTLVYVLLSGINPFLA--ETNQQIIENI-------MNAEYTFDEE 225
Query: 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
K+ + A + + R +E ++
Sbjct: 226 AFKEISIEAMDFV---DRLLVKERKSRMTASEALQ 257
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 109 bits (273), Expect = 1e-27
Identities = 37/295 (12%), Positives = 85/295 (28%), Gaps = 50/295 (16%)
Query: 161 FKDKLGQGGFGGVYKG-----------KLLDGLASISR-----------TSHVNVVTLLG 198
++G+G FG +++G K + + + +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
F EG + L+ + + + G + + + + ++ +H
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIH---E 119
Query: 259 TRILHFDIKPHNILLDQDFCP-----KISDFGLAKLC----TTKKGIVSSLLGARGTIGY 309
+++ DIKP N L+ + + DFG+ K T + GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369
+++ E S + D+ + G + M + + E+
Sbjct: 180 MSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQG--------LKAATNKQKYERIG 229
Query: 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPP 424
E K + + ++ + P + + + E L
Sbjct: 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (272), Expect = 2e-27
Identities = 50/290 (17%), Positives = 94/290 (32%), Gaps = 50/290 (17%)
Query: 156 KITNSFK--DKLGQGGFGGVYKG-----------KLLDGLASISRT-----------SHV 191
++ N ++ K+G G FG +Y G KL + V
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV 63
Query: 192 NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251
+ T+ EG+ ++ E + + F + + + + + + +E
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS------RKFSLKTVLLLADQMISRIE 117
Query: 252 YLHRGCSTRILHFDIKPHNIL---LDQDFCPKISDFGLAKLC----TTKKGIVSSLLGAR 304
Y+H S +H D+KP N L + I DFGLAK T +
Sbjct: 118 YIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 174
Query: 305 GTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364
GT Y ++ E S + D+ S G ++M +
Sbjct: 175 GTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQ--------GLKAATKRQK 224
Query: 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414
E+ E K+ + + +C R D+P + + ++ +
Sbjct: 225 YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 6e-27
Identities = 54/292 (18%), Positives = 108/292 (36%), Gaps = 55/292 (18%)
Query: 163 DKLGQGGFGGVYKGKLLDG-----------------------------LASISRTSHVNV 193
++G+G +G V+K + L L + H NV
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 194 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 253
V L C + +++ + P + E + +++ + +GL++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALE 313
H S R++H D+KP NIL+ K++DFGLA++ + + + S T+ Y A E
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV----VVTLWYRAPE 185
Query: 314 VFSRNFGEVSHKSDVYSFGMMIMELVGCK------NNLDS--------GVDNSSEVYFPH 359
V + + D++S G + E+ K +++D G+ +
Sbjct: 186 VLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 360 WIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
+ R + + + +E+ K ++ L C+ P R +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLL---LKCLTFNPAKRISAYSALS 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-26
Identities = 71/354 (20%), Positives = 119/354 (33%), Gaps = 70/354 (19%)
Query: 134 TLFSLQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG------------ 181
T+ + GP + +++D K I G G FG VY+ KL D
Sbjct: 5 TVVATPGQGPDRPQEVSYTDTKVI--------GNGSFGVVYQAKLCDSGELVAIKKVLQD 56
Query: 182 -------LASISRTSHVNVVTLLGFCLEGNNR------ALIYEFMPNGSLEKFVYNGDTS 228
L + + H N+V L F + L+ +++P + S
Sbjct: 57 KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY---S 113
Query: 229 KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD-FCPKISDFGLA 287
+ Q L + + + + L Y+H S I H DIKP N+LLD D K+ DFG A
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 170
Query: 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK----- 342
K + VS + + Y A E+ + DV+S G ++ EL+ +
Sbjct: 171 KQLVRGEPNVSYI----CSRYYRAPELIFGATD-YTSSIDVWSAGCVLAELLLGQPIFPG 225
Query: 343 -----------NNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIV 391
L + P++ Q + V + A +
Sbjct: 226 DSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALC-- 283
Query: 392 GLWCIQARPYDRPPMNEVI------EMLQGSTEALQIPPTPFLSSPPRASIDSS 439
++ P R E E+ + + TP L + + S+
Sbjct: 284 -SRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSN 336
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 2e-25
Identities = 46/206 (22%), Positives = 76/206 (36%), Gaps = 41/206 (19%)
Query: 161 FKDKLGQGGFGGVYKG-----------KLLDGLASISRT----------------SHVNV 193
LG+G FG V+ K L + H +
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 194 VTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYL 253
+ N + E++ G L + + C + I GL++L
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHI------QSCHKFDLSRATFYAAEIILGLQFL 119
Query: 254 HRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALE 313
S I++ D+K NILLD+D KI+DFG+ K ++ GT YIA E
Sbjct: 120 ---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF---CGTPDYIAPE 173
Query: 314 VFSRNFGEVSHKSDVYSFGMMIMELV 339
+ + +H D +SFG+++ E++
Sbjct: 174 ILLG--QKYNHSVDWWSFGVLLYEML 197
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 5e-25
Identities = 49/299 (16%), Positives = 100/299 (33%), Gaps = 54/299 (18%)
Query: 157 ITNSFK--DKLGQGGFGGVYKGKLLDG------------------------LASISRTSH 190
+ + +G+G +G V + + R H
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 191 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGL 250
N++ + + ++ + +Y ++ L + + + I +GL
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGL 122
Query: 251 EYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYI 310
+Y+H S +LH D+KP N+LL+ KI DFGLA++ L T Y
Sbjct: 123 KYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 311 ALEVFSRNFGEVSHKSDVYSFGMMIMELV------GCKNNLD------------SGVDNS 352
A E+ + G + D++S G ++ E++ K+ LD S D +
Sbjct: 180 APEIMLNSKG-YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 353 SEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
+ Y + + + A ++ + P+ R + + +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLL---DKMLTFNPHKRIEVEQALA 294
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 1e-24
Identities = 57/317 (17%), Positives = 107/317 (33%), Gaps = 66/317 (20%)
Query: 163 DKLGQGGFGGVYKGKLLDG----------------------------LASISRTSHVNVV 194
D LG+G F VYK + + + + SH N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 195 TLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLH 254
LL +N +L+++FM N L + ++ +GLEYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLH 117
Query: 255 RGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEV 314
+ ILH D+KP+N+LLD++ K++DFGLAK + + + T Y A E+
Sbjct: 118 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV---VTRWYRAPEL 171
Query: 315 FSRNFGEVSHKSDVYSFGMMIMELVGCK------------NNLDSGVDNSSEVYFPHWIY 362
D+++ G ++ EL+ + + +E +P
Sbjct: 172 L-FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQI 422
+ + + ++ + P R + ++M
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM---------- 280
Query: 423 PPTPFLSSPPRASIDSS 439
+ S+ P +
Sbjct: 281 ---KYFSNRPGPTPGCQ 294
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 2e-23
Identities = 62/298 (20%), Positives = 103/298 (34%), Gaps = 64/298 (21%)
Query: 147 KRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG------------------------- 181
++ N D ++LG G F V K +
Sbjct: 4 RQENVDDYYDT----GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59
Query: 182 ----LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE 237
++ + H NV+TL + LI E + G L F+ + L E
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK------ESLTEE 113
Query: 238 KMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCP----KISDFGLAKLCTTK 293
+ E + I G+ YLH I HFD+KP NI+L P KI DFGLA
Sbjct: 114 EATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
Query: 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSS 353
+ GT ++A E+ N+ + ++D++S G++ L+ + D
Sbjct: 171 ----NEFKNIFGTPEFVAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLG--DTKQ 222
Query: 354 EVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
E + +D F + +AK I + P R + + ++
Sbjct: 223 ETLANVSAVNYEFEDEYF-------SNTSALAKDFI---RRLLVKDPKKRMTIQDSLQ 270
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 96.1 bits (238), Expect = 6e-23
Identities = 52/289 (17%), Positives = 97/289 (33%), Gaps = 56/289 (19%)
Query: 163 DKLGQGGFGGVYKGKLLDG------------------------LASISRTSHVNVVTLLG 198
+K+G+G +G VYK + G ++ + H N+V L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCS 258
L++E + + L ++ + G+ Y H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCH---D 118
Query: 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN 318
R+LH D+KP N+L++++ KI+DFGLA+ V T+ Y A +V
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP---VRKYTHEIVTLWYRAPDVL-MG 174
Query: 319 FGEVSHKSDVYSFGMMIMELVGCK------------NNLDSGVDNSSEVYFPHWI----Y 362
+ S D++S G + E+V + + + +P+ Y
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 363 RHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
E K +E ++ ++ P R + +E
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLL---SKMLKLDPNQRITAKQALE 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 96.3 bits (239), Expect = 8e-23
Identities = 50/230 (21%), Positives = 80/230 (34%), Gaps = 61/230 (26%)
Query: 136 FSLQNYGPLPLKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKLLDG-------------- 181
+SLQ++ LG G FG V+ +
Sbjct: 1 YSLQDF------------------QILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV 42
Query: 182 ------------LASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSK 229
+S +H ++ + G + +I +++ G L +
Sbjct: 43 VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP 102
Query: 230 PCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289
+ LEYLH I++ D+KP NILLD++ KI+DFG AK
Sbjct: 103 NPVAKF------YAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY 153
Query: 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+ GT YIA EV S + D +SFG++I E++
Sbjct: 154 VPDVTYTL------CGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEML 195
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.1 bits (238), Expect = 9e-23
Identities = 47/292 (16%), Positives = 99/292 (33%), Gaps = 46/292 (15%)
Query: 163 DKLGQGGFGGVYKGKLLDG-------------------------LASISRTSHVNVVTLL 197
K+GQG FG V+K + + + H NVV L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
C + + + F + L + EI + L L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFD-FCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 134
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK-LCTTKKGIVSSLLGARGTIGYIALEVFS 316
+ILH D+K N+L+ +D K++DFGLA+ K + T+ Y E+
Sbjct: 135 RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL- 193
Query: 317 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVY--------FPHWIYRHVEQD 368
+ D++ G ++ E+ ++ + G ++ ++ +V+
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMW-TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252
Query: 369 REFKLLGVVTKKENEIAKKMIIVGL---------WCIQARPYDRPPMNEVIE 411
++ L +V ++ ++ ++ + P R ++ +
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 2e-22
Identities = 49/290 (16%), Positives = 99/290 (34%), Gaps = 56/290 (19%)
Query: 163 DKLGQGGFGGVYKGK-------------------------LLDGLASISRTSHVNVVTLL 197
+K+G+G +G VYK + + ++ + +H N+V LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
N L++EF+ + + + + + + +GL + H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMD-----ASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
+LH D+KP N+L++ + K++DFGLA+ + + Y A E+
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTL---WYRAPEILLG 176
Query: 318 NFGEVSHKSDVYSFGMMIMELVGCK------------NNLDSGVDNSSEVYFPHWI---- 361
S D++S G + E+V + + + EV +P
Sbjct: 177 C-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 362 YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
Y+ + V +E + ++ + P R +
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLL---SQMLHYDPNKRISAKAALA 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.0 bits (233), Expect = 2e-22
Identities = 52/284 (18%), Positives = 86/284 (30%), Gaps = 70/284 (24%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG-------------------------------LASISRTS 189
LG GGFG VY G + L +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 190 HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
V+ LL + ++ LI E L+ E + +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-----TERGALQEELARSFFWQVLEA 122
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQD-FCPKISDFGLAKLCTTKKGIVSSLLGARGTIG 308
+ + + +LH DIK NIL+D + K+ DFG L + GT
Sbjct: 123 VRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-----TVYTDFDGTRV 174
Query: 309 YIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVD-NSSEVYFPHWIYRHVEQ 367
Y E R + V+S G+++ ++V + + +V+F +
Sbjct: 175 YSPPEWI-RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV------ 227
Query: 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
+ + +I WC+ RP DRP E+
Sbjct: 228 --------------SSECQHLI---RWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.4 bits (226), Expect = 6e-21
Identities = 46/216 (21%), Positives = 78/216 (36%), Gaps = 43/216 (19%)
Query: 156 KIT-NSFK--DKLGQGGFGGVYKGK--------------------------LLDGLASIS 186
K+T N F LG+G FG V + + +
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 187 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 246
T H + L + + E+ G L + + E+ I
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL------SRERVFTEERARFYGAEI 114
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT 306
LEYLH +++ DIK N++LD+D KI+DFGL K + +++ GT
Sbjct: 115 VSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---ATMKTFCGT 168
Query: 307 IGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
Y+A EV + D + G+++ E++ +
Sbjct: 169 PEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.6 bits (221), Expect = 1e-20
Identities = 50/291 (17%), Positives = 93/291 (31%), Gaps = 58/291 (19%)
Query: 163 DKLGQGGFGGVYKGKLLDG-------------------------LASISRTSHVNVVTLL 197
+K+G+G +G V+K K + + + H N+V L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 198 GFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC 257
L++EF + F L E + + + KGL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSC------NGDLDPEIVKSFLFQLLKGLGFCHS-- 119
Query: 258 STRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSR 317
+LH D+KP N+L++++ K+++FGLA+ A +
Sbjct: 120 -RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP----VRCYSAEVVTLWYRPPDVLF 174
Query: 318 NFGEVSHKSDVYSFGMMIMELVGCK-------------NNLDSGVDNSSEVYFPHWI--- 361
S D++S G + EL + + +E +P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 362 -YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411
Y+ L V K N + ++ ++ P R E ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLL---QNLLKCNPVQRISAEEALQ 282
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 86.4 bits (213), Expect = 3e-19
Identities = 42/217 (19%), Positives = 84/217 (38%), Gaps = 45/217 (20%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG-----------------------LASISRTSHVNVVTLL 197
KLG+G + V++ + L ++ N++TL
Sbjct: 39 LVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG--GPNIITLA 96
Query: 198 GFCLEGNNR--ALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHR 255
+ +R AL++E + N ++ Q L + + I K L+Y H
Sbjct: 97 DIVKDPVSRTPALVFEHVNNTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHS 147
Query: 256 GCSTRILHFDIKPHNILLDQDFCP-KISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEV 314
I+H D+KPHN+++D + ++ D+GLA+ + + + + E+
Sbjct: 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV----ASRYFKGPEL 200
Query: 315 FSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDN 351
++ + D++S G M+ ++ K G DN
Sbjct: 201 L-VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 84.5 bits (208), Expect = 1e-18
Identities = 41/224 (18%), Positives = 75/224 (33%), Gaps = 45/224 (20%)
Query: 163 DKLGQGGFGGVYKGK--------------------------LLDGLASISRTSHVNVVTL 196
LG G FG V K L+ + + +V L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 197 LGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG 256
+ +N ++ E++ G + + I EYLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR------IGRFSEPHARFYAAQIVLTFEYLH-- 158
Query: 257 CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFS 316
S +++ D+KP N+L+DQ +++DFG AK + + GT +A E+
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL------CGTPEALAPEIIL 211
Query: 317 RNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHW 360
+ D ++ G++I E+ + D ++Y
Sbjct: 212 S--KGYNKAVDWWALGVLIYEMAAGYPPFFA--DQPIQIYEKIV 251
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 1e-17
Identities = 38/210 (18%), Positives = 69/210 (32%), Gaps = 42/210 (20%)
Query: 161 FKDKLGQGGFGGVYKGKLLDG------------------------------LASISRTSH 190
LG G +G V+ + + G +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 191 V-NVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKG 249
+VTL LI +++ G L + + + + + +
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY---------VGEI 138
Query: 250 LEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGY 309
+ L I++ DIK NILLD + ++DFGL+K + GTI Y
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET--ERAYDFCGTIEY 196
Query: 310 IALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
+A ++ D +S G+++ EL+
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELL 226
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.9 bits (196), Expect = 4e-17
Identities = 46/225 (20%), Positives = 82/225 (36%), Gaps = 43/225 (19%)
Query: 149 YNFSDVKKITNSFKD------KLGQGGFGGVYKGK------------------------- 177
+ +V K + +G G +G V
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 178 LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWE 237
L + H NV+ LL +F + + + L +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV--MPFMGTDLGKLMKHEKLGED 121
Query: 238 KMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIV 297
++ +V + KGL Y+H + I+H D+KP N+ +++D KI DFGLA+ ++
Sbjct: 122 RIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---- 174
Query: 298 SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCK 342
+ G T Y A EV N+ + D++S G ++ E++ K
Sbjct: 175 --MTGYVVTRWYRAPEVI-LNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.1 bits (173), Expect = 4e-14
Identities = 45/208 (21%), Positives = 72/208 (34%), Gaps = 49/208 (23%)
Query: 163 DKLGQGGFGGVYKGK-------------------------LLDGLASISRTSHVNVVTLL 197
+G G G V L + +H N+++LL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 198 GFCL------EGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLE 251
E + L+ E M + D E+M ++ + G++
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---------HERMSYLLYQMLCGIK 133
Query: 252 YLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIA 311
+LH I+H D+KP NI++ D KI DFGLA+ T + T Y A
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF----MMTPYVVTRYYRA 186
Query: 312 LEVFSRNFGEVSHKSDVYSFGMMIMELV 339
EV D++S G ++ E+V
Sbjct: 187 PEVILGM--GYKENVDIWSVGCIMGEMV 212
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 70.4 bits (171), Expect = 7e-14
Identities = 41/212 (19%), Positives = 69/212 (32%), Gaps = 38/212 (17%)
Query: 161 FKDKLGQGGFGGVYKGK----------------------LLDGLASISRTSHVNVVTLLG 198
KLG G F V+ K D + + R + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 199 FCLEGNNRALIY--EFMPNGSLEKFVYNGDTSKPCQYLR--------WEKMYEIVIGIAK 248
+ L + PNG V+ ++ + +I +
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 249 GLEYLHRGCSTRILHFDIKPHNILLDQ-DFCPKISDFGLAKLCTTKKGIVSSLLGARGTI 307
GL+Y+HR C I+H DIKP N+L++ D + +A L + T
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-YDEHYTNSIQTR 193
Query: 308 GYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
Y + EV +D++S +I EL+
Sbjct: 194 EYRSPEVLLG--APWGCGADIWSTACLIFELI 223
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.6 bits (164), Expect = 5e-13
Identities = 45/216 (20%), Positives = 81/216 (37%), Gaps = 43/216 (19%)
Query: 153 DVKKITNSFK--DKLGQGGFGGVYKGKLLDG-------------------------LASI 185
+ ++ ++ +G G +G V L +
Sbjct: 12 TIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 71
Query: 186 SRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPC--QYLRWEKMYEIV 243
H NV+ LL + + L + D + Q L + + ++
Sbjct: 72 KHMKHENVIGLLDVFTPARSLEEFNDVY----LVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 244 IGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGA 303
I +GL+Y+H S I+H D+KP N+ +++D KI DFGLA+ + G
Sbjct: 128 YQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT------GY 178
Query: 304 RGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELV 339
T Y A E+ N+ + D++S G ++ EL+
Sbjct: 179 VATRWYRAPEIM-LNWMHYNQTVDIWSVGCIMAELL 213
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 63.3 bits (153), Expect = 3e-12
Identities = 29/211 (13%), Positives = 62/211 (29%), Gaps = 53/211 (25%)
Query: 159 NSFKDKLGQGGFGGVYKGKLLDG--------------------------------LASIS 186
++ +G+G V+ +
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 187 RTSHVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGI 246
R + L G + Y + N L + + +R E E++ I
Sbjct: 62 RNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAK----ELYRVRVENPDEVLDMI 112
Query: 247 AKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGT 306
+ + + I+H D+ +N+L+ + I DF + + +L
Sbjct: 113 LEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV--EVGEEGWREIL--ERD 164
Query: 307 IGYIALEVFSRNFGEVSHKSDVYSFGMMIME 337
+ I + FSR + + D+ S I++
Sbjct: 165 VRNI-ITYFSRTYRT---EKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 450 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.79 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.5 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.83 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.23 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 91.86 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 90.59 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 81.01 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=381.33 Aligned_cols=242 Identities=26% Similarity=0.419 Sum_probs=186.8
Q ss_pred hHhhhccccccceEEEEEEE----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
+.+.++||+|+||+||+|++ .+|+.++++++|||||++++++.+ +..++||||+++|
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g 88 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGS 88 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEE
T ss_pred EEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCC
Confidence 34578899999999999962 346889999999999999998754 5689999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++...+. .+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 89 ~L~~~l~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 89 SLYHHLHIIET-----KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp EHHHHHHTSCC-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CHHHHHhhccC-----CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999975442 28999999999999999999995 89999999999999999999999999999876543222
Q ss_pred cccccCCCCccccccccccccc-cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 297 VSSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. ......||+.|||||++.+. .+.++.++|||||||++|||++|+.||...... ..+...+..... ..
T Consensus 161 ~-~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-------~~~~~~~~~~~~---~p 229 (276)
T d1uwha_ 161 H-QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-------DQIIFMVGRGYL---SP 229 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-------HHHHHHHHHTSC---CC
T ss_pred c-cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-------HHHHHHHhcCCC---CC
Confidence 1 23456799999999998653 235899999999999999999999999654211 111111111110 01
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
........+++++.+++.+||+.||++|||++||++.|+.+.+++
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 111223345678999999999999999999999999999887654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.1e-49 Score=379.66 Aligned_cols=245 Identities=26% Similarity=0.445 Sum_probs=185.1
Q ss_pred cchhHHHHHhhHh-----------hhccccccceEEEEEEE---------------------------cchhhhhhhcCC
Q 013074 149 YNFSDVKKITNSF-----------KDKLGQGGFGGVYKGKL---------------------------LDGLASISRTSH 190 (450)
Q Consensus 149 ~~~~ei~~~~~~~-----------~~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~H 190 (450)
++++|.++++.+| .+.||+|+||+||+|+. .+|++++++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 4555666655555 35799999999999953 246788999999
Q ss_pred CceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeecccc
Q 013074 191 VNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHN 270 (450)
Q Consensus 191 pnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~N 270 (450)
||||+++|+|.+++..++||||+++|+|.+++..... .+++..+..++.|+++||+|||+ .+|+||||||+|
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-----~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~N 158 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-----QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARN 158 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT-----CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC-----CCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccce
Confidence 9999999999999999999999999999998875432 28999999999999999999995 899999999999
Q ss_pred EEEcCCCCeEEeeccccccccCCCCcc--ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCC
Q 013074 271 ILLDQDFCPKISDFGLAKLCTTKKGIV--SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDS 347 (450)
Q Consensus 271 Ill~~~~~~kl~DFGla~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~ 347 (450)
|||+.++.+||+|||+++......... .......||+.|+|||.+.+. .++.++|||||||++|||++ |+.||..
T Consensus 159 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR--KFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp EEECTTCCEEECCC-----------------------CGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcC--CCCcccccccchHHHHHHHhCCCCCCCC
Confidence 999999999999999998765433221 112234578999999999874 89999999999999999998 7888864
Q ss_pred CCCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 348 GVDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 348 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
... ..+...+..+ .....+..++.++.+++.+||+.||++|||++||++.|+.+.+
T Consensus 237 ~~~--------~~~~~~i~~~-------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 237 MTN--------QDVINAIEQD-------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCH--------HHHHHHHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCH--------HHHHHHHHcC-------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 321 1111222111 1122233456789999999999999999999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-49 Score=371.57 Aligned_cols=233 Identities=25% Similarity=0.452 Sum_probs=179.4
Q ss_pred HhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 160 SFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
++.++||+|+||+||+|++ .+|++++++++|||||+++|+|.+++..++||||+++|+|
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L 87 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCL 87 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcH
Confidence 4578899999999999964 3468889999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
.+++..... .+++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.........
T Consensus 88 ~~~l~~~~~-----~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~- 158 (263)
T d1sm2a_ 88 SDYLRTQRG-----LFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS- 158 (263)
T ss_dssp HHHHHTTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred HHHhhcccc-----CCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCcee-
Confidence 999875432 38999999999999999999995 899999999999999999999999999998765433221
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
.....||..|+|||++.+. .++.++|||||||++|||++++.|+...... .+ +.+.+... ...
T Consensus 159 -~~~~~gt~~y~aPE~l~~~--~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~-~~~~i~~~-------~~~ 221 (263)
T d1sm2a_ 159 -STGTKFPVKWASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SE-VVEDISTG-------FRL 221 (263)
T ss_dssp -------CTTSCCHHHHTTC--CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HH-HHHHHHHT-------CCC
T ss_pred -ecceecCcccCChHHhcCC--CCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HH-HHHHHHhc-------CCC
Confidence 2345689999999999875 7999999999999999999976655433211 11 11222111 111
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
..+..++.++.+++.+||+.||++|||++||++.|+++.+
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 2223345778999999999999999999999999998765
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=369.01 Aligned_cols=229 Identities=24% Similarity=0.302 Sum_probs=183.9
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|++.++||+|+||+||+|+. .+|++++++++|||||++++++.+++..++||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccC
Confidence 45678999999999999952 346889999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+|+|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++......
T Consensus 87 gg~L~~~l~~~~------~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 87 GGELFDRIEPDI------GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp TEEGGGGSBTTT------BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCcHHHHHhcCC------CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999986543 39999999999999999999995 899999999999999999999999999998765432
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. ......+||+.|+|||++.+. ..++.++|||||||++|||++|+.||........ .+ ......
T Consensus 158 ~~-~~~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~-----~~~~~~------ 222 (271)
T d1nvra_ 158 RE-RLLNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY-----SDWKEK------ 222 (271)
T ss_dssp EE-CCBCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HH-----HHHHTT------
T ss_pred cc-ccccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HH-----HHHhcC------
Confidence 21 113456799999999999774 2346789999999999999999999975432211 00 111000
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.........++.++.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011112334567889999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=367.33 Aligned_cols=221 Identities=24% Similarity=0.375 Sum_probs=184.1
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||+||+|+. .+|+.++++++|||||++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 45778999999999999952 2467889999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++...+. +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 88 ~~~g~L~~~l~~~~~------l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 88 APLGTVYRELQKLSK------FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp CTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred cCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999976432 8999999999999999999995 9999999999999999999999999999987654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+....
T Consensus 159 ~~-----~~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~~--- 220 (263)
T d2j4za1 159 SR-----RTTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPFEANTY--------QETYKRISRVE--- 220 (263)
T ss_dssp CC-----CEETTEEGGGCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTC---
T ss_pred Cc-----ccccCCCCcccCHHHHcCC--CCCchhhhhhHhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC---
Confidence 32 2345699999999999875 789999999999999999999999964321 11112111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
...+..++.++.+++.+||+.||++|||++|+++
T Consensus 221 -----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 221 -----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1112235678899999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-48 Score=372.52 Aligned_cols=236 Identities=28% Similarity=0.453 Sum_probs=192.3
Q ss_pred hhHhhhccccccceEEEEEEE----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
.+.+.++||+|+||+||+|+. .+|++++++++|||||+++++|.+++..++||||+++
T Consensus 18 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~ 97 (287)
T d1opja_ 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 97 (287)
T ss_dssp GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccC
Confidence 445678999999999999963 3468899999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++.......
T Consensus 98 g~l~~~l~~~~~----~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 98 GNLLDYLRECNR----QEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CBHHHHHHHSCT----TTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cchHHHhhhccc----cchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 999999976543 238999999999999999999995 8999999999999999999999999999987654432
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
.. .....|+..|+|||++.+. .++.++|||||||++|||++|+.|+...... ..+.+.+...
T Consensus 171 ~~--~~~~~g~~~y~aPE~~~~~--~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~-------~~~~~~i~~~------- 232 (287)
T d1opja_ 171 TA--HAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKD------- 232 (287)
T ss_dssp EE--ETTEEECGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHTT-------
T ss_pred ee--eccccccccccChHHHcCC--CCCchhhhhhHHHHHHHHHhCCCCCCCcchH-------HHHHHHHhcC-------
Confidence 21 2334588999999999874 8999999999999999999988777544321 1112222111
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.....+..++.++.+++.+||+.||++|||++||++.|+.+.+
T Consensus 233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1122233456789999999999999999999999999987643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-48 Score=366.18 Aligned_cols=227 Identities=23% Similarity=0.364 Sum_probs=183.7
Q ss_pred hccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 163 DKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
++||+|+||+||+|.+ .+|++++++++|||||+++|+|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 4699999999999842 245788999999999999999865 567899999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++..... +++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 92 g~L~~~l~~~~~------l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQNRH------VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHHCTT------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhhccC------CCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999999976543 8999999999999999999995 8999999999999999999999999999997765544
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.........||+.|+|||.+.+. .++.++|||||||++|||++ |+.||..... ..+...+..+
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~~------ 226 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKG------ 226 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTT------
T ss_pred ccccccccCCCceecCchhhcCC--CCCchhhhccchhhhhHHhhCCCCCCCCCCH--------HHHHHHHHcC------
Confidence 44334456689999999999874 78999999999999999997 8889864321 1122222221
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
.....+..++.++.+++.+||+.||++|||+++|+++|+..
T Consensus 227 -~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 227 -ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 11222334567899999999999999999999999998753
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-48 Score=371.14 Aligned_cols=235 Identities=26% Similarity=0.435 Sum_probs=182.2
Q ss_pred HhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
++.+.||+|+||+||+|++ .+|+.++++++|||||+++|++.+.+..++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 3467899999999999852 246888999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+.++++.+.+..... .+++..+..++.|++.||+|||+ .+|+||||||+||||+.++.+||+|||+++...
T Consensus 90 ~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 90 YMENGALDKFLREKDG-----EFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp CCTTEEHHHHHHHTTT-----CSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred ecccCcchhhhhcccc-----cccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999988865542 28999999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
.............||+.|+|||++.+. .++.++|||||||++|||++++.|+...... ..+.+.+...
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~--~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-------~~~~~~i~~~--- 229 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYR--KFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDG--- 229 (283)
T ss_dssp ------------CCCGGGSCHHHHHSC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTT---
T ss_pred CCCccceEeccCCCCccccCHHHHccC--CCCCcccccccHHHHHHHHhCCCCccccCCH-------HHHHHHHhcc---
Confidence 543333223445689999999999774 8999999999999999999987776543221 1122222211
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.....+..++.++.+++.+||+.||++|||++||+++|+.+.+
T Consensus 230 ----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1122233456789999999999999999999999999987665
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-48 Score=376.13 Aligned_cols=237 Identities=24% Similarity=0.384 Sum_probs=188.3
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeCCceE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~~ 207 (450)
.+.+.++||+|+||+||+|+. .+|+.+++++ +|||||++++++.+.+..+
T Consensus 38 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 117 (325)
T d1rjba_ 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIY 117 (325)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEE
Confidence 345778999999999999853 2357778887 8999999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCC-----------------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTS-----------------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHN 270 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~N 270 (450)
+||||+++|+|.+++...... .....+++..++.++.|++.||+|||+ .+|+||||||+|
T Consensus 118 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~N 194 (325)
T d1rjba_ 118 LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARN 194 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGG
T ss_pred EEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhc
Confidence 999999999999999765321 112348999999999999999999995 899999999999
Q ss_pred EEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCC
Q 013074 271 ILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGV 349 (450)
Q Consensus 271 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~ 349 (450)
||++.++.+||+|||+|+.......... .....||+.|||||++.+. .++.++|||||||++|||++ |+.||....
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~--~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVV-RGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEE-ETTEEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cccccCCeEEEeeccccccccCCCceee-eccccCCCccCChHHHcCC--CCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999987655433222 2345589999999999874 89999999999999999997 888886432
Q ss_pred CCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 013074 350 DNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQ 414 (450)
Q Consensus 350 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~ 414 (450)
.. ..+.+.+... .....+..++.++.+++.+||+.||++|||++||+++|.
T Consensus 272 ~~-------~~~~~~~~~~-------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VD-------ANFYKLIQNG-------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CS-------HHHHHHHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HH-------HHHHHHHhcC-------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 21 1111221111 111223345678999999999999999999999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=365.01 Aligned_cols=232 Identities=22% Similarity=0.358 Sum_probs=188.1
Q ss_pred hh-ccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 162 KD-KLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 162 ~~-~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.+ +||+|+||+||+|.+ .+|++++++++|||||+++|++.+ +..++||||++
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~ 91 (285)
T d1u59a_ 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG 91 (285)
T ss_dssp EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCC
Confidence 44 599999999999942 246888999999999999999865 56899999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
+|+|.+++.... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 92 ~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 92 GGPLHKFLVGKR-----EEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp TEEHHHHHTTCT-----TTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred CCcHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 999999986443 238999999999999999999995 899999999999999999999999999999876654
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
..........||+.|+|||++.+. .++.++|||||||++|||++ |+.||...... + +...+..+
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~-------~-~~~~i~~~----- 228 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------E-VMAFIEQG----- 228 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-------H-HHHHHHTT-----
T ss_pred cccccccccccCccccChHHHhCC--CCCccchhhcchHHHHHHHhCCCCCCCCCCHH-------H-HHHHHHcC-----
Confidence 444434456689999999999774 78999999999999999998 89998643211 1 12222211
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
.....+..++.++.+++.+||+.||++|||+.+|++.|+.....
T Consensus 229 --~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 229 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11222344567899999999999999999999999999865443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=368.62 Aligned_cols=234 Identities=26% Similarity=0.433 Sum_probs=186.8
Q ss_pred hhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
.+.+.++||+|+||+||+|++ .+|+.++++++|||||+++|++.+ +..++||||+++|
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g 92 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENG 92 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTC
T ss_pred HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCC
Confidence 345678899999999999964 346888999999999999998754 5679999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|.+++..... ..+++..++.++.||+.||.|||+ .+|+||||||+||||++++.+||+|||+++........
T Consensus 93 ~L~~~~~~~~~----~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 93 SLVDFLKTPSG----IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp BHHHHTTSHHH----HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred cHHHHHhhcCC----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 99998754332 238999999999999999999995 89999999999999999999999999999977543322
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
......||+.|+|||++.+. .++.++|||||||++|||++|+.|+...... ..+...+... .
T Consensus 166 --~~~~~~gt~~y~APE~~~~~--~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-------~~~~~~i~~~-------~ 227 (272)
T d1qpca_ 166 --AREGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERG-------Y 227 (272)
T ss_dssp --CCTTCCCCTTTSCHHHHHHC--EECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTT-------C
T ss_pred --cccccCCcccccChHHHhCC--CCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHhc-------C
Confidence 13445689999999999864 7899999999999999999977666543211 1111222111 1
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
....+..++.++.+++.+||+.||++|||++||+++|+..-
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 11223345678999999999999999999999999998643
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-47 Score=362.32 Aligned_cols=225 Identities=23% Similarity=0.347 Sum_probs=184.2
Q ss_pred hHhhhccccccceEEEEEE-----------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 159 NSFKDKLGQGGFGGVYKGK-----------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~-----------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
|.+.++||+|+||+||+|+ +.+|++++++++|||||++++++.+++..++||||+++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g 101 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred cEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCC
Confidence 4557789999999999995 23468899999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 102 g~L~~~~~~~-------~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 102 GSLTDVVTET-------CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CBHHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CcHHHHhhcc-------CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 9999988653 28999999999999999999995 8999999999999999999999999999987654332
Q ss_pred ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcc
Q 013074 296 IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLG 375 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 375 (450)
. .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ..+....... .
T Consensus 172 ~---~~~~~gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-------~~~~~~~~~~------~ 233 (293)
T d1yhwa1 172 K---RSTMVGTPYWMAPEVVTRK--AYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNG------T 233 (293)
T ss_dssp C---BCCCCSCGGGCCHHHHSSS--CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHHC------S
T ss_pred c---ccccccCCCccChhhhcCC--CCCchhceehHhHHHHHHhhCCCCCCCCCHH-------HHHHHHHhCC------C
Confidence 2 2445699999999999874 7899999999999999999999999643210 1111111110 0
Q ss_pred cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 376 VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 376 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.....+..++.++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011222345678999999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-48 Score=374.68 Aligned_cols=242 Identities=19% Similarity=0.277 Sum_probs=183.9
Q ss_pred HHhhHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEE
Q 013074 156 KITNSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 156 ~~~~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
...|++.++||+|+||+||+|+. .+|+.++++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34456678999999999999952 346889999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++.+.+. +++..+..++.|++.||.|||+ .++|+||||||+|||+++++.+||+|||+|+...
T Consensus 85 y~~gg~L~~~l~~~~~------l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGR------IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp CCTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred cCCCCcHHHHHhhcCC------CCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 9999999999976542 8999999999999999999995 2489999999999999999999999999998764
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhh-----
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVE----- 366 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~----- 366 (450)
... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...............+.....
T Consensus 157 ~~~-----~~~~~GT~~Y~APEvl~~~--~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 157 DSM-----ANSFVGTRSYMSPERLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp HHT-----C---CCSSCCCCHHHHHCS--CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred CCc-----cccccCCccccCchHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcc
Confidence 332 2345799999999999885 7999999999999999999999999764322110000000000000
Q ss_pred ---------h-------------hhhhhhcc-cccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 367 ---------Q-------------DREFKLLG-VVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 367 ---------~-------------~~~~~~~~-~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
. ........ .........+.++.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0 00000000 0000011234678999999999999999999999873
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-47 Score=358.10 Aligned_cols=222 Identities=24% Similarity=0.374 Sum_probs=177.3
Q ss_pred HhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe----CCceEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE----GNNRALIY 210 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~----~~~~~lV~ 210 (450)
.|.++||+|+||+||+|+. .+|++++++++|||||++++++.+ +..+++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 3456899999999999952 346889999999999999999875 34679999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCc--eEeeeeccccEEEc-CCCCeEEeecccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTR--ILHFDIKPHNILLD-QDFCPKISDFGLA 287 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dikp~NIll~-~~~~~kl~DFGla 287 (450)
||+++|+|.+++..... +++..++.++.|++.||+|||+ .+ |+||||||+|||++ +++.+||+|||++
T Consensus 92 E~~~~g~L~~~l~~~~~------~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp ECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred eCCCCCcHHHHHhcccc------ccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 99999999999976432 8999999999999999999994 66 99999999999997 5789999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
+...... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||...... ..+.+.+..
T Consensus 163 ~~~~~~~-----~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-------~~~~~~i~~ 227 (270)
T d1t4ha_ 163 TLKRASF-----AKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSECQNA-------AQIYRRVTS 227 (270)
T ss_dssp GGCCTTS-----BEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-------HHHHHHHTT
T ss_pred eeccCCc-----cCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-------HHHHHHHHc
Confidence 8654332 234569999999999865 6899999999999999999999999643211 112222221
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.... .......+.++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 228 GVKP------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TCCC------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCC------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1110 1111223456889999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=362.66 Aligned_cols=231 Identities=21% Similarity=0.360 Sum_probs=171.4
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe--CCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE--GNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~--~~~~~lV~E 211 (450)
|++.+.||+|+||+||+|+. .+|++++++++|||||++++++.+ ++.+++|||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEe
Confidence 55678999999999999952 346888999999999999999865 456899999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC--CCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC--STRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|+++|+|.+++...... ...+++..++.++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 y~~~g~L~~~i~~~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 86 YCEGGDLASVITKGTKE--RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp CCTTEEHHHHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred cCCCCcHHHHHHhcccc--CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999998643211 123999999999999999999999621 23599999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+...
T Consensus 164 ~~~~~~~---~~~~~gt~~Y~APE~l~~~--~~~~~~DIwSlGvilyel~tg~~Pf~~~~~--------~~~~~~i~~~- 229 (269)
T d2java1 164 LNHDTSF---AKAFVGTPYYMSPEQMNRM--SYNEKSDIWSLGCLLYELCALMPPFTAFSQ--------KELAGKIREG- 229 (269)
T ss_dssp C--------------CCCSCCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHT-
T ss_pred cccCCCc---cccCCCCcccCCHHHHcCC--CCChHHHHHhhCHHHHHHhhCCCCCCCCCH--------HHHHHHHHcC-
Confidence 7543322 2345699999999999774 789999999999999999999999964311 1112222111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
.....+..++.++.+++.+||+.||++|||++|+++
T Consensus 230 ------~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 230 ------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111222345678999999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=353.51 Aligned_cols=229 Identities=24% Similarity=0.410 Sum_probs=188.2
Q ss_pred HhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCCCh
Q 013074 160 SFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNGSL 218 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~gsL 218 (450)
.|.++||+|+||+||+|+. .+|+.++++++||||++++|+|.+++..++||||+++|+|
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l 86 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEH
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcH
Confidence 4678999999999999974 2468889999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCccc
Q 013074 219 EKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVS 298 (450)
Q Consensus 219 ~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~ 298 (450)
..++..... .+++..++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++........
T Consensus 87 ~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~-- 156 (258)
T d1k2pa_ 87 LNYLREMRH-----RFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-- 156 (258)
T ss_dssp HHHHHSGGG-----CCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC--
T ss_pred HHhhhcccc-----CCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce--
Confidence 999765432 38899999999999999999995 89999999999999999999999999999876544322
Q ss_pred cccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhcccc
Q 013074 299 SLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVV 377 (450)
Q Consensus 299 ~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 377 (450)
......||..|+|||.+.+. .++.++|||||||++|||++ |+.||..... ..+...+.... .
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~--~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~--------~~~~~~i~~~~-------~ 219 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIAQGL-------R 219 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHHTTC-------C
T ss_pred eecccCCCCCcCCcHHhcCC--CCCcceeecccchhhHhHHhcCCCCCCCCCH--------HHHHHHHHhCC-------C
Confidence 23445689999999999875 78999999999999999998 7888864321 11222222211 1
Q ss_pred cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 013074 378 TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQG 415 (450)
Q Consensus 378 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~ 415 (450)
...+...+.++.+++.+||+.||++|||++|+++.|.+
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 12223445789999999999999999999999999875
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-47 Score=362.34 Aligned_cols=229 Identities=21% Similarity=0.283 Sum_probs=183.7
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
|++.++||+|+||+||+|+. .+|++++++++|||||++++++.+++..++||||+++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~ 93 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred eEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCC
Confidence 45578899999999999962 3468899999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKG 295 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~ 295 (450)
|+|.+++.+.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 94 g~L~~~~~~~~-----~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~ 165 (288)
T d2jfla1 94 GAVDAVMLELE-----RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165 (288)
T ss_dssp EEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH
T ss_pred CcHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc
Confidence 99999876533 228999999999999999999995 8999999999999999999999999999976543221
Q ss_pred ccccccCCCCccccccccccccc---cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 296 IVSSLLGARGTIGYIALEVFSRN---FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 296 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
......||+.|+|||++... ...++.++|||||||++|||++|+.||....... +...+....
T Consensus 166 ---~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--------~~~~i~~~~--- 231 (288)
T d2jfla1 166 ---RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--------VLLKIAKSE--- 231 (288)
T ss_dssp ---HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--------HHHHHHHSC---
T ss_pred ---cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCC---
Confidence 12345699999999998532 1367899999999999999999999996542110 111111110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
......+..++.++.+++.+||+.||++|||++|+++
T Consensus 232 --~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 --PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp --CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111223345678999999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-46 Score=361.59 Aligned_cols=228 Identities=23% Similarity=0.346 Sum_probs=174.3
Q ss_pred hhHhhhccccccceEEEEEE------------------------EcchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 158 TNSFKDKLGQGGFGGVYKGK------------------------LLDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~------------------------~~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
.|++.+.||+|+||+||+|+ +.+|++++++++|||||++++++.+++..++||||+
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 35678899999999999995 345789999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc---CCCCeEEeeccccccc
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD---QDFCPKISDFGLAKLC 290 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~~~ 290 (450)
++|+|.+++...+ .+++..+..++.|++.||+|||+ .+|+||||||+|||+. +++.+||+|||+++..
T Consensus 90 ~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 90 SGGELFDRIVEKG------FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CSCBHHHHHHTCS------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred CCCcHHHhhhccc------CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999997543 29999999999999999999995 9999999999999995 5789999999999866
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
..... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .+...+....
T Consensus 161 ~~~~~----~~~~~GT~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--------~~~~~i~~~~- 225 (307)
T d1a06a_ 161 DPGSV----LSTACGTPGYVAPEVLAQK--PYSKAVDCWSIGVIAYILLCGYPPFYDENDA--------KLFEQILKAE- 225 (307)
T ss_dssp ----------------CTTSCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--------HHHHHHHTTC-
T ss_pred cCCCe----eeeeeeCccccCcHHHcCC--CCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH--------HHHHHHhccC-
Confidence 44322 2345699999999999874 7899999999999999999999999643210 0111111110
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........++.++.+++.+||+.||++|||++|+++.
T Consensus 226 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 ---YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 001111223456789999999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-47 Score=361.95 Aligned_cols=224 Identities=23% Similarity=0.294 Sum_probs=181.2
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|.+.+.||+|+||+||+|+. .+|++++++++||||+++++++.+++..++||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 56788999999999999952 2467889999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++...+. +++..++.++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++....
T Consensus 90 ~~gg~L~~~~~~~~~------l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 90 AKNGELLKYIRKIGS------FDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CTTEEHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred cCCCCHHHhhhccCC------CCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999876543 8999999999999999999995 9999999999999999999999999999987654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+....
T Consensus 161 ~~~~~-~~~~~~GT~~Y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~--- 226 (288)
T d1uu3a_ 161 ESKQA-RANSFVGTAQYVSPELLTEK--SACKSSDLWALGCIIYQLVAGLPPFRAGNE--------YLIFQKIIKLE--- 226 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTC--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTC---
T ss_pred CCccc-ccccccCCccccCceeeccC--CCCcccceehhhHHHHHHhhCCCCCCCcCH--------HHHHHHHHcCC---
Confidence 32211 13345799999999999875 789999999999999999999999974321 11112211110
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVI 410 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl 410 (450)
...+..++.++.+++.+||+.||++|||++|++
T Consensus 227 -----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 227 -----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp -----CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred -----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 011223557789999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-47 Score=360.87 Aligned_cols=237 Identities=27% Similarity=0.426 Sum_probs=184.1
Q ss_pred hhHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
.+.+.+.||+|+||+||+|+. .+|+.++++++|||||+++|+|.+ +..++||||+++|
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g 96 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKG 96 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTC
T ss_pred HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCC
Confidence 356778999999999999963 346888999999999999999854 5689999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~ 296 (450)
+|..++..... ..++|..++.++.||+.||+|||+ .+|+||||||+||||++++.+||+|||+++........
T Consensus 97 ~l~~~~~~~~~----~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 97 SLLDFLKGETG----KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp BHHHHHSHHHH----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred chhhhhhhccc----ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 99988865332 238999999999999999999995 89999999999999999999999999999876443321
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
......||+.|+|||++... .++.++||||||+++|||++|+.|+....... . +...+... .
T Consensus 170 --~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~------~-~~~~i~~~-------~ 231 (285)
T d1fmka3 170 --ARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERG-------Y 231 (285)
T ss_dssp --------CCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTT-------C
T ss_pred --eeccccccccccChHHHhCC--CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH------H-HHHHHHhc-------C
Confidence 12345689999999999874 89999999999999999999877765543211 1 11111111 1
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
.......+++++.+++.+||+.||++|||+++|+++|+......
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 11223345678999999999999999999999999999876553
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-46 Score=362.10 Aligned_cols=223 Identities=25% Similarity=0.330 Sum_probs=180.9
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|+..++||+|+||+||+|+. .+|++++++++|||||++++++.+++..++||||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 96 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEe
Confidence 45567899999999999952 2468899999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
|.+|+|..++.... .+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~~~g~l~~~~~~~~------~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 97 CLGSASDLLEVHKK------PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CSEEHHHHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred cCCCchHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 99999987765543 28999999999999999999995 8999999999999999999999999999986543
Q ss_pred CCCccccccCCCCccccccccccccc-cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRN-FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
. ....||+.|+|||++.+. .+.++.++|||||||++|||++|+.||..... ...+.... ...
T Consensus 168 ~-------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~-~~~-- 230 (309)
T d1u5ra_ 168 A-------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIA-QNE-- 230 (309)
T ss_dssp B-------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHH-HSC--
T ss_pred C-------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHH-hCC--
Confidence 2 334699999999998652 24689999999999999999999999964321 01111111 110
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
........++.++.+++.+||+.||++|||++|+++
T Consensus 231 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 231 ----SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ----CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 011112234578999999999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-46 Score=356.50 Aligned_cols=233 Identities=22% Similarity=0.328 Sum_probs=177.4
Q ss_pred hhHhhhccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
.+++.+.||+|+||.||+|+. .+|+.++++++|||||++++++. ++..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEE
Confidence 455678999999999999953 23578899999999999999985 56789999
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
||+++|+|.+++..... .+++..++.++.|+++||.|||+ .+|+||||||+||++++++.+||+|||+++..
T Consensus 87 E~~~~g~l~~~~~~~~~-----~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKY-----SLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp ECCTTEEHHHHHHHTTT-----TSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EeccCCcHHhhhhccCC-----CCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence 99999999998765442 28999999999999999999995 99999999999999999999999999999876
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
....... .....||+.|+|||++.+. .++.++|||||||++|||++ |..||...... .+...+....
T Consensus 159 ~~~~~~~--~~~~~gt~~y~apE~l~~~--~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--------~~~~~i~~~~ 226 (273)
T d1mp8a_ 159 EDSTYYK--ASKGKLPIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--------DVIGRIENGE 226 (273)
T ss_dssp --------------CCGGGCCHHHHHHC--CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--------GHHHHHHTTC
T ss_pred cCCccee--ccceecCcccchhhHhccC--CCCCccccccchHHHHHHHhcCCCCCCCCCHH--------HHHHHHHcCC
Confidence 5433221 2344589999999999874 89999999999999999997 77777643211 1222222111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
....+..++.++.+++.+||+.||++|||++||++.|+.+.+
T Consensus 227 -------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 227 -------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112233456789999999999999999999999999987654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=357.24 Aligned_cols=248 Identities=24% Similarity=0.471 Sum_probs=192.9
Q ss_pred CcccchhHHHHHhhHhhhccccccceEEEEEEE--------------------------cchhhhhhhc-CCCceeeeee
Q 013074 146 LKRYNFSDVKKITNSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRT-SHVNVVTLLG 198 (450)
Q Consensus 146 ~~~~~~~ei~~~~~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l-~HpnIv~l~~ 198 (450)
++.+.++|+ ++.++||+|+||+||+|++ .+|+++++++ +|||||+++|
T Consensus 4 ~~~i~~~~~-----~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~ 78 (309)
T d1fvra_ 4 YPVLDWNDI-----KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLG 78 (309)
T ss_dssp SSBCCGGGC-----EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEE
T ss_pred CCccCHHHc-----EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEE
Confidence 344455444 3678999999999999853 2468889998 7999999999
Q ss_pred EEEeCCceEEEEEecCCCChhhhhhcCCC----------CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeecc
Q 013074 199 FCLEGNNRALIYEFMPNGSLEKFVYNGDT----------SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKP 268 (450)
Q Consensus 199 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp 268 (450)
+|.+++..++||||+++|+|.+++..... ......+++..++.++.|++.||.|||+ .+|+||||||
T Consensus 79 ~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp 155 (309)
T d1fvra_ 79 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAA 155 (309)
T ss_dssp EEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSG
T ss_pred EEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCcccccccc
Confidence 99999999999999999999999975421 1112449999999999999999999995 8999999999
Q ss_pred ccEEEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCC
Q 013074 269 HNILLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSG 348 (450)
Q Consensus 269 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~ 348 (450)
+|||++.++.+||+|||+++....... .....||..|+|||.+.+. .++.++|||||||++|||++|..++..+
T Consensus 156 ~NIL~~~~~~~kl~DfG~a~~~~~~~~----~~~~~gt~~y~aPE~l~~~--~~~~~sDvwSfGvil~ell~~~~~p~~~ 229 (309)
T d1fvra_ 156 RNILVGENYVAKIADFGLSRGQEVYVK----KTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 229 (309)
T ss_dssp GGEEECGGGCEEECCTTCEESSCEECC----C----CCTTTCCHHHHHHC--EECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ceEEEcCCCceEEcccccccccccccc----ccceecCCcccchHHhccC--CCCccceeehhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999986543322 2234589999999999874 7899999999999999999987654332
Q ss_pred CCCCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccC
Q 013074 349 VDNSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQ 421 (450)
Q Consensus 349 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~ 421 (450)
.. . ..+...+.... ....+..++.++.+++.+||+.||++||||+||++.|+.+.+...
T Consensus 230 ~~------~-~~~~~~i~~~~-------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 230 MT------C-AELYEKLPQGY-------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp CC------H-HHHHHHGGGTC-------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CC------H-HHHHHHHHhcC-------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 21 1 11222222211 122233456789999999999999999999999999999876543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-46 Score=357.78 Aligned_cols=238 Identities=22% Similarity=0.358 Sum_probs=187.7
Q ss_pred hHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
+++.++||+|+||+||+|+. .+|++++++++||||++++++|.+.+..++|
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 45678999999999999963 2357889999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCC------------------CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccE
Q 013074 210 YEFMPNGSLEKFVYNGDT------------------SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNI 271 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~------------------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NI 271 (450)
|||+++|+|.+++..... ......+++..++.++.|++.||+|||+ .+|+||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccce
Confidence 999999999999865321 1112348999999999999999999995 9999999999999
Q ss_pred EEcCCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCC-CCCCCCC
Q 013074 272 LLDQDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN-NLDSGVD 350 (450)
Q Consensus 272 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~-p~~~~~~ 350 (450)
|++.++.+||+|||+++......... ......||+.|+|||.+.+. .++.++|||||||++|||++|.. ||.....
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYK-ADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC-----CCBCGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred EECCCCcEEEccchhheeccCCcccc-ccCCCCcCcCcCCHHHHccC--CCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 99999999999999998664433222 23445688999999999875 89999999999999999999875 4543211
Q ss_pred CCCccchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 351 NSSEVYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 351 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
.+ +...+... .....+..++.++.+++.+||+.||++||||.||+++|+.+.
T Consensus 249 -------~e-~~~~v~~~-------~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 -------EE-VIYYVRDG-------NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -------HH-HHHHHHTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -------HH-HHHHHHcC-------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 01 11222111 112223345578999999999999999999999999999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.2e-45 Score=360.69 Aligned_cols=229 Identities=24% Similarity=0.317 Sum_probs=185.4
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
.|.+.+.||+|+||+||+|+. .+|+.++++++|||||++++++.+++..++||||++
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 456778999999999999952 346889999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc--CCCCeEEeeccccccccC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD--QDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DFGla~~~~~ 292 (450)
+|+|.+++.... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 107 gg~L~~~l~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 107 GGELFEKVADEH-----NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp SCBHHHHHTCTT-----SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCHHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999986443 239999999999999999999995 9999999999999996 467899999999987755
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
... .....||+.|||||++.+. .++.++|||||||++|||++|+.||..... .+ +...+....
T Consensus 179 ~~~----~~~~~gT~~Y~aPEv~~~~--~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~-~~~~i~~~~--- 241 (350)
T d1koaa2 179 KQS----VKVTTGTAEFAAPEVAEGK--PVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DE-TLRNVKSCD--- 241 (350)
T ss_dssp TSC----EEEECSCTTTCCHHHHHTC--CBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HH-HHHHHHHTC---
T ss_pred ccc----cceecCcccccCHHHHcCC--CCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HH-HHHHHHhCC---
Confidence 432 2334699999999999875 789999999999999999999999964321 11 111111100
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..........+++++.+++.+||+.||++|||++|+++.
T Consensus 242 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 242 -WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011112223456788999999999999999999999985
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=354.71 Aligned_cols=236 Identities=27% Similarity=0.452 Sum_probs=187.8
Q ss_pred HhhhccccccceEEEEEEE---------------------------cchhhhhhhcCCCceeeeeeEEEeC-CceEEEEE
Q 013074 160 SFKDKLGQGGFGGVYKGKL---------------------------LDGLASISRTSHVNVVTLLGFCLEG-NNRALIYE 211 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~---------------------------~~e~~~l~~l~HpnIv~l~~~~~~~-~~~~lV~E 211 (450)
+|.++||+|+||+||+|++ .+|++++++++||||++++|++.+. ...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 4567899999999999863 2457889999999999999998764 57899999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++..... .+++..++.++.|++.||.|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 110 ~~~~g~l~~~~~~~~~-----~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~ 181 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETH-----NPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY 181 (311)
T ss_dssp CCTTCBHHHHHHCTTC-----CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTT
T ss_pred EeecCchhhhhccccc-----cchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcc
Confidence 9999999999876543 27888999999999999999995 899999999999999999999999999998765
Q ss_pred CCCCcc-ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhh
Q 013074 292 TKKGIV-SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDRE 370 (450)
Q Consensus 292 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~ 370 (450)
...... .......||..|+|||.+... .++.++||||||+++|||++|+.||........ . ...+..+.
T Consensus 182 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~---~----~~~i~~g~- 251 (311)
T d1r0pa_ 182 DKEFDSVHNKTGAKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---I----TVYLLQGR- 251 (311)
T ss_dssp TTTCCCTTCTTCSSCCGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCC---------C----HHHHHTTC-
T ss_pred ccccccceecccccccccccChHHHhcC--CCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH---H----HHHHHcCC-
Confidence 443221 122345689999999999874 899999999999999999998888865432211 1 11111111
Q ss_pred hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 371 FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 371 ~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
....+..++.++.+++.+||+.||++||+|.||++.|+.+...
T Consensus 252 ------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 252 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1122233457789999999999999999999999999988765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=351.81 Aligned_cols=228 Identities=23% Similarity=0.296 Sum_probs=184.2
Q ss_pred hhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEE
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRAL 208 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~l 208 (450)
.|++.+.||+|+||+||+|+. .+|+.++++++|||||++++++.+++..++
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 356778999999999999952 236788999999999999999999999999
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC----CeEEeec
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF----CPKISDF 284 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~----~~kl~DF 284 (450)
||||+++|+|.+++...+. +++..++.++.|++.||+|||+ .+|+||||||+|||++.++ .+||+||
T Consensus 91 v~E~~~gg~L~~~i~~~~~------l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKES------LTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEECCCSCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEcCCCccccchhccccc------cchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence 9999999999999976532 8999999999999999999995 9999999999999998776 5999999
Q ss_pred cccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 285 GLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 285 Gla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
|+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... + ....
T Consensus 162 G~a~~~~~~~~----~~~~~~t~~y~APE~~~~~--~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-------~-~~~~ 227 (293)
T d1jksa_ 162 GLAHKIDFGNE----FKNIFGTPEFVAPEIVNYE--PLGLEADMWSIGVITYILLSGASPFLGDTKQ-------E-TLAN 227 (293)
T ss_dssp TTCEECTTSCB----CSCCCCCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------H-HHHH
T ss_pred hhhhhcCCCcc----ccccCCCCcccCHHHHcCC--CCCCcccchhhhHHHHHHHcCCCCCCCCCHH-------H-HHHH
Confidence 99987754332 2345689999999999874 7899999999999999999999999743210 0 1111
Q ss_pred hhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 365 VEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
+.... ...........+.++.+++.+||+.||++|||++|+++.
T Consensus 228 i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 228 VSAVN----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHTTC----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHhcC----CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11110 000111122345778999999999999999999999863
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=351.86 Aligned_cols=252 Identities=21% Similarity=0.253 Sum_probs=185.1
Q ss_pred HhhhccccccceEEEEEEEcc--------------------hhhhhhhcCCCceeeeeeEEEeCC----ceEEEEEecCC
Q 013074 160 SFKDKLGQGGFGGVYKGKLLD--------------------GLASISRTSHVNVVTLLGFCLEGN----NRALIYEFMPN 215 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~~~--------------------e~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~~ 215 (450)
.+.++||+|+||.||+|++.. |+..+++++|||||+++++|.+.+ ..++||||+++
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~ 85 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEH 85 (303)
T ss_dssp EEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTT
T ss_pred EEEEEEeeCCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccC
Confidence 356789999999999997432 233456789999999999998754 57899999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcC-----CCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRG-----CSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
|+|.+++.+.. ++|..++.++.|++.||+|||.. ...+|+||||||+||||++++.+||+|||+++..
T Consensus 86 g~L~~~l~~~~-------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 86 GSLFDYLNRYT-------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp CBHHHHHHHCC-------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred CCHHHHHhcCC-------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 99999997542 89999999999999999999952 1269999999999999999999999999999877
Q ss_pred cCCCCcc-ccccCCCCccccccccccccccC----CCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch-------h
Q 013074 291 TTKKGIV-SSLLGARGTIGYIALEVFSRNFG----EVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF-------P 358 (450)
Q Consensus 291 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~----~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~-------~ 358 (450)
....... .......||+.|+|||++.+... .++.++|||||||++|||++|..|+............ .
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence 5543222 12345679999999999875311 2577899999999999999999887644322211100 0
Q ss_pred hhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccc
Q 013074 359 HWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEA 419 (450)
Q Consensus 359 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~ 419 (450)
..+......... ...-.......+....+.+++.+||+.||++|||+.||++.|+.+.+.
T Consensus 239 ~~~~~~~~~~~~-~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 239 EEMRKVVCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHTTSCC-CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcccc-CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 111111100000 000001112334667899999999999999999999999999876643
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=352.09 Aligned_cols=233 Identities=22% Similarity=0.352 Sum_probs=180.1
Q ss_pred hHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
+++.+.||+|+||.||+|++ .+|+.++++++||||++++|+|.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 45678999999999999953 235778999999999999999965 567899
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 89 ~e~~~~~~l~~~~~~~~-----~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQ-----GHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EECCTTCBHHHHHHHHG-----GGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeecCcchhhhhhccc-----CCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999998876543 238999999999999999999995 8999999999999999999999999999998
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
...............|+..|+|||++.+. .++.++||||||+++|||++ |+.||..... .+.+......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-------~~~~~~i~~~- 230 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTR--TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKE- 230 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHC--EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTS-
T ss_pred cccCCCcceecCccccCcccCCHHHHhCC--CCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-------HHHHHHHHhC-
Confidence 76554433334455688999999999874 78999999999999999998 7888864311 1111111111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGS 416 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~ 416 (450)
+........++.++.+++.+||+.||++|||++||++.|++.
T Consensus 231 ------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 ------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111222334567899999999999999999999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=358.75 Aligned_cols=232 Identities=28% Similarity=0.419 Sum_probs=183.1
Q ss_pred hHhhhccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIY 210 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~ 210 (450)
|++.++||+|+||+||+|+. .+|++++++++|||||+++|+|.++ ..++++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~ 89 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 89 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEE
Confidence 45678999999999999852 2457889999999999999999865 567889
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
|++.+|+|.+++..... .+++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 90 e~~~~~~l~~~~~~~~~-----~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 90 QLMPFGCLLDYVREHKD-----NIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp ECCTTCBHHHHHHHTSS-----SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EeccCCccccccccccc-----CCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceec
Confidence 99999999998876542 38999999999999999999995 89999999999999999999999999999977
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
........ .....||..|+|||++.+. .++.++|||||||++|||+| |..||...... . +...+..+
T Consensus 162 ~~~~~~~~-~~~~~gt~~y~APE~l~~~--~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~----~----~~~~i~~~- 229 (317)
T d1xkka_ 162 GAEEKEYH-AEGGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS----E----ISSILEKG- 229 (317)
T ss_dssp TTTCC---------CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG----G----HHHHHHHT-
T ss_pred cccccccc-ccccccCccccChHHHhcC--CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH----H----HHHHHHcC-
Confidence 54433222 2344589999999999874 89999999999999999998 66676533211 0 12222111
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
.....+..++.++.+++.+||+.||++|||++||++.|+.+.
T Consensus 230 ------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 230 ------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp ------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 112223345678999999999999999999999999988754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=355.92 Aligned_cols=242 Identities=26% Similarity=0.379 Sum_probs=179.2
Q ss_pred HhhHhhhccccccceEEEEEEEc-----------------------------chhhhhhhc-CCCceeeeeeEEEeC-Cc
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKLL-----------------------------DGLASISRT-SHVNVVTLLGFCLEG-NN 205 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~~-----------------------------~e~~~l~~l-~HpnIv~l~~~~~~~-~~ 205 (450)
..+.+.++||+|+||+||+|+.. .|...+.++ +|+||+.+++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 34567789999999999998632 123445555 689999999998765 46
Q ss_pred eEEEEEecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~ 275 (450)
.++||||+++|+|.+++...... .....+++..++.++.|+++||.|||+ .+|+||||||+|||+++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence 89999999999999999754310 012348999999999999999999995 99999999999999999
Q ss_pred CCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCC-CCCCCCCCCCc
Q 013074 276 DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKN-NLDSGVDNSSE 354 (450)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~-p~~~~~~~~~~ 354 (450)
++.+||+|||+++.......... .....||+.|+|||++.+. .++.++|||||||++|||+++.. ||..... .
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~-~~~~~gt~~y~APE~l~~~--~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~-~-- 243 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVR-KGDARLPLKWMAPETIFDR--VYTIQSDVWSFGVLLWEIFSLGASPYPGVKI-D-- 243 (299)
T ss_dssp GGCEEECC------CCSCTTSCC-TTSCCCGGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC-S--
T ss_pred CCcEEEccCcchhhccccccccc-cCceeeCccccchhHhhcC--CCCcccceeehHHHHHHHHhCCCCCCCCCCH-H--
Confidence 99999999999987654433221 3455799999999999874 88999999999999999998765 5543221 1
Q ss_pred cchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 355 VYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 355 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
..+...+.... ....+...+.++.+++.+||+.||++|||++|++++|+.+.+
T Consensus 244 ----~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 244 ----EEFCRRLKEGT-------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp ----HHHHHHHHHTC-------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHhcCC-------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11222222111 112223345778999999999999999999999999998654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.6e-45 Score=359.35 Aligned_cols=231 Identities=21% Similarity=0.303 Sum_probs=186.5
Q ss_pred hHhhhccccccceEEEEEEE-----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPN 215 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~ 215 (450)
|++.+.||+|+||+||+|+. .+|++++++++|||||++++++.+++..++||||+++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g 110 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCC
Confidence 56778999999999999952 3478899999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc--CCCCeEEeeccccccccCC
Q 013074 216 GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD--QDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 216 gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~--~~~~~kl~DFGla~~~~~~ 293 (450)
|+|.+++.... ..+++..++.++.||+.||+|||+ .+|+||||||+|||++ .++.+||+|||+++.....
T Consensus 111 g~L~~~~~~~~-----~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 111 GELFDRIAAED-----YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CBHHHHTTCTT-----CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred ChHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99998875443 239999999999999999999995 9999999999999998 6789999999999887654
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKL 373 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~ 373 (450)
.. .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... . +...+....
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~-~~~~i~~~~---- 244 (352)
T d1koba_ 183 EI----VKVTTATAEFAAPEIVDRE--PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------E-TLQNVKRCD---- 244 (352)
T ss_dssp SC----EEEECSSGGGCCHHHHTTC--CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-------H-HHHHHHHCC----
T ss_pred Cc----eeeccCcccccCHHHHcCC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH-------H-HHHHHHhCC----
Confidence 32 2334589999999999875 7899999999999999999999999643210 0 111111100
Q ss_pred cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhc
Q 013074 374 LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQG 415 (450)
Q Consensus 374 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 415 (450)
..........++.++.+++.+||+.||.+|||++|+++. +++
T Consensus 245 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~ 288 (352)
T d1koba_ 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 288 (352)
T ss_dssp CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 001111223456788999999999999999999999874 544
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=354.17 Aligned_cols=243 Identities=26% Similarity=0.413 Sum_probs=191.8
Q ss_pred HhhHhhhccccccceEEEEEEE-----------------------------cchhhhhhhc-CCCceeeeeeEEEeCCce
Q 013074 157 ITNSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRT-SHVNVVTLLGFCLEGNNR 206 (450)
Q Consensus 157 ~~~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l-~HpnIv~l~~~~~~~~~~ 206 (450)
..+.+.++||+|+||.||+|++ .+|+.+++++ +|||||+++++|.++...
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 4556788999999999999963 2346777788 699999999999999999
Q ss_pred EEEEEecCCCChhhhhhcCCCC------------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc
Q 013074 207 ALIYEFMPNGSLEKFVYNGDTS------------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD 274 (450)
Q Consensus 207 ~lV~E~~~~gsL~~~l~~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~ 274 (450)
++||||+++|+|.+++...... .....+++..+..++.||+.||+|||+ .+++||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccccc
Confidence 9999999999999999764321 112348999999999999999999995 8999999999999999
Q ss_pred CCCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCc
Q 013074 275 QDFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSE 354 (450)
Q Consensus 275 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~ 354 (450)
.++.+|++|||+++.......... .....||+.|+|||++.+. .++.++|||||||++|||++++.|+........
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~--~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~- 255 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVV-KGNARLPVKWMAPESIFNC--VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS- 255 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEE-CSSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-
T ss_pred ccCcccccccchheeccCCCcceE-eeecccChHHcCHHHhcCC--CCCCcccccchHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999997765443322 3456789999999999874 889999999999999999996666554432211
Q ss_pred cchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 355 VYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 355 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
.+.+.+... .....+...+.++.+++.+||+.||++|||++||+++|++..+
T Consensus 256 -----~~~~~i~~~-------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 256 -----KFYKMIKEG-------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp -----HHHHHHHHT-------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHhcC-------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 111111111 1112223345789999999999999999999999999987554
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-46 Score=349.03 Aligned_cols=228 Identities=24% Similarity=0.384 Sum_probs=177.6
Q ss_pred HhhhccccccceEEEEEEE-------------------cchhhhhhhcCCCceeeeeeEEEe-CCceEEEEEecCCCChh
Q 013074 160 SFKDKLGQGGFGGVYKGKL-------------------LDGLASISRTSHVNVVTLLGFCLE-GNNRALIYEFMPNGSLE 219 (450)
Q Consensus 160 ~~~~~LG~G~fg~Vy~~~~-------------------~~e~~~l~~l~HpnIv~l~~~~~~-~~~~~lV~E~~~~gsL~ 219 (450)
.+.+.||+|+||.||+|++ .+|++++++++||||++++|+|.+ .+.+++||||+++|+|.
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~ 89 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89 (262)
T ss_dssp EEEEEEEECSSCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred EEeEEEecCCCeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHH
Confidence 4678899999999999964 346889999999999999999965 45689999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCCCcccc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKKGIVSS 299 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~ 299 (450)
+++..... ..+++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 90 ~~l~~~~~----~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----- 157 (262)
T d1byga_ 90 DYLRSRGR----SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----- 157 (262)
T ss_dssp HHHHHHHH----HHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred HHHHhcCC----CCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC-----
Confidence 99965432 238999999999999999999995 899999999999999999999999999998754432
Q ss_pred ccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccccc
Q 013074 300 LLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGVVT 378 (450)
Q Consensus 300 ~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 378 (450)
....+|..|+|||++.+. .++.++||||||+++|||++ |+.|+..... .. +...+..+ ...
T Consensus 158 -~~~~~~~~y~aPE~l~~~--~~t~~sDIwSfG~il~el~t~~~~p~~~~~~----~~----~~~~i~~~-------~~~ 219 (262)
T d1byga_ 158 -DTGKLPVKWTAPEALREK--KFSTKSDVWSFGILLWEIYSFGRVPYPRIPL----KD----VVPRVEKG-------YKM 219 (262)
T ss_dssp -----CCTTTSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG----GG----HHHHHTTT-------CCC
T ss_pred -ccccccccCCChHHHhCC--CCChHHHHHhHHHHHHHHHHCCCCCCCCCCH----HH----HHHHHHcC-------CCC
Confidence 233578999999999874 89999999999999999998 5666543211 11 22222221 112
Q ss_pred chhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccc
Q 013074 379 KKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGST 417 (450)
Q Consensus 379 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~ 417 (450)
..+...+.++.+++.+||+.||++|||+.|++++|+.+.
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 223344577899999999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-44 Score=349.54 Aligned_cols=221 Identities=24% Similarity=0.285 Sum_probs=183.0
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|++.+.||+|+||+||+|+. .+|+.++++++|||||++++++.+++..++||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 45678999999999999962 2457789999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|..++..... +++..+..++.|++.||+||| +.+|+||||||+|||++.++.+||+|||+++....
T Consensus 86 ~~gg~l~~~~~~~~~------~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 86 IEGGELFSLLRKSQR------FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCSCBHHHHHHHTSS------CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred cCCcccccccccccc------ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999876553 788899999999999999999 59999999999999999999999999999987754
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
. ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+...
T Consensus 157 ~------~~~~~Gt~~Y~APE~l~~~--~y~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~---- 216 (316)
T d1fota_ 157 V------TYTLCGTPDYIAPEVVSTK--PYNKSIDWWSFGILIYEMLAGYTPFYDSNT--------MKTYEKILNA---- 216 (316)
T ss_dssp C------BCCCCSCTTTCCHHHHTTC--CBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHC----
T ss_pred c------cccccCcccccCHHHHcCC--CCCchhhccccchhHHHHHhCCCCCCCcCH--------HHHHHHHHcC----
Confidence 3 2345799999999999874 789999999999999999999999965321 0111111111
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~ 412 (450)
....+..++.++.+++.+||+.||.+|+ |++|+++.
T Consensus 217 ----~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 217 ----ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0111233457789999999999999996 89999864
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=348.56 Aligned_cols=240 Identities=23% Similarity=0.398 Sum_probs=185.1
Q ss_pred hhHhhhccccccceEEEEEEEc-------------------------------chhhhhhhc-CCCceeeeeeEEEeCCc
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL-------------------------------DGLASISRT-SHVNVVTLLGFCLEGNN 205 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~-------------------------------~e~~~l~~l-~HpnIv~l~~~~~~~~~ 205 (450)
.+++.+.||+|+||.||+|+.. .|...+.++ +|||||+++++|.++..
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 3456789999999999998631 135566666 79999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCC----------CCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTS----------KPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ 275 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~ 275 (450)
.++||||+++|+|.+++...... .....+++..++.++.|++.||+|||+ .+|+||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecC
Confidence 99999999999999999755321 122458999999999999999999995 99999999999999999
Q ss_pred CCCeEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHc-CCCCCCCCCCCCCc
Q 013074 276 DFCPKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVG-CKNNLDSGVDNSSE 354 (450)
Q Consensus 276 ~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~ellt-g~~p~~~~~~~~~~ 354 (450)
++.+||+|||+++.......... .....+|+.|+|||.+.+. .++.++||||||+++|||++ |..||.....
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~y~aPE~l~~~--~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---- 243 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKK-TTNGRLPVKWMAPEALFDR--IYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---- 243 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCC-CTTSCCGGGGSCHHHHHHC--CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----
T ss_pred CCCeEeccchhhccccccccccc-cccCCCChhhhhhhHhcCC--CCCchhhhHHhHHHHHHhccCCCCCCCCCCH----
Confidence 99999999999987755433222 3445689999999999874 89999999999999999998 5666653221
Q ss_pred cchhhhhhhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 355 VYFPHWIYRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 355 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
..+.+.+.... ....+..++.++.+++.+||+.||++|||++||++.|+.+.+
T Consensus 244 ----~~~~~~i~~~~-------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 ----EELFKLLKEGH-------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ----HHHHHHHHTTC-------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHcCC-------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11222222211 112223455779999999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.2e-45 Score=346.34 Aligned_cols=235 Identities=20% Similarity=0.314 Sum_probs=179.3
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCc----eEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNN----RAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~----~~l 208 (450)
|.+.+.||+|+||+||+|+. .+|++++++++||||+++++++...+. .|+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEE
Confidence 45678999999999999952 346888999999999999999987543 789
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
||||+++++|.+++...+. +++..++.++.|++.||+|||+ .+|+||||||+|||++.++..+++|||.+.
T Consensus 89 vmE~~~g~~L~~~~~~~~~------l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEGP------MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEECCCEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEECCCCCEehhhhcccCC------CCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhh
Confidence 9999999999998876543 8999999999999999999995 999999999999999999999999999987
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
................||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+.....+...
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~--~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~~~~~~ 230 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGD--SVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVRED 230 (277)
T ss_dssp ECC----------------TTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCC
T ss_pred hhccccccccccccccCcccccCHHHHcCC--CCCcceecccchHHHHHHHhCCCCCCCcCH-------HHHHHHHHhcC
Confidence 665443333334556799999999999774 789999999999999999999999964321 11111111111
Q ss_pred hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcc
Q 013074 369 REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-PMNEVIEMLQGS 416 (450)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~ 416 (450)
.. ........++.++.+++.+||+.||.+|| |++++++.|..+
T Consensus 231 ~~-----~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 231 PI-----PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CC-----CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CC-----CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 10 01111234567899999999999999999 899999888764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=351.88 Aligned_cols=224 Identities=21% Similarity=0.267 Sum_probs=184.2
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|++.+.||+|+||+||+|+. .+|+.++++++||||+++++++.+++.+|+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 45678999999999999962 2457889999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+++|+|.+++...+. +++..++.++.|++.||+|||+ .+|+||||||+|||++++|.+||+|||+++....
T Consensus 87 ~~gg~L~~~~~~~~~------~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 87 ANGGELFFHLSRERV------FTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp CTTCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred cCCCchhhhhhcccC------CcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999976543 8999999999999999999995 9999999999999999999999999999986644
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.... ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+.+.....
T Consensus 158 ~~~~---~~~~~GT~~Y~aPE~~~~~--~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~~~---- 220 (337)
T d1o6la_ 158 DGAT---MKTFCGTPEYLAPEVLEDN--DYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILME---- 220 (337)
T ss_dssp TTCC---BCCCEECGGGCCGGGGSSS--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC----
T ss_pred CCcc---cccceeCHHHhhhhhccCC--CCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHhcC----
Confidence 3221 3456799999999999875 789999999999999999999999975421 0111111111
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIEM 412 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~ 412 (450)
....+..++.++.+++.+||+.||.+||+ ++|+++.
T Consensus 221 ----~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 221 ----EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 01122345677899999999999999995 7888763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.4e-44 Score=354.16 Aligned_cols=225 Identities=26% Similarity=0.314 Sum_probs=180.6
Q ss_pred hHhhhccccccceEEEEEEEcc-----------------------------hhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLD-----------------------------GLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~-----------------------------e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
|++.+.||+|+||.||+|+... ++.+++.++|||||++++++.+++..|+|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 4467899999999999996321 14456677899999999999999999999
Q ss_pred EEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccc
Q 013074 210 YEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKL 289 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~ 289 (450)
|||+++|+|.+++..... +++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++.
T Consensus 86 mE~~~gg~L~~~l~~~~~------~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHGV------FSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp ECCCCSCBHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEecCCCcHHHHHHhccc------ccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999976543 8899999999999999999995 9999999999999999999999999999987
Q ss_pred ccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 290 CTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 290 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
..... .....||+.|+|||++... ..++.++|||||||++|||++|+.||........ ..+....
T Consensus 157 ~~~~~-----~~~~~GT~~y~APE~~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-----~~~~~~~---- 221 (364)
T d1omwa3 157 FSKKK-----PHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HEIDRMT---- 221 (364)
T ss_dssp CSSSC-----CCSCCSCGGGCCHHHHSTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-----HHHHHHS----
T ss_pred cCCCc-----ccccccccccchhHHhhcC-CCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhc----
Confidence 65443 2345699999999998653 3689999999999999999999999975432211 0011110
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIE 411 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 411 (450)
.......+..++.++.+++.+||+.||++||| ++|+++
T Consensus 222 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 222 ----LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----SSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----ccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 00111112235677899999999999999999 688875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-44 Score=350.26 Aligned_cols=229 Identities=20% Similarity=0.256 Sum_probs=178.7
Q ss_pred hccccccceEEEEEEE------------------cchhhhhhhc-CCCceeeeeeEEEe----CCceEEEEEecCCCChh
Q 013074 163 DKLGQGGFGGVYKGKL------------------LDGLASISRT-SHVNVVTLLGFCLE----GNNRALIYEFMPNGSLE 219 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~------------------~~e~~~l~~l-~HpnIv~l~~~~~~----~~~~~lV~E~~~~gsL~ 219 (450)
+.||+|+||+||+|+. .+|++++.++ +|||||++++++.+ +..+|+|||||++|+|.
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~ 97 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELF 97 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEECSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHH
T ss_pred EEeeeccCeEEEEEEECCCCCEEEEEEECCcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHH
Confidence 4699999999999963 2357776655 79999999999875 45789999999999999
Q ss_pred hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC---CCCeEEeeccccccccCCCCc
Q 013074 220 KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ---DFCPKISDFGLAKLCTTKKGI 296 (450)
Q Consensus 220 ~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~---~~~~kl~DFGla~~~~~~~~~ 296 (450)
+++...+. ..+++..++.++.|++.||+|||+ .+|+||||||+|||+++ ++.+||+|||+++.......
T Consensus 98 ~~i~~~~~----~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~- 169 (335)
T d2ozaa1 98 SRIQDRGD----QAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS- 169 (335)
T ss_dssp HHHHSCSC----CCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC-
T ss_pred HHHHhcCC----CCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccCCCc-
Confidence 99976433 239999999999999999999995 99999999999999985 56799999999987755432
Q ss_pred cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhccc
Q 013074 297 VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLLGV 376 (450)
Q Consensus 297 ~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 376 (450)
.....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......... .+........ ...
T Consensus 170 ---~~~~~gt~~y~aPE~~~~~--~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~----~~~~~i~~~~----~~~ 236 (335)
T d2ozaa1 170 ---LTTPCYTPYYVAPEVLGPE--KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP----GMKTRIRMGQ----YEF 236 (335)
T ss_dssp ---CCCCSCCCSSCCCCCCCGG--GGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCS----SSC
T ss_pred ---cccccCCcccCCcHHHcCC--CCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH----HHHHHHhcCC----CCC
Confidence 2445699999999999875 78999999999999999999999996543221110 0111110000 001
Q ss_pred ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 377 VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 377 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.......++.++.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 112234567889999999999999999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.2e-44 Score=340.49 Aligned_cols=229 Identities=21% Similarity=0.278 Sum_probs=184.3
Q ss_pred hHhhhccccccceEEEEEEE--------------------------------cchhhhhhhcC-CCceeeeeeEEEeCCc
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------------LDGLASISRTS-HVNVVTLLGFCLEGNN 205 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------------~~e~~~l~~l~-HpnIv~l~~~~~~~~~ 205 (450)
|++.+.||+|+||+||+|+. .+|+.++++++ ||||+++++++.+++.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcc
Confidence 45678999999999999952 13577788887 9999999999999999
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
.++||||+++|+|.+++...+. +++..++.++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~~------l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKVT------LSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred eEEEEEcCCCchHHHHHHhcCC------CCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999976442 8999999999999999999995 899999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccc----cCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRN----FGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI 361 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i 361 (450)
+++....... .....||..|+|||.+.+. ...++.++||||+||++|||++|+.||..... ..+
T Consensus 156 ~a~~~~~~~~----~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~ 223 (277)
T d1phka_ 156 FSCQLDPGEK----LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLM 223 (277)
T ss_dssp TCEECCTTCC----BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH
T ss_pred heeEccCCCc----eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHH
Confidence 9987654322 2345699999999998642 13568899999999999999999999975321 111
Q ss_pred hhhhhhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 362 YRHVEQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.+.+..... .........++.++.+++.+||+.||++|||++|+++.
T Consensus 224 ~~~i~~~~~----~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 224 LRMIMSGNY----QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHTCC----CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHhCCC----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111111110 01112223466789999999999999999999998763
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.8e-44 Score=349.72 Aligned_cols=220 Identities=20% Similarity=0.228 Sum_probs=182.9
Q ss_pred hHhhhccccccceEEEEEEE--------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEe
Q 013074 159 NSFKDKLGQGGFGGVYKGKL--------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEF 212 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~--------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~ 212 (450)
|++.++||+|+||+||+|+. .+|+.++++++|||||++++++.+....++||||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 45678999999999999952 2457889999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccC
Q 013074 213 MPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTT 292 (450)
Q Consensus 213 ~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~ 292 (450)
+.+|+|..++...+. +++..++.++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 123 ~~~g~l~~~l~~~~~------l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 123 VAGGEMFSHLRRIGR------FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp CTTCBHHHHHHHHCC------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccchhhhHhhcCC------CCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999976543 8999999999999999999995 9999999999999999999999999999987754
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhh
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFK 372 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~ 372 (450)
.. ....||+.|||||++.+. .++.++|||||||++|||++|+.||..... ..+...+...
T Consensus 194 ~~------~~~~Gt~~Y~APE~~~~~--~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~i~~~---- 253 (350)
T d1rdqe_ 194 RT------WTLCGTPEALAPEIILSK--GYNKAVDWWALGVLIYEMAAGYPPFFADQP--------IQIYEKIVSG---- 253 (350)
T ss_dssp CB------CCCEECGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC----
T ss_pred cc------ccccCccccCCHHHHcCC--CCCccccccchhHHHHHHHhCCCCCCCcCH--------HHHHHHHhcC----
Confidence 32 345699999999999875 789999999999999999999999964311 1111111111
Q ss_pred hcccccchhHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 013074 373 LLGVVTKKENEIAKKMIIVGLWCIQARPYDRP-----PMNEVIE 411 (450)
Q Consensus 373 ~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~ 411 (450)
....+..++.++.+++.+||+.||.+|+ |++|+++
T Consensus 254 ----~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 254 ----KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1111234567889999999999999994 8999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=349.32 Aligned_cols=240 Identities=25% Similarity=0.388 Sum_probs=189.3
Q ss_pred hHhhhccccccceEEEEEEE-----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALI 209 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV 209 (450)
+.+.++||+|+||+||+|++ .+|+.++++++||||++++++|..+...++|
T Consensus 22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv 101 (308)
T d1p4oa_ 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 101 (308)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEE
T ss_pred eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEE
Confidence 34678899999999999853 2458889999999999999999999999999
Q ss_pred EEecCCCChhhhhhcCCC----CCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 210 YEFMPNGSLEKFVYNGDT----SKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 210 ~E~~~~gsL~~~l~~~~~----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
|||+++|+|.+++..... ......+++..+..++.|+++||.|||+ .+|+||||||+|||+++++.+||+|||
T Consensus 102 ~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 102 MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeecc
Confidence 999999999998864210 1112337999999999999999999995 899999999999999999999999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
+++.......... .....||+.|+|||.+.+. .++.++||||||+++|||++|..++..+... .+ +...+
T Consensus 179 la~~~~~~~~~~~-~~~~~~t~~y~aPe~l~~~--~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~-~~~~i 248 (308)
T d1p4oa_ 179 MTRDIYETDYYRK-GGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQ-VLRFV 248 (308)
T ss_dssp CCCGGGGGGCEEG-GGSSEECGGGCCHHHHHHC--CCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HH-HHHHH
T ss_pred cceeccCCcceee-ccceecccccCCHHHHccC--CCCcccccccHHHHHHHHHhCCCCCCCCCCH------HH-HHHHH
Confidence 9987654433222 3344689999999999874 7899999999999999999986444332211 11 11111
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccc
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTE 418 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~ 418 (450)
... .....+..++..+.+++.+||+.||++|||+++|+++|++..+
T Consensus 249 ~~~-------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 MEG-------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HTT-------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HhC-------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 111 1122233455789999999999999999999999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=344.58 Aligned_cols=228 Identities=20% Similarity=0.257 Sum_probs=183.3
Q ss_pred hHhhhccccccceEEEEEEE----------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL----------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~----------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
|.+.+.||+|+||+||+|+. .+|++++++++|||||++++++.+++.+|+||||+++|
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg 86 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCC
Confidence 45678999999999999952 35688999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCC--CCeEEeeccccccccCCC
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQD--FCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~--~~~kl~DFGla~~~~~~~ 294 (450)
+|.+++...+. .+++..++.++.||+.||+|||+ .+|+||||||+|||++.+ ..+||+|||+++......
T Consensus 87 ~L~~~i~~~~~-----~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~ 158 (321)
T d1tkia_ 87 DIFERINTSAF-----ELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD 158 (321)
T ss_dssp BHHHHHTSSSC-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred cHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence 99999975432 38999999999999999999995 999999999999999854 589999999998775443
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhhhhc
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREFKLL 374 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 374 (450)
.. ....+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||...... .+...+.... .
T Consensus 159 ~~----~~~~~t~~y~ape~~~~~--~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--------~~~~~i~~~~----~ 220 (321)
T d1tkia_ 159 NF----RLLFTAPEYYAPEVHQHD--VVSTATDMWSLGTLVYVLLSGINPFLAETNQ--------QIIENIMNAE----Y 220 (321)
T ss_dssp EE----EEEESCGGGSCHHHHTTC--EECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--------HHHHHHHHTC----C
T ss_pred cc----cccccccccccchhccCC--CCCchhhcccHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhCC----C
Confidence 22 234589999999999874 7899999999999999999999999754211 1111111110 0
Q ss_pred ccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 375 GVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 375 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.........++.++.+++.+||+.||++|||++|+++.
T Consensus 221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00011112346778999999999999999999999973
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-44 Score=344.94 Aligned_cols=236 Identities=24% Similarity=0.300 Sum_probs=178.3
Q ss_pred hccccccceEEEEEEE----------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 163 DKLGQGGFGGVYKGKL----------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 163 ~~LG~G~fg~Vy~~~~----------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
+.||+|+||+||+|+. .+|+.++++++|||||++++++.+++..++||||+.
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999999941 146889999999999999999999999999999998
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++++........ .+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~~~~~~~~~------~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 84 TDLEVIIKDNSL------VLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp EEHHHHHTTCCS------SCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred chHHhhhhhccc------CCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 877665554332 38889999999999999999995 999999999999999999999999999998765433
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh-----
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR----- 369 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~----- 369 (450)
.. .....||+.|+|||++... ..++.++|||||||++|||++|..||....... ....+.+......
T Consensus 155 ~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~----~l~~i~~~~~~~~~~~~~ 226 (299)
T d1ua2a_ 155 RA---YTHQVVTRWYRAPELLFGA-RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD----QLTRIFETLGTPTEEQWP 226 (299)
T ss_dssp CC---CCCSCCCCTTCCHHHHTTC-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCTTTSS
T ss_pred cc---ccceecChhhccHHHHccC-CCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH----HHHHHHHhcCCCChhhcc
Confidence 22 2345699999999998653 367999999999999999999999986432110 0000111000000
Q ss_pred ------hhhhcccc-----cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhc
Q 013074 370 ------EFKLLGVV-----TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQG 415 (450)
Q Consensus 370 ------~~~~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~ 415 (450)
........ .......++++.+++.+||+.||++|||++|+++. ++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred chhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 00000000 00011235678999999999999999999999874 543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=336.74 Aligned_cols=217 Identities=24% Similarity=0.341 Sum_probs=175.9
Q ss_pred hHhhhccccccceEEEEEE-----------------------------EcchhhhhhhcC--CCceeeeeeEEEeCCceE
Q 013074 159 NSFKDKLGQGGFGGVYKGK-----------------------------LLDGLASISRTS--HVNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~-----------------------------~~~e~~~l~~l~--HpnIv~l~~~~~~~~~~~ 207 (450)
|.+.+.||+|+||+||+|+ +.+|+.++++++ |||||++++++.+++..+
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~ 85 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEE
Confidence 4567899999999999984 234677888886 899999999999999999
Q ss_pred EEEEecCC-CChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-CCCeEEeecc
Q 013074 208 LIYEFMPN-GSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-DFCPKISDFG 285 (450)
Q Consensus 208 lV~E~~~~-gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-~~~~kl~DFG 285 (450)
+||||+.+ +++.+++..... +++..++.++.|++.||+|||+ .+|+||||||+|||++. ++.+||+|||
T Consensus 86 lv~e~~~~~~~l~~~~~~~~~------l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 86 LILERPEPVQDLFDFITERGA------LQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEECCSSEEEHHHHHHHHCS------CCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeccCcchHHHHHhccCC------CCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccc
Confidence 99999976 577777765432 8999999999999999999995 99999999999999985 4799999999
Q ss_pred ccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhh
Q 013074 286 LAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHV 365 (450)
Q Consensus 286 la~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~ 365 (450)
+++...... .....||+.|+|||++.+. ..++.++|||||||++|||++|+.||.... .+
T Consensus 157 ~a~~~~~~~-----~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------------~i 216 (273)
T d1xwsa_ 157 SGALLKDTV-----YTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EI 216 (273)
T ss_dssp TCEECCSSC-----BCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HH
T ss_pred cceeccccc-----ccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCCch--------------HH
Confidence 998764432 2345699999999999764 235678999999999999999999996321 00
Q ss_pred hhhhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 366 EQDREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... ......++.++.+++.+||+.||++|||++|+++.
T Consensus 217 ~~~~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 217 IRGQ--------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp HHCC--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhcc--------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0000 01112345778999999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-43 Score=343.14 Aligned_cols=223 Identities=22% Similarity=0.289 Sum_probs=180.4
Q ss_pred hHhhhccccccceEEEEEEEcc--------------------------hhhhhh-hcCCCceeeeeeEEEeCCceEEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKLLD--------------------------GLASIS-RTSHVNVVTLLGFCLEGNNRALIYE 211 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~~~--------------------------e~~~l~-~l~HpnIv~l~~~~~~~~~~~lV~E 211 (450)
|++.++||+|+||+||+|+... |..++. .++|||||++++++.+++..|+|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 4567899999999999996321 233343 5799999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccccccc
Q 013074 212 FMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCT 291 (450)
Q Consensus 212 ~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~ 291 (450)
|+++|+|.+++..... +++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 84 y~~~g~L~~~i~~~~~------~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCHK------FDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp CCTTCBHHHHHHHHSS------CCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred ecCCCcHHHHhhccCC------CCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999976543 8899999999999999999995 899999999999999999999999999998665
Q ss_pred CCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhhhh
Q 013074 292 TKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDREF 371 (450)
Q Consensus 292 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~~~ 371 (450)
..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ..+...+...
T Consensus 155 ~~~~~---~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~i~~~--- 218 (320)
T d1xjda_ 155 LGDAK---TNTFCGTPDYIAPEILLGQ--KYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHSIRMD--- 218 (320)
T ss_dssp CTTCC---BCCCCSCGGGCCHHHHTTC--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHC---
T ss_pred ccccc---ccccCCCCCcCCHHHHcCC--CCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC---
Confidence 43322 3345699999999999875 789999999999999999999999964321 1122222111
Q ss_pred hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 013074 372 KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMN-EVIE 411 (450)
Q Consensus 372 ~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl~ 411 (450)
....+..++.++.+++.+||+.||++|||+. |+++
T Consensus 219 -----~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 -----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -----CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1111233567789999999999999999995 7754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-43 Score=336.18 Aligned_cols=244 Identities=21% Similarity=0.313 Sum_probs=181.8
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|.+.++||+|+||+||+|+. .+|++++++++|||||++++++.++...++||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 34567899999999999952 24688999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
.+ ++..++..... ..+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~-~~~~~~~~~~~----~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 84 HQ-DLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp SE-EHHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred CC-chhhhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCC
Confidence 64 55555543322 239999999999999999999995 99999999999999999999999999999876543
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhh----------hh
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI----------YR 363 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i----------~~ 363 (450)
... .....||+.|+|||++... ...+.++|||||||++|+|++|+.||...... ..+.... ..
T Consensus 156 ~~~---~~~~~gt~~y~apE~~~~~-~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 156 VRT---YTHEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI---DQLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp SBC---TTCCBCCCTTCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHHHCCCCTTTST
T ss_pred ccc---ceeecccceeeehhhhccc-cCCCccccccccchhhhHHhhCCCCCCCCCHH---HHHHHHHHhcCCCchhhcc
Confidence 322 2344699999999998765 35689999999999999999999999643210 0000000 00
Q ss_pred hhhhhhhh--hhcccc----cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccc
Q 013074 364 HVEQDREF--KLLGVV----TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGST 417 (450)
Q Consensus 364 ~~~~~~~~--~~~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~ 417 (450)
........ ...... .......+.++.+++.+||+.||++|||++|+++. ++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 00000000 000000 00112345678999999999999999999999985 65543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.7e-42 Score=326.74 Aligned_cols=236 Identities=21% Similarity=0.281 Sum_probs=176.5
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEecC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFMP 214 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 214 (450)
|.+.++||+|+||+||+|+. .+|+.++++++||||+++++++.+++..++++|++.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeeh
Confidence 34567899999999999963 246888999999999999999999999999999997
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTKK 294 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~~ 294 (450)
++.+..+....+ .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||.+.......
T Consensus 84 ~~~~~~~~~~~~------~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 84 QDLKKLLDVCEG------GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp EEHHHHHHTSTT------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred hhhHHHHHhhcC------CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 766666554332 39999999999999999999995 899999999999999999999999999998765432
Q ss_pred CccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh----------
Q 013074 295 GIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH---------- 364 (450)
Q Consensus 295 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~---------- 364 (450)
.. .....+++.|+|||.+.+. ..++.++|||||||++|||++|+.||....... .+.+ +...
T Consensus 155 ~~---~~~~~~~~~y~~pE~~~~~-~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~---~~~~-i~~~~~~~~~~~~~ 226 (286)
T d1ob3a_ 155 RK---YTHEIVTLWYRAPDVLMGS-KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMR-IFRILGTPNSKNWP 226 (286)
T ss_dssp ----------CCCTTCCHHHHTTC-CSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHH-HHHHHCCCCTTTST
T ss_pred cc---cceecccchhhhHHHHhCC-CCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH---HHHH-HHHhhCCCChhhcc
Confidence 21 2233588999999999764 467999999999999999999999996432110 0000 0000
Q ss_pred -hhhhhh----hh--hcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 365 -VEQDRE----FK--LLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 365 -~~~~~~----~~--~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
...... .. ............+..+.+++.+||+.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 227 NVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 00 000001112234567899999999999999999999984
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=330.18 Aligned_cols=237 Identities=23% Similarity=0.336 Sum_probs=174.5
Q ss_pred hhHhhhccccccceEEEEEEEc--------------------------chhhhhhhc---CCCceeeeeeEEEe-----C
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL--------------------------DGLASISRT---SHVNVVTLLGFCLE-----G 203 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~--------------------------~e~~~l~~l---~HpnIv~l~~~~~~-----~ 203 (450)
.|++.++||+|+||+||+|+.. +|+.+++.+ +||||++++++|.. .
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~ 87 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 87 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSE
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccC
Confidence 3456789999999999999631 234555444 79999999999864 3
Q ss_pred CceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEee
Q 013074 204 NNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 204 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
...+++|||+.++.+........ ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|
T Consensus 88 ~~~~~~~e~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 88 TKLTLVFEHVDQDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EEEEEEEECCSCBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECS
T ss_pred ceEEEEEEeccCCchhhhhhccC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecc
Confidence 46889999998776654443332 238999999999999999999995 9999999999999999999999999
Q ss_pred ccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhh
Q 013074 284 FGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYR 363 (450)
Q Consensus 284 FGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~ 363 (450)
||+++...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .+. .+.+
T Consensus 160 fg~~~~~~~~~----~~~~~~gT~~Y~APE~~~~~--~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~---~~~-~i~~ 229 (305)
T d1blxa_ 160 FGLARIYSFQM----ALTSVVVTLWYRAPEVLLQS--SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLG-KILD 229 (305)
T ss_dssp CCSCCCCCGGG----GGCCCCCCCTTCCHHHHTTC--CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH-HHHH
T ss_pred hhhhhhhcccc----cCCCcccChhhcCcchhcCC--CCChhehhhchHHHHHHHHHCCCCCCCCCHHH---HHH-HHHH
Confidence 99988654332 23456799999999999875 79999999999999999999999997542110 000 0000
Q ss_pred hhhhh-----------hhh----hhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 364 HVEQD-----------REF----KLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 364 ~~~~~-----------~~~----~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
..... ... .............+..+.+++.+||+.||++|||++|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 000 00000111122345678899999999999999999999864
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-40 Score=319.27 Aligned_cols=247 Identities=15% Similarity=0.214 Sum_probs=191.1
Q ss_pred hHhhhccccccceEEEEEEE---------------------cchhhhhhhcCC-CceeeeeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSH-VNVVTLLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~~g 216 (450)
|.+.++||+|+||+||+|+. .+|++.++.++| +|++.+++++.++...++||||+ ++
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~ 85 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GP 85 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CC
Confidence 45678999999999999962 345777888876 89999999999999999999999 78
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcC-----CCCeEEeecccccccc
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQ-----DFCPKISDFGLAKLCT 291 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~-----~~~~kl~DFGla~~~~ 291 (450)
+|.+++...+. .+++.++..++.|++.||+||| +.+|+||||||+|||++. ++.+||+|||+++...
T Consensus 86 ~l~~~~~~~~~-----~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 86 SLEDLLDLCGR-----KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp BHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred CHHHHHHhhcc-----chhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99998876542 2899999999999999999999 599999999999999974 5789999999998765
Q ss_pred CCCCc----cccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 292 TKKGI----VSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 292 ~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
..... ........||+.|||||++.+. .++.++|||||||++|||++|+.||.......... ....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~--~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~-----~~~~i~~ 230 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGR--EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ-----KYERIGE 230 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC--CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH-----HHHHHHH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCC--CCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHH-----HHHHHHh
Confidence 43221 1123456799999999999874 79999999999999999999999997543322111 1111111
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccccccCCCC
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEALQIPP 424 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l~~p~ 424 (450)
.. ...........+++++.+++..|++.+|++||+++.+.+.|++..+......
T Consensus 231 ~~---~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~ 284 (293)
T d1csna_ 231 KK---QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE 284 (293)
T ss_dssp HH---HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred cc---CCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCC
Confidence 11 0011111122345778999999999999999999999999988776655443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-40 Score=320.52 Aligned_cols=243 Identities=18% Similarity=0.216 Sum_probs=181.1
Q ss_pred hHhhhccccccceEEEEEEE---------------------cchhhhhhhcCCCceee-eeeEEEeCCceEEEEEecCCC
Q 013074 159 NSFKDKLGQGGFGGVYKGKL---------------------LDGLASISRTSHVNVVT-LLGFCLEGNNRALIYEFMPNG 216 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~---------------------~~e~~~l~~l~HpnIv~-l~~~~~~~~~~~lV~E~~~~g 216 (450)
|.+.++||+|+||+||+|+. ..|++++++++|+|++. +.++..+++..++||||+ ++
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~ 87 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GP 87 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CC
T ss_pred EEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CC
Confidence 55678999999999999963 23578888998777555 455557778889999999 66
Q ss_pred ChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEc---CCCCeEEeeccccccccCC
Q 013074 217 SLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLD---QDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 217 sL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~---~~~~~kl~DFGla~~~~~~ 293 (450)
+|...+..... .+++..+..++.|++.||+|||+ .+|+||||||+|||++ .+..+||+|||+++.....
T Consensus 88 ~l~~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 88 SLEDLFNFCSR-----KFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp BHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred chhhhhhhccC-----CCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 77776654432 38999999999999999999995 9999999999999986 4557999999999977543
Q ss_pred CCcc----ccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhhh
Q 013074 294 KGIV----SSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQDR 369 (450)
Q Consensus 294 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~~ 369 (450)
.... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~-------- 229 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGI--EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-------- 229 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTB--CCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH--------
T ss_pred ccccceeccccCCcCCCccccCHHHHhCC--CCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh--------
Confidence 3221 123455799999999999875 78999999999999999999999997654322211111110
Q ss_pred hhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcccccc
Q 013074 370 EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEMLQGSTEAL 420 (450)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~l 420 (450)
..............++.++.+++.+||+.||++||+++++.+.|+......
T Consensus 230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 011111111112235577999999999999999999999999988765443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-41 Score=325.29 Aligned_cols=230 Identities=22% Similarity=0.234 Sum_probs=183.2
Q ss_pred hHhhhccccccceEEEEEE------------------------------EcchhhhhhhcCC-CceeeeeeEEEeCCceE
Q 013074 159 NSFKDKLGQGGFGGVYKGK------------------------------LLDGLASISRTSH-VNVVTLLGFCLEGNNRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~------------------------------~~~e~~~l~~l~H-pnIv~l~~~~~~~~~~~ 207 (450)
|.+.++||+|+||+||+|+ +.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 5577899999999999984 2357889999977 79999999999999999
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+.+|+|.+++...+. +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~------~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRER------FTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSC------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeecccccHHHHHHHhccc------ccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999976543 7788999999999999999995 89999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ 367 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~ 367 (450)
+......... .....|++.|+|||.+.+....++.++|||||||++|||++|+.||........ ...+.+...
T Consensus 177 ~~~~~~~~~~--~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~----~~~i~~~~~- 249 (322)
T d1vzoa_ 177 KEFVADETER--AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRIL- 249 (322)
T ss_dssp EECCGGGGGG--GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHHH-
T ss_pred hhhccccccc--ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhcc-
Confidence 8765433221 234568999999999977545678999999999999999999999975533221 111111100
Q ss_pred hhhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 013074 368 DREFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPP-----MNEVIE 411 (450)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~ 411 (450)
......+...+.++.+++.+||+.||++||| ++|+++
T Consensus 250 -------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 250 -------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 0011122345688999999999999999994 788886
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-41 Score=332.81 Aligned_cols=244 Identities=23% Similarity=0.246 Sum_probs=175.8
Q ss_pred hHhhhccccccceEEEEEEE-------------------cchhhhhhhcCCCceeeeeeEEEeC------CceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------LDGLASISRTSHVNVVTLLGFCLEG------NNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------~~e~~~l~~l~HpnIv~l~~~~~~~------~~~~lV~E~~ 213 (450)
|...++||+|+||+||+|+. .+|++++++++||||+++++++... ..+++||||+
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~ 101 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECC
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEecc
Confidence 33456899999999999963 3578999999999999999998643 2478999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-CeEEeeccccccccC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-CPKISDFGLAKLCTT 292 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~ 292 (450)
+++.+......... ...+++..++.++.|++.||+||| +.+|+||||||+|||++.++ .+||+|||+++....
T Consensus 102 ~~~~~~~l~~~~~~---~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~ 175 (350)
T d1q5ka_ 102 PETVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 175 (350)
T ss_dssp SEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred CCccHHHHHhhhhc---cCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence 76543333221111 123999999999999999999999 59999999999999999775 899999999987654
Q ss_pred CCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhh-----------
Q 013074 293 KKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWI----------- 361 (450)
Q Consensus 293 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i----------- 361 (450)
... .....||..|+|||.+.+. ..++.++||||+||++|||++|+.||....... .+...+
T Consensus 176 ~~~----~~~~~gt~~y~aPE~~~~~-~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~---~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 176 GEP----NVSYICSRYYRAPELIFGA-TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQI 247 (350)
T ss_dssp TSC----CCSCCSCTTSCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH---HHHHHHHHHCCCCHHHH
T ss_pred Ccc----cccccccccccChHHhhcc-cCCCcceeecccceEEEehhhCCCCCCCCCHHH---HHHHHHHHhCCChHHhh
Confidence 432 2345699999999998754 478999999999999999999999996542110 010000
Q ss_pred hhhhhhhhhhhhccc-----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcc
Q 013074 362 YRHVEQDREFKLLGV-----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGS 416 (450)
Q Consensus 362 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 416 (450)
............... ........+.++.+++.+||+.||++|||++|+++. +++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000000000000000 000112345678999999999999999999999964 5543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-40 Score=323.02 Aligned_cols=243 Identities=19% Similarity=0.268 Sum_probs=177.9
Q ss_pred hHhhhccccccceEEEEEEE------------------------cchhhhhhhcCCCceeeeeeEEEeCC----ceEEEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL------------------------LDGLASISRTSHVNVVTLLGFCLEGN----NRALIY 210 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~----~~~lV~ 210 (450)
|.+.++||+|+||+||+|+. .+|+++|++++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred eEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE
Confidence 34568999999999999952 24689999999999999999997653 234455
Q ss_pred EecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 211 EFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 211 E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
+++.+|+|.+++.... +++..+..++.|++.||+|||+ .+|+||||||+|||+++++.+||+|||+++..
T Consensus 90 ~~~~~g~L~~~l~~~~-------l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 90 THLMGADLYKLLKTQH-------LSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EECCCEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EeecCCchhhhhhcCC-------CCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 6666999999996532 8999999999999999999995 89999999999999999999999999999876
Q ss_pred cCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh---
Q 013074 291 TTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ--- 367 (450)
Q Consensus 291 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~--- 367 (450)
..............||+.|+|||++... ..++.++||||+||+++||++|+.||........ . .........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~---~-~~~~~~~~~~~~ 234 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNS-KGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---L-NHILGILGSPSQ 234 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTB-CSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H-HHHHHHHCSCCH
T ss_pred cCCCccceeeccccccceechHHHhhcC-CCCCchhhhhccCceehHHhhCCCCCCCCCHHHH---H-HHHhhhccCCCh
Confidence 5544433334556799999999998654 4678999999999999999999999965421100 0 000000000
Q ss_pred ----------hhhhh--hccc----ccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcc
Q 013074 368 ----------DREFK--LLGV----VTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGS 416 (450)
Q Consensus 368 ----------~~~~~--~~~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 416 (450)
..... .... ........+.++.+++.+||+.||++|||++|+++. ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~ 301 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00000 0000 000111234578899999999999999999999975 5543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-41 Score=328.48 Aligned_cols=243 Identities=21% Similarity=0.275 Sum_probs=174.8
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCC------ceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGN------NRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~------~~~ 207 (450)
|.+.++||+|+||+||+|+. .+|+.+|++++|||||+++++|...+ .++
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEE
Confidence 44567899999999999952 24688899999999999999998654 579
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+ +.+|...+.... +++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||++
T Consensus 100 lv~e~~-~~~l~~~~~~~~-------l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKHEK-------LGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp EEEECC-SEEHHHHHHHCC-------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEecc-cccHHHHHHhcc-------ccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccce
Confidence 999999 667877765432 9999999999999999999995 99999999999999999999999999999
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccch-------hhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYF-------PHW 360 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~-------~~~ 360 (450)
+..... .....||+.|+|||++.+. ..++.++||||+||++|||++|+.||............ +..
T Consensus 169 ~~~~~~------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 169 RQADSE------MTGYVVTRWYRAPEVILNW-MRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp EECCSS------CCSSCSCGGGCCTHHHHTT-TCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred eccCCc------cccccccccccCHHHHcCC-CCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHH
Confidence 876543 2345699999999998764 46789999999999999999999999654211000000 000
Q ss_pred hhhhhhhhhh----hhh----cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccccc
Q 013074 361 IYRHVEQDRE----FKL----LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGSTEA 419 (450)
Q Consensus 361 i~~~~~~~~~----~~~----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~~ 419 (450)
.......... ... ...........+..+.+++.+||+.||++|||++|+++. ++++.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 0000000000 000 000011112335678899999999999999999999986 6665443
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=320.57 Aligned_cols=240 Identities=20% Similarity=0.267 Sum_probs=173.8
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe--------CCc
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE--------GNN 205 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~--------~~~ 205 (450)
|.+.++||+|+||+||+|+. .+|+.++++++||||+++++++.. +..
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCce
Confidence 34567999999999999952 246889999999999999999865 346
Q ss_pred eEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecc
Q 013074 206 RALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFG 285 (450)
Q Consensus 206 ~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFG 285 (450)
.++||||+.++.+....... ..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 92 ~~iv~e~~~~~~~~~~~~~~------~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp EEEEEECCCEEHHHHHTCTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEeccCCCccchhhhcc------cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecc
Confidence 89999999776665443322 238899999999999999999995 999999999999999999999999999
Q ss_pred ccccccCCCC-ccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhh
Q 013074 286 LAKLCTTKKG-IVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRH 364 (450)
Q Consensus 286 la~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~ 364 (450)
+++....... .........||+.|+|||++.+. ..++.++|||||||++|||++|+.||....... ....+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~-~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~----~~~~i~~~ 237 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQL 237 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTC-SSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHH
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCC-CCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH----HHHHHHHh
Confidence 9986653322 12223345699999999998764 368999999999999999999999996432110 00001010
Q ss_pred hhhh-----------hh---hhhcccccch------hHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 365 VEQD-----------RE---FKLLGVVTKK------ENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 365 ~~~~-----------~~---~~~~~~~~~~------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
.... .. .......... .......+.+++.+||+.||++|||++|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000 00 0000000000 11123567889999999999999999999965
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=316.93 Aligned_cols=238 Identities=21% Similarity=0.295 Sum_probs=182.4
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeCCceEEEEEec
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEGNNRALIYEFM 213 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 213 (450)
|++.++||+|+||+||+|+. .+|+.++++++||||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 44568999999999999962 35688899999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccccccCC
Q 013074 214 PNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAKLCTTK 293 (450)
Q Consensus 214 ~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~~~~ 293 (450)
.+++|..++...+. +++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||.++.....
T Consensus 84 ~~~~l~~~~~~~~~------~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 84 DQDLKKYFDSCNGD------LDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp SEEHHHHHHHTTTC------CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred cccccccccccccc------cchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99888887765432 8899999999999999999995 89999999999999999999999999999877554
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh------
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ------ 367 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~------ 367 (450)
... .....++..|+|||.+... ..++.++|||||||+++||++|+.||..+..... .+. .+......
T Consensus 155 ~~~---~~~~~~~~~~~~pe~~~~~-~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~ 227 (292)
T d1unla_ 155 VRC---YSAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLK-RIFRLLGTPTEEQW 227 (292)
T ss_dssp CSC---CCSCCSCGGGCCHHHHTTC-SCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHH-HHHHHHCCCCTTTC
T ss_pred Ccc---ceeeccccchhhhhHhccC-CCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHH-HHHhhcCCCChhhh
Confidence 322 2233478899999998764 3578999999999999999999999865432111 000 00000000
Q ss_pred -----hhh------hhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 368 -----DRE------FKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 368 -----~~~------~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
... ..............+..+.+++.+||+.||++|||++|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 000011111223345678899999999999999999999863
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.3e-39 Score=317.35 Aligned_cols=234 Identities=20% Similarity=0.277 Sum_probs=177.7
Q ss_pred hhHhhhccccccceEEEEEEE--------------------cchhhhhhhcC-CCceeeeeeEEEeC--CceEEEEEecC
Q 013074 158 TNSFKDKLGQGGFGGVYKGKL--------------------LDGLASISRTS-HVNVVTLLGFCLEG--NNRALIYEFMP 214 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~--------------------~~e~~~l~~l~-HpnIv~l~~~~~~~--~~~~lV~E~~~ 214 (450)
.|.+.++||+|+||+||+|+. .+|+.++++++ ||||+++++++... ...++||||+.
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~ 115 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 115 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecC
Confidence 456778999999999999962 35688899985 99999999999754 56899999999
Q ss_pred CCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCC-CeEEeeccccccccCC
Q 013074 215 NGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDF-CPKISDFGLAKLCTTK 293 (450)
Q Consensus 215 ~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~-~~kl~DFGla~~~~~~ 293 (450)
+++|.... +.+++..+..++.||+.||+|||+ .+|+||||||+|||++.++ .+||+|||+++.....
T Consensus 116 ~~~L~~~~---------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 116 NTDFKQLY---------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp SCBGGGTT---------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred CCcHHHHh---------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 99987664 128999999999999999999995 9999999999999998655 6899999999876544
Q ss_pred CCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhh------
Q 013074 294 KGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQ------ 367 (450)
Q Consensus 294 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~------ 367 (450)
.. .....+|+.|+|||.+.+. ..++.++||||+||+++||++|+.||........ ....+......
T Consensus 184 ~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~---~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 184 QE----YNVRVASRYFKGPELLVDY-QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD---QLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp CC----CCSCCSCGGGCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH---HHHHHHHHHCHHHHHHH
T ss_pred Cc----ccccccCccccCcccccCC-CCCCcccchhhhhhhhHHhccCCCCCCCCchhHH---HHHHHHHHHCCchhhhh
Confidence 32 2345689999999998764 3579999999999999999999999976532111 00000000000
Q ss_pred --------hhhhh-h----------cccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 013074 368 --------DREFK-L----------LGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIE 411 (450)
Q Consensus 368 --------~~~~~-~----------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~ 411 (450)
..... . ..........++.++.+++.+||+.||++|||++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000 0 00011112234567899999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-38 Score=312.33 Aligned_cols=237 Identities=20% Similarity=0.233 Sum_probs=174.3
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEeC-----CceEE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLEG-----NNRAL 208 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~~-----~~~~l 208 (450)
|.+.++||+|+||+||+|+. .+|+.++++++|||||++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEE
Confidence 44567899999999999952 2468899999999999999998643 34466
Q ss_pred EEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 209 IYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 209 V~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
+++++.+|+|.+++... .+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||++.
T Consensus 100 i~~~~~gg~L~~~~~~~-------~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQ-------KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp EEEECCSEEHHHHHTTC-------CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeecCCchhhhcccc-------cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhc
Confidence 77788899999998542 29999999999999999999995 899999999999999999999999999987
Q ss_pred cccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCccchhhhhhhhhhhh
Q 013074 289 LCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEVYFPHWIYRHVEQD 368 (450)
Q Consensus 289 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~~~~~~i~~~~~~~ 368 (450)
..... .....||..|+|||.+.+. ..++.++|||||||++|+|++|+.||....... ....+.......
T Consensus 170 ~~~~~------~~~~~g~~~y~apE~~~~~-~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~----~~~~i~~~~~~~ 238 (348)
T d2gfsa1 170 HTDDE------MTGYVATRWYRAPEIMLNW-MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID----QLKLILRLVGTP 238 (348)
T ss_dssp CCTGG------GSSSCHHHHTSCHHHHTTC-SCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCC
T ss_pred ccCcc------cccccccccccCchhhcCC-ccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCC
Confidence 65433 2445689999999997764 357899999999999999999999996542110 000010000000
Q ss_pred -----------hhhh---hcccc-----cchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcc
Q 013074 369 -----------REFK---LLGVV-----TKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM--LQGS 416 (450)
Q Consensus 369 -----------~~~~---~~~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~ 416 (450)
.... ..... .......+.++.+++.+||+.||++|||++|+++. +++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 0000 00000 00011235678899999999999999999999974 5543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-38 Score=311.82 Aligned_cols=236 Identities=22% Similarity=0.228 Sum_probs=166.8
Q ss_pred hHhhhccccccceEEEEEEE-------------------------cchhhhhhhcCCCceeeeeeEEEe------CCceE
Q 013074 159 NSFKDKLGQGGFGGVYKGKL-------------------------LDGLASISRTSHVNVVTLLGFCLE------GNNRA 207 (450)
Q Consensus 159 ~~~~~~LG~G~fg~Vy~~~~-------------------------~~e~~~l~~l~HpnIv~l~~~~~~------~~~~~ 207 (450)
|.+.++||+|+||+||+|+. .+|+.++++++||||+++++++.. ....|
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 34567999999999999953 246788999999999999999964 36789
Q ss_pred EEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeEEeecccc
Q 013074 208 LIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPKISDFGLA 287 (450)
Q Consensus 208 lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~kl~DFGla 287 (450)
+||||+.+ ++.+.+. ..+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||++
T Consensus 99 iv~Ey~~~-~l~~~~~--------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 99 LVMELMDA-NLCQVIQ--------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEECCSE-EHHHHHT--------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEeccch-HHHHhhh--------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhh
Confidence 99999965 4444442 128999999999999999999995 89999999999999999999999999998
Q ss_pred ccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCcc--------chhh
Q 013074 288 KLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEV--------YFPH 359 (450)
Q Consensus 288 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~--------~~~~ 359 (450)
+....... .....+|+.|+|||++.+. .++.++||||+||+++||++|+.||.......... ..++
T Consensus 167 ~~~~~~~~----~~~~~~t~~y~aPE~l~~~--~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 167 RTAGTSFM----MTPYVVTRYYRAPEVILGM--GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp ------------------CCTTCCHHHHTTC--CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred hccccccc----cccccccccccChhhhcCC--CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHH
Confidence 86654332 2344689999999999874 78999999999999999999999996432110000 0000
Q ss_pred hhhh-------hhhhh-----------hhhhhcccccchhHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 013074 360 WIYR-------HVEQD-----------REFKLLGVVTKKENEIAKKMIIVGLWCIQARPYDRPPMNEVIEM 412 (450)
Q Consensus 360 ~i~~-------~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~ 412 (450)
++.. ..... ................+.++.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000 00000111122234567889999999999999999999999965
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-34 Score=285.32 Aligned_cols=257 Identities=21% Similarity=0.250 Sum_probs=174.9
Q ss_pred hhHhhhccccccceEEEEEEEc----------------------chhhhhhhcC-----------CCceeeeeeEEEeC-
Q 013074 158 TNSFKDKLGQGGFGGVYKGKLL----------------------DGLASISRTS-----------HVNVVTLLGFCLEG- 203 (450)
Q Consensus 158 ~~~~~~~LG~G~fg~Vy~~~~~----------------------~e~~~l~~l~-----------HpnIv~l~~~~~~~- 203 (450)
+|.+.++||+|+||+||+|+.. +|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~ 93 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecc
Confidence 3667889999999999999632 2455666554 67899999988653
Q ss_pred -CceEEEEEecCCCChh-hhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCC---
Q 013074 204 -NNRALIYEFMPNGSLE-KFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFC--- 278 (450)
Q Consensus 204 -~~~~lV~E~~~~gsL~-~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~--- 278 (450)
...+++++++..+... ........ ..+++..+..++.|++.||+|||+ ..+|+||||||+|||++.++.
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 94 PNGVHVVMVFEVLGENLLALIKKYEH----RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp TTEEEEEEEECCCCEEHHHHHHHTTT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred ccceeeeeeecccccccccccccccc----cCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence 4566777776554433 22222221 338899999999999999999995 478999999999999986653
Q ss_pred ---eEEeeccccccccCCCCccccccCCCCccccccccccccccCCCCccCchHhHHHHHHHHHcCCCCCCCCCCCCCcc
Q 013074 279 ---PKISDFGLAKLCTTKKGIVSSLLGARGTIGYIALEVFSRNFGEVSHKSDVYSFGMMIMELVGCKNNLDSGVDNSSEV 355 (450)
Q Consensus 279 ---~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~s~~sDiwSlGvvl~elltg~~p~~~~~~~~~~~ 355 (450)
++++|||.+....... ....||+.|+|||++... .++.++||||+||++++|++|+.||..........
T Consensus 168 ~~~~kl~dfg~s~~~~~~~------~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEHY------TNSIQTREYRSPEVLLGA--PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp EEEEEECCCTTCEETTBCC------CSCCSCGGGCCHHHHHTC--CCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred cceeeEeeccccccccccc------ccccccccccChhhcccc--CCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 8999999988654332 345699999999999864 78999999999999999999999987543221110
Q ss_pred chhhhhhh---hhhh-------h----h-------------------hhhhcccccchhHHHHHHHHHHHHHccccCCCC
Q 013074 356 YFPHWIYR---HVEQ-------D----R-------------------EFKLLGVVTKKENEIAKKMIIVGLWCIQARPYD 402 (450)
Q Consensus 356 ~~~~~i~~---~~~~-------~----~-------------------~~~~~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~ 402 (450)
.. ..+.. .+.. . . ...............+.++.+++.+||+.||.+
T Consensus 240 ~~-~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~ 318 (362)
T d1q8ya_ 240 DD-DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 318 (362)
T ss_dssp HH-HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred hh-HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence 00 00000 0000 0 0 000000011223466788999999999999999
Q ss_pred CCCHHHHHHH--hhcc--ccccCCCCCCCCC
Q 013074 403 RPPMNEVIEM--LQGS--TEALQIPPTPFLS 429 (450)
Q Consensus 403 RPs~~evl~~--L~~~--~~~l~~p~~p~~~ 429 (450)
|||++|+++. +++. .+....|+.+...
T Consensus 319 Rpta~e~L~Hp~f~~~~~~~~~~~p~~~~~~ 349 (362)
T d1q8ya_ 319 RADAGGLVNHPWLKDTLGMEEIRVPDRELYG 349 (362)
T ss_dssp CBCHHHHHTCGGGTTCTTCTTCCCTTSCTTC
T ss_pred CcCHHHHhcCcccCCCCCcccCCCCCcccCC
Confidence 9999999875 5532 3334455555553
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.79 E-value=2e-20 Score=166.32 Aligned_cols=140 Identities=18% Similarity=0.208 Sum_probs=101.1
Q ss_pred hhhccccccceEEEEEEEcc----------------------------------------hhhhhhhcCCCceeeeeeEE
Q 013074 161 FKDKLGQGGFGGVYKGKLLD----------------------------------------GLASISRTSHVNVVTLLGFC 200 (450)
Q Consensus 161 ~~~~LG~G~fg~Vy~~~~~~----------------------------------------e~~~l~~l~HpnIv~l~~~~ 200 (450)
+.++||+|+||+||+|+..+ |...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence 56789999999999996321 24456677899998877653
Q ss_pred EeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCCCCceEeeeeccccEEEcCCCCeE
Q 013074 201 LEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGCSTRILHFDIKPHNILLDQDFCPK 280 (450)
Q Consensus 201 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dikp~NIll~~~~~~k 280 (450)
..+++|||+++..+.. ++......++.|++.+|+|||+ .+|+||||||+|||++++ .++
T Consensus 84 ----~~~lvme~~~~~~~~~-------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR-------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp ----TTEEEEECCCCEEGGG-------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred ----CCEEEEEeeccccccc-------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence 2379999997755432 3334456789999999999995 899999999999999965 589
Q ss_pred EeeccccccccCCCCccccccCCCCcccccc------ccccccccCCCCccCchHhHHHHH
Q 013074 281 ISDFGLAKLCTTKKGIVSSLLGARGTIGYIA------LEVFSRNFGEVSHKSDVYSFGMMI 335 (450)
Q Consensus 281 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~s~~sDiwSlGvvl 335 (450)
|+|||+|........ ..|.. .+.+.+ .++.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~-----------~~~l~rd~~~~~~~f~r---~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGW-----------REILERDVRNIITYFSR---TYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTH-----------HHHHHHHHHHHHHHHHH---HHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCc-----------HHHHHHHHHHHHHHHcC---CCCCcccHHHHHHHH
Confidence 999999876543221 11111 122222 578899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.50 E-value=7.1e-05 Score=67.19 Aligned_cols=97 Identities=13% Similarity=0.044 Sum_probs=62.6
Q ss_pred hhhhhhhcC-CCceeeeeeEEEeCCceEEEEEecCCCChhhhhhcCCCCCCCccCCHHHHHHHHHHHHHHHHHhhcCC--
Q 013074 181 GLASISRTS-HVNVVTLLGFCLEGNNRALIYEFMPNGSLEKFVYNGDTSKPCQYLRWEKMYEIVIGIAKGLEYLHRGC-- 257 (450)
Q Consensus 181 e~~~l~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-- 257 (450)
|...+..+. +--+.+++.+..+++..++||+++++.++.+...... ....++.++++.+..||+..
T Consensus 59 E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~-----------~~~~~~~~l~~~l~~lH~~~~~ 127 (263)
T d1j7la_ 59 EKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQ-----------SPEKIIELYAECIRLFHSIDIS 127 (263)
T ss_dssp HHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCS-----------CHHHHHHHHHHHHHHHHTSCCT
T ss_pred HHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccccc-----------cHHHHHHHHHHHHHHHhccCcc
Confidence 344444442 3336778888888888999999998877754432110 11223344444445554310
Q ss_pred ------------------------------------------------------CCceEeeeeccccEEEcCCCCeEEee
Q 013074 258 ------------------------------------------------------STRILHFDIKPHNILLDQDFCPKISD 283 (450)
Q Consensus 258 ------------------------------------------------------~~~ivH~Dikp~NIll~~~~~~kl~D 283 (450)
...++|+|+.|.||++++++...|+|
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lID 207 (263)
T d1j7la_ 128 DCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFID 207 (263)
T ss_dssp TCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECC
T ss_pred ccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEee
Confidence 12479999999999999876677999
Q ss_pred ccccc
Q 013074 284 FGLAK 288 (450)
Q Consensus 284 FGla~ 288 (450)
|+.+.
T Consensus 208 we~a~ 212 (263)
T d1j7la_ 208 LGRSG 212 (263)
T ss_dssp CTTCE
T ss_pred chhcc
Confidence 98764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.83 E-value=0.00091 Score=59.25 Aligned_cols=29 Identities=21% Similarity=0.171 Sum_probs=25.1
Q ss_pred ceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 260 RILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 260 ~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
.++|+|+.|.||+++++..+.|+||+.+.
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 48999999999999987667899998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.23 E-value=0.0073 Score=57.22 Aligned_cols=31 Identities=19% Similarity=0.229 Sum_probs=26.2
Q ss_pred CceEeeeeccccEEEcCCCCeEEeeccccccc
Q 013074 259 TRILHFDIKPHNILLDQDFCPKISDFGLAKLC 290 (450)
Q Consensus 259 ~~ivH~Dikp~NIll~~~~~~kl~DFGla~~~ 290 (450)
..++|+|+.+.|||++++. ++|+||..+..-
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence 4699999999999999764 899999877643
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=91.86 E-value=0.077 Score=49.77 Aligned_cols=17 Identities=35% Similarity=0.503 Sum_probs=13.7
Q ss_pred ceEeeeeccccEEEcCC
Q 013074 260 RILHFDIKPHNILLDQD 276 (450)
Q Consensus 260 ~ivH~Dikp~NIll~~~ 276 (450)
.+.|+|+.+.||++.+.
T Consensus 219 v~CHnDL~~~NiL~~~~ 235 (395)
T d1nw1a_ 219 TFCHNDLQEGNILLPKA 235 (395)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred eEEecCCCcccEeeccc
Confidence 35799999999999653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=90.59 E-value=0.085 Score=47.59 Aligned_cols=31 Identities=23% Similarity=0.311 Sum_probs=27.3
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
..+++|+|+.++||+++++...-|+||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4689999999999999988777899998754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=81.01 E-value=0.76 Score=41.27 Aligned_cols=29 Identities=31% Similarity=0.354 Sum_probs=23.8
Q ss_pred CCceEeeeeccccEEEcCCCCeEEeeccccc
Q 013074 258 STRILHFDIKPHNILLDQDFCPKISDFGLAK 288 (450)
Q Consensus 258 ~~~ivH~Dikp~NIll~~~~~~kl~DFGla~ 288 (450)
..+++|+|+.+.|||++++ ..++||+-+.
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 4679999999999999754 4588998765
|